0001709048-24-000013.txt : 20240429 0001709048-24-000013.hdr.sgml : 20240429 20240429071526 ACCESSION NUMBER: 0001709048-24-000013 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 174 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBALFOUNDRIES Inc. CENTRAL INDEX KEY: 0001709048 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 980604079 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-40974 FILM NUMBER: 24886578 BUSINESS ADDRESS: STREET 1: 400 STONEBREAK ROAD EXTENSION CITY: MALTA STATE: NY ZIP: 12020 BUSINESS PHONE: (518) 305-9013 MAIL ADDRESS: STREET 1: 400 STONEBREAK ROAD EXTENSION CITY: MALTA STATE: NY ZIP: 12020 20-F 1 gfs-20231231.htm 20-F gfs-20231231
00017090482023FYfalse0.5P4Y00017090482023-01-012023-12-310001709048dei:BusinessContactMember2023-01-012023-12-3100017090482023-12-31xbrli:sharesiso4217:USD00017090482022-12-31iso4217:USDxbrli:shares00017090482022-01-012022-12-3100017090482021-01-012021-12-3100017090482021-12-3100017090482020-12-310001709048ifrs-full:IssuedCapitalMember2020-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2020-12-310001709048gfs:LoanFromShareholderMember2020-12-310001709048ifrs-full:RetainedEarningsMember2020-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2020-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310001709048ifrs-full:NoncontrollingInterestsMember2020-12-310001709048ifrs-full:IssuedCapitalMember2021-01-012021-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2021-01-012021-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2021-01-012021-12-310001709048gfs:LoanFromShareholderMember2021-01-012021-12-310001709048ifrs-full:RetainedEarningsMember2021-01-012021-12-310001709048ifrs-full:NoncontrollingInterestsMember2021-01-012021-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2021-01-012021-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-12-310001709048ifrs-full:IssuedCapitalMember2021-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2021-12-310001709048gfs:LoanFromShareholderMember2021-12-310001709048ifrs-full:RetainedEarningsMember2021-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2021-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310001709048ifrs-full:NoncontrollingInterestsMember2021-12-310001709048ifrs-full:IssuedCapitalMember2022-01-012022-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2022-01-012022-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2022-01-012022-12-310001709048ifrs-full:RetainedEarningsMember2022-01-012022-12-310001709048ifrs-full:NoncontrollingInterestsMember2022-01-012022-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2022-01-012022-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-12-310001709048ifrs-full:IssuedCapitalMember2022-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2022-12-310001709048gfs:LoanFromShareholderMember2022-12-310001709048ifrs-full:RetainedEarningsMember2022-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2022-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001709048ifrs-full:NoncontrollingInterestsMember2022-12-310001709048ifrs-full:IssuedCapitalMember2023-01-012023-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2023-01-012023-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2023-01-012023-12-310001709048ifrs-full:RetainedEarningsMember2023-01-012023-12-310001709048ifrs-full:NoncontrollingInterestsMember2023-01-012023-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2023-01-012023-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-01-012023-12-310001709048ifrs-full:IssuedCapitalMember2023-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2023-12-310001709048gfs:LoanFromShareholderMember2023-12-310001709048ifrs-full:RetainedEarningsMember2023-12-310001709048ifrs-full:ReserveOfCashFlowHedgesMember2023-12-310001709048ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-12-310001709048ifrs-full:EquityAttributableToOwnersOfParentMember2023-12-310001709048ifrs-full:NoncontrollingInterestsMember2023-12-310001709048gfs:DiscontinuedOperationsTampinesSingaporeFacilityMember2022-01-012022-12-310001709048srt:MaximumMembergfs:BuildingAndLeaseholdImprovementsMember2023-01-012023-12-310001709048srt:MinimumMemberus-gaap:EquipmentMember2023-01-012023-12-310001709048srt:MaximumMemberus-gaap:EquipmentMember2023-01-012023-12-310001709048ifrs-full:ComputerEquipmentMember2023-01-012023-12-310001709048srt:MinimumMembergfs:BuildingAndLeaseholdImprovementsMember2023-01-012023-12-310001709048gfs:ChangeInAccountingEstimateMembergfs:BuildingAndLeaseholdImprovementsMember2023-01-012023-12-310001709048srt:MinimumMember2023-01-012023-12-310001709048srt:MaximumMember2023-01-012023-12-310001709048gfs:RestrictedCashMember2021-12-310001709048gfs:RestrictedCashMember2022-12-310001709048gfs:GovernmentGrantsReceivableMember2021-12-310001709048gfs:GovernmentGrantsReceivableMember2022-01-012022-12-310001709048gfs:GovernmentGrantsReceivableMember2022-12-310001709048gfs:OtherReceivablesMember2021-12-310001709048gfs:OtherReceivablesMember2022-12-310001709048ifrs-full:LongtermBorrowingsMember2021-12-310001709048ifrs-full:LongtermBorrowingsMember2022-01-012022-12-310001709048ifrs-full:LongtermBorrowingsMember2022-12-310001709048ifrs-full:LeaseLiabilitiesMember2021-12-310001709048ifrs-full:LeaseLiabilitiesMember2022-01-012022-12-310001709048ifrs-full:LeaseLiabilitiesMember2022-12-310001709048ifrs-full:ClassesOfShareCapitalMember2021-12-310001709048ifrs-full:ClassesOfShareCapitalMember2022-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2021-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2022-01-012022-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2022-12-310001709048gfs:RestrictedCashMember2023-12-310001709048gfs:GovernmentGrantsReceivableMember2023-01-012023-12-310001709048gfs:GovernmentGrantsReceivableMember2023-12-310001709048gfs:OtherReceivablesMember2023-01-012023-12-310001709048ifrs-full:LongtermBorrowingsMember2023-01-012023-12-310001709048ifrs-full:LongtermBorrowingsMember2023-12-310001709048ifrs-full:LeaseLiabilitiesMember2023-01-012023-12-310001709048ifrs-full:LeaseLiabilitiesMember2023-12-310001709048ifrs-full:ClassesOfShareCapitalMember2023-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2023-01-012023-12-310001709048ifrs-full:AdditionalPaidinCapitalMember2023-12-310001709048country:US2023-12-310001709048country:US2022-12-310001709048country:SG2023-12-310001709048country:SG2022-12-310001709048gfs:OtherGeographicalAreaMember2023-12-310001709048gfs:OtherGeographicalAreaMember2022-12-310001709048ifrs-full:CurrentMember2023-12-310001709048ifrs-full:CurrentMember2022-12-310001709048ifrs-full:NotLaterThanOneMonthMember2023-12-310001709048ifrs-full:NotLaterThanOneMonthMember2022-12-310001709048ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2023-12-310001709048ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2022-12-310001709048ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2023-12-310001709048ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2022-12-310001709048ifrs-full:LandMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2021-12-310001709048ifrs-full:MachineryMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:LandMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2022-01-012022-12-310001709048ifrs-full:MachineryMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:LandMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2022-12-310001709048ifrs-full:MachineryMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:LandMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2023-01-012023-12-310001709048ifrs-full:MachineryMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:LandMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2023-12-310001709048ifrs-full:MachineryMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:LandMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:MachineryMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:LandMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:MachineryMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:LandMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:MachineryMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:LandMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:MachineryMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:LandMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:LeaseholdImprovementsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:MachineryMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:ComputerEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:ConstructionInProgressMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:LandMember2022-12-310001709048ifrs-full:LeaseholdImprovementsMember2022-12-310001709048ifrs-full:MachineryMember2022-12-310001709048ifrs-full:ComputerEquipmentMember2022-12-310001709048ifrs-full:ConstructionInProgressMember2022-12-310001709048ifrs-full:LandMember2023-12-310001709048ifrs-full:LeaseholdImprovementsMember2023-12-310001709048ifrs-full:MachineryMember2023-12-310001709048ifrs-full:ComputerEquipmentMember2023-12-310001709048ifrs-full:ConstructionInProgressMember2023-12-310001709048ifrs-full:CostOfSalesMember2023-01-012023-12-310001709048ifrs-full:CostOfSalesMember2022-01-012022-12-310001709048ifrs-full:CostOfSalesMember2021-01-012021-12-310001709048gfs:CostOfResearchAndDevelopmentMember2023-01-012023-12-310001709048gfs:CostOfResearchAndDevelopmentMember2022-01-012022-12-310001709048gfs:CostOfResearchAndDevelopmentMember2021-01-012021-12-310001709048ifrs-full:SellingGeneralAndAdministrativeExpenseMember2023-01-012023-12-310001709048ifrs-full:SellingGeneralAndAdministrativeExpenseMember2022-01-012022-12-310001709048ifrs-full:SellingGeneralAndAdministrativeExpenseMember2021-01-012021-12-310001709048ifrs-full:GrossCarryingAmountMembergfs:TechnologyLicensesAndSimilarRightsMember2021-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2021-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2021-12-310001709048ifrs-full:GoodwillMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2021-12-310001709048ifrs-full:GrossCarryingAmountMembergfs:TechnologyLicensesAndSimilarRightsMember2022-01-012022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-01-012022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-01-012022-12-310001709048ifrs-full:GoodwillMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2022-01-012022-12-310001709048ifrs-full:GrossCarryingAmountMembergfs:TechnologyLicensesAndSimilarRightsMember2022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2022-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-12-310001709048ifrs-full:GoodwillMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2022-12-310001709048ifrs-full:GrossCarryingAmountMembergfs:TechnologyLicensesAndSimilarRightsMember2023-01-012023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-01-012023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-01-012023-12-310001709048ifrs-full:GoodwillMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-12-310001709048ifrs-full:GrossCarryingAmountMembergfs:TechnologyLicensesAndSimilarRightsMember2023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2023-12-310001709048ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-12-310001709048ifrs-full:GoodwillMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2023-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2021-12-310001709048ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-01-012022-12-310001709048ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-12-310001709048ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2022-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-01-012023-12-310001709048ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-01-012023-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-12-310001709048ifrs-full:GoodwillMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2023-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMember2022-12-310001709048ifrs-full:ComputerSoftwareMember2022-12-310001709048ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2022-12-310001709048ifrs-full:GoodwillMember2022-12-310001709048ifrs-full:OtherIntangibleAssetsMember2022-12-310001709048gfs:TechnologyLicensesAndSimilarRightsMember2023-12-310001709048ifrs-full:ComputerSoftwareMember2023-12-310001709048ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2023-12-310001709048ifrs-full:GoodwillMember2023-12-310001709048ifrs-full:OtherIntangibleAssetsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2022-01-012022-12-31iso4217:EURiso4217:USDxbrli:pure0001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2022-01-012022-12-31iso4217:SGDgfs:uSD0001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2022-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2022-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2022-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2022-01-012022-12-31iso4217:JPYiso4217:USD0001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048ifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048srt:MinimumMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048srt:MaximumMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2022-01-012022-12-310001709048ifrs-full:CurrencySwapContractMembersrt:MinimumMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencySwapContractMembersrt:MaximumMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-01-012022-12-310001709048srt:MinimumMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048srt:MaximumMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2022-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2022-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2022-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:EuroForwardContractsMember2023-01-012023-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:SingaporeDollarForwardContractsMember2023-01-012023-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:JapaneseYenForwardContractsMemberifrs-full:CurrencyRiskMember2023-01-012023-12-310001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:ForwardContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048ifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048srt:MinimumMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048srt:MaximumMemberifrs-full:CurrencyRiskMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencySwapContractMemberifrs-full:CurrencyRiskMember2023-01-012023-12-310001709048ifrs-full:CurrencySwapContractMembersrt:MinimumMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencySwapContractMembersrt:MaximumMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-01-012023-12-310001709048srt:MinimumMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048srt:MaximumMemberifrs-full:CurrencyRiskMembergfs:CrossCurrencySwapsSingaporeMember2023-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2023-12-310001709048gfs:CommoditySwapMemberifrs-full:CurrencyRiskMember2023-01-012023-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencyRiskMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencyRiskMember2023-12-310001709048ifrs-full:CurrencyRiskMember2023-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:ForwardContractsCurrencySwapMember2022-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2022-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherNoncurrentFinancialAssetsMember2022-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:InterestRateSwapContractMember2022-12-310001709048ifrs-full:CurrencySwapContractMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencySwapContractMember2022-12-310001709048ifrs-full:CurrencySwapContractMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencySwapContractMember2022-12-310001709048gfs:CommoditySwapMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:CommoditySwapMember2022-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMembergfs:CommoditySwapMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:CommoditySwapMember2022-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:ForwardContractsCurrencySwapMember2022-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2022-12-310001709048gfs:OtherCurrentFinancialAssetsMember2022-12-310001709048gfs:OtherNoncurrentFinancialAssetsMember2022-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMember2022-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMember2022-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:ForwardContractsCurrencySwapMember2023-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2023-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherNoncurrentFinancialAssetsMember2023-12-310001709048ifrs-full:InterestRateSwapContractMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:InterestRateSwapContractMember2023-12-310001709048ifrs-full:CurrencySwapContractMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMemberifrs-full:CurrencySwapContractMember2023-12-310001709048ifrs-full:CurrencySwapContractMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMemberifrs-full:CurrencySwapContractMember2023-12-310001709048gfs:CommoditySwapMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:CommoditySwapMember2023-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMembergfs:CommoditySwapMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:CommoditySwapMember2023-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:ForwardContractsCurrencySwapMember2023-12-310001709048gfs:ForwardContractsCurrencySwapMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:ForwardContractsCurrencySwapMember2023-12-310001709048gfs:CommoditySwapMembergfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMembergfs:CommoditySwapMember2023-12-310001709048gfs:CommoditySwapMembergfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMembergfs:CommoditySwapMember2023-12-310001709048gfs:OtherCurrentFinancialAssetsMember2023-12-310001709048gfs:OtherNoncurrentFinancialAssetsMember2023-12-310001709048gfs:OtherCurrentFinancialLiabilitiesMember2023-12-310001709048gfs:OtherNoncurrentFinancialLiabilitiesMember2023-12-310001709048ifrs-full:CashFlowHedgesMember2023-01-012023-12-310001709048ifrs-full:CashFlowHedgesMember2022-01-012022-12-310001709048gfs:ForwardContractsCurrencySwapMember2022-01-012022-12-310001709048ifrs-full:InterestRateSwapContractMember2022-01-012022-12-310001709048ifrs-full:CurrencySwapContractMember2022-01-012022-12-310001709048gfs:CommoditySwapMember2022-01-012022-12-310001709048gfs:ForwardContractsCurrencySwapMember2023-01-012023-12-310001709048ifrs-full:InterestRateSwapContractMember2023-01-012023-12-310001709048ifrs-full:CurrencySwapContractMember2023-01-012023-12-310001709048gfs:FinanceExpenseMemberifrs-full:CurrencySwapContractMember2023-01-012023-12-310001709048ifrs-full:CurrencySwapContractMembergfs:OtherIncomeExpenseMember2023-01-012023-12-310001709048gfs:CommoditySwapMember2023-01-012023-12-310001709048gfs:CostOfRevenueAndOperatingExpensesMembergfs:CommoditySwapMember2023-01-012023-12-310001709048gfs:CommoditySwapMembergfs:OtherIncomeExpenseMember2023-01-012023-12-310001709048gfs:ForwardContractsCurrencySwapMember2021-01-012021-12-310001709048gfs:DeferredFinancingCostsNettingMember2023-12-310001709048gfs:DeferredFinancingCostsNettingMember2022-12-310001709048gfs:A2018ToolEquipmentPurchaseAndLeaseFinancingMember2023-12-310001709048gfs:A2018ToolEquipmentPurchaseAndLeaseFinancingMember2022-12-310001709048gfs:A2019ToolEquipmentPurchaseAndLeaseFinancingMember2023-12-310001709048gfs:A2019ToolEquipmentPurchaseAndLeaseFinancingMember2022-12-310001709048gfs:USDTermLoanAMember2023-12-310001709048gfs:USDTermLoanAMember2022-12-310001709048gfs:EURTermLoanAMember2023-12-310001709048gfs:EURTermLoanAMember2022-12-310001709048gfs:A2019USDDresdenEquipmentFinancingMember2023-12-310001709048gfs:A2019USDDresdenEquipmentFinancingMember2022-12-310001709048gfs:A2020USDEquipmentFinancingMember2023-12-310001709048gfs:A2020USDEquipmentFinancingMember2022-12-310001709048gfs:A2019EURDresdenEquipmentFinancingMember2023-12-310001709048gfs:A2019EURDresdenEquipmentFinancingMember2022-12-310001709048gfs:VariousFinancingMember2023-12-310001709048gfs:VariousFinancingMember2022-12-310001709048gfs:A2019USDDresdenEquipmentFinancingNonCurrentMember2023-12-310001709048gfs:A2019EURDresdenEquipmentFinancingNoncurrentMember2023-12-310001709048gfs:A2021SGDEDBLoanMember2023-12-310001709048gfs:A2021SGDEDBLoanMember2022-12-3100017090482018-03-02gfs:bank00017090482018-03-022018-03-020001709048gfs:EquipmentsMember2018-03-0200017090482019-01-2100017090482019-01-212019-01-210001709048gfs:A2019EURDresdenEquipmentFinancingMember2019-10-3100017090482020-04-232020-04-230001709048gfs:A2021SGDEDBLoanMember2021-09-03iso4217:SGD0001709048gfs:A2021SGDEDBLoanMember2021-09-032021-09-030001709048gfs:A2021SGDEDBLoanMember2023-01-012023-12-310001709048gfs:A2021SGDEDBLoanMember2022-01-012022-12-310001709048gfs:DeferredIncomeFromGovernmentGrantsMembergfs:A2021SGDEDBLoanMember2023-12-310001709048gfs:DeferredIncomeFromGovernmentGrantsMembergfs:A2021SGDEDBLoanMember2022-12-310001709048gfs:FiveYearRevolvingAndLetterOfCreditFacilitiesAgreementMember2021-10-132021-10-130001709048gfs:FiveYearRevolvingAndLetterOfCreditFacilitiesAgreementMember2021-10-130001709048gfs:CitibankRevolvingCreditFacilityMember2023-12-310001709048gfs:CitibankRevolvingCreditFacilityMember2022-12-310001709048gfs:OtherBorrowingsMember2023-12-310001709048gfs:OtherBorrowingsMember2022-12-310001709048ifrs-full:NotLaterThanOneYearMember2023-12-310001709048ifrs-full:NotLaterThanOneYearMember2022-12-310001709048ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2023-12-310001709048ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001709048ifrs-full:LaterThanFiveYearsMember2023-12-310001709048ifrs-full:LaterThanFiveYearsMember2022-12-310001709048srt:MinimumMember2022-01-012022-12-310001709048srt:MaximumMember2022-01-012022-12-310001709048ifrs-full:OrdinarySharesMember2021-10-270001709048gfs:OrdinarySharesInPrivatePlacementMember2021-10-270001709048ifrs-full:OrdinarySharesMember2023-12-310001709048ifrs-full:PreferenceSharesMember2023-12-3100017090482021-09-122021-09-120001709048gfs:WaterFabricationMember2023-01-012023-12-310001709048gfs:WaterFabricationMember2022-01-012022-12-310001709048gfs:WaterFabricationMember2021-01-012021-12-310001709048gfs:EngineeringAndOtherPreFabricationServicesMember2023-01-012023-12-310001709048gfs:EngineeringAndOtherPreFabricationServicesMember2022-01-012022-12-310001709048gfs:EngineeringAndOtherPreFabricationServicesMember2021-01-012021-12-310001709048ifrs-full:GoodsOrServicesTransferredOverTimeMember2023-01-012023-12-310001709048ifrs-full:GoodsOrServicesTransferredOverTimeMember2022-01-012022-12-310001709048ifrs-full:GoodsOrServicesTransferredOverTimeMember2021-01-012021-12-310001709048ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2023-01-012023-12-310001709048ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2022-01-012022-12-310001709048ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2021-01-012021-12-310001709048ifrs-full:ShareOptionsMember2023-01-012023-12-310001709048ifrs-full:ShareOptionsMember2022-01-012022-12-310001709048ifrs-full:ShareOptionsMember2021-01-012021-12-310001709048ifrs-full:ShareOptionsMemberifrs-full:AdditionalPaidinCapitalMember2023-12-310001709048ifrs-full:ShareOptionsMemberifrs-full:AdditionalPaidinCapitalMember2022-12-310001709048gfs:ShareIncentivePlan2018Member2023-12-310001709048gfs:ShareIncentivePlan2018Member2022-12-310001709048gfs:EquityCompensationPlan2021Member2023-12-310001709048gfs:EquityCompensationPlan2021Member2022-12-310001709048ifrs-full:RestrictedShareUnitsMember2023-12-310001709048ifrs-full:RestrictedShareUnitsMember2023-01-012023-12-310001709048gfs:RestrictedShareUnitsRSUMember2021-12-310001709048gfs:RestrictedShareUnitsRSUMember2022-01-012022-12-310001709048gfs:RestrictedShareUnitsRSUMember2022-12-310001709048gfs:RestrictedShareUnitsRSUMember2023-01-012023-12-310001709048gfs:RestrictedShareUnitsRSUMember2023-12-310001709048ifrs-full:RestrictedShareUnitsMember2022-12-310001709048ifrs-full:RestrictedShareUnitsMember2021-12-310001709048srt:MinimumMember2023-01-012023-12-310001709048srt:MaximumMember2023-01-012023-12-310001709048gfs:PerformanceShareUnitsPSUMember2021-12-310001709048gfs:PerformanceShareUnitsPSUMember2022-01-012022-12-310001709048gfs:PerformanceShareUnitsPSUMember2022-12-310001709048gfs:PerformanceShareUnitsPSUMember2023-01-012023-12-310001709048gfs:PerformanceShareUnitsPSUMember2023-12-310001709048srt:MaximumMemberifrs-full:ShareOptionsMember2017-01-012017-12-310001709048srt:MaximumMemberifrs-full:ShareOptionsMember2019-01-012019-12-31utr:Y0001709048ifrs-full:ShareOptionsMember2019-12-310001709048srt:MinimumMemberifrs-full:ShareOptionsMember2019-01-012019-12-310001709048ifrs-full:ShareOptionsMember2019-01-012019-12-310001709048ifrs-full:ShareOptionsMember2021-04-012021-06-300001709048gfs:ExercisePriceRangeOneMember2023-12-310001709048gfs:ExercisePriceRangeOneMember2023-01-012023-12-310001709048gfs:EmployeeSharePurchasePlanMember2023-12-310001709048gfs:EmployeeSharePurchasePlanMember2023-01-012023-12-310001709048gfs:EmployeeStockPurchasePlanMember2023-01-012023-12-310001709048gfs:EmployeeStockPurchasePlanMember2023-12-310001709048gfs:DiscontinuedOperationsTampinesSingaporeFacilityMember2021-01-012021-12-310001709048ifrs-full:OtherDisposalsOfAssetsMembergfs:DiscontinuedOperationsTampinesSingaporeFacilityMember2023-01-012023-01-310001709048gfs:DiscontinuedOperationsTampinesSingaporeFacilityMember2022-12-310001709048gfs:AcceleratedDepreciationOnPropertyPlantAndEquipmentMember2023-12-310001709048gfs:AcceleratedDepreciationOnPropertyPlantAndEquipmentMember2022-12-310001709048gfs:LossesCreditsAndInvestmentAllowancesAvailableForOffsettingAgainstFutureTaxableIncomeMember2023-12-310001709048gfs:LossesCreditsAndInvestmentAllowancesAvailableForOffsettingAgainstFutureTaxableIncomeMember2022-12-310001709048gfs:AccruedExpensesTaxDifferenceMember2023-12-310001709048gfs:AccruedExpensesTaxDifferenceMember2022-12-310001709048gfs:InventoryTaxDifferenceMember2023-12-310001709048gfs:InventoryTaxDifferenceMember2022-12-310001709048gfs:OtherComprehensiveIncomeEffectTaxDifferenceMember2023-12-310001709048gfs:OtherComprehensiveIncomeEffectTaxDifferenceMember2022-12-310001709048gfs:CurrencyEffectTaxDifferenceMember2023-12-310001709048gfs:CurrencyEffectTaxDifferenceMember2022-12-310001709048ifrs-full:OtherTemporaryDifferencesMember2023-12-310001709048ifrs-full:OtherTemporaryDifferencesMember2022-12-310001709048country:DE2023-01-012023-12-310001709048country:DE2022-01-012022-12-310001709048gfs:UnusedCapitalAllowancesMember2023-12-310001709048gfs:UnusedCapitalAllowancesMember2022-12-310001709048ifrs-full:UnusedTaxLossesMember2023-12-310001709048ifrs-full:UnusedTaxLossesMember2022-12-310001709048gfs:UnusedInvestmentAllowancesMember2023-12-310001709048gfs:UnusedInvestmentAllowancesMember2022-12-310001709048country:USifrs-full:UnusedTaxCreditsMember2023-12-310001709048country:USifrs-full:UnusedTaxCreditsMember2022-12-310001709048gfs:UnusedTaxCreditsDueToExpireMembercountry:US2023-12-310001709048stpr:CAifrs-full:UnusedTaxCreditsMember2023-12-310001709048stpr:CAifrs-full:UnusedTaxCreditsMember2022-12-310001709048gfs:OtherStatesMemberifrs-full:UnusedTaxCreditsMember2023-12-310001709048gfs:OtherStatesMemberifrs-full:UnusedTaxCreditsMember2022-12-310001709048gfs:UnusedResearchAndDevelopmentTaxCreditsMembercountry:US2023-12-310001709048gfs:UnusedResearchAndDevelopmentTaxCreditsMembercountry:US2022-12-310001709048gfs:UnusedResearchAndDevelopmentTaxCreditsMemberstpr:CA2023-12-310001709048gfs:UnusedResearchAndDevelopmentTaxCreditsMemberstpr:CA2022-12-310001709048stpr:NYgfs:NonrefundableNewYorkEmpireZoneMember2023-12-310001709048stpr:NYgfs:NonrefundableNewYorkEmpireZoneMember2022-12-310001709048gfs:TexasMinnesotaVermontNorthCarolinaAndNewJerseyMemberifrs-full:UnusedTaxCreditsMember2023-12-310001709048gfs:TexasMinnesotaVermontNorthCarolinaAndNewJerseyMemberifrs-full:UnusedTaxCreditsMember2022-12-310001709048srt:EuropeMember2023-12-310001709048srt:EuropeMember2022-12-310001709048ifrs-full:JointVenturesWhereEntityIsVenturerMember2023-12-310001709048ifrs-full:JointVenturesWhereEntityIsVenturerMember2022-12-310001709048ifrs-full:JointVenturesWhereEntityIsVenturerMember2023-01-012023-12-310001709048ifrs-full:JointVenturesWhereEntityIsVenturerMember2022-01-012022-12-310001709048ifrs-full:JointVenturesWhereEntityIsVenturerMember2021-01-012021-12-310001709048ifrs-full:JointControlOrSignificantInfluenceMember2023-01-012023-12-310001709048ifrs-full:JointControlOrSignificantInfluenceMember2022-01-012022-12-310001709048ifrs-full:JointControlOrSignificantInfluenceMember2021-01-012021-12-310001709048gfs:LoanFromShareholderMember2021-10-032021-10-030001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShortTermBenefitsMember2023-01-012023-12-310001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShortTermBenefitsMember2022-01-012022-12-310001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShortTermBenefitsMember2021-01-012021-12-310001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShareBasedPaymentsMember2023-01-012023-12-310001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShareBasedPaymentsMember2022-01-012022-12-310001709048gfs:ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShareBasedPaymentsMember2021-01-012021-12-310001709048gfs:BoardOfDirectorsMember2023-01-012023-12-310001709048gfs:BoardOfDirectorsMember2022-01-012022-12-310001709048gfs:BoardOfDirectorsMember2021-01-012021-12-310001709048ifrs-full:CurrencyRiskMemberus-gaap:EurodollarMember2022-12-310001709048currency:JPYifrs-full:CurrencyRiskMember2022-12-310001709048currency:SGDifrs-full:CurrencyRiskMember2022-12-310001709048ifrs-full:CurrencyRiskMemberus-gaap:EurodollarMember2023-12-310001709048currency:JPYifrs-full:CurrencyRiskMember2023-12-310001709048currency:SGDifrs-full:CurrencyRiskMember2023-12-310001709048gfs:TenLargestCustomersMembergfs:CustomerRiskMember2023-12-310001709048gfs:TenLargestCustomersMembergfs:CustomerRiskMember2022-12-310001709048ifrs-full:CreditRiskMember2022-12-310001709048ifrs-full:CreditRiskMemberifrs-full:CurrentMember2022-12-310001709048ifrs-full:CreditRiskMemberifrs-full:NotLaterThanOneMonthMember2022-12-310001709048ifrs-full:CreditRiskMemberifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2022-12-310001709048ifrs-full:CreditRiskMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanFourMonthsMember2022-12-310001709048ifrs-full:LaterThanFourMonthsMemberifrs-full:CreditRiskMember2022-12-310001709048ifrs-full:CreditRiskMember2023-12-310001709048ifrs-full:CreditRiskMemberifrs-full:CurrentMember2023-12-310001709048ifrs-full:CreditRiskMemberifrs-full:NotLaterThanOneMonthMember2023-12-310001709048ifrs-full:CreditRiskMemberifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2023-12-310001709048ifrs-full:CreditRiskMemberifrs-full:LaterThanThreeMonthsAndNotLaterThanFourMonthsMember2023-12-310001709048ifrs-full:LaterThanFourMonthsMemberifrs-full:CreditRiskMember2023-12-310001709048ifrs-full:LiquidityRiskMember2022-12-310001709048ifrs-full:NotLaterThanOneYearMemberifrs-full:LiquidityRiskMember2022-12-310001709048ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberifrs-full:LiquidityRiskMember2022-12-310001709048ifrs-full:LaterThanFiveYearsMemberifrs-full:LiquidityRiskMember2022-12-310001709048ifrs-full:LiquidityRiskMember2023-12-310001709048ifrs-full:NotLaterThanOneYearMemberifrs-full:LiquidityRiskMember2023-12-310001709048ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberifrs-full:LiquidityRiskMember2023-12-310001709048ifrs-full:LaterThanFiveYearsMemberifrs-full:LiquidityRiskMember2023-12-310001709048ifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2022-12-310001709048ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMembergfs:CashEquivalentMember2022-12-310001709048ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2022-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2022-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:DebtSecuritiesMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001709048ifrs-full:DebtSecuritiesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:DebtSecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:DerivativesMemberifrs-full:RecurringFairValueMeasurementMember2022-12-310001709048ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001709048ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMember2022-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMember2022-12-310001709048ifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2023-12-310001709048ifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMembergfs:CashEquivalentMember2023-12-310001709048ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2023-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMembergfs:CashEquivalentMember2023-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMember2023-12-310001709048ifrs-full:TradingEquitySecuritiesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:TradingEquitySecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:DebtSecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:DebtSecuritiesMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:Level1OfFairValueHierarchyMember2023-12-310001709048ifrs-full:DebtSecuritiesMemberifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:DebtSecuritiesMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:DerivativesMemberifrs-full:RecurringFairValueMeasurementMember2023-12-310001709048ifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMemberifrs-full:Level1OfFairValueHierarchyMember2023-12-310001709048ifrs-full:Level2OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMember2023-12-310001709048ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:RecurringFairValueMeasurementMemberifrs-full:DerivativesMember2023-12-310001709048ifrs-full:LongtermBorrowingsMember2023-12-310001709048ifrs-full:LongtermBorrowingsMember2022-12-310001709048gfs:PILOTBondsLettersOfCreditMember2023-12-310001709048gfs:PILOTBondsLettersOfCreditMember2022-12-3100017090482021-04-280001709048country:US2023-01-012023-12-310001709048country:US2022-01-012022-12-310001709048country:US2021-01-012021-12-310001709048gfs:EuropeTheMiddleEastAndAfricaMember2023-01-012023-12-310001709048gfs:EuropeTheMiddleEastAndAfricaMember2022-01-012022-12-310001709048gfs:EuropeTheMiddleEastAndAfricaMember2021-01-012021-12-310001709048gfs:OtherGeographicalAreaMember2023-01-012023-12-310001709048gfs:OtherGeographicalAreaMember2022-01-012022-12-310001709048gfs:OtherGeographicalAreaMember2021-01-012021-12-310001709048country:US2023-12-310001709048country:US2022-12-310001709048country:DE2023-12-310001709048country:DE2022-12-310001709048country:SG2023-12-310001709048country:SG2022-12-310001709048gfs:OtherGeographicalAreaMember2023-12-310001709048gfs:OtherGeographicalAreaMember2022-12-310001709048gfs:CustomerAMember2023-01-012023-12-310001709048gfs:CustomerAMember2022-01-012022-12-310001709048gfs:CustomerAMember2021-01-012021-12-310001709048gfs:CustomerBMember2023-01-012023-12-310001709048gfs:CustomerBMember2022-01-012022-12-310001709048gfs:CustomerBMember2021-01-012021-12-310001709048gfs:CustomerAMember2023-12-310001709048gfs:CustomerAMember2022-12-310001709048gfs:CustomerBMember2023-12-310001709048gfs:CustomerBMember2022-12-310001709048gfs:SOIWafersMembergfs:SupplierRiskMember2023-12-310001709048gfs:SOIWafersMembergfs:SupplierRiskMember2022-12-310001709048gfs:SOIWafersMembergfs:SupplierRiskMember2021-12-310001709048gfs:SOIWafersMember2023-12-310001709048gfs:SOIWafersMember2022-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________________
FORM 20-F
_________________________
oREGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
oSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
For the transition period from                to                
Commission file number 001-40974
_________________________
GLOBALFOUNDRIES Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________
N/ACayman Islands
(Translation of Registrant’s Name Into English)(Jurisdiction of Incorporation or Organization)
400 Stonebreak
Road Extension
Malta, NY 12020
(518) 305-9013
(Address of Principal Executive Offices)
John Hollister, Chief Financial Officer
400 Stonebreak Road Extension
Malta, NY 12020
(518) 305-9013
E-mail: ir@gf.com
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Ordinary shares, par value US$0.02 per shareGFSThe NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act:
_________________________
None
(Title of Class)
______________
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
(Title of Class)
______________
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.
As of December 31, 2023, 553,548,190 ordinary shares, par value US$0.02 per share, were outstanding.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or (15)(d) of the Securities Exchange Act of 1934. Yes No
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer  Accelerated Filer Non-Accelerated FilerEmerging Growth Company
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
U.S. GAAP
International Financial Reporting Standards as issued by the International Accounting Standards Board ☑
Other
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.
Item 17 Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No



TABLE OF CONTENTS
GlobalFoundries Inc.
Page
ITEM 16B.
CODE OF ETHICS
i


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Certain statements in this Annual Report on Form 20-F (the “Annual Report”) are, or may be deemed to be, “forward-looking statements” within the meaning of U.S. securities laws. These forward-looking statements are based on current expectations, estimates, forecasts, and projections. These forward-looking statements appear in a number of places throughout this Annual Report including, but not limited to “Risk Factors,” “Business Overview,” and “Results of Operations.” Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall” and variations of these terms and similar expressions are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and our actual results of operations, financial condition and liquidity, and the development of the industries in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Annual Report. Important factors that could cause those differences include, but are not limited to:
general global economic and geopolitical conditions;
our ability to manage reduced demand and average selling prices (“ASPs”) in a prolonged inflationary environment;
the cyclical nature, volatility and seasonality of the semiconductor and microelectronics industry;
our ability to secure and maintain design wins, particularly single-source design wins, and manage our long-term supply agreements (“LTAs”);
our business and operating strategies and plans for the development of existing and new businesses, ability to implement such strategies and plans and expected time;
our reliance on a small number of customers;
our future business development, financial condition, and results of operations;
expected changes in our revenue, costs or expenditures;
our assumptions and estimates regarding design wins;
our expectations regarding demand for and market acceptance of our products and services;
our expectations regarding our relationships with customers, contract manufacturers, component suppliers, third-party service providers, strategic partners and other stakeholders;
our expectations regarding our capacity to develop, manufacture and deliver semiconductor products in fulfillment of our contractual commitments;
our ability to conduct our manufacturing operations without disruptions;
our ability to manage our capacity and production facilities effectively;
our ability to develop new technologies successfully and remain a technological leader;
our ability to maintain control over expansion and facility modifications;
our ability to generate growth or profitable growth;
our ability to maintain and protect our intellectual property;
our ability to hire and maintain qualified personnel;
our effective tax rate or tax liability;
our dividend policy;
our ability to acquire required equipment and supplies necessary to meet customer demand;
the increased competition from other companies and our ability to retain and increase our market share;
developments in, or changes to, laws, regulations, governmental policies, incentives and taxation affecting our operations relating to our industry; and
assumptions underlying or related to any of the foregoing.
We caution you that the foregoing list does not contain all of the forward-looking statements made in this Annual Report.
Forward-looking statements include, but are not limited to, statements regarding our strategy and future plans, future business condition and financial results, our capital expenditure plans, our capacity management plans, expectations as to the commercial production using more advanced technologies, technological upgrades, investment in research and
1


development, future market demand, future regulatory or other developments in our industry, business expansion plans or new investments as well as business acquisitions and financing plans. Please see “Item 3. Key Information—D. Risk Factors” for a further discussion of certain factors that may cause actual results to differ materially from those indicated by our forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. In any event, these statements speak only as of their dates, and we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.
You should carefully consider the “Risk Factors” and subsequent public statements, or reports filed with or furnished to the SEC, before making any investment decision with respect to our securities. If any of these trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.
As used in this Annual Report, all references to “we”, “us”, “our”, the “Company” and "GF” are to GlobalFoundries Inc. and its consolidated subsidiaries.
2


PART I
ITEM 1.    IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS
Not applicable.
ITEM 2.    OFFER STATISTICS AND EXPECTED TIMETABLE
Not applicable.
ITEM 3.    KEY INFORMATION
A.Reserved.
B.Capitalization and Indebtedness
Not applicable.
C.Reasons for the Offer and Use of Proceeds
Not applicable.
D.Risk Factors
The following important factors, and those factors described in other reports submitted to, or filed with, the U.S. Securities and Exchange Commission (“SEC”), among other factors, could affect our actual results and could cause our actual results to differ materially from those expressed in any forward-looking statements made by us or on our behalf, and such factors may adversely affect our business and financial status and therefore the value of your investment:
Risk Factors Summary
Risks Related to our Business and Industry
General global economic and geopolitical conditions could materially and adversely affect our results of operations, financial condition, business and prospects.
Reductions in demand and ASPs for our customers’ end products (e.g., consumer electronics) and a prolonged inflationary environment may decrease demand for our products and services, and could materially and adversely affect our results of operations, financial condition, business and prospects.
The cyclical nature and seasonality of the semiconductor industry and periodic overcapacity make us vulnerable to significant and sometimes prolonged economic downturns.
Securing and maintaining design wins, in particular single-sourced awards, and managing our long term agreement (“LTAs”) may present challenges to our business in differing demand environments.
We depend on a small number of customers for a significant portion of our revenue and any loss of this or our other key customers, including potentially through further customer consolidation, could result in significant declines in our revenue.
We rely on a complex silicon supply chain and breakdowns in that chain could affect our ability to produce our products and could materially and adversely affect our results of operations, financial condition, business and prospects.
If we are unable to attract customers with our technology, respond to fast-changing semiconductor market dynamics or maintain our leadership in product quality, we will become less competitive.
Overcapacity in the semiconductor industry may reduce our revenue, earnings and margins.
If we are unable to compete effectively with other sophisticated players in the highly competitive foundry segment of the semiconductor industry, we may lose customers and our profit margins and earnings may decrease.
Our competitors and Integrated Device Manufacturers (“IDMs”) have announced expansions and may continue to expand in the United States and Europe, which could materially and adversely affect our competitive position.
The semiconductor industry is capital-intensive and, if we are unable to invest the necessary capital to operate and grow our business, we may not remain competitive.
We receive subsidies and grants in certain countries and regions in which we operate, and a reduction in the amount of governmental funding available to us or demands for repayment could increase our costs and affect our results of operations.
3


Strong government support in China for capacity expansion, combined with strained economic relations with that country, could lead to underutilization or significant average selling price erosion for our fabrication facilities (“fabs”).
We may not be able to implement our planned growth and development or maintain the differentiation of our solutions if we are unable to recruit and retain skilled technical personnel, key executives and managers.
Sales to government entities and highly regulated organizations are subject to a number of challenges and added risks, and our failure to comply with these heightened compliance requirements, or effectively manage these challenges or risks, could impact our operations and financial results.
The implementation of our restructuring plan is ongoing, and it is possible that we may not achieve all of the plan’s expected benefits and, if we do not, the plan may have a material adverse effect on our business, operations, financial condition and results of operations.
Risks Related to Manufacturing, Operations and Expansion
If we are unable to manage our capacity and production facilities effectively, our competitiveness may be weakened.
Our manufacturing processes are highly complex, costly and potentially vulnerable to impurities and other disruptions and cost increases that can significantly increase our costs and delay product shipments to our customers.
We are subject to risks associated with the development and implementation of new manufacturing technologies.
Our profit margin may substantially decline if we are unable to continually improve our manufacturing yields, maintain high shipment utilization or fail to optimize the process technology mix of our wafer production.
Failure to adjust our supply chain volume due to changing market conditions or failure to estimate our customers’ demand could adversely affect our sales and/or our gross margin and could result in additional charges for obsolete or excess inventories or non-cancelable purchase commitments.
If we are unable to obtain adequate supplies of raw materials in a timely manner and at commercially reasonable prices, our revenue and profitability may decline.
The risk of cyberattacks and other data security breaches requires us to incur significant costs to maintain the security of our networks and data, and, in the event of such breaches, may expose us to liability, adversely affect our operations, damage our reputation, and affect our net revenue and profitability, and our efforts to combat breach and misuse of our systems and unauthorized access to our data may not be successful.
Aging infrastructure and power grids and risks to the supply of natural gas, electricity or fresh water could interrupt production.
If we are unable to successfully deploy artificial intelligence and machine learning (“AI/ML”) across our products and services and our business operations and adequately anticipate and account for legal, regulatory and social developments in the AI/ML space, we may become less competitive against our peers and we may incur significant costs that do not provide us with commensurate returns.
Risks Related to Intellectual Property
Any failure to obtain, maintain, protect or enforce our intellectual property and proprietary rights could impair our ability to protect our proprietary technology and our brand.
There is a risk that our trade secrets, know-how and other proprietary information will be stolen, used in an unauthorized manner, or compromised, which could materially and adversely affect our results of operations, financial condition, business and prospects.
The laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate.
We have been, and may continue to be, subject to intellectual property disputes, which are costly and may subject us to significant liability and increased costs of doing business.
Our success depends, in part, on our ability to develop and commercialize our technology without infringing, misappropriating or otherwise violating the intellectual property rights of third parties and we may not be aware of such infringements, misappropriations or violations.
We may be unable to provide technology to our customers if we lose the support of our technology partners.
Political, Regulatory and Legal Risks
We are subject to governmental export and customs compliance requirements that could impair our ability to compete in international markets or subject us to liability if we violate the controls.
4


We currently are, and may in the future continue to be, subject to litigation that could result in substantial costs, divert or continue to divert management’s attention and resources, and materially and adversely affect our results of operations, financial condition, business and prospects.
Risks Related to Our Status as a Controlled Company and Foreign Private Issuer
Mubadala Investment Company PJSC (“Mubadala”) will continue to have substantial control over the Company, which could limit our ability to influence the outcome of key transactions, including a change of control, and otherwise affect the prevailing market price of our ordinary shares.
We are a foreign private issuer and, as a result, are not subject to U.S. proxy rules but are subject to reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. issuer.
Risks Related to Operating as a Public Company
Our management has identified material weaknesses in our internal control over financial reporting (“ICFR”) and has concluded that our ICFR was not effective as of December 31, 2023, which may have a material adverse result on our results of operation and financial condition for future periods.

Risk Factors
Risks Related to our Business and Industry
General global economic and geopolitical conditions could materially and adversely affect our results of operations, financial condition, business and prospects.
The semiconductor industry relies on a global supply chain and is considered strategically important by major trading countries, including the United States, China, and countries in the European Union (“EU”). Political, economic and financial crises have in the past negatively affected and in the future could negatively affect the semiconductor industry and its end markets. Our business may also be materially affected by the impact of geopolitical tensions and related actions. Recently, there have been political and trade tensions among and between a number of the world’s major economies, most notably in our industry between the United States and China, with Taiwan implicated in the tensions, the possible spillover hostilities between Russia and other nearby member nations of the North American Treaty Organization and, more recently, the tensions in the Middle East, as well as others. These tensions have resulted in the implementation of trade barriers, including the use of economic sanctions and export control restrictions against certain countries and individual companies. For example, in 2022, the United States significantly increased U.S. export controls on semiconductor manufacturing equipment, artificial intelligence and advanced computing products. In 2023, the United States added to the restrictions in all three areas and also worked with Japan and the Netherlands to align on additional restrictions on semiconductor manufacturing equipment. During this time, the United States has increasingly added Chinese companies to prohibited/entity lists. In response, China has restricted U.S. access to certain minerals and has blocked certain companies that provide products to Taiwan's military from selling products in China. China has imposed tariffs or scrutiny on the importation of foreign chips, particularly in sensitive sectors like telecommunications and national security. Recently China banned operators of key domestic infrastructure from purchasing products from U.S. memory chip producer Micron Technology, noting that Micron’s chips pose “serious network security risks.” China has also announced it’s intention to phase out use of Intel and AMD processors from Chinese government computers and servers. In addition to these national security related measures, China has implemented measures to promote domestic chip production and reduce reliance on foreign technology, including pursuant to initiatives such as the "Made in China 2025" program, by providing significant support to domestic semiconductor companies, including foundries and IDMs. Failure to clear Chinese regulatory hurdles has also caused a number of merger and acquisition transactions to collapse, including the proposed Intel-Tower Semiconductor transaction.
Violations of these economic sanctions and export control restrictions can result in significant civil and criminal penalties. These trade barriers have had a particular impact on the semiconductor industry and related markets. Prolonged or increased use of trade barriers may result in a decrease in the growth of the global economy and semiconductor industry and could cause turmoil in global markets, which in turn often results in declines in our customers’ electronic products sales and could decrease demand for our products and services. Also, any increase in the use of economic sanctions, export control restrictions or retaliatory state actions to target certain countries, industries and/or companies could impact our ability to continue supplying products and services to customers and our customers’ demand for our products and services, and could disrupt semiconductor supply chains. The ongoing conflict between Russia and Ukraine has created uncertainty regarding supply of materials needed for our operations (including natural gas), particularly in Europe where we have operations in both Germany and Bulgaria, as well as our customers’ potential sales of electronic products and components to customers in Russia. More recently, the war between Israel and Hamas and related conflicts in the region have disrupted shipping through the Red Sea, which could cause shipping delays and increase costs for materials needed for our operations. These conflicts have created uncertainty about broader impacts that economic sanctions, export control restrictions and continued geopolitical uncertainty may have on global supply chains and markets generally.
Any current and future systemic political, economic or financial crisis or market volatility, including interest rate fluctuations, inflation or deflation, recession and changes in economic, trade, fiscal and monetary policies in major economies, could
5


cause revenue or profits for us or the semiconductor industry as a whole to decline dramatically. If the economic conditions in the markets in which our customers operate or the financial condition of our customers were to deteriorate, the demand for our products and services may decrease and impairments, write-downs and other accounting charges may be required, which could reduce our operating income and net income. Further, in times of market instability, sufficient external financing, including equity capital, debt financing, customer prepayments and government subsides, may not be available to us on a timely basis, on commercially reasonable terms or at all. If sufficient external financing is not available when we need such financing to meet our demand-driven capital requirements, we may be forced to curtail expansion, modify plans and delay the deployment of new or differentiated technologies, products, or services until we obtain such financing. Further escalation of trade tensions, the increased use of economic sanctions or export control restrictions or any future global systemic crisis or economic downturn could materially and adversely affect our results of operations, financial condition, business and prospects.

Reductions in demand and ASPs for our customers’ end products (e.g., consumer electronics) and prolonged inflationary market environments may decrease demand for our products and services and could materially and adversely affect our results of operations, financial condition, business and prospects.
The substantial majority of our revenue is derived from customers who use our products in intelligent and highly connected devices in markets such as Smart Mobile Devices, Home and Industrial internet of things (“IoT”), Communications Infrastructure & Datacenter, Automotive and Personal Computing. A deterioration or a slowdown in the growth of such end markets, due to, among other things, a potential recession and/or prolonged inflation, resulting in a substantial decrease in the demand for overall global semiconductor foundry services, including our products and services, could adversely affect our revenue and profit margins. Semiconductor manufacturing facilities require substantial investment to construct and are largely fixed-cost assets once they are in operation. Because we own our manufacturing facilities, a significant portion of our operating costs are fixed. In general, these costs do not decline when customer demand or our shipment utilization rate drops, and thus declines in customer demand, among other factors, may significantly decrease our profit margins. Our costs may also increase as a result of, among other things, inflation, which may have a greater impact on our profit margins than ASPs. In the past, there have been periods of sustained decline in ASPs of our customers’ end products and applications, and such periods have sometimes coincided with periods of economic volatility, including recessions. A return to historical trends could place downward pressure on the prices of the components, including our products, that go into such end products and applications. If ASPs decline, potentially due to a recession, and our cost reduction programs and actions do not offset the decrease or our costs increase due to inflation or otherwise and are not offset by an increase in ASPs, our results of operations, financial condition, business and prospects may be materially and adversely affected.

The cyclical nature and seasonality of the semiconductor industry and periodic overcapacity make us vulnerable to significant and sometimes prolonged economic downturns.
The semiconductor industry has exhibited cyclicality in the past and, at various times, has experienced downturns from time to time, as a result of global economic conditions as well as industry-specific factors, including inventory corrections, excess capacity, price volatility in raw materials and other inputs, and changes in end-customer preferences. Fluctuations in our customers’ demand drive significant variations in order levels for our products and services and can result in volatility in our revenue and earnings. Also, increases in inflation rates in the markets in which we operate may affect our business by increasing costs of our manufacturing inputs and by decreasing demand for our customers’ products. The recent increase in inflation rates in the markets in which we operate may lead us to experience higher costs related to labor, energy, water, transportation, research and development, wafer and other raw materials costs from suppliers. Because our business is, and will continue to be, largely dependent on the requirements of both consumer and industrial high-end technology product suppliers for our services, downturns in this broad industry will likely lead to reduced demand for our products and services.
Demand for our customers’ end products is affected by seasonal variations in market conditions that contribute to the fluctuations of demand and prices for semiconductor services and products. The seasonal sales trends for semiconductor services and products closely mirror those for automotive, consumer electronics, communication and computer sales. These seasonal variations, and seasonal variation changes that we cannot anticipate, may result in increased volatility in our results of operation and could materially and adversely affect our results of operations, financial condition, business and prospects

Securing and maintaining design wins, in particular single-sourced awards, and managing our LTAs may present challenges to our business in differing demand environments.
We endeavor to utilize our existing manufacturing capacity and pursue growth beyond our existing capacity via a design funnel to design award process, with the aim of securing as many single-sourced awards through differentiation as possible. We define single-sourced products as those that we believe can only be manufactured with our technology and cannot be manufactured elsewhere without significant customer redesigns. Given the time and costs associated with moving a single-sourced product to a competitor, clients are more likely to continue awarding us single-source contracts for such products. If we are unable to fill the funnel and convert enough opportunities into design wins and ultimately awards due to
6


differentiation, pricing, competition, or any other reasons, there will be a material adverse impact on our financial performance.
Over the last few years, and especially during the pandemic as global supply was tight, we were able to sell production capacity through LTAs as opposed to shorter contracts or via more traditional purchase order based contracts. In light of current demand dynamics, our ability to enter into LTAs has diminished, and the focus of our commercial operations has shifted to building a wider funnel of potential customers across a breadth of end markets, aiming to secure more single-sourced design wins.
Notwithstanding this shift in industry dynamics, we continue to have a significant number of existing LTAs, which continue to be an important part of our strategy, especially for certain longer, more durable end markets, like automotive. For example, we recently entered into a long-term agreement with Infineon at the end of 2023 to secure wafers primarily for the automotive sector.
Entering into LTAs to secure supply contractually is subject to certain risks, which can be magnified in the case of unpredictable market demand, including: customers defaulting on their obligations to us, which may include significant payment obligations and customers seeking to renegotiate key terms of their contracts, such as pricing and specified volume commitments, in the event market conditions change during the contract term. Against the current backdrop of macroeconomic and geopolitical uncertainty, some customers under LTAs have requested to adjust their demand outlook downward and have sought renegotiation of their LTAs. We have renegotiated a number of LTAs with certain of our customers, as a result of which some of our LTAs now have longer commitment periods over which the customer may purchase the same volume as originally negotiated, and some of our LTAs have lower pricing or volume commitments than originally negotiated. We expect these discussions to continue into 2024. We also face the risk that we may be unable to extend contracts when they expire and cannot backfill with additional customer demand. If we are unsuccessful in preserving the economic benefits of our existing LTAs in negotiations with our customers and we are unable to backfill that demand with customers through our design awards process, such renegotiations could lead to a reduction of our revenue and long-term outlook.
We must maintain sufficient capacity or expand our capacity in a timely manner, as well as manage manufacturing risks detailed elsewhere in these “Risk Factors,” to meet anticipated customer demand for our products and capacity reservation commitments we have made to our customers. We have entered into multiple LTAs that provide for significant customer commitments in return for capacity reservation commitments from us. If we’re unable to meet the capacity reservation commitments, we face the risk of defaulting on our obligations to our customers, which could result in us owing substantial cash penalties to our customers. Capacity reserved for certain customers could also prevent us from securing potentially more profitable business. If we overestimate customer demand or a customer defaults on its contractual obligations to us, we could experience underutilization of capacity at these facilities without a corresponding reduction in fixed costs. Given the breadth of the end markets we serve, these risks are not mutually exclusive and we may experience demands for additional capacity from some customers at the same time other customers are seeking to renegotiate their LTAs.
Our ability to successfully manage our LTAs depends on a variety of factors, including, among other things, our ability to finance our operations, maintain high-quality and efficient manufacturing operations, respond to competitive and regulatory changes, access semiconductor manufacturing equipment or quality raw materials in a cost-effective and timely manner, and retain and attract highly skilled personnel. As a result, we may not realize the anticipated benefits of these contracts.

We depend on a small number of customers for a significant portion of our revenue and any loss of this or our other key customers, including potentially through further customer consolidation, could result in significant declines in our revenue.
We have been largely dependent on a small number of customers for a substantial portion of our revenue. Our ten largest customers in 2023, 2022 and 2021 accounted for approximately 72%, 70% and 67% of our wafer shipment volume, respectively. We expect that a significant portion of our revenue will continue to come from a relatively limited number of customers. We cannot assure you that our revenue generated from these customers, individually or in the aggregate, will reach or exceed historical levels in any future period. Loss or cancellation of business from, significant changes in scheduled deliveries to, or a decrease of products and services sold to, any of these customers could significantly reduce our revenue.

We rely on a complex silicon supply chain and breakdowns in that chain could affect our ability to produce our products and could materially and adversely affect our results of operations, financial condition, business and prospects.
We rely on a small number of suppliers for wafers, which is a key input into our products. In particular, only a limited number of companies in the world are able to produce silicon-on-insulator (“SOI”) wafers. If there is an insufficient supply of wafers, particularly SOI wafers, to satisfy our requirements, we may need to limit or delay our production, which could materially and adversely affect our results of operations, financial condition, business and prospects. If our limited source suppliers and suppliers for wafer preparation were to experience difficulties that affected their manufacturing yields or the quality of the materials they supply to us, it could materially and adversely affect our results of operations, financial condition, business and prospects. In particular, we depend on Soitec S.A. (“Soitec”), our largest supplier of SOI wafers, for the timely provision
7


of wafers in order to meet our production goals and obligations to customers. Soitec supplied 63% of our SOI wafers in 2023. Our supply agreements with Soitec impose mutual obligations, in the form of capacity requirements, minimum purchase requirements and supply share percentages. We may be subject to penalties if we fail to comply with such obligations. In November 2020, we agreed with Soitec on an addendum to our original materials supply agreement to secure supply for 300 millimeter (“mm”) RF SOI, partially depleted SOI and Silicon Photonics (“SiPh”) wafers and in the fourth quarter of 2023 we updated the agreement with the latest outlook of future wafer mix for these technologies. In order to secure attractive pricing, we have undertaken risk purchases of raw wafers ahead of customer demand, risking the build up of excess inventory. If we are unable to obtain 300mm SOI wafers from Soitec for any reason, we expect that it would take us an extended period to find a replacement supplier on commercially acceptable terms. While we are in the process of developing relationships with alternate suppliers, we do not expect to be able to acquire a significant amount of SOI wafers from those suppliers in the near term, and there is no assurance that we will ever be able to do so.
The ability of our suppliers to meet our requirements could be impaired or interrupted by factors beyond their control, such as earthquakes or other natural phenomena, labor strikes or shortages, or political unrest or failure to obtain materials for their suppliers. For example, Soitec is reliant on third-party providers to obtain raw silicon wafers—difficulties in obtaining raw silicon wafers may result in Soitec’s inability to produce SOI wafers. In the event one of our suppliers is unable to deliver products to us or is unwilling to sell materials or components to us, our operations may be adversely affected. Further, financial or other difficulties faced by our suppliers, or significant changes in demand for the components or materials they use in the products they supply to us, could limit the availability of those products, components, or materials to us. Any breakdown of our wafer supply chain could materially and adversely affect our results of operations, financial condition, business and prospects.

If we are unable to attract customers with our technology, respond to fast-changing semiconductor market dynamics or maintain our leadership in product quality, we will become less competitive.
The semiconductor industry and the technologies it brings to market are constantly being created and evolving. We compete by developing process technologies that incorporate increasingly higher performance and advanced features, offering increasing functionality depending upon the customer’s application requirements. If we do not anticipate these changes in technology requirements and fail to rapidly develop new and innovative solutions to meet these demands, we may not be able to provide foundry services on competitive terms with respect to cost, schedule or volume manufacturing capacity. There is a risk that our competitors may successfully adopt new or more differentiated technology before we do, resulting in us losing design wins (including in cases in which we have expended significant resources to pursue design wins) and market share. If we are unable to continue to offer differentiated services and processes on a competitive and timely basis, we may lose customers to competitors providing similar or better technologies.
Some of our customers may alter their process technology roadmaps and adopt single-digit nanometer manufacturing technologies (e.g. 3nm, 5nm, 7nm) faster than their original plans. If this happens and we are unable to offset with additional revenue from existing and new customers in the technology offerings we do provide, our results of operations, financial condition, business and prospects may be materially and adversely affected.
A key differentiator in the marketplace is to significantly reduce the time in which differentiated technology products or services are launched into the market. If we are unable to meet the shorter time-to-market requirements of our customers or fail to impress them with our newer feature sets or differentiated technology solutions or are unable to allocate or develop new production capacity to meet those customers’ demands in a timely manner, we risk losing their business and not generating the market adoption needed to pay for our development efforts. These factors have also been intensified by the shift of the global technology market to consumer-driven products and increasing concentration of customers and competition. Further, the increasing complexity of technology also imposes challenges for achieving expected product quality, cost and time-to-market expectations. If we fail to maintain quality, it may result in loss of revenue and additional cost, as well as loss of business or customer trust. If we are unable to meet the expected production yields of a new technology, we will not be able to meet the expected costs of that technology. In addition, the market prices for technology and services tend to fall over time, except in times of extreme supply shortage. As a result, if we are unable to offer new differentiated services and processes on a competitive and timely basis, we may need to decrease the prices that we set for our existing services and processes. If we are unable to innovate new and differentiated technologies and bring them to a cost-competitive volume manufacturing scale that meets the demand of our customers, we may become less competitive and our revenue and margins may decline significantly.
External risks also exist that can impact our position as a technology leader. Differentiated technology offerings may rely upon unique or specialized materials as compared to our competitors, including specialized wafers upon which some of our technologies are currently manufactured, raw materials for wafer fabrication, and materials used in the packaging of ICs to enable them to be used in the end products. A disruption in the availability or quality of these raw materials, as well as a significant increase in the price of these new or unique materials during technology development can have a variety of negative impacts. These impacts include increased time-to-market, decreased quality of finished goods or increased cost of finished goods in the marketplace. Similarly, our technology roadmap relies on externally sourced design tools and component circuit designs that allow our end customers to more readily realize their products in our technologies, and disruption or delays in our ability to obtain those resources may impair our ability to compete effectively and serve our customers.
8


The rapidly changing nature of advanced semiconductor technology can also culminate in the emergence of highly disruptive or unconventional technologies and new disruptive solutions using existing technologies, which can create a rapid inflection point leaving those on a conventional technology roadmap path at a significant disadvantage and unprepared to react in a timely manner.

Overcapacity in the semiconductor industry may reduce our revenue, earnings and margins.
The prices that we can charge our customers for manufacturing services are significantly related to the overall worldwide supply of integrated circuits (“ICs”) and semiconductor products. The overall supply of semiconductors is based in part on the capacity of other companies, which is outside of our control. For example, we and some other companies, including IDMs and competitors with access to material government support, have announced plans to increase capacity expenditures. As IDMs expand internal capacity to service internal production needs, the demand from those companies for foundry services from us and other pure-play foundries may be negatively impacted as they service a higher percentage or all of their production requirements. In addition, the increased capacity and internal production may allow those IDMs to more effectively compete with pure-play foundry customers in certain markets, including our customers, resulting in lower demand for pure-play foundry services in markets we serve. For example, as an IDM adds internal capacity, if it is successful in securing market share from competitors that utilize pure-play foundry services, the overall market we serve could be negatively impacted, which could result in a material and adverse effect to our results of operations, financial condition, business and prospects.
In addition, in periods of overcapacity, the Company may have aged construction in progress due to equipment that may not be installed until customer demand recovers. Accordingly, the Company faces the risk of potential future impairment if demand does not recover in a timely manner. See Note 3 and Note 8 to our Annual Consolidated Financial Statements.
Additionally, some nations, including China, are investing heavily in developing additional domestic capacity for semiconductor fabrication. In 2022, the U.S. implemented export controls that are intended to, among other things, prevent Chinese expansion with respect to leading-edge semiconductor process technologies (e.g. 14nm FinFET). Following the implementation of those controls, the Chinese semiconductor industry, with significant government support, has accelerated building its own foundry capacity, and shifted to focus domestic manufacturing on mature nodes (i.e. 22/28nm and larger technology nodes). China’s foundry capacity is expected to grow faster than expected demand at those nodes. This projected oversupply of capacity, if carried out as planned, will increase the industry-wide capacity and could result in overcapacity in the future, including in key end markets in which we operate.
In periods of overcapacity, if we are unable to offset the adverse effects of overcapacity through, among other things, our technology and product mix, we may have to lower the prices we charge our customers for our products and services and/or our average cost per wafer could increase given the high fixed cost nature of our industry. Such actions could reduce our margin and profitability and weaken our financial condition and results of operations. We cannot give any assurance that an increase in the demand for foundry services in the immediate and short-term will not lead to overcapacity in the future, which could materially and adversely affect our results of operations, financial condition, business and prospects.

If we are unable to compete effectively with other sophisticated players in the highly competitive foundry segment of the semiconductor industry, we may lose customers and our profit margins and earnings may decrease.
We believe the foundry market is comprised of five major foundries (including four scaled pure-play foundries) that accounted for the vast majority of worldwide foundry revenue in 2022. We define a scaled pure-play foundry as a company that focuses on producing ICs for other companies, rather than those of its own design, with more than $2.5 billion of annual foundry revenue. Taiwan Semiconductor Manufacturing Company, Limited (“TSMC”) at $75.8 billion of revenue in 2022 accounted for more than 50% of the total market. Other key competitors include SMIC and United Microelectronics Corporation, as well as the foundry operation services of some IDMs, such as Samsung Electronics Co., Ltd. (“Samsung”) and, more recently, Intel. IDMs principally manufacture and sell their own proprietary semiconductor products but may also offer foundry services. Other smaller dedicated foundry competitors include X-FAB Silicon Foundries, Tower Semiconductor Ltd., Vanguard International Semiconductor Corporation and WIN Semiconductors Corp. Some of our competitors may offer more advanced or differentiated technologies than we do and some have greater access to capital and substantially greater production capacity, research and development (“R&D”), marketing and other resources, including access to government subsidies and economic stimulus (including protective demand-side measures), than we do. As a result, these companies may be able to compete more aggressively over a longer period of time than we can.
The principal elements of competition in the wafer foundry market include:
scale and the ability to access capital, whether public or private, to fund future growth;
capacity utilization;
technical competence, including internal and access to external design enablement capabilities;
technology leadership and differentiation, coupled with a strong patent portfolio;
9


price;
cost management;
time-to-volume production and cycle time;
time-to-market;
investment in R&D and related quality of results;
manufacturing yields;
optimization of the technology mix of wafer production at particular process technology nodes;
design/technology interaction and resulting chip reliability;
customer service and design support;
management expertise; and
strategic alliances in both the private and public sectors and geographic diversification.
We may fail to compete successfully in any one or more of these elements, any or all of which could impair our business performance and our ability to scale our operations in a way that adequately responds to our long-term strategy.
Our ability to compete successfully also depends on factors partially outside of our control, including component supply, intellectual property, including cell libraries that our customers embed in their product designs, and industry and general economic trends.

Our competitors and IDMs have announced expansions and may continue to expand in the United States and Europe, which could materially and adversely affect our competitive position.
TSMC, Samsung, Intel, Texas Instruments, Inc. (“Texas Instruments”) and others have initiated plans to develop new fabs and substantially increase their manufacturing capacity in the United States, and other competitors may seek to do likewise. Similarly, our competitors are seeking to develop new fabs in Europe (including in Dresden, Germany) and substantially increase their manufacturing capacity. Such expansions may increase the attractiveness of our competitors to customers who wish to utilize fabs located in the United States or Europe, use geographically dispersed suppliers or mitigate risks posed by geopolitical tensions and export controls. Further, it may lead to increased competition for funding and talent in those jurisdictions. This increased competition could materially and adversely affect our results of operations, financial condition, business and prospects.

The semiconductor industry is capital-intensive and, if we are unable to invest the necessary capital to operate and grow our business, we may not remain competitive.
To remain competitive and comply with evolving regulatory requirements, we must constantly improve our facilities and process technologies and carry out extensive R&D, each of which requires investment of significant amounts of capital. The costs of manufacturing facilities and semiconductor manufacturing equipment continue to rise and because we operate primarily in countries with higher labor and overhead costs relative to many of our competitors, we are exposed to higher costs than some of our peers. Our actual expenditures may exceed our planned spend due to global economic and industry-wide equipment or material price increases during the long lead time to build capacity. Given the fixed-cost nature of our business, we have in the past incurred, and may in the future incur, operating losses if our revenue and planned cost reductions do not adequately offset the impact of our capital expenditures and the cost of financing these expenditures.
We invest significantly in R&D, and to the extent our R&D efforts are unsuccessful, our competitive position may be harmed and we may not be able to realize a return on our investments. To compete successfully, we must maintain a successful R&D effort, develop new product technologies, features and manufacturing processes, and improve our existing products and services, technologies and processes. Our R&D efforts may not deliver the benefits we anticipate. To the extent we do not timely introduce new technologies and features relative to competitors, we could face cost, product performance, and time-to-market disadvantages, which could materially and adversely affect our results of operations, financial condition, business and prospects.
Financing, including equity capital, debt financing, customer co-investments and government subsidies, may not be available on commercially acceptable terms or at all. Any additional debt financing we may undertake could require debt service and financial and operational requirements that could adversely affect our business. If we are unable to generate sufficient cash or raise sufficient capital to meet both our debt service and capital investment requirements, or if we are unable to raise required capital on favorable terms when needed, we may be forced to curtail revenue expansion plans or delay capital investment, which could materially and adversely affect our results of operations, financial condition, business and prospects.
10


Subject to market requirements and customer demand as well as receipt of expected government funding, among other factors, GF plans to invest more than $12 billion over the next 10 or more years across our Fab 8 facility and our Fab 9 facility. While GF intends to begin work as soon as reasonably possible, there is no guarantee at this time as to when GF will be able to start work and how (or to what degree) the total $12 billion investment will be allocated to each year over the next 10 or more years (or that the total amount actually invested will be $12 billion or more). GF intends to execute such investments through public-private partnerships with support from the federal and state governments as well as from its ecosystem partners, including anticipated key strategic customers, but such plans are subject to GF receiving such support in the manner and on the timelines expected, and may be subject to change. There can be no assurance these projects will not be delayed or otherwise impacted if we are unable to secure the funding we expect. In the event we have invested a substantial portion of our expected $12 billion into these projects and we are not able to receive the governmental funding described above (or if they seek to recover any subsidies or grants from us), these projects may be indefinitely delayed until we can secure sufficient funding to complete them, and we may not see returns on our $12 billion investment until we do.

We receive subsidies and grants in certain countries and regions in which we operate, and a reduction in the amount of governmental funding available to us or demands for repayment could increase our costs and affect our results of operations.
As is the case with other large semiconductor companies, we receive subsidies and grants from governments in certain countries and regions in which we operate. In response to increased geopolitical tensions, national security and supply chain concerns, the United States and the European Union are implementing new semiconductor industry incentive programs. For example, the United States enacted the Creating Helpful Incentives to Produce Semiconductors for America and Science Act of 2022 (the “CHIPS and Science Act”) and the European Union approved the European Chips Act in 2023 (see also Note 3 to our Annual Consolidated Financial Statements). These programs represent potentially significant new sources of government funding for capital and R&D investment for our industry, that we and various participants in our industry hope to benefit from. The CHIPS and Science Act provided for a 25% investment tax refund and appropriated $52 billion in grants to support the domestic semiconductor industry. The EU has enacted the European Chips Act, which is intended to provide significant funding to strengthen the EU’s semiconductor industry. Historically, we have benefited from these kinds of government programs, and we intend to continue to benefit from government programs to help fund our expansion efforts.
Starting in 2023, GF began benefiting from the CHIPS and Science Act, and has sought a refund of $66.4 million, and GF anticipates continuing to benefit from this law going forward, which should help subsidize 25% of all capital investment made by us in the U.S., at our Fab 8 and Fab 9 facilities, in the States of New York and Vermont, respectively. In February 2024, the U.S. Department of Commerce announced approximately $1.5 billion in planned direct funding for us under the CHIPS and Science Act. This planned investment will enable us to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets. The proposed funding will support three potential GF projects: expansion of our existing Fab 8 facility, construction of a new state-of-art fab on the Fab 8 campus, and modernization of our Fab 9 facility in Burlington, Vermont. In support of the two Fab 8 projects, the State of New York also announced that it intends to provide $575 million in planned direct funding. The preliminary awards are non-binding commitments, and receipt of any funding will be subject to certain terms and conditions including GF hitting specific milestones.
We may be unable to secure this or other government funding at the levels we expect or at all, and the availability of government funding is outside our control. Moreover, should we terminate or fail to commence any activities or operations, or fail to achieve milestones, related to government funds that we receive or upon which government funds have been conditioned, we may face adverse consequences. In particular, government agencies could seek to recover subsidies or grants from us, seek repayment of loans, or could cancel, reduce or deny our requests for future subsidies or grants. This could materially and adversely affect our results of operations, financial condition, business and prospects.

Strong government support in China for capacity expansion, combined with strained economic relations with that country could lead to underutilization or significant ASP erosion for our fabs.
The Chinese government has invested heavily in its indigenous semiconductor manufacturing, and has continued to promote the expansion of fabrication capacity for semiconductors. This has contributed to and may continue to lead to overcapacity and increased competition, in particular in the current and legacy node market. China’s decision to build capacity for China, to be sourced primarily from indigenous suppliers, will likely have the dual effect of limiting the Chinese market for other global suppliers like us and significantly increasing the competition we face globally. We have a material amount of direct business in China, and if we cannot adequately compete with Chinese semiconductor manufacturers, our market share in China could be impacted, which could result in a material impact to our business and financial performance. The United States has implemented export controls that are intended to, among other things, prevent Chinese expansion with respect to leading edge semiconductor process technologies (i.e., 14nm FinFET and smaller technology nodes). Following the implementation of those controls, the Chinese semiconductor industry, with significant government support, has accelerated building its own foundry capacity, and shifted to focus domestic manufacturing on mature nodes (i.e. 28nm and larger technology nodes). and China's foundry capacity is expected to grow faster than expected demand at those nodes. This projected oversupply of capacity, if carried out as planned, will increase the industry-wide capacity and could
11


result in overcapacity in the future and our business performance and financial results may be materially impacted. Further, the business we do around the world outside of China, in markets in which Chinese semiconductor manufacturers are our direct competitors, also represents a significant portion of our business. If we are unable to keep up with competition from such Chinese manufacturers, our market share in jurisdictions outside of China could also be impacted as they work to saturate the market, which could materially impact our business and financial performance.
Further, there can be no assurance that the tightening of export controls and other countermeasures (e.g., tariffs) established by the U.S. government and other governments will meaningfully limit China’s semiconductor manufacturing supply to current or mature nodes in the long term. To the extend any such measures are put in place, not only may they be ineffective, but may also heighten the potential risk to our business of retaliatory measures. See “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to our Business and Industry—Global economic and geopolitical conditions could materially and adversely affect our results of operations, financial condition, business and prospects.” Any changes or further developments (many of which would be outside our control and ability to adequately predict with any certainty) may make it more difficult for us to retain existing and obtain new customers, may result in material reductions in ASPs, and may have material impacts on our business operations, financial performance, and strategy.

We may not be able to implement our planned growth and development or maintain the differentiation of our solutions if we are unable to recruit and retain skilled technical personnel, key executives and managers.
We rely on the continued services and contributions of our skilled technical and professional personnel and management team. In this industry, the competitive pressures to find and retain the most talented personnel are intense and constant. The sources for highly skilled talent in the industry are often well-known and pursued by competitors for talent, including IDMs. With the rapid pace of technological and business change, skills need to be constantly refreshed and built upon. Our business could suffer if we are unable to fulfill and sustain resource requirements with qualified individuals in required positions globally. Fulfilling new resource needs on a timely basis continues to be a challenge in this highly competitive market for semiconductor talent. Competition for talent is particularly high both in locations where we and our competitors have operations and in locations where our competition is hiring in anticipation of planned expansion. Competition for talent exists in all of our operating regions, at all levels, emphasizing the importance of strong employee retention, and if we fail to attract and retain highly skilled talent, our business and results of operations could be materially adversely impacted.

Sales to government entities and highly regulated organizations are subject to a number of challenges and added risks, and our failure to comply with these heightened compliance requirements, or effectively manage these challenges or risks, could impact our operations and financial results.
We currently sell to the U.S. federal government and to customers in highly regulated industries, and may sell to state and local governments and to foreign governmental agency customers in the future. Sales to such entities are subject to a number of compliance challenges and risks, including regarding access to and required protection of classified information. Failure to comply with Foreign Ownership, Control or Influence agreements could lead to a loss of our security clearance and, therefore, certain government business and reputational harm. Selling to governmental and highly regulated entities can be highly competitive, expensive and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate a sale. Government contracting requirements may change and in doing so restrict our ability to sell into the government sector until we have attained any revised necessary certification or authorization. Government demand and payment for our products and services are affected by public sector budgetary cycles and funding authorizations, with funding reductions or delays adversely affecting public sector demand for our products and services. Such sales are made more difficult by the fact that many of our product design and life cycles are very long, compared to public fiscal budget calendars.
Further, governmental and highly regulated entities may demand contract terms that differ from our standard commercial arrangements, and those contract terms may be in some respects less favorable than terms agreed to by private sector customers. Governments routinely retain certain rights to IP developed in connection with government contracts. Such entities may have statutory, contractual or other legal rights to terminate contracts with us or our partners for convenience or for other reasons that are out of our control or influence. Any such terminations, or other adverse actions, may materially adversely affect our ability to contract with other government customers, as well as our reputation, results of operations, financial condition, business and prospects. In addition, our U.S. government contracts obligate us to comply with various cybersecurity requirements. These requirements include ongoing investment in systems, policies and personnel, and we expect these requirements to continue to impact our business in the future by increasing our legal, operational and compliance costs.
Certain of our government contracts require us to notify the applicable governmental agency and discuss options with the governmental agency before making certain potential transfers of intellectual property developed under those contracts, and certain of our government contracts impose specific limitations on our use and licensing of certain of our intellectual property. Additionally, production of sensitive, export-controlled products for governmental and highly regulated entities requires adherence to strict export and security controls. In the event of a breach or other security event involving one of these products, we may be subject to investigations to determine the extent and impact to such products, regulatory proceedings, litigation, mitigation and other actions, as well as penalties, fines, increased insurance premiums,
12


indemnification expenditures and administrative, civil and criminal liabilities and reputational harm, each of which could negatively impact operations for multiple products and future business, cause production and sales delays and materially and adversely affect our results of operations, financial condition, business and prospects.

The implementation of our restructuring plan is ongoing, and it is possible that we may not achieve all of the plan’s expected benefits and, if we do not, the plan may have a material adverse effect on our business, operations, financial condition and results of operations.
We communicated and implemented a restructuring plan in order to realign our business and strategic priorities. This worldwide restructuring plan includes a reduction in the number of full time employees, as well as a reduction in leased workspaces and engagement of consultants for strategic support.
The implementation of the restructuring plan is ongoing, and it is possible that we may not be able to maintain all the cost savings and benefits that are anticipated in connection with such plan.
Our reduction in workforce, or similar restructuring program actions, may present a number of significant
risks, including:
actual or perceived disruption of our manufacturing and/or delivery processes;
potential adverse effects on our internal control environment and inability to preserve adequate internal controls
relating to our general and administrative functions in connection with the decision to outsource certain business
service activities;
actual or perceived disruption to distribution networks and other important operational relationships and the inability
to resolve potential conflicts in a timely manner;
potential difficulty in or failure of meeting our financial or production targets;
diversion of management attention from ongoing business activities and strategic objectives; and
failure to maintain employee morale and retain key employees.
Because of these and other factors, we may not fully realize the purpose and anticipated operational benefits or cost
savings of any productivity actions and, if we do not, it may have a material adverse effect on our business, operations,
financial condition and results of operations.

We may be exposed to liabilities if it is determined that our compensation arrangements do not comply with, or are not exempt from, Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).
Section 409A (“Section 409A”) of the Code, sets forth the rules governing non-qualified deferred compensation arrangements. Section 409A contains many technical, complicated and ambiguous rules and regulations, including proposed but not yet finalized regulations that do not currently have the force of law, making compliance with Section 409A difficult to assess and to ensure. While we have attempted to structure our compensation arrangements (including our equity incentive awards) so that they either comply with, or are exempt from, Section 409A, it is possible that some of these compensation arrangements are not so exempt or compliant. In some instances, we have determined that amendments to certain of our compensation arrangements were advisable in order to mitigate or eliminate potential Section 409A non-compliance risk, though there can be no assurance that such amendments will mitigate or eliminate any such risk. If it is determined that any of our compensation arrangements are neither compliant with, nor exempt from, Section 409A, we may be subject to significant liabilities and costs, including penalties for failing to properly report deferred compensation arrangements under Section 409A and to withhold taxes payable by our service providers, including our employees, and we may be required to pay to the applicable governmental authorities the amount of taxes we should have withheld and related interest and penalties. In addition, those of our service providers, including our employees, participating in such arrangements may experience significant adverse tax consequences under Section 409A, including a 20% federal penalty tax imposed on the amount of compensation involved (and, as applicable, similar excise taxes under state law or foreign law). These liabilities may be significant and the imposition of such liabilities may materially affect our employee relations. In addition, in the event any such liabilities were imposed on our service providers, including our employees, we could decide to take remedial action, including making cash payments to adversely affected service providers, including our employees. Any amounts so paid by us could materially and adversely affect our results of operations, financial condition, business and prospects.
13


Improper disclosure of confidential information could negatively impact our business.
In the ordinary course of our business, we maintain sensitive data on our networks, including our and our customers’ intellectual property and proprietary or confidential business information relating to our business and that of our customers and business partners. In addition, we regularly enter into confidentiality obligations with our customers, suppliers and parties that we license intellectual property to or from. The secure maintenance of this information is critical to our business and reputation. We have put in place policies, procedures and technological safeguards designed to protect the security of this information. However, we cannot guarantee that this information will not be improperly disclosed or accessed. Disclosure of this information could harm our reputation, subject us to liability under our contracts and harm our relationships with key counterparties, including our customers, which could materially and adversely affect our results of operations, financial condition, business and prospects.

Any outbreak of contagious disease could materially and adversely affect our results of operations, financial condition, business and prospects.
Any outbreak of contagious disease may disrupt our ability to adequately staff our business and may generally disrupt our operations. Generalized outbreaks of contagious diseases may slow economic growth, including in regions of the world where we, our customers and suppliers operate, and can negatively impact the global supply chain, market and economies. We have significant operations in the United States, Europe, and Singapore, including supply chain and manufacturing facilities and sales and marketing channels and information technology (“IT”) design and other support services in these regions as well as in other countries, including Japan, India, Taiwan and China.
If a new pandemic or new outbreaks of contagious diseases occur, we may experience material adverse effects on our business, including, among other things:
declines in sales activities and customer orders;
significant fluctuations in demand for our products and services, which could in turn cause uncertainty for our capacity planning, production delays and reduced workforce availability;
difficulties in domestic and international travel and interruption of communications;
temporary governmental work stoppage orders to control infection rates or as a result of border closures with neighboring countries, both of which occurred in Singapore during the COVID-19 pandemic;
delays in potential expansion plans; or
slowdown of R&D activities.
Likewise, such an outbreak of disease could slow or suspend the operations of our suppliers and cause them to be unable to deliver needed raw materials as required. Any of these factors could materially and adversely affect our results of operations, financial condition, business and prospects.

Risks Related to Manufacturing, Operations and Expansion
If we are unable to manage our capacity and production facilities effectively, our competitiveness may be weakened.
We perform long-term market demand forecasts for our products to manage, and plan for, our overall capacity. Because market conditions are dynamic, our market demand forecasts may change significantly, or prove to be inaccurate, at any time. During periods of decreased demand, certain manufacturing lines or tools in some of our manufacturing facilities may be idled or shut down temporarily, to save costs while preserving capacity. However, if subsequent demand increases rapidly, we may not be able to restore the capacity in a timely manner to take advantage of the upturn. In light of long-term market demand forecasts, we have been adding capacity to meet market needs for our products. In order to respond to expected orders, or to assure sufficient line loading for planned process or yield learning, we may initiate “risk starts” in anticipation of actual orders. This could result in periodically increased inventory costs and/or obsolescence costs if those expected orders do not materialize.
In some instances, we may increase or otherwise manage capacity by transferring technologies from one location to another. Expansion of our capacity will increase our costs. For example, we will need to purchase additional equipment, and hire and train additional personnel to operate the new equipment. In case of a technology transfer, we may also need to source new tooling and materials, train personnel to learn and stabilize new processes and, depending on the technology, obtain government approval for such transfer. If demand does not increase as planned, expansion is delayed or we fail to successfully transfer a technology as planned, we may not increase our net revenue accordingly, which could materially and adversely affect our results of operations, financial condition, business and prospects.
Because we own and operate high-tech manufacturing facilities, our operations have high costs that are fixed or difficult to reduce in the short term, including our costs related to utilization of existing facilities, facility construction and equipment, R&D, and the employment and training of a highly skilled workforce. Additionally, as part of our strategy to effectively
14


manage our capacity and production facilities, we concentrate some of our fabs on certain technologies and/or products, particularly when there is significant demand and we expect continued demand for those particular technologies and/or products. However, this strategy exposes us to the risk that our operations, including our utilization rate for entire fabs, may be severely impacted if there is a sudden or prolonged downturn in demand for those technologies and/or products, particularly if we are unable to predict such downturn sufficiently in advance to pivot our operations. To the extent demand decreases, capacity does not increase in time to meet demand or we fail to forecast demand accurately, we could be required to write off inventory or record underutilization charges, which would lower our gross margin. To the extent any demand decrease is prolonged, our manufacturing capacity could be underutilized, and we may be required to write down our long-lived assets, which would increase our expenses. In addition, deployment of capital for new capacity projects occurs prior to full factory utilization. Consequently, increases in depreciation could be misaligned with planned revenue growth until the factory achieves full utilization, which could materially and adversely affect our operations and financial results. We may also be required to shorten the useful life of under-used facilities and equipment and accelerate depreciation.

Our manufacturing processes are highly complex, costly and potentially vulnerable to impurities and other disruptions and cost increases that can significantly increase our costs and delay product shipments to our customers.
Our semiconductor manufacturing processes are highly complex, require advanced and costly equipment, are difficult to transfer and are continuously being modified to improve manufacturing yields and product performance intended to improve or protect our ability to achieve our revenue and profit plan. Disruptions in manufacturing operations could be caused by numerous issues including impurities in our raw materials (such as chemicals, gases and wafers), supply chain changes to support expansion plans, facilities issues (such as electrical power and water outages), equipment failures (such as performance issues or defects) or IT issues (such as down computer systems and viruses). Any of these issues, and others, could lower production yields or interrupt manufacturing, which could result in the loss of products in process that could cause delivery delays, reduced revenue, increased cost or reduced quality delivered to our customers. These factors could significantly affect our financial results as well as our ability to attract new and retain existing customers.
In the past, we have encountered, among other issues:
capacity constraints due to changes in product mix or the delayed delivery of equipment critical to our production;
construction delays during expansions of our clean rooms and other facilities;
difficulties in upgrading or expanding existing facilities;
failure of manufacturing execution system or automatic transportation systems;
unexpected breakdowns in manufacturing equipment and/or related facilities;
disruptions in connection with changing, transferring or upgrading our process technologies;
electrical power outages and disruptions;
raw materials shortages and impurities; and
delays in delivery or shortages of spare parts used in the maintenance of our equipment.
If the above issues recur or we face similar challenges in the future, we may suffer delays in our ability to deliver our products, which could have a material and adverse effect on our results of operations, financial condition, business and prospects. In addition, we cannot guarantee that we will be able to increase our manufacturing capacity and efficiency in the future to the same extent as in the past. Module 7H, an extension of our existing 300mm Fab 7 operations, began limited production in September 2023. If the above issues recur or we face similar challenges in the future, our ability to ramp production in Module 7H as planned may be delayed. Additionally, if we are unable to offset increases in the costs of key inputs to fabs (including raw materials, electric power and water) through cost reduction programs, the cost increases could materially and adversely affect our results of operations, financial condition, business and prospects.

We are subject to risks associated with the development and implementation of new manufacturing technologies.
Production of ICs is a complex process. We are continually engaged in the development of new manufacturing process technologies and features. Forecasting our progress and schedule for developing new process technologies and features is challenging, and at times we encounter unexpected delays due to the complexity of interactions among steps in the manufacturing process, challenges in using new materials, and other issues. We may expend substantial resources on developing new technologies that are ultimately not successful, which may result in our recognizing significant impairment charges. Diagnosing defects in our manufacturing processes often takes a long time, as manufacturing throughput times can delay our receipt of data about defects and the effectiveness of fixes. We are not always successful or efficient in developing or implementing new technologies and manufacturing processes.
15


Our profit margin may substantially decline if we are unable to continually improve our manufacturing yields, maintain high shipment utilization or fail to optimize the process technology mix of our wafer production.
Our ability to maintain our profit margin depends, in part, on our ability to:
maintain high capacity utilization;
maintain or improve our production yields; and
optimize the technology mix of our production by increasing the number of wafers manufactured by utilizing different processing technologies.
Our shipment utilization affects our operating results because a large percentage of our operating costs is fixed. Our manufacturing yields directly affect our ability to attract and retain customers, as well as the prices of our services. Different technologies load the available capacity differently, and an increase of lower margin product demand could lower the financial performance of a factory while still fully utilizing the available capacity. If we are unable to continuously maintain high capacity utilization, improve our manufacturing yields or optimize the technology mix of our wafer production, our profit margin may substantially decline.
Our manufacturing processes are highly complex, require advanced and costly equipment and are continuously being modified in an effort to improve yields and product performance. Minute impurities or other difficulties in the manufacturing process can lower yields. Further, at the beginning of each semiconductor technological upgrade, the manufacturing yield utilizing the new technology may be lower than the yield under current technology. Our manufacturing efficiency is an important factor in our profitability, and we cannot assure you that we will be able to maintain our manufacturing efficiency or increase manufacturing efficiency to the same extent as our competitors.
We may experience manufacturing problems in achieving acceptable yields or experience product delivery delays in the future as a result of, among other things, capacity constraints, upgrading or expanding our existing facilities, transferring technologies between our sites or introducing new manufacturing materials (e.g. GaN).

If we are unable to obtain adequate supplies of raw materials in a timely manner and at commercially reasonable prices our revenue and profitability may decline.
Our production operations require that we obtain adequate supplies of raw materials, such as silicon wafers, gases, chemicals and photoresist, on a timely basis and at commercially reasonable prices, many of which are not commodities easily replaced with substitutions. In the past, shortages in the supply of some materials, whether by specific vendors or by the industry generally, have resulted in occasional industry-wide price adjustments and delivery delays. Moreover, major natural disasters, trade barriers and political or economic turmoil occurring within the country of origin of such raw materials may also significantly disrupt the availability of such raw materials or increase their prices. Further, since we procure some of our raw materials from sole-sourced suppliers, including raw materials that are significant to our production operations, there is a risk that our need for such raw materials may not be met or that back-up supplies may not be readily available. In addition, recent trade tensions between the United States and China, as well as the conflict in Ukraine, have resulted in substantial price volatility and reduced availability of raw materials, including rare earth metals and natural gas used in our products or in our production operations. Similar price volatility risks may be presented by the war in Israel and its potential expansion. Tariffs, sanctions, export controls, other non-tariff barriers, and other measures undertaken by state actors due to global or local economic conditions could also affect material cost and availability. If the availability of such raw materials is disrupted, manufacturing lines may be stopped or significantly disrupted, impacting our supply chain, which could materially and adversely affect our results of operations. From time to time, including recently, we are advised of shortages of raw materials that could impact our operations. We currently are seeking, and in the future will continue to seek, alternative suppliers and substitute materials and work closely with our existing vendors to support their efforts to provide us with uninterrupted supply. Recently, as a result of demand driven by the semiconductor supply shortage, the costs of raw wafers as well as certain other raw materials were relatively high. Failure to obtain adequate supplies could result in our being unable to meet commitments under our contracts with customers, which could expose us to substantial liquidated damages and other claims, which could materially and adversely affect our results of operations, financial condition, business and prospects.
For some supplies and raw materials, we have, and may in the future, enter into long-term agreements with minimum purchase agreements. Due to the perishable nature of some of these supplies and materials, and the possibility of delayed customer orders, we may negatively impact our costs in a given period or increase our obsolescence charges, impacting our profitability.

If we are unable to obtain adequate supplies of energy at commercially reasonable prices our profitability may decline.
Certain energy products (e.g., electricity, natural gas, petroleum) and water, necessary for our production operations have recently experienced and may continue to experience substantial price volatility, including related to shortages or political or economic instability, in regions where we operate our fabs. We have recently experienced and may continue to experience
16


increases in electricity costs, particularly in Dresden, Germany and Singapore. Electricity costs may fluctuate as a result of various factors. For example, climate change is increasing governmental regulation, which could impact costs. In Vermont, all industries are now required to seek renewable sources of energy, which may result in increased costs to secure supply suitable for the sensitive equipment our production facilities require. Additionally, the war in Israel, especially if it expands throughout the Middle East, may result in substantial volatility of oil prices, which could impact all our sites worldwide. Hedging transactions for many of these materials and other inputs are not always available to us, or are not always available on terms we believe are commercially acceptable. Hedges that we enter into with respect to certain inputs, such as electricity, oil, or alternative energy supplies we may seek to secure, may not be effective to avoid disruptions to our manufacturing operations. Additionally, once our prices with a customer are negotiated, we are generally unable to revise pricing with that customer until our next regularly scheduled price adjustment. As a result, if market prices for essential components increase, we may be unable to pass the price increases through to our customers for products purchased under an existing agreement. Consequently, we are exposed to the risks associated with the volatility of prices for these components and our cost of revenue could increase and our gross margins could decrease in the event of price increases.

Failure to adjust our supply chain volume due to changing market conditions or failure to estimate our customers’ demand could adversely affect our sales and/or our gross margin and could result in additional charges for obsolete or excess inventories or non-cancelable purchase commitments.
We make significant decisions, including determining the levels of business that we will seek and accept, production schedules, personnel needs and other resource requirements, based on our estimates of customer requirements. The possibility of rapid changes in demand for our customers’ products reduces our ability to accurately estimate our customers’ future requirements for our products. On occasion, our customers may require rapid increases in production, which can challenge our resources. We may not have sufficient capacity at any given time to meet our customers’ demands. Conversely, downturns in the semiconductor industry have in the past caused and may in the future cause our customers to significantly reduce the amount of products ordered from us. Because many of our sales, R&D, and manufacturing expenses are relatively fixed, a reduction in customer demand may decrease our gross margins and operating income, which could materially and adversely affect our results of operations, financial condition, business and prospects.
In addition, we base many of our operating decisions, and enter into purchase commitments, on the basis of anticipated sales, which are highly unpredictable. Some of our purchase commitments are non-cancelable, and in some cases we are required to recognize a charge representing the amount of material or capital equipment purchased or ordered that exceeds our actual requirements. For example, we have non-cancelable purchase commitments with vendors and LTAs with certain of our third-party wafer fabrication partners, under which we are required to purchase a minimum number of wafers per year or face financial penalties. These types of commitments and agreements could reduce our ability to adjust our inventory to address declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional charges. If sales in future periods fall substantially below our expectations, or if we fail to accurately forecast changes in demand mix, we could again be required to record substantial charges for obsolete or excess inventories or non-cancelable purchase commitments.
Moreover, during a market upturn, we may not be able to purchase sufficient supplies or components to meet increasing product demand, which could prevent us from taking advantage of opportunities and reduce our sales. In addition, a supplier could discontinue a component necessary for our design, extend lead times, limit supply or increase prices due to capacity constraints or other factors. Our failure to adjust our supply chain volume or estimate our customers’ demands could materially and adversely affect our results of operations, financial condition, business and prospects.
Historically, we do not typically operate with any significant backlog, except in periods of capacity shortage. The historic lack of significant backlog and the unpredictable length and timing of semiconductor cycles makes it more difficult for us to accurately forecast revenue in future periods. Moreover, our expense levels are based in part on our expectations of future revenue, and we may be unable to fully adjust costs in a timely manner to compensate for revenue shortfalls.

Aging infrastructure and power grids and risks to the supply of natural gas, electricity or fresh water could interrupt production.
The semiconductor fabrication process requires extensive amounts of fresh water and a stable source of electricity and natural gas. In addition, it requires effective facilities to manage wastewater. As our production capabilities and our business grow, our requirements for these factors will grow substantially. Although we have not, to date, experienced any instances of lack of sufficient supplies of natural gas or water, or material disruptions in the electricity supply to, or wastewater processing capacity of, any of our fabs beyond temporary or short-term stoppages, the ongoing conflict between Russia and Ukraine has in the past created, and may in the future again create, a substantial risk of natural gas shortage in Europe, which may impact our manufacturing site in Dresden, Germany. Further, we may not have access to sufficient supplies of natural gas, electricity, water or wastewater processing capacity to accommodate our planned growth. Pipeline interruptions, power interruptions, electricity shortages, droughts, geopolitical tensions, or government intervention, particularly in the form of rationing, are factors that could restrict our access to these utilities in the areas in which our fabs are located. If there is an insufficient supply of fresh water, natural gas, electricity or wastewater processing capacity to satisfy our requirements, we may need to limit or delay our production. In addition, a power outage, even of very limited duration, could result in a loss of
17


wafers in production and a deterioration in yield. Any of these occurrences could materially and adversely affect our results of operations, financial condition, business and prospects.

The risk of cyberattacks and other data security breaches requires us to incur significant costs to maintain the security of our networks and data, and, in the event of such breaches, may expose us to liability, adversely affect our operations, damage our reputation, and affect our net revenue and profitability, and our efforts to combat breach and misuse of our systems and unauthorized access to our data may not be successful.
In the ordinary course of our business, we maintain sensitive data on our networks, including our and our customers’ intellectual property and proprietary or confidential business information relating to our business and that of our customers and business partners. Our and our service providers’ IT and computer systems store and transmit customer information, trade secrets, corporate data and personal information, and are otherwise essential to the operation of our production lines, which may make us a target for cyberattacks. The secure maintenance of this information is critical to our business and reputation. In addition, our accreditation as a Trusted Foundry by the Defense Microelectronics Activity and our processing of sensitive information may make us an attractive target for attacks, including industrial or nation-state espionage, organized criminals, and terrorist cyberattacks. Further, we depend on our employees and the employees of our service providers to appropriately handle confidential and sensitive data and deploy our IT resources in a safe and secure manner that does not expose our network systems to security breaches or the loss of data. However, there is always a risk that inadvertent disclosure or actions or internal malfeasance by our employees or those of our service providers could result in a loss of data or a breach or interruption of our IT systems.
As a result of the nature of our business and operations, we have been subject to and will continue to be subject to cyberattacks from various bad actors. In September 2023, we did experience a cyber-related incident, which is described in more detail in “Item 16K. Cybersecurity—Governance.” Although to date, we have not been subject to cyberattacks which, to our knowledge, have had a material impact to our operations or financial condition (individually or in aggregate), there is no certainty that future cyberattacks will not have a material adverse effect on our business, operations, or financial results.
We continue to make significant investments in cybersecurity and data security, as well as other efforts to combat breach and misuse of our systems and unauthorized access to our and our customers’ data by third parties. While we seek to continuously review and assess our cybersecurity policies and procedures to ensure their adequacy and effectiveness, all IT and computer systems are vulnerable to attacks, especially via methods that have not been observed yet or quickly evolve. The risk of security breaches may be higher during times of a natural disaster or pandemic due to remote working arrangements. Also, the development and proliferation of AI/ML in addition to other related technologies, may increase our exposure to cyber attacks and other cybersecurity risks by providing third parties with enhanced capabilities to breach our systems, and may require us to spend additional resources to further strengthen our defenses against such threats. We cannot guarantee that our IT and computer systems which control or maintain vital corporate functions, such as our manufacturing operations and enterprise accounting, would be immune to cyberattacks. In the event of a serious cyberattack, our systems may lose important customer information, trade secrets, corporate data or personal information, or our production lines may be shut down pending the resolution of such an attack.
We employ certain third-party service providers for us and our affiliates worldwide with whom we need to share highly sensitive and confidential information to enable them to provide the relevant services. Some of our third-party service providers have experienced cyberattacks of which we have been made aware.
Despite requiring certain third-party service providers to comply with the confidentiality and security requirements in our service agreements with them, there is no assurance that each of them will strictly fulfill any of their obligations or that they will be successful in preventing further cyberattacks. The on-site network systems and the off-site cloud computing networks such as servers maintained by these service providers and/or their contractors are also subject to risks associated with cyberattacks. While we attempt to take prompt action once we are alerted to a cyberattack against one of our third-party service providers and implement steps designed to mitigate associated risks to our systems and data, we may in the future not be made aware of such events in a timely manner or may be unable to successfully sever network connectivity or otherwise limit the risk to our own systems.
If we or our service providers are not able to timely contain, remediate and resolve the respective issues caused by cyberattacks and data breaches, or ensure the integrity and availability of our systems and data (or data belonging to our customers or other third parties) or control of our or our service providers’ IT or computer systems, then such attacks, breaches or failures could:
disrupt the proper functioning of these networks and systems and, therefore, our operations and/or those of certain of our customers;
result in the unauthorized access to, and destruction, loss, theft, misappropriation or release of, proprietary, confidential, sensitive or otherwise valuable information of ours, our customers or our employees, including trade secrets, which could be used to compete against us or for disruptive, destructive or otherwise harmful purposes and outcomes;
result in litigation and governmental investigation and proceedings that could expose us to civil or criminal liabilities;
18


compromise national security and other sensitive government functions;
require significant management attention and resources to remedy the damages that result;
result in our incurring significant expenses in implementing remedial and improvement measures to enhance our IT network or computer systems;
result in costs which exceed our insurance coverage and/or indemnification arrangements;
subject us to claims for contract breach, damages, credits, penalties or termination; and
damage our reputation with our customers (including the U.S. government) and the general public.
Further, remediation efforts may not be successful and could result in interruptions, delays or cessation of service, unfavorable publicity, damage to our reputation, customer allegations of breach-of-contract, possible litigation, and loss of existing or potential customers that may impede our sales or other critical functions. Additionally, any such attack or unauthorized access may require spending resources on correcting the breach and indemnifying the relevant parties and litigation, regulatory investigations, regulatory proceedings, increased insurance premiums, lost revenue, penalties fines and other potential liabilities.
Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

We may be unable to obtain manufacturing equipment in a timely manner and at a reasonable cost that is necessary for us to remain competitive.
Our operations and ongoing revenue expansion plans depend on our ability to obtain complex and specialized manufacturing equipment and related services from a limited number of suppliers in a market that is characterized from time to time by limited supply and long delivery cycles. During such times, supplier-specific or industry-wide lead times for delivery can be as long as twelve months or more. Further, growing complexities of the most valuable equipment may delay the timely delivery of such equipment and parts needed to capitalize on time-sensitive and perishable business opportunities. Industry-wide demand increases for this equipment could increase its market price as well as the market price of replacement parts and consumable materials needed to operate the equipment. Due in part to demand driven by significant new sources of funding in China as well as potentially other governments (such as Korea, the United States and Europe), the demand for semiconductor manufacturing equipment may result in longer than normal lead times for such equipment. Similarly, an industry-wide increase in demand may result in longer than normal lead times for such equipment or higher prices. If we are unable to obtain equipment in a timely manner to fulfill our customers’ demand on technology and production capacity, or at a reasonable cost, we may be unable to meet commitments under our contracts with customers, which could expose us to substantial liquidated damages and other claims and could materially and adversely affect our results of operations, financial condition, business and prospects.

We may be subject to the risk of loss due to fire because the materials we use in our manufacturing processes are highly flammable.
We use highly flammable materials such as silane and hydrogen in our manufacturing processes and may therefore be subject to the risk of loss arising from fires. The risk of fire associated with these materials cannot be completely eliminated. We maintain insurance policies to reduce losses caused by fire, including business interruption insurance. However, our insurance coverage is subject to deductibles and self-insured retention and may not be sufficient to cover all of our potential losses. If any of our fabs were to be damaged or cease operations as a result of a fire, our manufacturing capacity would be reduced, which could materially and adversely affect our results of operations, financial condition, business and prospects.

Our operations are subject to the risks of earthquakes, wildfires, floods, severe weather incidents and other natural catastrophic events, and to interruption by man-made problems such as power disruptions, industrial accidents, or terrorism.
Significant natural disasters such as earthquakes, wildfires, floods, severe weather incidents or acts of terrorism occurring in any of our manufacturing or office locations, or where a business partner, such as a customer or supplier, is located, could adversely affect our operational and financial performance. In addition, natural disasters, spills or hazardous exposure incidents, accidents and acts of terrorism could cause disruptions in our business or our suppliers’ or customers’ businesses, national economies or the global economy as a whole, and we may not have insurance coverage for these matters. Our operations, as well as our computing systems, are vulnerable to interference, or interruption from terrorist attacks, natural disasters or pandemics, the effects of climate change (such as sea level rise, drought, flooding, wildfires, increased average temperatures and increased storm severity), power loss, telecommunications failures, criminal fraud or impersonation, inadvertent or intentional actions by our employees, or other attempts to harm or access our systems. In the event of a major disruption caused by a natural disaster or any of the foregoing, we may be unable to continue our operations and may endure system interruptions, reputational harm, delays in our development activities, lengthy interruptions in service,
19


breaches of data security and loss of critical data or personal information, any of which could materially and adversely affect our results of operations, financial condition, business and prospects.

If we are unable to successfully deploy AI/ML across our products and services and our business operations and adequately anticipate and account for legal, regulatory and social developments in the AI/ML space, we may become less competitive against our peers and we may incur significant costs that do not provide us with commensurate returns.
AI/ML has the potential to generate significant business value for semiconductor companies, including foundries. Manufacturing is the semiconductor industry's largest cost driver and AI/ML has the potential to, among other things, reduce costs, improve yields, shorten processing times, and increase production. Use cases include utilizing AI/ML to handle repetitive tasks, improve predictive maintenance, develop and optimize process design kits, optimize process times, improve and shorten wafer inspections and optimize inventory and supply chain management and operations. If we do not adopt and deploy AI/ML as quickly or efficiently as our competitors, we may not be able to provide foundry services on competitive terms, including with respect to cost, schedule, and volume manufacturing capacity, which may lead to us losing design wins, losing market share and losing customers. The rapid pace of AI/ML’s development may require the investment of significant resources for us to remain competitive, and we may not receive commensurate returns if we are not successful in achieving the outcomes we expect (either on the timelines we expect or at all). The risk of falling behind our competitors could expose us to higher costs than our peers, as we operate primarily in countries that have higher labor and overhead costs relative to many of our competitors. If we do not have competitive products and services available to meet our customers’ AI/ML related needs, or if we fail to anticipate the changing needs and preferences of our key stakeholders, we may lose significant business and growth opportunities and lose market share. Any failure on our part to effectively and efficiently utilize AI/ML to enhance our operations, products and services and manufacturing strategy may result in material impacts to our financial performance, financial results and overall business strategy.

Any use of AI/ML technologies in our operations may present additional labor, legal, regulatory, and social risks, which could lead to additional costs and impact our competitive position.
AI/ML and related new technologies could disrupt our workforce needs. As AI/ML becomes more prevalent in the semiconductor industry, there may be higher demand for, and fiercer competition to recruit, personnel with specific skillsets that are currently not abundant in the industry. GF’s existing workforce may also need to undergo changes to account for developments in the way semiconductor manufacturing and foundries operate as a result of incorporating AI/ML. New technologies in the market that disrupt our workforce needs may also cause us to undergo other changes to better respond to changing market conditions and to stay ahead of our peers. All of these may result in significant costs to GF, and there can be no assurance that any initiatives, strategies or projects GF pursues will be successful in mitigating or preventing these risks.
Because AI/ML is a developing technology in its nascency, legal frameworks for AI/ML governance are unsettled, quickly developing, and unpredictable. Some uses of AI pose emerging ethical issues and present a number of risks that cannot be fully mitigated. Using AI/ML while the technology is still developing may expose us to additional liability, reputational harm, and threats of litigation, particularly if the AI/ML we adopt produces errors, AI bias, AI hallucination, harmful content, discrimination, intellectual property infringement or misappropriation, data privacy or cybersecurity issues, or otherwise does not function as intended. For example, AI/ML technologies are highly reliant on the collection and analysis of large amounts of data and complex algorithms, which may be overbroad, insufficient, or contain biased information. Moreover, with the use of AI/ML technologies, there often exists a lack of transparency of the sources of data used to train or develop the AI/ML technologies or how inputs are converted to outputs and we cannot fully validate this process and its accuracy. The accuracy of such inputs and the resulting impacts on the results of AI/ML technologies cannot be verified and could result in outputs that may include or be derived from inaccurate or erroneous information.
The use of AI/ML, including potential inadvertent disclosure of confidential information or personal identifiable information, could also lead to legal and regulatory investigations and enforcement actions, or may give rise to specific obligations, including required notices, consents and opt-outs, under various data privacy, protection and cybersecurity laws and regulations in a number of jurisdictions. See “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to Manufacturing, Operations and Expansion—Compliance with applicable data security and data privacy laws and regulations may be costly and, in the case of a breach of applicable law, could harm our reputation” for more information relating to risks relating to data protection and compliance with existing and future laws and regulations. See also “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to Manufacturing, Operations and Expansion—The risk of cyberattacks and other data security breaches requires us to incur significant costs to maintain the security of our networks and data, and, in the event of such breaches, may expose us to liability, adversely affect our operations, damage our reputation, and affect our net revenue and profitability, and our efforts to combat breach and misuse of our systems and unauthorized access to our data may not be successful” for more information on the cybersecurity risks relating to AI/ML technologies.
Further, despite our investment in AI/ML, there is no assurance that new laws and regulations will not restrict the ways we can use the AI/ML we have adopted, including by limiting or changing global AI/ML adoption trends that may impede our strategy. Moreover, regulations relating to AI/ML technologies may also impose certain obligations on organizations, and the
20


costs of monitoring and responding to such regulations, as well as the consequences of non-compliance, could have an adverse effect on our operations or financial condition. For example, provisional political agreement on a proposed EU AI Act was reached between co-legislators in December 2023, and formally approved in February 2024, and such proposed legislation includes that specific transparency and other requirements would be introduced for general purpose AI systems and the models on which those systems are based, which may apply to the AI/ML we have adopted. The EU AI Act is expected to apply after a transitional period of two years after its entry into force (which may come into effect as early as May or June 2024). Once in effect, the EU AI Act would impose material requirements on both the providers and deployers of AI/ML technologies, with infringement punishable by sanctions of up to 7% of annual worldwide turnover or EUR 35 million (whichever is higher) for the most serious breaches. In addition, the White House's Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence devises a framework for the U.S. government, among other things, to regulate private sector use and development of certain foundation models. Unfavorable legal and regulatory developments could also impact our vendors, suppliers and industry as a whole, and we may be exposed to increased risk of liability, reputational harm, and other significant costs if we need to make business and operational changes in response to such developments. Our failure, or perceived failure, to comply fully with developing interpretations of AI/ML laws and regulations, or meet evolving and varied stakeholder expectations and industry standards, could harm our business, reputation, financial condition, and operating results.

Certain of our debt agreements contain covenants that may constrain the operation of our business, and our failure to comply with these covenants could materially and adversely affect our results of operations, financial condition, business and prospects.
Restrictive covenants in our credit facilities may prevent us from pursuing certain transactions or business strategies, including by limiting our ability to, in certain circumstances:
incur additional indebtedness;
pay dividends or make distributions;
acquire assets or make investments outside of the ordinary course of business;
sell, lease, license, transfer or otherwise dispose of assets;
enter into transactions with our affiliates;
create or permit liens;
guarantee indebtedness;
enter into change of control transactions; and
engage in certain extraordinary transactions.
Failure to comply with any of the covenants in our debt agreements, including due to events beyond our control, could result in an event of default. The holders of the defaulted debt could terminate commitments to lend and accelerate amounts outstanding to be due and payable immediately. This could also result in cross-defaults under our other debt instruments, significantly impacting our liquidity and ability to fund our operations. Any of these occurrences could materially and adversely affect our results of operations, financial condition, business and prospects.

Compliance with applicable data security and data privacy laws and regulations may be costly and, in the case of a breach of applicable law, could harm our reputation.
In the United States, federal and state laws impose limits on, or requirements regarding the collection, distribution, use, security and storage of personal information of individuals, and there has been increased regulation of data privacy and security particularly at the state level, including the California Consumer Privacy Act (effective on January 1, 2020), and the California Privacy Rights Act (effective on January 1, 2023). Furthermore, many other states, such as Virginia, Colorado, Connecticut, Utah and others have enacted or are actively considering or enacting similar laws and we operate in many of these jurisdictions. Outside the United States, the European Union and other countries in which we operate also have privacy and data protection laws, regulations and standards, including the European Union’s General Data Protection Regulation (the “EU GDPR”), the United Kingdom’s GDPR (the “UK GDPR”), and India’s new Digital Personal Data Protection Act.
The interpretation and application of many of these existing or recently enacted laws and regulations are increasingly complex, uncertain and fluid, and could be inconsistent with our existing data management practices. For example, the EU GDPR and UK GDPR generally restrict the transfer of personal information to countries outside the European Economic Area (“EEA”) and the United Kingdom (“UK”) to the United States and other jurisdictions without appropriate safeguards or other measures. Additionally, while the EU-U.S. Data Privacy Framework, which went into effect on July 10, 2023, allows companies to transfer personal information from the European Union to the United States without additional safeguard measures (e.g., standard contractual clauses or binding corporate rules), such framework (like past frameworks) is subject
21


to legal challenge. These developments could lead to substantial costs, require significant changes, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities. If we are unable to transfer personal data between and among countries and regions in which we operate, it could affect the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results. In addition, the existing EU and UK privacy laws on cookies and e-marketing are also in flux and are likely to be replaced by new regulations, which may introduce more stringent requirements for using cookies and similar technologies for direct marketing and significantly increase fines for non-compliance in-line with the GDPR. Stricter enforcement of such laws could limit the effectiveness of our marketing activities, divert the attention of our technology personnel, increase costs and subject us to additional liabilities.
Inappropriate disclosure of personal and other sensitive data, even if inadvertent, or other actual or perceived violations of or noncompliance with such laws and regulations could expose us to significant administrative, civil or criminal liability as well as reputational harm. For example, a breach of the GDPR could result in fines of up to 20 million euros (“EUR”) under the EU GDPR or British pound sterling (“GBP”) 17.5 million under the UK GDPR or up to 4% of the annual global revenue of the infringer, whichever is greater, as well as regulatory investigations, reputational damage, orders to cease or change our processing of personal data, enforcement notices and/or assessment notices (for a compulsory audit). Privacy-related claims or lawsuits initiated by governmental bodies, employees or other third parties, whether meritorious or not, could be time-consuming, result in costly regulatory proceedings, litigation, penalties and fines, or require us to change our business practices, sometimes in expensive ways, or other potential liabilities.
Additionally, a failure to comply with the National Institute of Standards and Technology Special Publication 800-171 or the Department of Defense (”DoD”)’s cybersecurity requirements, including the Cyber Security Material Model Certificate (“CMMC”), which will require all contractors to receive specific third-party cybersecurity certifications to be eligible for contract awards, could restrict our ability to bid for, be awarded and perform on DoD contracts. The DoD expects that all new contracts will be required to comply with the CMMC by 2026, and initial requests for information and for proposal have already begun. We are in the process of evaluating our readiness and preparing for the CMMC. To the extent we, or our subcontractors or other third parties on whom we rely are unable to achieve certification in advance of contract awards that specify the requirement, we may be unable to bid on contract awards or follow-on awards for existing work with the DoD, which could materially and adversely affect our results of operations, financial condition, business and prospects. We will also be required to go through a recertification process every two years. In addition, any obligations that may be imposed on us under the CMMC may be different from or in addition to those otherwise required by applicable laws and regulations, which may cause additional expense for compliance.

Our products may contain defects that could harm our reputation, be costly to correct, delay revenue and expose us to litigation.
Our products are highly complex and sophisticated and, from time to time, may contain defects, errors, hardware failures or other failures that are difficult to detect and correct. Errors, defects and other failures may be found in new solutions, products or services or improvements to existing solutions, products or services after delivery to our customers. If these defects, errors and failures are discovered, we may not be able to successfully correct them in a timely manner or otherwise mitigate or eliminate the impact of the error or failure. The occurrence of errors, defects and other failures in our products could result in the delay or the denial of market acceptance of our products and alleviating such errors, defects and other failures may require us to make significant expenditure of our resources. Our products are often used for critical business processes and as a result, any defect in or failure of our products may cause customers to reconsider renewing their contract with us, cause significant customer dissatisfaction and possibly giving rise to claims for indemnification or other monetary damages. The harm to our reputation resulting from errors, defects and other failures may be material. Any claims for actual or alleged losses to our customers’ businesses may require us to spend significant time and money in litigation or arbitration or to pay significant settlements or damages. Defending a lawsuit, regardless of merit, can be costly and divert management’s attention and resources. Accordingly, any such claim could materially and adversely affect our results of operations, financial condition, business and prospects.

Any problem in the semiconductor outsourcing infrastructure could materially and adversely affect our results of operations, financial condition, business and prospects.
Many of our customers depend on third parties to provide assembly, testing and other related services. Many of these services are geographically concentrated primarily in Asia. If these customers cannot timely obtain those services on reasonable terms, they may not order foundry products and services from us, which could materially and adversely affect our results of operations, financial condition, business and prospects.




22


Risks related to Intellectual Property
Any failure to obtain, maintain, protect or enforce our intellectual property and proprietary rights could impair our ability to protect our proprietary technology and our brand.
Our success depends to a significant degree on our ability to obtain, maintain, protect and enforce our intellectual property rights. We rely on a combination of patents, trade secrets, copyrights, trademarks, service marks, and other forms of intellectual property, contractual restrictions and confidentiality procedures to establish and protect our proprietary rights. However, the steps we take to obtain, maintain, protect and enforce our intellectual property rights may be inadequate. We may not be able to protect our technology, know-how, and/or brand if we are unable to enforce our rights for whatever reason or if we do not detect unauthorized use of our intellectual property rights. If we fail to protect our intellectual property rights adequately, our competitors may gain access to our proprietary technology and develop and commercialize substantially similar products, services or technologies, which could materially and adversely affect our results of operations, financial condition, business and prospects.
We have filed various applications for certain aspects of our intellectual property in the United States and other countries, and we have built a comprehensive patent portfolio of approximately 9,000 worldwide patents. In the future, we may acquire additional patents or patent portfolios, license patents from third parties or agree to license the technology of third parties, which could require significant cash expenditures. Our patents do not cover all of our technologies, systems, products and product components and our competitors or others may design around our patented technologies. Further, when we seek patent protection for a particular technology, there is no assurance that the applications we file will result in issued patents or that if patents do issue as a result that they will be found to be valid and enforceable or that they will effectively block competitors from creating competing technology. In addition, we may need to license technology from third parties to develop and market new products and we cannot be certain that we could license that technology on commercially reasonable terms or at all. Our inability to license this technology could harm our ability to compete and materially and adversely affect our results of operations, financial condition, business and prospects.
Some of our know-how or technology is not patented or patentable and may constitute trade secrets. To protect our trade secrets, we have a policy of requiring our employees, consultants, advisors and other collaborators who contribute to our material intellectual property to enter into confidentiality agreements. We also rely on customary contractual protections with our suppliers and customers, and we implement security measures intended to protect our trade secrets, know-how and other proprietary information. However, no assurances can be given that those contracts will not be breached. Further, those contracts and arrangements may be ineffective in protecting our intellectual property and may not prevent unauthorized disclosure. See also “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to Intellectual Property—There is a risk that our trade secrets, know-how and other proprietary information will be stolen, used in an unauthorized manner, or compromised, which could materially and adversely affect our results of operations, financial condition, business and prospects.” In addition, third parties may independently develop technologies that may be substantially equivalent or superior to our technology.

There is a risk that our trade secrets, know-how and other proprietary information will be stolen, used in an unauthorized manner, or compromised, which could materially and adversely affect our results of operations, financial condition, business and prospects.
Our trade secrets, know-how and other proprietary information may be stolen, used in an unauthorized manner, or compromised through a direct intrusion by private parties or foreign actors, including those affiliated with or controlled by state actors, through cyber intrusions into our computer systems, physical theft through corporate espionage or other means, or through more indirect routes, including by joint venture partners, licensees that do not honor the terms of the license, potential licensees that were ultimately not licensed, or other parties reverse engineering our company’s solutions, products or components. For example, in 2023, we filed a trade secret misappropriation lawsuit against IBM based on IBM’s disclosure to Intel Corp. and Rapidus Inc. of technology and know-how that GF contends IBM was not authorized to disclose.
AI/ML technologies can also be misused or misappropriated by third parties and/or our employees. Moreover, there is a risk that an employee may input confidential information, including material non-public information, trade secrets or personal identifiable information, into AI/ML technologies applications, resulting in such information becoming accessible by third parties, including our competitors. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

The laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate.
The absence of internationally harmonized intellectual property laws and different enforcement regimes makes it more difficult to ensure consistent protection of our proprietary rights. Our strong international presence may lead to increased exposure to unauthorized copying and use of our manufacturing technologies and proprietary information. Moreover, policing unauthorized use of our technologies, trade secrets, and intellectual property may be difficult, expensive and time-consuming, particularly in foreign countries where the laws may not be as protective of intellectual property rights as those in
23


the United States and where mechanisms for enforcement of intellectual property rights may be weak. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon, misappropriating or otherwise violating our intellectual property rights. Our inability to secure or enforce our intellectual property rights could materially and adversely affect our results of operations, financial condition, business and prospects.

We have been, and may continue to be, subject to intellectual property disputes, which are costly and may subject us to significant liability and increased costs of doing business.
The semiconductor industry is subject to claims of infringement by patent owners and is characterized by frequent litigation regarding patent rights. From time to time, we receive communications from third parties that allege that our products or technologies infringe their patent or other intellectual property rights and we have had patent infringement lawsuits filed against us claiming that certain of our products, services, or technologies infringe the intellectual property rights of others. We may continue to become subject to such intellectual property disputes in the future. Further, we have entered into licenses, including patent licenses with third parties in settlements of claims or in order to avoid intellectual property disputes and the loss of license rights, including as a result of a termination or expiration of such licenses, may limit our ability to use certain technologies in the future, which could cause us to incur significant costs, prevent us from commercializing certain of our products or otherwise have a material adverse effect on us. In addition, there may be issued patents held by third parties that, if found to be valid and enforceable, could be alleged to be infringed by our current or future technologies or products. There also may be pending patent applications of others that may result in issued patents, which could be alleged to be infringed by our current or future technologies or products.
In order to protect our intellectual property rights, we may be required to spend significant resources to monitor and protect those rights. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming and distracting to management. Further, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims and countersuits attacking the validity and enforceability of our intellectual property rights, and if such defenses, counterclaims or countersuits are successful, we could lose valuable intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay the implementation of our manufacturing technologies, delay introductions of new solutions or injure our reputation and could have a material and adverse effect on our results of operations, financial condition, business and prospects.
Further, many of our agreements with our customers and partners, the terms of which often survive termination or expiration of the applicable agreement, require us to defend such parties against certain intellectual property infringement claims and indemnify them for damages and losses arising from certain intellectual property infringement claims against them, which have in the past resulted, and could in the future result, in increased costs for defending such claims or significant damages if there is an adverse ruling in any such claims. These defense costs and indemnity payments could materially and adversely affect our results of operations, financial condition, business and prospects. Such customers and partners may also discontinue the use of our products, services, and solutions, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business. We may also have to seek a license for the technology, which may not be available on reasonable terms, if at all, and may significantly increase our operating expenses or may require us to restrict our business activities and limit our ability to develop and deliver our products. As a result, we may also be required to develop alternative non-infringing technology, which could require significant effort and expense or which may not be possible, which could negatively affect our business. Moreover, intellectual property indemnities provided to us by our suppliers, when obtainable, may not cover all damages and losses suffered by us and our customers arising from intellectual property infringement claims. Even if we were to prevail in such a dispute, any litigation regarding our intellectual property could be costly and time-consuming and divert the attention of our management and key personnel from our business operations.
Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

Our success depends, in part, on our ability to develop and commercialize our technology without infringing, misappropriating or otherwise violating the intellectual property rights of third parties and we may not be aware of such infringements, misappropriations or violations.
Third parties may bring claims alleging infringement, misappropriation or violation of intellectual property rights. We cannot guarantee that we have not, do not or will not infringe, misappropriate or otherwise violate the intellectual property rights of others. Our technologies may not be able to withstand any third-party claims against their use. In addition, some companies may have the capability to dedicate substantially greater resources to enforce their intellectual property rights and to defend claims that may be brought against them. Furthermore, third parties have and may continue to assert infringement claims against us in the future, including the sometimes aggressive and opportunistic actions of non-practicing entities whose business model is to obtain patent-licensing revenue from operating companies such as us. Regardless of the merit of such claims, any claim that we have violated intellectual property or other proprietary rights of third parties, whether or not it results in litigation, is settled out of court or is determined in our favor, could be expensive and time-consuming, and could divert the time and attention of management and technical personnel from our business. The litigation process is subject to
24


inherent uncertainties, and we may not prevail in litigation matters regardless of the merits of our position. In some jurisdictions, plaintiffs can also seek injunctive relief that may limit the operation of our business or prevent the marketing and selling of our services that infringe or allegedly infringe on the plaintiff’s intellectual property rights. If a third party is able to obtain an injunction preventing us from using our technology, accessing third-party intellectual property rights, or if we cannot license or develop alternative technology for any infringing aspect of our business, we could be forced to limit or stop manufacturing activities or sales of our products or cease other business activities related to such intellectual property. To resolve these claims, we may enter into licensing agreements with restrictive terms or significant fees, stop selling our products or services or be required to implement costly or inferior redesigns to the affected products or services, or pay damages to satisfy contractual obligations to others. If we do not resolve these claims in advance of a trial, there is no guarantee that we will be successful in court. These outcomes could materially and adversely affect our results of operations, financial condition, business and prospects.

We may be unable to provide technology to our customers if we lose the support of our technology partners.
Enhancing our manufacturing process technologies is critical to our ability to provide services for our customers. We intend to continue to advance our process technologies through internal R&D and alliances with other companies. In addition to our internal R&D focused on developing new and improved semiconductor manufacturing process technologies, our business involves collaboration, including customization and other development of technologies and intellectual property, with and for our customers, vendors and other third parties. We frequently enter into agreements with customers, vendors, equipment suppliers and others that involve customization and other development of technologies and intellectual property. As a result of these agreements, we may be required to limit use of, or refrain from using, certain technologies and intellectual property rights in parts of our business. Determining inventorship and ownership of technologies and intellectual property rights resulting from development activities can be difficult and uncertain.
Disputes may arise with customers, vendors and other third parties regarding ownership of and rights to use and enforce these technologies and intellectual property rights or regarding interpretation of our agreements with these third parties, and these disputes may result in claims against us or claims that intellectual property rights are not owned by us, are not enforceable, or are invalid. The cost and effort to resolve these types of disputes, or the loss of rights in technologies in intellectual property rights if we lose these types of disputes, could harm our business and financial condition. In addition, our customers, vendors and other third parties may suffer delays, quality issues, or other problems affecting their development activities and ability to supply us with certain technology and intellectual property, which could adversely affect our business and operating results. Further, if we are unable to continue any of our joint development arrangements or other agreements, on mutually beneficial terms, or if we cannot re-evaluate the technological and economic benefits of such relationships with these partners, vendors or suppliers in a timely manner sufficient to support our ongoing technology development, we may be unable to continue providing our customers with leading edge or differentiated mass-producible process technologies and may, as a result, lose important customers, which could have a materially adverse effect on our results of operations, financial condition, businesses and prospects.

Risks Related to Strategic Transactions
We may make strategic transactions, and such transactions may introduce significant risks and uncertainties, including risks related to integrating the acquired companies, assets or businesses.
We have in the past sought, and may in the future seek, to acquire or invest in businesses, joint ventures and technologies that we believe could complement or expand our capacity, enhance our technology offerings or otherwise offer growth opportunities. These transactions, particularly acquisitions, may be subject to regulatory approvals, including approval from the Committee on Foreign Investment in the United States (“CFIUS”) and approvals from antitrust authorities. With regard to CFIUS, our transactions may be more likely to require CFIUS review given the expansion of CFIUS jurisdiction to critical technologies as well as the increased public scrutiny on the industry due to the CHIPS and Science Act. Failure to obtain CFIUS approval, as applicable, and other required regulatory approvals may delay or otherwise limit our ability to make strategic transactions. In addition to domestic regulatory focus, semiconductor technology has been the focus of international regulatory review. China has been particularly focused on transactions in the technology industry and has rejected some proposed transactions. The changing nature of government reviews may impact the ability for inorganic growth of our business.
Our integration efforts may periodically expose deficiencies in the controls and procedures relating to cybersecurity and the compliance with data privacy and protection laws, regulations and standards of an acquired company or business that were not identified in our due diligence undertaken prior to consummating the acquisition. Additionally, we may encounter difficulties assimilating or integrating the businesses, technologies, products, personnel or operations of any acquired companies, particularly if the key personnel of an acquired company cannot be retained, or we have difficulty preserving the customers of any acquired business. These transactions could also result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our results of operations.
We have also in the past sought, and may in the future seek, to divest ourselves of businesses, dispose of assets, cease investments, or wind down joint ventures or manufacturing alliances. Current market conditions may increase the difficulty
25


and costs of finding buyers and may cause us to obtain less-favorable transaction terms. Winding down joint ventures or manufacturing alliances may cause us to be subject to penalties, unrecoverable initial investments, and other losses. In addition, in the case of the divestiture of manufacturing facilities, we may be obligated to rely on buyers’ wafer production in order to fulfil existing customer commitments in the short run.
These efforts may divert the attention of management and cause us to incur various expenses in identifying, investigating and pursuing suitable opportunities, whether or not the transactions are completed, and may result in unforeseen operating difficulties and expenditures. Any such transactions that we are able to complete may not result in the synergies, efficiencies or other benefits we expected to achieve, which could result in substantial impairment charges and other losses. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

We are in the process of implementing a strategic collaboration with ST Microelectronics (“ST”) pursuant to which ST and the Company are building and fitting out a new, jointly-operated fab in Crolles, France. Failure to successfully implement and manage the strategic collaboration may adversely affect our results of operation, financial conditions, business and prospects.
In August 2022, we entered into a Commercial and Cooperation Agreement with ST for the build-out and joint operation of a new 300mm semiconductor manufacturing facility. This facility is targeted to ramp up to 620,000 300mm wafers per year production at full build-out. In June 2023, the Company announced the conclusion of the agreement for the jointly operated semiconductor manufacturing facility, which would benefit from significant financial support from the state of France.
Implementing this strategic collaboration is a complex and lengthy process that requires, among other things, both parties receiving substantial government funding that is dependent on meeting various milestones, both parties paying their respective share of agreed capital investments, and both parties cooperating on the joint operation of the facility.
We may, at any time, have disagreements with ST or have interests or goals that are inconsistent with ST’s goals, which may result in conflicting views as to plan and timing of the build-out and the operation of the facility, which disagreements or conflicts may not be resolved in our favor. Because ST will own the building for the manufacturing facility, we inherently have a lesser degree of control over business operations, thereby increasing the financial, legal, operational, and/or compliance risks to us. We may not be able to oversee all aspects of the build-out and operation, which may lead to a potential inability to implement adequate internal controls covering the collaboration. Additionally, we will depend on ST to commit sufficient resources to the project, over which we will have no control. The collaboration requires us to partially rely on the financial condition of ST and could be adversely affected by any significant change in its financial conditions.
The collaboration is also subject to the risk that we or ST may not meet the milestones required to obtain the substantial government funding that is needed to make the project a success.
We may not be successful in our efforts to build and operate this new facility, and we may not achieve the anticipated benefits that we expected to achieve. Further, we may decide not to move forward with the joint operation of the facility depending on any of the above-mentioned factors and/or due to current market dynamics. As a result, any existing investments, including in purchases of equipment or payments for construction, may result in losses.
If any of the above risks come to fruition, we may be delayed or may be unsuccessful in our efforts to implement this collaboration or jointly operate the facility, or we may incur losses on the project, all of which could have a material adverse effect on our results of operations and our financial condition.

Political, Regulatory and Legal Risks
Environmental, health and safety laws and regulations expose us to liability and risk of non-compliance, and any such liability or non-compliance could adversely affect our business.
In each jurisdiction in which we operate, our operations are subject to diverse environmental, health and safety laws and regulations that govern, among other things, emissions of pollutants into the air, wastewater discharges, the use and handling of hazardous substances, waste disposal, the investigation and remediation of soil and ground water contamination and the health and safety of our employees. Semiconductor manufacturing depends on a wide array of process materials, including hazardous materials that are subject to local, state, national and international regulations. These materials, our manufacturing operations and our products and services are subject to diverse environmental, health and safety laws, regulations and regulatory requirements. Sourcing of materials could also present reputational risks if our direct or indirect suppliers are found to be in violation of environmental health and safety regulations, or ethical or human rights regulations or standards.
Regulatory changes, including restrictions on new or existing materials critical to our manufacturing processes, proposed regulations to address emerging contaminants such as per- and polyfluoroalkyl substances, increased restrictions related to discharges into water, air emissions and hazardous substances, changes to necessary permitting requirements, or changes in interpretations, could cause disruptions to our operations or necessitate additional costs or capital expenditures, such as those associated with identifying and qualifying substitute materials or processes, or with installing additional controls related to wastewater, air emissions or waste management. Regulatory limitations or restrictive covenants at contaminated
26


properties could affect our ability to expand manufacturing operations or capacities and may affect our ability to import materials or equipment.
Industrial accidents or releases, including those associated with storage, use, transportation or disposal of hazardous materials or wastes, could expose us to liabilities or remediation obligations and we may not have insurance coverage for such matters. Non-compliance with environmental, health and safety regulations or associated permit requirements may result in liabilities or monetary penalties. Non-compliance with or public controversy regarding environmental, health and safety matters could result in reputational harm.
Certain environmental laws, including the Comprehensive Environmental Response, Compensation and Liability Act, the Resource Conservation and Recovery Act and state equivalents, make us potentially liable on a strict, joint and several basis for the investigation and remediation of contamination at, or originating from, facilities that are currently or formerly owned or operated by us and third-party sites to which we send or have sent materials for disposal or materials for recycling, along with related natural resources damages. We could become subject to potential material liabilities for the investigation and cleanup of historic contamination (including, potentially, emerging contaminants) on the U.S. properties where we operate should the currently responsible parties cease their ongoing remediation efforts notwithstanding their contractual obligations to us.
Regulations and customer-imposed requirements in response to climate change could result in additional costs related to changes in process materials, control of process emissions, “carbon taxes” or related fees, and sourcing of energy supplies. Increased frequency of extreme weather events, and chronic conditions like higher temperatures and droughts could cause disruptions to our manufacturing facilities, non-manufacturing operations and supply chain.
We have policies, controls, and procedures designed to help ensure compliance with applicable laws, including as part of our Environmental, Social and Governance (“ESG”) initiatives. However, there can be no assurance that our employees, contractors, suppliers or agents will not violate such laws or our policies. Violations of these laws and regulations can result in fines, criminal sanctions against us, our officers, or our employees, prohibitions on the conduct of our business, and damage to our reputation. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

We are subject to anti-corruption, anti-bribery, anti-money laundering, counter-terrorist financing laws and similar laws and regulations, and non-compliance with such laws, regulations and standards can subject us to administrative, criminal or civil liability and harm our business, financial condition, results of operations and reputation.
We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, U.S. anti-bribery laws and other anti-corruption, anti-bribery, anti-money laundering and counter-terrorist financing laws and regulations in the countries in which we conduct business. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies, their employees and their third-party intermediaries from authorizing, offering or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sectors. In connection with our international sales and business and sales to the public sector, we may engage with business partners and third-party intermediaries to market our products and services and to obtain necessary permits, licenses, and other regulatory approvals. In addition, our third-party intermediaries, or other business partners, may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for corrupt or other illegal activities of these third-party intermediaries or other business partners, their employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. Although we have policies and procedures to address compliance with such laws and regulations, there is a risk that our employees and agents will take actions in violation of our policies and applicable law, for which we may be ultimately held responsible.
Detecting, investigating and resolving actual or alleged violations of anti-corruption laws can require a significant diversion of time, resources and attention from senior management. In addition, noncompliance with anti-corruption, anti-bribery, anti-money laundering or counter-terrorist financing laws and regulations could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, enforcement actions, fines, damages, other civil or criminal penalties or injunctions, suspension or debarment from contracting with certain persons, reputational harm, adverse media coverage and other collateral consequences. In the past, we have experienced minor issues related to anti-corruption investigations involving vendors attempting to influence employees at our Singapore location. To date, we have not experienced any such investigations that were determined to be material to our business or financial results. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal proceeding, our results of operations, financial condition, business and prospects could be materially and adversely affected. Even in the event of a positive outcome in such an investigation or proceeding, the cost of the investigation or defense could be significant and negatively affect our financial performance.
These laws, regulations and standards are driving the review and updating of many corporate policies and systems, often at significant expense. Until there is a settling of a consistent and stable global approach, our company, with customers and employees around the world, will be exposed to financial risk in complying with these requirements. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.
27



We are subject to governmental export and customs compliance requirements that could impair our ability to compete in international markets or subject us to liability if we violate the controls.
Our products and technology are subject to export controls in the jurisdictions where we do business. For example, in the United States, we are subject to the Export Administration Regulations and the International Traffic in Arms Regulations (“ITAR”). Under these regulations, certain commodities, software and technology may be exported only with the required export authorizations. Some technology and software that we create or possess is controlled under these regulations, and in certain cases, we are required to maintain controls limiting the access to such technology and software, even among our own employees. Furthermore, our activities are subject to economic sanctions laws and regulations, including U.S. economic sanctions laws and regulations administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control that prohibit or restrict dealings that are within U.S. jurisdiction with, in or involving certain jurisdictions subject to comprehensive U.S. sanctions and certain designated persons and entities. We have corporate policies and procedures in place reasonably designed to ensure compliance with all applicable export control and economic sanctions laws and regulations.
In some cases, our compliance obligations may result in the loss of sales opportunities. In other cases, we may experience delays in our ability to conduct business as we await government authorization. Violations of economic sanctions or export control regulations can result in significant administrative fines or penalties or even criminal prosecution.

We currently are, and may in the future continue to be, subject to litigation that could result in substantial costs, divert or continue to divert management’s attention and resources, and materially and adversely affect our results of operations, financial condition, business and prospects.
On June 7, 2021 we filed a complaint in the Supreme Court of New York seeking declaratory judgment that we had not violated certain agreements entered into with International Business Machines Corporation (“IBM”) relating to our acquisition of IBM’s Microelectronics division in 2015, and subsequent development and research activities and sales of our products to IBM. On June 8, 2021, IBM filed a complaint in the Supreme Court of New York asserting intentional breach of contract and fraudulent misrepresentation claims under the same set of agreements. IBM argues that it is entitled to a return of its $1.5 billion payment to the company and at least $1 billion in damages. On September 14, 2021, the Court granted our motion to dismiss IBM’s claims of fraud, unjust enrichment and breach of the implied covenant of good faith and fair dealing. Our complaint seeking declaratory judgment was dismissed. On April 7, 2022, the Appellate Division reversed the lower court's dismissal of the fraud claim. Discovery and dispositive motion practice have been completed and the parties are awaiting a trial date. We believe, based on discussions with legal counsel, that we have meritorious defenses against IBM’s claims. We dispute IBM’s claims and intend to vigorously defend against them. We do not currently anticipate this proceeding to have a material impact on our results of operations, financial condition, business and prospects.
In addition, we have been, and may continue to be, subject to legal proceedings and claims that arise in the ordinary course of business, such as claims brought by our customers in connection with commercial disputes, product liability claims, employment claims made by our current or former employees or claims of infringement raised by intellectual property owners, in connection with the technology used in our manufacturing operations. The risk of such litigation may increase due to use of our products in safety-related systems of other advanced technologies, including automobiles.
Any existing or future disputes, claims or proceedings could result in substantial costs and may divert management’s attention and resources. Insurance might not cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims and might not continue to be available on terms acceptable to us. A claim brought against us that is uninsured or underinsured could result in unanticipated costs, potentially harming our business, financial position and results of operations. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects. Further, negative publicity arising from disputes, claims or proceedings may damage our reputation and adversely affect the image of our brand and our products. In addition, if any verdict or award is rendered against us, we could be required to pay significant monetary damages, assume other liabilities and even to suspend or terminate related business ventures or projects.

If regular or statutory consultation processes with employee representatives such as works councils fail or are delayed, or if our employees were to engage in a strike or other work stoppage, our results of operations, financial condition, business and prospects could be materially and adversely affected.
We may be required to consult with our employee representatives, such as works councils, on items such as work hours, restructurings, acquisitions and divestitures. Although we believe that our relations with our employees, employee representatives, labor unions and works councils are satisfactory, no assurance can be given that we will be able to successfully extend or renegotiate these agreements as they expire from time to time or, in the case of transactions, to conclude potential consultation processes in a timely way. A significant number of our employees in Dresden, Germany are covered by collective bargaining agreements, and our employees in the U.S. could also potentially unionize. If we fail to extend or renegotiate our labor agreements, collective bargaining agreements, and social plans, if significant disputes with unions arise, or if our workers engage in a strike or other work stoppage, we could incur higher ongoing labor costs or
28


experience a significant disruption of operations. We have in the past faced minor work stoppages at certain of our manufacturing facilities in connection with negotiations of labor agreements. While none of these past incidents have resulted in material impacts to our production, there can be no assurance that there will not be material impacts to our production and our ability to timely provide products to our customers in the event that larger, longer or more frequent work stoppages occur in the future. Our collective bargaining agreements are typically subject to negotiation every one to two years, and our ability in the past to resolve such negotiations does not mean that we will be able to resolve future negotiations without strikes or disruptions, or on terms we consider reasonable. Any of the foregoing factors could materially and adversely affect our results of operations, financial condition, business and prospects.

Currency and Interest Rate Risks
We are exposed to foreign currency risk, which could materially adversely affect our expenses and profit margins and could result in exchange losses.
The majority of our sales are denominated in U.S. dollars, and therefore, our revenue is not subject to foreign currency risk. However, an increase in the value of the U.S. dollar can increase the real cost to our customers of our products and services in those markets outside of the United States where we sell in U.S. dollars. Conversely, a weakened U.S. dollar can increase the cost of expenses such as our direct labor, raw materials and overhead that are incurred outside of the United States. These operating expenses are denominated in foreign currencies and are subject to fluctuations due to changes in foreign currency exchange rates. Additionally, this could impact our capital expenditures with foreign suppliers we pay in non-U.S. dollar currencies. We also engage in financing activities in local currencies. Our hedging programs may not be able to effectively offset any, or more than a portion, of the impact of currency exchange rate movements. As a result, unfavorable changes in exchange rates could materially and adversely affect our results of operations, financial condition, business and prospects.

We have significant exposure to the Secured Overnight Financing Rate (“SOFR”) and other floating interest rates and fluctuations in interest rates may have adverse effects on our financial condition and results of operations.
SOFR is a broad measure of the cost of borrowing cash overnight collateralized by U.S. Treasury securities. SOFR has a limited history, and the future performance of SOFR cannot be predicted based on its limited historical performance. The level of SOFR may bear little or no relation to historical, actual or indicative data. Prior observed patterns, if any, in the behavior of market variables and their relation to SOFR, such as correlations, may change in the future. While some pre-publication historical data have been released by the Federal Reserve Bank of New York, such analysis inherently involves assumptions, estimates and approximations, and hypothetical or historical performance data are not indicative of, and have no bearing on, the potential performance of SOFR. The future performance of SOFR is therefore impossible to predict, and no future performance of SOFR may be inferred from any of the historical, actual or indicative data. Changes in the levels of SOFR will affect the interest rate we have to pay under our outstanding debt agreements, given that we have fully transitioned to SOFR from the London Interbank Offered Rate (“LIBOR”).
Because a majority of our debt is primarily based on floating interest rate benchmarks (including SOFR), fluctuations in interest rates could have a material effect on our business. We currently utilize, and may in the future utilize, derivative financial instruments such as interest rate swaps or interest rate caps to hedge some of our exposure to interest rate fluctuations, but such instruments may not be effective in reducing our exposure to interest fluctuations, and we may discontinue utilizing them at any time. As a result, we may incur higher interest costs if interest rates increase. These higher interest costs could have a material adverse impact on our financial condition and the levels of cash we maintain for working capital.
Interest rates are highly sensitive to many factors, including governmental monetary policies, domestic and international economic and political conditions, and other factors beyond our control. If SOFR increases as a result of events over which we have no control, this could have a material adverse effect on our financial condition and results of operations. If SOFR increases, our debt service obligations would increase even if the amount borrowed remained the same, and our net loss will increase and cash flows from operating activities, including cash available for servicing our indebtedness, will correspondingly decrease.

Risks Related to Changes in Effective Tax Rate and Accounting Principles
Changes in our effective tax rate or tax liability may have an adverse effect on our results of operations.
Our effective tax rate or tax liability could increase due to several factors, including, but not limited to:
changes in the relative amounts of income before taxes in the various jurisdictions in which we operate that have differing statutory tax rates;
changes in tax laws, tax treaties and regulations or the interpretation of them;
29


changes to our assessment about our ability to realize our deferred tax assets that are based on estimates of our future results, the prudence and feasibility of possible tax planning strategies, and the economic and political environments in which we do business;
the outcome of current and future tax audits, examinations or administrative appeals;
limitations or adverse findings regarding our ability to do business in some jurisdictions; and
significant changes to our majority ownership may inhibit our utilization of net operating losses and certain tax attributes against future income tax liabilities.

Changes such as these that affect our effective tax rate could materially and adversely affect our results of operations and financial condition.

Our international operations subject us to potentially adverse tax consequences.
We generally conduct our international operations through subsidiaries and report our taxable income in various jurisdictions worldwide based upon our business operations in those jurisdictions. Our intercompany relationships are subject to complex transfer pricing regulations administered by taxing authorities in various jurisdictions. The relevant taxing authorities may disagree with our determinations as to the value of assets sold or acquired or income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, and our position were not sustained, we could be required to pay additional taxes, interest, and penalties, which could result in one-time tax charges, higher effective tax rates, reduced cash flows, and lower overall profitability of our operations. There is also a high level of uncertainty in today’s tax environment stemming from both global initiatives put forth by the Organisation for Economic Co-operation and Development, or the “OECD”, and unilateral measures being implemented by various countries due to a historic lack of consensus on these global initiatives. As an example, the OECD has put forth two proposals—Pillar One and Pillar Two—that revise the existing profit allocation and nexus rules (profit allocation based on location of sales versus physical presence) and ensure a minimal level of taxation, respectively. Changes in multilateral agreements and the tax laws of foreign jurisdictions are underway as a result of the base erosion and profit shifting project undertaken by the OECD and could significantly increase our tax provision, cash taxes paid, and effective tax rate.
The jurisdictions in which we conduct business where we are primarily subject to income taxes are Germany, Singapore and the United States, and these jurisdictions may also have the most material Pillar Two impacts. Singapore has passed legislation implementing OECD compliant rules expected to be effective in 2025 which may dilute benefits of current Singapore Economic Development Board incentives, while Germany has draft legislation and may implement rules effective in 2024 or 2025. The United States and Cayman Islands have not yet introduced legislation to comply with OECD Pillar Two guidelines but our income in those jurisdictions may become subject to Pillar Two regimes in other jurisdictions.
A global minimum corporate tax rate and any other implemented changes could significantly increase tax uncertainty due to differing interpretations and increased audit scrutiny. Our status as a Controlled Company may subject us to further complexities related to OECD initiatives in relation to our position in Mubadala’s global portfolio as further OECD and jurisdictional guidance is released. We will continue to monitor and evaluate the impact of OECD policy changes. On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act of 2022 (“IRA”) into law effective for tax years starting after December 31, 2022. The IRA includes a variety of incentives to promote clean energy but also adds a new corporate alternative minimum tax of 15% on adjusted financial statement income. The U.S. corporate alternative minimum tax did not have an impact on our effective tax rate or cash taxes in 2023 but is expected to have an adverse impact on the effective tax rate and require cash tax payments beginning in 2024.

Risks Related to Our Status as a Controlled Company and Foreign Private Issuer
Our majority shareholder, Mubadala, will continue to have substantial control of the business, which could limit your ability to influence the outcome of key transactions, including a change of control, and otherwise affect the prevailing market price of our ordinary shares.
Mubadala beneficially owns, in the aggregate, approximately 84.82% of our outstanding ordinary shares. See “Item 7. Major Shareholder and Related Party Transactions.” In addition, we have entered into a shareholder’s agreement with Mubadala, which will entitle Mubadala, subject to the level of Mubadala’s beneficial ownership of our ordinary shares, to certain consent rights and director nomination rights and, from time to time, we contract with Mubadala to provide management and operations support, including the services of our Chief Operating Officer. As a result, Mubadala will continue to have significant influence over the management and affairs of our company, as well as the ability to control the outcome of matters submitted to our shareholders for approval, including the election of directors and the approval of significant corporate transactions, including any merger, consolidation or sale of all or substantially all of our assets and the issuance or redemption of equity interests in certain circumstances. The interests of Mubadala may not always coincide with, and in some cases may conflict with, our interests and the interests of our other shareholders. For instance, Mubadala could attempt to delay or prevent a change in control of our company even if such change in control would benefit our other
30


shareholders, or attempt to force or accelerate a change in control even if such change in control would not benefit our other shareholders. Additionally, Mubadala could sell their shares at a discount. Any of the above could deprive our other shareholders of an opportunity to receive a premium for their ordinary shares. This concentration of ownership may also affect the prevailing market price of our ordinary shares due to investors’ perceptions that conflicts of interest may exist or arise, and because Mubadala may sell, or investors may perceive that Mubadala is likely to sell, a significant amount of our ordinary shares.

As a foreign private issuer and a controlled company, we are not subject to certain corporate governance rules applicable to U.S.-listed companies.
As a foreign private issuer that has listed our ordinary shares on Nasdaq, we rely on a provision in the Nasdaq corporate governance listing standards that allows us to follow Cayman Islands law with regard to certain aspects of corporate governance. This allows us to follow certain corporate governance practices that differ in significant respects from the corporate governance requirements applicable to U.S. companies listed on Nasdaq.
For example, we are exempt from Nasdaq regulations that require a listed U.S. company to:
have a majority of the board of directors consist of independent directors;
require non-management directors to meet on a regular basis without management present;
have an independent compensation committee;
have an independent nominating committee; and
seek shareholder approval for the implementation of certain equity compensation plans and issuances of ordinary shares.
As a foreign private issuer, we are permitted to follow home country practice in lieu of the above requirements. Our Audit, Risk and Compliance Committee (“Audit Committee”) is required to comply with the provisions of Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which is applicable to U.S. companies listed on Nasdaq. Accordingly, we have a fully independent Audit Committee.

We are a foreign private issuer and, as a result, are not subject to U.S. proxy rules but are subject to reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. issuer.
We are a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act, and although we follow the laws and regulations of the Cayman Islands with regard to such matters, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. public companies, including: (i) the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act, (ii) the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time and (iii) the rules under the Exchange Act requiring the filing of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events. Foreign private issuers are required to file their annual report on Form 20-F within four months after the end of each fiscal year. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information. As a result of the above, you may not have the same protections afforded to shareholders of companies that are not foreign private issuers. This may be the case even though we intend to make interim reports available to our shareholders, copies of which we are required to furnish to the SEC on a Form 6-K, and even though we are required to file reports on Form 6-K disclosing whatever information we have made or are required to make public pursuant to Cayman Islands law or distribute to our shareholders and that is material to us.

We are a Cayman Islands company and, because judicial precedent regarding the rights of shareholders is more limited under Cayman Islands law than that under U.S. law, you may have less protection for your shareholder rights than you would under U.S. law.
Our corporate affairs are governed by our Amended and Restated Memorandum and Articles of Association (the “Memorandum and Articles of Association”), as amended and restated from time to time, the Cayman Islands Companies Act (as amended) (the “Cayman Companies Act”) and the common law of the Cayman Islands. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as that from English common law, which has persuasive, but not binding, authority on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are not as clearly defined as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a less prescriptive body of securities laws than the United States. In addition, some U.S. states, such as
31


Delaware, have more fulsome and judicially interpreted bodies of corporate law than the Cayman Islands. As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders than they would as shareholders of a corporation incorporated in a jurisdiction in the United States.

Our officers and directors presently have, and any of them in the future may have, additional fiduciary or contractual obligations to other entities, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
Our directors and officers presently have, and any of them in the future may have, additional fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business opportunity to such entity, subject to his or her fiduciary duties under Cayman Islands law. Accordingly, they presently or in the future may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential business opportunity may be presented to another entity prior to its presentation to us, subject to their fiduciary duties under Cayman Islands law.
Our Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other; and (iii) no individual serving as a director or an officer shall have a duty to communicate or offer any such corporate opportunity to us, nor shall such individuals be liable to us for a breach of fiduciary duty solely by reason of the fact that such party pursues or acquires such corporate opportunity for himself or herself, directs such corporate opportunity to another person, or does not communicate information regarding such corporate opportunity to us.
For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Item 6. Directors, Senior Management and Employees” and “Item 7. Major Shareholders and Related Party Transactions.”

The Cayman Islands Economic Substance Act may affect our operations.

The Cayman Islands has recently enacted the International Tax Co-operation (Economic Substance) Act, or the Cayman Economic Substance Act. The Cayman Economic Substance Act generally requires legal entities domiciled or registered in the Cayman Islands which conduct certain geographically mobile activities to have demonstrable substance in the Cayman Islands. The Cayman Economic Substance Act was introduced by the Cayman Islands to ensure that it meets its commitments to the European Union, as well as its obligations under the OECD’s global Base Erosion and Profit Shifting initiatives. We are required to comply with the Cayman Economic Substance Act.
As we are a Cayman Islands company, compliance obligations include filing annual notifications for us, which need to state whether we are carrying out any relevant activities and, if so, whether we have satisfied economic substance tests to the extent required under the Cayman Economic Substance Act. As it is a relatively new regime, it is anticipated that the Cayman Economic Substance Act will evolve and be subject to further clarification and amendments. We may need to allocate additional resources to keep updated with these developments, and may have to make changes to our operations in order to comply with all requirements under the Cayman Economic Substance Act. Failure to satisfy these requirements may subject us to penalties under the Cayman Economic Substance Act. The Cayman Islands Tax Information Authority shall impose a penalty of CI$10,000 (or US$12,500) on a relevant entity for failing to satisfy the economic substance test or CI$100,000 (or US$125,000) if such failures are not remedied in the subsequent financial year after the initial notice of failure. Following failure after two consecutive years the Grand Court of the Cayman Islands may make an order requiring the relevant entity to take specified action to satisfy the economic substance test or ordering it that it is defunct or be struck off. Pursuant to the Companies Act, any property vested in or belonging to a company which has been struck off shall vest in the Cayman Islands government.
During 2022, the Company received a notice of failure to satisfy the economic substance test for the 2020 financial year, and a penalty of CI$10,000 (or US$12,500). During 2023, the Company received a second notice of failure to satisfy the economic substance test for the 2020 financial year, and a further penalty of CI$10,000 (or US$12,500). The Company has
32


paid the foregoing monetary penalties and taken appropriate remedial steps in 2022 and 2023 to satisfy the economic substance test.

Risks Related to Operating as a Public Company
Our management has identified material weaknesses in our ICFR and has concluded that our ICFR was not effective as of December 31, 2023, which may have a material adverse result on our results of operation and financial condition for future periods.
Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our ICFR is a process meant to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles. We regularly undertake the process of documenting, reviewing and improving our internal controls and procedures for compliance with Section 404 of SOX, which requires annual management assessment of the effectiveness of our ICFR. Over the course of 2023, we completed the testing of our internal controls, as we worked to comprehensively evaluate our controls following our first full year as a public company.
For the fiscal year ended December 31, 2023, our management identified two material weaknesses in our ICFR. For further information on the material weaknesses identified by our management in 2023, see “Item 15—Controls and Procedures—Management’s Annual Report on internal control over financial reporting.” In light of the identified material weaknesses, our management concluded that our ICFR was not effective as of December 31, 2023. Although we are developing and implementing several measures to remedy these material weaknesses, we cannot be certain that there will be no other material weaknesses in our ICFR in the future. There can also be no assurance as to the effectiveness of our remediation plan, whether the actions we are taking and plan to take will give us the results we expect, or that our remediation plan will be completed on the timelines that we expect.
If our efforts to remediate the material weaknesses identified in fiscal year 2023 are unsuccessful, we may be unable to report our results of operations for future periods accurately and in a timely manner and make our required filings with government authorities, including the SEC. We cannot be certain that additional material weaknesses will not develop or be discovered in the future. In the course of remediating the material weaknesses, there may also be impacts to our disclosure controls and procedures, whereby we may not have the ability to prevent or detect on a timely basis (or at all) any material misstatement in the Company’s accounts or disclosures that could result in a material misstatement to the Company’s consolidated financial statements or other disclosures.
Implementing any appropriate changes to our internal controls will require the attention of our officers and employees, entail substantial costs to modify our existing processes and take significant time to complete the change and any required training. In addition, investors’ perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm the trading price of our ordinary shares and make it more difficult for us to effectively market and sell our products and services to new and existing customers. Any of these occurrences could adversely affect our results of operation and financial condition.

We are incurring increased costs and expenses as a result of operating as a public company and our management is required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.
As a public company, we incur significant legal, accounting and other expenses related to compliance matters. We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002 (“SOX”), the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), and the rules and regulations of Nasdaq, which impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. These requirements may invite lawsuits or shareholder actions that could distract management and negatively impact financial results due to required responses and increased our legal, accounting, and financial compliance costs and make some activities more difficult, time-consuming, and costly, and place significant strain on our personnel, systems and resources.
These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.

33


Risks Related to our Ordinary Shares
Future sales or distributions of our shares by Mubadala could depress the price of our ordinary shares.
Sales by Mubadala in the public market or other distributions of substantial amounts of our ordinary shares, or the filing of a registration statement relating to a substantial amount of our ordinary shares, could depress our ordinary share price. We have entered into agreements with Mubadala that provide a framework for our ongoing relationship, including a Shareholder’s Agreement and Registration Rights Agreement. Under the Registration Rights Agreement, Mubadala has the right, subject to certain conditions, to require us to file registration statements covering its shares or to include its shares in other registration statements that we may file. By exercising its registration rights and selling a large number of shares, Mubadala could cause the price of our ordinary shares to decline.

We do not expect to declare or pay any dividends on our ordinary shares for the foreseeable future.
We do not intend to pay cash dividends on our ordinary shares for the foreseeable future. Consequently, investors must rely on sales of their shares of our ordinary shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking dividends should not purchase shares of our ordinary shares. Any future determination to pay dividends will be at the discretion of the Company’s board of directors (the “Board of Directors” or “Board”) and subject to, among other things, our compliance with applicable law, and depending on, among other things, our business prospects, financial condition, results of operations, cash requirements and availability, debt repayment obligations, capital expenditure needs, the terms of any preferred equity securities we may issue in the future, covenants in the agreements governing our current and future indebtedness, other contractual restrictions, industry trends and any other factors or considerations our Board of Directors may regard as relevant. See “Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Dividends and Dividend Policy.”

Anti-takeover provisions in our organizational documents and Cayman Islands law may discourage or prevent a change of control, even if an acquisition would be beneficial to our shareholders, which could depress the price of our ordinary shares and prevent attempts by our shareholders to replace or remove our current management.
Our Memorandum and Articles of Association contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best interests. Our Board of Directors is divided into three classes with staggered, three-year terms. Our Board of Directors has the ability to designate the terms of and issue preferred shares without shareholder approval. We are also subject to certain provisions under Cayman Islands law that could delay or prevent a change of control. Together these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our ordinary shares.

Our Memorandum and Articles of Association provide that the courts of the Cayman Islands will be the exclusive forum for certain disputes between us and our shareholders, which could limit our shareholders’ ability to obtain a favorable judicial forum for complaints against us or our directors, officers or employees.
Our Memorandum and Articles of Association provide that unless we consent in writing to the selection of an alternative forum, the courts of the Cayman Islands will, to the fullest extent permitted by the law, have exclusive jurisdiction over any claim or dispute arising out of or in connection with our Memorandum and Articles of Association or otherwise related in any way to each shareholder’s shareholding in us, including but not limited to (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of any fiduciary or other duty owed by any of our current or former directors, officers or other employees to us or our shareholders, (iii) any action asserting a claim arising pursuant to any provision of the Cayman Companies Act or our Memorandum and Articles of Association, and (iv) any action asserting a claim against us governed by the “Internal Affairs Doctrine” (as such concept is recognized under the laws of the United States) and that each shareholder irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over all such claims or disputes. Our Memorandum and Articles of Association provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States will be the exclusive forum for the resolution of any complaint asserting a cause or causes of action arising under the Securities Act of 1933, as amended (“Securities Act”), or Exchange Act, including all causes of action asserted against any defendant named in such complaint.
Our Memorandum and Articles of Association also provide that, without prejudice to any other rights or remedies that we may have, each of our shareholders acknowledges that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum and that accordingly we shall be entitled, without proof of special damages, to the remedies of injunction, specific performance or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.
This choice of forum provision may increase a shareholder’s cost and limit the shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Any person or entity purchasing or otherwise acquiring
34


any of our shares or other securities, whether by transfer, sale, operation of law or otherwise, shall be deemed to have notice of and have irrevocably agreed and consented to these provisions. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies’ charter documents has been challenged in legal proceedings. It is possible that a court could find this type of provisions to be inapplicable or unenforceable, and if a court were to find this provision in our Memorandum and Articles of Association to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could have adverse effect on our business and financial performance.

Our Memorandum and Articles of Association provide for indemnification of officers and directors at our expense, which may result in a major cost to us and hurt the interests of our shareholders because corporate resources may be expended for the benefit of officers and/or directors.
Our Memorandum and Articles of Association and applicable law of the Cayman Islands provide for the indemnification of our directors and officers, under certain circumstances, against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions in connection with our company, other than such liability (if any) that they may incur by reason of their own actual fraud, dishonesty, willful neglect or willful default. We will also bear the expenses of such litigation for any of our directors or officers, upon such person’s undertaking to repay any amounts paid, advanced, or reimbursed by us if it is ultimately determined that any such person shall not have been entitled to indemnification. This indemnification policy could result in substantial expenditures by us that we will be unable to recoup.
We have been advised that, in the opinion of the SEC, indemnification for liabilities arising under federal securities laws is against public policy as expressed in the Securities Act, and is, therefore, unenforceable.

ITEM 4.    INFORMATION ON THE COMPANY
A.    History and Development of the Company
Our History
We were established in 2009 when a subsidiary of Mubadala acquired the manufacturing operations of Advanced Micro Devices, Inc. (“AMD”) in Dresden, Germany, and their fab project site in Malta, New York. Since our inception, we have grown through a combination of acquisitions, greenfield expansions and strategic partnerships. In 2010, we combined with Chartered Semiconductor Manufacturing (“Chartered Semiconductor”), the third-largest foundry by revenue at the time, forming the basis for our Singapore manufacturing hub. In 2015, we acquired IBM’s Microelectronics division with manufacturing facilities in New York and Vermont, adding distinctive technology capabilities, including more than 2,000 IBM engineers. By 2017, we had successfully ramped our most advanced manufacturing site in Malta, New York.
In 2018, we undertook a strategic pivot to focus on the pervasive foundry market opportunity and the growing demand for specialized process technologies. The pervasive semiconductor market comprises the ICs that serve applications in wide-ranging end markets and industries rather than just processor-centric compute. As part of this strategic pivot, we streamlined our manufacturing footprint by divesting three assets that were not aligned with our strategic priorities.
On November 1, 2021, we completed our initial public offering (“IPO”). Our ordinary shares have been listed on Nasdaq under the symbol “GFS” since October 28, 2021.
In September 2023, Module 7H, an extension of our existing 300mm Fab 7 operations in Singapore, began limited production. Once fully ramped, we anticipate Module 7H having an aggregate 450,000 wafers of annual capacity.
Through our organic and strategic growth initiatives, we increased manufacturing capacity and now have a global footprint, encompassing three continents, with approximately 12,000 employees and approximately 9,000 worldwide patents. We currently operate four manufacturing sites in the following locations: Dresden, Germany; Singapore; Malta, New York; and Burlington, Vermont. On December 31, 2022 we completed the sale of our EFK business to ON Semiconductor. In 2023, we shipped approximately 2.2 million 300mm equivalent semiconductor wafers. With this level of market presence and capability, our technologies are found across most semiconductor end markets in devices used on a daily basis.
Today, we focus on essential chip solutions for the pervasive semiconductor market, where we are trusted to reliably innovate and deliver premium performance, functionality, efficiency and quality, rather than focusing merely on transistor density and processing speed.
For a description of our principal capital expenditures in the last three fiscal years and a discussion of our acquisitions and dispositions, see “Item 5. Operating and Financial Review and Prospects.”
Corporate Information
Our legal and commercial name is GlobalFoundries Inc. We are an exempted company that was incorporated in the Cayman Islands with limited liability on October 7, 2008. We have appointed Corporation Service Company as our agent to
35


receive service of process with respect to any action brought against us in the United States under the federal securities laws of the United States or of any state in the United States. The address of Corporation Service Company is 251 Little Falls Drive, Wilmington, DE 19808. Our principal executive offices are located at 400 Stonebreak Road Extension, Malta, New York 12020, United States, and our telephone number is (518) 305-9013.
Our website address is www.gf.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into this Annual Report, and you should not consider information on our website to be part of this Annual Report. In addition, the SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.
The GF design logo, “GF” and our other registered or common law trademarks, service marks, or trade names appearing in this Annual Report are the property of GlobalFoundries Inc. Other trade names, trademarks and service marks used in this Annual Report are the property of their respective owners.

B.     Business Overview
We manufacture complex, essential ICs that are used in billions of electronic devices across various industries. Our specialized foundry manufacturing processes, extensive library of qualified circuit-building block designs (known as IP titles or IP blocks), and advanced transistor and device technology allow us to serve a wide range of customers, including global leaders in IC design. We focus on providing optimized solutions for critical applications that drive key secular growth end markets, ensuring function, performance, and power requirements are met. As the only scaled pure-play foundry with a global footprint that is not based in China or Taiwan, we offer our customers the advantage of mitigating geopolitical risk and ensuring greater supply chain certainty. Our definition of a scaled pure-play foundry is a company that specializes in producing ICs for other companies, with annual foundry revenue exceeding $2.5 billion. Our differentiated foundry solutions redefine the industry by offering essential chip solutions that empower our customers to develop innovative products for a wide range of applications in diverse markets.
Since our founding in 2009, we have invested over $23 billion to create a global manufacturing footprint with state-of-the-art facilities across three continents. This allows us to provide our customers with the flexibility and supply chain security they require. Additionally, as semiconductor technologies become more complex, we offer comprehensive design solutions and services to help our customers bring their products to market quickly and cost-effectively. We continuously expand our ecosystem of partners, including IP, electronic design automation, outsourced assembly and test, and design services, to enhance our offerings. With a vast library of IP titles and ongoing development across multiple process nodes, we are committed to delivering high-quality, cost-effective solutions that meet the evolving needs of our customers.
We focus on essential devices that include digital, analog, mixed-signal, radio frequency (“RF”), ultra-low power and embedded memory solutions that connect, secure and process data, and efficiently power the digital world around us. Our core technology portfolio includes a range of differentiated technology platforms, including our industry-leading RF SOI solutions, advanced high-performance Fin Field-Effect Transistor (“FinFET”), Complementary Metal-Oxide Semiconductor (“CMOS”), our proprietary FDXTM, high-performance Silicon Germanium (“SiGe”) and Gallium Nitride (“GaN”) products and SiPh, all of which can be purposely engineered, innovated and designed for a broad set of demanding applications.
The combination of our highly differentiated technology and our scaled manufacturing footprint enables us to attract a large share of single-sourced products and LTAs, providing a high degree of revenue visibility and significant operating leverage, resulting in improved financial performance and bottom line growth. These agreements include binding, multi-year, reciprocal annual (and, in some cases, quarterly) minimum purchase and supply commitments with wafer pricing and associated mechanics outlined for the contract term. Through an intense focus on collaboration, we have built deep strategic partnerships with a broad base of more than 250 customers as of December 31, 2023, many of whom are the global leaders in their field.
For the year 2023, our top ten customers, based on wafer shipment volume, included some of the largest semiconductor companies in the world: AMD, Cirrus Logic, Inc. (“Cirrus Logic”), Infineon Technologies AG (“Infineon”), Marvell Technology Inc., MediaTek Inc., NXP Semiconductors N.V., Qorvo, Inc., Qualcomm Inc. (“Qualcomm”), Samsung, and Sony Semiconductor Manufacturing Corporation. A key measure of our position as a strategic partner to our customers is the mix of our wafer shipment volume attributable to single-sourced business, which represented approximately 62% of wafer shipment volume in 2023. We define single-sourced products as those that we believe can only be manufactured with our technology and cannot be manufactured elsewhere without significant customer redesigns.
Since foundry production is concentrated in China and Taiwan, we believe our global manufacturing footprint is a key differentiator that makes us the ideal partner for local and regional government stakeholders at a time when many regions, in particular the United States and Europe, have passed legislation contemplating significant funding to secure and grow their respective domestic semiconductor manufacturing capabilities. For a breakdown of our revenue by geography (based on the location of our customers’ headquarters), see Note 32 to our Annual Consolidated Financial Statements.
With four world-class manufacturing sites on three continents and approximately 2.2 million 300mm equivalent semiconductor wafers shipped in 2023, we provide the geographic diversification, scale and technology differentiation that we believe are critically important to our customers’ success.
36



Technology Platforms
We offer a wide range of essential chip solutions that can address the needs of mission-critical applications in Smart Mobile Devices, Home and Industrial IoT, Communications Infrastructure & Datacenter, Automotive and Personal Computing. To solve our customers’ most complex challenges, we have developed a broad range of sophisticated technology platforms that leverage our extensive patent portfolio and deep technical expertise in digital, analog, mixed-signal, RF and embedded memory.
We devote the majority of our R&D efforts to our three primary differentiated technology platforms, namely CMOS, RF and Power:
1.Feature-Rich CMOS: Our CMOS platforms combined with foundational and complex IP and design enablement offer mixed-technology solutions on volume production-proven processes and are well-suited for a wide variety of applications, with features including high-voltage triple-gate oxide for display drivers, and embedded non-volatile memory for micro-controllers. We organize our CMOS platforms across several product platforms, including FDX, FinFET and SiPh.
i.FDXTM: Our proprietary FDXTM process technology platform is especially well-suited for efficient single-chip integration of digital and analog signals delivering cost-effective performance for connected and low-power embedded applications. A full range of features, such as Ultra-Low Power (“ULP”), Ultra-Low Leakage (“ULL”), RF and mmWave, embedded Magnetoresistive Random Access Memory (“MRAM”) and automotive, makes our FDXTM process technology platform especially well-matched for IoT/wireless, 5G (including mmWave), automotive radar, and satellite communications applications.
ii.FinFET: Our FinFET process technology is purpose-built for high-performance, power-efficient Systems-on-a-Chip (“SoCs”) in demanding, high-volume applications. Advanced features such as RF, automotive, ultra-low power memory and logic provide a best-in-class (12 to 16 nanometer (“nm”)) combination of performance, power and area, and are well-suited for compute and AI, mobile/consumer and automotive processors, high-end IoT applications, high performance transceivers and wired/wireless networking applications.
iii.SiPh: Our SiPh platforms address the increasing need for data centers to handle ever higher data rates and volumes with greater power efficiency, as conventional copper wire connections are becoming prohibitive from a power consumption perspective. Our SiPh platforms integrate photonics components with CMOS logic and RF to enable a fully integrated, monolithic electrical and optical computing and communications engine. Our SiPh technologies are also being extended to applications such as Light Detection and Ranging (“LiDAR”), quantum computing and consumer optical networks.
2.    RF
i.RF SOI: Our industry-leading RF SOI technologies are utilized in high-growth, high-volume wireless and Wi-Fi markets and are optimized for low power, low noise and low latency/high frequency applications that enable longer battery life for mobile applications and high cellular signal quality. Our RF SOI technologies are found in almost all cellular handsets from major manufacturers and in cellular ground station transceivers.
ii.SiGe: Our SiGe Bipolar CMOS (“BiCMOS”) technologies are uniquely optimized for either power amplifier applications or very-high-frequency applications for optical and wireless networking, satellite communications and communications infrastructure. Our SiGe technologies are performance-competitive with more costly compound semiconductor technologies while taking full advantage of being integrated with conventional Silicon CMOS (“Si CMOS”).
3. Power
i.GaN: Our next-generation GaN on silicon technology will enable a wide range of future power conversion and RF applications. With their unique ability to handle significant heat and power levels, GaN semiconductors are positioned to enable game-changing performance and efficiency in applications including 5G and 6G smartphones, RF wireless infrastructure, electric vehicles, power grids, solar energy, and other technologies.
ii.BCD: Our Bipolar-CMOS-DMOS (“BCD”) and BCDLite platforms provide high performance, resilient and flexible platforms for efficient power management. Equipped with embedded memory options and automotive qualifications, the platforms offer power management solutions for a range of market applications, including automotive, smart mobile devices and IoT. High-performance and ultra-efficient, the BCD platforms provide performance and low power.

37


Recent Industry and Market Dynamics
Semiconductor Industry Inventory Correction
In 2023, the semiconductor industry experienced an excess of inventory and reduced levels of demand across several of the end-markets that we serve, compounded by slowdowns in consumer spending, a volatile macro-economic environment, elevated interest rates and geopolitical tensions. Inventory levels for several of our customers, particularly those with concentrated exposures to consumer-centric end-markets, continued to rise during the first half of 2023 and remained elevated throughout the second half of 2023. Based on conversations with our customers, we expect that the catalyst for reducing inventory levels and improving demand will be driven by the stabilization of key macro-economic indicators, such as inflation, interest rates and GDP growth.
For a discussion of our business’s seasonality, see “Item 3. Key information—D. Risk Factors—Risk Factors—Risks Related to Our Business and Industry—The cyclical nature and seasonality of the semiconductor industry and periodic overcapacity make us vulnerable to significant and sometimes prolonged economic downturns.”
Government Incentives to Secure Supply
Governments have created bold new incentive programs to fund and secure their local semiconductor manufacturing industries. In the United States, the CHIPS and Science Act of 2022, which was signed into law by the President of the United States of America in August 2022, provided for a 25% investment tax refund and appropriated $52 billion in grants to support the domestic semiconductor industry. The EU has enacted the European Chips Act, which is intended to provide significant funding to strengthen the EU’s semiconductor industry.
The CHIPS and Science Act was designed to boost investments in high-tech research and development and catalyze investment in domestic semiconductor manufacturing capacity. The CHIPS and Science Act provides a 25% refundable advance manufacturing investment tax credit on certain investments and other financial incentives to promote investments in manufacturing beginning in 2023. Starting in 2023, GF began benefiting from this law, and has sought a refund of $66.4 million, and GF anticipates continuing to benefit from this law going forward, which should help subsidize 25% of all capital investments made by us in the U.S., at our Fab 8 and Fab 9 facilities in the States of New York and Vermont, respectively. In addition, under the CHIPS and Science Act, $52 billion in grants were made available, and in 2023, GF applied to participate in this grant program via the U.S. Department of Commerce’s CHIPS office In February 2024, the CHIPS office announced $1.5 billion in planned direct funding for us. This planned investment will enable us to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets. The proposed funding will support three potential GF projects: expansion of our existing Fab 8 facility, construction of a new state-of-art fab on the Malta, New York, campus, and modernization of our Fab 9 facility in Vermont. In support of the two Fab 8 projects in New York, the State of New York also announced that it intends to provide $575 million in planned direct funding. The preliminary awards are non-binding commitments, and receipt of any funding will be subject to certain terms and conditions, including GF hitting specific milestones.
In April 2023, the European Commission approved the award of direct grant funding to GF and ST to support the construction and operation of a new 300mm manufacturing facility in Crolles, France. The funds are being made available under the European Chips Act and the project will enable the development of a large-scale manufacturing site in Europe for high performance chips. The specific amounts allocated to each of GF and ST are confidential, but France has announced that the project is expected to benefit from significant financial support of roughly €2.9 billion from France, under EU State Aid Rules. See “Item 3. Key information—D. Risk Factors—Risk Factors—Risks Related to Strategic Transactions—We are in the process of implementing a strategic collaboration with ST Microelectronics (“ST”) pursuant to which ST and the Company are building and fitting out a new, jointly-operated fab in Crolles, France. Failure to successfully implement and manage the strategic collaboration may adversely affect our results of operation, financial conditions, business and prospects.”
The anticipated timing and capacity of the foregoing proposed expansions or modernizations are always contingent on market demand, the receipt of anticipated funding, whether public or private, satisfaction of conditions for the receipt of certain public funding, and customer commitments for secured supply. See “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to our Business and Industry—We receive subsidies and grants in certain countries and regions in which we operate, and a reduction in the amount of governmental funding available to us or demands for repayment could increase our costs and affect our results of operations.”
We believe that foundry customers are increasingly seeking to diversify and secure their semiconductor supply chains, and are looking for foundry partners with manufacturing footprints in Europe, the United States and Asia, outside of China and Taiwan. Fabless companies, IDMs and OEMs increasingly view their foundry relations as highly strategic. This trend has the potential to help balance the geographical distribution of manufacturing and drive increased long-term visibility and profitability of the foundry industry.
Technology Megatrends
Semiconductors are the core building blocks of electronic devices and systems, including those used in mobile devices, automobiles, consumer electronics, wearables, smart home devices, 5G wireless infrastructure, robotics, PCs, cloud computing, data networking and others. Historically, semiconductor innovation was driven by a few select compute-centric applications—initially PCs and later the internet and mobile phones. Mobile devices have evolved from a convenient
38


communication appliance to an always-connected device, enabling users to do and control nearly everything in their lives. This has driven significant growth in semiconductor demand.
Another significant driver of semiconductor demand has been, and we believe will continue to be, the tremendous growth in the deployment of intelligent software which is increasingly transforming a wide variety of business functions across all sectors. Semiconductors enable the functionality that software delivers. With wide-scale adoption of mobile devices and software solutions, society has grown to expect high-speed connectivity, convenience and security in all applications, providing a catalyst for increased semiconductor content in nearly every industry. These trends were accelerated by the COVID-19 pandemic, which emphasized the criticality of connectivity to allow the world to continue to work, communicate, educate, and deliver goods and services. We believe that accelerated adoption of technologies such as video conferencing, telemedicine, e-education and e-commerce will serve to drive increased requirements for these technologies going forward.
Semiconductors are enabling the transformation of other sectors of the economy as well. In particular, the electrification of automobiles, including autonomous driving applications are driving a sharp increase in semiconductor sensors. Semiconductors are increasingly integral to the performance, safety and comfort of vehicles, and we believe the continued electrification of automobiles will only further accelerate this trend.
Semiconductors have become mission-critical to the functionality, safety, transformation and success of many industries in addition to the automotive industry. As a result, the diversification of semiconductor demand across a wide range of industries has made the sector more foundational and central to the broader economy.
Technology megatrends including IoT, 5G, cloud, artificial intelligence (“AI”) and next-generation automotive are reshaping the global economy and driving a new golden age for semiconductors. Semiconductors have become ubiquitous, powering a broad range of applications from consumer devices to enterprise and industrial applications. Semiconductor innovation is essential to the growth and development of many parts of the technology ecosystem. This includes the software and AI revolution and data collection, transmission and processing at an unprecedented scale, as well as increasing use of advanced driver-assistance systems (“ADAS”) and electrification of automobiles. Semiconductor innovation is also essential for many industrial applications. As the manufacturing backbone of the semiconductor industry, foundries are the bedrock of the global technology ecosystem, and, by extension, the world economy. Foundries such as GF drive innovation by providing advances in process technologies, materials science and IC design IP within the global supply chain to enable customers to develop ICs, accelerate time-to-market and offer value-added services.

Raw Materials
One of the most important raw materials used in our production processes is silicon wafers, which is the basic raw material from which ICs are made. In recent years, the silicon substrate market has experienced price volatility and supply shortages. The principal suppliers for our wafers are GlobalWafers Singapore Pte. Ltd. (“GlobalWafers”), Shin-Etsu Handotai (“S.E.H.”), Siltronic AG, SK Siltron, Inc., Soitec and Sumco Corporation. In order to secure a reliable and flexible supply of high-quality wafers, we have entered into multiple long-term agreements with the majority of our principal suppliers, the largest of which is Soitec. We have entered into multiple long-term agreements with Soitec across a wide spectrum of SOI products. See also “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to our Business and Industry—We rely on a complex silicon supply chain and breakdowns in that chain could affect our ability to produce our products and could materially and adversely affect our results of operations, financial condition, business and prospects.”
Research and Development
We have a strong heritage of innovation, stemming from our roots at AMD, Chartered Semiconductor and IBM, and have built a comprehensive technology portfolio supported by approximately 9,000 worldwide patents. As of December 31, 2023, we had approximately 1,500 employees dedicated to R&D. We have a strong commitment to R&D, and, since our strategic repositioning in 2018, have been able to invest more efficiently, focusing our R&D efforts primarily on delivering a comprehensive and expanded portfolio of highly-differentiated, essential chip solutions for our customers, including RF, FinFET, CMOS, FDXTM, SiGe, GaN and SiPh. Our investments cover a broad range of innovation vectors, including materials and substrates, architecture, integration, services, including packaging, and the development of our ecosystem. We have developed and continue to develop resources that allow our customers to develop innovative products to fuel the global economy. In 2023, 2022 and 2021, we spent $428 million, $482 million and $478 million, respectively, on R&D, which represented approximately 6%, 6% and 7% of our net revenue in each respective year.
Intellectual Property
We rely on IP rights, particularly patents and trade secrets, as well as contractual arrangements, to protect our core process and design enablement technologies and provide our customers with protected technology to enable their mission-critical offerings. As of December 31, 2023, we held 6,930 U.S.-issued patents and 1,916 patents issued outside of the United States. We periodically conduct in-depth reviews of our patents and the industry’s manufacturing technologies, and we cull patents having limited or no value, yielding both savings in patent office maintenance fees and a strong, active patent portfolio.
We have entered into patent cross-licenses with a number of other leading advanced semiconductor companies, including AMD, Samsung, TSMC and IBM. These cross-licenses provide us with valuable freedom of operation under patents owned
39


or subsequently divested by such companies. As is the case with many companies in the semiconductor industry, we have from time to time received communications from third parties, asserting patents that allegedly cover certain of our technologies, and we expect to receive similar communications in the future. Some of the patents that others have chosen to assert against us are not valid based on pre-existing prior art, and we have successfully defended ourselves using inter partes review (“IPR”) and other procedures in the U.S. Patent and Trademark Office. Regardless of the validity or the successful assertion of such claims, we could incur significant costs and devote significant management resources to the defense of these claims, which could seriously harm our company. Additionally, many of our agreements with our customers and partners require us to defend such parties against certain IP infringement claims and indemnify them for damages and losses arising from certain intellectual property infringement claims against them. See “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to Intellectual Property—We have been, and may continue to be, subject to intellectual property disputes, which are costly and may subject us to significant liability and increased costs of doing business.”

Environmental, Social and Governance (ESG) Initiatives
We are dedicated to ethical and responsible business practices, the personal and social well-being of our employees, and supply chain and environmental stewardship. ESG is fundamental to our culture and our value proposition to our customers, the communities in which we live and do business, and our full range of global stakeholders. For the second year in a row, we earned a place on Newsweek's esteemed list of "America's Most Responsible Companies," underscoring the Company’s longstanding commitment to ESG and environmentally sustainable manufacturing practices.
Employee Safety, Health and Well-being
Our Journey to Zero commitment is the leading theme of our Global Environmental Health and Safety (“EHS”) Policy and Standards, which serves as the foundation of health and safety programs at each of our manufacturing locations. We strive to continuously reduce occupational injuries and illnesses in all of our operations, and aspire to achieve the goal of zero annual incidents. Our enterprise-wide health and safety management system is certified to the ISO 45001:2018 standard.
Environmentally Sustainable Manufacturing and Operations
Semiconductor manufacturing is generally resource-intensive. Therefore, our Journey to Zero commitment also represents our pursuit of sustainable and environmentally efficient operations, seeking to minimize environmental- and climate-related impacts from our operations through pollution prevention and resource conservation. Our Global EHS Policy and Standards establish a continual improvement process and performance requirements that apply throughout the company. Our enterprise-wide environmental management system is certified to the ISO 14001:2015 standard. In August 2021, we launched our Journey to Zero Carbon commitment that aims to reduce greenhouse gas emissions by 25% by 2030, compared to a 2020 baseline.
Responsible Sourcing
As a member of the Responsible Business Alliance (“RBA”), we are committed to responsible sourcing practices. We progressively apply the RBA Code of Conduct to our major suppliers and monitor its application. We encourage and support our suppliers to do the same in our continuous pursuit of excellence in corporate responsibility and extension of responsible practices throughout the supply chain.
Technology Solutions for Humanity
We are focused on creating innovations in the largest and most pervasive segments of the semiconductor industry. As power efficiency has become a critical success factor for the semiconductor industry, we strive to develop solutions that can lower the power consumption of digital technology.
Human Capital: Diversity & Inclusion and Talent Development
We believe that our success rests on empowering employees to bring their whole selves to the company and that building a culture of inclusion drives better business outcomes. As a global company, we recognize and value the wide variety of cultural values, traditions, experiences, education and perspectives of our team and communities. We previously established a Diversity & Inclusion office and as of December 31, 2023, we employed a multicultural workforce across three continents, representing more than 83 nationalities across 13 countries. We believe that our culture of inclusion leads to higher levels of belonging, engagement and ultimately, higher-performing teams. We strive to focus on all aspects of the employee lifecycle, including recruitment, retention, professional development, and advancement of diverse talent. As part of this effort, in 2013, we established our first employee resource group, GLOBALWOMEN, to have a positive impact on our business through the enrichment of our female employees. Since then, we have established the Black Resource Affinity Group (“B.R.A.G.”), Globalfamilies, the United States Veteran’s Resource Group (“VRG”), Early Career and Tenure Resource Group, Asian Society for Inclusion and Awareness, ConnectAbility, Unidos, Pride and Remote Group. Employee driven, our employee resource groups support our diversity and inclusion strategy. We use an annual engagement survey process to help measure employee engagement and our diversity and inclusion strategy progress.
Global Support Strategy
40


We have continued to grow our operations in India, Malaysia and Bulgaria as an important part of our global support strategy. Our operations in those locations span a broad range of functions including engineering, operations support, design enablement, procurement, IT and Human Resources.

Community Support and Engagement
We have a long history of community involvement, with well-established programs and global and local teams dedicated to enriching the lives of the people in our communities around the world. Through our worldwide GlobalGives program, we provide employees with the opportunity to make a positive impact in their local communities through personal donations, company-matched donations as well as through volunteering their time.
41



C.    Organizational Structure
The following is a chart of our corporate structure as of December 31, 2023:
Organization chart - Final.jpg
* Please refer to Note 29 to our Annual Consolidated Financial Statements for more information on our subsidiaries.

D.    Property, Plant and Equipment
Fab Facilities
In 2023, we shipped approximately 2.2 million 300mm equivalent semiconductor wafers. We currently operate four manufacturing sites in the following locations: Dresden, Germany; Singapore; Malta, New York; and Burlington, Vermont.

Global Footprint
Our focus on highly-differentiated solutions, quality, security and reliability requires world-class manufacturing capabilities. We have four world-class manufacturing sites on three continents, providing the scale, technology differentiation and geographic diversification that we believe are critically important to our customers’ success.
The total clean room space is approximately 238,000 square meters spread across our four manufacturing sites. As of December 31, 2023, our total 300 mm equivalent installed capacity is 2,618 kilo wafers per annum (“kwpa”). The Company defines installed capacity as the anticipated output of installed manufacturing equipment across all our fabs, assuming
42


uninterrupted runs of such manufacturing equipment for a full year, adjusted for, among other factors, down time for maintenance and set up and current product mix.
In 300mm equivalent wafers, we shipped approximately: 2 million in 2020, 2.4 million in 2021; 2.5 million in 2022; and 2.2 million in 2023. Meanwhile over the same period, we have continued to invest in our capacity footprint and by the end of 2024, we expect to have invested in our total capacity to produce approximately 3 million 300mm equivalent wafers. The rate and pace at which we expect to increase shipments within our capacity footprint, will be subject to, amongst other things, a reduction in channel inventory across the end markets we serve, improvement in the global macro-economic landscape and increased customer demand.
The following table describes each of our manufacturing facilities as of December 31, 2023:
Fab Facility Location
Key Technologies
Key Process Technologies
Wafer Size (mm)
2023 Shipments
(kwpa, 300mm
equivalent in thousands)(1)
Clean Room Area (sqm)
Dresden, Germany
DX, NVM, ISP, HV/DDI, BCD-lite
55nm-22nm
30069852,000
SingaporeBCD/BCDlite, HV, NVM, DDI, RF SOI, LP SiGe
180nm-40nm
300,20094287,000
Malta, New York, USA
FinFET
14nm-12nm
30037258,000
Burlington, Vermont, USA
RF SOI, SiGe
 90nm
20012741,000
Totals
2,139238,000
(1) Does not include 72 kwpa, 300mm equivalent of shipments enabled from manufacturing outsource partners.
Each site is equipped with thousands of highly sophisticated pieces of manufacturing equipment and tools. We currently have more than 7,500 tools across all of our fabs. Each site has dedicated power, water, gas and chemical distribution systems. Various assets have been pledged to secure borrowings under pledged agreements for the Company. re 12 to our Annual Consolidated Financial Statements.
From time to time, we announce plans to expand our global capacity. The anticipated timing and capacity of these proposed expansions or modernizations are always contingent on market demand, the receipt of anticipated funding, whether public or private, achievement of conditions to receipt of certain public funding, and customer commitments for secured supply.
On June 22, 2021, we announced fab expansion plans in Singapore, with the addition of Module 7H, an extension of our existing 300mm Fab 7 operations. This expansion was funded in part by the Singapore Economic Development Board (“EDB”) in the form of long-term developmental loans and grants. In September 2023, Module 7H began limited production. Once fully ramped, we anticipate having an aggregate annual capacity of 450,000 wafers.
The majority of our manufacturing facilities are built on land we own, with the exception of our Malta, New York, and Singapore fabs, which are built on land leased to the Company by the industrial development agencies of their respective regions.
On August 4, 2022, we agreed on a Commercial and Cooperation agreement with ST to build a jointly-operated 300mm manufacturing facility adjacent to ST’s existing 300mm facility in Crolles, France. This facility is targeted to ramp to an aggregate 620,000 300mm wafers per year production at full build-out. Our partnership with ST on the facility is subject to our customers’ volume requirements and other market considerations. In April 2023, the European Commission approved the award of direct grant funding to GF and ST to support this project. The specific amounts allocated to each of GF and ST are confidential, but France has announced that the project is expected to benefit from significant financial support of roughly €2.9 billion from France, under EU State Aid Rules.
In February 2024, the U.S. Department of Commerce announced $1.5 billion in planned direct funding for us as part of the CHIPS and Science Act. This planned investment will enable us to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets. The proposed funding will support three potential GF projects: expansion of our existing Fab 8 facility, construction of a new state-of-art fab on the New York/Fab 8 campus, and modernization of our Fab 9 facility in Vermont. In support of the two Fab 8 projects, the State of New York also announced that it intends to provide $575 million in planned direct funding. The preliminary awards are non-binding commitments, and receipt of any funding will be subject to certain terms and conditions, including GF hitting specific milestones. Subject to market requirements and customer demand as well as receipt of expected government funding, among other factors, GF plans to invest more than $12 billion over the next 10 or more years across its two U.S. sites.
For risks related to funding of the foregoing projects, see “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to our Business and Industry—We receive subsidies and grants in certain countries and regions in which we
43


operate, and a reduction in the amount of governmental funding available to us or demands for repayment could increase our costs and affect our results of operations.” See also “Item 3. Key information—D. Risk Factors—Risk Factors—Risks Related to Strategic Transactions—We are in the process of implementing a strategic collaboration with ST Microelectronics (“ST”) pursuant to which ST and the Company are building and fitting out a new, jointly-operated fab in Crolles, France. Failure to successfully implement and manage the strategic collaboration may adversely affect our results of operation, financial conditions, business and prospects.”


ITEM 4A.    UNRESOLVED STAFF COMMENTS
None.
44


ITEM 5.    OPERATING AND FINANCIAL REVIEWS AND PROSPECTS
You should read the following discussion and analysis together with the consolidated financial statements and the notes to such statements included in this Annual Report. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Item 3. Key Information—D. Risk Factors” or in other parts of this Annual Report on Form 20-F.
A discussion of the changes in our results between the years ended December 31, 2021 and 2022, has been omitted from this Annual Report on Form 20-F for the year ended December 31, 2023. In order to view that discussion, please see “Item 5. Operating and Financial Review and Prospects—A. Operating Results” and “Item 5. Operating and Financial Reviews and Prospects—B. Liquidity and Capital Resources” in our Annual Report on Form 20-F for the year ended December 31, 2022, filed with the SEC on April 14, 2023, which is available on the SEC’s website at www.sec.gov and our website at https://gf.com/.
Executive Overview and Other Recent Events
GlobalFoundries is one of the world’s leading semiconductor foundries. We manufacture complex ICs that enable billions of electronic devices that are pervasive throughout nearly every sector of the global economy. With our specialized foundry manufacturing processes, a library consisting of thousands of IP titles, and differentiated transistor and device technology, we serve a broad range of customers, including the global leaders in IC design, and provide optimized solutions for the function, performance and power requirements of critical applications driving key secular growth end markets.
The combination of our highly-differentiated technology and our scaled manufacturing footprint enables us to attract a large share of single-sourced products and LTAs, providing improved revenue visibility and significant operating leverage, resulting in improved financial performance. As of December 31, 2023, the aggregate remaining long-term revenue commitment reflected by these agreements amounted to more than $20 billion (spread out across varying numbers of years, depending on each LTA), and $4 billion of refundable and non-refundable advance payments and capacity reservation fees. These LTA agreements include binding, multi-year, reciprocal annual (and, in some cases, quarterly) minimum purchase and supply commitments with wafer pricing and associated mechanics outlined for the contract term. Through an intense focus on collaboration, we have built deep strategic partnerships with a broad base of more than 250 customers as of December 31, 2023, many of whom are the global leaders in their field.
The principal source of our revenue is wafer fabrication and sales of finished semiconductor wafers, which accounted for approximately 92% of our net revenue in 2023. The rest of our net revenue was mainly derived from photomask manufacturing, sourcing services and pre-fab manufacturing services.
Our business has experienced weaker demand across several of the end markets within which we operate, as our customers manage elevated inventory levels and tighter monetary policies, which adversely impacted our revenues. As discussed in “Item 3. Key Information—D. Risk Factors,” we have had to renegotiate certain of our LTAs with existing customers to reflect lower volume commitments and/or longer commitment timelines, and we expect that we will continue to have to renegotiate additional LTAs in 2024. We remain cautious as the global macroeconomic uncertainty continues, reflecting the impacts of inflation, high interest rates, and geopolitical conflicts. Although we are starting to see the inflationary headwinds moderate, the ongoing high interest rate environment has led to a prolonged and deeper cyclical downturn than was first anticipated. The extent to which these uncertainties will impact our business activities will depend on future developments that cannot be predicted at this time. We continue to collaborate closely with our customers to support the acceleration of their inventory depletion, while seeking to preserve the economic value of the commercial agreements we have entered into.

Components of Results of Operations
Net Revenue
We generate the majority of our revenue from volume production and sales of finished semiconductor wafers, which are priced on a per-wafer basis for the applicable design. We also generate revenue from rendering of non-recurring engineering (“NRE”) services, mask production and pre-fabrication services such as bump, test, and packaging. Pricing is typically agreed prior to production and then updated based on subsequent period negotiations.
Cost of Revenue
Cost of revenue consists primarily of material expenses, depreciation and amortization, employee-related expenses, facility costs and costs of fixed assets, including maintenance and spare parts. Material expenses primarily include the costs of raw wafers, test wafers, photomasks, resists, process gases, process chemicals, other operating supplies and external service costs for wafer manufacturing. Costs related to NRE services are also included within the cost of revenue. As it pertains to inflation and inflationary headwinds we are facing within our business, we have experienced an increase in costs for materials and energy, and we expect these increases to continue to have an adverse impact on our financial results of operations, while these economic conditions persist.
45


Depreciation and amortization charges primarily include the depreciation of clean room production equipment. Commencement of depreciation related to construction in progress and property, plant and equipment involves determining when the assets are available for their intended use (see Note 3 to our Annual Consolidated Financial Statements). Employee-related expenses primarily include employee wages and salaries, social security contributions and benefit costs for operators, maintenance technicians, process engineers, supply chain, IT production, yield improvement and health and safety roles. Facility costs primarily consist of the costs of electricity, water and other utilities and services.
Operating Expenses
Our operating expenses consist of R&D, selling, general and administrative expenses, and restructuring charges. Personnel costs are the most significant component of our operating expenses and consist of salaries, benefits, bonuses, share-based compensation, and commissions.
Research and Development
Our R&D efforts are focused on developing highly-differentiated process technologies and solutions. As part of our strategic repositioning, we shifted our R&D efforts to focus on technologies where we can deliver highly-differentiated solutions and discontinued our R&D-intensive single-digit node program. Our R&D expense includes personnel costs, material costs, software license and intellectual property expenses, facility costs, supplies, professional and consulting fees, and depreciation on equipment used in R&D activities. Our development roadmap includes new platform investments, platform features and extensions, and investments in emerging technology capabilities and solutions. We expense R&D costs as incurred. We believe that continued investment in our technology portfolio is important for our future growth and acquisition of new customers. We expect our R&D as a percentage of revenue to modestly increase.
Selling, General and Administrative (“SG&A”)
SG&A expenses consist primarily of personnel-related costs, including sales commissions to independent sales representatives and professional fees, including the costs of accounting, audit, legal, regulatory and tax compliance. Additionally, costs related to advertising, trade shows, corporate marketing and allocated overhead costs are also included in SG&A expenses. Beginning in the third quarter of 2023, SG&A expenses also include certain contract cancellation fees,(gain) loss on tool sales and withholding taxes. Certain contract cancellation fees and (gain) loss on tool sales were previously included in other income (expense) while withholding taxes were previously recorded in income tax expense. We expect our SG&A as a percentage of revenue to modestly increase.
Restructuring Charges
We incur restructuring charges related to a reduction in our global workforce, reduction in leased workspace and engaging consultants for strategic support.
Other Operating Charges
Finance Income
Finance income consists primarily of income related to investing activities.
Finance Expenses
Finance expenses consists primarily of interest on borrowings, amortization of debt issuance costs under our term loans, revolving credit facility, finance leases and the other credit facilities we maintain with various financial institutions.
Gain on Sale of a Business
Gain on sale of a business relates to the sale of the EFK business in December 2022.
Other Income (Expense), net
Other income (expense), net consists of one-time gains and losses and other miscellaneous income and expense items unrelated to our core operations. Included are gains and losses relating to hedging activities. Prior to third quarter of 2023, other income (expense), net also included (gain) loss on tool sales and certain contract cancellation fees.
Income Tax Expense
Income tax expense consists primarily of income taxes in certain foreign jurisdictions in which we conduct business, which mainly include Germany, Singapore and U.S. federal and state income taxes.

The following discussion covers items for and a comparison between the years ended December 31, 2023 and 2022.
46


A.Operating Results
The following table sets forth our consolidated statements of operations data for the periods indicated:
For the year ended December 31,
20232022
(in millions)
Net revenue$7,392 $8,108 
Cost of revenue (1)
5,291 5,869 
Gross profit2,101 2,239 
Operating expenses
Research and development(1)
428 482 
Selling, general and administrative(1)
473 496 
Restructuring charges71 94 
Total operating expenses
972 1,072 
Operating profit
1,129 1,167 
Finance income149 51 
Finance expenses(137)(111)
Gain on sale of a business
— 403 
Other income (expense)
(57)22 
Income before income taxes
1,084 1,532 
Income tax expense
(66)(86)
Net income
$1,018 $1,446 
(1)Includes share-based compensation expense as follows:
For the year ended December 31,
(in millions)20232022
Cost of revenue$48 $64 
Research and development$25 $27 
Selling, general and administrative$96 $92 
Comparison of Years Ended December 31, 2023 and 2022
Net Revenue
(in millions)
Year ended December 31,
20232022Change% Change
Net revenue$7,392 $8,108 $(716)(8.8)%
Net revenue decreased by $716 million, or 8.8%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. The change was primarily due to lower 300mm equivalent wafer shipment volumes of 2.2 million, an 11% reduction from the prior year, which was a result of lower customer demand. The decrease was partially offset by a $91 million or 18.9% increase in revenue generated from engineering and other services.
Cost of Revenue
(in millions)
Year ended December 31,
20232022Change% Change
Cost of revenue$5,291 $5,869 $(578)(9.8)%
Gross margin %28.4 %27.6 %80bps
Cost of revenue decreased by $578 million, or 9.8%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. The decrease was driven by $347 million reduction in costs associated with the sale of our East Fishkill
47


facility in December 2022, $108 million reduction in depreciation and amortization, $107 million reduction in employee related expenses and $16 million decrease in share-based compensation.
Gross margin increased to 28.4% for the year ended December 31, 2023 from 27.6% for the year ended December 31, 2022. The increase was largely attributable to reduced costs associated with the sale of our East Fishkill facility, reduced depreciation and amortization and reduced labor expenses.
Research and Development Expenses
(in millions)
Year ended December 31,
20232022Change% Change
Research and development expenses
$428 $482 $(54)(11.2)%
As a % of revenue5.8 %5.9 %
Research and development expenses decreased by $54 million, or 11.2%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. The year-over-year change was driven by a $48 million reduction in employee-related expenses due to 70% reduction in employee bonuses and 3% lower headcount. Additionally, pre-production costs decreased by $15 million which was partly offset by an increase in research and development portfolio spend of $12 million.
Selling, General and Administrative Expenses
(in millions)
Year ended December 31,
20232022Change% Change
Selling, general and administrative expenses
$473 $496 $(23)(4.6)%
As a % of revenue6.4 %6.1 %
Selling, general and administrative expenses decreased by $23 million, or 4.6%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. The decrease was driven by $46 million in advanced manufacturing income tax credits in 2023 as a result of the CHIPS and Science Act and $43 million reduction in employee bonuses. Offsetting the decrease was an increase in withholding tax of $33 million and increased professional and digital transformation costs of $25 million. Additionally, gain on tool sales recorded in SG&A totaled $8 million for 2023. This was as a result of gain (loss) tool sales previously recorded in Other income (expense), being recorded in SG&A, beginning in the third quarter 2023.

Restructuring Charges
(in millions)
Year ended December 31,
20232022Change% Change
Restructuring charges
$71 $94 $(23)(24.5)%
Restructuring charges decreased by $23 million for the year ended December 31, 2023 compared to the year ended December 31, 2022. The decrease was driven by $17 million lower employee related expenses and $19 million reduction in leased workspace and professional fees. Offsetting this decrease was $12 million associated with tool deinstallation costs, qualification costs and transition costs related to phase two of the restructuring plan.

48


Finance income
Year ended December 31,
(in millions)20232022Change% Change
Finance Income$149 $51 $98 192.2 %
Finance income increased by $98 million, or 192.2%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. The increase was primarily due to higher interest income generated as a result of higher market interest rates.
Finance expense
(in millions)
Year ended December 31,
20232022Change% Change
Finance expenses
$(137)$(111)$(26)23.4 %
Finance expenses increased by $26 million, or 23.4%, for the year ended December 31, 2023, compared to the year ended December 31, 2022. This increase was primarily a result of increased floating interest rates associated with third-party debt.
Gain on the sale of a business
(in millions)
Year ended December 31,
20232022Change% Change
Gain on sale of a business$— $403 $(403)(100.0)%
There was no gain on the sale of a business in 2023, as we did not sell any part of our business during 2023. Gain on the sale of a business was $403 million for the year ended December 31, 2022, as we completed the sale of the EFK business in 2022.

Other Income (expense), net
(in millions)
Year ended December 31,
20232022Change% Change
Other income (expense), net
$(57)$22 $(79)(359.1)%
Other income (expense), net decreased by $79 million for the year ended December 31, 2023, compared to the year ended December 31, 2022. The year-over-year change is attributable to an increase of approximately $49 million due to hedging activity losses in 2023 and $27 million decrease in gain on tool sales to third parties. Partially offsetting this decrease was an $8 million gain on tool sales recorded in SG&A. Commencing during the third quarter 2023, we began recording gain (loss) on tool sales to third parties in SG&A.

49


Income tax expense
(in millions)
Year ended December 31,
20232022Change% Change
Income tax expense$(66)$(86)$20 (23.3)%
Income tax expense decreased by $20 million, or 23.3% for the year ended December 31, 2023, compared to the year ended December 31, 2022. The decrease is primarily the result of $16 million withholding tax accrued in the United States reclassified from income tax expense to other taxes in the current year as it is not creditable against income taxes. The decrease is also partially attributable to an overall reduction in tax expense due to a decrease in global income subject to income tax compared to the prior year.

B.Liquidity and Capital Resources
We have historically financed operations primarily through cash and cash equivalents, marketable securities, as well as cash generated from our business operations, including prepayments under LTAs, debt and government grants. As of December 31, 2023, our cash and cash equivalents and marketable securities balances of $3.9 billion included $2.4 billion of cash and cash equivalents and $1.5 billion of marketable securities. As of December 31, 2022, our cash and cash equivalents and marketable securities of $3.3 billion included $2.4 billion of cash and cash equivalents and $994 million of marketable securities.
As of December 31, 2023 and 2022, respectively, we had an undrawn revolving credit facility of $1.0 billion. In addition to our available revolvers, we had $2.4 billion and $2.5 billion of debt outstanding as of December 31, 2023, and 2022, respectively, which was primarily comprised of multiple term loans in various currencies. Our future capital requirements will depend on many factors, including our revenue growth rate, the timing and the amount of payments we receive from customers pursuant to our LTAs and other business arrangements, the timing and extent of spending to support development efforts, the introduction of new and enhanced products and solutions, the continuing market adoption of our platform, and our obligations to repay our indebtedness from time to time. We may from time to time seek to raise additional capital to support our growth. As of December 31, 2023, we believe that our existing cash, cash equivalents, investment in marketable securities, credit under our revolving credit facility, and expected cash generated from operations are sufficient to meet our capital requirements for at least the next 12 months and beyond.
The following table shows a summary of our term loan facilities, other debt facilities, which consist primarily of equipment financing and our committed undrawn revolvers.
For the year ended December 31,
20232022
(in millions)
Term loan facilities$1,249 $1,456 
Other debt facilities1,115 1,055 
Revolvers and letters of credit1,012 1,012 

Government grants are also a source of capital. Those grants are primarily provided in connection with construction and operation of our wafer manufacturing facilities, employment and R&D. For the years ended December 31, 2023, 2022 and 2021, we received $251 million, $93 million and $83 million, respectively, in proceeds from government grants. The change in grants relates primarily to grant programs in Singapore.
We monitor capital using a gearing ratio, which is net debt divided by total capital plus net debt. Our policy is to keep the gearing ratio within a range to meet our business needs. We may from time to time seek to raise additional capital to support our growth. Any equity financing we may undertake could be dilutive to our shareholders, and any additional debt financing we may undertake could require debt services and financial and operational requirements that could adversely affect our business. We cannot provide any assurance that we would be able to obtain future financing on favorable terms or at all.
Cash Flows
The following table shows a summary of our cash flows for the periods presented:
Years Ended December 31,
20232022
(in millions)
50


Cash provided by operating activities$2,125 $2,624 
Cash used in investing activities$(1,882)$(4,058)
Cash provided by (used in) financing activities
$(212)$842 
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents$35 $(587)
Operating Activities
Net cash provided by operating activity of $2,125 million for the year ended December 31, 2023 was primarily related to net income of $1,018 and depreciation and amortization of $1,451 million. Other drivers for the period include lower share based compensation of $150 million and deferred income taxes of $50 million. Unfavorable working capital of $506 million include a decrease of trade and other payables of $190 million driven by lower customer prepayments, an increase in receivables and prepayments of $169 million and favorable movements in inventory of $148 million due to higher shipments.
Investing Activities
Cash used in investing activities was $1,882 million for the year ended December 31, 2023, compared to cash used in investing activities of $4,058 million for the year ended December 31, 2022, reflecting a $2,176 million decrease. The year-over-year change was primarily attributable to lower purchases of property, plant, equipment and intangibles of $1,255 million, lower net outflows related to net proceeds of marketable securities of $522 million, proceeds from the sale of our East Fishkill facility of $236 million received in 2023, and higher proceeds from government grants of $138 million.
Financing Activities
Cash used in financing activities was $212 million for the year ended December 31, 2023, compared to cash provided by financing activities of $842 million for the year ended December 31, 2022, reflecting a $1,054 million change. The year-over-year changes were due to a decrease in proceeds from borrowing of $925 million, reduced proceeds from the issuance of equity instruments of $126 million and $88 million reduction in proceeds from government grants due to reclassification of proceeds in government grant from a financing activity to an investing activity in 2023. This was offset by lower repayments of debt and finance lease obligations of $85 million.
Contractual Obligations
As of December 31, 2023, we had $3.9 billion of unconditional purchase commitments, $1.1 billion of which related to contracts for capital expenditures, and $2.8 billion of contracts related to operating expenditures. Of the total balance as of December 31, 2023, $970 million is due within the next 12 months. See Note 31 to our Annual Consolidated Financial Statements for additional details.
C.Research and Development, Patents and Licenses
Refer to “Item 4. Information on the Company” for discussion on our research and development and intellectual property.
D.Trend information
Our financial condition and results of operations have been, and will continue to be, affected by numerous factors and trends, including the following:
Global Demand for Semiconductor Products
Demand for our products is dependent on market conditions in the end markets in which our customers operate, which are generally subject to seasonality, as well as cyclical and competitive conditions. Additionally, we derive a portion of our net revenue from sales to customers that purchase large volumes of our products. Customers generally provide periodic forecasts of their requirements, but these forecasts do not commit such customers to minimum purchases except when long-term contracts are in place.
The semiconductor industry is susceptible to uncertain economic conditions that could impact demand. We remain cautious regarding the macroeconomic headwinds facing our industry in 2024. We continue to implement a long-term partnership-driven model with our industry, which is driving improved visibility for our business through this period of uncertainty.
Single-sourced Revenue Mix
We manufacture products based on a combination of our own technologies and our customers’ IP, resulting in a significant number of products that can only be sourced from us. Our sales and marketing strategy centers on deepening relationships with top customers and investing in technologies to become their single-source supplier for mission-critical applications. We believe a key measure of our success as a differentiated technology partner to our customers is the mix of our wafer shipment volume attributable to single-sourced business, which represented approximately 62% of wafer shipment volume in 2023. We define single-sourced products as those that we believe can only be manufactured with our technology and cannot be manufactured elsewhere without significant customer redesigns.
51


Technology Solution Mix and Pricing
Product mix is among the most important factors affecting revenue and margins, as our wafer price varies significantly across technology platforms. The value of a wafer is determined principally by the uniqueness and complexity of the technology, performance characteristics, yield and defect density. Devices with richer feature sets, higher performance, better yields and greater system-level integration require more substantial R&D investments and more complex manufacturing expertise and equipment, and thus generally command higher wafer prices.
Pricing and margins depend on the volumes and features of the solutions we deliver. We continually monitor and work to reduce the cost of our products and improve the potential value that our solutions deliver to our customers as we target new win opportunities. While individual product prices may decline, we believe our R&D investments, differentiated product and single-sourced strategy should lead to improvements in pricing mix and overall ASPs if we compete effectively.
Long-Term Agreements.
We have entered into multiple LTAs with leading companies in the industry. Many of these contracts include customer advanced payments and capacity reservation fees in order to secure future supply. We have approximately $20 billion in aggregate revenue commitment over the term of the agreements as of December 31, 2023.
During 2023, some customers under LTAs have requested to adjust their short term demand outlook downward. From time to time our wafer revenue consists of restructuring or underutilization payments from customers unable to meet their volume commitments. We expect certain of our customers under LTAs will continue to request for similar adjustments in 2024. We continue to collaborate closely with our customers to support the acceleration of their inventory depletion, while seeking to preserve the economic value of these commercial agreements.
Shipment Utilization
We define shipment utilization as the ratio of wafer shipment volume divided by our estimated total capacity for wafer manufacturing in a specified period. Shipment utilization remains a very important factor in driving our financial performance, as we incur significant costs regardless of the number of wafers we actually produce. These fixed costs include staffing, electricity, infrastructure, depreciation and maintenance costs at each fab.
Our average shipment utilization rate across our global fabs was 81% and 101% for the years ended December 31, 2023 and 2022, respectively. Factors affecting shipment utilization rates include efficiency in production facilities, complexity and mix of wafer types ordered by customers, including the impact of export controls and other regulatory changes affecting customers and competitors. Our production capacity is determined based on the capacity ratings of the equipment in the fab, adjusted for expected down time due to set up for production runs and maintenance and R&D. In 2023, we operated below our production capacity driven by customer demand and market conditions.
CHIPS and Science Act
In February 2024, the U.S. Department of Commerce announced $1.5 billion in planned direct funding for GF as part of the CHIPS and Science Act. This planned investment will enable us to expand and create new manufacturing capacity and capabilities to securely produce more essential chips for automotive, IoT, aerospace, defense, and other vital markets. The proposed funding will support three potential GF projects: expansion of our existing Fab 8 facility, construction of a new state-of-art fab on the Fab 8 campus, and modernization of our Fab 9 facility. In support of the two Fab 8 projects, the State of New York also announced that it intends to provide $575 million in planned direct funding. The preliminary awards are non-binding commitments, and receipt of any funding will be subject to certain terms and conditions, including us hitting specific milestones. Subject to market requirements and customer demand as well as receipt of expected government funding, among other factors, GF plans to invest more than $12 billion over the next 10 or more years across its two U.S. sites. While GF intends to begin work as soon as reasonably possible, there is no guarantee at this time as to when GF will be able to start work and how (or to what degree) the total $12 billion investment will be allocated to each year over the next 10 or more years (or that the total amount actually invested will be $12 billion or more). GF intends to execute such investments through public-private partnerships with support from the federal and state governments as well as from its ecosystem partners, including anticipated key strategic customers, but such plans are subject to GF receiving such support in the manner and on the timelines expected, and may be subject to change.

E.Critical Accounting Policies and Estimates
Our consolidated financial statements included elsewhere in this annual report have been prepared in accordance with IFRS as issued by the International Accounting Standard Board (“IASB”). Management must make certain estimates and assumptions that affect the amounts reported in the financial statements, based on experience, existing and known circumstances, authoritative accounting guidance and pronouncements and other factors that management believes to be reasonable, but actual results could differ materially from these estimates. To the extent there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.
52


We believe that the accounting policies described below involve a degree of judgment and complexity. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our consolidated financial condition and results of operations.
Revenue Recognition—The Company generates revenue primarily from fabricating semiconductor wafers for its customers using the manufacturing processes based on their own or third parties’ proprietary IC designs and, to a lesser extent, the Company also generates revenue from engineering and other pre-fabrication services such as non-recurring engineering (“NRE”) services, which include design services and mask production.
The Company recognizes revenue when performance obligations are satisfied. The performance obligations are satisfied at the point at which control of the wafers is transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location. NRE services are recognized over time as the Company performs the services based on a percentage of costs incurred over total expected costs.
The Company accounts for the breakage fee arising from not meeting the minimum purchase requirements under certain LTAs with customers as variable consideration and includes such fee in the contract transaction price if not constrained, and accordingly, recognizes as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreement. Given the volumes under these arrangements are usually not guaranteed and subject to subsequent negotiations or changes, breakage fees that are constrained are not included in the contract transaction price for revenue recognition purposes.
The Company estimates the variable consideration related to volume rebates and yield adjustments for certain contracts that may be refundable to customers through the issuance of a credit note, and accordingly, recognizes revenue in accordance with the pattern applicable to the performance obligation, subject to a constraint. The Company determines the amounts to be recognized based on the amount of potential refund required by the contract, historical experience and other surrounding facts and circumstances. These potential revenue adjustments are accrued and netted against accounts receivable on the consolidated statements of financial position.
Our contracts may be subsequently modified to reflect changes in scope or customer requirements. Generally, our contract modifications are for goods or services that are distinct from the existing contract and are accounted for as a new contract and performance obligation, which are recognized prospectively. If contract modifications are for goods or services that are not distinct from the existing contract, they are accounted for as if they are part of the original contract with the effect of the contract modification recognized as an adjustment to revenue on a cumulative catch-up basis.
A contract asset (“unbilled accounts receivables”) is recognized when the Company has recognized revenue, but not issued an invoice for payment. The Company has determined that unbilled accounts receivables are not considered a significant financing component of the Company’s contracts. Contract assets are included in receivables, prepayments and other assets on the consolidated statements of financial position and are transferred to trade receivables when invoiced (see Note 6).
A contract liability is recognized when the Company receives payments in advance of the satisfaction of performance obligations and are included as deferred revenue on the consolidated statements of financial position (see Note 11). This includes upfront non-refundable capacity access fees under certain LTAs with customers which are accounted for as additional wafer price considerations and recognized as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreements.
Determination of useful lives of property, plant and equipment—The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023. The impact of the change in estimated useful lives of certain buildings resulted in an increase to income before income taxes of $76 million for the year ended December 31, 2023.
53


Inventory Valuation—Inventory is based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost. The cost of raw materials is determined using applicable raw material purchase prices. The cost of supplies is determined based on a weighted-average cost formula. Work in process and finished goods are valued at the cost of direct materials and a proportion of manufacturing labor and overhead costs based on normal operating capacity.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Impairment Assessment of Non-Financial Assets—Impairment exists when the carrying value of an asset or CGU exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The fair value less costs to sell calculation is based on a discounted cash flow analysis that a potential buyer would perform in determining a transaction value of the CGU less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. When preparing the discounted cash flow analysis, the Company makes judgments in determining the independent cash flows that can be related to a specific CGU based on its asset usage model and manufacturing capabilities in addition to the discount rate used in the analysis. In addition, because judgments are made regarding the remaining useful lives of assets and expected future revenue and expenses associated with the assets, changes in these estimates based on changes in economic conditions or business strategies could result in material impairment charges in future periods.
Income Taxes and Realization of Deferred Tax Assets—In determining taxable income for financial statement reporting purposes, management makes certain estimates and judgments specific to taxation issues. These estimates and judgments are applied in the calculation of certain tax liabilities and in the determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for income tax and financial statement reporting purposes.
Deferred taxes are recognized for unused losses, among other factors, to the extent that it is probable that taxable profit will be available against which the losses can be utilized.
This evaluation requires the exercise of judgment with respect to, among other things, benefits that could be realized from available tax strategies and future taxable income, as well as other positive and negative factors. The ultimate realization of deferred tax assets is dependent upon, among other things, the Company’s ability to generate future taxable income that is sufficient to utilize loss carry-forwards or tax credits before their expiration or the Company’s ability to implement prudent and feasible tax planning strategies.
If estimates of projected future taxable income and benefits from available tax strategies are reduced as a result of a change in the assessment or due to other factors, or if changes in current tax regulations are enacted that impose restrictions on the timing or extent of the Company’s ability to utilize net operating losses and tax credit carry-forwards in the future, the Company may be required to reduce the amount of total deferred tax assets resulting in a decrease of total assets. Likewise, a change in the tax rates applicable in the various jurisdictions or unfavorable outcomes of any ongoing tax audits could have a material impact on the future tax provisions in the periods in which these changes could occur.
In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax rules and the potential for future adjustment of uncertain tax positions by the tax authorities in the countries in which the Company operates. If estimates of these taxes are greater or less than actual results, an additional tax benefit or charge may result.
Share-based compensationShare-based compensation expense is recognized based on the grant date fair value of the awards. The fair value of Restricted Share Units (“RSUs”) is determined based on the closing price of the ordinary stock on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model for options. The fair value of Performance Share Units (“PSUs”) is estimated using a Monte Carlo simulation. Both models require management to make certain assumptions of future expectations based on historical and current data. The assumptions include the estimated fair value of the Company’s stock, expected term of the awards, expected volatility, dividend yield, and risk-free interest rate. These estimates involve inherent uncertainties and the application of management’s judgment.
The principles of modification accounting are applied when a new share-based payment is granted as a replacement for another share-based payment that is cancelled. When modification accounting is applied, the entity accounts for any incremental fair value in addition to the grant-date fair value of the original award. In the case of a replacement, the incremental fair value is the difference between the fair value of the replacement award and the net fair value of the cancelled award, both measured at the date on which the replacement award is issued. The net fair value is the fair value of the cancelled award measured immediately before the cancellation, less any payment made to the employees on cancellation.
A package of modifications might include several changes to the terms of a grant, some of which are favorable to the employee and some not. In the event the net effect is not beneficial to the employee, cancellation accounting will be applied. Cancellations or settlements of equity-settled share-based payments during the vesting period by the Company are accounted for as accelerated vesting; therefore, the amount that would otherwise have been recognized for services received is recognized immediately.
54


In September 2023, the people and compensation committee of GlobalFoundries approved a modification to the 2023 PSUs, to adjust the return on invested capital (“ROIC”) performance threshold. The modification did not increase the fair value of the 2023 PSUs as the non-market performance condition was not considered when determining the fair value on the modification date. The Company will cumulatively adjust the expense based on the number of shares probable of vesting based on ROIC metrics and the grant date fair value.

Off Balance Sheet Arrangements
During the periods presented, we did not have, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Safe Harbor
See “Cautionary Statement Regarding Forward-Looking Information.”
55


ITEM 6.    DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
A.Directors and Senior Management
The following table sets forth information for our executive officers and directors as of the date of this Annual Report:
NameAgeTitle
Executive Officers*
Dr. Thomas Caulfield65President and Chief Executive Officer, Board Director
John Hollister*54Chief Financial Officer
Niels Anderskouv55Chief Business Officer
Saam Azar47Chief Legal Officer
Tim Breen46Chief Operating Officer, Board Director
Pradheepa Raman43Chief People Officer
Board of Directors 
Ahmed Yahia51Chairman of the Board, Chairman of Strategy and Technology Committee
Dr. Thomas Caulfield65President and Chief Executive Officer, Board Director
Ahmed Saeed Al Calily51Board Director
Tim Breen46Chief Operating Officer, Board Director
Glenda Dorchak69Board Director
Martin L. Edelman82Board Director, Chairman of Nominating and Governance Committee
David Kerko51Lead Independent Director, Chairman of People and Compensation Committee
Jack Lazar58Board Director, Chairman of Audit, Risk and Compliance Committee
Elissa E. Murphy55Board Director
Carlos Obeid59Board Director
Dr. Bobby Yerramilli-Rao57Board Director
*David Reeder was CFO on December 31, 2023. John Hollister succeeded Mr. Reeder as CFO on February 5, 2024.
Executive Officers
Dr. Thomas Caulfield is the President and Chief Executive Officer (“CEO”) of GF, a position he has held since March 2018. He was also elected to the Board of Directors in March 2018. Dr. Caulfield joined the Company in May 2014 as Senior Vice President and General Manager of the Company’s Fab 8 semiconductor wafer manufacturing facility in Malta, New York, where he led operations, process development, and the expansion and ramp-up of semiconductor manufacturing production. Dr. Caulfield has an extensive career spanning engineering, executive management and global operational leadership with leading technology companies. Prior to joining GF, Dr. Caulfield served as President and Chief Operations Officer at Soraa from May 2012 to May 2014, a leading developer of GaN on GaNTM (gallium nitride on gallium nitride) solid-state lighting technology. Before Soraa, Dr. Caulfield served as President and COO of Ausra from 2009 to 2010, a leading provider of large-scale concentrated solar power solutions for electrical power generation and industrial steam production. Prior to leading at Ausra, Dr. Caulfield served as Executive Vice President of Sales, Marketing and Customer Service at Novellus Systems, Inc. Before that, Dr. Caulfield spent 17 years at IBM in a variety of senior leadership roles, ultimately serving as Vice President of 300mm semiconductor operations for IBM’s Microelectronics division, leading its wafer fabrication and R&D operations in East Fishkill, New York. He currently serves as a member of the board of directors for Western Digital Corporation and has been a Trustee for Union College since 2018. Dr. Caulfield earned a Bachelor of Science in Physics from St. Lawrence University before entering Columbia University’s Fu Foundation School of Engineering and Applied Science, where he earned both his Bachelor and Master of Science in Materials Science and Engineering as well as a Doctorate in Materials Science and Engineering. Dr. Caulfield was also a postdoctoral fellow at Columbia’s Engineering Center for Strategic Materials.
John Hollister is the Chief Financial Officer (“CFO”) at GF, a position he has held since February 2024. Mr. Hollister is responsible for the Company’s financial operations and strategy. Mr. Hollister brings more than two decades of finance and operations experience in the semiconductor industry and a proven track record as a CFO of a publicly traded company. Prior to his role at GF, Mr. Hollister was at Silicon Labs from 2004 to early 2024, serving as CFO and Senior Vice President for 10 years and leading the company’s growth in broad-based semiconductor and Internet of Things (IoT) markets. Prior to his role at Silicon Labs, John held various finance positions at Cicada Semiconductor, Cirrus Logic, Veritas DGC, 3-D
56


Geophysical and PricewaterhouseCoopers LLP. Mr. Hollister currently serves as a member of the board of directors of MacroFab. Mr. Hollister is a Certified Public Accountant and holds a master’s degree in professional accounting as well as a bachelor’s degree in business administration from The University of Texas at Austin.
Niels Anderskouv is Chief Business Officer (“CBO”) at GF, a position he has held since May 2023. Mr. Anderskouv is responsible for leading GF’s product and technology roadmap, business and commercial strategy as well as its go-to-market execution. As CBO, Mr. Anderskouv also oversees GF’s product management, design platforms and business strategy and planning teams. Mr. Anderskouv brings more than 25 years of experience spanning engineering, executive management and global leadership in the semiconductor industry. Most recently, from 2017 to 2021, Mr. Anderskouv served as Senior Vice President and Executive Officer at Texas Instruments, where he was responsible for the company’s multi-billion-dollar Analog Power business. He is an expert in power management, analog and mixed-signal technologies and has a track record of driving and delivering financial performance. Mr. Anderskouv has been the Chairman of the board of directors of KeepIt since 2017. Mr. Anderskouv earned a Master of Science degree in Electrical Engineering from the Technical University of Denmark (DTU) in Copenhagen.
Saam Azar is Chief Legal Officer for GF, a position he has held since January 2017. He oversees all legal, compliance, government relations, environmental, health, safety and security matters worldwide. Mr. Azar also serves as Secretary to the GF Board of Directors and has been involved with the Company since its founding in 2009. From 2006 to 2017, Mr. Azar has also served in various roles at Mubadala Investment Company, as a senior member of its Legal & Compliance Unit, working primarily on complex, cross border partnerships. Prior to Mubadala, he worked as a corporate associate at the international law firm of Cleary Gottlieb in New York, where he supported numerous corporate transactions with an emphasis on debt and equity capital markets. Mr. Azar holds a J.D. from New York University School of Law and a Bachelor of Science degree in Civil and Environmental Engineering and Public Policy from Duke University.
Tim Breen is the Chief Operating Officer (“COO”) of GF, a position he has held since September 2023, and was elected to the Board of Directors in January 2018. In this role, he oversees GF’s global operations, including the manufacturing, quality, supply chain, and digital transformation teams. Prior to becoming COO, he served as senior advisor to the CEO with a focus on supporting GF’s business, supply chain and digital transformations. Starting in 2018, he supported the Company in various executive roles including leading strategy, business transformation and finance. Since 2010, Mr. Breen served as a member of the senior leadership team of GF’s founding shareholder, Mubadala Investment Company. He also serves on the board of directors of a number of Mubadala’s private North American investments, including as Chairman of the board of directors of NOVA Chemicals. Prior to joining Mubadala, Mr. Breen was a Partner with McKinsey in Abu Dhabi. He holds a Master of Business Administration degree from London Business School.
Pradheepa Raman is Chief People Officer at GF, a position she was appointed to in 2022. She has global responsibility for GF’s human resources practice areas including talent acquisition, development and retention, creation and delivery of people solutions, total rewards, organizational development and expanding on GF’s culture of innovation, diversity, inclusion and safety. Prior to joining GF, Ms. Raman was Global Head of Human Resources and Chief Transformation Officer for the Global Tools & Storage business unit of Stanley Black & Decker, Chief Talent Officer of Stanley Black & Decker, and held senior human resources positions at Samsung Electronics America and Avaya. Ms. Raman began her career as a software developer. Ms. Raman holds a Bachelor’s degree in Electronics and Communication Engineering from Anna University in India, and a Master’s degree in Human Resources from Rutgers University.
Board of Directors
Ahmed Yahia was elected to the Board of Directors as Chairman in December 2013. Mr. Yahia is currently the Chief Executive Officer, Direct Investments at Mubadala Investment Company with oversight of the Technology, Life Sciences, Financial Services, Consumer, Industrials & Business Services, and Energy & Sustainability portfolios. Mr. Yahia is also Chief Executive Officer of MGX, an artificial intelligence-focused investment company. Mr. Yahia is a member of Mubadala's Investment Committee, which develops Mubadala's investment policies and reviews proposed projects. Prior to joining Mubadala, Mr. Yahia was a Partner at McKinsey & Company, where he co-led the Principal Investor practice and was also the Managing Partner of the Abu Dhabi practice. He was formerly a Marketing Manager at Procter & Gamble, where he led several flagship brands. He serves as Chairman of the board of directors of Compañía Española de Petróleos and is a member of the board of directors of Abu Dhabi Investment Council, Mubadala Capital, and Emirates Global Aluminum . Previously, he served as a board member of Advanced Micro Devices Inc. from 2012 to 2019. Mr. Yahia holds a Bachelor of Science in Industrial Engineering from École Centrale Paris and a Master of Science in Mechanical Engineering/Product Strategy from the Massachusetts Institute of Technology. Mr. Yahia is an independent, non-executive director pursuant to applicable Nasdaq rules.
Dr. Thomas Caulfield is the President and CEO of GF and was elected to the Board of Directors in March 2018. Please see “Item 6. Directors, Senior Management and Employees—A. Directors and Senior Management—Executive Officers” for a description of Dr. Caulfield’s business experience.
Ahmed Saeed Al Calily was elected to the Board of Directors in March 2018. Mr. Al Calily is the Chief Strategy & Risk Officer for Mubadala Investment Company, overseeing portfolio strategy, enterprise risk management, and responsible investing. Prior to that, Mr. Al Calily was the Chief Executive Officer of Energy at Mubadala, where he oversaw the company’s energy assets. Prior to re-joining Mubadala, Mr. Al Calily was Director General of the Abu Dhabi Technology Development Committee and Chief Executive Officer and managing director of the Abu Dhabi Ports Company. Mr. Al Calily
57


also served as Deputy Director of the Infrastructure and Services unit at Mubadala. He currently serves as a member of the board of directors at Abu Dhabi Future Energy Company, Abu Dhabi Investment Council, Mubadala Capital, and Emirates Global Aluminum. Mr. Al Calily holds a bachelor’s degree in Economics and Political Science from Boston University. Mr. Al Calily is an independent, non-executive director pursuant to applicable Nasdaq rules.
Tim Breen is the Chief Operating Officer of GF and was elected to the Board of Directors in January 2018. Please see “Item 6. Directors, Senior Management and Employees—A. Directors and Senior Management—Executive Officers” for a description of Mr. Breen’s business experience.
Glenda Dorchak was elected to the Board of Directors in June 2019. Ms. Dorchak spent over thirty years in operational leadership roles in the technology industry, most recently as Executive Vice President and General Manager of Global Business with Spansion, Inc., a flash memory manufacturer. She started her career with 20 years at IBM where she held a range of operating roles including General Manager PC Direct. She later moved to e-retailer Value America where she was part of the IPO team eventually becoming Chairman and Chief Executive Officer. Ms. Dorchak subsequently joined Intel Corp. as Vice President and COO of Intel Communications Group, then went on to serve as Vice President and General Manager, Broadband Products Group and later, Vice President and General Manager, Consumer Electronics Group. After Intel, Ms. Dorchak was Chairperson and Chief Executive Officer of Intrinsyc Software and Vice Chairman and Chief Executive Officer of VirtualLogix. Ms. Dorchak currently does advisory and board work and serves as a member of the board of directors at ANSYS, Inc. and Wolfspeed Inc. Ms. Dorchak is an independent, non-executive director pursuant to applicable Nasdaq rules.
Martin L. Edelman was elected to the Board of Directors in February 2017. Mr. Edelman is General Counsel of G42 and MGX, and Of Counsel of Paul Hastings LLP. He is an advisor to Mubadala and is a partner at Fisher Brothers, a real estate partnership. Mr. Edelman serves as Executive Chairman at Manchester Life. He is also a director of Equity Commonwealth, Aldar Properties, City Football Group, and currently serves on the boards of various nongovernmental organizations. He has more than 40 years of experience and concentrates his practice on real estate and corporate mergers and international transactions. Mr. Edelman holds a Bachelor of Arts degree from Princeton University and a law degree from Columbia Law School. Mr. Edelman is an independent, non-executive director pursuant to applicable Nasdaq rules.
David Kerko was elected to the Board of Directors in January 2018. Mr. Kerko is Head of North America Private Equity at Elliott Investment Management L.P. Prior to joining Elliott, Mr. Kerko was an advisor, member and co-head of the Technology Group at Kohlberg Kravis Roberts & Co. Inc. (“KKR”). Prior to joining KKR, he worked for Gleacher NatWest Inc. on mergers and acquisition transactions and financing. Mr. Kerko is a member of the board of directors of Cubic Corporation, Nielsen and Cloud Software Group. Mr. Kerko holds a Bachelor of Science degree and a Bachelor of Science in Engineering degree, summa cum laude, from the University of Pennsylvania. Mr. Kerko is an independent, non-executive director pursuant to applicable Nasdaq rules and serves as Lead Independent Director.
Jack Lazar was elected to the Board of Directors in July 2021. Mr. Lazar has spent over thirty years in operational and finance leadership roles at technology companies across multiple industries, most recently as Chief Financial Officer of GoPro, Inc., which he helped to take public in 2014. Prior to GoPro, Mr. Lazar served as Senior Vice President of Corporate Development and General Manager of Qualcomm Atheros, Inc. From 2003 until the time in which it was acquired by Qualcomm in 2011, he served in a variety of leadership roles at Atheros Communications, Inc., most recently as Chief Financial Officer and Senior Vice President of Corporate Development. In 2004, Mr. Lazar was part of the team that took Atheros public. He also served in leadership roles at NetRatings, Apptitude, and Electronics for Imaging, Inc. Mr. Lazar currently serves as a member of the board of directors of several publicly traded companies including Astera Labs, Box, Resideo Technologies, and thredUP. Mr. Lazar holds a Bachelor of Science in Commerce degree with an emphasis in Accounting from Santa Clara University and is a certified public accountant (inactive). Mr. Lazar is an independent, non-executive director pursuant to applicable Nasdaq rules.
Elissa Murphy was elected to the Board of Directors in September 2021. Ms. Murphy is Senior Vice President at Cisco Systems, Inc. Prior to Cisco, she served as a Vice President of Engineering at Google, Inc. from 2016 to April 2023. Before Google, she was the Chief Technology Officer and Executive Vice President of Cloud Platforms at GoDaddy from 2013 to 2016. Ms. Murphy previously served as Vice President of Engineering at Yahoo! from late 2010 to 2013, where she oversaw the world’s largest private Hadoop cluster, a technology essential to massive-scale computing that is the basis of big data today. Prior to her time at Yahoo!, Ms. Murphy spent 13 years at Microsoft in various engineering positions including part of the original team responsible for Microsoft’s shift to the cloud, which led to the creation of Azure, and as a member of the High Performance Computing team. Ms. Murphy began her technology career designing and building many of the best-selling computer security and system utilities with 5th Generation Systems, Quarterdeck and the Norton Group, a division at Symantec responsible for Norton Antivirus and other Norton products. Previously, Ms. Murphy served on the board of directors of Inphi from 2015 to 2021. Ms. Murphy brings expertise in global-scale platforms, AI/ML, big data, distributed systems, and security. Ms. Murphy is an independent, non-executive director pursuant to applicable Nasdaq rules.
Carlos Obeid was elected to the Board of Directors in January 2012. Mr. Obeid is currently the Chief Financial Officer of Mubadala Investment Company, with oversight of its commercial functions including treasury, investor relations, financial planning, business performance, financial governance and reporting. Before joining Mubadala, Mr. Obeid worked with the United Arab Emirates Offset Program Bureau where he led a wide range of initiatives including privatization, utilities and financial services. He is a member of the board of directors of Mubadala Capital LLC, Abu Dhabi Commercial Bank PJSC and Abu Dhabi Investment Council. Mr. Obeid holds a Bachelor of Science in Electrical Engineering degree from American
58


University of Beirut, Lebanon, and a Master of Business Administration degree from INSEAD in Fontainebleau, France. Mr. Obeid is an independent, non-executive director pursuant to applicable Nasdaq rules.
Dr. Bobby Yerramilli-Rao was elected to the Board of Directors in March 2022. Dr. Yerramilli-Rao has served as Chief Strategy Officer and Corporate Vice President, Corporate Strategy at Microsoft Corporation since 2020. Prior to Microsoft, he was Co-founder and Managing Partner of Fusion Global Capital, from 2011 to 2020. Dr. Yerramilli-Rao previously served as Corporate Strategy Director and Internet Services Director of Vodafone, from 2006 to 2010, where he was responsible for strategy and acquisitions related to digital services, serving on the company’s Investment Committee. Prior to his time at Vodafone, Dr. Yerramilli-Rao spent more than a decade at McKinsey, having been elected Partner in 2000. He helped co-lead the telecom, media and technology practice. Dr. Yerramilli-Rao also served as a member of the board of directors of Cambridge Epigenetix Ltd. from 2012 to 2023. He holds a Master of Arts degree in Electrical Engineering from the University of Cambridge and a Doctorate in Robotics from the University of Oxford. Dr. Yerramilli-Rao is an independent, non-executive director pursuant to applicable Nasdaq rules.
For information on the role of the Shareholder’s Agreement and the Memorandum and Articles of Association in leadership selection, see “Item 6. Directors, Senior Management and Employees—C. Board Practices—Composition of our Board of Directors.”
B.Compensation
Under Cayman Islands law, we are not required to disclose compensation paid to our directors and executive officers on an individual basis and we have not otherwise publicly disclosed this information elsewhere.
Executive Compensation Philosophy
Our executive compensation programs are designed to attract, motivate, reward and retain the high-caliber executives necessary to accomplish our strategy. GF’s compensation philosophy includes the following key design principles:
Align with shareholder interest;
Strong link between pay and performance; and
Motivate our talent to achieve short-term and long-term goals that lead to sustainable long-term shareholder value creation.
Our executive officers receive fixed and variable compensation. They also receive benefits in line with market practice and with the benefits extended to our broad-based employee population.
Certain of our executive officers are entitled to certain benefits upon termination, including a cash severance payment if we terminate their employment without cause.
Base Salary
The fixed component of compensation consists of base salary. This provides a fixed source of income and acts as the foundation for other pay components. The base salary is reflective of the executive role, responsibility, and individual performance, and it is designed to be market-competitive at the median of our peer group and industry and attract and retain critical talent. We review base salaries annually, and make adjustments as appropriate based on market, performance and any change in responsibility.
Variable Incentive Programs
In 2023, the variable pay elements of our executive officers’ compensation consisted of an annual incentive program (“AIP”) and awards of performance stock units (“PSUs”) and restricted stock units (“RSUs”) under our 2021 Equity Compensation Plan.
Aggregate Compensation
For the year ended December 31, 2023, the aggregate compensation paid by us and our subsidiaries for our directors and executive officers for services in all capacities to us and our subsidiaries was $51.3 million* which includes both benefits paid in kind and compensation, as well as grants of, in the aggregate, 308,253 RSUs and 360,548 PSUs, pursuant to the terms and conditions of our 2021 Equity Compensation Plan. RSUs and PSUs vest as set forth in “2021 Equity Compensation Plan” below.
Of the amounts above, for the year ended December 31, 2023, $59,400 was set aside or accrued by us or our subsidiaries to provide defined contribution retirement benefits or similar benefits to our directors and executive officers.
* This aggregate number includes reimbursements by GF to Mubadala in connection with Mr. Tim Breen’s service as COO, senior advisor to the CEO and as a member of the Board of Directors. Please see “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Mubadala—Secondments” for further information on payments made
59


to Mubadala in connection with secondments. The aggregate number also includes compensation paid to Mr. David Reeder in connection with Mr. Reeder’s service as CFO during fiscal year 2023.
Annual Incentive Program
The AIP is a short-term annual cash incentive that incentivizes and rewards our executive officers for achieving critical company financial and operational goals, as well as individual goals. Each of our executives has an AIP target opportunity, set as a percentage of their base salary, which is reviewed annually to assure that both our performance and pay opportunities are aligned with competitive practices and that our rewards are reflective of Company and individual performance.
In 2023, our executive officers’ awards under the AIP were determined as follows:
Financial and operational performance: 70% for our CEO and CFO and 50% for other executives;
Strategic scorecard performance: 30% for our CEO and CFO and 50% for other executives; and
Individual Modifier (0.8x-1.2x): Based on the discretion of the Board, People and Compensation Committee or CEO, as appropriate, including but not limited to considerations of leadership, employee engagement, diversity and inclusion, collaboration, business process improvement, strategic contributions and business context.
Long-term Incentive Programs
We maintain a number of long-term incentive plans (the “Long-term Incentive Plans”), including the GlobalFoundries Inc. Share Incentive Plan (the “2017 Plan”), the GlobalFoundries 2018 Share Incentive Plan (the “2018 Plan”) and the GlobalFoundries 2021 Equity Compensation Plan (the “2021 Plan”) to enable our executives and other high performing and high potential participants to share in the value creation of the Company as we execute our business plan and deliver returns to our shareholders. Our Long-Term Incentive Plans are administered by the People and Compensation Committee, which was delegated authority to administer these plans by our Board of Directors.
Our Long-term Incentive Plans consist of non-qualified stock options, RSUs and PSUs for eligible participants.
In 2023, our executive officers received a combination of PSU and RSU awards as follows:
70% PSU and 30% RSU for our CEO and CFO; and
60% PSU and 40% RSU for other executive officers
The final number of PSUs will range from 0% to 200% of the PSUs granted, based on achievement of performance targets related to absolute Return on Invested Capital (“ROIC”) and relative Total Shareholder Return (“TSR”) versus the SOX Index, and 100% will vest after three years, subject to continued employment through the end of the performance period.
RSUs will generally vest in three annual installments, with 33.33% vesting on each one-year anniversary of the vesting commencement date subject to the employee’s continued employment with the Company.
Additional information on our Long-Term Incentive Programs are as follows:
2017 Plan
A small number of current employees continue to hold vested share options that were granted under the 2017 Plan. Share options granted under the 2017 Plan became exercisable upon the first anniversary of our IPO following the vesting date but during the term of the share option. In connection with the establishment and adoption of the 2018 Plan, we ceased making awards under the 2017 Plan. As of December 31, 2023, there are 4,515 non-qualified share options (“options”) to buy ordinary shares outstanding under the 2017 Plan.
2018 Plan
Awards under the 2018 Plan may be granted in the form of options, share awards, or share unit awards.
Participants in the 2018 Plan typically received a one-time grant upon hire or promotion into an eligible role. The majority of options granted in 2019 vest over five years, with 20% of the options vesting on the later of December 31 of the first five years following the grant date and the six-month anniversary of the consummation of our IPO, subject to continued employment through the applicable vesting date (with limited exceptions for certain qualifying terminations). Generally, awards of options granted in 2020 or later vest over four years, with 25% of the options vesting on the later of December 31 of the first four years following the grant date and the six-month anniversary of the consummation of our IPO, subject to continued employment through the applicable vesting date (with limited exceptions for certain qualifying terminations). Options held by U.S. taxpayers that vested on the six-month anniversary of our IPO were exercisable for a period commencing on the vesting date and ending on December 2, 2022. Any outstanding in the money exercisable options not exercised as of December 2, 2022, were automatically exercised on that date. All other outstanding options held by U.S. taxpayers will become exercisable for a period commencing on January 1 of the year following the year in which such
60


options vest and ending on a fixed date in such year, with any outstanding exercisable options not exercised as of the end of such period being automatically exercised as of a fixed date in that year. Options held by non-U.S. taxpayers will become exercisable on the date such options vest and will remain exercisable, pursuant to normal option exercise procedures under the terms and conditions of the 2018 Plan for the duration of the term of the option, with any outstanding exercisable options not exercised before the expiration of such options in accordance with their terms being automatically exercised as of the expiration date of the options by means of “net exercise” in order to satisfy the exercise price and applicable taxes due in respect of such options.
Awards of RSUs vest over four years, with 25% of the share units vesting on each of the first four anniversaries of the earlier of the grant date or the participant’s hire or promotion date, subject to continued employment through the applicable vesting date (with limited exceptions for certain qualifying terminations). Certain RSU grants made to certain current and former non-employee members of our Board of Directors in connection with our IPO generally vest over three years, with 33% of the share units vesting on the first three anniversaries of the grant date, subject to their continued provision of services (whether as a non-employee director or otherwise) to the Company through the applicable vesting date.
Under the 2018 Plan, as of December 31, 2023, there are 1.6 million options to buy ordinary shares and 326,504 RSU awards to our employees outstanding.
In addition, under the 2018 Plan there are 3,211,764 ordinary shares that remain available for grant. No awards may be granted under the 2018 Equity Plan after our Board of Directors terminates the 2018 Equity Plan or ten years from its effective date, whichever is earlier.
Shareholder Proceeds Bonus Program
Between 2019 and 2021, we maintained a bonus program (the “Shareholder Proceeds Bonus Program”) pursuant to which eligible option holders under our 2018 Equity Plan may receive cash awards depending on financial results linked to annual operating cash flow and other financial metrics.
During those years, if our Board of Directors determined that any amounts are to be paid under the Shareholder Proceeds Bonus Program, the aggregate amount of the cash payment to be received by any participant is based on the per share bonus payment amount, a multiple determined by the Board and the number of outstanding share options to which the award under the Shareholder Proceeds Bonus Program relates, with the aggregate cash payment pro-rated based on the number of vested share options as of each payment date over the vesting schedule of the share option. Payment of any amounts under the Shareholder Proceeds Bonus Program is independent of and not contingent upon the exercise of any share options.
No new awards have been granted under the Shareholder Proceeds Bonus Program since calendar year 2021. All existing awards will continue to be paid out on their current payment schedule.
2021 Plan
In connection with our IPO, our Board of Directors adopted, and Mubadala approved, the 2021 Plan. The 2021 Plan provides for the issuance of incentive share options, non-qualified share options, share awards, share units, share appreciation rights, and other share-based awards.
In 2023, the Company granted RSUs and PSUs under the 2021 Plan. The RSUs have a time-based vesting requirement, which provides that the RSUs will generally vest in three annual installments, with 33.33% vesting on each anniversary of the vesting commencement date subject to the employee’s continued employment with the Company. The Company may make awards with different vesting conditions to help the Company achieve its talent strategy. The PSUs vest subject to achievement of performance targets based on an absolute ROIC and relative TSR versus the SOX Index over a 3-year performance period subject to the grantee remaining employed by the Company through the end of the applicable performance period.
As of December 31, 2023, there are 3.8 million RSUs and 1.2 million PSUs outstanding under the 2021 Plan. In addition, as of December 31, 2023, there are 17 million ordinary shares that remain available for grant under the 2021 Plan.
Employee Stock Purchase Plan
In connection with, and prior to the consummation of the Company's IPO in 2021, the Company's Board of Directors adopted the GLOBALFOUNDRIES Inc. 2021 Employee Stock Purchase Plan (the “ESPP”). The ESPP is administered by the Company's Board of Directors or, as applicable, its delegate (the “ESPP Administrator”).
The ESPP provides eligible employees with an opportunity to purchase ordinary shares of the Company through payroll deduction of up to 10% of their eligible compensation. A participant may purchase a maximum of 2,500 ordinary shares during a purchase period. Amounts deducted and accumulated by the participant are used to purchase ordinary shares at the end of each six-month purchase period. Participants in the ESPP receive a one-time grant of 50 RSUs upon first time enrollment in the ESPP. The Company matches 20% of each employee’s contribution on an after-tax basis.
Subject to certain equitable adjustments in connection with certain events affecting the outstanding ordinary shares reserved for issuance as awards, the maximum aggregate number of our ordinary shares that may be issued or transferred under the
61


ESPP with respect to awards is 7,500,000 ordinary shares; provided that the share reserve under the ESPP will, unless otherwise determined by our Board of Directors, automatically increase on January 1 of each year for 8 years commencing on January 1, 2023 and ending on (and including) January 1, 2031 in an amount equal to 0.25% of the total number of ordinary shares outstanding on December 31 of the preceding year. In no event will the number of ordinary shares that may be issued or transferred pursuant to rights granted under the ESPP exceed 18,750,000, in the aggregate, subject to the adjustments described above.
As of December 31, 2023, of the Company has issued 1.47 million shares under this plan reflecting employees’ contribution and the 20% Company match.

C.Board Practices
Composition of our Board of Directors
Our Board of Directors currently consists of eleven members, all of whom were elected pursuant to our Memorandum and Articles of Association. The Board is divided into three classes designated as Class I, Class II and Class III, with the members of each class each serving staggered, three-year terms. The terms of our Class I directors will expire at the 2025 annual general meeting of shareholders; the terms of our Class II directors will expire at the 2026 annual meeting of shareholders; and the terms of our Class III directors will expire at the 2024 annual meeting of shareholders. At the expiration of the respective terms of the Class I, Class II and Class III directors, new Class I, Class II and Class III directors will be elected to serve for a full term of the three years respectively.
Dr. Thomas Caulfield, Ahmed Saeed Al Calily, Tim Breen and Glenda Dorchak serve as Class I directors (with terms expiring in 2025). Martin L. Edelman, David Kerko, Jack Lazar and Carlos Obeid serve as Class II directors (with terms expiring in 2026). Ahmed Yahia, Elissa E. Murphy and Bobby Yerramilli-Rao serve as Class III directors (with terms expiring in 2024).
In selecting Board members, our Nominating and Governance Committee and Board of Directors consider a broad range of factors relating to the qualifications and background of nominees, including those factors set out in the Statement on Diversity and Member Section of our Board Charter (which include but are not limited to race, gender, sexual orientation, cultural background and membership in underrepresented groups). Our Nominating and Governance Committee’s and Board of Directors’ priority in selecting Board members is identification of persons who will further the interests of our shareholders through their established record of professional accomplishment, the ability to contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape and professional and personal experiences and expertise relevant to our growth strategy. Under a shareholder’s agreement entered into with Mubadala through two of its subsidiaries holding our ordinary shares, Mubadala Technology Investment Company (“MTIC”) and MTI International Investment Company LLC (“MTIIIC”) (the “Shareholder’s Agreement”) prior to the consummation of our IPO in 2021, we agreed to nominate for election to our Board of Directors a certain number of designees selected by Mubadala. See “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Mubadala—Shareholder’s Agreement.”
There is no Cayman Islands law requirement that a director must hold office for a certain term and stand for re-election unless the resolutions appointing the director impose a term on the appointment. We do not have any age limit requirements relating to our director’s term of office.
The Shareholder’s Agreement provides that, for so long as MTIC, MTIIIC and certain of their affiliates (the “Mubadala Entities”), in the aggregate, beneficially own 50% or more of the ordinary shares held by the Mubadala Entities upon consummation of our IPO, MTIC will be entitled to nominate a number of designees (the “Mubadala Designees”) to our Board of Directors representing a majority of our directors. MTIC designated the following directors as Mubadala Designees as of the date of our IPO: Ahmed Yahia, Ahmed Saeed Al Calily, Tim Breen, Martin L. Edelman, and Carlos Obeid. By making such designation, MTIC retains the right to appoint any additional Mubadala Designees in accordance with the Shareholder’s Agreement and the Memorandum and Articles of Association.
Our Memorandum and Articles of Association also provide that our directors may only be removed for cause by an affirmative vote of 75% of our shareholders, provided that (1) a Mubadala Designee may only be removed with or without cause by MTIC, and (2) as long as the Mubadala Entities beneficially own in the aggregate at least 50% of our outstanding ordinary shares, directors other than Mubadala Designees may be removed with or without cause by a majority of shareholders. Any vacancy resulting from an enlargement of our Board of Directors (which shall not exceed any maximum number stated in our Memorandum and Articles of Association), may be filled by ordinary resolution or by vote of a majority of our directors then in office; provided that any vacancy with respect to a Mubadala Designee may only be filled by a decision of majority of the Mubadala Designees then in office, or if there are none, by MTIC.
Board’s Role in Risk Oversight
Our Board of Directors oversees the management of risks inherent in the operation of our business and the implementation of our business strategies. Our Board of Directors performs this oversight role by using several different levels of review. In connection with its reviews of our operations and corporate functions, our Board of Directors addresses the primary risks associated with those operations and corporate functions. In addition, our Board of Directors reviews the risks associated
62


with our business strategies periodically throughout the year as part of its consideration of undertaking any such business strategies.
Each of our Board committees also oversees the management of our risk that falls within the committee’s areas of responsibility. In performing this function, each committee has full access to management, as well as the ability to engage advisors. Our Chief Financial Officer provides reports to the Audit Committee and is responsible for identifying, evaluating and implementing risk management controls and methodologies to address any identified risks. In connection with its risk management role, our Audit Committee meets privately with representatives from our independent registered public accounting firm and our Chief Financial Officer. The Audit Committee oversees the operation of our risk management program, including the identification of the primary risks associated with our business and periodic updates to such risks, and reports to our Board of Directors regarding these activities.
The Board met eight times in 2023. From the time each director became a member of the Board, attendance or participation at Board meetings in 2023 was 98%.
Board Committees
Our Board of Directors has established an Audit Committee, a People and Compensation Committee, a Strategy and Technology Committee and a Nominating and Governance Committee, each of which operates pursuant to a separate charter adopted by our Board of Directors.
Audit, Risk and Compliance Committee
Glenda Dorchak, Jack Lazar and Elissa E. Murphy currently serve on the Audit Committee, which is chaired by Jack Lazar. Our Board of Directors has determined that each member of the Committee is “independent” for Audit Committee purposes as that term is defined in the rules of the SEC and the applicable rules of Nasdaq. The Audit Committee’s responsibilities include:
appointing our independent registered public accounting firm, and approving the audit and permitted non-audit services to be provided by our independent registered public accounting firm;
evaluating the performance and independence of our independent registered public accounting firm;
monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our financial statements or accounting matters;
reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures;
establishing and overseeing procedures for the receipt, retention and treatment of accounting-related complaints and concerns;
reviewing and discussing with the independent registered public accounting firm the results of our year-end audit, and recommending to our Board of Directors, based upon such review and discussions, whether our financial statements shall be included in our Annual Report on Form 20-F;
reviewing all related party transactions for potential conflict of interest situations, approving all such transactions and overseeing the Company’s director conflict of interest policy;
overseeing the Company’s ESG programs and periodically reporting to the Board of Directors;
reviewing with management cybersecurity, privacy and IT risks, including the initiatives, action plans and programs to manage such risks; and
overseeing and reviewing major corporate risks and periodically reporting to the Board of Directors.
We have one financial expert as of the date hereof. Our Board of Directors has determined that Jack Lazar qualifies as an “audit committee financial expert” as defined in SEC rules and satisfies the financial sophistication requirements of the Nasdaq.
The Audit Committee met nine times in 2023. From the time each director became a member of the Committee, attendance or participation at Audit Committee meetings in 2023 was 100%.
People and Compensation Committee
Ahmed Saeed Al Calily, David Kerko and Elissa E. Murphy currently serve on the People and Compensation Committee, which is chaired by David Kerko. The People and Compensation Committee’s responsibilities include:
establishing and reviewing the goals and objectives of our executive compensation plans;
establishing the goals and objectives relevant to Chief Executive Officer compensation, and making recommendations to our Board of Directors in evaluating our Chief Executive Officer’s performance in light of these goals and objectives;
63


evaluating the performance of our executive officers in light of the goals and objectives of our executive compensation plans and making recommendations to our Board of Directors with respect to the compensation of our executive officers, including our Chief Executive Officer;
making recommendations to our Board of Directors with respect to improvement of existing, or adoption of new, employee compensation plans and programs; and
retaining and approving executive compensation advisors and other advisors advising the People and Compensation Committee.
The People and Compensation Committee met seven times in 2023. From the time each director became a member of the Committee, attendance or participation at People and Compensation Committee meetings in 2023 was 100%.
Strategy and Technology Committee
Ahmed Yahia, Dr. Thomas Caulfield, Tim Breen, David Kerko and Dr. Bobby Yerramilli-Rao currently serve on the Strategy and Technology Committee, which is chaired by Ahmed Yahia. The Strategy and Technology Committee’s responsibilities include:
assisting our Board of Directors in reviewing significant investments, divestment, joint ventures, partnerships, and other strategic agreements;
providing guidance to our Board of Directors on long-range strategy and business plans;
assisting our Board of Directors in reviewing our technology road map; and
assisting our Board of Directors in reviewing strategic long-term customer and supplier agreements.
The Strategy and Technology Committee met four times in 2023. From the time each director became a member of the Committee, attendance or participation at Strategy and Technology Committee meetings in 2023 was 95%.
Nominating and Governance Committee
Ahmed Yahia, Glenda Dorchak, Martin L. Edelman and David Kerko currently serve on the Nominating and Governance Committee, which is chaired by Martin L. Edelman. The Nominating and Governance Committee’s responsibilities include:
assisting our Board of Directors in identifying prospective director nominees and recommending nominees for election by the shareholders or appointment by our Board of Directors;
reviewing and assessing the adequacy of our corporate governance guidelines and recommending proposed changes to our Board of Directors; and
overseeing the evaluation of our Board of Directors.
The Nominating and Governance Committee met two times in 2023. From the time each director became a member of the Committee, attendance or participation at Nominating and Governance Committee meetings in 2023 was 100%.
D.Employees
We have a highly skilled employee base and as of December 31, 2023, we employed approximately 12,000 employees primarily located at our manufacturing sites. As of December 31, 2023, approximately 37% of our employees were located in North America, approximately 25% in EMEA, and approximately 38% in APAC. We also engage temporary employees and consultants. Overall, we believe we have good relations with our employees. As of December 31, 2023, approximately 71% of our employees were engineers or technicians.
E.Share Ownership
Refer to “Item 7. Major Shareholders and Related Party Transactions” below for information on share ownership.
See “Item 6. Directors, Senior Management and Employees—B. Compensation” for information on our arrangements for involving employees in the capital of the Company.

F.     Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation
Not applicable.
64


ITEM 7.    MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
A.Major Shareholders
The following table sets forth certain information with respect to the beneficial ownership of our ordinary shares as of December 31, 2023 for (i) each person known by us to be the beneficial owner of more than 5% of our outstanding shares of ordinary shares and (ii) all of our directors and executive officers as a group. Our majority shareholder, Mubadala, does not have different voting rights from those of other shareholders. As discussed below, prior to the consummation of our IPO in 2021, we entered into a Shareholder’s Agreement with Mubadala through two of its subsidiaries.
Name of Beneficial OwnerNumber of
Ordinary
Shares Owned
Percentage of
Ordinary
Shares Owned
Mubadala469,501,99484.8 %
FMR LLC(1)
34,899,7976.3 %
Directors and named executive officers:
Dr. Thomas Caulfield**
David Reeder(2)
**
Niels Anderskouv**
Saam Azar**
Tim Breen**
Pradheepa Raman**
Ahmed Yahia**
Ahmed Saeed Al Calily**
Glenda Dorchak**
Martin L. Edelman**
David Kerko**
Jack Lazar**
Elissa E. Murphy**
Carlos Obeid**
Bobby Yerramilli-Rao**
*Represents beneficial ownership of less than 1% of our issued and outstanding ordinary shares.
(1)According to report on Schedule 13G filed with the SEC on February 9, 2024, by FMR LLC.
(2)David Reeder was CFO on December 31, 2023. John Hollister succeeded Mr. Reeder as CFO on February 5, 2024.

B. Related Party Transactions
Mubadala
Secondments
Between January 1, 2023, and the date of this Annual Report, Mubadala has seconded a limited number of persons to us, including Tim Breen, who serves as our COO and is a member of our Board of Directors and continues to be seconded to us as of the date of this Annual Report. From January 1, 2023 to December 31, 2023, we paid Mubadala approximately $5 million* in consideration of the services provided by the secondees, pursuant to individual secondment agreements with Mubadala. On November 7, 2023, we entered into a new secondment agreement that sets forth the terms of Mr. Breen’s secondment to GF, including Mr. Breen’s compensation and GF’s reimbursement obligations to Mubadala, beginning in January 1, 2024, for Mr. Breen’s compensation.
The secondment agreements relating to other Mubadala secondees have been superseded by a Consulting Service Agreement, dated January 1, 2024, between Mubadala and GF (the “Consulting Services Agreement”). The Consulting Services Agreement sets forth the terms of all other employee secondments by Mubadala to GF, including employee compensation and related reimbursement obligations, and provides Mubadala and GF with the flexibility to second additional employees from Mubadala to GF in the future, as appropriate. Under the terms of the Consulting Services Agreement, Mubadala Performance Partners will provide services including strategic planning and execution support, operational process optimization, talent acquisition and management, supply chain and logistics optimization, cost efficiency improvement support, and analysis of M&A and corporate development opportunities. The Company will pay Mubadala Performance Partners an annual fee of $8 million for such services. The Company may terminate the Consulting Services Agreement at any time by providing written notice, and the Consulting Services Agreement includes other customary termination provisions.
65


* The portion of this amount paid in consideration of the services provided by Mr. Breen to GF is also included in the aggregate compensation amount reported in “Item 6. Directors, Senior Management and Employees—B. Compensation—Aggregate Compensation.”
Shareholder’s Agreement
Prior to the consummation of our IPO in 2021, we entered into the Shareholder’s Agreement with Mubadala through two of its subsidiaries holding our ordinary shares, MTIC and MTIIIC. The Shareholder’s Agreement provides that, for so long as the Mubadala Entities, in the aggregate, beneficially own 50% or more of the ordinary shares held by the Mubadala Entities, MTIC is entitled to nominate a number of Mubadala Designees to our Board of Directors representing a majority of our directors. The Shareholder’s Agreement specifies how such nomination rights decrease as the Mubadala Entities’ beneficial ownership of our ordinary shares decreases. Specifically, for so long as the Mubadala Entities, in the aggregate, beneficially own (i) 40% or more, but less than 50%, (ii) 30% or more, but less than 40%, (iii) 20% or more, but less than 30%, and (iv) 5% or more, but less than 20%, of the ordinary shares held by the Mubadala Entities, MTIC shall be entitled to Mubadala Designees on our Board of Directors representing at least 50%, 40%, 30% and 20%, respectively, of our directors. The Shareholder’s Agreement provides that for so long as MTIC is entitled to nominate at least 30% of our directors, the chairman of our Board of Directors shall be appointed by a majority vote of the Mubadala Designees directors.
The Shareholder’s Agreement specifies that, where there is a vacant Board position in respect of a Mubadala Designee director, such vacancy shall be filled only by a decision of a majority of the Mubadala Designee directors then in office or, if there are no such directors then in office, by MTIC. Additionally, we will include the Mubadala Designees on the slate that is included in our proxy statement relating to the appointment of directors of the class to which such persons belong and provide the highest level of support for the appointment of each such person as we provide to any other individual standing for appointment as a director.
The Shareholder’s Agreement also specifies that until such time as the Mubadala Entities no longer beneficially own at least 30% of our outstanding ordinary shares, we will not, nor will we permit our subsidiaries, to take certain significant actions specified therein without the prior consent of MTIC. These actions include:
• amendments or modifications to, or repealing of, (whether by merger, consolidation or otherwise) any provisions of our organizational documents in a manner that would adversely affect the Mubadala Entities beneficially owning outstanding ordinary shares;
• issuances of equity securities, subject to customary exceptions;
• acquisitions or dispositions in an amount exceeding $300 million in any single transaction or $500 million in any calendar year, other than pursuant to ordinary course transactions;
• mergers, consolidations, or other transactions that would involve a change of control of our company;
• incurring financial indebtedness in an amount exceeding $200 million, subject to certain exceptions;
• hiring or terminating our Chief Executive Officer, Chief Financial Officer or Chief Legal Officer or designating any replacement thereto;
• liquidation, dissolution or winding up of our company;
• any material change in the nature of the business of our company and our subsidiaries, taken as a whole; or
• changes to the size of our Board of Directors.
The Shareholder’s Agreement entitles the Mubadala Entities to certain information rights. The Mubadala Entities are permitted to share such disclosed information with other Mubadala Entities and their directors, officers, employees, consultants, advisers, and financing providers, provided that the recipient maintain the confidentiality of such disclosed information.
We will use our reasonable best efforts, if permitted by applicable law and regulation (including, in particular, our Audit Committee’s responsibilities under U.S. securities laws and regulations) and if in the best interests of the company, to select the same independent certified public accounting firm, or auditor, used by Mubadala (or an affiliate of such auditor) and to provide to Mubadala as much prior notice as reasonably practical of any change in our auditor until the first fiscal year end occurring after the date on which Mubadala and any entities owned by the Government of Abu Dhabi, together with their subsidiaries, no longer own in aggregate at least 25% of the voting power of our then outstanding securities. When selecting our auditor, we have agreed that we will give due consideration to the benefits arising to our company from the use of the same auditor as Mubadala (or an affiliate of such auditor).
The Shareholder’s Agreement is governed by Cayman Islands law and will terminate on the earlier to occur of (i) such time as the Mubadala Entities, in aggregate, cease to beneficially own 5% or more of our outstanding ordinary shares, and (ii) upon the delivery of a written notice by MTIC to us requesting its termination.
Certain of the provisions of the Shareholder’s Agreement have been included in our Memorandum and Articles of Association.
66


Registration Rights Agreement
Prior to the consummation of our IPO in 2021, we entered into a registration rights agreement with MTIC and MTIIIC, pursuant to which those holders of ordinary shares are entitled to demand the registration of the sale of certain or all of our ordinary shares that they beneficially own (the “Registration Rights Agreement”). Among other things, under the terms of the Registration Rights Agreement:
• Each holder has an unlimited right, subject to certain conditions and exceptions, to request that we file registration statements with the SEC for one or more underwritten offerings of all or part of our ordinary shares that the holder beneficially owns, and we are required to cause any such registration statements (a) to be filed with the SEC as promptly as practicable and (b) to use commercially reasonable efforts to cause such registration statements to become effective as soon as reasonably practicable;
• If we propose to file certain types of registration statements under the Securities Act with respect to an offering of equity securities by us, we are required to use commercially reasonable efforts to offer the other parties to the Registration Rights Agreement, if any, the opportunity to register the sale of all or part of their shares on the terms and conditions set forth in the Registration Rights Agreement (customarily known as “piggyback rights”); and
• All expenses of registration under the Registration Rights Agreement, including the legal fees of one counsel retained by or on behalf of the holders, will be paid by us.
The registration rights granted in the Registration Rights Agreement are subject to customary restrictions such as minimum offering sizes, blackout periods and, if a registration is underwritten, any limitations on the number of shares to be included in the underwritten offering as reasonably advised by the managing underwriter. The rights of the holders under the Registration Rights Agreement are assignable to certain transferees of the holders’ ordinary shares. The Registration Rights Agreement also contains customary indemnification and contribution provisions. The Registration Rights Agreement is governed by New York law.
SMP
Silicon Manufacturing Partners Pte Ltd. (“SMP”) is a joint venture between Avago Technologies International Sales Pte. Limited (“Avago Singapore”) and Globalfoundries Singapore Pte. Ltd. During 2022, Avago Singapore acquired 51% of the shares in the share capital of SMP from LSI Technology (Singapore) Pte. Ltd. (“LSI”) and the rights and obligations of LSI under the existing Joint Venture Agreement were novated to Avago Singapore. We hold a 49% interest in SMP and manage all aspects of its manufacturing operations. In the year ended December 31, 2023, we purchased products, primarily wafers, from SMP for an aggregate of $61 million. We also reimbursed expenses of and contributed tools to SMP in that period, with an aggregate expense of $61 million.
C.Interests of Experts and Counsel.
Not applicable.
ITEM 8.    FINANCIAL INFORMATION
A.Consolidated Financial Statements and Other Financial Information
Please see “Item 18. Financial Statements”. Other than as disclosed elsewhere in this Annual Report, no significant change has occurred since the date of the Annual Consolidated Financial Statements.
Legal Proceedings
On April 28, 2021, IBM sent us a letter alleging for the first time that we did not fulfill our obligations under the contracts we entered into with IBM in 2014 and 2015 associated with our acquisition of IBM’s Microelectronics division. IBM asserted that we engaged in fraudulent misrepresentations during the underlying negotiations, and claimed we owed them $2.5 billion in damages and restitution. On June 7, 2021, the Company filed a complaint with the New York State Supreme Court (the “Court”) seeking a declaratory judgment that the Company did not breach the relevant contracts. IBM subsequently filed its complaint with the Court on June 8, 2021. On September 14, 2021, the Court granted our motion to dismiss IBM’s claims of fraud, unjust enrichment and breach of the implied covenant of good faith and fair dealing. IBM appealed the dismissal of its fraud claim, and on April 7, 2022, the New York Appellate Division reversed the Court’s decision. Discovery and dispositive motion practice have been completed and the parties are awaiting a trial date. The Company believes, based on discussions with legal counsel, that the Company has meritorious defenses against IBM’s claims. The Company disputes IBM’s claims and intends to vigorously defend against IBM. We do not currently anticipate this proceeding to have a material impact on our results of operations, financial condition, business and prospects.
In addition to the foregoing proceeding, from time to time, we become involved in legal proceedings arising in the ordinary course of our business, such as claims brought by our customers in connection with commercial disputes, product liability claims, employment claims made by our current or former employees or claims of infringement raised by intellectual property owners, in connection with the technology used in our manufacturing operations. Based on the information currently
67


available to us, we believe that the outcome of these proceedings would not have a material impact on our results of operations, financial condition, business and prospects.
Dividends and Dividend Policy
We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. Therefore, we do not anticipate declaring or paying any cash dividends to our shareholders in the foreseeable future. Any future determination as to the declaration and payment of dividends, if any, will be at the discretion of our Board of Directors, subject to applicable laws, and will depend on a number of factors, including our business prospects, results of operations, financial condition, cash requirements and availability, debt repayment obligations, capital expenditure needs, covenants in the agreements governing our current and future indebtedness, other contractual restrictions, industry trends and any other factors or considerations our Board of Directors may regard as relevant.
Under Cayman Islands law, dividends may be declared and paid only out of funds legally available therefor, namely out of either profit or distributable reserves, including our share premium account, and provided further that a dividend may not be paid if this would result in us being unable to pay our debts as they fall due in the ordinary course of business.
For additional information, see “Item 3. Key Information—D. Risk Factors—Risk Factors—Risks Related to our Ordinary Shares—We do not expect to declare or pay any dividends on our ordinary shares for the foreseeable future.”
B.Significant Changes
None.
ITEM 9.    THE OFFER AND LISTING
A.Offer and Listing Details
On November 1, 2021, we completed our IPO. The principal trading market for our ordinary shares is Nasdaq. Our ordinary shares have been listed on Nasdaq under the symbol “GFS” since October 28, 2021.
B.Plan of Distribution
Not applicable.
C.Markets
See “Item 9. The Offer and Listing—A. Offer and Listing Details” above.
D.Selling Shareholders
Not applicable.
E.Dilution
Not applicable.
F.Expenses of the Issue
Not applicable.
ITEM 10.    ADDITIONAL INFORMATION
A.Share Capital
Not applicable.
B.Memorandum and Articles of Association
The information required to be disclosed under this item is incorporated by reference to Exhibit 2.3 to this Annual Report on Form 20-F.

Differences in Corporate Law
The Cayman Companies Act was modelled originally after similar laws in England and Wales but does not follow subsequent statutory enactments in England and Wales. In addition, the Cayman Companies Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences between the provisions of the Cayman Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders.
Mergers and Similar Arrangements
68


The Cayman Companies Act permits mergers or consolidations between two Cayman Islands companies, or between a Cayman Islands company and a company incorporated in another jurisdiction (provided that is facilitated by the laws of that other jurisdiction).
Where the merger or consolidation is between two Cayman Islands companies, the directors of each company must approve a written plan of merger or consolidation, which must then be authorized by (a) a special resolution of the shareholders of each company; and (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. No shareholder resolution is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary company) and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent company must be obtained, unless the court waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Cayman Companies Act (which includes certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or consolidation. Where the merger or consolidation involves a foreign company, the procedure is similar, save that with respect to the foreign company, the director of the Cayman Islands company is required to make a declaration to the effect that, having made due inquiry, the director is of the opinion that the requirements set out below have been met: (i) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of those constitutional documents have been or will be complied with; (ii) that no petition or other similar proceeding has been filed and remains outstanding or order made or resolution adopted to wind up or liquidate the company in any foreign jurisdictions; (iii) that no receiver, trustee, administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs or property or any part thereof; and (iv) that no scheme, order, compromise or similar arrangement has been entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted.
Where the surviving company is the Cayman Islands company, the director of the Cayman Islands company is further required to make a declaration to the effect that, having made due inquiry, the director is of the opinion that the requirements set out below have been met: (i) that the foreign company is able to pay its debts as they fall due and that the merger or consolidated is bona fide and not intended to defraud unsecured creditors of the foreign company; (ii) that in respect of the transfer of any security interest granted by the foreign company to the surviving or consolidated company (a) consent or approval to the transfer has been obtained, released or waived; (b) the transfer is permitted by and has been approved in accordance with the constitutional documents of the foreign company; and (c) the laws of the jurisdiction of the foreign company with respect to the transfer have been or will be complied with; (iii) that the foreign company will, upon the merger or consolidation becoming effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction; and (iv) that there is no other reason why it would be against the public interest to permit the merger or consolidation.
Where the above procedures are adopted, the Cayman Companies Act provides for a right of dissenting shareholders to be paid a payment of the fair value of his shares upon their dissenting to the merger or consolidation if they follow a prescribed procedure. In essence, that procedure is as follows:
a.the shareholder must give the shareholder’s written objection to the merger or consolidation to the constituent company before the vote on the merger or consolidation, including a statement that the shareholder proposes to demand payment for the shareholder’s shares if the merger or consolidation is authorized by the vote;
b.within 20 days following the date on which the merger or consolidation is approved by the shareholders, the constituent company must give written notice to each shareholder who made a written objection;
c.a shareholder must within 20 days following receipt of such notice from the constituent company, give the constituent company a written notice of the shareholder’s intention to dissent including, among other details, a demand for payment of the fair value of his shares;
d.within seven days following the date of the expiration of the period set out in paragraph (c) above or seven days following the date on which the plan of merger or consolidation is filed, whichever is later, the constituent company, the surviving company or the consolidated company must make a written offer to each dissenting shareholder to purchase the shareholder’s shares at a price that the company determines is the fair value and if the company and the shareholder agree the price within 30 days following the date on which the offer was made, the company must pay the shareholder such amount; and
e.if the company and the shareholder fail to agree a price within such 30-day period, within 20 days following the date on which such 30-day period expires, the company (and any dissenting shareholder) must file a petition with the Grand Court of the Cayman Islands to determine the fair value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements as to the fair value of their shares have not been reached by the company. At the hearing of that petition, the court has the power to determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon the amount determined to be the fair value.
Any dissenting shareholder whose name appears on the list filed by the company may participate fully in all proceedings until the determination of fair value is reached. These rights of a dissenting shareholder are not available in certain
69


circumstances, for example, to dissenters holding shares of any class in respect of which an open market exists on a recognized stock exchange or recognized interdealer quotation system at the relevant date or where the consideration for such shares to be contributed are shares of any company listed on a national securities exchange or shares of the surviving or consolidated company.
Moreover, Cayman Islands law also has separate statutory provisions that facilitate the reconstruction or amalgamation of companies. In certain circumstances, schemes of arrangement will generally be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as a “scheme of arrangement,” which may be tantamount to a merger. In the event that a merger is sought pursuant to a scheme of arrangement (the procedures of which are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United States), the arrangement in question must be approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and, in the case of a creditors’ scheme who must in addition represent three-fourths in value of each such class of creditors, that are present and voting either in person or by proxy at a meeting, or meetings summoned for that purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder would have the right to express to the court the view that the transaction should not be approved, the court can be expected to approve the arrangement if it satisfies itself that:
we are not proposing to act illegally or beyond the scope of our corporate authority and the statutory provisions as to majority vote have been complied with;
the shareholders have been fairly represented at the meeting in question;
the arrangement is such as a businessman would reasonably approve; and
the arrangement is not one that would more properly be sanctioned under some other provision of the Cayman Companies Act or that would amount to a “fraud on the minority.”
If a scheme of arrangement or takeover offer (as described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of U.S. corporations, providing rights to receive payment in cash for the judicially determined value of the shares.
Our Memorandum and Articles of Association provide that until such time as the Mubadala Entities no longer beneficially own at least 30% of our outstanding ordinary shares, the Board of Directors shall not cause our company to merge or consolidate with another entity without the prior written approval of MTIC.
Squeeze-out Provisions
When a takeover offer is made and accepted by holders of 90% of the shares to whom the offer is made within four months, the offeror may, within a two-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection may be made to the Grand Court of the Cayman Islands but is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.
If the arrangement and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which might otherwise ordinarily be available to dissenting shareholders of United States corporations and allow such dissenting shareholders to receive payment in cash for the judicially determined value of the shares. However, appraisal rights would also not be available to shareholders of a Delaware target in a business combination transaction if the shares of the target were listed on a national securities exchange and target shareholders receive only shares of a corporation which shares are also listed on a national securities exchange.
Further, transactions similar to a merger, reconstruction and/or an amalgamation may in some circumstances be achieved through other means to these statutory provisions, such as a share capital exchange, asset acquisition or control, through contractual arrangements, of an operating business.
Shareholders’ Suits
A shareholder of a Delaware corporation has the right to bring a derivative action on behalf of the corporation if the shareholder was a shareholder of the corporation at the time of the transaction in question. Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, we will be the proper plaintiff in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors usually may not be brought by a shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:
a company is acting or proposing to act illegally or beyond the scope of its authority;
the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes which have actually been obtained; and
those who control the company are perpetrating a “fraud on the minority.”
70


A shareholder may have a direct right of action against us where the individual rights of that shareholder have been infringed or are about to be infringed.
Our Memorandum and Articles of Association provide that each shareholder agrees to waive any claim or right of action he or she might have, whether individually or by or in the right of our Company, against any director or officer on account of any action taken by such director or officer, or the failure of such director to take any action in the performance of their duties with or for our company. However, such waiver shall not extend to any matter in respect of any dishonesty, actual fraud or willful default which may attach to such director or officer.
Maples and Calder (Cayman) LLP, our Cayman Islands counsel, is not aware of any reported class action suits having been brought in a Cayman Islands court. However, a class action suit could nonetheless be brought in the United States courts pursuant to an alleged violation of the securities laws of the United States.
Directors’ Fiduciary Duties
As a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company. Accordingly, directors and officers owe the following fiduciary duties:
duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;
duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
directors should not improperly fetter the exercise of future discretion;
duty to exercise powers fairly as between different sections of shareholders;
duty to exercise independent judgment; and
duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests.
However, this obligation may be varied by the company’s articles of association, which may permit a director to vote on a matter in which the director has a personal interest provided that the director has disclosed that nature of his interest to the board of directors. With respect to the duty of directors to avoid conflicts of interest, our Memorandum and Articles of Association vary from the applicable provisions of Cayman Islands law mentioned above by providing that a director must disclose the nature and extent of the director’s interest in any contract or proposed contract or arrangement, and following such disclosure and subject to any separate requirement under applicable law or applicable listing rules, and unless disqualified by the chairman of the relevant meeting, such director may vote in respect of any transaction or arrangement in which the director is interested and may be counted in the quorum at the meeting.
In addition to the above, under Cayman Islands law, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director has.
As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the Memorandum and Articles of Association or alternatively by shareholder approval at general meetings. The Memorandum and Articles of Association provide that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the other. Accordingly, as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. In addition, conflicts of interest may arise when our Board evaluates a particular business opportunity with respect to the above-listed criteria. However, under our Memorandum and Articles of Association, we renounced our interest in any corporate opportunity offered to any director or officer. Additionally, any such director or officer shall be permitted to pursue competing opportunities without any liability to us. Furthermore, each of our officers and directors may have pre-existing fiduciary obligations to other businesses of which they are officers or directors.
A director of a Cayman Islands company also owes to the company duties to exercise independent judgment in carrying out his functions and to exercise reasonable skill, care and diligence, which has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise the care, skill and diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience reasonably to be expected of a person acting as a director. Additionally, a director must exercise the knowledge, skill and experience which the director actually possesses.
71


A general notice may be given to the board of directors to the effect that:
the director is a member or officer of a specified company or firm and is to be regarded as interested in any contract or arrangement which may after the date of the notice be made with that company or firm; or
the director is to be regarded as interested in any contract or arrangement which may after the date of the notice to the board of directors be made with a specified person who is connected with the director, will be deemed sufficient declaration of interest.
This notice shall specify the nature of the interest in question. Following the disclosure being made pursuant to our Memorandum and Articles of Association and subject to any separate requirement under applicable law or applicable listing rules, a director may vote in respect of any transaction or arrangement in which the director is interested and may be counted in the quorum at the meeting.
In comparison, under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, directors must inform themselves of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that directors act in a manner they reasonably believe to be in the best interests of the corporation. They must not use their corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.
Shareholder Action by Written Consent
Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our Memorandum and Articles of Association provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.
Shareholder Proposals
Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. The Delaware General Corporation Law does not provide shareholders an express right to put any proposal before the annual meeting of shareholders, but Delaware corporations generally afford shareholders an opportunity to make proposals and nominations provided that they comply with the notice provisions in the certificate of incorporation or bylaws. A special meeting may be called by the board of directors, or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.
The Cayman Companies Act does not provide shareholders with rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company’s articles of association. Our Memorandum and Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting rights entitled to vote at general meetings, the Board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. Our Memorandum and Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary general meetings.
Cumulative Voting
Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation’s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting power with respect to electing such director. As permitted under Cayman Islands law, our Memorandum and Articles of Association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.
Removal of Directors
Under the Delaware General Corporation Law, a director of a corporation may be removed with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles of Association, directors can be removed for cause by an affirmative vote of at least 75% of shareholders, provided that (1) Mubadala Designees may only be removed with or without cause by MTIC and (2) as long as the
72


Mubadala Entities beneficially own in the aggregate at least 50% of the outstanding shares, directors other than the Mubadala Designees may be removed with or without cause by a majority of shareholders.
The notice of general meeting must contain a statement of the intention to remove the director and must be served on the director not less than ten calendar days before the meeting. The director is entitled to attend the meeting and be heard on the motion for his removal.
The office of a director will be vacated automatically if the director:
becomes prohibited by law from being a director;
becomes bankrupt or makes an arrangement or composition with the director’s creditors;
dies or is in the opinion of all the director’s co-directors, incapable by reason of mental disorder of discharging his duties as director;
resigns the director’s office by notice to us; or
has for more than six months been absent without permission of the directors from meetings of the Board of Directors held during that period, and the remaining directors resolve that the director’s office be vacated.
Our Memorandum and Articles of Association provide that any vacancy on the Board of Directors in respect of a Mubadala Designee may only be filled by a decision of majority of the Mubadala Designees then in office, or if there are none, by MTIC.

Proceedings of the Board of Directors
Our business is to be managed and conducted by the Board of Directors. The quorum necessary for any meeting of our Board of Directors shall consist of a simple majority of the members provided that, for so long as the Mubadala Entities are entitled to nominate one Mubadala Designee to our Board of Directors, the presence of at least one Mubadala Designee shall be required on first call to a meeting of the Board of Directors.
Subject to the provisions of our Memorandum and Articles of Association, the Board of Directors may regulate its proceedings as they determine is appropriate.
Subject to the provisions of our Memorandum and Articles of Association, to any directions given by ordinary resolution of the shareholders and applicable listing rules, the Board of Directors may from time to time at its discretion exercise all of our powers, including, subject to the Cayman Companies Act, the power to issue debentures, bonds and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company or of any third party.
Transactions with Interested Shareholders
The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an “interested shareholder” for three years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or group who owns or owned 15% or more of the target’s outstanding voting shares within the past three years. This has the effect of limiting the ability of a potential acquiror to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquiror of a Delaware corporation to negotiate the terms of any acquisition transaction with the target’s board of directors.
Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that the board of directors owes duties to ensure that these transactions are entered into bona fide in the best interests of the company and for a proper corporate purpose and, as noted above, a transaction may be subject to challenge if it has the effect of constituting a fraud on the minority shareholders.
Dissolution; Winding Up
Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. If the dissolution is initiated by the board of directors, it may be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board. Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company resolves by ordinary resolution that it be wound up because it is unable to pay its debts as they fall due. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so.
73


Under the Cayman Companies Act, we may be dissolved, liquidated or wound up by a special resolution of shareholders (requiring a two-thirds majority vote of those shareholders attending and voting at a quorate meeting). Our Memorandum and Articles of Association also give our Board of Directors the authority to petition the Cayman Islands Court for our wind up.
Variation of Rights of Shares
Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under Cayman Islands law and our Memorandum and Articles of Association, if our share capital is divided into more than one class of shares, we may vary the rights attached to any class without the consent of the holders of the issued shares of that class where such variation is considered by the directors not to have a material adverse effect upon such rights. Otherwise, all or any of the special rights attached to any class of shares may be varied with either the written consent of the beneficial holders of two-thirds of the issued shares of that class, or with the approval of a special resolution passed at a general meeting of the holders of the shares of that class.
The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely affected by the creation, allotment or issuance of further shares (whether ranking in priority to, pari passu or subordinated to them) pursuant to the Board of Director’s ability to issue preference shares. The rights of the beneficial holders of the issued shares shall not be deemed to be materially adversely varied by the creation, allotment or issuance of shares with preferred or other rights including, without limitation, the creation of shares with enhanced or weighted voting rights.
Amendment of Governing Documents
Under the Delaware General Corporation Law, a corporation’s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under Cayman Islands law, our Memorandum and Articles of Association generally (and save for certain amendments to share capital described in this section) may only be amended by special resolution of shareholders (requiring a two-thirds majority vote of those shareholders attending and voting at a quorate meeting).
Indemnification of Directors and Executive Officers and Limitation of Liability
The Cayman Companies Act does not limit the extent to which a company’s articles of association may provide for indemnification of directors and officers, except to the extent that it may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum and Articles of Association provide that we shall indemnify and hold harmless our directors and officers against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions in connection with the company other than such liability (if any) that they may incur by reason of their own actual fraud, dishonesty, willful neglect or willful default. We will also bear the expenses of any reasonable attorneys’ fees and other costs and expenses incurred in connection with the defense of any action, suit, proceeding or investigation involving such director or officer, upon such person’s undertaking to repay any amounts paid, advanced, or reimbursed by us if it is ultimately determined that any such person shall not have been entitled to indemnification. No director or officer shall be liable to our company for any loss or damage incurred by our company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through the actual fraud, dishonesty, willful neglect or willful default of such officer or director. This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
Enforcement of Civil Liabilities
We have been advised by Maples and Calder (Cayman) LLP, our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state in the United States; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state in the United States, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.
74


C.Material Contracts
For information concerning certain contracts important to our business, see “Item 4. Information on the Company—B. Business Overview—Raw Materials” and “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions.”
2021 SGD EDB Loan—On September 3, 2021, the Company entered into a loan agreement with Singapore Economic Development Board (“EDB”), which provided loan facilities with maximum drawdown of $1,149 million (SGD 1,541 million) at a fixed nominal interest rate of 1.4%. The difference between the nominal interest rate of the loan and the market interest rate for an equivalent loan is recognized as a government grant. The loan matures on June 3, 2041, with interest-only payments for the first 5 years and principal repayments commence thereafter, payable on a semi-annual basis.
2023 Soitec MSA Addendum—On December 14, 2023, the Company executed an addendum to the 2017 Materials Supply Agreement (“MSA”) with Soitec S.A. for 300mm RFSOI, PDSOI, Silicon Photonics and FD Products. The addendum establishes the required supply volumes, pricing and other terms for materials essential to our processes through September 30, 2024.
Except as otherwise described in this Annual Report on Form 20-F (including the documents filed as exhibits to this Annual Report on Form 20-F), we have not entered into any material contracts other than in the ordinary course of business.
D.Exchange Controls
The Cayman Islands currently has no exchange control restrictions.
E.Taxation
Cayman Islands Tax Considerations
The following summary contains a description of certain Cayman Islands tax consequences of the acquisition, ownership and disposition of our ordinary shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase our ordinary shares. The summary is based upon the tax laws of Cayman Islands and regulations thereunder as of the date hereof, which are subject to change. If you are considering the purchase of our ordinary shares, you should consult your own tax advisors concerning the particular tax consequences to you of the purchase, ownership and disposition of our ordinary shares, as well as the consequences to you arising under the laws of your country of citizenship, residence or domicile.
The following is a discussion of certain Cayman Islands income tax consequences of an investment in our ordinary shares. The discussion is a general summary of present law, which is subject to prospective and retroactive change. It is not intended to be tax advice, does not consider any investor’s particular circumstances, and does not consider tax consequences other than those arising under Cayman Islands law.
Under Existing Cayman Islands Laws
Payments of dividends and capital in respect of our ordinary shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of interest and principal or a dividend or capital to any holder of our ordinary shares, as the case may be, nor will gains derived from the disposal of our ordinary shares be subject to Cayman Islands income or corporation tax. The Cayman Islands currently has no income, corporation or capital gains tax and no estate duty, inheritance tax or gift tax. The Cayman Islands have not yet indicated any changes to their taxation rules in response to the Organization for Economic Co-operation and Development (“OECD”) Pillar Two global minimum tax rates.
No stamp duty is payable in respect of the issue of ordinary shares or on an instrument of transfer in respect of an ordinary share.
We were incorporated under the laws of the Cayman Islands as an exempted company with limited liability and, as such, has received an undertaking from the Governor in Cabinet of the Cayman Islands in substantially the following form:
The Tax Concessions Law
(1999 Revision)
Undertaking as to Tax Concessions
In accordance with Section 6 of the Tax Concessions Law (1999 Revision) the Governor in Cabinet undertakes with GLOBALFOUNDRIES Inc.:
(a)that no Law which is hereafter enacted in the Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to us the company or our operations; and
(b)in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable:
a.on or in respect of the shares, debentures or other obligations of the company; or
75


b.by way of the withholding in whole or part, of any relevant payment as defined in Section 6(3) of the Tax Concessions Law (20181 Revision).
These concessions shall be for a period of TWENTY years from 21st day of October 2008.
United States Federal Income Taxation
The following is a summary of material U.S. federal income tax considerations that are likely to be relevant to the purchase, ownership and disposition of our ordinary shares by a U.S. Holder (as defined below).
This summary is based on provisions of the Code, and regulations, rulings and judicial interpretations thereof, in force as of the date hereof. Those authorities may be changed at any time, perhaps retroactively, so as to result in U.S. federal income tax consequences different from those summarized below.
This summary is not a comprehensive discussion of all of the tax considerations that may be relevant to a particular investor’s decision to purchase, hold, or dispose of ordinary shares. In particular, this summary is directed only to U.S. Holders that hold ordinary shares as capital assets and does not address particular tax consequences that may be applicable to U.S. Holders who may be subject to special tax rules, such as banks, brokers or dealers in securities or currencies, traders in securities electing to mark to market, financial institutions, life insurance companies, tax-exempt entities, regulated investment companies, real estate investment trusts, entities or arrangements that are treated as partnerships for U.S. federal income tax purposes (or partners therein), holders that own or are treated as owning 10% or more of our stock by vote or value, persons holding ordinary shares as part of a hedging or conversion transaction or a straddle, persons whose functional currency is not the U.S. dollar, or persons holding our ordinary shares in connection with a trade or business outside the United States. Moreover, this summary does not address state, local or foreign taxes, the U.S. federal estate and gift taxes, the Medicare contribution tax applicable to net investment income of certain non-corporate U.S. Holders, or alternative minimum tax consequences of acquiring, holding or disposing of ordinary shares.
For purposes of this summary, a “U.S. Holder” is a beneficial owner of ordinary shares that is a citizen or resident of the United States or a U.S. domestic corporation or that otherwise is subject to U.S. federal income taxation on a net income basis in respect of such ordinary shares.
You should consult your own tax advisors about the consequences of the acquisition, ownership, and disposition of the ordinary shares, including the relevance to your particular situation of the considerations discussed below and any consequences arising under foreign, state, local or other tax laws.
Taxation of Distributions
Subject to the discussion below under “Item 10. Additional Information—E. Taxation—United States Federal Income Taxation—Passive Foreign Investment Company Status,” the gross amount of any distribution of cash or property with respect to our shares that is paid out of our current or accumulated earnings and profits (as determined for U.S. federal income tax purposes) will generally be includible in your taxable income as ordinary dividend income on the day on which you receive the dividend and will not be eligible for the dividends-received deduction allowed to corporations under the Code.
We do not expect to maintain calculations of our earnings and profits in accordance with U.S. federal income tax principles. U.S. Holders therefore should expect that distributions generally will be treated as dividends for U.S. federal income tax purposes.
Subject to certain exceptions for short-term positions, dividends received by an individual with respect to the shares will be subject to taxation at a preferential rate if the dividends are “qualified dividends.” Dividends paid on the shares will be treated as qualified dividends if:
the shares are readily tradable on an established securities market in the United States, or we are eligible for the benefits of a comprehensive tax treaty with the United States that the U.S. Treasury determines is satisfactory for purposes of this provision and that includes an exchange of information program; and
we were not, in the year prior to the year in which the dividend was paid, and are not, in the year in which the dividend is paid, a passive foreign investment company (a “PFIC”).
The ordinary shares are listed on Nasdaq, and will qualify as readily tradable on an established securities market in the United States so long as they are so listed. Based on our financial statements and relevant market and shareholder data, we believe that we were not treated as a PFIC for U.S. federal income tax purposes with respect to our 2022 and 2023 taxable years. In addition, based on our financial statements and our current expectations regarding the value and nature of our assets, the sources and nature of our income, and relevant market and shareholder data, we do not anticipate becoming a PFIC for our current taxable year or in the foreseeable future. Holders should consult their own tax advisors regarding the availability of the reduced dividend tax rate in light of their own particular circumstances.
Dividend distributions with respect to our shares generally will be treated as “passive category” income from sources outside the United States for purposes of determining a U.S. Holder’s U.S. foreign tax credit limitation.
U.S. Holders that receive distributions of additional shares or rights to subscribe for shares as part of a pro rata distribution to all our shareholders generally will not be subject to U.S. federal income tax in respect of the distributions, unless the U.S.
76


Holder has the right to receive cash or property instead, in which case the U.S. Holder will be treated as if it received cash equal to the fair market value of the distribution.
Taxation of Dispositions of Shares
Subject to the discussion below under “Item 10. Additional Information—E. Taxation—United States Federal Income Taxation—Passive Foreign Investment Company Status,” upon a sale, exchange or other taxable disposition of the shares, U.S. Holders will realize gain or loss for U.S. federal income tax purposes in an amount equal to the difference between the amount realized on the disposition and the U.S. Holder’s adjusted tax basis in the shares, as determined in U.S. dollars as discussed below. Such gain or loss will be capital gain or loss, and will generally be long-term capital gain or loss if the shares have been held for more than one year. Long-term capital gain realized by a U.S. Holder that is an individual generally is subject to taxation at a preferential rate. The deductibility of capital losses is subject to limitations.
Gain, if any, realized by a U.S. Holder on the sale or other disposition of the shares generally will be treated as U.S. source income.
Passive Foreign Investment Company Status
Special U.S. tax rules apply to companies that are considered to be PFICs. We will be classified as a PFIC in a particular taxable year if either:
75% or more of our gross income for the taxable year is passive income; or
the average percentage of the value of our assets that produce or are held for the production of passive income is at least 50%.
For this purpose, passive income generally includes dividends, interest, gains from certain commodities transactions, rents, royalties and the excess of gains over losses from the disposition of assets that produce passive income.
We believe, and this discussion assumes, that we were not a PFIC for our taxable year ending December 31, 2023 and that, based on the present composition of our income and assets and the manner in which we conduct our business, we will not be a PFIC in our current taxable year or in the foreseeable future. Whether we are a PFIC is a factual determination made annually, and our status could change depending, among other things, upon changes in the composition of our gross income and the relative quarterly average value of our assets. If we were a PFIC for any taxable year in which you hold ordinary shares, you generally would be subject to additional taxes on certain distributions and any gain realized from the sale or other taxable disposition of the ordinary shares regardless of whether we continued to be a PFIC in any subsequent year. You are encouraged to consult your own tax advisor as to our status as a PFIC, the tax consequences to you of such status, and the availability and desirability of making a mark-to-market election to mitigate the unfavorable rules mentioned in the preceding sentence.
Foreign Financial Asset Reporting
Individual U.S. Holders that own “specified foreign financial assets” with an aggregate value in excess of US$50,000 on the last day of the taxable year or US$75,000 at any time during the taxable year are generally required to file an information statement along with their tax returns, currently on Form 8938, with respect to such assets. “Specified foreign financial assets” include any financial accounts held at a non-U.S. financial institution, as well as securities issued by a non-U.S. issuer that are not held in accounts maintained by financial institutions. Higher reporting thresholds apply to certain individuals living abroad and to certain married individuals. Regulations extend this reporting requirement to certain entities that are treated as formed or availed of to hold direct or indirect interests in specified foreign financial assets based on objective criteria. U.S. Holders who fail to report the required information could be subject to substantial penalties. In addition, the statute of limitations for assessment of tax would be suspended, in whole or part. Prospective investors are encouraged to consult with their own tax advisors regarding the possible application of these rules, including the application of the rules to their particular circumstances.
Backup Withholding and Information Reporting
Dividends paid on, and proceeds from the sale or other disposition of, the shares to a U.S. taxpayer generally may be subject to the information reporting requirements of the Code and may be subject to backup withholding unless the U.S. taxpayer provides an accurate taxpayer identification number and makes any other required certification or otherwise establishes an exemption. Backup withholding is not an additional tax. The amount of any backup withholding from a payment to a U.S. taxpayer will be allowed as a refund or credit against the U.S. taxpayer’s U.S. federal income tax liability, provided the required information is furnished to the U.S. Internal Revenue Service in a timely manner.
A holder that is not a U.S. taxpayer may be required to comply with certification and identification procedures in order to establish its exemption from information reporting and backup withholding.
F.Dividends and Paying Agents
Not applicable.
G.Statements by Experts
Not applicable.
77


H.Documents on Display
The SEC maintains a website www.sec.gov that contains reports and other information regarding registrants, including the Company, that file electronically with the SEC. Please note that copies of the Company’s annual reports on Form 20-F and reports on Form 6-K filed by us can be inspected at the website set forth above and are also available on our website at www.gf.com (the website does not form part of this Annual Report on Form 20-F).
I.Subsidiary Information
Not applicable.
ITEM 11.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates and foreign currency exchange rates. See Note 30 to our Annual Consolidated Financial Statements for additional details.
Foreign Currency Risk—As a result of foreign operations, we have costs, assets and liabilities denominated in foreign currencies, primarily the Euro, the Singapore dollar and the Japanese yen. Therefore, movements in exchange rates could cause foreign currency-denominated expenses to increase as a percentage of net revenue, which are denominated in U.S. dollars, affecting profitability and cash flows. We use foreign currency forward contracts to reduce exposure to foreign currency fluctuations. We also incur a certain portion of our interest expenses in Euro and Singapore Dollar, exposing us to exchange rate fluctuations between U.S. dollar and Euro and Singapore Dollar. We use cross currency swaps to reduce our exposure to variability from foreign exchange impacting cash flows arising from our foreign currency-denominated debt cash flows to the extent that it is practicable and cost effective to do so. As of December 31, 2023, we do not believe that a hypothetical 10% change in the relative value of the U.S. dollar to currencies other than the Euro, Japanese Yen, and Singapore Dollar would have a material effect on our operating results.
Interest Rate Risk—The Company’s exposure to market risk for changes in interest rates relates primarily to interest-earning financial assets and interest-bearing financial liabilities. The Company’s interest-earning financial assets are mostly highly liquid investments and includes money market funds, marketable securities and time deposits. As these financial assets have weighted-average maturity of less than one year with majority of the assets in fixed-rate instruments, the Company’s exposure to interest risk is not material. The Company’s interest-bearing financial liabilities include fixed and floating rate loans and lease obligations. Floating rate loans bear interest at Base Rate or SOFR or EURIBOR plus a premium, which is fixed. The Company uses pay-fixed / receive-float interest rate swaps to protect the Company against adverse fluctuations in interest rates and to reduce its exposure to variability in cash flows on the Company’s forecasted floating-rate debt facility to the extent that it is practicable and cost effective to do so. As of December 31, 2023, a hypothetical 10% change in existing interest rates would not have a material impact on our consolidated financial statements (see Note 30 to our Annual Consolidated Financial Statements).
ITEM 12.    DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
None.
PART II
ITEM 13.    DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
None.
ITEM 14.    MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS
A.Material Modifications to Instruments
Not applicable.
B.Material Modifications to Rights
Not applicable.
C.Withdrawal or Substitution of Assets
Not applicable.
D.Change in Trustees or Paying Agents
Not applicable.
E.Use of Proceeds
78


The following “Use of Proceeds” information relates to the registration statement on Form F-1, as amended (File No. 333-260003), filed in relation to our IPO. We issued and sold an aggregate 31,845,744 ordinary shares in our IPO and the Private Placement at the IPO price of $47.00 per share, after deducting underwriting commissions of $43 million and estimated offering expenses payable by us of $30 million, for approximately $1.4 billion of net proceeds.
For the period from the closing of our IPO on November 1, 2021 to December 31, 2023, the Company applied $1.4 billion from the net proceeds of our IPO to support construction related to our fab in Singapore and capacity expansion projects in certain other facilities. There was no material change in the actual use of proceeds from what was described in the registration statement.
ITEM 15.    CONTROLS AND PROCEDURES
A.Disclosure Controls and Procedures.
At the end of the period covered by this report, we performed an evaluation of the effectiveness of our disclosure controls and procedures that are designed to ensure that the information required to be disclosed by the Company in the report that we file or submit pursuant to Rule 13(a)-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of the design and operations of our disclosure controls and procedures as of December 31, 2023, which is the end of the period covered by this Annual Report on Form 20-F. Based on such evaluations, our CEO and CFO have concluded that as of December 31, 2023, our disclosure controls and procedures were not effective in light of material weaknesses in the design and implementation of our ICFR as described in “Item 15. Controls and Procedures - B. Management’s Annual Report on Internal Control over Financial Reporting” below. While the material weaknesses described below did not result in any identified material misstatements to the consolidated financial statements or any changes to previously released financial results or other disclosures in the Company’s prior period Annual Reports on Form 20-F that are filed with the SEC, the material weaknesses create a reasonable possibility that a material misstatement to our consolidated financial statements or other disclosures may not have been able to be prevented or detected on a timely basis. Of course, there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. As such, there is a risk of errors occurring even when a company’s disclosure controls and procedures are determined to be effective. Accordingly, effective disclosure controls and procedures can provide only reasonable assurance of achieving their control objectives.
Notwithstanding the material weaknesses in internal control over financial reporting described below, management believes and has concluded that the consolidated financial statements included in this Annual Report on Form 20-F fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with IFRS as issued by the IASB
B.Management’s Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate ICFR as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act. ICFR is a process designed under the supervision of our principal executive and principal financial officers to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of consolidated financial statements for external purposes in accordance with IFRS as issued by the IASB. Our ICFR includes those policies and procedures that:
•     Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
•     Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
•     Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, ICFR may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Management has documented and evaluated the effectiveness of the ICFR of the Company as of December 31, 2023, in accordance with the criteria established in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Based on our assessment, management believes that, as of December 31, 2023, our ICFR was not effective based on these criteria, as the following material weaknesses were identified in our ICFR as of December 31, 2023.
79


Our independent registered public accounting firm, KPMG LLP, who audited the consolidated financial statements included in this Annual Report on Form 20-F issued an adverse opinion on the effectiveness of the Company’s internal control over financial reporting, which is included herein.

Material Weaknesses
Management, with the participation of the CEO and CFO, and under the oversight of the Audit Committee, identified two material weaknesses in our ICFR as of December 31, 2023. As defined in the standards established by the SEC, a material weakness is a deficiency, or a combination of deficiencies, in ICFR, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The Company has identified the following material weaknesses in ICFR due to the lack of an effective control environment including the retention of personnel with an appropriate level of expertise, knowledge and training in internal controls, and insufficient policies and procedures developed and documented to effectively design and implement control activities:
a.A material weakness in our ICFR related to the design and implementation of general IT user access controls for information systems that are relevant to the preparation of the consolidated financial statements. Other general IT and process-level automated controls that are dependent on the affected user access controls, and manual controls that rely on the integrity of data or reports from the affected IT systems, were also deemed ineffective because they could have been adversely impacted.
b.A material weakness in the design and implementation of manual controls resulting from deficiencies across the Company’s business processes. The deficiencies include inadequate review and documentation of financial and other information used in manual controls over financial statement accounts and disclosures.
These material weaknesses did not result in a material misstatement of the Company’s consolidated financial statements. However, these material weaknesses create a reasonable possibility that a material misstatement to our consolidated financial statements or other disclosures may not have been able to be prevented or detected on a timely basis.

C.Attestation Report of the Independent Registered Public Accounting Firm.
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
GLOBALFOUNDRIES Inc.:
Opinion on Internal Control Over Financial Reporting
We have audited GLOBALFOUNDRIES Inc. and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of financial position of the Company as of December 31, 2023 and 2022, the related consolidated statements of operations, other comprehensive income (loss), changes in equity, and cash flows for each of the years in the three‑year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements), and our report dated April 29, 2024 expressed an unqualified opinion on those consolidated financial statements.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses due to the lack of an effective control environment including the retention of personnel with an appropriate level of expertise, knowledge and training in internal controls, and insufficient policies and procedures developed and documented to effectively design and implement control activities have been identified and included in management’s assessment: (i) A material weakness in internal control over financial reporting related to the design and implementation of general information technology user access controls for information systems that are relevant to the preparation of the consolidated financial statements. Other general information technology and process-level automated controls that are dependent on the affected user access controls, and manual controls that rely on the integrity of data or reports from the affected information technology systems, were also deemed ineffective because they could have been adversely impacted; and (ii) A material weakness in the design and implementation of manual controls resulting from deficiencies across the Company’s business processes. The deficiencies include inadequate review and documentation of financial and other information used in manual controls over financial statement accounts and disclosures. The material weaknesses were considered in determining the nature, timing, and
80


extent of audit tests applied in our audit of the 2023 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.

Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP
Singapore
April 29, 2024

D. Changes in Internal Control over Financial Reporting.
Other than as described above, there were no changes in our internal control over financial reporting that occurred during the period covered by this Annual Report on Form 20-F that have materially affected, or that are reasonably likely to materially affect, our ICFR.
Remediation Plan
In response to the two material weaknesses described above, we are in the process of executing a remediation plan that includes the following actions:
a.Conducting training activities dedicated to control owners to ensure control awareness and compliance with Sarbanes-Oxley requirements, with particular regard to formalized review of financial and other information used in manual controls over financial statement accounts and disclosures;
b.Removing inappropriate user access, performing periodic activity reviews on all user access privileges, and develop a formalized plan related to the design and implementation of IT general controls; and
c.Redesign certain manual review controls over financial statement accounts and disclosures, establish policies and procedures to effectively deploy controls as designed, and establish documentation requirements to sufficiently evidence the performance of the Company’s key controls.

These actions and any additional actions we intend to implement in the future are subject to ongoing management evaluation and will require validation and testing of the design, implementation, and operating effectiveness of internal
81


controls over a sustained period of time. The above actions and any additional actions we intend to implement in the future are designed to effectively remediate the material weaknesses, and we believe that our successful completion of such actions will improve our ICFR environment. However, these material weaknesses in our ICFR will not be considered remediated (and we cannot come to any such conclusion) until our remediation plan has been fully implemented and the operation of the remediated controls are sufficiently tested.
ITEM 16A.    AUDIT COMMITTEE FINANCIAL EXPERT
We have one financial expert serving on our Audit Committee as of the date hereof. Our Board of Directors has determined that Jack Lazar qualifies as an “audit committee financial expert” as defined in SEC rules and satisfies the financial sophistication requirements of the Nasdaq. In addition, our Board of Directors has determined that Jack Lazar is “independent” for Audit Committee purposes as that term is defined in the rules of the SEC and the applicable rules of Nasdaq.
ITEM 16B.    CODE OF ETHICS
Our Board has adopted a code of conduct that applies to all of our directors, officers and employees (the “Code of Conduct”). Our Board has also adopted a code of ethics applicable to our executive officers and senior finance executives (the “Code of Ethics”), who must also comply with the Code of Conduct. Both the Code of Conduct and the Code of Ethics are available on our website: www.gf.com. We intend to disclose any amendments to the Code of Ethics, and any waivers of the Code of Ethics or the Code of Conduct for our directors, executive officers and senior finance executives, on our website to the extent required by applicable U.S. federal securities laws and the corporate governance rules of Nasdaq.
ITEM 16C.    PRINCIPAL ACCOUNTANT FEES AND SERVICES
The following table sets forth the aggregate fees in connection with certain professional services provided to us by KPMG LLP (PCAOB ID 1051), our independent registered public accounting firm during the years ended December 31, 2023 and 2022.

(in thousands)20232022
Audit fees$5,644$4,744
Audit-related fees61
Tax fees
All other fees6
Total$5,650$4,805

Audit fees
Audit fees are fees billed for professional services rendered by the principal accountant for the audit of the registrant’s annual combined financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years. It includes the audit of our financial statements, interim reviews and other services that generally only the independent accountant reasonably can provide, such as comfort letters, statutory audits, consents and assistance with and review of documents filed with the SEC.
Audit-related fees
Audit-related fees are fees billed for assurance and related services by the principal accountant that are reasonably related to the performance of the audit or review of the registrant’s financial services.
Tax fees
Tax fees are fees billed for professional services for tax compliance, tax advice and tax planning.
All other fees
All other fees are fees billed for payroll processing, human resources administration and immigration services.
Audit Committee Pre-Approval Policies and Procedures
In accordance with applicable requirements of the U.S. Sarbanes-Oxley Act of 2002 and rules issued by the SEC, the policy of our audit committee is to pre-approve all audit and non-audit services provided by KPMG LLP since their appointment as the independent registered public accounting firm, including audit-related services, tax services and other services.
ITEM 16D.    EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
Not applicable.
82


ITEM 16E.    PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS
There were no purchases of equity securities by us or by any affiliated purchaser during the period covered by this Annual Report.
ITEM 16F.    CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT
On January 23, 2024, the Audit Committee appointed PricewaterhouseCoopers LLP (“PwC”) as its independent registered public accounting firm for the fiscal year ending December 31, 2024 subject to completion of PwC’s standard client acceptance procedures and execution of an engagement letter. PwC will be engaged upon completion of the audit of the Company’s consolidated financial statements as of and for the year ended December 31, 2023, and the effectiveness of internal control over financial reporting as of December 31, 2023.
Pursuant to the Company’s prior practice and to the extent permitted by applicable law, the Company endeavors to appoint the same independent registered public accounting firm (or affiliate of such auditor) as its majority shareholders, MTIC and MTIIIC, as well as their indirect parent company, Mamoura Diversified Global Holding PJSC and its subsidiaries (the “MDGH Group”), so long as such appointment is determined to be in the best interests of the Company. The audit committee of the MDGH Group selected a PwC member firm in December 2023 as its independent registered public accounting firm for the fiscal year ending December 31, 2024.
In accordance with the aforementioned prior practice and following a competitive process, the Audit Committee assessed the qualifications, performance, expertise in IFRS and audit of financial statements, resources and the effectiveness of PwC’s audit process, as well as the benefits arising to the Company from the selection of the same firm as the MDGH Group, and determined to appoint PwC as the auditors for the fiscal year ending December 31, 2024. Accordingly, KPMG LLP was dismissed as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The Audit Committee’s appointment of PwC is also consistent with the terms of the Shareholder’s Agreement between the Company and MTIC and MTIIIC, which is filed as an exhibit to this annual report on Form 20-F.
During the years ended December 31, 2023 and 2022, KPMG LLP’s reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2023 and December 31, 2022 did not contain any adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles or practices, except that KPMG LLP’s report dated April 29, 2024 expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 because of the effect of material weaknesses as disclosed in Item 15 of the Company’s 2023 Annual Report on Form 20-F.
During the two fiscal years ended December 31, 2023 and 2022 and the subsequent interim period through the filing of this Annual Report, neither the Company nor anyone acting on the Company’s behalf consulted with PwC regarding (1) the application of accounting principles to a specific transaction, either completed or proposed; (2) the type of audit opinion that might be rendered on the Company’s financial statements and neither a written report nor oral advice was provided to the Company that PwC concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue; or (3) any matter that was the subject of a disagreement (as described in Item 16F (a)(1)(iv) of Form 20-F
We have provided KPMG LLP with a copy of the foregoing disclosure and requested that KPMG LLP furnish to us a letter addressed to the SEC stating whether KPMG LLP agrees with such disclosure, as specified by Item 16F(a)(3) of Form 20-F. We have included as Exhibit 15.2 to this Form 20-F a copy of such letter from KPMG LLP.
ITEM 16G.    CORPORATE GOVERNANCE
We are a “foreign private issuer” under the securities laws of the United States and the rules of Nasdaq. Nasdaq listing rules include certain accommodations in the corporate governance requirements that allow foreign private issuers, such as us, to follow “home country” corporate governance practices in lieu of the otherwise applicable corporate governance standards of Nasdaq. The application of such exceptions requires that we disclose each Nasdaq corporate governance standard that we do not follow and describe the Cayman Islands corporate governance practices we do follow in lieu of the relevant Nasdaq corporate governance standard. We currently follow Cayman Islands corporate governance practices in lieu of the corporate governance requirements of Nasdaq in respect of the following:
the requirement under Section 5605(e) of the Nasdaq listing rules that director nominees be selected or recommended for selection by either a majority of the independent directors or a nominations committee comprised solely of independent directors; and
the Shareholder Approval Requirements under Section 5635 of the Nasdaq listing rules.
On a voluntary basis, we have adopted corporate governance principles, policies and practices, which are set out primarily in our Corporate Governance Framework, Board Charter, committee charters, Code of Conduct, Code of Ethics and Director Conflict of Interest Policy, the current versions of which are published on our Investors Relations website (www.investors.gf.com). We note in particular the following policies and practices that we have voluntarily adopted to align more with Nasdaq’s corporate governance standards for domestic issuers:
A majority of our Board of Directors is comprised of independent directors pursuant to applicable Nasdaq rules.
83


Our independent, non-executive directors who are not affiliated with or appointed by Mubadala meet in executive sessions at Board meetings. Our lead independent director presides over such executive sessions.
We have a separation of the CEO and Board chairman roles, with our CEO focused on managing the Company and our Board chairman driving accountability to shareholders at the Board level.
Annually, the Board of Directors, its committees and individual directors undertake a self-evaluation, including one-on-one interviews.
We have updated our Board Charter to address (i) periodic meetings among committee chairs and the Board chairman, (ii) overboarding, (iii) duties of the lead independent director, (iv) diversity, (v) periodic assessment of processes facilitating communications between shareholders and directors and financial and non-financial information, (vi) effective implementation and operation of information and reporting systems or controls designed to inform of material risks, (vii) the Board being apprised of the Company’s positions on corporate social responsibility, public policy and philanthropy, (viii) change in director circumstances, (ix) the minimum number of times the Board of Directors would meet each year, (x) each committee chair setting an annual schedule of meetings for their respective committees, and (xi) each director’s ability to provide input on the Board or any committee agenda.
Our Board members and executive officers are subject to stock ownership guidelines that help align their interests with GF’s long-term performance. Within five years of becoming a covered individual, such covered individual is expected to own, outright or beneficially, (a) for a non-employee Board member, five times his or her annual retainer, (c) for the CEO, six times his base salary, (d) for a C-level executive, three times his or her base salary, and (e) for a senior vice president, one time his or her base salary.
We adopted a Director Conflict of Interest Policy, which complements GF’s Code of Conduct.
The head of internal audit reports to the Audit Committee. Any employee concerns regarding questionable accounting or auditing matters may be submitted anonymously through our third-party operated Ethics Whistleblower hotline. The Audit Committee oversees the ethics and compliance program and reviews claims submitted through the hotline.
In February 2023, rating agency ISS again recognized GF for “Prime” corporate ESG performance. GF’s ESG efforts were also evaluated by Morningstar Sustainalytics, which recognized GF with a “Low Risk” rating and included the Company in its 2023 “ESG Industry Top-rated” list for the semiconductor industry group.
Our Board of Directors consists of both underrepresented minority and female Board members. Our Board diversity matrix is available at www.investors.gf.com.
ITEM 16H.    MINE SAFETY DISCLOSURE
Not applicable.
ITEM 16I.    DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.

ITEM 16J.     INSIDER TRADING POLICIES
Not applicable
ITEM 16K. CYBERSECURITY
In the ordinary course of our business, we maintain sensitive data on our networks, including our intellectual property and proprietary or confidential business information relating to our business and that of our customers and business partners. Our and our service providers’ IT and computer systems store and transmit customer information, trade secrets, corporate data and personal information, and are otherwise essential to the operation of our production lines, which may make us a target for cyberattacks. The secure maintenance of this information is critical to our business and reputation.
Risk Management and Strategy
GF’s cybersecurity strategy focuses on implementing effective and efficient controls, technologies, and other processes to assess, identify, and manage material cybersecurity risks. We maintain a comprehensive process for assessing, identifying and managing material risks from cybersecurity threats, including risks relating to disruption of business operations or financial reporting systems, intellectual property theft; fraud; extortion; harm to employees or customers; violation of privacy laws and other litigation and legal risk; and reputational risk, as part of our overall risk management system and processes. We carry insurance that provides protection against the potential losses arising from a cybersecurity incident.
GF maintains a comprehensive, company-wide commitment and program to engage every employee to safeguard and protect our and our customers’ intellectual property and products. The program integrates information security, product
84


security, operational security and cybersecurity into a comprehensive program that covers all phases of the customer experience. Annually, we conduct comprehensive security training for all employees, as well as more focused role-specific training for employees whose job roles require an enhanced level of security awareness and control as well as data and government product security. The program leverages and embraces GF’s experience as a Trusted Foundry and supplier of advanced semiconductors to the U.S. government and the aerospace and defense industry, as well as GF’s experience as a certified international Common Criteria standard (ISO 15408, CC Version 3.1) manufacturer, and adopts many of those stringent security capabilities to all GF locations and customers. We also work with outside consultants and external legal counsel to support our program in assessing, identifying and managing material risks from, and internal controls and processes relating to, cybersecurity threats, and ensuring compliance with all applicable related laws, regulations and rules (including notice, disclosure and remediation requirements).
As part of our security programs, we have mechanisms to detect and monitor unusual network activity and other cybersecurity threats, along with containment and incident response tools. We monitor issues that are internally discovered or externally reported that may affect our products and have processes to assess those issues for potential cybersecurity impact or risk. Our dedicated cybersecurity team continually monitor cybersecurity threats to GF, and any incidents or potential incidents are flagged in our systems and escalated in accordance with our cybersecurity incident response policies and procedures. Our cybersecurity team receives regular reports on any incidents and potential incidents, with anything requiring further escalation to be reported to our Chief Executive Officer and Chief Legal Officer. We also have processes in place to manage cybersecurity risks associated with our third-party service providers , including our suppliers, vendors and other partners, as well as our outside consultants, legal counsel and auditors who help us with our cybersecurity risk management and strategy processes. We impose security requirements upon our suppliers, including maintaining an effective security management program, abiding by information handling and asset management requirements, and notifying us in the event of any known or suspect cyber incident. We continue to make significant investments in cybersecurity and data security, as well as other efforts to combat breach and misuse of our systems and unauthorized access to our and our customers’ data by third parties.
Governance
The governance structure for GF’s comprehensive information protection and overall cybersecurity program includes frequent reviews with GF’s senior leadership team, at least quarterly reviews by our Audit Committee and annual reviews by the Board. These reviews include alignment on our comprehensive information security and cybersecurity strategy, risk management, and execution to program plans. As part of our cybersecurity and information protection program, GF’s Chief Information Security Officer (“CISO”) executes, enforces and maintains GF’s global information and cybersecurity strategy, policies and procedures. In addition, GF maintains a global IT security policy detailing acceptable use of GF information resources. Our CISO reports to our Chief Information Officer (“CIO”), who reports to our COO. Our CISO and CIO have extensive experience assessing and managing cybersecurity programs and cybersecurity risk. Prior to joining GF, our CISO served in similar positions at GE Renewable Energy since 2017. Our CIO has more than two decades of experience in enterprise-wide technology transformations and digital thought leadership. Prior to joining GF, our CIO served in senior management positions leading corporate information and compliance processes and strategies.
In consultation with the Audit Committee, GF has adopted a framework for making and reporting cybersecurity materiality determinations. The materiality assessment framework has been incorporated into our overall global crisis management process and utilizes the NIST FIPS 199 Framework, in combination with other factors noted in the Commission’s cybersecurity rule-making process.
We employ certain third-party service providers for us and our affiliates worldwide with whom we need to share highly sensitive and confidential information to enable them to provide the relevant services. Some of our third-party service providers have experienced cyberattacks of which we have been made aware.
Our business strategy, results of operations and financial condition have not been materially affected by risks from cybersecurity threats, including as a result of previous cybersecurity incidents, but we cannot provide assurance that they will not be materially affected in the future by such risks and any future material incidents. In September 2023, we became aware that one or more third parties had gained limited unauthorized access to our IT network. Following an in-depth review with the assistance of outside consultants and legal counsel, we have no reason to believe that there was any exfiltration of sensitive information, and we do not believe the incident had a material adverse effect on or material impact to our business, operations or financial results.
85


PART III
ITEM 17.    FINANCIAL STATEMENTS
See “Item 18. Financial Statements.”
ITEM 18.    FINANCIAL STATEMENTS
See pages F-1 through F-46, incorporated herein by reference.
86


INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Consolidated Financial Statements of Global Foundries Inc. and Subsidiaries
F-1


Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
GLOBALFOUNDRIES Inc.:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated statements of financial position of GLOBALFOUNDRIES Inc. and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of operations, other comprehensive income (loss), changes in equity, and cash flows for each of the years in the three‑year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three‑year period ended December 31, 2023, in conformity with International Financial Reporting Standards issued by the International Accounting Standards Board.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated April 29, 2024 expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.
Determination of useful life of 300mm production equipment
As discussed in Note 8 to the consolidated financial statements, the Company reported $4,793 million of equipment which included 300mm production equipment as of December 31, 2023. Management estimated the useful life of production equipment including 300mm based on production equipment current use, historical age patterns, as well as an analysis of industry trends and practices. We identified the determination of the useful life of 300mm production equipment as a critical audit matter. To evaluate management’s judgement in determining the useful life of ten years for the 300mm production equipment, we used significant auditor judgement, subjectivity, and effort in performing procedures to evaluate the reasonableness of the significant assumptions used in determining the useful life.
The following are the primary procedures we performed to address this critical audit matter. We tested management’s process for determining a ten-year useful life and assessed the reasonableness of the significant assumptions used by management, which included (1) testing the completeness, accuracy and relevance of the underlying data used in management’s historical length of service assessment, and (2) evaluating the completeness, accuracy, and relevance of the useful lives utilized by peer companies and used in management’s assessment.

/s/ KPMG LLP
We have served as the Company’s auditor since 2021.
Singapore
April 29, 2024
F-2



GLOBALFOUNDRIES INC.
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Dollars in millions)
As of December 31,
20232022
ASSETS
Current assets:
Cash and cash equivalents$2,387 $2,352 
Marketable securities1,033 622 
Receivables, prepayments and other assets1,420 1,487 
Inventories1,487 1,339 
Total current assets6,327 5,800 
Non-current assets:
Property, plant and equipment, net10,164 10,596 
Goodwill and intangible assets, net391 363 
Marketable securities468 372 
Deferred tax assets241 292 
Receivables, prepayments and other assets343 281 
Other non-current financial assets110 137 
Total non-current assets11,717 12,041 
Total assets$18,044 $17,841 
LIABILITIES AND EQUITY
Current liabilities:
Trade payables and other current liabilities$2,349 $2,849 
Current portion of long-term debt571 223 
Current portion of lease obligations32 75 
Provisions 54 102 
Current portion of deferred income from government grants93 110 
Total current liabilities3,099 3,359 
Non-current liabilities:
Non-current portion of long-term debt1,801 2,288 
Other non-current liabilities1,190 1,474 
Non-current portion of lease obligations350 270 
Provisions186 196 
Non-current portion of deferred income from government grants267 294 
Total non-current liabilities3,794 4,522 
Total liabilities$6,893 $7,881 
Equity:
Share capital
Ordinary shares, $0.02 par value, 553,548 thousand and 547,755 thousand shares issued and outstanding as of December 31, 2023 and 2022, respectively
$11 11 
Additional paid-in capital24,027 23,831 
Accumulated deficit(13,001)(14,021)
Accumulated other comprehensive loss67 92 
Equity attributable to the shareholders of GLOBALFOUNDRIES INC.11,104 9,913 
Non-controlling interests47 47 
Total equity11,151 9,960 
Total liabilities and equity$18,044 $17,841 

See accompanying notes to consolidated financial statements
F-3


GLOBALFOUNDRIES INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Share amounts and dollars in millions)
For the year ended December 31,
202320222021
Net revenue$7,392 $8,108 $6,585 
Cost of revenue5,291 5,869 5,572 
Gross profit
2,101 2,239 1,013 
Research and development expense
428 482 478 
Selling, general and administrative expense
473 496 595 
Restructuring expense
71 94  
Operating expenses972 1,072 1,073 
Income (loss) from operations1,129 1,167 (60)
Finance income149 51 6 
Finance expense
(137)(111)(114)
Gain on sale of East Fishkill (“EFK”) business 403  
Other income (expense), net(57)22 (8)
Income (loss) before income taxes1,084 1,532 (176)
Income tax expense
(66)(86)(78)
Net income (loss) for the year$1,018 $1,446 $(254)
Attributable to:
Shareholders of GLOBALFOUNDRIES INC.$1,020 $1,448 $(250)
Non-controlling interests(2)(2)(4)
Net income (loss) for the year$1,018 $1,446 $(254)
Net income (loss) per share attributable to the equity holders of the Company:
Basic weighted average ordinary shares outstanding
552 539 506 
Diluted weighted average ordinary shares outstanding
556 552 506 
Basic earnings (loss) per share$1.85 $2.69 $(0.49)
Diluted earnings (loss) per share$1.83 $2.62 $(0.49)
See accompanying notes to consolidated financial statements
F-4


GLOBALFOUNDRIES INC.
CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS)
(Dollars in millions)

For the year ended December 31,
202320222021
Net income (loss) for the year$1,018 $1,446 $(254)
Attributable to:
Shareholder of GLOBALFOUNDRIES INC.1,020 1,448 (250)
Non-controlling interest(2)(2)(4)
Net income (loss) for the year$1,018 $1,446 $(254)
Other comprehensive income (loss), net of tax:
Items that may be reclassified subsequently to profit or loss:
Share of foreign exchange fluctuation reserve of joint ventures$14 $(23)$(12)
Effective portion of changes in the fair value of cash flow hedges(27)187 (45)
Fair value gain (loss) on investments measured at fair value through other comprehensive income
9 (9) 
Income tax effect(19)(18)3 
(23)137 (54)
Total other comprehensive income (loss)
Attributable to:
Shareholders of GLOBALFOUNDRIES INC.$(25)$146 $(50)
Non-controlling interests2 (9)(4)
Total other comprehensive income (loss) for the year$(23)$137 $(54)
Total comprehensive income (loss)
Attributable to:
Shareholders of GLOBALFOUNDRIES INC.$995 $1,594 $(300)
Non-controlling interests (11)(8)
Total comprehensive income (loss) for the year$995 $1,583 $(308)

See accompanying notes to consolidated financial statements
F-5


GLOBALFOUNDRIES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
For the year ended December 31,
202320222021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)$1,018 $1,446 $(254)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 1,451 1,623 1,618 
Share-based payments150 181 223 
Interest and income taxes paid, net(1)
(9)(68)(107)
Finance income(149)(51)(6)
Finance expense
137 111 114 
Amortization of deferred income from government grants(29)(28)(33)
Deferred income taxes50 82 93 
(Gain) Loss on disposal of property, plant and equipment and other
13 (103)(39)
Gain on the sale of a business (403) 
Change in assets and liabilities:
Receivables, prepayments and other assets(169)35 (387)
Inventories(148)(261)(202)
Trade and other payables(190)60 1,819 
Net cash provided by operating activities$2,125 $2,624 $2,839 
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment and intangible assets(1,804)(3,059)(1,767)
Proceeds from government grants
138   
Advances and proceeds from sale of property, plant and equipment and intangible assets
24 41 324 
Purchase of marketable securities
(1,419)(1,302) 
Proceeds from sale of marketable securities945 306  
Proceeds from sale of a business
236   
Other investing activities(2)(44)(7)
Net cash used in investing activities$(1,882)$(4,058)$(1,450)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of equity instruments42 168 1,444 
Repayments of shareholder loan  (568)
Net proceeds from borrowings46 971 617 
Repayments of debt and finance lease obligations(305)(390)(960)
Proceeds from government grants5 93 83 
Increase in restricted cash
  34 
Net cash provided by (used in) financing activities
$(212)$842 $650 
Effect of exchange rate changes on cash and cash equivalents4 5 (8)
Net increase (decrease) in cash and cash equivalents$35 $(587)$2,031 
Cash and cash equivalents at the beginning of the year2,352 2,939 908 
Cash and cash equivalents at the end of the year$2,387 $2,352 $2,939 
(1)Includes interest paid of $121 million, $96 million and $101 million for years ended December 31, 2023, 2022 and 2021, respectively, and interest received of $123 million, $32 million and $1 million for the years ended December 31, 2023, 2022 and 2021, respectively, and taxes paid of $11 million, $4 million and $7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
See accompanying notes to consolidated financial statements
F-6


GLOBALFOUNDRIES INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Share amounts and dollars in millions)
Equity Attributable to Shareholders of GLOBALFOUNDRIES INC.
Ordinary Share
Additional
Paid-In
Capital
Loan from
Shareholder
Accumulated
Deficit
Hedging
Reserve
Foreign
Currency
Translation
 Reserve and Investments Reserves
Total
Non-
 controlling
Interest
Total Equity
SharesAmount
As of December 31, 2020
500 $10 $11,707 $10,681 $(15,219)$(15)$11 $7,175 $66 $7,241 
Proceeds from issuance of equity instruments32 1 1,444     1,445  1,445 
Share-based payments  223     223  223 
Repayment of loan from shareholder   (568)   (568) (568)
Conversion of loan from shareholder  10,113 (10,113)      
Net loss for the year    (250)  (250)(4)(254)
Other comprehensive income
     (42)(8)(50)(4)(54)
As of December 31, 2021
532 $11 $23,487 $ $(15,469)$(57)$3 $7,975 $58 $8,033 
Proceeds from issuance of equity instruments6  163     163  163 
Share-based payments10  181     181  181 
Net income for the year    1,448   1,448 (2)1,446 
Other comprehensive income (loss)
     160 (14)146 (9)137 
As of December 31, 2022
548 $11 $23,831 $ $(14,021)$103 $(11)$9,913 $47 $9,960 
Proceeds from issuance of equity instruments6 — 46 — — — — 46 — 46 
Share-based payments— — 150 — — — — 150 — 150 
Net income for the year— — — — 1,020 — — 1,020 (2)1,018 
Other comprehensive income (loss)
— — — — — — (37)12 (25)2 (23)
As of December 31, 2023
554 $11 $24,027 $ $(13,001)$66 $1 $11,104 $47 11,151 
F-7


GLOBALFOUNDRIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED December 31, 2023, 2022 AND 2021
(Dollars in millions)
1.Organization
GLOBALFOUNDRIES Inc. (“GLOBALFOUNDRIES”) is an exempted company with limited liability incorporated under the laws of the Cayman Islands. The address of GLOBALFOUNDRIES’ registered office is P.O. Box 309, Ugland House, Grand Cayman, KY1-1104 Cayman Islands.
GLOBALFOUNDRIES and its subsidiaries (together referred to as the “Company”) is one of the world’s largest pure-play semiconductor foundries and offers a full range of mainstream wafer fabrication services and technologies. The Company manufactures a broad range of semiconductor devices, including microprocessors, mobile application processors, baseband processors, network processors, radio frequency modems, microcontrollers, and power management units.
GLOBALFOUNDRIES is a majority owned subsidiary of Mubadala Technology Investments LLC (“Shareholder”) through its subsidiaries, Mubadala Technology Investment Company and MTI International Investment Company LLC. Mubadala Technology Investments LLC is a subsidiary of Mamoura Diversified Global Holding PJSC (“MDGH”). Mubadala Investment Company PJSC (“MIC”) is the ultimate parent company. See Note 29 for further discussion of the Company’s related party disclosures.
The Company previously entered into an agreement with Semiconductor Components Industries, LLC (“ON Semiconductor”) to sell the Company’s business in East Fishkill, New York, including buildings, facilities, certain equipment, inventories, and certain contracts. Under the agreement the Company will manufacture 300mm wafers for ON Semiconductor until the end of 2025 for additional fees, allowing ON Semiconductor to increase its 300mm production at the East Fishkill fab over several years. Under the agreement, ON Semiconductor committed to minimum fixed cost payments in each year through 2023. On December 31, 2022, the Company completed the sale of the EFK business for a total purchase price of $406 million, and recognized a gain amounting to $403 million.
The consolidated financial statements were authorized by the GLOBALFOUNDRIES’ Board of Directors on April 29, 2024 to be issued and subsequent events have been evaluated for their potential effect on the consolidated financial statements through April 29, 2024.
2.Basis of Presentation
The consolidated financial statements of the Company have been presented in United States (“U.S.”) dollars, and prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). These financial statements have been prepared on the historical cost basis except as otherwise described in the notes below.
Basis of Consolidation—The consolidated financial statements comprise the financial statements of GLOBALFOUNDRIES and its subsidiaries. Subsidiaries are fully consolidated from the date of acquisition, being the date on which GLOBALFOUNDRIES obtains control, and continue to be consolidated until the date when such control ceases. All intercompany transactions, balances, income and expenses are eliminated in full on consolidation. Wholly-owned subsidiaries and controlled entities included in these consolidated financial statements are disclosed in Note 29.
Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the subsidiary and has the ability to affect those returns through its power over the subsidiary. Specifically, the Company controls a subsidiary if the Company (a) has power over the subsidiary, (b) is exposed, or has rights, to variable returns from its involvement with subsidiary, and (c) has the ability to use the power to affect its returns.
Profit or loss and each component of other comprehensive income (loss) (“OCI”) are attributed to the Shareholder of the Company and to the non-controlling interests.
A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.
If the Company loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized in the consolidated statements of operations. Any investment retained is recognized at fair value.

Foreign Currency Translation—Assets and liabilities of foreign operations having a functional currency other than the U.S. dollar are translated at the rate of exchange prevailing at the reporting date and revenue and expenses at the rate of exchange prevailing at the dates of the transactions during the period. Gains or losses on translation of foreign operations are included in OCI.
F-8

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
In preparing the consolidated financial statements of the Company, foreign currency-denominated monetary assets and liabilities are translated into the functional currency using the closing rate at the applicable consolidated statement of financial position dates. Non-monetary assets and liabilities, denominated in a foreign currency and measured at fair value, are translated at the rate of exchange prevailing at the date when the fair value was determined and non-monetary assets measured at historical cost are translated at the historical rate. Revenue and expenses are measured in the functional currency at the rates of exchange prevailing at the dates of the transactions with gains or losses included in the statements of operations.

3.Summary of Material Accounting Policies
The Company has consistently applied the following accounting policies to all periods presented in these consolidated financial statements, except if mentioned otherwise. In addition, the Company adopted Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) from 1 January 2023. The amendments require the disclosure of ‘material’, rather than ‘significant’, accounting policies. The amendments also provide guidance on the application of materiality to disclosure of accounting policies, assisting entities to provide useful, entity-specific accounting policy information that users need to understand other information in the financial statements. Management reviewed the accounting policies and made updates to the information disclosed in Note 3 Material accounting policies (2022: Significant accounting policies) in certain instances in line with the amendments.
Investments in Joint Operations—A joint operation is an arrangement in which the Company has joint control whereby the Company has rights to assets, and obligations for the liabilities, relating to an arrangement. The Company accounts for each of its assets, liabilities and transactions, including its share of those held or incurred jointly, in relation to the joint operation.
Cash and Cash Equivalents—Cash and cash equivalents consist of highly liquid time deposits and investments that are readily convertible into cash, which are not subjected to significant risk of changes in value, and have original maturities of three months or less at the time of purchase.
Trade Accounts Receivable—Trade accounts receivable are recognized initially at fair value. A provision for impairment of trade accounts receivable is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivable.
Inventories—Inventories are stated at standard cost adjusted to the lower of cost or net realizable value. The Company measures the cost of its inventory based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Financial Instruments:
Category of financial instruments and measurement
Recognition and Initial Measurement—Trade receivables are initially recognized when they are originated. All other financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.
A financial asset (unless it is a trade receivable without a significant financing component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value in the profit and loss (“FVPL”), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant financing component is initially measured at the transaction price.
Classification and Measurement—All recognized financial assets are measured based on amortized cost or fair value. The classification is based on two criteria, the Company’s business model for managing the assets and whether the instrument’s contractual cash flows represent solely payments of principal and interest (“SPPI”).
The assessment of whether contractual cash flows on debt instruments are solely comprised of principal and interest is made based on the facts and circumstances at the initial recognition of assets.
Financial assets include trade and other receivables. These are recorded at amortized cost when such financial assets are held with the objective to collect contract cash flows that meet the SPPI criterion.
Financial assets recorded at FVPL comprise unquoted equity instruments which the Company had not irrevocably elected, at initial recognition, to classify at fair value through other comprehensive income (“FVOCI”).
Financial assets recorded at FVOCI comprise marketable securities that are quoted debt instruments when such financial assets are held with the objectives of both collecting contractual cash flows and selling these financial assets, and meet the SPPI criterion. Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or
F-9

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
losses and interest income which are recognized in the consolidated statements of operations. Interest income from these financial assets is included in finance income using the effective interest rate method.
Derecognition of financial assets
The Company derecognizes a financial asset only when the contractual rights to the cash flows from the financial asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the financial asset to another entity. On derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in the consolidated statements of operations.
On derecognition of an investment in a debt instrument at FVOCI, the difference between the asset’s carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss that had been recognized in OCI is recognized in the consolidated statements of operations.
Impairment of financial assets
The Company will record an allowance for expected credit losses (“ECL”) for all loans to related parties, marketable securities (that are quoted debt instruments), contract assets, and trade receivables and other receivables not recorded at FVPL. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive. The shortfall is then discounted using the asset’s effective interest rate.
The Company estimated its ECL for its contract assets and trade receivables at an amount equal to lifetime credit losses, while marketable securities and other receivables are measured at 12-months ECL if they are determined to have low credit risk at the reporting date.
Offsetting of Financial Instruments—Financial assets and financial liabilities are offset and the net amount reported in the consolidated statements of financial position when there is an enforceable legal right to offset the recognized amounts, and there is an intention to settle on a net basis, or to realize the assets and settle the liabilities simultaneously.
Derivative Financial Instruments and Hedge Accounting—Through its operating, investing and financing activities in the normal course of business, the Company is exposed to various types of market risk including foreign exchange risk, interest rate risk and risks associated with changes in the market price of certain commodities. The Company uses derivative financial instruments, such as foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps to mitigate a portion of the risks associated with changes in foreign currency exchange rates, interest rates and commodity prices. The Company’s objective for holding derivatives include reducing, eliminating and efficiently managing the economic impact of these exposures as effectively as possible. The Company’s derivative programs include strategies that both qualify and do not qualify for hedge accounting treatment. However, the Company does not use derivative financial instruments for trading or speculative purposes.
Derivative financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently remeasured at fair value at each reporting date. Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Foreign currency forward contracts are used to hedge a portion of certain foreign currency-denominated forecasted operating expenditures, primarily in Euro (“EUR”), Japanese Yen (“JPY”) and Singapore Dollar (“SGD”). The Company also hedges future cash flows for certain foreign currency-denominated forecasted capital expenditures, primarily in EUR and JPY. Certain foreign currency forward contracts not designated as hedging instruments are also used to manage the variability in foreign exchange rates on certain balance sheet amounts and to manage other foreign currency exposures.
The Company uses interest rate swaps, cross-currency interest rate swaps and cross-currency swaps to protect itself against adverse fluctuations in interest rates and foreign currency exchange rates and to reduce its exposure to variability in forecasted cash flows associated with the Company’s floating-rate and foreign currency-denominated debt.
The Company also uses commodity swaps to hedge forecasted electricity and natural gas purchases to minimize the impact of commodity price movements on the reported earnings of the Company and on future cash flows related to fluctuations of the contractually specified, separately identifiable and reliably measurable commodity risk component.
At the inception of the hedge relationship, the Company documents the relationship between the hedging instrument and the hedged item along with its risk management objectives and its strategy for undertaking various hedge transactions. Furthermore, at the inception of the hedge, and on an ongoing basis, the Company documents whether there continues to be an economic relationship between the hedged item and the hedging instruments. The Company designates these derivative instruments in cash flow hedges of forecasted operating and capital expenditures or floating-rate and foreign currency-denominated debt, as applicable, and evaluates hedge effectiveness prospectively.
The effective portion of the gain or loss on these contracts is reported as a component of OCI and reclassified to the consolidated statements of operations in the same line item and in the same period during which the associated hedged forecasted transaction affects earnings. For hedges of capital expenditures, the amount in OCI is incorporated into the initial carrying amounts of the non-financial assets and depreciated over the average useful life of the associated assets. Any
F-10

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
ineffective portion of hedges or changes in fair value from excluded components of the hedge are immediately recorded in the consolidated statements of operations.
Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated, or exercised, or when it no longer meets the criteria for hedge accounting. When a forecasted transaction is no longer expected to occur, the gain or loss accumulated in OCI is recognized immediately in the consolidated statements of operations.
Property, Plant and Equipment —Construction in progress and property, plant and equipment are stated at historical cost, net of accumulated depreciation. The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Major additions and improvements are capitalized as appropriate, only when it is probable that future economic benefits associated with the item and the cost of the item can be measured reliably; minor replacements and repairs are charged to the consolidated statements of operations. The Company also capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company also records capital-related government grants as a reduction to property, plant and equipment.
Commencement of depreciation related to construction in progress and property, plant and equipment involves determining when the assets are available for their intended use. The Company considers various factors which include functionality, engineering specifications, nature and usage of assets among others, in assessing the conditions necessary for the assets to be capable of operating in the manner intended by the management. The Company also factors in the length of time it takes for the assets to reach the tooling qualification criteria from the initial point of when the assets are received. Depreciation is calculated on a straight-line basis over the estimated useful life of the assets as follows:
Building and leasehold/land improvements
Up to 50 years (or the remaining lease term of related land on which the buildings are erected, if shorter)
Equipment
2 to 10 years
Computers
5 years
The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023. The impact of the change in estimated useful lives of certain buildings resulted in an increase to income before income taxes of $76 million for the year ended December 31, 2023.
Leases—The Company determines if an arrangement is a lease or contains a lease at inception. That is, if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
Right-of-use assets—Right-of-use (“ROU”) assets are reported within property, plant and equipment, and are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. ROU assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets.
Lease liabilities—At the commencement date of the lease, the Company recognizes lease liabilities at the present value of the lease payments to be made over the lease term.
In calculating the present value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. The carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments or a change in the assessment of an option to purchase the underlying assets. The Company’s lease liabilities are separately reported in the consolidated statements of financial position under non-current portion of lease obligations and current portion of lease obligations.
Short-term leases and leases of low-value assets—The Company applies the short-term lease recognition exemption to leases that have a lease term not exceeding 12 months, or for leases of low-value assets. The payment for such leases is recognized in the Company’s consolidated statements of operations on a straight-line basis over the lease term.
Intangible Assets—Technology, patent, software licenses and similar rights acquired separately are stated at cost less accumulated amortization or are adjusted to fair value when impaired. Intangible assets acquired through business combinations which include customer relationships and manufacturing and process technology, are recorded at estimated fair values at the date of acquisition. Intangible assets are amortized based on the pattern in which the economic benefits of the respective intangible asset are consumed, which is, in general, on a straight-line basis over their estimated useful lives of between 3 and 10 years. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.
F-11

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Impairment of Non-Financial Assets—The Company reviews, at each reporting date, the carrying amount of the Company’s property, plant and equipment and finite lived intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.
If any indication exists, the recoverable amount of the asset is estimated in order to determine the extent, if any, of the impairment loss. Where it is not possible to estimate the recoverable amount of an individual assets, the Company estimates the recoverable amount of the cash generating unit (“CGU”) to which the asset belongs. The recoverable amount of an asset or CGU is estimated to be the higher of an asset’s or CGU’s fair value less costs to dispose and its value in use. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset or CGU is considered impaired and is written down to its recoverable amount. The Company also evaluates, and adjusts, if appropriate, the asset’s useful lives, at each reporting date or when impairment indicators exist.
In assessing value in use, the estimated future post-tax cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
Impairment losses are recognized in the consolidated statements of operations to the extent the recoverable amount, measured at the present value of discounted cash flows attributable to the assets, is less than their carrying value.
If the recoverable amount subsequently increases, the impairment loss previously recognized will be reversed to the extent of the increase in the recoverable amount, provided that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset in prior years. The impairment loss reversal is recognized immediately in the consolidated statements of operations.
Revenue Recognition—The Company generates revenue primarily from fabricating semiconductor wafers for its customers using the manufacturing processes based on their own or third parties’ proprietary integrated circuit designs and, to a lesser extent, the Company also generates revenue from engineering and other pre-fabrication services such as non-recurring engineering (“NRE”) services, which include design services and mask production.
The Company recognizes revenue when performance obligations are satisfied. The performance obligations are satisfied at the point at which control of the wafers is transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location. NRE services are recognized over time as the Company performs the services based on a percentage of costs incurred over total expected costs.
The Company generally requires a purchase order from all of its customers, to which the Company responds with an order acknowledgement and a copy of the Company’s standard terms and conditions. The Company also enters into master supply agreements (“MSA”) with certain of its customers that may specify additional terms and conditions, such as pricing formulas based on volume, volume discounts, calculation of yield adjustments, indemnifications, transfer of title and risk of loss, and payment terms. The Company also requires a purchase order from its customers with which it has MSAs for specific products and quantities. As a result, the Company has concluded that the combination of a purchase order and order acknowledgement, including the Company’s standard terms and conditions, and the MSA, if applicable, create enforceable rights and obligations between the Company and its customers. For certain customers under long-term supply agreements (“LTAs”) with minimum volume requirements that are subject to a certain breakage fee if such commitment is not met, the Company has concluded that LTAs’ terms and conditions generally constitute enforceable rights and obligations for revenue recognition purposes, unless the underlying facts and circumstances vary and indicate otherwise.
Typically, goods and services provided under the Company’s contracts are accounted for as a single performance obligation. However, in some contracts, the Company provides multiple distinct goods or services to a customer. In those cases, the Company accounts for the distinct contract deliverables as separate performance obligations at the stated contract value, which appropriately represents the individual performance obligation’s estimated standalone selling price.
The Company estimates for the breakage fee arising from not meeting the minimum purchase requirements under certain LTAs with customers as variable consideration and includes such fee in the contract transaction price if not constrained, and accordingly, recognizes as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreement. Given the volumes under these arrangements are usually not guaranteed and subject to subsequent negotiations or changes, breakage fees that are constrained are not included in the contract transaction price for revenue recognition purposes.
The Company estimates the variable consideration related to volume rebates and yield adjustments for certain contracts that may be refundable to customers through the issuance of a credit note, and accordingly, recognizes revenue in accordance with the pattern applicable to the performance obligation, subject to a constraint. The Company determines the amounts to be recognized based on the amount of potential refund required by the contract, historical experience and other surrounding facts and circumstances. These potential revenue adjustments are accrued and netted against accounts receivable on the consolidated statements of financial position.
Our contracts may be subsequently modified to reflect changes in scope or customer requirements. Generally, our contract modifications are for goods or services that are distinct from the existing contract and are accounted for as a new contract and performance obligation, which are recognized prospectively. If contract modifications are for goods or services that are
F-12

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
not distinct from the existing contract, they are accounted for as if they are part of the original contract with the effect of the contract modification recognized as an adjustment to revenue on a cumulative catch-up basis.
A contract asset (“unbilled accounts receivables”) is recognized when the Company has recognized revenue, but not issued an invoice for payment. The Company has determined that unbilled accounts receivables are not considered a significant financing component of the Company’s contracts. Contract assets are included in receivables, prepayments and other assets on the consolidated statements of financial position and are transferred to trade receivables when invoiced (see Note 6).
A contract liability is recognized when the Company receives payments in advance of the satisfaction of performance obligations and are included as deferred revenue on the consolidated statements of financial position (see Note 11). This includes upfront non-refundable capacity access fees under certain LTAs with customers which are accounted for as additional wafer price considerations and recognized as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreements.
Provisions—Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Provisions are mainly made up of site restoration obligations, as well as restructuring charges. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived assets.
A provision for restructuring is recognized when the Company has approved a detailed and formal restructuring plan, and the restructuring either has commenced or has been announced publicly. Future operating losses are not provided for.
The Company records site restoration obligations in the period in which they are incurred at their estimated fair value. Site restoration obligations consist of the present value of the estimated costs of dismantlement, removal, site reclamation and similar activities associated with facilities built on land held under long-term operating leases. The site restoration obligations are recorded as a liability at the estimated present value as of the related long-lived asset’s inception discounted using a pre-tax rate that reflects the current market assessment of the time value of money and risks specific to the site restoration obligations. After initial recognition, the liability is increased for the passage of time, with the increase being reflected as accretion expense in the line item “finance expenses” in the consolidated statements of operations. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived asset. Subsequent adjustments in the discount rates, estimated amounts, timing and probability of the estimated future costs and changes resulting from the passage of time are recognized as an increase or decrease in the carrying amount of the liability and the related site restoration cost capitalized as part of the carrying amount of the related long-lived asset on a prospective basis. If the decrease in the liability exceeds the remaining carrying amount of the related long-lived assets, the excess is recognized in the consolidated statements of operations.
Deferred Tax Assets—Deferred tax assets are recognized for all deductible temporary differences, carryforward of unused tax credits and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized except in respect of deductible temporary differences associated with investments in subsidiaries, associates and interests in joint ventures, deferred tax assets are recognized only to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized.
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each balance sheet date and are recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance sheet date.
Earnings Per Share—Basic earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding during the year.
Diluted earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding, adjusted for the effects of all potentially dilutive ordinary shares. The weighted average number of ordinary shares outstanding is increased by the number of additional ordinary shares that would have been issued by the Company assuming exercise of all options with exercise prices below the average market price for the year.
Share-based compensation—Share-based compensation expense related to share awards is recognized based on the fair value of the awards granted.
F-13

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The grant date fair value of equity-settled share-based payment awards granted to employee is recognized as an employee benefit expense, with a corresponding increase in equity, over the vesting period of the awards, The amount recognized as an expense is adjusted to reflected the number of awards for which the service and non-market performance conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that meet the service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual performance.
Government Grants—Government grants are recognized when there is reasonable assurance that the grant will be received and the Company will be in compliance with all attached conditions. When the grant relates to an expense item it is recognized as deferred income and released to the consolidated statements of operations over the period necessary to match the grant on a systematic basis to the costs that it is intended to compensate and is presented as a reduction of those costs. Where the grant relates to acquisition of assets, it is recognized as a reduction in the basis of the asset and released as a reduction to depreciation expense in equal amounts over the expected useful life of the related asset. Grants the Company received are primarily provided in connection with construction and operation of the Company’s manufacturing facilities, employment and research and development.
Research and Development Costs—Research costs are expensed as incurred. Development costs are recognized as intangible assets if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the assets.
Borrowing Costs—Borrowing costs directly attributable to the construction phase of property, plant and equipment are capitalized as part of the cost of assets which are constructed by the Company and for which a considerable period of time (at least six months) is planned for construction. Borrowing costs are capitalized from the start of construction until the date the asset is ready for its intended use. All other borrowing costs are recognized as an expense in the period in which they are incurred.
Current Income Tax—Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted by the balance sheet date.
Recent Accounting Pronouncements and Developments
Recent Accounting Pronouncement, Adopted:
Amendments to IFRS 7, IFRS 9 and IAS 39 Interest Rate Benchmark Reform
Phase 1 Amendments - On 1 January 2020, the Company adopted the Phase 1 amendments arising from the Interbank Offered Rate (“IBOR”) reform amendments issued in September 2019, which provides temporary relief from applying specific hedge accounting requirements to hedge relationships directly affected by IBOR reform, such that the effect is that IBOR reform should not generally cause hedge accounting to terminate.
Phase 2 Amendments - On 1 January 2021, the Company adopted the Phase 2 amendments arising from the IBOR reform issued in August 2020. The Phase 2 amendments address issues that arise from the implementation of the IBOR reform, including the replacement of an interest rate benchmark with an alternative benchmark rate. The key reliefs provided to the Company are as follows:
financial instruments measured at amortized cost are allowed to account for changes in the basis for determining contractual cash flows as a direct consequence of the IBOR reform by updating the effective interest rate, provided that the new basis is economically equivalent to the previous basis, such that there is no immediate gain or loss recognized; and
most IFRS 9 hedge relationships that are directly affected by the IBOR reform are allowed to continue.
As of June 30, 2023, the Company had completed the transition of the affected rates on borrowings from USD London Interbank Offered Rate to Term Secured Overnight Financing Rate (“SOFR”) and assessed the changes to be economically equivalent in accordance with IFRS 9. Any future impact has been deemed to be immaterial to the Company.

Recent Accounting Pronouncements, Not Adopted:
The Company has not adopted the following new, revised or amended IFRS standards that have been issued by the IASB but are not yet effective:
Non-current Liabilities with Covenants - Amendments to IAS 1 - Effective for annual periods beginning on or after January 01, 2024;
F-14

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Lease Liability in a Sale and Leaseback - Amendments to IFRS 16 - Effective for annual periods beginning on or after January 01, 2024;
Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7-Effective for annual periods beginning on or after January 01, 2024
General Requirement for Disclosure of Sustainability-related Financial Information - IFRS S1 -Effective for annual reporting periods beginning on or after January 1, 2024; and
Climate Related Disclosures - IFRS S2 - Effective for annual reporting periods beginning on or after January 1, 2024
As of the date the accompanying financial statements were authorized for issue, the Company continues to evaluate the impact on its financial position and performance as a result of the initial adoption of the aforementioned standards or interpretations and related applicable period. The Company does not anticipate the impacts of the standards effective for annual periods beginning on or after January 01, 2024 will have a material impact on the financial statements.
New Legislation:
In August 2022, the CHIPS and Science Act was signed into U.S. law. Designed to boost investment in domestic high tech-research and development and catalyze investment in domestic semiconductor manufacturing capacity the CHIPS and Science Act provides a 25% refundable advanced manufacturing investment tax credit (“AMITC”) on certain investment and other financial incentives to promote investments in domestic semiconductor manufacturing beginning in 2023. The Company has analyzed the provisions of the new law and determined that certain capital expenditures will qualify under the law and provide a refundable tax credit to the Company on its 2023 tax return.
In August 2022, the U.S. Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new corporate alternative minimum tax ("CAMT") of 15% for corporations with an average global adjusted financial statement income in excess of $1 billion over a consecutive three year period, as well as a 1% excise tax on qualifying stock repurchases. The CAMT is effective for tax years beginning after December 31, 2022. The Company has estimated no tax liability relating to CAMT for the current fiscal year. It is possible that the CAMT could result in an additional tax liability in a particular year due to offsetting the U.S. tax liability with prior year losses. The Company continues to evaluate the impact the IRA may have on its operations and consolidated financial statements in future periods.
Legislation and administrative guidance continue to evolve under the Organization for Economic Co-operation and Development's ("OECD") international tax reform centering on a global minimum tax regime ("Pillar 2") effective beginning in fiscal year 2024. The Pillar 2 regime seeks to collect additional top-up taxes from multinational groups whose effective tax rates are lower than 15% at a jurisdictional level. The initiative will also trigger additional compliance obligations, such as the requirement to file an annual GloBE Information Return within 15 months of the end of the fiscal year. Pillar 2 is being accounted for under the scope of IAS 12 Income Taxes, which includes an amendment in May 2023 granting temporary relief from accounting for deferred taxes arising from jurisdictions implementing Pillar 2 minimum taxes. Under the amendment, the Company is applying the exception of neither recognizing nor disclosing deferred tax adjustments related to Pillar 2 income taxes.
The effective tax rate is computed at a jurisdictional level with reference to GloBE income for all constituent entities of the multinational group in that jurisdiction. Singapore announced in its 2024 budget that it will enact a domestic top-up tax and income inclusion rule (“IIR”) effective in 2025. The Company and its subsidiaries are considered constituent entities forming part of the multinational group led by Mubadala Diversified Global Holding, PJSC. Eligibility to safe harbor and Pillar 2 top-up taxes payable as well as Pillar 2 filing and reporting requirements by the Company are partially dependent upon and influenced by GloBE income calculations of Mubadala subsidiaries having operations in the jurisdictions in which it operates.
The Company and its subsidiaries operate in Germany, the Netherlands, France, Bulgaria, the United Kingdom, Japan, Korea and Malaysia which have enacted Pillar 2 rules in 2023, Singapore announced in its 2024 budget that it will enact domestic top-up tax and income inclusion rule effective in 2025. The Dutch IIR regime may apply to GloBE income from the United States and Germany entities in the Company’s structure but the Company continues to analyze whether a Pillar 2 income tax expense and cash tax detriment are expected to arise from the Netherlands or any other material jurisdictions in 2024. Similarly, the recently announced Singapore rules may cause an additional liability beginning in 2025. Several jurisdictions are yet to finalize their Pillar 2 implementation timeline, including the United States, India, Cayman Islands and the United Arab Emirates. The Cayman Islands and Bulgaria are jurisdictions in which the Company operates with statutory tax rates below 15% and the Company’s Singapore operations include incentive tax rates below 15% which may be more likely to result in a tax liability under Pillar 2 if transitional safe harbor rules do not apply. The Company is tracking legislative updates from these and other jurisdictions to determine if any Pillar 2 taxes may be payable in fiscal 2024.

4.Critical Accounting Judgements, Estimates and Assumptions
The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities,
F-15

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
income and expenses as well as the disclosure of commitments and contingencies. Actual results may differ from these estimates and such differences may be material to the consolidated financial statements.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised if the revision affects only that year, or in the year of the revision and future years if the revision affects both current and future years.
Determination of useful lives of property, plant and equipment—The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023. The impact of the change in estimated useful lives of certain buildings resulted in an increase to income before income taxes of $76 million for the year ended December 31, 2023.
Inventory Valuation—Inventory is based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost. The cost of raw materials is determined using applicable raw material purchase prices. The cost of supplies is determined based on a weighted-average cost formula. Work in process and finished goods are valued at the cost of direct materials and a proportion of manufacturing labor and overhead costs based on normal operating capacity.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Impairment Assessment of Non-Financial Assets—Impairment exists when the carrying value of an asset or CGU exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The fair value less costs to sell calculation is based on a discounted cash flow analysis that a potential buyer would perform in determining a transaction value of the CGU less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. When preparing the discounted cash flow analysis, the Company makes judgments in determining the independent cash flows that can be related to a specific CGU based on its asset usage model and manufacturing capabilities in addition to the discount rate used in the analysis. In addition, because judgments are made regarding the remaining useful lives of assets and expected future revenue and expenses associated with the assets, changes in these estimates based on changes in economic conditions or business strategies could result in material impairment charges in future periods.
Income Taxes and Realization of Deferred Tax Assets—In determining taxable income for financial statement reporting purposes, management makes certain estimates and judgments specific to taxation issues. These estimates and judgments are applied in the calculation of certain tax liabilities and in the determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for income tax and financial statement reporting purposes.
Deferred taxes are recognized for unused losses, among other factors, to the extent that it is probable that taxable profit will be available against which the losses can be utilized.
This evaluation requires the exercise of judgment with respect to, among other things, benefits that could be realized from available tax strategies and future taxable income, as well as other positive and negative factors. The ultimate realization of deferred tax assets is dependent upon, among other things, the Company’s ability to generate future taxable income that is sufficient to utilize loss carry-forwards or tax credits before their expiration or the Company’s ability to implement prudent and feasible tax planning strategies.
If estimates of projected future taxable income and benefits from available tax strategies are reduced as a result of a change in the assessment or due to other factors, or if changes in current tax regulations are enacted that impose restrictions on the timing or extent of the Company’s ability to utilize net operating losses and tax credit carry-forwards in the future, the Company may be required to reduce the amount of total deferred tax assets resulting in a decrease of total assets. Likewise, a change in the tax rates applicable in the various jurisdictions or unfavorable outcomes of any ongoing tax audits could have a material impact on the future tax provisions in the periods in which these changes could occur.
In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax rules and the potential for future adjustment of uncertain tax positions by the tax authorities in the countries in which the Company operates. If estimates of these taxes are greater or less than actual results, an additional tax benefit or charge may result.
Share-based compensationShare-based compensation expense is recognized based on the grant date fair value of the awards. The fair value of Restricted Share Units (“RSUs”) is determined based on the closing price of the ordinary stock on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model for options. The fair value of Performance Share Units (“PSUs”) is estimated using a Monte Carlo simulation. Both models require management to make certain assumptions of future expectations based on historical and current data. The assumptions
F-16

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
include the estimated fair value of the Company’s stock, expected term of the awards, expected volatility, dividend yield, and risk-free interest rate. These estimates involve inherent uncertainties and the application of management’s judgment.
The principles of modification accounting are applied when a new share-based payment is granted as a replacement for another share-based payment that is cancelled. When modification accounting is applied, the entity accounts for any incremental fair value in addition to the grant-date fair value of the original award. In the case of a replacement, the incremental fair value is the difference between the fair value of the replacement award and the net fair value of the cancelled award, both measured at the date on which the replacement award is issued. The net fair value is the fair value of the cancelled award measured immediately before the cancellation, less any payment made to the employees on cancellation.
A package of modifications might include several changes to the terms of a grant, some of which are favorable to the employee and some not. In the event the net effect is not beneficial to the employee, cancellation accounting will be applied. Cancellations or settlements of equity-settled share-based payments during the vesting period by the Company are accounted for as accelerated vesting; therefore, the amount that would otherwise have been recognized for services received is recognized immediately.
In September 2023, the people and compensation committee of GlobalFoundries approved a modification to the 2023 PSUs, to adjust the return on invested capital (“ROIC”) performance threshold. The modification did not increase the fair value of the 2023 PSUs as the non-market performance condition was not considered when determining the fair value on the modification date. The Company will cumulatively adjust the expense based on the number of shares probable of vesting based on ROIC metrics and the grant date fair value.

5.Cash And Cash Equivalents
(in millions)December 31,
2023
December 31,
2022
Cash balances on hand and at banks$490 $990 
Other cash and cash equivalents1,897 1,362 
Total$2,387 $2,352 
Movements in cash and cash equivalents are presented in the Company’s consolidated statements of cash flows.
The following presents the reconciliation of assets, liabilities and equity arising from financing activities:
Non-cash changes
(in millions)
As of December 31, 2021
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2022
Assets
(Liabilities and Equity)
Restricted cash$1 $— $— $— $— $1 
Government grants receivable(1)
47 (93)18 (1)81 $52 
Other receivables(1)— — — — $(1)
Debt(2,013)(670)(6)10 168 $(2,511)
Lease obligations(426)89 (18)9 1 $(345)
Share capital(11)— — — — $(11)
Additional Paid-In Capital(23,487)(168)— — (176)$(23,831)
Total$(25,890)$(842)$(6)$18 $74 $(26,646)
F-17

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Non-cash changes
(in millions)
As of
December 31, 2022
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2023
Assets
(Liabilities and Equity)
Restricted cash$1 $— $— $— $— $1 
Government grants receivable(1)
52 (5)23 1 101 $172 
Other receivables(1)— — 1 — $— 
Debt(2,511)182 (17)(30)4 $(2,372)
Lease obligations(345)77 (117)(5)8 $(382)
Share capital(11)— — — — $(11)
Additional Paid-In Capital
(23,831)(42)— (154)$(24,027)
Total$(26,646)$212 $(111)$(33)$(41)$(26,619)
(1)Government grants receivable of $172 million and $52 million are included in receivables, prepayments and other assets in the consolidated statements of financial position as of December 31, 2023 and 2022, respectively.

Geographical concentration of cash and cash equivalents is as follows:
(in millions)December 31,
2023
December 31,
2022
United States of America$481 $484 
Republic of Singapore1,666 1,775 
Other240 93 
Total$2,387 $2,352 
6.Receivables, Prepayments and Other Assets
(in millions)December 31, 2023December 31, 2022
Current:
Trade receivables, other than related parties(1)
$1,002 $824 
Other receivables255 497 
Unbilled accounts receivable(2)
33 24 
Receivables from government grant66 52 
Receivables from related parties (Note 29)
12 11 
  Other current financial assets52 79 
Total$1,420 $1,487 
Non-current:
Advances to suppliers(3)
213 235 
Non-trade receivables
 10 
Receivables from government grant
106  
Payment in Lieu of Tax (“PILOT”) Bonds
 11 
Other24 25 
Total$343 $281 
(1)The Company’s trade receivables, other than related parties, are all classified as current and are expected to be collected within one year. The Company’s provision for sales returns was not material for either of the years ended December 31, 2023 and 2022. See the table below for the aging of the Company’s trade receivables, other than related parties.
(2)Unbilled accounts receivable represents amounts recognized on revenue contracts less associated advances and progress billings. These amounts will be billed in accordance with the agreed-upon contractual terms or upon shipment of products or rendering services.
(3)Primarily represents advances to supplier to offset against future purchases.
F-18

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following table presents the activities in unbilled accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$24 $43 
Revenue recognized during the year101 87 
Amounts invoiced(92)(106)
Ending balance$33 $24 
The following table presents the aging of accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Receivables neither past due nor impaired$880 $708 

Less than 30 days114 83 
31 to 60 days4 22 
61 to 90 days4 11 
Total$1,002 $824 
7.Inventories
Inventories consist of the following:
(in millions)December 31,
2023
December 31,
2022
Work in progress$928 $1,024 
Raw materials and supplies559 315 
Total$1,487 $1,339 


F-19

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
8.Property, Plant and Equipment
(in millions)
Land and
Land
Improvements
Building and
Leasehold
Improvements
EquipmentComputer
Construction
in Progress
Total
Cost
As of December 31, 2021
$130 $7,576 $22,350 $435 $1,423 $31,914 
Additions(1)
 67 27  3,564 3,658 
Transfers from construction in progress1 409 935 21 (1,366) 
Disposals(8)(182)(725)(17)(237)(1,169)
Effects of exchange rate changes(1)(3)(18)  (22)
As of December 31, 2022
122 7,867 22,569 439 3,384 34,381 
Additions(1)
16 121 19 4 745 905 
Transfers from construction in progress 616 1,979 7 (2,602) 
Disposals (25)(297)(2)(15)(339)
Effect of exchange rate changes 2 11   13 
As of December 31, 2023
$138 $8,581 $24,281 $448 $1,512 $34,960 
Accumulated Depreciation
As of December 31, 2021
$37 $4,266 $18,507 $384 $7 $23,201 
Additions(1)
6 443 975 23  1,447 
Disposals(4)(164)(674)(16) (858)
Effects of exchange rate changes (1)(4)  (5)
As of December 31, 2022
$39 $4,544 $18,804 $391 $7 $23,785 
Additions(1)
5 322 976 19  1,322 
Disposals (18)(296)(2) (316)
Effect of exchange rate changes 1 4   5 
As of December 31, 2023
$44 $4,849 $19,488 $408 $7 $24,796 
Net book value as of December 31, 2022
$83 $3,323 $3,765 $48 $3,377 $10,596 
Net book value as of December 31, 2023
$94 $3,732 $4,793 $40 $1,505 $10,164 
(1)     The Company earned investment tax credits related to the Company’s construction of a wafer fabrication facility in Saratoga County, New York (which were netted against additions relating to Building and Leasehold Improvements and Equipment). These credits were generally earned based on when the related assets were placed in service. The Company recorded the investment tax credits as a reduction of property, plant and equipment costs. As of December 31, 2023, and 2022, the investment tax credits included in property, plant and equipment amounted to $226 million and $179 million, respectively.
Construction in progress includes property, plant and equipment that are still in progress of construction and qualification process for equipment, necessary for these assets to be operating in the manner for their intended use. When these assets are completed and placed in service, they are transferred to property, plant and equipment and depreciation commences. The Company transferred $2.6 billion and $1.4 billion in 2023 and 2022, respectively, from construction in progress to the respective property, plant and equipment category.
The gross amount of ROU assets recorded under leases, which are included in property, plant and equipment amounted to $996 million and $888 million as of December 31, 2023 and 2022, respectively. The net carrying value of ROU assets amounted to $335 million and $282 million as of December 31, 2023 and 2022, respectively. Amortization of ROU assets is included in depreciation expense. Depreciation expense for the years ended December 31, 2023, 2022 and 2021 for all ROU assets was $57 million, $82 million and $81 million, respectively.
Depreciation expense on property, plant and equipment is as follows:
F-20

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
(in millions)202320222021
Cost of revenue$1,259 $1,377 $1,309 
Research and development expenses38 40 73 
Selling, general and administrative expenses25 30 29 
Total$1,322 $1,447 $1,411 
9.Goodwill and Intangible Assets
Cost (in millions)
Technology,
Licenses and
Similar Rights
SoftwarePatentsGoodwillOthersTotal
As of December 31, 2021
$1,202 $284 $229 $18 $132 $1,865 
Additions62 96   5 163 
Disposals(47)(12)(3)  (62)
As of December 31, 2022
1,217 368 226 18 137 1,966 
Additions61 96    157 
Disposals(40)    (40)
As of December 31, 2023
$1,238 $464 $226 $18 $137 $2,083 
Accumulated Amortization
As of December 31, 2021
$867 $278 $212 $ $131 $1,488 
Additions150 10 16   176 
Disposals(46)(12)(3)  (61)
As of December 31, 2022
971 276 225  131 1,603 
Additions121 7   1 129 
Disposals(40)    (40)
As of December 31, 2023
$1,052 $283 $225 $ $132 $1,692 
Net book value as of December 31, 2022
$246 $92 $1 $18 $6 $363 
Net book value as of December 31, 2023
$186 $181 $1 $18 $5 $391 

Amortization expense on intangible assets is as follows:
(in millions)202320222021
Cost of revenue$61 $91 $113 
Research and development expenses63 70 74 
Selling, general and administrative expenses5 15 20 
Total$129 $176 $207 
F-21

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
10.Other Financial Assets And Liabilities
The following foreign currency forward contracts are outstanding at December 31, 2023 and 2022 (in millions, except average foreign currency/US$):
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Notional
Amount
Average
Foreign
Currency/
US$
Average
Strike
Price
Maturity
Outstanding as of December 31, 2022:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$46 $3 $(32)$ $1,203 0.94  2023 - 2024
Singapore dollar forward contracts (receive Singapore$/pay US$)15  (1) 496 1.37  2023
Japanese yen forward contracts (receive Japanese yen/pay US$)18  (20) 236 127.22  2023 - 2024
79 3 (53) 1,935 
Interest rate swaps 42   795 — 
0.382% - 1.731%
2023 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
 2  (3)535 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$) 51   796 1.37 
1.830% - 1.941%
2028
Commodity swaps
  (8)(2)47 — 512.562023
Total$79 $98 $(61)$(5)$4,108 
Outstanding as of December 31, 2023:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$14 $ $(4)$ $845 0.91  2024 - 2025
Singapore dollar forward contracts (receive Singapore$/pay US$)8  (1) 483 1.33  2024 - 2025
Japanese yen forward contracts (receive Japanese yen/pay US$)
6 1 (7) 116 140.20  2024 - 2025
28 1 (12) 1,444 
Interest rate swaps17 5   653 — 
0.442% - 1.761%
2024 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
5 1 (3) 519 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$) 73   1,127 1.37 
1.83% - 1.941%
2028
Commodity swaps
2  (27)(14)237 0.91 73.592024 - 2025
Total$52 $80 $(42)$(14)$3,980 
F-22

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following table presents the fair values and locations of these derivative instruments recorded in the consolidated statements of financial position:
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Outstanding as of December 31, 2022:
Derivatives designated as hedging instruments
Foreign currency forwards$69 $3 $(52)$ 
Interest rate swaps 42   
Cross currency swaps and cross currency interest rate swaps  53  (3)
Commodity swaps  (8)(2)
Derivatives not designated as hedging instruments
Foreign currency forwards10  (1) 
Total$79 $98 $(61)$(5)
Outstanding as of December 31, 2023:
Derivatives designated as hedging instruments
Foreign currency forwards$24 $ $(9)$ 
Interest rate swaps17 5   
Cross currency swaps and cross currency interest rate swaps5 74 (3) 
Commodity swaps2  (22)(11)
Derivatives not designated as hedging instruments
Foreign currency forwards4 1 (3) 
Commodity swaps  (5)(3)
Total$52 $80 $(42)$(14)
F-23

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following table presents the effect of derivatives designated as hedging instruments on the consolidated statements of operations and comprehensive income (loss) (net of tax):
As of December 31, 2023 and 2022, the estimated amount of loss from cash flow hedges currently retained in consolidated statements of comprehensive income (loss) expected to be reclassified into the consolidated statements of operations within the next 12 months is approximately $15 million and $17 million, respectively.
(in millions)
Amount of
Gains
(Losses)
Recognized in
Accumulated
OCI
on Derivatives
(effective
Portion)
Amount of
Gains (Losses)
Reclassified
from
Accumulated
OCI to cost of
Property,
Plant and
Equipment
Location of
Gains (Losses)
Reclassified from
Accumulated
OCI into Income
Amounts of
Gains
(Losses)
Reclassified
from
Accumulated
OCI into
Income
(Effective
Portion)
Amount of
Gain
(Losses)
Reclassified
into
Income
(Missed Forecast)
Location of Gains
(Losses)
 Recognized into
Income (Ineffective
Portion)
Amount of
Gain
(Losses)
Recognized
into
Income
(Ineffective
Portion)
Year ended December 31, 2022
Derivatives designated as hedging instruments— Forward currency forward contracts$(105)$(93)Cost of revenue and operating expenses$(76) Other income (expense)$(5)
Derivatives designated as hedging instruments— Interest rate swaps55  Finance expense6  Other income (expense) 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
72  Cost of revenue and operating expenses  Other income (expense) 4 
Derivatives designated as hedging instruments – Commodity swaps
(5) Cost of revenue and operating expenses26  Other income (expense)(8)
Year ended December 31, 2023
Derivatives designated as hedging instruments— Forward currency forward contracts$17 $(17)Cost of revenue and operating expenses$34  Other income (expense) 
Derivatives designated as hedging instruments— Interest rate swaps8  Finance expense28  Other income (expense) 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
31  Finance expense6  Other income (expense)(4)
Other income (expense)31  
Derivatives designated as hedging instruments – Commodity swaps
(32) Cost of revenue and operating expenses(4)Other income (expense) 
Other income (expense) (13)
F-24

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following table presents the effect of derivatives not designated as hedging instruments on the consolidated statements of operations:
(in millions)
Location of Gains (Losses) Recognized in Income on Derivative
Amount of Gains (Losses) Recognized in Income on Derivative
Year ended December 31, 2021
Derivatives not designed as hedging instruments—foreign currency forwards contractsSelling, general and administrative expenses$(17)
Year ended December 31, 2022
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(22)
Total gain/(loss)
$(22)
Year ended December 31, 2023
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(16)
Derivatives not designed as hedging instruments—commodity swaps
Other income (expense)(8)
Total gain/(loss)
$(24)
11.Trade Payables and Other Liabilities
(in millions)December 31,
2023
December 31,
2022
Current:
Trade payables$511 $532 
Accrued expenses496 573 
Contract liabilities(1)
895 592 
Advances and deposits(2)
68 93 
Payable for property, plant and equipment and Intangible Assets
282 961 
Other(3)
97 98 
Total$2,349 $2,849 
Non-current:
Payable for Intangible Assets76 92 
Contract liabilities(1)
1,088 1,326 
Other(3)
26 56 
Total$1,190 $1,474 
(1)Contract liabilities comprises contract liabilities for payments received in advance of the satisfaction of performance obligations for wafers, as well as NRE services.
(2)Advances and deposits include advances from customers of $22 million (2022: $73 million) collected for purchase orders.
(3)Other includes other financial liabilities, due from related parties, deferred tax liabilities and non-current advances and deposits. See Note 10 for further details on other financial liabilities.
F-25

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following table presents the activities in contract liabilities for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning contract liabilities balance$1,918 $1,901 
Cash receipts in advance of satisfaction of performance obligations805 1,189 
Released to the consolidated statements of operations (1)
(759)(951)
Amounts credited to customers (221)
Other(2)
19  
Ending contract liabilities balance$1,983 $1,918 
Current$895 $592 
Non-current1,088 1,326 
Total$1,983 $1,918 
(1)Of revenue released to the consolidated statements of operations for the years ended December 31, 2023 and 2022, $476 million and $522 million, respectively were included in the beginning balance of the contract liabilities.
(2)Includes $19 million reclassification from accrued liabilities to contract liabilities.
12.Long-Term Debt
(in millions)December 31,
2023
December 31,
2022
Current:
Term loans$571 $223 
Non-current:
Term loans1,801 2,288 
Total$2,372 $2,511 
The above balances are net of $7 million and $12 million of unamortized debt issuance costs for the years ended December 31, 2023 and 2022, respectively.
Movements in interest bearing borrowings for the year ended December 31, 2023 and 2022 were as follows:
(in millions)December 31, 2023December 31, 2022
Opening balance$2,511 $2,013 
New loans and borrowings46 971 
Repayments(228)(301)
Other43 (172)
Ending balance$2,372 $2,511 
F-26

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Terms and Debt Repayment Schedule
The following table summarizes term loan facilities. The below arrangements are all considered to be secured.
DescriptionCurrencyNominal Interest
Rate
Interest
Payment
Terms
Principal
Payment
Terms
Year
of
Maturity
2023
Carrying
Amount
2022
Carrying
Amount
2018 Tool Equipment Purchase and Lease Financing(1)
USD
SOFR + 1.60%
QuarterlyQuarterly2023 19 
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly202421 85 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual202564  
EUR Term Loan A
EUR
EURIBOR + 2.60%
QuarterlySemi-Annual20259  
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 1.75%
Semi- AnnualSemi-Annual202636 36 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202560 59 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 1.75%
Semi- AnnualSemi-Annual2024368 13 
Various
EUR, USDVarious2024-202613 11 
Current total571 223 
Non-current:
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly2024 21 
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 2.25%
Semi-AnnualSemi-Annual202672 108 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202534 93 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual2025586 649 
EUR Term Loan AEUR
EURIBOR + 2.60%
QuarterlySemi-Annual202582 89 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 2.25%
Semi-AnnualSemi-Annual202630 387 
2021 SGD EDB LoanSGD1.40%Semi-AnnualSemi-Annual2041987 923 
Various
EUR, USDVarious2024-202710 18 
Non-current total1,801 2,288 
Total$2,372 $2,511 
(1)On March 2, 2018, GLOBALFOUNDRIES SINGAPORE PTE, LTD. (“GFS”) entered into several Equipment Purchase and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $375 million. The total minimum lease payments amount to $375 million, to be paid in equal quarterly installments through March 1, 2023.
(2)On January 21, 2019, GFS entered into several Equipment Purchase Agreements and Lease Agreements with five banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ Fabs in Singapore for a total of $425 million.
(3)On October 31, 2019, the Company, GLOBALFOUNDRIES Dresden Module One Limited Liability Company & Co., KG. and GLOBALFOUNDRIES Dresden Module Two Limited Liability Company & Co. KG. entered into a term facilities agreement with Bank of America Merrill Lynch International Designated Activity Company and ING Bank, a branch of ING-DIBA AG, as coordinating mandated lead arrangers, and Bank of America Merrill Lynch International Designated Activity Company as facility and security agent, which provides a maximum incremental facility commitment totaling $750 million secured by certain qualifying equipment assets.
(4)On April 23, 2020, GFS entered into several Equipment Purchase Agreements and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $300 million.
2021 SGD EDB Loan—On September 3, 2021, the Company entered into a loan agreement with Singapore Economic Development Board (“EDB”), which provided loan facilities with maximum drawdown of $1,149 million (SGD 1,541 million) at a fixed nominal interest rate of 1.4%. The difference between the nominal interest rate of the loan and the market interest rate for an equivalent loan is recognized as a government grant. The loan matures on June 1, 2041, with interest-only payments for the first 5 years and principal repayments commence thereafter, payable on a semi-annual basis.
As of December 31, 2023, the Company’s total drawdown was $1.1 billion, of which $971 million was drawn down in 2022.
As of December 31, 2023 and 2022, $987 million and $923 million respectively, were recorded in long-term debt based on an effective interest rate of 3.20% and $179 million and $184 million respectively, were recorded in deferred income from government grants.
F-27

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
5-year Revolving and Letter of Credit Facilities Agreement—On October 13, 2021, the Company entered into an amendment to the 5-year Revolving and Letter of Credit Facilities Agreement to increase the commitment to $1.0 billion.
The following table summarizes unutilized credit facilities available to the Company to maintain liquidity to fund operations:
(in millions)December 31, 2023December 31, 2022
SGD EDB Loan$ $42 
Revolving Credit Facility1,012 1,012 
Uncommitted Credit Facilities(1)
46 64 
Total$1,058 $1,118 
(1) Credit facility made available to the Company, but the lender is not obligated to loan funds.
Assets pledged as security Various assets have been pledged to secure borrowings under pledged agreements for the Company. Cash and cash equivalents, trade accounts receivables, property, plant and equipment, inventories, and financial assets have been pledged to secure borrowings under pledged agreements for the Company. The Company is not allowed to pledge these assets as security for other borrowings or to sell them outside normal course of business.
13.Leases
The Company has various lease agreements for certain of its offices, facilities, and equipment. Leases may include one or more options to renew. Renewals are not in the determination of the lease term unless the renewals are deemed to be reasonably certain at lease commencement. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. All leases were measured under a single criterion with the exception of those with terms not exceeding 12 months and low-value leases.
(in millions)December 31,
2023
December 31,
2022
Amortization of right-of-use assets$57 $82 
Interest expense on lease liabilities21 23 
Short-term and low-value leases expense 1 
Total net lease cost$78 $106 
Weighted average remaining lease term12.4 years7.18 years
Weighted average discount rate5.16 %4.75 %
The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2023 and 2022:
December 31, 2023December 31, 2022
(in millions)
Minimum
Lease
Payments
Present
Value of
Payments
Minimum
Lease
Payments
Present
Value of
Payments
Within 1 year$44 $32 $92 $75 
2-5 years194 128 184 146 
After 5 years283 222 151 124 
$521 $382 $427 $345 
Less: amounts representing
finance charges(139)— (82)— 
Present value of minimum
lease payments
$382 $382 $345 $345 
Current32 75 
Non-current350 270 
Total$382 $345 
F-28

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Supplemental cash flow information related to leases is as follows:
(in millions)December 31,
2023
December 31,
2022
Cash flows used in operating activities:
Payments of short-term and low-value leases$ $(1)
Interest paid(21)(23)
Cash flows used in financing activities:
Payment of lease obligations(77)(89)
The following table summarizes the movement of ROU assets which primarily relates to building and leasehold improvements during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$282 $305 
Additions 117 59 
Disposals
(7) 
Amortization(57)(82)
Ending balance$335 $282 
14.Provisions
The movement in provision for asset retirement obligations and restructuring expenses during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$298 $349 
Arising during the period2 2 
Accretion cost5 (4)
Restructuring expenses
71 91 
Utilized(1)
(136)(52)
Released to the consolidated statements of operations(2)
$ (88)
Ending balance$240 $298 
(1) Includes $10 million and $40 million related to asset retirement obligations, $126 million and $5 million related to restructuring expense and $0 and $7 million related to sale of EFK business for the years ended December 31, 2023 and 2022, respectively.
(2) Relates to the derecognition of asset retirement obligation related to the sale of the EFK business.
The Company records a provision for site restoration costs as required by legal and contractual obligations if assessed to be probable that it will incur such costs. Because of the long-term nature of the liability, the greatest uncertainty in estimating the provision is the costs that will be incurred. The Company has estimated costs based on currently available information provided by experts about the extent of restoration work required.
The provision has been calculated using a discount rate of 1.72% to 3.35% (2022: 1.58% to 4.04%), which is the risk-free rate in the jurisdiction of the liability. The site restoration costs are expected to be incurred on site abandonment for owned property and on lease expiration for leasehold land. The expected timing of incurring site restoration costs is consistent with the remaining useful lives of the underlying property, plant and equipment.
See Note 21 for information regarding the Company’s restructuring initiative.
F-29

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
15.Government Grants
The following table presents the movement in deferred income from government grants for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$404 $176 
Received/receivable during the period81 270 
Fair value of EDB loan
7  
Capitalized to fixed assets
(74) 
Released to the consolidated statements of operations(58)(42)
Ending balance$360 $404 
Current93 110 
Non-current267 294 
Total$360 $404 
Government grants were recognized in the consolidated statements of operations as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Cost of revenue$29 $30 $33 
Research and development expenses29 11  
Selling, general and administrative 1  
Total balance$58 $42 $33 
The Company has received government support in the form of investment grants, research and development subsidies, refundable credits, subsidized loans and miscellaneous receipts for employee support. Amounts receivable from the government but not yet received have been included in receivables, prepayments and other assets. Certain investment grants are subject to forfeiture in declining amounts over the life of the agreement if the Company does not maintain agreed upon conditions specified in the relevant grant agreements. The Company continues to comply with the government grant conditions mainly relating to qualifying property, plant and equipment and employment levels.
16.Issued Capital and Reserves
Share Capital—On September 12, 2021, the Company effected a 1-for-2 reverse share split, which was approved by our board of directors on September 9, 2021.
On October 27, 2021, the Company completed an initial public offering, issuing 30,250,000 ordinary shares, as well as 1,595,744 ordinary shares in a concurrent private placement agreement.
As of December 31, 2023, there were 1,300 million ordinary shares and 200 million preferred shares with a par value of $0.02 authorized, and 554 million ordinary shares issued and outstanding.
Additional Paid-In Capital—Additional paid-in capital represents the excess of assets less liabilities contributed to GLOBALFOUNDRIES by shareholders over the share capital issued in exchange for those contributions and share-based compensation charges for share-based payments.
Reserves
All other reserves as stated in the consolidated statements of changes in equity:
Hedging Reserve—The cash flow hedge reserve contains the effective portion of the cash flow hedge relationships incurred as at the reporting date.
Foreign Currency Translation Reserve—The foreign currency translation reserve is used to record exchange differences arising from the translation of Advanced Mask Technology Centre GmbH & Co. KG (“AMTC”) and Maskhouse Building Administration GmbH & Co. KH (“BAC”)’s financial statements for consolidation purpose.
F-30

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
17.Net Revenue
The following table presents the Company’s revenue disaggregated based on revenue source and timing of revenue recognition. The Company believes these categories best depict the nature and timing of revenue.
(in millions)202320222021
Type of goods and services:
Wafer fabrication$6,820 $7,627 $6,204 
Engineering and other services
572 481 381 
Total$7,392 $8,108 $6,585 
Timing of revenue recognition:
Revenue recognized over time$471 $445 $357 
Revenue recognized at a point in time6,9217,6636,228
Total
$7,392 $8,108 $6,585 
The Company recognizes revenue when wafers are transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location, as determined by the agreed shipping terms.
The Company’s remaining performance obligations that are completely or partially unsatisfied as of December 31, 2023, was approximately $20 billion pertaining to wafer products under certain long-term supply arrangements with customers. The Company recognizes revenue as the wafer products are shipped based on the agreed shipping terms. Generally, the amount and timing of recognition of the remaining performance obligations are subject to change and are affected by several factors, including terminations, subsequent modifications in the scope of contracts, and uncertainty in meeting volume commitments. Based on the current terms of the contracts, these performance obligations are expected to be substantially satisfied within the next five years.

18.Cost of Revenue
(in millions)202320222021
Depreciation of property, plant and equipment and amortization of intangible assets (1)
$1,321 $1,468 $1,422 
Inventory changes materials costs and other
1,742 1,834 1,726 
Staff costs, maintenance costs, and utilities(2)
2,228 2,567 2,424 
Total$5,291 $5,869 $5,572 
(1)Amounts are net of amortization of government grants relating to assets. See Note 8 for the detailed movements of property, plant and equipment.
(2)Staff costs, maintenance costs, and utilities costs include share-based compensation of $48 million, $64 million and $55 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
19.Research and Development Expenses
(in millions)202320222021
Staff costs, maintenance costs, and utilities(1)
$230 $247 $257 
Depreciation of property, plant and equipment and amortization of intangible assets
119 110 147 
Other (2)
79 125 74 
Total$428 $482 $478 
(1)Staff costs, maintenance costs, and utilities costs include share-based compensation of $25 million, $27 million and $22 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
(2)Other primarily includes material costs and net (income) expenses related to research funding agreements and wafer, labor, software license costs allocated (to) and from cost of revenue.
20.Selling, General and Administrative Expenses
F-31

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
(in millions)202320222021
Staff costs, maintenance costs, and utilities (1)
$342 $417 $537 
Depreciation of property, plant and equipment and amortization of intangible assets25 45 49 
Other (2)
106 34 9 
Total$473 $496 $595 
(1)Staff costs, maintenance costs, and utilities costs include share-based payments of $96 million, $92 million and $152 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively. See Note 3 for further discussion on the timing of expense recognition.
(2)Other primarily includes net professional charges, marketing expenses and facility costs, (gain) loss on tool sales and certain contract cancellation fees. Real estate transfer taxes are also included in Other.
21.Restructuring
In December 2022, the Company’s management approved and commenced a restructuring plan aimed to realign the Company’s business and strategic priorities. This worldwide restructuring plan included a reduction in the number of full-time employees, as well as a reduction in leased workspaces and engagement of consultants for strategic support. The Company met the recognition criteria for the provisioning of phase one restructuring costs in the fourth quarter of 2022.
In February 2023, the Company announced phase two to the restructuring plan. Costs arising from this restructuring program comprised of termination benefits and costs associated with direct transition works.
The Company incurred $71 million and $94 million of restructuring charges for the years ended December 31, 2023, and 2022, respectively, which included $3 million of accelerated share-based compensation expense in 2022. These expenses are included in restructuring expense in the Company’s consolidated statements of operations, and unpaid amounts are included in provisions within current liabilities on the consolidated statements of financial position.
The changes to the restructuring provisions recorded on the consolidated statements of financial position as of December 31, 2023 and 2022 are summarized as follows:
(in millions)20232022
Beginning balance
$86 $ 
Provision7191 
Amounts paid(126)(5)
Ending balance
$31 $86 
The actual costs that the Company will incur may differ from these estimates based on the timing required to complete the restructuring plan, the number of people invoiced and the final termination benefits.
22.Share-Based Compensation
The Company incurred share-based compensation expense of $148 million, $173 million, and $223 million during the years ended December 31, 2023, 2022 and 2021, respectively. As of December 31, 2023 and 2022, the additional paid-in capital related to the share proceeds amounted to $46 million and $163 million, respectively. The Company incurred $21 million, $10 million and $5 million of payroll taxes associated with the share-based compensation expense for the years ended December 31, 2023 ,2022, and 2021 respectively.
As of December 31, 2023 and 2022, the Company has 3,485,505 shares and 2,826,758 shares respectively, available for future grant under the 2018 Share Incentive Plan (as described below).
As of December 31, 2023 and 2022, the Company has 17,011,837 shares and 13,648,116 shares respectively, available for future grant under the 2021 Equity Compensation Plan.
RSUs
In 2023 and 2022, the Company granted RSUs under the 2021 Equity Compensation Plan. The RSUs have a time-based vesting requirement, which provides that the RSUs will generally vest in three annual installments, with 33.33% vesting on each one-year anniversary of the vesting commencement date subject to the employee’s continued employment with the Company.
F-32

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Number of
RSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
847,430 $39.59 
Granted3,416,545 $57.09 
Forfeited(314,158)$55.36 
Exercised
(738,387)$49.51 
Outstanding as of December 31, 2022
3,211,430 $54.39 
Granted2,426,183 $62.94 
Forfeited(390,769)$55.35 
Exercised(1,093,061)$55.28 
Outstanding as of December 31, 2023
4,153,783 $58.87 
Prior to the IPO, the value of the RSUs was determined by the Company’s Board of Directors. Because there had been no public market for the ordinary shares, the Board of Directors determined the fair value at the time of grant of the RSU by contemporaneous valuations performed by unrelated third-party valuation firms as well as a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors.
As of December 31, 2023, 2022 and 2021, there was $107 million, $88 million, and $26 million, respectively, of total unrecognized compensation cost related to outstanding RSUs.
PSUs
In 2023 and 2022, the Company granted performance stock units (“PSUs”) under the 2021 Equity Compensation Plan to certain senior level employees. Each PSU represents a contingent right to receive shares of the Company’s stock if the Company meets certain performance measures over the requisite performance period. The PSU awards entitle recipients to receive, upon vesting, a number of shares that ranges from 0% to 200% of the number of PSUs awarded, depending on the level of achievement of the specified performance conditions.
The PSUs vest subject to achievement of a performance target based on an absolute ROIC and relative total shareholder return (“TSR”) versus the SOX Index over a 3 year performance period subject to the grantee remaining employed by the Company through the end of the applicable performance period.
Number of
PSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
  
Granted
571,277 70.85 
Forfeited
(34,082)70.91 
Outstanding as of December 31, 2022
537,195 $70.91 
Granted875,646 $69.73 
Forfeited(220,422)$69.90 
Outstanding as of December 31, 2023
1,192,419 $69.96 
The Company uses the Monte Carlo simulation model to estimate the fair value of the PSUs at the date of grant. The equity volatility was determined based on the historical volatilities of comparable publicly traded companies over a look back period of 2.84 years and 2.74 years in 2023 and 2022, respectively, commensurate with the remaining term of the PSUs. The risk-free interest rate is based on the United States Treasury with a remaining term equivalent to the remaining performance measurement period. Dividends are not paid on the Company’s stock.
The assumptions used to value the Company’s PSUs granted during the period presented and their expected lives were as follows:
December 31, 2023
December 31, 2022
Expected dividend yield
Expected volatility50.93%45.50%
Risk-free interest rate4.60%2.55%
F-33

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Compensation expense is recognized for the PSU awards based on a graded attribution basis over the vesting period. As of December 31, 2023, and 2022 there was $22 million and $24 million, respectively, of total unrecognized compensation expense related to the PSUs.

Share Options
In 2017, the Company approved the Share Incentive Plan, which was intended to attract and retain talented employees and align shareholder and employee interests. Share options under the Share Incentive Plan vested over a five-year period.
In 2019, the Company offered to exchange the share options under the Share Incentive Plan with new share options under the “2018 Share Incentive Plan,” under which the Company may grant up to 25 million options to purchase shares in the Company with an exercise price of $10.00 per share. The options vest based on service over four or five years, depending on the timing of the grant, and contingent upon a liquidity event (change in control or IPO) with the earliest vesting date on the one-year anniversary of a liquidity event. On April 19, 2019, the Company issued the share options subject to the tender offer. The exchange of 2017 plan options into 2018 plan options resulted in a total incremental fair value of $64 million, of which $39 million was recognized in the second quarter of 2021 when an IPO became probable. The remainder was attributed prospectively. In the fourth quarter of 2021, the Company modified the earliest vesting date from one year post-anniversary of a liquidity event to six-months post-anniversary of a liquidity event, and shortened the contractual term for options held by US taxpayers to be the calendar year end after or within the year of vest. The options that remain outstanding at expiration will be auto-exercised through the broker.
The share options are effective for a term of 10 years from the grant date. Because the vesting and exercisability of these share options were dependent on a qualified liquidity event, the Company had to assess the probability of such an event in order to determine the expenses related to the share-based payments for the period. On June 30, 2021, the Company deemed an IPO to be probable under IFRS.
Upon the tender offer, the Company measured the pre-modification value of the old share options and compared that to the fair value of the new share options using the Black-Scholes option pricing model. The equity volatility was determined based on the historical volatilities of comparable publicly traded companies over a period equal to the expected average share-based payments life. The risk-free rate of interest was interpolated from the U.S. Constant Maturity Treasury rate curve to reflect the remaining expected life of share options. The fair value of the ordinary shares underlying the stock options has historically been determined by the Company’s Board of Directors. Because there had been no public market for the ordinary shares, the Board of Directors determined the fair value of the ordinary shares at the time of grant of the option by contemporaneous valuations performed by unrelated third-party valuation firms as well as a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors.
The Company did not grant any stock options in 2023 and 2022.
The following table shows a summary of the share option’s activity for the year ended December 31, 2023 and 2022.
Number of
Share options
Weighted
average
exercise price
per Share
Outstanding as of December 31, 2021
21,749,558 $10.03 
Exercised
(14,956,321)$10.00 
Forfeited(532,634)$10.00 
Outstanding as of December 31, 2022
6,260,603 $10.02 
Exercised(4,468,985)$10.02 
Forfeited(151,579)$10.00 
Outstanding as of December 31, 2023
1,640,039 $10.02 
Exercisable balance as of December 31, 2023
1,485,670 $10.03 
The following table summarizes information about employees’ share options outstanding as of December 31, 2023:
Outstanding
Range of exercise prices
Number
Outstanding
Weighted
average
remaining
 contractual life
(in years)
$10.02 1,640,039 2.67
F-34

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The weighted average remaining contractual life is calculated based on the 10-year contract terms of the options and the weighted average exercise price is calculated using the exercise price of the outstanding options, which pertain to the 2018 Share Incentive Plan.
As of December 31, 2023, 2022 and 2021, there was $1 million, $7 million and $63 million, respectively, of total unrecognized compensation cost related to outstanding stock options.
ESPP
In connection with, and prior to the consummation of the Company's initial public offering in 2021, the Company's board of directors adopted the GLOBALFOUNDRIES Inc. 2021 Employee Stock Purchase Plan (the “ESPP”). The ESPP is administered by the Company's board of directors or, as applicable, its delegate (the “ESPP Administrator”).
The ESPP provides eligible employees with an opportunity to purchase ordinary shares through payroll deduction of up to 10% of their eligible compensation. A participant may purchase a maximum of 2,500 ordinary shares during a purchase period. Amounts deducted and accumulated by the participant are used to purchase ordinary shares at the end of each six-month purchase period. Participants in the ESPP receive a one-time grant of 50 RSUs upon enrollment in the ESPP. The Company matches 20% of each employee’s contributions on an after-tax basis.
Subject to certain equitable adjustments in connection with certain events affecting the outstanding ordinary shares reserved for issuance as awards, the maximum aggregate number of ordinary shares that may be issued or transferred under the ESPP with respect to awards is 7,500,000 ordinary shares; provided that the share reserve under the ESPP will, unless otherwise determined by the board of directors, automatically increase on January 1 of each year for 8 years commencing on January 1, 2023 and ending on (and including) January 1, 2031 in an amount equal to 0.25% of the total number of ordinary shares outstanding on December 31 of the preceding year. In no event will the number of ordinary shares that may be issued or transferred pursuant to rights granted under the ESPP exceed 18,750,000, in the aggregate, subject to the adjustments described above.
As of December 31, 2023, of the Company has issued 620,481 shares under this plan reflecting employees’ contribution and the 20% Company match.
23.Finance Income and Expenses
Finance Income
(in millions)202320222021
Interest income - deposits
$92 $31 $1 
Interest income on FVOCI investments
30 8  
Accretion income
27 12 5 
Total finance income
$149 $51 $6 
Finance Expenses
(in millions)202320222021
Interest on long-term debt$80 $69 $72 
Interest on lease obligations21 23 27 
Commitment fees and amortization of debt issuance costs13 13 12 
Accretion costs and other23 6 3 
Total finance expenses$137 $111 $114 
24.Gain on Sale of a Business
In April 2019, the Company entered into an Asset Purchase Agreement with ON Semiconductor pursuant to which the Company agreed to transfer substantially all the assets and employees related to the EFK business. On December 31, 2022, the Company completed the sale of the EFK business for a total purchase price of $406 million, of which $170 million was received in prior years, and the remaining $236 million was received in January 2023. The Company recognized a gain upon the completion of the sale of $403 million after derecognition of net liabilities of $9 million.
F-35

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
The following is the breakdown of the net liabilities that were derecognized:
(in millions)December 31,
2022
Property, plant and equipment$83 
Inventories43 
Total Assets126 
Lease liabilities(47)
Other current and non-current liabilities(88)
Total Liabilities(135)
Net Liabilities$(9)
25.Other Income (Expense), Net
(in millions)202320222021
Loss on hedging activities
$(78)$ $ 
Other(1)
21 $22 $(8)
Total other income (expense), net$(57)$22 $(8)
(1) Relates primarily to share of profits of joint ventures, and gains on the sales of property, plant and equipment and intangible assets.
26.Income Taxes
For tax reporting purposes, the Company consolidates its entities under GLOBALFOUNDRIES Inc., a Cayman Islands entity as described in Note 1. Accordingly, the Company has presented the domestic portion of the disclosures below based on its country of domicile in the Cayman Islands.
As a Cayman Islands corporation, the Company’s domestic statutory income tax rate is 0.00%. The difference between the Company’s domestic statutory income tax rate and its (expense) benefit for income taxes is due to the effect of the tax rates in the other jurisdictions in which the Company operates. Principally, for the years ended December 31, 2023 and 2022, the Company is subject to United States’ federal and state taxes with a combined statutory tax rate of 21.6% and 22.1%, respectively; German corporation and trade taxes with a combined statutory tax rate of 31.6%; and Singapore’s statutory tax rate of 17.0%.
Income tax expense consisted of the following:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Current income tax expense:
       Current income tax benefit (expense)$(13)$(14)$2 
       Adjustments in respect of current income tax of previous year(3)(5)(1)
Deferred tax
     Net operating and investment allowance carryforwards(74)(44)(78)
     Currency effect on non-monetary assets of subsidiary23 (12)(37)
     Other change in temporary differences1 (11)36 
Income tax expense reported in the consolidated statements of operations
$(66)$(86)$(78)
F-36

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
A reconciliation between tax expense and accounting profit multiplied by the Company’s statutory rate of 0.0% is as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Income (Loss) before income taxes$1,084 $1,532 $(176)
Tax at Enacted Statutory Rate$ $ $ 
Foreign tax rate differential(65)(98)(75)
Adjustments in respect to current income tax of previous years(1)(5)(1)
Government grants exempt from tax7 7 5 
Deductible expense for tax purpose(2) (1)
Impact of unrecognized deferred tax assets(20)57 9 
Non-deductible expenses for tax purposes (21)(4)
Effects of foreign exchange gains (loss)10 (14)(22)
Impact of change in liability for uncertain tax positions3 1 7 
Withholding Tax (11) 
Other effects2 (2)4 
Income tax (expense) benefit
$(66)$(86)$(78)
Effective income tax rate(6.1)%(5.6)%44.3 %
The Company has determined that it is probable that 100% of deferred tax assets can be realized in Singapore. The Company has determined that realization of deferred taxes associated with loss carryforwards is limited to reserves for uncertain tax positions in the United States and Germany that would generate future taxable income, and deferred tax assets resulting from consolidation of AMTC and BAC.

Components of the Company’s deferred tax assets and liabilities are attributable as follows:
(in millions)December 31,
2023
December 31,
2022
Accelerated depreciation on property, plant and equipment$(12)$(18)
Losses, credits and investment allowances available for offsetting against future taxable income231 277 
Accrued expenses11 16 
Inventory3 1 
Other comprehensive income (loss)
2 (8)
Currency effect(1) 
Other1 (2)
Net deferred tax assets$235 $266 
The classification of the net deferred tax assets in the statements of financial position is as follows:
(in millions)December 31,
2023
December 31,
2022
Deferred tax assets$241 $292 
Deferred tax liabilities(1)
(6)(26)
Net deferred tax assets$235 $266 
(1) Included in Other non-current liabilities in the statements of financial position.
Total unrecognized deferred tax assets as of December 31, 2023 and 2022 was $3,665 million and $3,708 million, respectively. The Company does not anticipate any significant changes to the total amounts of unrecognized deferred tax assets within the next 12 months of the reporting date. Deferred tax assets have not been recognized in respect to these items because it is not probable that future taxable profit will be available against which the Company can utilize the benefits.
As of December 31, 2023 and 2022, the Company has accumulated corporate losses in Germany of $1,119 million and $1,132 million, respectively, and trade tax losses in Germany of $830 million and $851 million, respectively. Except for a fully deductible base amount, utilization of German net operating loss carryforwards is limited to 60.0% of taxable income in any one year. German net operating losses do not expire with the passage of time, but may forfeit partially or completely as a result of legal entity restructurings.
F-37

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
As of December 31, 2023 and 2022, the Company has unutilized capital allowances on the property, plant and equipment held in Singapore of $440 million and $713 million, respectively, and unutilized tax losses available for carryforward of $58 million and $58 million, respectively. Under Singapore tax law, unutilized capital allowances and unutilized tax losses are deductible to the extent of income available. Unutilized capital allowances and unutilized tax losses can be carried forward indefinitely subject to compliance with the conditions that there is no substantial change in shareholders and no change in the Company’s principal activities, where applicable. As of December 31, 2023 and 2022, the Company has investment allowances of $843 million and $843 million, respectively in Singapore which can be carried forward indefinitely. These carryforward tax attributes have been fully recognized as deferred tax assets.
As of December 31, 2023 and 2022, the Company has gross operating loss carryforwards in the United States of $5,984 million and $7,307 million, respectively; $4,434 million will expire in years 2029 through 2037. As of December 31, 2023 and 2022, the Company has $821 million and $822 million, respectively of California gross operating loss carryforwards and, in the other states in which it operates, it has gross operating loss carryforwards of $868 million and $885 million, respectively. The state carryforwards expire beginning in 2026. In addition, the Company has U.S. research and development tax credit carryforwards of $186 million and $157 million for the years December 31, 2023 and 2022, respectively, that will expire in years 2030 through 2043. The Company has California research and development tax credits of $22 million and $17 million as of December 31, 2023 and 2022, respectively, that do not expire. In addition, the Company has nonrefundable New York Empire Zone credit carryforwards of $947 million and $1,115 million as of December 31, 2023 and 2022, respectively, that do not expire. Five other states have research and development tax credits, Texas, Minnesota, Vermont, North Carolina, and New Jersey for which the Company has calculated a total credit carryforward of $10 million and $8 million for the years December 31, 2023 and 2022, respectively. These credits have a carryforward that expire between 2030 through 2043. These carryforward attributes have not been recognized as deferred tax assets.
At December 31, 2023 and 2022, no deferred tax liabilities were recorded for taxes that would be payable on the undistributed earnings of the Company’s subsidiaries. It is the Company’s intention to indefinitely reinvest the undistributed earnings of its foreign subsidiaries except in certain limited cases, which are not expected to have a material tax effect. The cash that is permanently reinvested is typically used to expand operations.
A reconciliation of deferred taxes, net is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$266 $351 
Tax (expense) benefit recognized to consolidated statements of operations
(50)(67)
Tax (expense) benefit recognized to other comprehensive income (loss)
19 (18)
Ending balance$235 $266 
As of December 31, 2023 and 2022, the Company’s current tax receivables were $0 and $1 million, respectively, related to its subsidiaries in Europe.
As of December 31, 2023 and 2022, the Company’s current income tax payable of $19 million and $14 million is composed of $10 million, $4 million, $5 million and $2 million, $3 million, $9 million, respectively, for entities incorporated in Europe, the United States/Cayman Islands and Singapore, respectively. The current income tax payable amounts include the following uncertain tax provisions: $2 million in the United States for December 31, 2023 and $0 for December 31, 2022; $5 million and $8 million in Singapore for December 31, 2023 and 2022, respectively; $2 million and $3 million in Europe for December 31, 2023 and 2022, respectively, for exposure arising from unutilized capital allowances and domestic related party transactions. Europe had no current income taxable amounts included in uncertain tax provisions for either December 31, 2023 and 2022.
27.Earnings Per Share
F-38

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Basic and diluted earnings (loss) per share has been calculated for the years ended December 31, 2023, 2022, and 2021 as follows:
(in millions except per share amounts)
202320222021
Net income (loss) attributable to equity shareholders of the Company
$1,020 $1,448 $(250)
Weighted average ordinary shares outstanding
Basic552 539 506 
Diluted556 552 506 
Total basic and diluted earnings per share attributable to equity shareholders
Basic$1.85 $2.69 $(0.49)
Diluted$1.83 $2.62 $(0.49)
For the years ended December 31, 2023, 2022 and 2021, there were 1 million, 6 million and 22 million share options outstanding, respectively. Share options for the years ended December 31, 2023, 2022 and 2021 were not included in the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.
28.Employee Benefits Plans
Retirement Savings Plans—The Company has a retirement savings plan, commonly known as a 401(k) plan, which allows participating employees in the United States to contribute a portion of their pre-tax salary up to Internal Revenue Service limits. The Company matches employee contributions dollar for dollar for the first 3% of participants’ contributions and 50 cents on each dollar of additional 3% of participants’ contributions, to a maximum of 4.5% of eligible compensation. The Company’s contributions to the 401(k) plan were $25 million, $32 million and $31 million for the years ended December 31, 2023, 2022 and 2021, respectively.
The Company also has an employee benefits plan that requires the Company to make monthly contributions based on the statutory funding requirement into a Central Provident Fund for substantially all Singapore citizens and permanent residents. The Company’s contributions under this plan were $29 million, $31 million and $29 million for the years ended December 31, 2023, 2022 and 2021, respectively.
See Note 22 for our Employee Stock Purchase Plan.
29.Related Party Disclosures
The consolidated financial statements include the following subsidiaries which are all wholly owned, except for Advanced Mask Technology Centre GmbH & Co. KG, Maskhouse Building Administration GmbH & Co. KG, Advanced Mask Technology Center Verwaltungs GmbH, and Maskhouse Building Administration Verwaltungs GmbH:

F-39

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Subsidiary
Jurisdiction of
Incorporation or
Organization
December 31, 2023December 31, 2022December 31, 2021
GLOBALFOUNDRIES Dresden Module One LLCUnited StatesXXX
GLOBALFOUNDRIES Dresden Module Two LLCUnited StatesXXX
GLOBALFOUNDRIES Innovation LLC (formerly GLOBALFOUNDRIES Innovation Investments LLC)United StatesXXX
GLOBALFOUNDRIES Investments LLCUnited StatesXXX
GLOBALFOUNDRIES U.S. Inc.United StatesXXX
GLOBALFOUNDRIES U.S. 2 LLCUnited StatesXXX
GLOBALFOUNDRIES Borrower LLCUnited StatesXXX
Hudson Valley Research Park Sewage Works CorporationUnited StatesN/AXX
Hudson Valley Research Park Water-Works CorporationUnited StatesN/AXN/A
GF Power LLCUnited StatesXXN/A
GLOBALFOUNDRIES Finance Inc.Cayman IslandsXXN/A
GLOBALFOUNDRIES France SASFranceXXN/A
GLOBALFOUNDRIES Dresden Module One Holding GmbHGermanyXXX
GLOBALFOUNDRIES Dresden Module One LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two Holding GmbHGermanyXXX
GLOBALFOUNDRIES Management Services LLC & Co. KGGermanyXXX
Advanced Mask Technology Center GmbH & Co. KG (50%)GermanyXXX
Maskhouse Building Administration GmbH & Co. KG (50%)GermanyXXX
Advanced Mask Technology Center Verwaltungs GmbH (50%)GermanyXXX
Maskhouse Building Administration Verwaltungs GmbH (50%)GermanyXXX
GLOBALFOUNDRIES Europe Sales & Support GmbHGermanyXXX
GLOBALFOUNDRIES Engineering Private LimitedIndiaXXX
GLOBALFOUNDRIES Japan Ltd.JapanXXX
GLOBALFOUNDRIES Malaysia Sdn. Bhd.MalaysiaXXN/A
GLOBALFOUNDRIES Netherlands Cooperatief U.A.The NetherlandsXXX
GLOBALFOUNDRIES Netherlands Holding B.V.The NetherlandsXXX
GLOBALFOUNDRIES Bulgaria EADBulgariaXXX
GF Asia Investments Pte. Ltd.SingaporeXXX
GF Asia Sales Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Singapore Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Taiwan Ltd.TaiwanXXX
GLOBALFOUNDRIES Europe Ltd.United KingdomXXX
GA (Chengdu) Technology Co., Limited ChinaXXX
GLOBALFOUNDRIES China (Beijing) Co., LimitedChinaXXX
GLOBALFOUNDRIES China (Shanghai) Co., LimitedChinaXXX
Nanjing APD Technologies Co. Ltd.ChinaN/AN/AX
Related parties represent associated companies, the shareholder, directors and key management personnel of the Company and entities controlled, or significantly influenced by such parties. Pricing policies and terms of these transactions are approved by the Audit Committee or the Company’s management, as applicable.
F-40

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Below are the related parties which the Company has entered into transactions with:
December 31,
2023
December 31,
2022
Related Party Name
SMPJoint ventureJoint venture
Mubadala Investment Company PJSC
Shareholder entityShareholder entity
Mubadala Technology Investment Company
Shareholder entityShareholder entity
MDC General Services Holding Company L.L.C
Shareholder entityShareholder entity
Balances with related parties included in the consolidated statements of financial positions are as follows:
December 31, 2023December 31, 2022
(in millions)Due from
Related
Parties
Due to
Related
Parties
Due from
Related
Parties
Due to
Related
Parties
SMP$12 $10 $11 $10 
Total(1)
$12 $10 $11 $10 
(1)The total amounts of $12 million and $11 million due from related parties as of the years ended December 31, 2023 and 2022, respectively, have been included in receivables, prepayments and other assets (see Note 6). The total amounts of $10 million and $10 million due to related parties’ balance for the years ended December 31, 2023 and 2022, respectively, have been included in trade and other payables (see Note 11).
The following table presents the related party transactions included in the consolidated statements of operations:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Purchases and recharges from:
SMP(1)
$61 $60 $60 
Total
$61 $60 $60 
Other transactions with:
SMP (reimbursement of expenses and contribution of tools)$61 $52 $45 
MDC General Services Holding Company L.L.C (recharge of expenses)
5  3 
Total$66 $52 $48 
(1)Purchases from SMP were primarily comprised of wafers.
Terms and Conditions of Transactions with Related Parties
Outstanding balances at the year-end are unsecured, interest free, repayable on demand and settlement occurs in cash. The Company has not recorded any allowance relating to amounts owed by related parties for the years ended December 31, 2023 and 2022. This assessment is undertaken each financial year through examining the financial position of the related party and the market in which the related party operates.
Transactions with Shareholder:
Shareholder Loan Agreement—The Company, as a borrower, entered into loan facilities with its shareholder in 2012 to 2016 (collectively the “Shareholder Loans”). The Shareholder Loans were non-interest bearing and principal repayment, in whole or in part, was entirely at the Company’s discretion as explicitly stated in the loan agreement. The Shareholder Loans were subordinated to any claims of other unsubordinated and subordinated creditors, including beneficiaries under guarantees issued, of the Company. The loans had no maturity date and remained outstanding until the loans were paid in full. Further, there were no contingent settlements in the agreements. Since the Shareholder Loans did not contain any contractual obligations to deliver cash, but rather allowed the Company to make repayment at its absolute discretion and further prohibited the shareholder from demanding repayment, the Company treated the Shareholder Loans as equity.
The Company repaid $568 million during the year ended December 31, 2021.
On October 1, 2021, the Company’s board approved the conversion of the Shareholder Loans to additional paid-in-capital, and on October 3, 2021, the Company executed an agreement with Mubadala Investment Company PJSC (“Mubadala”) to convert the remaining $10.1 billion of the Shareholder Loan balance into additional paid-in-capital (the ”Conversion”). The Conversion did not have an impact on shares outstanding or have any dilutive effects, as no additional shares were issued.
F-41

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Compensation of Key Management Personnel
The compensation of key management personnel during the following years were as follows:
(in millions)202320222021
Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer
     Short-term benefits(1)
$9 $5 $8 
     Share-based payments(1)
21 19 42 
Board of Directors3 5 3 
Total
$33 $29 $53 
(1) For the year ended December 31, 2023, the amounts include short-term benefits and share-based payments for the Chief Business Officer and Chief Operating Officer.
30.Financial Risk Management Objectives and Policies
GLOBALFOUNDRIES has implemented a cash investment policy which determines the overall objectives of the Company’s investment strategy. This policy is aimed to ensure the preservation of capital and the maintenance of sufficient liquidity necessary to fund operations while balancing the needs for appropriate returns. The cash investment policy limits permissible investments and credit quality.
The primary objective of the Company’s capital management is to ensure that it maintains a healthy capital ratio in order to support its business and maximize shareholder value.
The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions. There are no regulatorily-imposed requirements on the level of share capital which the Company is required to maintain.
The Company monitors capital using a gearing ratio, which is net debt divided by total capital plus net debt. The Company’s policy is to keep the gearing ratio within a range to meet the business needs of the Company.
The Company includes within net debt, interest bearing loans and borrowings and obligations under lease less bank balances, cash and marketable securities. Capital includes total equity including non-controlling interests less cumulative changes in fair value.
The Company’s interest-bearing loans and borrowings have certain financial covenants. Restrictive covenants in the Company’s credit facilities may prevent the Company from pursuing certain transactions or business strategies, including by limiting the Company’s ability to, in certain circumstances:
incur additional indebtedness;
pay dividends or make distributions;
acquire assets or make investments outside of the ordinary course of business;
sell, lease, license, transfer or otherwise dispose of assets;
enter into transactions with the affiliates;
create or permit liens;
guarantee indebtedness; and
engage in certain extraordinary transactions.
As of December 31, 2023, the Company is in compliance with the financial covenants.
Risks Arising from Financial Instruments—The main risks arising from the Company’s financial instruments are market risk (including foreign currency risk, interest rate risk and commodity price risk), credit risk and liquidity risk. The Board of Directors reviews and approves policies for managing each of these risks which are summarized below.
Market Risk—Market price risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market prices comprise the following types of risk: interest rate risk, foreign currency risk and commodity price risk.
Commodity Risk— Although the Company operates facilities that consume commodities, the Company’s exposure to commodity price risk is not material. The Company has established forecasted transaction risk management programs to protect against fluctuations in commodity prices and may use commodity derivatives contracts, such as commodity swaps, in these hedging programs. In addition, the Company has sourcing plans in place that are designed to mitigate the risk of a potential supplier concentration for its key commodities.
Interest Rate Risk—The Company’s exposure to market risk for changes in interest rates relates primarily to interest-earning financial assets and interest-bearing financial liabilities. The Company’s interest-earning financial assets are mostly
F-42

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
highly liquid investments and include money market funds, marketable securities and time deposits. As these financial assets have weighted-average maturity of less than one year, the Company’s exposure to interest risk is not material. The Company’s interest-bearing financial liabilities include fixed and floating rate loans and lease obligations. Floating rate loans bear interest at Base Rate or SOFR or EURIBOR plus a fixed premium. The Company uses pay-fixed / receive-float interest rate swaps to protect itself against adverse fluctuations in interest rates and to reduce its exposure to variability in cash flows from forecasted interest payments on its floating-rate debt facility to the extent that it is practicable and cost effective to do so.
Cash Flow Sensitivity Analysis for Variable Rate InstrumentsThe sensitivity of net income in the consolidated statements of operations is the effect of the assumed changes in interest rates on the Company’s net income for one year, based on the floating rate financial liabilities held on December 31, 2023, after taking into account interest rate hedges.
A hypothetical change in benchmark interest rates of 10% from current rates would not have a material impact on the consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021, after taking into account interest rate hedges.
Foreign Currency RiskAs a result of foreign operations, the Company has non-US-dollar denominated costs, assets and liabilities, primarily denominated in the EUR, JPY and SGD. Movements in foreign exchange rates could cause foreign currency denominated expenses to increase as a percentage of net revenue, affecting the Company’s profitability and cash flows. The Company uses foreign currency forward contracts to reduce exposure to foreign currency fluctuations from its foreign currency denominated expenditures. The Company may also economically hedge foreign currency risk related to its non-US-dollar denominated assets and liabilities with currency forward contracts.
The Company also incurs a certain portion of its interest expense in EUR and SGD, exposing the Company to exchange rate fluctuations between US dollar and the EUR or SGD. The Company uses cross-currency swaps and cross-currency interest rate swaps to reduce its exposure to variability from foreign exchange rates impacting cash flows arising from Company’s foreign currency denominated debt to the extent that it is practicable and cost effective to do so.
Exposure to Currency RiskThe Company’s exposure to foreign currency risk against financial assets and financial liabilities was as follows, based on notional amounts:
(in millions)
EUR
JPY
SGD
December 31, 2022
Receivables and prepayments
$120 $ $16 
Cash and cash equivalents
48 4 420 
Loans and borrowings
45   
Trade and other payables
(388)(73)(149)
$(175)$(69)$287 
December 31, 2023
Receivables and prepayments
$86 $ $28 
Cash and cash equivalents
$104 $5 $19 
Loans and borrowings
$11 $ $ 
Trade and other payables
$(253)$(97)$(121)
$(52)$(92)$(74)
A hypothetical 10% change in the relative value of the U.S. dollar to other currencies would not have a material impact on the consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021, after taking into account foreign currency hedges
Credit Risk—Credit risk can be defined as the risk of suffering financial loss from financial instruments due to the failure by a counterparty to fulfill an obligation. Financial instruments that subject the Company to concentrations of credit risk include investments and cash equivalents, accounts receivable and derivatives. The Company generally places investments with high-credit-quality counterparties and, by policy, limits the amount of credit exposure to any one counterparty based on an analysis of that counterparty's relative credit standing. As required per the investment policy, substantially all of the Company’s investments in debt instruments are in investment-grade instruments. Counterparty credit-rating criteria for derivatives are similar to those for other investments.
The Company generally does not require collateral to secure accounts receivable. Credit risk with respect to trade receivables is mitigated by credit evaluations the Company performs on its customers, the short duration of payment terms for the significant majority of its customer contracts and by the diverse nature of the Company’s customer base. The expected credit losses of trade and other receivables are not significant.
The Company’s ten largest customers account for approximately 79% and 74% of the outstanding trade receivables balance as of December 31, 2023 and 2022, respectively. The Company considers the concentration of credit risk for the remaining accounts receivable not material.
F-42

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
Exposure to Credit Risk—The carrying amount of financial assets represents the assets’ maximum credit exposure.
The aging of financial assets including trade receivables is as follows:
Past Due but Not Impaired
(in millions)TotalNeither past
Due Nor
Impaired
< 30 Days31-90 Days91-120 DaysGreat
than
120 days
December 31, 2022$2,254 $2,137 $84 $33 $ $ 
December 31, 2023$2,785 $2,651 $127 $7 $ $ 
Liquidity RiskThe Company monitors its risk of a shortage of funds by monitoring its cash flow situation. Ongoing cash forecasting and review processes have been set up to determine the amount of internal and external funding needed in order to meet the Company’s financial obligations as they become due. The Company has set up a process of mid- and long-term financial planning. The Company’s financing structure, including maturities of debt, is determined in response to the financing requirements identified with the long-term business planning process.
The table below summarizes the maturity profile of the Company’s financial liabilities:
(in millions)Carrying
Value
Contractual
Cash Flows
1 Year or
Less
1 to 5 Years
Greater
than
5 Years
December 31, 2022
Loans and borrowings$2,511 $2,706 $229 $1,443 $1,034 
Lease obligations345 427 92 184 151 
Derivative liabilities
66 66 61 5  
Trade payables and other liabilities2,265 2,265 2,171 63 31 
Total$5,187 $5,464 $2,553 $1,695 $1,216 
December 31, 2023
Loans and borrowings$2,372 $2,558 $575 $971 $1,012 
Lease obligations382 521 44 194 283 
Derivative liabilities
56 56 42 14  
Trade payables and other liabilities1,438 1,438 1,354 55 29 
Total$4,248 $4,573 $2,015 $1,234 $1,324 
In preparing the maturity profile, undiscounted interest payments are calculated based on contractual interest rates where these are fixed, or, in the case of discounted liabilities for leases, based on the interest rate implicit in the financing arrangement. For variable interest arrangements undiscounted payments are determined based on the interest rate prevailing at the reporting date.
Assets and Liabilities Measured at Fair Value—The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:
Level 1—observable inputs such as quoted prices in active markets for identical assets or liabilities
Level 2—inputs other than quoted prices in active markets in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar assets or liabilities that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability; and
Level 3—unobservable inputs for which little or no market data exists, therefore requiring management judgment to develop the Company’s own models with estimates and assumptions.
Cash Equivalents - Cash equivalents include investments in government obligation-based money market funds, other money market instruments and interest-bearing deposits with initial or remaining terms of three months or less. The fair value of cash equivalents approximates its carrying value due to the short-term nature of these instruments.
Marketable Securities - Marketable securities utilizing Level 1 and Level 2 inputs include U.S. Treasury Securities, U.S. Government Sponsored Enterprises, floating rate securities, money market mutual funds, corporate debt instruments and other Notes, bonds or debt securities issued by non-U.S. sovereign or multilateral entities, as these securities all have quoted prices in active markets.
For assets and liabilities that are recognized at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period. Foreign currency forward contracts are classified within Level 2. The fair values of foreign currency forward contracts are determined using quantitative models that require the use of multiple market inputs, including interest rates, prices and maturity dates to generate pricing curves,
F-43

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
which are used to value the positions. The market inputs are generally actively quoted and can be validated through external sources. For foreign currency forward contract asset and liability positions with maturity dates which fall between the dates of quoted prices, interpolation of rate or maturity scenarios are used in determining fair values. During the years ended December 31, 2023 and 2022, there were no transfers between Level 1, 2 and Level 3 fair value measurements.
Financial Instruments Measured at Fair Value on a Recurring Basis
The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis:
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2022
Assets:
Cash equivalents(1)
$961 $961 $ $ 
Investments in equity instruments(2)
$15 $ $ $15 
Investment in marketable securities(3)
$994 $994 $ $ 
Derivatives(3)
$177 $ $177 $ 
Liabilities:
Derivatives(3)
$66 $ $66 $ 
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2023
Assets:
Cash equivalents (1)
$1,897 $1,626 $271 $ 
Investments in equity instruments (2)
$19 $ $ $19 
Investments in marketable securities(3)
$1,501 $1,189 $312 $ 
Derivatives(4)
$132 $ $132 $ 
Liabilities:
Derivatives(4)
$56 $ $56 $ 
(1)Included in cash and cash equivalents on the Company’s consolidated statements of financial position.
(2)Included in current and non-current receivables, prepayments and other assets on the Company’s consolidated statements of financial position.
(3)Included in current and non-current marketable securities on the Company’s consolidated statements of financial position.
F-44

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
(4)Consists of foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps. Included in other current and non-current financial assets and liabilities, as applicable, on the Company’s consolidated statements of financial position.
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
Certain assets such as equity method investments, intangible assets and property, plant and equipment, and other non-financial assets, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities (that have not been re-measured or impaired in the current period), grants receivable, loans receivable, lease obligations and the current and non-current portions of the Company’s long-term debt.
The following table shows the carrying and fair values of the Company’s financial liabilities at amortized cost (“FLAC”) not recorded at fair value on a recurring basis. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.
(in millions)December 31, 2023December 31, 2022
Financial Liability
Category
Carrying
Amount
Fair ValueCarrying
Amount
Fair Value
Other long-term debtFLAC$2,372 $2,319 $2,511 $2,414 
Total$2,372 $2,319 $2,511 $2,414 
Estimated fair values of loans and borrowings is based on quoted prices for similar liabilities for which significant inputs are observable and represents a Level 2 valuation. The fair values are estimated based on the type of loan and maturity. The Company estimates the fair value using market interest rates for the Company’s debts with similar maturities.
31.Commitments and Contingencies
CommitmentsThe Company’s unconditional purchase commitments are as follows:
(in millions)December 31,
2023
December 31,
2022
Contracts for capital expenditures$1,136 $2,774 
Contracts for operating expenditures2,786 3,587 
Total
$3,922 $6,361 
Due within the next 12 months
$970 $2,732 
In addition to the above, the Company obtained letters of credit to primarily guarantee payments for utility supplies and foreign statutory payroll related charges. The Company has obtained letters of credit of $23 million and $20 million at December 31, 2023 and 2022, respectively, and bank guarantees of $54 million and $4 million at December 31, 2023 and 2022, respectively.
The Company has a patent license agreement with LSI Technology Corporation (“LSI”) under which the parties grant to one another a license to use certain of each other’s patents. Under the terms of the patent license agreement, the Company may provide wafer capacity in lieu of payment for royalties. Such royalties under the patent license agreement are waived until such time the interest of LSI in SMP falls below 49%. In exchange, the Company has waived capacity shortfall obligations from LSI. Should the interest of LSI in SMP fall below 49%, the Company may be required to make royalty payments to LSI under this patent license agreement. The Company has not made any royalty payments to LSI. The patent license agreement continues for as long as the joint venture agreement between the parties remains.
On April 28, 2021, IBM sent the Company a letter alleging for the first time that it did not fulfill its obligations under the contracts entered into with IBM in 2014 and 2015 associated with the acquisition of IBM’s Microelectronics division. IBM asserted that the Company engaged in fraudulent misrepresentations during the underlying negotiations, and claimed the Company owed them $2.5 billion in damages and restitution. On June 7, 2021, the Company filed a complaint with the New York State Supreme Court (the “Court”) seeking a declaratory judgment that the Company did not breach the relevant contracts. IBM subsequently filed its complaint with the Court on June 8, 2021. On September 14, 2021, the Court granted the Company’s motion to dismiss IBM’s claims of fraud, unjust enrichment and breach of the implied covenant of good faith and fair dealing. IBM appealed the dismissal of its fraud claim, and on April 7, 2022, the New York Appellate Division reversed the Court’s decision. Discovery and dispositive motion practice have been completed and the parties are awaiting a trial date. The Company believes, based on discussions with legal counsel, that it has meritorious defenses against IBM’s claims and intends to vigorously defend against them.
32.Operating Segments Information
F-45

GLOBALFOUNDRIES INC.
Notes to the Consolidated Financial Statements
(a)Operating segments, segment revenue, operating results
The Company’s chief operating decision-maker is the Company’s Chief Executive Officer who makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis. There are no segment managers who are held accountable by the chief operating decision-maker, or anyone else, for operations, operating results, and planning for levels or components below the consolidated unit level. Accordingly, the Company has determined that the Company has a single reportable segment and operating segment structure.
(b)Revenue based on customers’ headquarters and non-current assets by geography were as follows:
For the year ended December 31,
Revenue by Geography202320222021
(in millions)
United States$4,262 $4,898 $3,975 
Europe, the Middle East, and Africa1,533 1,182 805 
Other1,597 2,028 1,805 
Total
$7,392 $8,108 $6,585 
Non-current Assets by Geography20232022
(in millions)
United States$4,738 $5,149 
Germany2,400 2,462 
Singapore3,801 3,508 
Other457 532 
Total$11,396 $11,651 
Non-current assets include property, plant, equipment, right-of-use assets, intangible assets, investments in joint venture and associates, restricted cash (non-current) and receivables, prepayments and other assets (non-current).

33.Customer And Supplier Concentration
Significant customers and suppliers are those that account for greater than 10% of the Company’s revenue and purchases in any of the years presented.
The Company earned a substantial portion of revenue from two customers in 2023 , 2022 and 2021: Customer A amounted to 8%, 9% and 12% of total revenue, respectively, and Customer B amounted to 17%, 16%, and 15% of total revenue, respectively. As of December 31, 2023 and 2022, the amounts due from Customer A included in accounts receivable were $122 million and $71 million, respectively, and the amounts due from Customer B included in accounts receivable were $237 million and $163 million, respectively. The loss of the significant customers or the failure to attract new customers could have a material adverse effect on the Company’s business, results of operations and financial condition.
For the year ended December 31,
Revenue by major customer
202320222021
(in millions)Amount%Amount%Amount%
Customer A$620 8$746 9$811 12
Customer B$1,279 17$1,329 16$995 15
The Company purchased 63%, 54% and 46%, of its SOI wafers, a key input into its products, from a single supplier in 2023, 2022 and 2021, respectively. As of December 31, 2023 and 2022, the net amount due to the supplier was $61 million and $56 million, respectively. Any failure in the supplier’s ability to provide SOI wafers could materially and adversely affect the Company’s results of operations, financial condition, business and prospects.

F-46


ITEM 19.    EXHIBITS
Documents filed as exhibits to this Form 20-F:
1.1

2.1
2.2
2.3

4.1
4.2
4.3
4.4
4.5
4.6
4.7†
4.8†
4.9†
4.10†

4.11†

4.12*†
4.13
4.14

47


4.15
4.16

4.17*
4.18
4.19*
8*
12.1*
12.2*
13.1*
15.1*
15.2*
97*
101.INS*Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*    Filed herewith.
Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks [***] as the identified confidential information is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

48


SIGNATURE
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.
GLOBALFOUNDRIES Inc.
Date: April 29, 2024
By:
/s/ John Hollister
Name:
John Hollister
Title:
Chief Financial Officer

49
EX-4.12 2 exhibit412-redactedgfxsoit.htm EX-4.12 Document
Exhibit 4.12
CONFIDENTIAL
            

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Addendum for 300mm RFSOI, PDSOI, Silicon Photonics, and FD Products
to Materials Supply Agreement, dated April 25, 2017

This Addendum for 300mm RFSOI, PDSOI, Silicon Photonics and FD Products to GLOBALFOUNDRIES’ contract number 00037735.0 (the “2023-2024 Mixed Product Addendum”) to the Materials Supply Agreement, dated April 25, 2017, GLOBALFOUNDRIES contract number 00037735.0, and as amended (the “Agreement”) is effective as of the date of last signature (the “Commencement Date”) by and between GLOBALFOUNDRIES U.S. Inc., a corporation organized under the laws of the State of Delaware, with its principal place of business at 400 Stonebreak Road Extension, Malta, NY 12020, USA (“GF”) and SOITEC S.A., a Societe Anonyme organized under the laws of France with its principal office at Parc Technologique des Fontaines, Bernin 38926 Crolles Cedex (the “Supplier”). Both GF and Supplier are referenced herein as a Party or the Parties, as the case may be.

WHEREAS, the Parties have entered into the 2023 Addendum for FDSOI Products to Materials Supply Agreement, dated April 25, 2017, on November 28, 2022 (the “2023 FD Addendum”), with a termination date of [***] (the “FD Term”)

WHEREAS, the Parties have entered into the Addendum for 300mm RSOI, PDSOI & Silicon Photonics Products to Materials Supply Agreement, dated April 1, 2017, on [***] (the “2021 Addendum”), with a termination date of December 31, 2023 (the “2021 Addendum Term”)

WHEREAS, the Parties acknowledge that they wish to enter into a purchase and supply arrangement for 300mm RFSOI, PDSOI, and Silicon Photonics products (together referred to as the “300mm Products”,) and FD products (the “FD Product”)as itemized in Table 1, below, and based upon agreed upon applicable Product Specifications (as defined below), for the volumes and prices, set forth herein, during the Term (as defined below) of this 2023-2024 Mixed Product Addendum;

WHEREAS, GF and GF’s Affiliates (together, the “GF Parties”, or if only one, the “GF Party”) wish to purchase the 300mm Products and the FD Product (collectively referred to as the “Products”) from Supplier, and Supplier wishes to sell the Products to GF based upon the terms and provisions set forth in the Agreement and this 2023-2024 Mixed Product Addendum;

WHEREAS, as set forth in this 2023-2024 Mixed Product Addendum, Supplier’s Affiliate, Soitec Microelectronics Singapore Pte. Ltd, located at 81 Pasir Ris Industrial Drive 1, Singapore 518220 (“Supplier Singapore”, and together Supplier and Supplier Singapore are referred to as the “Supplier Group”), will participate in the supply of Products to GF Parties, as more specifically set forth, below.

NOW THEREFORE, in consideration of the mutual covenants, rights and obligations set forth herein and, in the Agreement, the receipt and sufficiency of which each Party hereby
1


Exhibit 4.12
CONFIDENTIAL
            
acknowledges, the Parties intending to be legally bound, and the Parties hereby agree as follows:





1. Introduction:

a.All capitalized terms in this 2023-2024 Mixed Product Addendum shall have the same meaning as set forth in the Agreement, unless otherwise defined in this 2023-2024 Mixed Product Addendum.

b.Where the context so admits or requires, references to the plural in any defined term herein shall include the singular and vice versa.

c.For the avoidance of doubt, the Parties agree that this 2023-2024 Mixed Product Addendum is hereby incorporated into the Agreement. Subject to Section 1(a) of the Agreement, in the event of any conflict between the terms of this 2023-2024 Mixed Product Addendum and the Agreement, terms of this 20223-2024 Mixed Product Addendum shall control. For the avoidance of doubt, to the extent this 2023-2024 Mixed Product Addendum remains silent on a topic or matter, then the Agreement shall apply.

d.The GF Parties and Supplier Group have entered into various product purchase addenda [***] (collectively referred to as the “Product Purchase Addenda”). Such Product Purchase Addenda [***] set forth in this 2023-2024 Mixed Product Addendum; and in the event of any conflict between the terms of this 2023-2024 Mixed Product Addendum and such Product Purchase Addenda, the terms of this 2023-2024 Mixed Product Addendum shall control.
e.[***], this 2023-2024 Mixed Product Addendum [***] 2021 Addendum or the 2023 FD Addendum; and such 2021 Addendum and 2023 FD Addendum remain in effect until [***]. This 2023-2024 Mixed Product Addendum shall apply to the [***] Volumes (defined below) ordered by GF Parties ,to be delivered by Supplier, pursuant to [***] after the Commencement Date.

2. Term and Termination of the 2023-2024 Mixed Product Addendum:

This 2023-2024 Mixed Product Addendum shall commence on the Commencement Date and shall remain in effect [***] (the “Term”), unless otherwise terminated as set forth in the Agreement.

3. Products and Product Specifications:

a.The Product(s) to be purchased by GF Parties and sold by the Supplier Group, pursuant to this 2023-2024 Mixed Product , are listed in Table 1, below; and the term “Product(s)
2


Exhibit 4.12
CONFIDENTIAL
            
used in this 2023-2024 Mixed Product Addendum shall mean the product items listed in Table 1.
b.The applicable Products specification(s) for each of the Products is identified in Exhibit A, by a Product specification number (each a “Product Specification”); and each such Product Specification correlates to a corresponding GF part number, as itemized in Table 1, below.


Table 1- Products for 2023-2024 Mixed Product Addendum
300mm Products ProgramProducts (GF PN)
[***][***][***]
[***][***]
[***][***]
[***][***]
[***][***]
[***][***][***]
[***][***]
[***][***][***]
FD ProductsProgramProducts (GF PN)
[***][***][***]
[***][***]

c.[***] for the Products purchased and delivered to GF and applicable GF Parties pursuant to this 2023-2024 Mixed Product Addendum [***].

4.Pricing, Volumes, Purchase Orders, and [***] Volumes:

a.The price for each Product is set forth in Table 2, below (each a “Price”).

Table–2 - Product Price per wafer (US $) & [***] Volumes for Products
300mm Products ProductPrice/wafer [***] Volumes
[***][***][***][***]
[***][***][***]
[***][***][***]
[***][***][***]
[***][***][***]
[***][***][***][***]
[***][***][***]
[***][***][***][***]
3


Exhibit 4.12
CONFIDENTIAL
            
FD ProductsProductPrice/wafer
[***] Volumes
[***]
[***]
[***]
[***]

[***]
b. GF and each applicable GF Party shall order from Supplier Group the volumes of each Product specified in Table 2 (above), for the [***]) (the “[***]Volumes”); for delivery and purchase from Suppler from the Commencement Date through [***], as more fully described in [***] and GF and each applicable GF Party [***] Volumes, at the Price(s) set forth in Table 2 (above), within [***] of the Commencement Date. For the avoidance of doubt, the [***] issued by GF’s Affiliates shall be subject to the terms of the Agreement and this 2023-2024 Mixed Product Addendum.

c.The [***] for the FD Products, [***], is as set forth in Table 3, below (the “[***]”).

Table 3 [***] for FD [***] Volumes
GF Part No. for
FD Product
[***]
Percentage of [***] Volume of FD Product
[***]
[***][***]
[***][***][***]
d.Within [***] of receipt of the [***], Supplier and/or Supplier Singapore, as applicable, will [***], and the relevant [***] for Products delivered [***] collectively referred to as the [***]. [***] shall be followed for each [***] and the Parties further agree that the volume of Products ordered by the GF Parties, [***] and applicable [***] (x) are [***] and (y) Supplier shall deliver [***] to the corresponding [***] in the [***] in the [***].
e.[***] in the Agreement [***], the Parties agree that [***] to this 2023-2024 Mixed Product Addendum.

f.The Parties agree that [***] for Products purchased under this 2023-2024 Mixed Product Addendum; in all other respects, [***] to the correlating Products purchased and supplied hereunder:

i.For the Product Purchase Addendum between GLOBALFOUNDRIES Dresden Module One LLC & Co. KG and Soitec S.A., with a Commencement Date [***] (the “GF Dresden PPA”), the following provisions [***]: Sections [***].

ii.For the Product Purchase Addendum between GLOBALFOUNDRIES Singapore Pte. Ltd (“GF Singapore”) and Soitec Microelectronics Singapore Pte. Ltd, with [***] (the “SG PPA”): (x) [***], this 2023-2024 Mixed Product Addendum shall also be deemed to be referenced and [***]; and (y) the following provisions [***]: Sections [***] and the [***] Section [***].

iii.For the Product Purchase Addendum between GLOBALFOUNDRIES US Inc. and Soitec S.A., with [***] (the “US PPA”), the following provisions [***]: Sections [***]
4


Exhibit 4.12
CONFIDENTIAL
            
g.With reference to the [***]” provisions that are provided for in [***] for purposes of [***] the following “[***]” provision shall [***] such Product Purchase Addendum:

“If the applicable GF Parties do not [***] Product(s) [***] after such Products were [***], the [***] for such Products [***] to be the [***] and [***] the Products will [***] the applicable GF Parties [***] (the “[***]”). The applicable GF Parties will then [***] terms for [***], which have [***].”

5.[***]: In the event the GF Parties [***] of (by [***] set forth in Section [***]) and [***] for all the [***] Volumes, then Supplier will [***]”) upon such [***]. Such [***] will be [***] for [***] to Supplier.
    
        [the balance of the page intentionally left blank]

5


Exhibit 4.12
CONFIDENTIAL
            
IN WITNESS WHEREOF, the Parties hereto have executed this 2023-2024 Mixed Product Addendum to the Materials Supply Agreement, effective as of the Commencement Date.




GLOBALFOUNDRIES U.S. Inc.                SOITEC S.A.
“GF”                                “Supplier”


/s/ Roger Kao/s/ Peirre Barnabe
Authorized Signature Authorized Signature
Roger KaoPeirre Barnabe
Print NamePrint Name
VP ProcurementCEO
TitleTitle


GlobalFoundries Dresden Module One LLC & Co KG
GF Dresden


__/s/ Yvonne Keil____________________________
Authorized Signature & Company Seal (if applicable)


__Yvonne Keil______________________________
Print Name


_Sr. Director Procurement_____________________
Title


__________________________________________
Date

6


Exhibit 4.12
CONFIDENTIAL
            
EXHIBIT A
Product Specifications


TechnologyProgramProducts ( GF PN)Specs*
[***][***][***][***] 
[***][***] 
[***][***] 
[***][***][***] 
[***][***]
[***][***][***] 
[***][***][***]
[***][***][***] 
[***] 
[***][***][***][***] 
[***][***] 
[***][***][***] 
[***][***][***][***] 
[***][***][***] 
[***][***][***][***] 

7

EX-4.17 3 exhibit417-2023amendmentag.htm EX-4.17 Document
Exhibit 4.17
EXECUTION VERSION

Date 28 June 2023

GLOBALFOUNDRIES INC.
as the Company

- and -

CITIBANK EUROPE PLC, UK BRANCH
as Facility Agent
___________________________________________
AMENDMENT AGREEMENT
relating to the Revolving and L/C Facilities Agreement originally dated 18 October 2019

___________________________________________







CONTENTS


    


THIS AMENDMENT AGREEMENT is made on 28 June 2023
BETWEEN:
(1)    GLOBALFOUNDRIES INC., an exempted company incorporated in the Cayman Islands with its registered office at Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands on behalf of itself and as Obligors' Agent (as defined in the Original Facilities Agreement (as defined below)) (the "Company"); and
(2)    CITIBANK EUROPE PLC, UK BRANCH as facility agent of the other Finance Parties (as defined in the Original Facilities Agreement (as defined below)) (the "Facility Agent").
WHEREAS:
(A)The Company and the Facility Agent (among others) entered into a revolving and L/C credit facilities agreement dated 18 October 2019 pursuant to which the lenders thereunder made available to the Original Borrowers a Revolving Facility in an original aggregate amount of $235,000,000 and a L/C Facility in an original aggregate amount of $20,000,000 (each as defined therein) (as amended, amended and restated and/or supplemented from time to time prior to the date hereof, the "Original Facilities Agreement").
(B)The Facility Agent, for itself and on behalf of the Lenders under the Original Facilities Agreement and the Company, for itself and on behalf of the other Obligors pursuant to Clause 2.4 (Obligors' Agent) of the Original Facilities Agreement have agreed to enter into this Amendment Agreement in order to amend the terms of the Original Facilities Agreement in the manner set out below.
NOW IT IS HEREBY AGREED:
1.DEFINITIONS AND INTERPRETATION
1.1Definitions
In this Amendment Agreement:
"Amended Facilities Agreement" means the Original Facilities Agreement, as amended by this Amendment Agreement; and
"Effective Date" means the date of this Amendment Agreement.
1.2Incorporation of defined terms
(a)Unless a contrary indication appears, a term defined in the Original Facilities Agreement has the same meaning when used herein.
(b)The principles of construction set out in clause 1 (Definitions and Interpretation) of the Original Facilities Agreement shall also apply in the interpretation hereof as if expressly set out herein with each reference to the "Agreement" being deemed to be a reference to this Amendment Agreement.
1.3Clauses
    1


In this Amendment Agreement, any reference to a "Clause" or a "Schedule" is, unless the context otherwise requires, a clause of or a schedule to this Amendment Agreement.
1.4Third party rights
Unless expressly provided to the contrary in this Amendment Agreement, a person who is not a party to this Amendment Agreement has no right under the Contracts (Rights of Third Parties) Act 1999 to enforce or to enjoy the benefit of any term of this Amendment Agreement.
1.5Designation
In accordance with the Original Facilities Agreement, each of the Company and the Facility Agent designate this Amendment Agreement as a Finance Document.
2.REPRESENTATIONS
The Company makes the Repeating Representations (for itself and, if applicable, on behalf of each Obligor) on the date of this Amendment Agreement as if references to the Original Facilities Agreement were references to the Amended Facilities Agreement and with reference to the facts and circumstances then existing.
3.AMENDMENTS TO ORIGINAL FACILITIES AGREEMENT
3.1Subject to Clause 3.2 below, with effect from the date of this Amendment Agreement, the Original Facilities Agreement shall be amended as set out in Schedule 1 (Amendments to Original Facilities Agreement).
3.2If the Effective Date falls before the last day of an Interest Period for any outstanding Loan in USD, that Loan shall remain outstanding with interest calculated by reference to LIBOR (as defined in the Original Facilities Agreement) until the end of that Interest Period and on and from the first day of the next Interest Period (if any) such Loan shall constitute a Term Rate Loan and interest shall accrue on that Loan as set out in Clause 14.1 (Calculation of interest) of the Amended Facilities Agreement.
3.3Except as amended by the terms of this Amendment Agreement, the Original Facilities Agreement and the other Finance Documents will remain in full force and effect and, as from the date of this Amendment Agreement, references in the Original Facilities Agreement or any other Finance Document to the Original Facilities Agreement or to any provision of the Original Facilities Agreement shall be construed as a reference to the Original Facilities Agreement, as amended by this Amendment Agreement, or that provision, as amended by this Amendment Agreement.
4.FACILITY AGENT
The Facility Agent has been authorised to enter into this Amendment Agreement by the Majority Lenders in accordance with Clause 42.5 (Replacement of Screen Rate) of the Original Facilities Agreement.
5.MISCELLANEOUS
Clauses 38 (Notices), 40 (Partial Invalidity), 46 (Counterparts) and 50 (Enforcement) of the Original Facilities Agreement shall be deemed incorporated in this Amendment Agreement (with such
    2


conforming amendments as the context requires) as if set out herein with each reference to the "Agreement" being deemed to be a reference to this Amendment Agreement.
6.GOVERNING LAW
This Amendment Agreement and any non-contractual obligations arising out of or in connection with it are governed by English law.
This Amendment Agreement has been executed by the duly authorised representatives of the parties hereto and is entered into on the date specified above.
    3


SCHEDULE 1
AMENDMENTS TO ORIGINAL FACILITIES AGREEMENT
(a)The following provisions shall be deleted in their entirety from the Original Facilities Agreement:
(i)the following defined terms from Clause 1.1 (Definitions):
(A)"Business Day";
(B)"EURIBOR";
(C)"Funding Rate";
(D)"Historic Screen Rate";
(E)"Interpolated Historic Screen Rate";
(F)"Interpolated Screen Rate";
(G)"LIBOR";
(H)"Quotation Day";
(I)"Reference Bank Rate";
(J)"Relevant Market";
(K)"Screen Rate";
(L)"TARGET2"; and
(M)"TARGET Day";
(ii)Clause 4.3 (Conditions relating to Optional Currencies);
(iii)Clause 14.1 (Calculation of Interest);
(iv)Clause 16 (Changes to the Calculation of Interest);
(v)Clause 42.5 (Replacement of Screen Rate); and
(vi)Schedule 4, Part 1 (Loans).
(b)The provisions set out in Schedule 2 (Interest Rate Setting Amendments) shall be incorporated into the Original Facilities Agreement.
(c)The references to Clause 42.5 (Replacement of Screen Rate) in Clauses 42.2 (All Lender matters) and 42.3 (Super Majority matters) of the Original Facilities Agreement shall be deemed to be references to Clause 42.5 (Replacement of Primary Term Rate).

    4


SCHEDULE 2
INTEREST RATE SETTING AMENDMENTS
I.The following definitions shall be added to Clause 1.1 (Definitions) in the appropriate alphabetical order:
""Additional Business Day" means any day other than:
(a)a Saturday or a Sunday; and
(b)a day on which the Securities Industry and Financial Markets Association (or any successor organisation) recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in US Government securities.
"Business Day" means:
(a)for the purposes of determining the Term Reference Rate applicable to Loans in Euro, a TARGET Day;
(b)for the purposes of fixing an interest rate in relation to a Term Rate Loan in Dollars, an Additional Business Day;
(c)for the purposes of delivering any Utilisation Request or Renewal Request, identifying any Utilisation Date, issuing any Letters of Credit, funding any Utilisation (or calculating any amounts for the relevant Utilisation) and making any other payment, a day (other than a Saturday or Sunday) on which banks are open for general business in London, New York and Singapore provided that such day is a TARGET Day for payment or purchase of Euro; and
(d)for all other purposes, a day (other than a Friday, Saturday or Sunday) on which banks are open for general business in London, New York, Abu Dhabi and Singapore.
"Central Bank Rate" means the short-term interest rate target set by the US Federal Open Market Committee as published by the Federal Reserve Bank of New York from time to time or if that target is not a single figure, the arithmetic mean (calculated by the Facility Agent (in consultation with the Company) or (with the prior written consent of the Company) by any other Finance Party which agrees to do so in place of the Facility Agent) of:
(a)the upper bound of the short-term interest rate target range set by the US Federal Open Market Committee and published by the Federal Reserve Bank of New York; and
(b)the lower bound of that target range.
"Central Bank Rate Adjustment" means the mean of the spread of Term SOFR to the Central Bank Rate (expressed as a percentage rate per annum) over the previous five Additional Business Days on which Term SOFR has been published, excluding the highest spread (or if there is more than one highest spread, only one of those highest spreads) and lowest spread (or, if there is more than one lowest spread, only one of those lowest spreads), calculated by the Facility Agent (in consultation with the Company) or (with the prior written consent of the Company) by any other Finance Party which agrees to do so in place of the Facility Agent) and rounded to five decimal places.
"EURIBOR" means the euro interbank offered rate administered by the European Money Markets Institute (or any other person which takes over the administration of that rate) for the relevant period displayed (before any correction, recalculation or republication by the administrator) on page EURIBOR01 of the Thomson Reuters screen.
    5


"Funding Rate" means any individual rate notified by a Lender to the Facility Agent pursuant to paragraph (a)(ii) of Clause 16.4 (Cost of funds).
"Historic Primary Term Rate" means, in relation to any Term Rate Loan denominated in Euro, the most recent applicable Primary Term Rate for a period equal in length to the Interest Period of that Loan and which is as of a day which is no more than 3 calendar days before the Quotation Day.
"Interpolated Historic Primary Term Rate" means, in relation to any Term Rate Loan denominated in Euro, the rate (rounded to the same number of decimal places as the relevant Primary Term Rate) which results from interpolating on a linear basis between:

(a)the most recent applicable Primary Term Rate (as of a day which is not more than three (3) calendar days before the Quotation Day) for the longest period (for which that Primary Term Rate is available) which is less than the Interest Period of that Loan; and
(b)the most recent applicable Primary Term Rate (as of a day which is not more than 3 calendar days before the Quotation Day) for the shortest period (for which that Primary Term Rate is available) which exceeds the Interest Period of that Loan.
"Interpolated Primary Term Rate" means, in relation to any Term Rate Loan, the rate (rounded to the same number of decimal places as the relevant Primary Term Rate) which results from interpolating on a linear basis between:
(a)either:
(i)the applicable Primary Term Rate (as of the Quotation Time) for the longest period (for which that Primary Term Rate is available) which is less than the Interest Period of that Loan; or
(ii)if no such Primary Term Rate is available for a period which is less than the Interest Period of that Loan, the applicable Overnight Rate (if any) for the Overnight Reference Day; and
(b)the applicable Primary Term Rate (as of the Quotation Time) for the shortest period (for which that Primary Term Rate is available) which exceeds the Interest Period of that Loan.
"Market Disruption Rate" means:
(a)in relation to a Loan in Dollars, the percentage rate per annum which is the aggregate of the applicable Term Reference Rate and the applicable Term Reference Rate CAS; and
(b)in relation to a Loan in Euro, the applicable Term Reference Rate,
provided that, in each case, if such rate is less than zero, the Market Disruption Rate for Loans in such currency shall be deemed to be zero.
"Overnight Rate" means:
(a)in relation to a Term Rate Loan denominated in Dollars, the secured overnight financing rate (SOFR) administered by the Federal Reserve Bank of New York (or any other person which takes over the administration of that rate) published (before any correction, recalculation or republication by the administrator) by the Federal Reserve Bank of New York (or any other person which takes over the publication of that rate); and
(b)in relation to a Term Rate Loan denominated in Euro, not applicable.
    6


"Overnight Reference Day" means:
(a)in relation to a Term Rate Loan denominated in Dollars, the day which is two (2) Additional Business Days before the Quotation Day; and
(b)in relation to a Term Rate Loan denominated in Euro, not applicable.
"Primary Term Rate" means:
(a)in relation to a Term Rate Loan denominated in Dollars, Term SOFR;
(b)in relation to a Term Rate Loan denominated in Euro, EURIBOR; and
"Quotation Day" means, in relation to any period for which an interest rate is to be determined:
(a)if the currency is the Base Currency, two (2) Additional Business Days before the first day of the relevant Interest Period;
(b)if the currency is Euros, two (2) TARGET Days before the first day of that period; or
(c)(for any other currency), two (2) Business Days before the first day of that period,
(in each case, unless market practice differs in the Relevant Market for that currency, in which case the Quotation Day will be determined by the Facility Agent in accordance with market practice in the Relevant Market (and if quotations would normally be given by leading banks in the Relevant Market on more than one (1) calendar day, the Quotation Day will be the last of those days)).
"Quotation Time" means:
(a)in relation to a Term Rate Loan denominated in Dollars, 6:00 a.m. (New York time) on the Quotation Day; and
(b)in relation to a Term Rate Loan denominated in Euro, 11:00 a.m. (Brussels time) on the Quotation Day.
"Quoted Tenor" means, in relation to a Primary Term Rate, any period for which that rate is customarily displayed on the relevant page or screen of an information service.
"Reference Bank Rate" means, in relation to the Term Reference Rate applicable to Loans denominated in Euro, the arithmetic mean of the rates (rounded upwards to four decimal places) as supplied to the Facility Agent at its request by the Reference Banks:
(a)(other than where paragraph (b) below applies) as the rate at which the relevant Reference Bank believes one prime bank is quoting to another prime bank for interbank term deposits in Euro within the Participating Member States for the relevant period; or
(b)if different, as the rate (if any and applied to the relevant Reference Bank and the relevant period) which contributors to the applicable Term Reference Rate are asked to submit to the relevant administrator.
"Relevant Market" means:
(a)in relation to Dollars, the market for overnight cash borrowing collateralized by US Government securities; and
(b)in relation to Euros, the European interbank market.
    7


"T2" means the real time gross settlement system operated by the Eurosystem, or any successor system.
"TARGET Day" means any day on which T2 is open for the settlement of payments in euro.
"Term Rate Currency" means:
(a)Dollars; and
(b)Euros.
"Term Rate Loan" means any Loan or, if applicable, Unpaid Sum in a Term Rate Currency.
"Term Reference Rate" means in relation to a Term Rate Loan:
(a)the applicable Primary Term Rate as of the Quotation Time for a period equal in length to the Interest Period of that Loan; or
(b)as otherwise determined pursuant to Clause 16.1 (Unavailability of Primary Term Rate (USD Term Rate Loans)) or Clause 16.1A (Unavailability of Primary Term Rate (Euro Term Rate Loans)), as applicable.
"Term Reference Rate CAS" means a percentage rate per annum as set forth below for each Interest Period of such Loan:
Interest PeriodPercentage rate
One month 0.11448%
Three months0.26161%
Six months0.42826%
provided that, in respect of an Interest Period of a length shorter than six months but which has a length other than as specified above, the Term Reference Rate CAS for that Interest Period shall be the percentage per annum which results from interpolating on a linear basis between the Term Reference Rate CAS for the longest period specified above which is less than such Interest Period and the Term Reference Rate CAS for the shortest period specified above which exceeds such Interest Period.
"Term SOFR" means the term SOFR reference rate administered by CME Group Benchmark Administration Limited (or any other person which takes over the administration of that rate) for the relevant period published (before any correction, recalculation or republication by the administrator) by CME Group Benchmark Administration Limited (or any other person which takes over the publication of that rate)."
II.The following new Clauses 1.2(r) and 1.2(s) shall be added to Clause 1.2 (Construction):
"(r)     A reference in this Agreement to a page or screen of an information service displaying a rate shall include:
(i)    any replacement page of that information service which displays that rate; and
(ii)    the appropriate page of such other information service which displays that rate from time to time in place of that information service,
and, if such page or service ceases to be available, shall include any other page or service displaying that rate specified by the Facility Agent after consultation with the Company.
    8


(s)    A reference in this Agreement to a Central Bank Rate shall include any successor rate to, or replacement rate for, that rate."
III.The following new Clause 4.3 (Conditions relating to Optional Currencies) shall be added:
"4.3    Conditions relating to Optional Currencies
(a)A currency will constitute an Optional Currency in relation to a Utilisation if:
(i)it is Euro; or
(ii)it:
(A)is readily available in the amount required and freely convertible into the Base Currency in the wholesale market for that currency on the Quotation Day and the Utilisation Date for that Utilisation;
(B)has been requested of the Facility Agent at least five (5) Business Days prior to the date of the relevant Utilisation Request; and
(C)has been approved by the Facility Agent (in both its capacity as such and acting on the instructions of all the Lenders under the relevant Facility) on or prior to receipt by the Facility Agent of the relevant Utilisation Request for that Utilisation,
provided that, on or before the Specified Time, the Obligors' Agent and the Facility Agent (both in its capacity as such and acting on the instructions of all the Lenders under the relevant Facility), have agreed and effected such amendments to this Agreement that are reasonably necessary (if any) to implement such currency as an Optional Currency for the purposes of this Agreement (including, without limitation, to specify the primary rate of interest to apply to a Utilisation or Unpaid Sum in such currency and any fallback rate(s) in the event such primary rate of interest is unavailable). The Facility Agent and the Lenders shall consider any amendments proposed by the Obligors' Agent for such purposes in good faith and in a timely manner.
(b)If the Facility Agent has received a written request from the Company for a currency to be approved under paragraph (a)(ii)(C) above, then, subject to paragraph (a)(ii) above, the Facility Agent will confirm to the Company by the Specified Time:
(i)whether or not each of it and the relevant Lenders have granted their approval; and
(ii)if approval has been granted, the minimum amount for any subsequent Utilisation in that currency."
IV.The following new Clause 14.1 (Calculation of interest) shall be added:
"14.1 Calculation of interest
(a)The rate of interest of each Term Rate Loan in Dollars for an Interest Period is the percentage rate per annum which is the aggregate of the applicable:
    9


(i)Margin;
(ii)Term Reference Rate; and
(iii)Term Reference Rate CAS,
provided that, if the aggregate of the applicable Term Reference Rate and Term Reference Rate CAS is less than zero, the aggregate of the applicable Term Reference Rate and Term Reference Rate CAS shall be deemed to be zero.
(b)The rate of interest of any Term Rate Loan in Euro for an Interest Period is the percentage rate per annum which is the aggregate of the applicable:
(i)Margin; and
(ii)Term Reference Rate,
provided that, if the applicable Term Reference Rate is less than zero, the applicable Term Reference Rate shall be deemed to be zero."
I.The following new Clause 16 (Changes to the calculation of interest) shall be added:
"16.    CHANGES TO THE CALCULATION OF INTEREST
16.1     Unavailability of Primary Term Rate (USD Term Rate Loans)
(a)Interpolated Primary Term Rate: If no Primary Term Rate is available for the Interest Period of a Term Rate Loan denominated in Dollars, the Term Reference Rate shall be the Interpolated Primary Term Rate for a period equal in length to the Interest Period of that Loan.
(b)Central Bank Rate: If paragraph (a) above applies but it is not possible to calculate the Interpolated Primary Term Rate, the applicable Term Reference Rate shall be:
(i)the percentage rate per annum which is the aggregate of:
(A)the Central Bank Rate for the Quotation Day; and
(B)any applicable Central Bank Rate Adjustment; or
(ii)if the Central Bank Rate for the Quotation Day is not available, the percentage rate per annum which is the aggregate of:
(A)the most recent Central Bank Rate for a day which is no more than five (5) Additional Business Days before the Quotation Day; and
(B)the applicable Central Bank Rate Adjustment.
(c)Cost of funds. If paragraph (b) above applies but there is no applicable Central Bank Rate, Clause 16.4 (Cost of funds) shall apply to that Loan for that Interest Period.
16.1A     Unavailability of Primary Term Rate (Euro Term Rate Loans)
    10


(a)Interpolated Primary Term Rate: If no Primary Term Rate is available for the Interest Period of a Term Rate Loan denominated in Euro, the Term Reference Rate shall be the Interpolated Primary Term Rate for a period equal in length to the Interest Period of that Loan
(b)Shortened Interest Period: If paragraph (a) above applies but it is not possible to calculate the Interpolated Primary Term Rate, the Interest Period of the Loan the Interest Period of that Loan shall (if it is longer than the applicable Fallback Interest Period) be shortened to the applicable Fallback Interest Period and the Term Reference Rate shall be determined pursuant to such definition.
(c)Shortened Interest Period and Historic Primary Term Rate: If paragraph (b) above applies but no Primary Term Rate is available for the Interest Period of that Loan and it is not possible to calculate the Interpolated Primary Term Rate, the applicable Term Reference Rate shall be the Historic Primary Term Rate for that Loan.
(d)Shortened Interest Period and Interpolated Historic Primary Term Rate: If paragraph (c) above applies but no Historic Primary Term Rate is available for the Interest Period of the Loan, the applicable Term Reference Rate shall be the Interpolated Historic Primary Term Rate for a period equal in length to the Interest Period of that Loan.
(e)Reference Bank Rate: If paragraph (d) above applies but it is not possible to calculate the Interpolated Historic Primary Term Rate, the Interest Period of that Loan shall, if it has been shortened pursuant to paragraph (b) above, revert to its previous length and the applicable Primary Term Rate shall be the Reference Bank Rate as of the Quotation Time for the currency of that Loan and for a period equal in length to the Interest Period of that Loan.
(f)If the applicable Term Reference Rate for Loans denominated in Euro is no longer available or in place of the applicable Term Reference Rate for Loans denominated in Euro the lending market has adopted a common alternative reference rate, then subject to consent from the Company, the Facility Agent may specify that such common alternative reference rate be used.
(g)Cost of funds: If either (A) paragraph (e) above applies but no Reference Bank Rate is available for Euros for the relevant Interest Period or (B) paragraph (f) above is applicable, Clause 16.4 (Cost of funds) shall apply to that Loan for that Interest Period.
16.2    Calculation of Reference Bank Rate
(a)Subject to paragraph (b) below, if a Term Reference Rate is to be determined on the basis of a Reference Bank Rate but a Reference Bank does not supply a quotation by the Specified Time, the Reference Bank Rate shall be calculated on the basis of the quotations of the remaining Reference Banks.
(b)If at or about noon on the Quotation Day, none or only one of the Reference Banks supplies a quotation, there shall be no Reference Bank Rate for the relevant Interest Period.
16.3    Market Disruption
If before close of business in London (17:00 London time) on the Quotation Day for the relevant Interest Period, the Facility Agent receives notifications from a Lender or Lenders (whose
    11


participations in that Loan exceed fifty-one per cent. (51.0%) of that Loan) that the cost to it or them of funding its or their participations in that Loan:
(a)in respect of a Loan in Dollars, from the wholesale market for Dollars would be in excess of the applicable Market Disruption Rate; and
(b)in respect of a Loan in Euro, from the wholesale market for Euros would be in excess of the applicable Market Disruption Rate;
(c)in respect of a Loan in any other currency, from the wholesale market for that currency would be in excess of the rate agreed in respect of that currency pursuant to Clause 4.3 (Conditions relating to Optional Currencies),
then Clause 16.4 (Cost of funds) shall apply to that Loan for the relevant Interest Period.
16.4    Cost of Funds
(a)If this Clause 16.4 applies, the rate of interest on each Lender’s share of the relevant Loan for the relevant Interest Period shall be the percentage rate per annum which is the sum of:
(i)the applicable Margin; and
(ii)the rate notified to the Facility Agent by that Lender as soon as practicable and in any event by the close of business on the date falling two (2) Business Days after the relevant Quotation Day (or, if earlier, on the date falling two (2) Business Days prior to the date on which interest is due to be paid in respect of that Interest Period), to be that which expresses as a percentage rate per annum the cost to that Lender of funding its participation in that Loan from whatever source it may reasonably select.
(b)If this Clause 16.4 applies and the Facility Agent or the Company so requires, the Facility Agent and the Company shall enter into negotiations (for a period of not more than sixty (60) calendar days) with a view to agreeing a substitute basis for determining the rate of interest.
(c)Any alternative basis agreed pursuant to paragraph (b) above shall, with the prior consent of all the Lenders and the Company, be binding on all Parties.
(d)If this Clause 16.4 applies pursuant to Clause 16.3 (Market disruption) and:
(i)a Lender’s Funding Rate is less than:
(A)in relation to any Loan in Dollars or Euro, the applicable Market Disruption Rate; or
(B)in respect of any other currency, the rate as agreed in respect of that currency pursuant to Clause 4.3 (Conditions relating to Optional Currencies); or
(ii)a Lender does not supply a quotation by the time specified in paragraph (a)(ii) above,
the cost to that Lender of funding its participation in that Loan for that Interest Period shall be deemed, for the purposes of paragraph (a) above, to be (1) in relation to a Loan in Dollars or
    12


Euro, the applicable Market Disruption Rate or (2) in relation to another currency, the rate as agreed in respect of that currency pursuant to Clause 4.3 (Conditions relating to Optional Currencies).
16.5    Notification to Company
If Clause 16.4 (Cost of funds) applies the Facility Agent shall, as soon as is practicable, notify the Company.
16.6     Break Costs
(a)The Company shall, within three (3) Business Days of demand by a Finance Party, pay to that Finance Party its Break Costs attributable to all or any part of a Loan or Unpaid Sum being paid by that Borrower on a day other than the last day of an Interest Period for that Loan or Unpaid Sum.
(b)Each Lender shall, as soon as reasonably practicable after a demand by the Facility Agent, provide a certificate confirming the amount of its Break Costs for any Interest Period in which they accrue."
II.The following new Clause 42.5 (Replacement of Primary Term Rate) shall be added:
"42.5    Replacement of Primary Term Rate
(a)Subject to Clause 42.4 (Other exceptions), any amendment or waiver which relates to:
(i)providing for the use of a Replacement Reference Rate; and
(ii)
(A)aligning any provision of any Finance Document to the use of that Replacement Reference Rate;
(B)enabling that Replacement Reference Rate to be used for the calculation of interest under this Agreement (including, without limitation, any consequential changes required to enable that Replacement Reference Rate to be used for the purposes of this Agreement);
(C)implementing market conventions applicable to that Replacement Reference Rate;
(D)providing for appropriate fallback (and market disruption) provisions for that Replacement Reference Rate; or
(E)adjusting the pricing to reduce or eliminate, to the extent reasonably practicable, any transfer of economic value from one Party to another as a result of the application of that Replacement Reference Rate (and if any adjustment or method for calculating any adjustment has been formally designated, nominated or recommended by the Relevant Nominating Body, the adjustment shall be determined on the basis of that designation, nomination or recommendation).
    13


may be made with the consent of the Facility Agent (acting on the instructions of the Majority Lenders) and the Company.
(b)In this Clause 42.5 (Replacement of Primary Term Rate):
"Published Rate" means:
(a)an Overnight Rate; or
(b)the Primary Term Rate for any Quoted Tenor.
"Relevant Nominating Body" means any applicable central bank, regulator or other supervisory authority or a group of them, or any working group or committee sponsored or chaired by, or constituted at the request of, any of them or the Financial Stability Board.
"Replacement Reference Rate" means a benchmark rate which is:
(a)    formally designated, nominated or recommended as the replacement for a Published Rate by:
(i)the administrator of that Published Rate; or
(ii)any Relevant Nominating Body,
and if replacements have, at the relevant time, been formally designated, nominated or recommended under both paragraphs, the "Replacement Reference Rate" will be the replacement under paragraph (ii) above;
(c)in the opinion of the Majority Lenders and the Company, generally accepted in the international or any relevant domestic syndicated loan markets as the appropriate successor to a Published Rate; or
(d)in the opinion of the Majority Lenders and the Company, an appropriate successor to a Published Rate."
III.Part 1 (Loans) of Schedule 4 (Specified Times) shall be deleted and replaced with the following:
Loans in USDLoans in EURLoans in other currencies
Facility Agent notifies the Company if a currency is approved as an Optional Currency in accordance with Clause 4.3 (Conditions relating to Optional Currencies).
--U-4 as soon as possible
    14


Delivery of a duly completed Utilisation Request in accordance with Clause 5.1 (Delivery of a Utilisation Request).
U-3
10:00am London time
U-3
10:00am London time
U-3
10:00am London time
Facility Agent notifies the relevant Lenders of the Loan in accordance with paragraph (e) of Clause 5.4 (Lenders' Participation).
U-3 as soon as possible U-3 as soon as possibleU-3 as soon as possible
Reference Bank Rate calculated by reference to available quotations in accordance with Clause 16.2 (Calculation of Reference Bank Rate).
Not applicableQuotation Day as soon as possible
As (and to the extent) agreed in respect of that currency pursuant to Clause 4.3 (Conditions relating to Optional Currencies)
"U" =     date of utilisation or, if applicable, in the case of a Loan that has already been borrowed, the first day of the relevant Interest Period for that Loan.
"U – X" =     X Business Days prior to the proposed date of utilisation or, if applicable, in the case of a Loan that has already been borrowed, the first day of the relevant Interest Period for that Loan.


    15



    16


SIGNATORIES
THE COMPANY
SIGNED by
GLOBALFOUNDRIES INC.
for and on behalf of itself and the other Obligors
acting by an authorised signatory




By:…/s/ Samak L. Azar
Name: Samak L. Azar
Title: General Counsel



[Signature page to Amendment Agreement – 2019 RCF]


THE FACILITY AGENT
SIGNED by
CITIBANK EUROPE PLC, UK BRANCH
acting by an authorised signatory




By: /s/ Henrik S. Slotsaa
Name: Henrik S. Slotsaa
Title: Vice President

[Signature page to Amendment Agreement – 2019 RCF]
EX-4.19 4 exhibit4192023formofindemn.htm EX-4.19 Document
Exhibit 4.19
Execution Version
FORM OF INDEMNIFICATION AGREEMENT
This INDEMNIFICATION AGREEMENT (“Agreement”), dated as of [DATE], is by and between GLOBALFOUNDRIES Inc., an exempted company incorporated in the Cayman Islands with limited liability (the “Company”) NAME OF INDEMNITEE] (the “Indemnitee”).
WHEREAS, Indemnitee is [a director/an officer/an employee with certain managerial responsibilities] of the Company;
WHEREAS, both the Company and Indemnitee recognize the increased risk of litigation and other claims being asserted against directors and officers of public companies;
WHEREAS, the Amended and Restated Memorandum and Articles of Association of the Company (as they may be further amended and restated, the “Memorandum and Articles of Association”), require the Company to indemnify its directors, officers and employees with certain managerial responsibilities against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses, whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions in connection with the Company other than such liability (if any) that they may incur by reason of their own actual fraud, dishonesty, wilful neglect or wilful default and Indemnitee serves as a director or officer of the Company in part in reliance on such Memorandum and Articles of Association;
WHEREAS, the board of directors of the Company (the “Board”) has determined that enhancing the ability of the Company to retain and attract as directors, officers and management employees the most capable persons is in the best interests of the Company and that the Company therefore should seek to assure such persons that indemnification and insurance coverage is available; and
WHEREAS, in recognition of the need to provide Indemnitee with substantial protection against personal liability in connection with Indemnitee's service as [a director/an officer/ an employee with certain managerial responsibilities]of the Company and to enhance Indemnitee's ability to serve the Company in an effective manner, in recognition of Indemnitee’s reliance on the aforesaid Memorandum and Articles of Association and to provide assurance that such protections as expressed in the Memorandum and Articles of Association will be available to Indemnitee (regardless of, among other things, any amendment to or revocation of such Memorandum and Articles of Association or any change in the composition of the Board or any change in control or business combination transaction relating to the Company), the Company wishes to provide in this Agreement for the indemnification of, and the advancement of Expenses (as defined in Section 1(j) below) to, Indemnitee to the fullest extent (whether partial or complete) permitted by law and as set forth in this Agreement and to the extent insurance is maintained, for the continued coverage of Indemnitee under the Company's directors' and officers' liability insurance policies.
NOW, THEREFORE, in consideration of the foregoing and the Indemnitee's agreement to continue to provide services to the Company, the parties agree as follows:
1.Definitions. For purposes of this Agreement, the following terms shall have the following meanings:
(a)Agreement” has the meaning set forth in the preamble.
[EMEA_ACTIVE 301757657_10]


(b)Beneficial Owner” has the meaning given to the term “beneficial owner” in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and “Beneficial Ownership” shall have correlative meaning.
(c)Board” has the meaning set forth in the preamble.
(d)Change in Control” means the occurrence after the date of this Agreement of any of the following events:
(i)the acquisition, directly or indirectly, by a Person (other than a Person that at the time of the acquisition is a party to the Shareholder's Agreement) of Beneficial Ownership of more than 50% of the combined voting power of the Voting Securities of the Company; provided, however, that the following acquisitions of Voting Securities of the Company shall not constitute a Change in Control: (A) any acquisition by or from the Company or any of its Subsidiaries, or by any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its Subsidiaries, (B) any acquisition by any underwriter in any firm commitment underwriting of securities to be issued by the Company, or (C) any acquisition by any Person if, immediately following such acquisition, 50% or more of the then outstanding shares of ordinary shares (or other equity unit) of such Person and the combined voting power of the then outstanding voting securities of such Person, are Beneficially Owned by all or substantially all of the individuals or entities who, immediately prior to such acquisition, were the beneficial owners of the then outstanding Voting Securities of the Company in substantially the same proportions, respectively, as their ownership immediately prior to the acquisition of such Voting Securities; or
(ii)the consummation of the sale or other disposition of all or substantially all of the assets of the Company, other than to a Subsidiary of the Company or to a holding company of which the Company is a direct or indirect wholly owned subsidiary prior to such transaction; or
(iii)the consummation of a reorganization, scheme of arrangement, merger or consolidation of the Company, other than a reorganization, scheme of arrangement, merger or consolidation, which would result in the Voting Securities of the Company outstanding immediately prior to the transaction continuing to represent (whether by remaining outstanding or by being converted to voting securities of the surviving entity) 50% or more of the Voting Securities of the Company or the voting power of the voting securities of such surviving entity outstanding immediately after such transaction; or
(iv)the consummation of a plan of complete liquidation of the Company; or
(v)the following individuals cease for any reason to constitute a majority of the Board: (A) individuals who, as of the date hereof, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including, but not limited to, a consent solicitation relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company’s stockholders was approved or recommended by a vote of at least two-thirds of the directors then still in office who either were directors on the date of this Agreement or whose



appointment, election or nomination for election was previously so approved or recommended; and (B) any directors nominated pursuant to the Shareholder’s Agreement.
(e)Claim” means:
(i)any threatened, pending or completed action, suit, proceeding or alternative dispute resolution mechanism, whether civil, criminal, administrative, arbitrative, investigative or other, and whether made pursuant to federal, state or other law; or
(ii)any inquiry, hearing or investigation that the Indemnitee in good faith believes might lead to the institution of any such action, suit, proceeding or alternative dispute resolution mechanism.
(f)Company” has the meaning set forth in the preamble.
(g)Delaware Court” has the meaning set forth in Section 9(e) below.
(h)“Disinterested Director” means a director of the Company who is not and was not a party to the Claim in respect of which indemnification is sought by Indemnitee.
(i)Enterprise” has the meaning set forth in Section 1(m) below.
(j)ERISA” means the Employee Retirement Income Security Act of 1974, as amended.
(k)Expenses” means any and all expenses, including attorneys' and experts' fees, court costs, transcript costs, travel expenses, duplicating, printing and binding costs, telephone charges, and all other costs and expenses incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness or participate in, any Claim. Expenses also shall include (i) Expenses incurred in connection with any appeal resulting from any Claim, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of Section 5 only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement, by litigation or otherwise. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.
(l)Expense Advance” means any payment of Expenses advanced to Indemnitee by the Company pursuant to Sections 4 or 5 hereof.
(m)Indemnifiable Event” means any event or occurrence, whether occurring on or after the date of this Agreement, related to the fact that Indemnitee is or was a director, officer, employee or agent of the Company or any subsidiary of the Company, or is or was serving at the request of the Company as a director, officer, employee, member, manager, trustee or agent of any other corporation, limited liability company, partnership, joint venture, trust or other entity or enterprise (collectively with the Company, “Enterprise”) or by reason of an action or inaction by Indemnitee in any such capacity (whether or not serving in such capacity at the time any Loss is incurred for which indemnification can be provided under this Agreement).



(n)Indemnitee” has the meaning set forth in the preamble.
(o)Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of company law and neither presently performs, nor in the past three (3) years has performed, services for either: (i) the Company or Indemnitee (other than in connection with matters concerning Indemnitee under this Agreement or of other indemnitees under similar agreements) or (ii) any other party to the Claim giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee's rights under this Agreement.
(p)Losses” means any and all Expenses, damages, losses, liabilities, judgments, fines, penalties (whether civil, criminal or other), ERISA excise taxes, amounts paid or payable in settlement, including any interest, assessments, together with any federal, state, local or foreign taxes imposed as a result of the actual or deemed receipt of any payments under this Agreement and all other charges paid or payable in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness or participate in, any Claim.
(q)Memorandum and Articles of Association” has the meaning set forth in the preamble.
(r)Notification Date” has the meaning set forth in Section 9(c) below.
(s)Person” means any individual, company, exempted company, partnership, exempted limited partnership, corporation, limited liability company, association, joint stock company, trust, joint venture, unincorporated organization, or other form of business organization, whether or not regarded as a legal entity under applicable Law, or any governmental authority or any department, agency or political subdivision thereof and includes the meaning set forth in Sections 13(d) and 14(d) of the Exchange Act.
(t)Shareholder’s Agreement” means the Shareholder’s Agreement, dated November 1, 2021, by and among the Company, Mubadala Technology Investment Company and MTI International Investment Company LLC, as amended or restated from time to time.
(u)Standard of Conduct Determination” has the meaning set forth in Section 9(b) below.
(v)Subsidiary” or “Subsidiaries” shall mean a Person of which 50% or more of the Voting Securities or 50% or more of the equity interests is owned, directly or indirectly, by the Company.
(w)Voting Securities” means, with respect to a Person, voting securities of such Person entitled to vote generally in the election of directors.
2.Services to the Company. Indemnitee agrees to continue to serve as a director, officer or in a certain managerial position of the Company for so long as Indemnitee is duly elected or



appointed or until Indemnitee tenders his/her resignation or is otherwise no longer serving in such capacity. This Agreement shall not be deemed an employment agreement between the Company (or any of its subsidiaries or Enterprise) and Indemnitee. Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written agreement between Indemnitee and the Company (or any of its subsidiaries or Enterprise), other applicable formal severance policies duly adopted by the Board or, with respect to service as a director [or officer/or employees in certain managerial positions] of the Company, by the Company's Memorandum and Articles, or Cayman law.
3.Indemnification. Subject to Section 9 and Section 10 of this Agreement, the Company shall indemnify and hold harmless Indemnitee, to the fullest extent permitted by applicable law, against any and all Losses if Indemnitee was or is or becomes a party to or participant in, or is threatened to be made a party to or participant in, any Claim by reason of or arising in part out of an Indemnifiable Event, including, without limitation, Claims brought by or in the right of the Company, Claims brought by third parties, and Claims in which Indemnitee is solely a witness, provided that the Company shall have no obligation to indemnify and hold harmless Indemnitee for any Losses arising by reason of the Indemnitee’s actual fraud, dishonesty, wilful neglect or wilful default.
4.Advancement of Expenses. Indemnitee shall have the right to advancement by the Company, prior to the final disposition of any Claim by final adjudication to which there are no further rights of appeal, of any and all Expenses actually and reasonably paid or incurred by Indemnitee in connection with any Claim arising out of an Indemnifiable Event. Indemnitee's right to such advancement is not subject to the satisfaction of any standard of conduct. Without limiting the generality or effect of the foregoing, as soon as practicable, but in any event not later than thirty (30) days after any request by Indemnitee, the Company shall, in accordance with such request, (a) pay such Expenses on behalf of Indemnitee, (b) advance to Indemnitee funds in an amount sufficient to pay such Expenses, or (c) reimburse Indemnitee for such Expenses. In connection with any request for Expense Advances, Indemnitee shall provide any vouchers, invoices or similar evidence documenting in reasonable detail the Expenses incurred or to be incurred by Indemnitee but shall not be required to provide any documentation or information to the extent that the provision thereof would undermine or otherwise jeopardize attorney-client privilege. In connection with any request for Expense Advances, Indemnitee shall execute and deliver to the Company an undertaking (which shall be accepted without reference to Indemnitee’s ability to repay the Expense Advances), to repay any amounts paid, advanced, or reimbursed by the Company for such Expenses to the extent that it is ultimately determined, following the final disposition of such Claim, that Indemnitee is not entitled to indemnification hereunder. Indemnitee’s obligation to reimburse the Company for Expense Advances shall be unsecured.
5.Indemnification for Expenses in Enforcing Rights. To the fullest extent allowable under applicable law and this Agreement, the Company shall also indemnify against, and, if requested by Indemnitee, shall advance to Indemnitee subject to and in accordance with Section 4, any Expenses actually and reasonably paid or incurred by Indemnitee in connection with any action or proceeding by Indemnitee for (a) indemnification or reimbursement or advance payment of



Expenses by the Company under any provision of this Agreement, or under any other agreement or provision of the Memorandum and Articles of Association now or hereafter in effect relating to Claims relating to Indemnifiable Events, and/or (b) recovery under any directors' and officers' liability insurance policies maintained by the Company. However, in the event that Indemnitee is ultimately determined not to be entitled to such indemnification or insurance recovery, as the case may be, then all amounts advanced under this Section 5 shall be repaid. Indemnitee shall also be required to reimburse the Company in the event that a final judicial determination is made that such action brought by Indemnitee was frivolous or not made in good faith.
6.Partial Indemnity. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for a portion of any Losses in respect of a Claim related to an Indemnifiable Event but not for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.
7.Notification and Defense of Claims.
(a)Notification of Claims. Indemnitee shall notify the Company in writing as soon as practicable of any Claim which could relate to an Indemnifiable Event or for which Indemnitee could seek Expense Advances, including a brief description (based upon information then available to Indemnitee) of the nature of, and the facts underlying, such Claim. The failure of Indemnitee to timely notify the Company hereunder shall not relieve the Company from any liability hereunder except that the Company shall not be liable to indemnify Indemnitee under this Agreement with respect to any judicial award in a Claim related to an Indemnifiable Event if the Company was not given a reasonable and timely opportunity to participate at its expense in the defense of such action.
(b)Notice to Insurers. If at the time of the receipt of such notice, the Company has directors' and officers' liability insurance in effect under which coverage for Claims related to Indemnifiable Events is potentially available, the Company shall give prompt written notice to the applicable insurers (with a copy to Indemnitee) in accordance with the procedures set forth in the applicable policies. The Company shall promptly upon receipt or delivery provide to Indemnitee a copy of any subsequent correspondence between the Company and such insurers regarding the Claim.
(c)Defense of Claims. To the extent the Company so wishes, the Company shall be entitled to participate in the defense of any Claim relating to an Indemnifiable Event at its own expense and, except as otherwise provided below, it may select counsel and assume the defense thereof. Where the Company decides to assume the defense, notice of such decisions should be provided to Indemnitee in writing. Following delivery of such notice to the Indemnitee, the Company shall not be liable to Indemnitee under this Agreement or otherwise for any Expenses subsequently directly incurred by Indemnitee in connection with Indemnitee's defense of such Claim other than reasonable costs of investigation or as otherwise provided below. Indemnitee shall have the right to employ its own legal counsel in such Claim, but all Expenses related to such counsel incurred after notice from the Company of its assumption of the defense shall be at Indemnitee's own expense; provided, however, that if (i) Indemnitee's employment of its own legal counsel has been authorized by the Company and such authorization has not been



withdrawn, (ii) counsel for Indemnitee shall have provided the Company with a written legal opinion that there is, or there is reasonably likely to be, a conflict of interest between the Company and Indemnitee in the defense of such Claim, (iii) after a Change in Control, Indemnitee's employment of its own counsel has been approved by the Independent Counsel, or (iv) the Company shall not in fact have employed counsel to assume the defense of such Claim, then Indemnitee shall be entitled to retain its own separate counsel (but not more than one law firm plus, if applicable and deemed reasonable by the Company or, after a Change in Control, the Independent Counsel, local counsel in respect of any such Claim) and all Expenses related to such separate counsel shall be borne by the Company.
8.Procedure upon Application for Indemnification. In order to obtain indemnification pursuant to this Agreement, Indemnitee shall submit to the Company a written request therefor pursuant to Section 20, including in such request such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of the Claim, provided that documentation and information need not be so provided to the extent that the provision thereof would undermine or otherwise jeopardize attorney-client privilege. Indemnification shall be made insofar as the Company determines Indemnitee is entitled to indemnification in accordance with  9 below.
9.Determination of Right to Indemnification.
(a)Mandatory Indemnification; Indemnification as a Witness.
(i)To the extent that Indemnitee shall have been successful on the merits or otherwise in defense of any Claim relating to an Indemnifiable Event or any portion thereof or in defense of any issue or matter therein, including without limitation dismissal without prejudice, Indemnitee shall be indemnified against all Losses relating to such Claim in accordance with Section 3 to the fullest extent allowable by law, and no Standard of Conduct Determination shall be required.
(ii)To the extent that Indemnitee's involvement in a Claim relating to an Indemnifiable Event is to prepare to serve and serve as a witness, and not as a party, the Indemnitee shall be indemnified against all Losses incurred in connection therewith to the fullest extent allowable by law, and no Standard of Conduct Determination shall be required.
(b)Standard of Conduct. To the extent that the provisions of Section 9(a) are inapplicable to a Claim related to an Indemnifiable Event that shall have been finally disposed of, any determination of whether Indemnitee has satisfied any applicable standard of conduct under applicable law and this Agreement that is a legally required condition to indemnification of Indemnitee hereunder against Losses relating to such Claim and any determination that Expense Advances must be repaid to the Company (a "Standard of Conduct Determination") shall be made as follows:
(i)if no Change in Control has occurred, (A) by a majority vote of the Disinterested Directors, even if less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum or



(C) if there are no such Disinterested Directors, by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee; and
(ii)if a Change in Control shall have occurred, (A) if the Indemnitee so requests in writing, by a majority vote of the Disinterested Directors, even if less than a quorum of the Board or (B) otherwise, by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee.
The Company shall indemnify and hold harmless Indemnitee against and, if requested by Indemnitee, shall reimburse Indemnitee for, or advance to Indemnitee, within thirty (30) days of such request, any and all Expenses incurred by Indemnitee in cooperating with the person or persons making such Standard of Conduct Determination.
(c)Making the Standard of Conduct Determination. The Company shall use its reasonable best efforts to cause any Standard of Conduct Determination required under Section 9(b) to be made as promptly as practicable. If the person or persons designated to make the Standard of Conduct Determination under Section 9(b) shall not have made a determination within thirty (30) days after the later of (A) receipt by the Company of a written request from Indemnitee for indemnification pursuant to Section 8 (the date of such receipt being the “Notification Date”) and (B) the selection of an Independent Counsel, if such determination is to be made by Independent Counsel, then Indemnitee shall be deemed to have satisfied the applicable standard of conduct, absent (I) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee's statement not materially misleading, in connection with the request for indemnification, or (II) a prohibition of such indemnification under applicable law; provided that such thirty (30)-day period may be extended for a reasonable time, not to exceed an additional thirty (30)-days, if the person or persons making such determination in good faith requires such additional time to obtain or evaluate information relating thereto. Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of any Claim.
(d)Payment of Indemnification. If, in regard to any Losses:
(i)Indemnitee shall be entitled to indemnification pursuant to Section 9(a);
(ii)no Standard Conduct Determination is legally required as a condition to indemnification of Indemnitee hereunder; or
(iii)Indemnitee has been determined or deemed pursuant to Section 9(b) or Section 9(c) to have satisfied the Standard of Conduct Determination,
then the Company shall pay to Indemnitee, within ten (10) days after the later of (A) the Notification Date or (B) the earliest date on which the applicable criterion specified in Section 9(d)(i), 9(d)(ii) or 9(d)(iii) is satisfied, an amount equal to such Losses.



(e)Selection of Independent Counsel for Standard of Conduct Determination. If a Standard of Conduct Determination is to be made by Independent Counsel pursuant to Section 9(b)(i), the Independent Counsel shall be selected by the Board of Directors, and the Company shall give written notice to Indemnitee advising [him/her] of the identity of the Independent Counsel so selected. If a Standard of Conduct Determination is to be made by Independent Counsel pursuant to Section 9(b)(ii), the Independent Counsel shall be selected by Indemnitee, and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either case, Indemnitee or the Company, as applicable, may, within five (5) days after receiving written notice of selection from the other, deliver to the other a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not satisfy the criteria set forth in the definition of “Independent Counsel” in Section 1(o), and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person or firm so selected shall act as Independent Counsel. If such written objection is properly and timely made and substantiated, (i) the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit; and (ii) the non-objecting party may, at its option, select an alternative Independent Counsel and give written notice to the other party advising such other party of the identity of the alternative Independent Counsel so selected, in which case the provisions of the two immediately preceding sentences, the introductory clause of this sentence and numbered clause (i) of this sentence shall apply to such subsequent selection and notice. If applicable, the provisions of clause (ii) of the immediately preceding sentence shall apply to successive alternative selections. If no Independent Counsel that is permitted under the foregoing provisions of this Section 9(e) to make the Standard of Conduct Determination shall have been selected within twenty (20) days after the Company gives its initial notice pursuant to the first sentence of this Section 9(e) or Indemnitee gives its initial notice pursuant to the second sentence of this Section 9(e), as the case may be, either the Company or Indemnitee may petition the Court of Chancery of the State of Delaware (“Delaware Court”) to resolve any objection which shall have been made by the Company or Indemnitee to the other's selection of Independent Counsel and/or to appoint as Independent Counsel a person to be selected by the Delaware Court or such other person as the Delaware Court shall designate, and the person or firm with respect to whom all objections are so resolved or the person or firm so appointed will act as Independent Counsel. In all events, the Company shall pay all of the reasonable fees and expenses of the Independent Counsel incurred in connection with the Independent Counsel's determination pursuant to Section 9(b).
(f)Presumptions and Defenses.
(i)Indemnitee's Entitlement to Indemnification. In making any Standard of Conduct Determination, the person or persons making such determination shall presume that Indemnitee has satisfied the applicable standard of conduct and is entitled to indemnification, and the Company shall have the burden of proof to overcome that presumption and establish that Indemnitee is not so entitled. Any Standard of Conduct Determination that is adverse to Indemnitee, may be challenged by the Indemnitee in the Delaware Court. No determination by the Company (including by its directors or any Independent Counsel) that Indemnitee has not



satisfied any applicable standard of conduct may be used as a defense to any legal proceedings brought by Indemnitee to secure indemnification or reimbursement or advance payment of Expenses by the Company hereunder or create a presumption that Indemnitee has not met any applicable standard of conduct.
(ii)Reliance as a Safe Harbor. For purposes of this Agreement, and without creating any presumption as to a lack of good faith if the following circumstances do not exist, Indemnitee shall be deemed to have acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company if Indemnitee's actions or omissions to act are taken in good faith reliance upon the records of the Company, including its financial statements, or upon information, opinions, reports or statements furnished to Indemnitee by the officers or employees of the Company or any of its subsidiaries in the course of their duties, or by committees of the Board or by any other Person (including legal counsel, accountants and financial advisors) as to matters Indemnitee reasonably believes are within such other Person's professional or expert competence and who has been selected with reasonable care by or on behalf of the Company. In addition, the knowledge and/or actions, or failures to act, of any director, officer, agent or employee of the Company (other than the Indemnitee) shall not be imputed to Indemnitee for purposes of determining the right to indemnity hereunder.
(iii)Defense to Indemnification and Burden of Proof. It shall be a defense to any action brought by Indemnitee against the Company to enforce this Agreement (other than an action brought to enforce a claim for Losses incurred in defending against a Claim related to an Indemnifiable Event in advance of its final disposition) that it is not permissible under applicable law for the Company to indemnify Indemnitee for the amount claimed.
10.Exclusions from Indemnification. Notwithstanding anything in this Agreement to the contrary, the Company shall not be obligated to:
(a)indemnify or advance funds to Indemnitee for Expenses or Losses with respect to proceedings initiated by Indemnitee, including any proceedings against the Company or its directors, officers, employees or other indemnitees and not by way of defense, except:
(i)proceedings referenced in Section 5 above (unless a court of competent jurisdiction determines that each of the material assertions made by Indemnitee in such proceeding was not made in good faith or was frivolous); or
(ii)where the Company has joined in or the Board has consented to the initiation of such proceedings.
(b)indemnify Indemnitee if a final decision by a court of competent jurisdiction determines that such indemnification is prohibited by applicable law.
(c)indemnify Indemnitee for the disgorgement of profits arising from the purchase or sale by Indemnitee of securities of the Company in violation of Section 16(b) of the Exchange Act, or any similar successor statute (if applicable).



(d)indemnify or advance funds to Indemnitee for Indemnitee's reimbursement to the Company of any bonus or other incentive-based or equity-based compensation previously received by Indemnitee or payment of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements under Section 304 of the Sarbanes-Oxley Act of 2002 in connection with an accounting restatement of the Company or the payment to the Company of profits arising from the purchase or sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act).
(e)indemnify or advance funds to Indemnitee for Expenses or Losses arising from the Indemnitee’s actual fraud, dishonesty, wilful neglect or wilful default.
(f)indemnify or advance funds to Indemnitee for Indemnitee’s reimbursement to the Company for any amounts that the Company is entitled to recover from Indemnitee under the Company’s Compensation Recoupment Policy.
11.Contribution. To the fullest extent permissible under applicable law, if the indemnification and/or hold harmless rights provided for in this Agreement are unavailable to the Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying or holding harmless the Indemnitee, shall pay, in the first instance, the entire amount of Losses incurred by the Indemnitee in respect of which the indemnification and/or hold harmless rights provided for in this Agreement are unavailable, without requiring the Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have at any time against the Indemnitee.
12.Settlement of Claims. The Company shall not be liable to Indemnitee under this Agreement for any amounts paid in settlement of any threatened or pending Claim related to an Indemnifiable Event effected without the Company's prior written consent, which shall not be unreasonably withheld; provided, however, that if a Change in Control has occurred, the Company shall be liable for indemnification of the Indemnitee for amounts paid in settlement if an Independent Counsel has approved the settlement. The Company shall not settle any Claim related to an Indemnifiable Event in any manner that would impose any Losses on the Indemnitee without the Indemnitee's prior written consent.
13.Duration. All agreements and obligations of the Company contained herein shall continue during the period that Indemnitee is a director or officer of the Company (or is serving at the request of the Company as a director, officer, employee, member, trustee or agent of another Enterprise) and shall continue thereafter (i) so long as Indemnitee may be subject to any possible Claim relating to an Indemnifiable Event (including any rights of appeal thereto) and (ii) throughout the pendency of any proceeding (including any rights of appeal thereto) commenced by Indemnitee to enforce or interpret his or her rights under this Agreement, even if, in either case, he or she may have ceased to serve in such capacity at the time of any such Claim or proceeding.
14.Non-Exclusivity. The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee may have under the Memorandum and Articles of Association, the Cayman



Islands Companies Act (as amended), any other contract or otherwise (collectively, “Other Indemnity Provisions”). The Company will not adopt any amendment to the Memorandum and Articles of Association, the effect of which would be to deny, diminish or encumber Indemnitee's right to indemnification under this Agreement.
15.Liability Insurance. For the duration of Indemnitee's service as [a director/an officer/an employee holding certain managerial position] [of/at] the Company, and thereafter for so long as Indemnitee shall be subject to any pending Claim relating to an Indemnifiable Event, the Company shall use commercially reasonable efforts (taking into account the scope and amount of coverage available relative to the cost thereof) to continue to maintain in effect policies of directors' and officers' liability insurance providing coverage in commercially reasonable amounts from established and reputable insurers (taking into consideration the scope and amount of coverage available relative to the cost thereof). In all policies of directors' and officers' liability insurance maintained by the Company, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits as are provided to the Company's similarly situated directors, if Indemnitee is a director, or of the Company's similarly situated officers or employee in certain mangerial positions, if Indemnitee is an officer or employee in certain managerial positions (and not a director) by such policy.
16.No Duplication of Payments. The Company shall not be liable under this Agreement to make any payment to Indemnitee in respect of any Losses to the extent Indemnitee has otherwise received payment under any insurance policy, the Memorandum and Articles of Association, Other Indemnity Provisions or otherwise of the amounts otherwise indemnifiable by the Company hereunder.
17.Subrogation. In the event of payment to Indemnitee under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee. Indemnitee shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable the Company effectively to bring suit to enforce such rights.
18.Amendments. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be binding unless in the form of a writing signed by the party against whom enforcement of the waiver is sought, and no such waiver shall operate as a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided herein, no failure to exercise or any delay in exercising any right or remedy hereunder shall constitute a waiver thereof.
19.Binding Effect. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), assigns, spouses, heirs and personal and legal representatives. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part of the business and/or assets of the Company, by written agreement in form and substances



satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.
20.Severability. The provisions of this Agreement shall be severable in the event that any of the provisions hereof (including any portion thereof) are held by a court of competent jurisdiction to be invalid, illegal, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the fullest extent permitted by law. Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.
21.Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given (i) if delivered by hand, against receipt, (ii) if delivered by reputable overnight or international courier, upon actual delivery, or (iii) if delivered by electronic mail, provided no message is received by sender indicating that the electronic mail was not delivered to its intended recipient, and, in the case of clauses (ii) and (iii), delivered:
(a)if to Indemnitee, to the address set forth on the signature page hereto.
(b)if to the Company, to:
400 Stonebreak Road Extension
Malta, NY 12020
United States
Attention: General Counsel
E-Mail: legal.notices@gf.com
Notice of change of address shall be effective only when given in accordance with this Section.
22.Governing Law and Forum. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware applicable to contracts made and to be performed in such state without giving effect to its principles of conflicts of laws. The Company and Indemnitee hereby irrevocably and unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state or federal court in the United States, (b) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement and (c) waive, and agree not to plead or make, any claim that the Delaware Court lacks venue or that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.THE COMPANY AND INDEMNITEE HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT.



23.Headings. The headings of the sections and paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction or interpretation thereof.
24.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original, but all of which together shall constitute one and the same Agreement.
[SIGNATURE PAGE FOLLOWS]



IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.        

GLOBALFOUNDRIES Inc.

By:         
Name:         
Title:         



[Signature Page to Indemnification Agreement]



INDEMNITEE

By:         
Name:         
Address:         
E-Mail:             

[Signature Page to Indemnification Agreement]
EX-8 5 ex8asofdec312023.htm EX-8 Document

EXHIBIT 8
Subsidiaries of GLOBALFOUNDRIES Inc.
 
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries Inc.
GF Asia Investments Pte. Ltd.
  Singapore  100%
GF Asia Sales Pte. Ltd.
  Singapore  100%
GlobalFoundries Borrower LLC
  Delaware  100%
GlobalFoundries Investments LLC
  Delaware  100%
GlobalFoundries Netherlands Cooperatief U.A.
  Netherlands  99%
GlobalFoundries Singapore Pte. Ltd.
  Singapore  100%
GlobalFoundries Finance Inc.
  Cayman  100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GF Asia Investments Pte. Ltd.
GA (Chengdu) Technology Co. Ltd.  China  100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries Investments LLC
GlobalFoundries Netherlands Cooperatief U.A.
  Netherlands  1%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries Netherlands
Cooperatief U.A.
GlobalFoundries Netherlands Holding B.V.
  Netherlands  100%
GlobalFoundries U.S. Inc.
  Delaware  100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries U.S. Inc.
GlobalFoundries Engineering Private Limited
  India  0.01%
GlobalFoundries Innovation LLC
  Delaware  100%
GlobalFoundries U.S. 2 LLC
  Delaware  100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries U.S. 2 LLC
GF Power LLC
Vermont100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries Netherlands 
Holding B.V.
GlobalFoundries Bulgaria EAD
  Bulgaria  100%
GlobalFoundries Dresden Module One LLC
  Delaware  6%
GlobalFoundries Dresden Module Two LLC
  Delaware  100%
GlobalFoundries Engineering Private Limited
  India  99.99%



GlobalFoundries Europe Sales & Support GmbH
  Germany  100%
GlobalFoundries Management Services LLC & Co. KG
  Germany  89.8%
GlobalFoundries France SAS
  France  100%
Name of Subsidiary  
Jurisdiction of
Incorporation
  
Ownership by
GlobalFoundries Management
Services LLC & Co. KG
Advanced Mask Technology Center GmbH & Co. KG
  Germany  50%(a)
GlobalFoundries Dresden Module One LLC
  Delaware  94%
GlobalFoundries Dresden Module One Holding GmbH
  Germany  100%
GlobalFoundries Dresden Module Two Holding GmbH
  Germany  100%
Maskhouse Building Administration GmbH & Co. KG
  Germany  50%(b)
Name of Subsidiary
Jurisdiction 
of
Incorporation
Ownership by
Advanced Mask Technology Center
GmbH & Co. KG
Advanced Mask Technology Center Verwaltungs GmbH
Germany100%
Name of Subsidiary
Jurisdiction 
of
Incorporation
Ownership by
Maskhouse Building Administration
GmbH & Co. KG
Maskhouse Building Administration Verwaltungs GmbH
Germany100%
Name of Subsidiary
Jurisdiction 
of
Incorporation
Ownership by
GlobalFoundries Dresden Module One
Holding GmbH
GlobalFoundries Dresden Module One LLC & Co. KG
Germany100%
GlobalFoundries Management Services LLC & Co. KG
Germany5.1%
Name of Subsidiary
Jurisdiction 
of
Incorporation
Ownership by
GlobalFoundries Dresden Module
Two Holding GmbH
GlobalFoundries Dresden Module Two LLC & Co. KG
Germany100%
GlobalFoundries Management Services LLC & Co. KG
Germany5.1%
Name of Subsidiary
Jurisdiction 
of
Incorporation
Ownership by
GlobalFoundries Singapore Pte. Ltd.
GlobalFoundries China (Beijing) Co., Limited
China100%
GlobalFoundries China (Shanghai) Co., Limited
China100%
GlobalFoundries Europe Ltd.
U.K.100%



GlobalFoundries Japan Ltd.
Japan100%
GlobalFoundries Taiwan Ltd.
Taiwan100%
GlobalFoundries Malaysia Sdn. Bhd. (Malaysia)
Malaysia100%


(a)50% held by Toppan Photomasks, Inc.
(b)50% held by Toppan Photomasks, Inc.


EX-12.1 6 exhibit121-2024xcaulfieldx.htm EX-12.1 Document

Exhibit 12.1
CERTIFICATION
I, Dr. Thomas Caulfield, certify that:
1.   I have reviewed this annual report on Form 20-F of GLOBALFOUNDRIES Inc.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4.    The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and



5.    The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
Date: April 29, 2024                            
By:
/s/ Thomas Caulfield
Name:Dr. Thomas Caulfield
Title:President & Chief Executive Officer


EX-12.2 7 exhibit122-2024xhollisterx.htm EX-12.2 Document

Exhibit 12.2
CERTIFICATION
I, John Hollister, certify that:
1.   I have reviewed this annual report on Form 20-F of GLOBALFOUNDRIES Inc.;
2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
4.    The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)    Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)    Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and



5.    The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):
(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
Date: April 29, 2024                            
By:
/s/ John Hollister
Name:John Hollister
Title:Chief Financial Officer


EX-13.1 8 exhibit131-2024section906c.htm EX-13.1 Document

Exhibit 13.1

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of GLOBALFOUNDRIES Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:
1.The Annual Report on Form 20-F for the year ended December 31, 2023 (the “Form 20-F”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 29, 2024
By:/s/ Thomas Caulfield
Name:Dr. Thomas Caulfield
Title:President & Chief Executive Officer


Date: April 29, 2024
 
By:/s/ John Hollister
Name:John Hollister
Title:Chief Financial Officer



EX-15.1 9 exhibit151consentletterfin.htm EX-15.1 Document

Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement (No. 333-260674) on Form S-8 of our reports dated April 29, 2024, with respect to the consolidated financial statements of GLOBALFOUNDRIES Inc. and subsidiaries and the effectiveness of internal control over financial reporting.


/s/ KPMG LLP
Singapore
April 29, 2024


EX-15.2 10 exhibit152responseletter.htm EX-15.2 exhibit152responseletter
KPMG LLP 12 Marina View, #15-01 Asia Square Tower 2 Singapore 018961 Telephone Fax Website +65 6213 3388 +65 6225 0984 kpmg.com.sg KPMG LLP (Registration No. T08LL1267L), an accounting limited liability partnership registered in Singapore under the Limited Liability Partnerships Act 2005 and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. April 29, 2024 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We are currently principal accountants for GLOBALFOUNDRIES Inc. and, under the date of April 29, 2024, we reported on the consolidated financial statements of GLOBALFOUNDRIES Inc. as of and for the years ended December 31, 2023 and 2022, and the effectiveness of internal control over financial reporting as of December 31, 2023. On January 23, 2024, we were notified that GLOBALFOUNDRIES Inc. will engage PricewaterhouseCoopers LLP (“PwC”) as its principal accountant for the year ending December 31, 2024 and that the auditor-client relationship with KPMG LLP will cease upon completion of the audit of GLOBALFOUNDRIES Inc.’s consolidated financial statements as of and for the year ended December 31, 2023, and the effectiveness of internal control over financial reporting as of December 31, 2023, and the issuance of our reports thereon. We have read GLOBALFOUNDRIES Inc.’s statements included under Item 16F of its Form 20-F dated April 29, 2024, and we agree with such statements, except that we are not in a position to agree or disagree with GLOBALFOUNDRIES Inc’s stated reason for changing principal accountants, and we are not in a position to agree or disagree with GLOBALFOUNDRIES Inc.’s statement that PwC was not engaged regarding the application of accounting principles to a specified transaction or the type of audit opinion that might be rendered on GLOBALFOUNDRIES Inc.’s consolidated financial statements or the effectiveness of internal control over financial reporting. Very truly yours, /s/ KPMG LLP Singapore


 
EX-97 11 exhibit97-recoupmentpolicy.htm EX-97 Document
Exhibit 97


Compensation Recoupment Policy of
GlobalFoundries Inc.
October 2, 2023



DB1/ 137062232.10



Article A.Purpose and General Terms
Section A-1.Purpose.

GlobalFoundries Inc. (the “Company”) has adopted this Compensation Recoupment Policy (this “Policy”) to:
(a)implement a mandatory Clawback Policy in the event of a Restatement in compliance with the applicable rules of the Nasdaq Global Market (“Nasdaq”), which is set forth in Article B of this Policy; and
(b)implement a discretionary Clawback Policy to recoup certain compensation in circumstances involving misconduct, as determined advisable in the discretion of the Committee, which is set forth in Article C of this Policy.
Any capitalized terms used, but not immediately defined, in this Policy have the meanings set forth in Section A-6, Section B-1 or Section C-1, as applicable.
Section A-2. Administration.

This Policy shall be administered in the sole discretion of the Committee. The Committee shall have the discretion to interpret the Policy and make all determinations with respect to this Policy, consistent with applicable law and this Policy. Without limiting the foregoing:
(a)Article B of this Policy shall be interpreted in a manner that is consistent with the requirements of the Applicable Rules, and compliance with this Policy shall not be waived by the Committee, the Board or the Company in any respect; and
(b)Article C of this Policy shall be interpreted in the Committee’s sole discretion; provided that the Board may assume any or all powers and authority of the Committee with respect to administration of Article C, in which case references to the Committee shall be deemed to include the Board, as applicable.
Any interpretations and determinations made by the Committee shall be final and binding on all affected individuals.
Section A-3.Effective Date; Term.

This Policy is effective as of October 2, 2023 (the “Effective Date”). Article B of this Policy applies to Incentive-Based Compensation that is Received by any Executive Officer on or after the Effective Date as described in Section B-3 below.
Section A-4.Amendment.

The Committee may amend this Policy from time to time in its discretion, subject to any limitations under applicable law or listing standards, including, in the case of Article B, the Applicable Rules.
1
DB1/ 137062232.10



Without limiting the foregoing, the Committee may amend this Policy as it deems necessary to reflect any amendment of the Applicable Rules or regulations or guidance issued under the Applicable Rules.
Section A-5.No Substitution of Rights; Non-Exhaustive Rights.

Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights that may be available to the Company pursuant to (a) the GlobalFoundries Inc. 2018 Omnibus Stock Incentive Plan, as amended, or any successor plan thereto, the GlobalFoundries Inc. 2021 Equity Compensation Plan, as amended, or any successor plan thereto, the Company’s annual bonus plan or any other incentive plan of the Company or any of its subsidiaries, (b) the terms of any recoupment policy or provision in any employment agreement, compensation agreement or arrangement, or other agreement, or (c) any other legal remedies available to the Company under applicable law.
In addition to recovery of compensation as provided for in this Policy, the Company may take any and all other actions as it deems necessary, appropriate and in the Company’s best interest in connection with the Committee determining that this Policy should apply, including termination of the employment of, or initiating legal action against, an Executive Officer or Covered Person (as applicable), and nothing in this Policy limits the Company’s rights to take any such appropriate actions.
Section A-6.Defined Terms.

The following capitalized terms used in this Policy have the following meanings:

(a)Applicable Rules” means Section 10D of the Exchange Act and Rule 10D-1 promulgated thereunder and Listing Rule 5608 of the Listing Rules of The Nasdaq Stock Market.
(b)Board” means the Board of Directors of the Company.
(c)Clawback Compensation” means, for the purposes of Article B, Incentive-Based Compensation and, for the purposes of Article C, Covered Compensation, in each case as determined to be subject to repayment pursuant to this Policy.
(d)Committee” means the People and Compensation Committee of the Company, or, in the absence of such committee, a majority of independent directors serving on the Board.
(e)Exchange Act” means the Securities Exchange Act of 1934, as amended.
(f)Regulators” means, as applicable, the Securities and Exchange Commission and Nasdaq.

Article B.Dodd-Frank Recoupment Policy for
Executive Officers
Section B-1.Specific Defined Terms. For the purposes of this Article B, the following terms have the following meanings, which will be interpreted to comply with the Applicable Rules:

2
DB1/ 137062232.10



(a)Executive Officer” means each officer of the Company who serves as the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice president of the Company in charge of a principal business unit, division or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar significant policy-making functions for the Company, as determined pursuant to 17 CFR § 229.401(b).1

(b)Financial Reporting Measures” means (i) measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures, (ii) the Company’s stock price, and (iii) total shareholder return in respect of the Company. A “Financial Reporting Measure” need not be presented within the financial statements or included in a filing with the SEC.
(c)Incentive-Based Compensation” means any compensation that is granted, earned, or vested, based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive-Based Compensation does not include, among other forms of compensation, equity awards that vest exclusively upon completion of a specified employment period, without any performance condition, and bonus awards that are discretionary or based on subjective goals or goals unrelated to Financial Reporting Measures.
(d)Received” – Incentive-Based Compensation is deemed “Received” for the purposes of this Policy in the Company’s fiscal period during which the Financial Reporting Measure applicable to the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period.
(e)Recovery Period” means the three completed fiscal years immediately preceding the date on which the Company is required to prepare a Restatement, which date is the earlier of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement or (ii) a date that a court, regulator or other legally authorized body directs the Company to prepare a Restatement.
(f)Restatement” means that the Company is required to prepare an accounting restatement due to a material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements (i) that is material to the previously issued financial statements, or (ii) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
1 The intent of this Policy is that “Executive Officers” will be consistent with the officers listed in the 20-F and consistent with the Applicable Rules.
3
DB1/ 137062232.10



Section B-2.Recovery on a Restatement.

In the event the Company is required to prepare a Restatement, the Company shall reasonably promptly recover from an Executive Officer the amount of any erroneously awarded Incentive-Based Compensation that is Received by such Executive Officer during the Recovery Period. The amount of erroneously Received Incentive-Based Compensation will be the excess of the Incentive-Based Compensation Received by the Executive Officer (whether in cash or shares) based on the erroneous data in the original financial statements over the Incentive-Based Compensation (whether in cash or in shares) that would have been Received by the Executive Officer had such Incentive-Based Compensation been based on the restated results, without respect to any tax liabilities incurred or paid by the Executive Officer.
Without limiting the foregoing, for Incentive-Based Compensation based on the Company’s stock price or total shareholder return, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the Restatement, (a) the amount shall be based on the Company’s reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received and (b) the Company shall maintain documentation of the determination of that reasonable estimate and provide such estimate to Nasdaq.
Section B-3.Covered Executive Officers and Covered Incentive-Based Compensation.

This Article B covers all persons who are Executive Officers at any time during the Recovery Period for which Incentive-Based Compensation is Received. Incentive-Based Compensation shall not be recovered under this Article B to the extent Received by any person before the date the person served as an Executive Officer. Subsequent changes in an Executive Officer’s employment status, including retirement or termination of employment, do not affect the Company’s right to recover Incentive-Based Compensation pursuant to this Article B.
Article B of this Policy shall apply to Incentive-Based Compensation that is Received by any Executive Officer on or after the Effective Date, consistent with the Applicable Rules.
Section B-4.Methods of Recovery; Limited Exceptions.

The Committee shall determine, in its sole discretion, the method of recovering any Incentive-Based Compensation Received pursuant to this Article B, consistent with applicable law, which may include, without limitation, the methods of recovery described in Article D.
No recovery shall be required if any of the following conditions are met and the Committee determines that, on such basis, recovery would be impracticable:
(a)the direct expense paid to a third party to assist in enforcing this Article B would exceed the amount to be recovered; provided that prior to making a determination that it would be impracticable to recover any Incentive-Based Compensation based on the expense of enforcement, the Company shall (i) have made a reasonable attempt to recover the Incentive-Based Compensation, (ii) have documented such reasonable attempts to recover, and (iii) provide the documentation to Nasdaq;
4
DB1/ 137062232.10



(b)recovery would violate home country law where that law was adopted prior to November 28, 2022; provided that, prior to making a determination that it would be impracticable to recover any Incentive-Based Compensation based on a violation of home country law, the Company shall (i) have obtained an opinion of home country counsel, acceptable to Nasdaq, that recovery would result in such violation, and (ii) provide a copy of such opinion to Nasdaq; or
(c)recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and U.S. Treasury regulations promulgated thereunder.
Section B-5.Reporting; Disclosure; Monitoring.

The Company shall make all required disclosures and filings with the Regulators with respect to this Policy in accordance with the requirements of the Applicable Rules, and any other requirements applicable to the Company, including the disclosures required in connection with SEC filings.

Article C.Discretionary Compensation Clawback Policy for
Certain Acts of Misconduct
Section C-1.Specific Defined Terms. For the purposes of this Article C, the following terms have the following meanings:

(a)Covered Compensation” means all (i) incentive-based cash compensation granted to a Covered Person, including, without limitation, any annual bonuses and other short- and long-term cash incentives, (ii) performance share units, and (iii) any proceeds or earnings received in respect of (i) or (ii). For the avoidance of doubt, the foregoing includes any compensation that was previously paid, earned, vested, deferred or paid or payable as a component of severance or termination compensation.
(b)Covered Event” means the date on which the Committee makes the following determination:
(i)a Restatement has occurred and the Committee determines that a Covered Person engaged in misconduct that directly or indirectly resulted in the Restatement, or
(ii)the Committee determines that a Covered Person has engaged in any of the following acts or failures to act: (A)  any willful, intentional or grossly negligent act having the effect of materially injuring (whether financially or otherwise) the business or reputation of the Company or any of its affiliates (other than acts that were performed in a good faith attempt to advance the business interests of the Company); (B) conviction of any felony involving moral turpitude (including entry of a guilty or nolo contendere plea) with respect to the Company or its affiliates; (C)  material breach of a Company policy, including the Company’s Code of Conduct; (D) any material misappropriation or embezzlement of the property of the Company or its affiliates (whether or not a
5
DB1/ 137062232.10



misdemeanor or felony); and/or (E) breach of any material provision of any restrictive covenant or other agreement between the Covered Person and the Company or any of its affiliates that is materially injurious to the Company or its affiliates.

(c)Covered Period” means the fiscal year in which the Committee determines a Covered Event has occurred and the three completed fiscal years immediately preceding such fiscal year.

(d)Covered Person” means (i) each Executive Officer; (ii) and all Senior Vice Presidents and above who are not Executive Officers of the Company and its subsidiaries or affiliates as may be determined by the Committee to be subject to this Article C.
Section C-1.Discretionary Recovery on a Covered Event.

If a Covered Event occurs with respect to a Covered Person, the Committee may determine whether, and the extent to which, the following forms of Covered Compensation should be recovered from such Covered Person: (a) Covered Compensation that is outstanding (whether vested or unvested) as of the date of the Committee’s Covered Event determination, and (b) Covered Compensation that is or was granted, Received (as defined for purposes of Article B), vested, settled or distributed (including, in the case of stock options or stock appreciation rights, compensation received upon exercise) during the Covered Period.
Section C-2. Coverage.

Subsequent changes in a Covered Person’s employment status or status as a service provider, including retirement or termination of employment, do not affect the Company’s rights to recover Covered Compensation pursuant to this Article C.

Article D.Methods of Recovery
Section D-1.Subject to Section B-4, in the event that the Committee determines that this Policy should apply, to the extent permitted by applicable law, the Company shall, as determined by the Committee in its sole discretion, take any such actions as it deems necessary or appropriate to recover Clawback Compensation. The actions may include, without limitation (and as applicable):

(a)forfeit, reduce or cancel any Clawback Compensation (whether vested or unvested) that has not been distributed or otherwise settled;
(b)seek recovery of any Clawback Compensation that was previously paid to the Executive Officer or Covered Person (as applicable);
(c)seek recovery of any amounts realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based Clawback Compensation;
(d)recoup any amount in respect of Clawback Compensation that was contributed or deferred to a plan that takes into account Clawback Compensation (excluding certain tax-qualified plans, but
6
DB1/ 137062232.10



including deferred compensation plans, and supplemental executive retirement plans, and insurance plans to the extent otherwise permitted by applicable law, including Section 409A of the Code) and any earnings accrued on such Clawback Compensation;
(e)except as otherwise required by Article B, determine whether Clawback Compensation should be recouped on a pre-tax or after-tax basis;
(f)offset, withhold or eliminate any compensation that could be paid or awarded to the Executive Officer or Covered Person (as applicable) after the date of determination; and
(g)take any other remedial and recovery action permitted by law, as determined by the Committee.
In addition, the Committee may authorize legal action for breach of fiduciary duty or other violation of law and take such other actions to enforce the obligations of the Executive Officer or Covered Person (as applicable) to the Company as the Committee deems appropriate.

Section D-2.Notice. Before the Company takes action to seek recovery of compensation pursuant to this Policy against an Executive Officer or Covered Person (as applicable), the Company shall take commercially reasonable steps to provide such individual with advance written notice of such clawback; provided that this notice requirement shall not in any way delay the reasonably prompt recovery of any erroneously awarded Incentive-Based Compensation pursuant to Article B.
Section D-3.No Indemnification. The Company shall not indemnify any current or former Executive Officer or Covered Person (as applicable) against the loss of erroneously awarded compensation, and shall not pay or reimburse any such person for premiums incurred or paid for any insurance policy to fund such person’s potential recovery obligations.

7
DB1/ 137062232.10

EX-101.SCH 12 gfs-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Summary of Material Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Cash And Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Receivables, Prepayments and Other Assets link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Other Financial Assets And Liabilities link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Trade Payables and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Provisions link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Government Grants link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Issued Capital and Reserves link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Net Revenue link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Cost of Revenue link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Research and Development Expenses link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Selling, General and Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Restructuring link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Finance Income and Expenses link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Gain on Sale of a Business link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Other Income (Expense), Net link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Employee Benefits Plans link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Related Party Disclosures link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Financial Risk Management Objectives and Policies link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Operating Segments Information link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Customer And Supplier Concentration link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Summary of Material Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Summary of Material Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Cash And Cash Equivalents (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Receivables, Prepayments and Other Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Other Financial Assets And Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Trade Payables and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Government Grants (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Net Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Cost of Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Research and Development Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Selling, General and Administrative Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Finance Income and Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Gain on Sale of a Business (Tables) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Other Income (Expense), Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Related Party Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Financial Risk Management Objectives and Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Operating Segments Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Customer And Supplier Concentration (Tables) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Summary of Material Accounting Policies - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Receivables, Prepayments and Other Assets - Maturity Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Inventories - Summary of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Property, Plant and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Property, Plant and Equipment - Schedule of Depreciation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Other Financial Assets And Liabilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Other Financial Assets And Liabilities - Effect on Financial Statements (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Long-Term Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Long-Term Debt - Movements in Interest bearing Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Long-Term Debt - Summary of Term Loan Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - Long-Term Debt - Summary of Unutilized Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - Leases - Additional Information about Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - Leases - Maturity of Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - Leases - Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - Leases - Schedule of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - Provisions - Movement in Provision for Asset Retirement Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - Provisions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954534 - Disclosure - Government Grants - Roll forward of Government Grants (Details) link:presentationLink link:calculationLink link:definitionLink 9954535 - Disclosure - Government Grants - Located in Consolidated Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954536 - Disclosure - Issued Capital and Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 9954537 - Disclosure - Net Revenue - Disaggregated Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 9954538 - Disclosure - Net Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954539 - Disclosure - Cost of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954540 - Disclosure - Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954541 - Disclosure - Selling, General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954542 - Disclosure - Restructuring (Details) link:presentationLink link:calculationLink link:definitionLink 9954543 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954544 - Disclosure - Share-Based Compensation - RSU and PSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954545 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954546 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954547 - Disclosure - Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details) link:presentationLink link:calculationLink link:definitionLink 9954548 - Disclosure - Finance Income and Expenses- Finance Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954549 - Disclosure - Finance Income and Expenses- Finance Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954550 - Disclosure - Gain on Sale of a Business - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954551 - Disclosure - Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details) link:presentationLink link:calculationLink link:definitionLink 9954552 - Disclosure - Other Income (Expense), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954553 - Disclosure - Income Taxes - Income tax benefit (expense) (Details) link:presentationLink link:calculationLink link:definitionLink 9954554 - Disclosure - Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details) link:presentationLink link:calculationLink link:definitionLink 9954555 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954556 - Disclosure - Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954557 - Disclosure - Income Taxes - Classification of deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954558 - Disclosure - Income Taxes - Reconciliation of Deferred Tax assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954559 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954560 - Disclosure - Employee Benefits Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954561 - Disclosure - Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details) link:presentationLink link:calculationLink link:definitionLink 9954562 - Disclosure - Related Party Disclosures - Transactions with Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 9954563 - Disclosure - Related Party Disclosures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954564 - Disclosure - Related Party Disclosures - Compensation to Key Management Personnel (Details) link:presentationLink link:calculationLink link:definitionLink 9954565 - Disclosure - Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details) link:presentationLink link:calculationLink link:definitionLink 9954566 - Disclosure - Financial Risk Management Objectives and Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954567 - Disclosure - Financial Risk Management Objectives and Policies - Aging of Financial assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954568 - Disclosure - Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954569 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954570 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954571 - Disclosure - Commitments and Contingencies - Unconditional Purchase Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 9954572 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954573 - Disclosure - Operating Segments Information - Revenue by Geography (Details) link:presentationLink link:calculationLink link:definitionLink 9954574 - Disclosure - Operating Segments Information - Noncurrent Assets by Geography (Details) link:presentationLink link:calculationLink link:definitionLink 9954575 - Disclosure - Customer And Supplier Concentration - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954576 - Disclosure - Customer And Supplier Concentration - Revenue by Major Customers (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 gfs-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 14 gfs-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 15 gfs-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Inventory Inventory Tax Difference [Member] Inventory Tax Difference Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Table] Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Table] Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities Cost Gross carrying amount [member] Non-controlling interests Other comprehensive income, attributable to non-controlling interests Non-current liabilities: Non-current liabilities [abstract] Ranges of exercise prices for outstanding share options [member] Ranges of exercise prices for outstanding share options [member] 91-120 Days Later than three months and not later than four months [member] Financial assets, category [member] Financial assets, category [member] Cash equivalents Cash Equivalent [Member] Cash Equivalent Provisions Current provisions Depreciation and amortization Adjustments for depreciation and amortisation expense Investments in equity instruments Trading equity securities [member] Other states Other states [Member] Other states Non-deductible expenses for tax purposes Tax effect of expense not deductible in determining taxable profit (tax loss) Released to the consolidated statements of operations Contract Liabilities, Released Contract Liabilities, Released Other change in temporary differences Other components of deferred tax expense (income) Number of shares authorised (in shares) Number of shares authorised Employee Share Purchase Plan Employee Share Purchase Plan [Member] Employee Share Purchase Plan Trade payables Current trade payables Disclosure of major customers Disclosure of major customers [text block] Receivables, Prepayments and Other Assets Disclosure of trade and other receivables [text block] 2019 EUR Dresden Equipment Financing Noncurrent 2019 EUR Dresden Equipment Financing Noncurrent [Member] 2019 EUR Dresden Equipment Financing Noncurrent Share Capital, Reserves, and Other Equity Interest [Abstract] Share Capital, Reserves, and Other Equity Interest [Abstract] Revenue recognized over time Goods or services transferred over time [member] Disposals Disposals, intangible assets and goodwill Annual increase percentage Share-Based Payment Arrangement, Annual Increase Percentage Share-Based Payment Arrangement, Annual Increase Percentage Other Other Research And development Expenses Other Research And development Expenses Range [axis] Range [axis] Depreciation of property, plant and equipment and amortization of intangible assets Selling, General And Administrative Expenses, Depreciation And Amortisation Selling, General And Administrative Expenses, Depreciation And Amortisation Contact Personnel Email Address Contact Personnel Email Address RSUs Restricted share units [member] Past due status Past due status [member] Weighted average exercise price per Share Weighted Average Exercise Price Per Share [Abstract] Weighted Average Exercise Price Per Share Finance income Total finance income Finance income Financial instruments, class [member] Financial instruments, class [member] Due within the next 12 months Contractual Capital And Operating Commitments, Current Contractual Capital And Operating Commitments, Current Trading Symbol Trading Symbol Other transactions with: Other Purchases Of Goods, Related Party Transactions Other Purchases Of Goods, Related Party Transactions Analysis of income and expense [abstract] All Currencies [Domain] All Currencies [Domain] Assets Arising From Financing Activities [Axis] Assets Arising From Financing Activities [Axis] Assets Arising From Financing Activities Minimum interest on license agreement License Agreement, Minimum Interest Percentage License Agreement, Minimum Interest Percentage Term (in years) Share-Based Compensation Arrangement By Share-Based Payment Award, Award Term Share-Based Compensation Arrangement By Share-Based Payment Award, Award Term Share-Based Compensation Disclosure of share-based payment arrangements [text block] Schedule of balances with related parties included in the consolidated statements of financial position Disclosure Of Balances With Related Parties In The Consolidated Statements Of Financial Position [Table Text Block] Disclosure Of Balances With Related Parties In The Consolidated Statements Of Financial Position Effect of exchange rate changes on cash and cash equivalents Effect of exchange rate changes on cash and cash equivalents Due to Related Parties Amounts payable, related party transactions Disclosure of detailed information about property, plant and equipment [line items] Disclosure of detailed information about property, plant and equipment [line items] Trade Payables and Other Liabilities Disclosure of trade and other payables [text block] Interest paid Interest paid, classified as operating activities Minimum present value of operating lease payments due Minimum Present Value Of Operating Lease Payments due Minimum Present Value Of Operating Lease Payments due Total liabilities and equity Equity and liabilities Provisions at beginning of period Provisions at end of period Provisions Other provisions Schedule of unbilled accounts receivables Disclosure Of Detailed Information About Activity In Unbilled Accounts Receivables [Table Text Block] Disclosure Of Detailed Information About Activity In Unbilled Accounts Receivables Employee contributions matched by employer (as a percent) Percent Of Match, Defined Contribution Plans Defined Benefit Liability, Percentage Of Employee Contributions Matched By Company Total comprehensive income (loss) Comprehensive income [abstract] Local Phone Number Local Phone Number Basis of Consolidation Description of accounting policy for subsidiaries [text block] Additional Paid-In Capital Additional paid-in capital [member] Forfeited (in dollars per share) Weighted average exercise price of share options forfeited in share-based payment arrangement Short-term and low-value leases expense Payments of short-term and low-value leases Expense Relating To Short-Term And Low-Value Leases For Which Recognition Exemption Has Been Used Expense Relating To Short-Term And Low-Value Leases For Which Recognition Exemption Has Been Used Contract liabilities Current Current contract liabilities Non- controlling Interest Non-controlling interests [member] Temporary difference, unused tax losses and unused tax credits [member] Temporary difference, unused tax losses and unused tax credits [member] Vesting percentage Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Percentage Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Percentage Revenue recognized at a point in time Goods or services transferred at point in time [member] Maturity [axis] Maturity [axis] Financial Instruments Description of accounting policy for financial instruments [text block] Trade receivables Trade receivables Investments in marketable securities Debt securities [member] Other receivables Other Receivables [Member] Other Receivables Inventories Disclosure of inventories [text block] Other Other Selling, General And Administrative Expenses Other Selling, General And Administrative Expenses Borrowing Costs Description of accounting policy for borrowing costs [text block] Construction in Progress Construction in progress [member] Other Non-current Financial Liabilities Other Noncurrent Financial Liabilities [Member] Other Noncurrent Financial Liabilities Adjustments in respect of current income tax of previous year Adjustments for current tax of prior periods Exercised (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Total current liabilities Current liabilities Cross currency swaps (receive Singapore $/pay US$) Cross Currency Swaps, Singapore [Member] Cross Currency Swaps, Singapore Disclosure of provision matrix [table] Disclosure of provision matrix [table] Useful life (in years) Useful life measured as period of time, intangible assets other than goodwill Document Accounting Standard Document Accounting Standard Geographical areas [axis] Geographical areas [axis] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Share-based payment arrangement, performance period (in years) Share-Based Payment Arrangement, Performance Period Share-Based Payment Arrangement, Performance Period Attributable to: Other comprehensive income [abstract] Basis of Measurement Description of accounting policy for fair value measurement [text block] Withholding Tax Tax Effect Of Withholding Taxes Tax Effect Of Withholding Taxes Property, plant and equipment, net Beginning of period End of period Property, plant and equipment including right-of-use assets Currency effect Currency Effect Tax Difference [Member] Currency Effect Tax Difference Debt Other long-term debt Long-term borrowings [member] Income from government grants Income from government grants Total non-current assets Non-current assets Disclosure of other provisions [line items] Disclosure of other provisions [line items] Exercisable (in dollars per share) Weighted average exercise price of share options exercisable in share-based payment arrangement Purchase of marketable securities Purchase Of Investment In Marketable Securities Purchase Of Investment In Marketable Securities Equity attributable to the shareholders of GLOBALFOUNDRIES INC. Equity attributable to owners of parent Current income tax receivable Current tax assets, current Cash flow hedges Cash flow hedges [member] Great than 120 days Later than four months [member] Gain on the sale of a business Adjustments For Gain (Loss) Recognised On Measurement To Fair Value Less Costs To Sell Or On Disposal Of Assets Or Disposal Groups Constituting Discontinued Operation Adjustments For Gain (Loss) Recognised On Measurement To Fair Value Less Costs To Sell Or On Disposal Of Assets Or Disposal Groups Constituting Discontinued Operation Inventories Adjustments for decrease (increase) in inventories Disclosure of detailed information about borrowings [table] Disclosure of detailed information about borrowings [table] Security Exchange Name Security Exchange Name Ten Largest Customers Ten Largest Customers [Member] Ten Largest Customers Beginning contract liabilities balance Ending contract liabilities balance Contract liabilities After 5 years Later than five years [member] Maximum Maximum [Member] Marketable securities Non-current financial assets available-for-sale Document Type Document Type Cash Flows (Inflows)/ Outflows Increase (Decrease) Through Changes In Fair Values, Assets Arising From Financing Activities Increase (Decrease) Through Changes In Fair Values, Assets Arising From Financing Activities Gross profit Gross profit Operating Segments Information Disclosure of entity's operating segments [text block] Finance expense Total finance expenses Finance costs Other income (expense), net Total other income (expense), net Other operating income (expense) Amount incurred by entity for provision of key management personnel services provided by separate management entity Amount incurred by entity for provision of key management personnel services provided by separate management entity Schedule of selling, general and administrative expenses Disclosure Of Summary Of Selling, General And Administrative Expenses [Table Text Block] Disclosure Of Summary Of Selling, General And Administrative Expenses Beginning balance (in shares) Ending balance (in shares) Number Outstanding Number of share options outstanding in share-based payment arrangement Inventories Inventories Staff costs, maintenance costs, and utilities Research And Development Expenses, Staff Costs Research And Development Expenses, Staff Costs Non-controlling interest Profit (loss), attributable to non-controlling interests Continuing operations [member] Continuing operations [member] Amortization of deferred income from government grants Adjustments For Amortization Of Deferred Income From Government Grants Adjustments For Amortization Of Deferred Income From Government Grants Property, Plant and Equipment Disclosure of property, plant and equipment [text block] Disclosure of detailed information about property, plant and equipment [table] Disclosure of detailed information about property, plant and equipment [table] Government grants [Abstract] Government grants [Abstract] Non-current: Noncurrent Borrowings [Abstract] Noncurrent Borrowings Risks [member] Risks [member] Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Profit or loss [abstract] Title of 12(b) Security Title of 12(b) Security Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of disaggregation of revenue from contracts with customers [table] Board of Directors Board Of Directors [Member] Board Of Directors Interest expense on lease liabilities Interest paid Interest on lease obligations Interest expense on lease liabilities Goodwill and Intangible Assets Disclosure of intangible assets and goodwill [text block] Minimum Undiscounted Operating Lease Payments due Minimum Undiscounted Operating Lease Payments due Minimum Undiscounted Operating Lease Payments due Cash Flows (Inflows)/ Outflows Increase (decrease) through financing cash flows, liabilities arising from financing activities Statistical Measurement [Axis] Statistical Measurement [Axis] Net increase (decrease) in cash and cash equivalents Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Goodwill and intangible assets, net Intangible assets and goodwill at beginning of period Intangible assets and goodwill at end of period Intangible assets and goodwill Entity Interactive Data Current Entity Interactive Data Current Expected volatility, share options granted Expected volatility, share options granted Building and leasehold/land improvements Building And Leasehold Improvements [Member] Building And Leasehold Improvements Non-current portion of deferred income from government grants Non-current government grants Attributable to: Comprehensive income attributable to [abstract] Quoted Prices Identical Assets/ Liabilities (Level 1) Level 1 of fair value hierarchy [member] Disclosure of summary of restructuring Disclosure of summary of restructuring [Table Text Block] Disclosure of summary of restructuring Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Shareholder of GLOBALFOUNDRIES INC. Profit (loss), attributable to owners of parent Net income (loss) attributable to equity shareholders of the Company Profit (loss), attributable to owners of parent 31 to 60 days Later than one month and not later than two months [member] Disclosure of number and weighted average exercise prices of share options Disclosure of number and weighted average exercise prices of share options [text block] Released to the consolidated statements of operations Government Grants Released To Financial Statements Government Grants Released To Financial Statements Location, Income Statement [Domain] Location, Income Statement [Domain] Location, Income Statement [Domain] Conversion of loan from shareholder Conversion of loan from shareholder Increase (Decrease) Through Transactions With Owners, Conversion Of Loan To Equity Increase (Decrease) Through Transactions With Owners, Conversion Of Loan To Equity Loss on hedging activities Gain (Loss) On Hedging Activities Gain (Loss) On Hedging Activities Software Computer software [member] Trade and other payables Trade payables and other liabilities Trade and other payables Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Receivables, prepayments and other assets Total Non-Current Prepayments And Other Current Assets Non-Current Prepayments And Other Current Assets Schedule of amortization expense Disclosure of detailed information about intangible assets [text block] Non-adjusting events after reporting period [member] Non-adjusting events after reporting period [member] Average Foreign Currency/ US$ Average foreign exchange rate Related Party Disclosures Disclosure of related party [text block] Adjustments in respect to current income tax of previous years Tax Effect Of Prior Year Income Tax Effect Of Prior Year Income Addition Increase (Decrease) Through Additional Changes, Assets Arising From Financing Activities Increase (Decrease) Through Additional Changes, Assets Arising From Financing Activities Current income tax payable Current tax liabilities Schedule of leases Disclosure of quantitative information about right-of-use assets [text block] Disclosure of maturity analysis of operating lease payments [table] Disclosure of maturity analysis of operating lease payments [table] Auditor Location Auditor Location Nonrefundable New York Empire Zone Nonrefundable New York Empire Zone [Member] Nonrefundable New York Empire Zone Hedging Reserve Reserve of cash flow hedges [member] Income Taxes Disclosure of income tax [text block] Classes of financial instruments [axis] Classes of financial instruments [axis] Expected dividend yield Expected dividend as percentage, share options granted Total equity Beginning balance Ending balance Additional-paid in capital Equity Operating Loss Carryforward Unused tax credits [member] Borrowing costs [Abstract] Borrowing costs Abstract [Abstract] Borrowing costs [Abstract] Germany GERMANY Unbilled accounts receivable Beginning balance Ending balance Current Unbilled Receivables Current Unbilled Receivables Maximum employee contributions matched by employer (as a percent) Maximum Percentage Of Employee Contributions Matched, Defined Contribution Plans Maximum Percentage Of Employee Contributions Matched, Defined Contribution Plans Description of nature of entity's operations and principal activities Description of nature of entity's operations and principal activities Derivative financial assets Derivative financial assets Operating Segments [Abstract] Operating Segments [Abstract] Components of equity [axis] Components of equity [axis] Fair value gain (loss) on investments measured at fair value through other comprehensive income Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax Document Shell Company Report Document Shell Company Report SMP Joint ventures where entity is venturer [member] Credit risk Credit risk [member] Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) Reclassification adjustments on cash flow hedges for which hedged item affected profit or loss, net of tax Repayments of shareholder loan Repayments Of Shareholder Loans Repayments Of Shareholder Loans Amount of Gain (Losses) Recognized into Income (Ineffective Portion) Gain (loss) on hedge ineffectiveness recognised in profit or loss 2019 Tool Equipment Purchase and Lease Financing 2019 Tool Equipment Purchase and Lease Financing [Member] 2019 Tool Equipment Purchase and Lease Financing Significant Unobservable Inputs (Level 3) Level 3 of fair value hierarchy [member] Total liabilities Total Liabilities Liabilities Liabilities Total other comprehensive income that will be reclassified to profit or loss, net of tax Other comprehensive income that will be reclassified to profit or loss, net of tax Other comprehensive income that will be reclassified to profit or loss, net of tax Research and Development Expenses Disclosure of research and development expense [text block] Cost of revenue Total cost of revenues Cost of sales 2-5 years Later than one year and not later than five years [member] Aggregated measurement [member] Aggregated measurement [member] Revolving Credit Facility Citibank Revolving Credit Facility [Member] Citibank Revolving Credit Facility Disclosure of fair value of financial instruments Disclosure of fair value of financial instruments [text block] Accumulated Amortization Accumulated depreciation and amortisation [member] Useful life (in years) Useful life measured as period of time, property, plant and equipment Disclosure of reclassifications or changes in presentation [line items] Disclosure of reclassifications or changes in presentation [line items] Effective income tax rate Tax rate effect from change in tax rate Lease obligations Lease liabilities [member] Other current financial assets Other current financial assets Provisions Disclosure of provisions [text block] Net cash provided by (used in) financing activities Cash flows from (used in) financing activities Disclosure of detailed information about property, plant and equipment [abstract] Disclosure of detailed information about property, plant and equipment [abstract] Schedule of research and development expenses Disclosure Of Summary Of Research And Development Expenses [Table Text Block] Disclosure Of Summary Of Research And Development Expenses Other disposals of assets Other disposals of assets [member] Disclosure of detailed information about borrowings Disclosure of detailed information about borrowings [text block] Financial assets, at fair value Fair Value Financial assets, at fair value Accretion cost Increase (Decrease) Through Change In Accretion Cost, Other Provision Increase (Decrease) Through Change In Accretion Cost, Other Provision Total Derivative And Non-Derivative Financial Liabilities, Undiscounted Cash Flows Derivative And Non-Derivative Financial Liabilities, Undiscounted Cash Flows Other comprehensive income (loss) Other Comprehensive Income Effect Tax Difference [Member] Other Comprehensive Income Effect Tax Difference Explanation of significant changes in contract assets and contract liabilities Explanation of significant changes in contract assets and contract liabilities [text block] Uncertain tax provisions Potential Income Tax Consequences Potential Income Tax Consequences Amortization of right-of-use assets Amortization Depreciation, right-of-use assets Receivables from government grant Non-current Receivables From Government Grants Non-current Receivables From Government Grants Issued Capital and Reserves Disclosure of share capital, reserves and other equity interest [text block] Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Short-term benefits Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer Short-Term Benefits [Member] Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Short-Term Benefits Non-current portion of long-term debt Non-current portion of non-current borrowings Non-current portion of non-current borrowings Government Grants [Line Items] Government Grants [Line Items] Government Grants [Line Items] Eurodollar [Member] Eurodollar [Member] Receivables neither past due nor impaired Current [member] Location, Income Statement [Axis] Location, Income Statement [Axis] Location, Income Statement Summary of commitments Disclosure of commitments [text block] Changes in estimates Disclosure of changes in accounting policies, accounting estimates and errors [text block] Interest received Interest received, classified as operating activities Change In Accounting Estimate Change In Accounting Estimate [Member] Change In Accounting Estimate Net operating and investment allowance carryforwards Adjustments for deferred tax of prior periods Computer Computer equipment [member] Total other comprehensive income (loss) for the year Other comprehensive income Other comprehensive income Proceeds from sale of a business Proceeds From Settlement Of loans Issued To Joint Ventures Proceeds From Settlement Of loans Issued To Joint Ventures Number of Share options Number Of Share Options [Abstract] Number Of Share Options Non-current portion of lease obligations Non-current Non-current lease liabilities Entity Emerging Growth Company Entity Emerging Growth Company Statement of financial position [abstract] Disclosure of reconciliation of liabilities arising from financing activities [line items] Disclosure of reconciliation of liabilities arising from financing activities [line items] Deferred tax Deferred tax expense (income) [abstract] Deferred income taxes Adjustments for deferred tax expense Investments in Joint Operations Description of accounting policy for investments in joint ventures [text block] Classes of share capital [axis] Classes of share capital [axis] Disclosure of geographical areas Disclosure of geographical areas [text block] Line items by function Line items by function [member] Inventories Total Current inventories Due from Related Parties Amounts receivable, related party transactions Other investing activities Other inflows (outflows) of cash, classified as investing activities Ranges [member] Ranges [member] Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] Unused Capital Allowances Unused Capital Allowances [Member] Unused Capital Allowances Entity Address, Postal Zip Code Entity Address, Postal Zip Code 2018 Tool Equipment Purchase and Lease Financing 2018 Tool Equipment Purchase and Lease Financing [Member] 2018 Tool Equipment Purchase and Lease Financing Types of risks [axis] Types of risks [axis] Finance expense Finance Expense [Member] Finance Expense Borrowings by name [axis] Borrowings by name [axis] Assets arising from financing activities at beginning of period Assets arising from financing activities at end of period Assets Arising From Financing Activities Assets Arising From Financing Activities Maximum employee subscription (in shares) Share-Based Payment Arrangement, Maximum Employee Subscription, Shares Share-Based Payment Arrangement, Maximum Employee Subscription, Shares Sensitivity analysis for types of market risk Sensitivity analysis for types of market risk [text block] Non-controlling interests Comprehensive income, attributable to non-controlling interests Other Current Financial Liabilities Other Current Financial Liabilities [Member] Other Current Financial Liabilities Minimum Minimum [Member] Accounting estimates [axis] Accounting estimates [axis] Aggregated time bands [member] Aggregated time bands [member] Business Contact Business Contact [Member] Disclosure of financial assets and liabilities Disclosure of financial liabilities [text block] Hedging instruments [axis] Hedging instruments [axis] Derivatives Derivatives [member] 2019 EUR Dresden Equipment Financing 2019 EUR Dresden Equipment Financing [Member] 2019 EUR Dresden Equipment Financing Equity: Equity [abstract] Schedule of components of income tax benefit (expense) Disclosure Of Major Components Of Tax Expense (Income) [Table Text Block] Disclosure Of Major Components Of Tax Expense (Income) Amounts paid Amounts paid Reversal of provisions for cost of restructuring Schedule of current and noncurrent trade and other payables Disclosure Of Current And Noncurrent Trade And Other Payables [Table Text Block] Disclosure Of Current And Noncurrent Trade And Other Payables Research and development expenses Cost of research and development [Member] Cost of research and development Number of RSUs Number Of Other Equity Instruments Outstanding, Shares [Abstract] Number Of Other Equity Instruments Outstanding, Shares Equipment Machinery [member] Disclosure of government grants recognized in consolidated statement of operations Disclosure Of Government Grants Recognized In Consolidated Statement Of Operations [Table Text Block] Disclosure Of Government Grants Recognized In Consolidated Statement Of Operations Inventories Description of accounting policy for measuring inventories [text block] Share-based payment arrangements [member] Share-based payment arrangements [member] 31-90 Days Later than one month and not later than three months [member] Net Revenue Disclosure of revenue from contracts with customers [text block] Net revenue Revenue Disclosure of other provisions [table] Disclosure of other provisions [table] Depreciation expense Depreciation expense Disclosure of geographical areas [line items] Disclosure of geographical areas [line items] Liabilities arising from financing activities at beginning of period Liabilities arising from financing activities at end of period Liabilities arising from financing activities Document Transition Report Document Transition Report Property, plant and equipment Property, plant and equipment [member] Disclosure of major customers [line items] Disclosure of major customers [line items] Entity's total for related parties [member] Entity's total for related parties [member] Granted (in shares) Number of other equity instruments granted in share-based payment arrangement Proceeds from sale of marketable securities Proceeds From Sale Of Marketable Securities Proceeds From Sale Of Marketable Securities Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Non-trade receivables Non-Current Nontrade Receivables Non-Current Nontrade Receivables Trade Accounts Receivable Description of accounting policy for trade and other receivables [text block] Current income tax benefit (expense) Current tax expense (income) Gain on Sale of a Business Disclosure of non-current assets held for sale and discontinued operations [text block] Liquidity risk Liquidity risk [member] Types of hedges [axis] Types of hedges [axis] Disclosure of provision matrix [line items] Disclosure of provision matrix [line items] Diluted loss per share (in USD per share) Total basic and diluted earnings per share attributable to equity shareholders (in USD per share) Diluted earnings (loss) per share Contribution 401(K) expense Post-employment benefit expense, defined contribution plans Impact of unrecognized deferred tax assets Tax Effect Of Unrecognized Deferred Tax assets Tax Effect Of Unrecognized Deferred Tax assets Supplier concentration risk (as a percent) Risk Exposure Associated With Major Suppliers, Concentration Percentage Risk Exposure Associated With Major Suppliers, Concentration Percentage Schedule of basic and diluted earnings per share Earnings per share [text block] Deferred Tax Assets Description of accounting policy for deferred income tax [text block] Other cash and cash equivalents Other cash and cash equivalents Schedule of inventories Disclosure Current Inventory [Text Block] Disclosure Current Inventory Disclosure of transactions between related parties [line items] Disclosure of transactions between related parties [line items] Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Other non-current liabilities Other non-current liabilities Granted (in USD per share) Weighted average exercise price of other equity instruments granted in share-based payment arrangement Accelerated share-based compensation expense Expense of restructuring activities, accelerated share-basd compensation expense Expense of restructuring activities, accelerated share-basd compensation expense Europe, the Middle East, and Africa Europe, The Middle East, And Africa [Member] Europe, The Middle East, And Africa Unused Investment Allowances Unused Investment Allowances [Member] Unused Investment Allowances Granted (in shares) Number of share options granted in share-based payment arrangement Derivative financial liabilities held for trading Derivative financial liabilities held for trading Customers [member] Customers [member] Effects of exchange rate changes Increase (decrease) through net exchange differences, property, plant and equipment Earnings Per Share Description of accounting policy for earnings per share [text block] Amount of Gain (Losses) Reclassified into Income (Missed Forecast) Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Profit Or Loss Due To Missed Forecast, Net Of Tax Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Profit Or Loss Due To Missed Forecast, Net Of Tax Maximum grant limit (in shares) Share-Based Payment Arrangement, Maximum Grant Limit Share-Based Payment Arrangement, Maximum Grant Limit Intangible Assets Description of accounting policy for intangible assets other than goodwill [text block] Currency effect on non-monetary assets of subsidiary Deferred Tax, Currency Effect On Non-Monetary Assets Of subsidiary Deferred Tax, Currency Effect On Non-Monetary Assets Of subsidiary Document Period End Date Document Period End Date Government Grants [Table] Government Grants [Table] Government Grants [Table] Interest and income taxes paid, net Interest And Income Taxes Paid Interest And Income Taxes Paid Other Current Financial Assets Other Current Financial Assets [Member] Other Current Financial Assets Schedule of related party transactions Disclosure of transactions between related parties [text block] Weighted average remaining contractual life (in years) Weighted average remaining contractual life of outstanding share options Foreign currency forwards Forward Contracts, Currency Swap [Member] Forward Contracts, Currency Swap Receivables from related parties (Note 29) Current receivables due from related parties Beginning balance (in dollars per share) Ending balance (in dollars per share) Weighted average exercise price of share options outstanding in share-based payment arrangement Operating loss carryforward Unused tax losses for which no deferred tax asset recognised Other Contract Liabilities, Other Contract Liabilities, Other Foreign exchange movement Increase (Decrease) Through Effect Of Changes In Foreign Exchange Rates, Assets Arising From Financing Activities Increase (Decrease) Through Effect Of Changes In Foreign Exchange Rates, Assets Arising From Financing Activities Percentage of entity's revenue Percentage of entity's revenue Weighted average grant date fair value Number Of Other Equity Instruments, Weighted Average Exercise Price [Abstract] Number Of Other Equity Instruments, Weighted Average Exercise Price 2019 USD Dresden Equipment Financing 2019 USD Dresden Equipment Financing [Member] 2019 USD Dresden Equipment Financing Contractual Cash Flows Financial Liabilities, Undiscounted Cash Flows [Abstract] Financial Liabilities, Undiscounted Cash Flows Total Contractual Capital And Operating Commitments Contractual Capital And Operating Commitments Classes of liabilities [axis] Classes of liabilities [axis] Disclosure of geographical areas [table] Disclosure of geographical areas [table] Finance Income and Expenses Disclosure of finance cost [text block] Repayment of loan from shareholder Increase (Decrease) Through Transactions With Owners, Repayment Of Loan To Shareholder Increase (Decrease) Through Transactions With Owners, Repayment Of Loan To Shareholder Property, plant and equipment Property, plant and equipment Government grants exempt from tax Tax Effect Of Government Grants Exempt From Tax Tax Effect Of Government Grants Exempt From Tax Forfeited (in USD per share) Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement Proceeds from issuance of equity instruments (in shares) Increase (decrease) in number of ordinary shares issued Non-current: Trade and other non-current payables [abstract] Disclosure of detailed information about hedging instruments [line items] Disclosure of detailed information about hedging instruments [line items] Total net lease cost Cash outflow for leases Loans and borrowings Bank borrowings, undiscounted cash flows Disclosure of analysis of single amount of discontinued operations [table] Disclosure of analysis of single amount of discontinued operations [table] Deferred tax assets Deferred tax assets Forfeited (in shares) Number of share options forfeited in share-based payment arrangement Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Unrecognized deferred tax asset Unused tax credits for which no deferred tax asset recognised Stock split (in shares) Number Of Ordinary Shares Issued, Stock Split Conversion Ratio Number Of Ordinary Shares Issued, Stock Split Conversion Ratio Transfers from construction in progress Increase (decrease) through transfers from construction in progress, property, plant and equipment Intangible Assets [Abstract] Intangible Assets [Abstract] Disclosure of changes in accounting estimates [line items] Disclosure of changes in accounting estimates [line items] Exercised (in dollars per share) Weighted average exercise price of share options exercised in share-based payment arrangement Financial liabilities, at fair value Financial liabilities, at fair value Employee Benefits Plans Disclosure of employee benefits [text block] Disclosure of temporary difference, unused tax losses and unused tax credits [table] Disclosure of temporary difference, unused tax losses and unused tax credits [table] Statement of cash flows [abstract] Government Grants Description of accounting policy for government grants [text block] Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-based payments Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-Based Payments [Member] Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-Based Payments Disclosure of contingent liabilities [table] Disclosure of contingent liabilities [table] Total comprehensive income (loss) for the year Comprehensive income Government grants receivable Government Grants Receivable [Member] Government Grants Receivable Cash and cash equivalents Cash and cash equivalents at the beginning of the year Cash and cash equivalents at the end of the year Total Cash and cash equivalents Document Annual Report Document Annual Report Total non-current liabilities Non-current liabilities Exercised (in shares) Number of share options exercised in share-based payment arrangement Cover [Abstract] Cash and Cash Equivalents Description of accounting policy for determining components of cash and cash equivalents [text block] Total Assets Assets Assets Equipment Equipments [Member] Equipments United States of America UNITED STATES Discount rate (as a percent) Discount Rates Used In Provision Estimates Discount Rates Used In Provision Estimates Recurring fair value measurement Recurring fair value measurement [member] Foreign Currency Translation Reserve and Investments Reserves Reserve of exchange differences on translation [member] Notional Amount Notional amount Number of banks Borrowings, Number Of Banks Borrowings, Number Of Banks CASH FLOWS FROM FINANCING ACTIVITIES Cash flows used in financing activities: Cash flows from (used in) financing activities [abstract] Inventories [Abstract] Inventories [Abstract] Receivables from government grant Current Receivables From Government Grants Current Receivables From Government Grants Current: Trade and other current payables [abstract] Ordinary Share Issued capital [member] Entity Current Reporting Status Entity Current Reporting Status Other Other non-current payables Proceeds from government grants Proceeds from government grants, classified as investing activities Accumulated deficit Retained earnings Organization Disclosure of basis of consolidation [text block] Increase in restricted cash Cash flows From (Used In) Decrease (Increase) In Restricted Cash And Cash Equivalents, Investing Activities Cash flows From (Used In) Decrease (Increase) In Restricted Cash And Cash Equivalents, Investing Activities Basic weighted average ordinary shares outstanding (in shares) Weighted average number of ordinary shares used in calculating basic earnings per share Unused tax losses Unused tax losses [member] Republic of Singapore SINGAPORE Disclosure of geographical concentration of cash and cash equivalents Disclosure Of Geographical Concentration Of Cash And Cash Equivalents [Table Text Block] Disclosure Of Geographical Concentration Of Cash And Cash Equivalents Disclosure of terms and conditions of share-based payment arrangement [line items] Disclosure of terms and conditions of share-based payment arrangement [line items] Scenario [Domain] Scenario [Domain] Capitalized to fixed assets Government Grants Capitalized To Fixed Assets Government Grants Capitalized To Fixed Assets Supplier Name [Domain] Supplier Name [Domain] Supplier Name [Domain] Restricted Share Units (RSU) Restricted Share Units (RSU) [Member] Restricted Share Units (RSU) Discontinued operations [member] Discontinued operations [member] Schedule of compensation to key management personnel Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block] Trade and other payables Adjustments for increase (decrease) in trade and other payables Accrued expenses Accrued Expenses Tax Difference [Member] Accrued Expenses Tax Difference Revenue from Contracts with Customers [Abstract] Revenue from Contracts with Customers [Abstract] Revenue from Contracts with Customers [Abstract] Current liabilities: Current liabilities [abstract] Liabilities [member] Liabilities [member] Finance income Adjustments for finance income Entity Voluntary Filers Entity Voluntary Filers Summary of Material Accounting Policies Disclosure of material accounting policy information [text block] Statistical Measurement [Domain] Statistical Measurement [Domain] Consideration received Consideration paid (received) Proceeds from issuance of equity instruments Proceeds from issuing other equity instruments SOI Wafers SOI Wafers [Member] SOI Wafers Inventory changes materials costs and other Raw materials and consumables used Interest rate swaps Interest rate swap contract [member] Share capital Share capital [member] Disclosure of derivative financial liabilities Disclosure of Derivative Financial Liabilities [Table Text Block] Disclosure of Derivative Financial Liabilities Schedule of depreciation expense Disclosure of depreciation and amortisation expense [text block] Income (loss) from operations Profit (loss) from operating activities Amortization expenses Amortisation, intangible assets other than goodwill Operating expenses Operating expense Continuing and discontinued operations [axis] Continuing and discontinued operations [axis] Fair value of options Incremental fair value granted, modified share-based payment arrangements Number of shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Number of shares outstanding Income tax expense Income tax (expense) benefit Tax expense (income) Number of instruments that are antidilutive in period presented (in shares) Number of instruments that are antidilutive in period presented Disclosure of lease liabilities Disclosure Of Lease Liabilities [Table Text Block] Disclosure Of Lease Liabilities Geographical [Axis] Geographical [Axis] Non-current assets: Non-current: Non-current assets [abstract] Contracts for capital expenditures Contractual capital commitments Derivatives Not Designated As Hedging Instruments [Abstract] Derivatives Not Designated As Hedging Instruments [Abstract] Derivatives Not Designated As Hedging Instruments Deferred Financing costs Netting Deferred Financing costs Netting [Member] Deferred Financing costs Netting Disclosure of nature and extent of risks arising from financial instruments [table] Disclosure of nature and extent of risks arising from financial instruments [table] Provisions Non-current provisions Derivative financial assets held for trading Derivative financial assets held for trading Intangible assets and goodwill Intangible assets and goodwill [member] Earnings Per Share Disclosure of earnings per share [text block] Ordinary shares, $0.02 par value, 553,548 thousand and 547,755 thousand shares issued and outstanding as of December 31, 2023 and 2022, respectively Issued capital Japanese yen forward contracts (receive Japanese yen/pay US$) Japanese Yen Forward Contracts [Member] Japanese Yen Forward Contracts Disclosure of major customers [table] Disclosure of major customers [table] Various Various Financing [Member] Various Financing Income taxes [Abstract] Income taxes [Abstract] Income taxes [Abstract] Disclosure of transactions between related parties [table] Disclosure of transactions between related parties [table] Preference shares Preference shares [member] Interest on long-term debt Interest expense on debt instruments issued Bank guarantees Bank Guarantees Bank Guarantees Income taxes paid, classified as operating activities Income taxes paid, classified as operating activities Contract liabilities Non-current Non-current contract liabilities Utilized Provision used, other provisions Accrued expenses Accruals classified as current Other effects Other tax effects for reconciliation between accounting profit and tax expense (income) Basic loss per share (in USD per share) Total basic and diluted earnings per share attributable to equity shareholders (in USD per share) Basic earnings (loss) per share Other Other non-current assets Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract] Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract] Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract] Derivatives Designated As Hedging Instruments [Abstract] Derivatives Designated As Hedging Instruments [Abstract] Derivatives Designated As Hedging Instruments New loans and borrowings Proceeds from non-current borrowings Disclosure of movement in deferred income from government grants Disclosure Of Movement In Deferred Income From government Grants [Table Text Block] Disclosure Of Movement In Deferred Income From government Grants Other income (expense) Other Income (Expense) [Member] Other Income (Expense) Derivative liabilities Derivative financial liabilities Beginning balance Ending balance Restructuring provision Schedule of cost of revenues Disclosure of attribution of expenses by nature to their function [text block] Forecast Forecast [Member] Repayments of debt and finance lease obligations Payments Of Debt And Finance Lease Obligations Payments Of Debt And Finance Lease Obligations Share-based payments Adjustments for share-based payments Attribution of expenses by nature to their function [axis] Attribution of expenses by nature to their function [axis] Disclosure of financial assets Disclosure Of Financial Assets [Table Text Block] Disclosure Of Financial Assets Research and Development Costs Description of accounting policy for research and development expense [text block] Lease obligations Gross lease liabilities Schedule of movement in provision for asset retirement obligation Disclosure of other provisions [text block] Share of foreign exchange fluctuation reserve of joint ventures Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, before tax Singapore dollar forward contracts (receive Singapore$/pay US$) Singapore Dollar Forward Contracts [Member] Singapore Dollar Forward Contracts Exercised (in USD per share) Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Disclosure of fair value measurement of assets [table] Disclosure of fair value measurement of assets [table] Customer And Supplier Concentration Disclosure Of Concentration Risk [Text Block] Disclosure Of Concentration Risk Europe Europe [Member] Amounts credited to customers Contract Liabilities, Amounts Credited To Customers Contract Liabilities, Amounts Credited To Customers Reconciliation of changes in property, plant and equipment [abstract] Reconciliation of changes in property, plant and equipment [abstract] Type of goods and services: Product and Service [Domain] Restricted cash Restricted Cash [Member] Restricted Cash (Gain) Loss on disposal of property, plant and equipment and other Adjustments for gain (loss) on disposals, property, plant and equipment Expense from share-based payment transactions with employees Expense from share-based payment transactions with employees Timing of transfer of goods or services [axis] Timing of transfer of goods or services [axis] Current assets: Current: Current assets [abstract] Commitments and Contingencies Disclosure of commitments and contingent liabilities [text block] Categories of related parties [axis] Categories of related parties [axis] Reconciliation of changes in deferred tax liability (asset) [abstract] Reconciliation of changes in deferred tax liability (asset) [abstract] Other Other current payables Weighted average discount rate Leases, Weighted Average Discount Rate Leases, Weighted Average Discount Rate Total Trade and other non-current payables Payable for property, plant and equipment and Intangible Assets Property, Plant, And Equipment And Intangible Assets Payable, Current Property, Plant, And Equipment And Intangible Assets Payable, Current Statement of changes in equity [line items] Statement of changes in equity [line items] Income tax effect Income tax relating to components of other comprehensive income that will be reclassified to profit or loss Payment in Lieu of Tax (“PILOT”) Bonds Non-Current Bonds Receivable Non-Current Bonds Receivable Restructuring [Abstract] Restructuring [Abstract] Others Increase (decrease) through other changes, liabilities arising from financing activities Cost of Revenue Disclosure of cost of sales [text block] ASSETS Assets [abstract] Effective portion of changes in the fair value of cash flow hedges Other comprehensive income, before tax, cash flow hedges Foreign tax rate differential Tax effect of foreign tax rates Entity File Number Entity File Number Other non-current financial assets Other non-current financial assets Derivative liabilities Contractual amounts to be exchanged in derivative financial instrument for which gross cash flows are exchanged CASH FLOWS FROM INVESTING ACTIVITIES Cash flows from (used in) investing activities [abstract] Supplier Risk Supplier Risk [Member] Supplier Risk Net income (loss) for the year Net income (loss) for the year Net income (loss) Profit (loss) Par value per share (in dollars per share) Par value per share Auditor Firm ID Auditor Firm ID Entity Shell Company Entity Shell Company Engineering and other services Engineering And Other Pre-Fabrication Services [Member] Engineering And Other Pre-Fabrication Services USD Term Loan A USD Term Loan A [Member] USD Term Loan A Trade payables and other liabilities Trade and other payables, undiscounted cash flows Singapore, Dollars Singapore, Dollars Fair value of EDB loan Government Grants, Adjustment For Fair Value Of EDB Loan Government Grants, Adjustment For Fair Value Of EDB Loan Disclosure of range of exercise prices of outstanding share options [line items] Disclosure of range of exercise prices of outstanding share options [line items] Current Income Tax Description of accounting policy for income tax [text block] Arising during the period Increase through adjustments arising from passage of time, other provisions Schedule of sale of facility and business Disclosure of analysis of single amount of discontinued operations [text block] MDC General Services Holding Company L.L.C (recharge of expenses) Entities with joint control or significant influence over entity [member] Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items] Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items] Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities Disclosure of financial assets and liabilities [Line Items] Disclosure of financial assets and liabilities [Line Items] Disclosure of financial assets and liabilities [Line Items] Disclosure of fair value measurement of assets Disclosure of fair value measurement of assets [text block] Work in progress Current work in progress Other Income (Expense), Net Disclosure Of Other (Income) Expense [Text Block] Disclosure Of Other (Income) Expense Share Options Share options [member] Other Other Geographical Area [Member] Other Geographical Area Statement of changes in equity [abstract] Commodity swaps Commodity Swap [Member] Commodity Swap Less than 30 days Not later than one month [member] Contact Personnel Name Contact Personnel Name Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion) Gains (losses) on cash flow hedges, net of tax Trade tax losses Trade Tax Gains (Losses) Trade Tax Gains (Losses) Lookback period (in years) Share-Based Payment Arrangement, Lookback Period Share-Based Payment Arrangement, Lookback Period Basis of Presentation Disclosure of basis of preparation of financial statements [text block] Deferred tax assets realized (as a percent) Recognizable Deferred Tax Assets, Percentage Recognizable Deferred Tax Assets, Percentage Document Registration Statement Document Registration Statement Entity Address, Address Line One Entity Address, Address Line One Contribution expense Post-employment benefit expense in profit or loss, defined benefit plans Share-based payment arrangements [Abstract] Share-based payment arrangements [Abstract] Share-based payment arrangements [Abstract] Income (Loss) before income taxes Accounting profit Assets [member] Assets [member] Schedule of goodwill and intangible assets rollforward Disclosure of reconciliation of changes in intangible assets and goodwill [text block] Others Increase (Decrease) Through Other Changes, Assets Arising From Financing activities Increase (Decrease) Through Other Changes, Assets Arising From Financing activities Building and Leasehold Improvements Leasehold improvements [member] Total Forward Contracts Forward contract [member] Current portion of lease obligations Current Current lease liabilities Share-based payments Increase (decrease) through share-based payment transactions, equity Disclosure of detailed information about borrowings [line items] Disclosure of detailed information about borrowings [line items] Present Value of Payments Present Value Of Operating Lease Payments To Be Received Present Value Of Operating Lease Payments To Be Received Share-based compensation Description of accounting policy for share-based payment transactions [text block] Attributable to: Profit (loss), attributable to [abstract] Contracts for operating expenditures Contractual Operating Commitments Contractual Operating Commitments Disclosure of changes in accounting estimates [table] Disclosure of changes in accounting estimates [table] CASH FLOWS FROM OPERATING ACTIVITIES Cash flows used in operating activities: Cash flows from (used in) operating activities [abstract] Within 1 year Not later than one year [member] Leases Description of accounting policy for leases [text block] Non-Current Asset Held For Sale And Discontinued Operations [Abstract] Non-Current Asset Held For Sale And Discontinued Operations [Abstract] Non-Current Asset Held For Sale And Discontinued Operations [Abstract] Deferred revenue Accruals and deferred income including contract liabilities Disclosure of reconciliation of assets and liabilities arising from financing activities Disclosure of reconciliation of liabilities arising from financing activities [text block] Depreciation of property, plant and equipment and amortization of intangible assets Research And development Expenses, Depreciation And Amortisation Research And development Expenses, Depreciation And Amortisation Amount due to supplier Trade payables Advances and deposits Current Advances And Deposits Current Advances And Deposits Vesting period (in years) Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period Items that may be reclassified subsequently to profit or loss: Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract] Total current assets Current assets 2019 USD Dresden Equipment Financing Non-Current 2019 USD Dresden Equipment Financing Non-Current [Member] 2019 USD Dresden Equipment Financing Non-Current Current portion of long-term debt Current portion of non-current borrowings Current portion of non-current borrowings Payments to related parties Expense recognised during period for bad and doubtful debts for related party transaction Disclosure of analysis of single amount of discontinued operations [line items] Disclosure of analysis of single amount of discontinued operations [line items] Maximum operating loss carryforwards (as a percent) Maximum Operating Loss Carryforwards, Percentage Maximum Operating Loss Carryforwards, Percentage Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Share options available for future grant (in shares) Number of Share Options Available For Future Grant Number of Share Options Available For Future Grant Disclosure of classes of share capital [table] Disclosure of classes of share capital [table] Texas, Minnesota, Vermont, North Carolina, and New Jersey Texas, Minnesota, Vermont, North Carolina, And New Jersey [Member] Texas, Minnesota, Vermont, North Carolina, And New Jersey Japan, Yen Japan, Yen Reconciliation between tax benefit and accounting profit multiplied by the Company's tax rate Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate [Table Text Block] Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate Risk free interest rate, share options granted Risk free interest rate, share options granted Unused Research and Development Tax Credits Unused Research and Development Tax Credits [Member] Unused Research and Development Tax Credits Accelerated depreciation on property, plant and equipment Accelerated Depreciation On Property, Plant, And Equipment [Member] Accelerated Depreciation On Property, Plant, And Equipment Entity Address, State or Province Entity Address, State or Province Auditor Information [Abstract] Auditor Information Share Incentive Plan 2018 Share Incentive Plan 2018 [Member] Share Incentive Plan 2018 Amount of Gains (Losses) Recognized in Income on Derivative Gains (losses) on financial assets at fair value through profit or loss Borrowing term (in years) Borrowing Maturity, Term Borrowing Maturity, Term Discontinued Operations - Tampines, Singapore Facility Discontinued Operations - Tampines, Singapore Facility [Member] Discontinued Operations - Tampines, Singapore Facility Received/receivable during the period Government Grants Received During Period Government Grants Received During Period Released to the consolidated statement of operations New provisions, other provisions Nominal Interest Rate Nominal Interest Rate Borrowings, interest rate Hedges [member] Hedges [member] Categories of financial assets [axis] Categories of financial assets [axis] Restructuring Disclosure of restructuring [Text Block] Disclosure of restructuring CALIFORNIA CALIFORNIA Liabilities arising from financing activities [member] Liabilities arising from financing activities [member] Schedule of lease liabilities Disclosure Of Lease Liabilities Explanatory [Table Text Block] Disclosure Of Lease Liabilities Explanatory 2020 USD Equipment Financing 2020 USD Equipment Financing [Member] 2020 USD Equipment Financing Raw materials and supplies Current raw materials Current income tax expense: Current tax expense (income) and adjustments for current tax of prior periods [abstract] Disclosure of maturity analysis for derivative financial liabilities Disclosure of maturity analysis for derivative financial liabilities [text block] Shareholders of GLOBALFOUNDRIES INC. Comprehensive income, attributable to owners of parent Selling, General and Administrative Expenses Disclosure of general and administrative expense [text block] Share-based payment expenses Expense from share-based payment transactions Proceeds from issuance of equity instruments Issue of equity Deferred Income From Government Grants Deferred Income From Government Grants [Member] Deferred Income From Government Grants Long-Term Debt Disclosure of borrowings [text block] Supplier Name [Axis] Supplier Name [Axis] Supplier Name Measurement [axis] Measurement [axis] Employee subscription rate (as a percent) Share-Based Payment Arrangement, Employee Subscription Rate Share-Based Payment Arrangement, Employee Subscription Rate 2021 SGD EDB Loan 2021 SGD EDB Loan [Member] 2021 SGD EDB Loan Receivables, prepayments and other assets Total Current prepayments and other current assets Investment tax credits, property plant and equipment Investment Tax Credits, Property Plant And Equipment Investment Tax Credits, Property Plant And Equipment Property, Plant, and Equipment Description of accounting policy for property, plant and equipment [text block] Provision Expense of restructuring activities, after accelerated share-based compensation expense Expense of restructuring activities, after accelerated share-based compensation expense Deferred tax liabilities Deferred tax liabilities Net proceeds from borrowings Proceeds from borrowings, classified as financing activities Disclosure of reconciliation of liabilities arising from financing activities [table] Disclosure of reconciliation of liabilities arising from financing activities [table] Selling, general and administrative expense Total Selling, general and administrative expense Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Revenue Revenue from contracts with customers Revenue from contracts with customers Payment of lease obligations Payments of lease liabilities, classified as financing activities Restructuring [Roll Forward] Restructuring [Roll Forward] Restructuring Provisions related to asset retirement obligations New Provisions, Other Provisions, Asset Retirement Obligations New Provisions, Other Provisions, Asset Retirement Obligations Proceeds from government grants Proceeds from government grants, classified as financing activities Addition Increase through new leases, liabilities arising from financing activities Technology, Licenses and Similar Rights Technology, Licenses And Similar Rights [Member] Technology, Licenses And Similar Rights Cost of revenue Cost of sales [member] Foreign exchange movement Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities Entity Filer Category Entity Filer Category Schedule of deferred tax assets, net Disclosure Of Deferred Tax Assets [Table Text Block] Disclosure Of Deferred Tax Assets Ordinary shares Ordinary shares [member] Repayments Repayments of non-current borrowings Current Fiscal Year End Date Current Fiscal Year End Date Amounts invoiced Current Unbilled Receivables, Amounts Invoiced Current Unbilled Receivables, Amounts Invoiced Related party [Abstract] Related party [Abstract] Related party [Abstract] Address Type [Domain] Address Type [Domain] Unrecognized compensation costs Unrecognized Expense From Share-Based Payment Transactions With Employees Unrecognized Expense From Share-Based Payment Transactions With Employees Accumulated Deficit Retained earnings [member] Classes of property, plant and equipment [axis] Classes of property, plant and equipment [axis] Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustments to reconcile profit (loss) [abstract] Cash receipts in advance of satisfaction of performance obligations Revenue that was included in contract liability balance at beginning of period Marketable securities Current financial assets available-for-sale Provisions related to the sale of a business New Provisions, Other Provisions, Sale Of Business New Provisions, Other Provisions, Sale Of Business Disclosure of cash and cash equivalents Disclosure Of Cash And Cash Equivalents [Table Text Block] Disclosure Of Cash And Cash Equivalents Employee Benefits [Abstract] Employee Benefits [Abstract] Unutilized borrowing facilities Undrawn borrowing facilities Disclosure of number and weighted average remaining contractual life of outstanding share options Disclosure of number and weighted average remaining contractual life of outstanding share options [text block] Disclosure of financial assets and liabilities [Table] Disclosure of financial assets and liabilities [Table] Disclosure of financial assets and liabilities [Table] Effects of foreign exchange gains (loss) Tax Effect On Foreign Exchange Rates Tax Effect On Foreign Exchange Rates Commencement period (in years) Share-Based Payment Arrangement, Commencement Period Share-Based Payment Arrangement, Commencement Period Shareholders of GLOBALFOUNDRIES INC. Other comprehensive income, attributable to owners of parent Additions Additions other than through business combinations, intangible assets other than goodwill Cash balances on hand and at banks Balances with banks New loans and borrowings Proceeds From Loans And Other Borrowings Proceeds From Loans And Other Borrowings Cash receipts from futures contracts, forward contracts, option contracts and swap contracts Cash receipts from futures contracts, forward contracts, option contracts and swap contracts, classified as investing activities Net income (loss) per share attributable to the equity holders of the Company: Earnings per share [abstract] Cost of revenue and operating expenses Cost Of Revenue And Operating Expenses [Member] Cost Of Revenue And Operating Expenses Payable for Intangible Assets Intangible Assets Payable, Noncurrent Intangible Assets Payable, Noncurrent Schedule of finance expenses Disclosure Of Summary Of Finance Costs [Table Text Block] Disclosure Of Summary Of Finance Costs Restructuring expenses Increase (decrease) through transfers and other changes, other provisions Finance expense Adjustments for finance costs Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] Other receivables Other current receivables Disclosure of fair value measurement of assets [line items] Disclosure of fair value measurement of assets [line items] Tax (expense) benefit recognized to consolidated statements of operations Deferred tax expense (income) recognised in profit or loss Statement of changes in equity [table] Statement of changes in equity [table] Non-controlling interests Non-controlling interests Goodwill Goodwill [member] Net cash provided by operating activities Cash flows from (used in) operating activities Document Fiscal Period Focus Document Fiscal Period Focus Other Borrowings, Other Increase (Decrease) Borrowings, Other Increase (Decrease) Accretion costs and other Other finance cost Reconciliation of changes in other provisions [abstract] Reconciliation of changes in other provisions [abstract] Revenue Recognition Description of accounting policy for recognition of revenue [text block] City Area Code City Area Code Product and Service [Axis] Product and Service [Axis] Recent Accounting Pronouncements and Developments Description Of Accounting Policy For Recent Accounting Pronouncements [Policy Text Block] Description Of Accounting Policy For Recent Accounting Pronouncements Net deferred tax assets Beginning balance Ending balance Deferred tax liability (asset) Assets Arising From Financing Activities [Domain] Liabilities Arising From Financing Activities [Domain] Liabilities Arising From Financing Activities [Domain] Schedule of disaggregation of revenue Disclosure of disaggregation of revenue from contracts with customers [text block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Notes and other explanatory information [abstract] Currency risk Currency risk [member] Deferred income Deferred Income Tax Difference [Member] Deferred Income Tax Difference Changes in liabilities arising from financing activities [abstract] Changes in liabilities arising from financing activities [abstract] Accounting estimates [member] Accounting estimates [member] Staff, maintenance, and utility costs Cost Of Sales, Staff, Maintenance, And Utility Costs Cost Of Sales, Staff, Maintenance, And Utility Costs Staff, maintenance, and utility costs Research And Development Expense, Staff, Maintenance, And Utility Costs Research And Development Expense, Staff, Maintenance, And Utility Costs Less: amounts representing finance charges Lease Payments, Finance Charges Lease Payments, Finance Charges Ranges of exercise prices for outstanding share options [axis] Ranges of exercise prices for outstanding share options [axis] Disclosure of Leases [Abstract] Disclosure of Leases Beginning balance Ending balance Total Government grants Losses, credits and investment allowances available for offsetting against future taxable income Losses, Credits And Investment Allowances Available For Offsetting Against Future Taxable Income [Member] Losses, Credits And Investment Allowances Available For Offsetting Against Future Taxable Income Deposits from customers Deposits from customers $10.02 Exercise Price Range One [Member] Exercise Price Range One Disposals Disposals Of Right-Of-Use Assets Disposals Of Right-Of-Use Assets Research and development expense Research and development expense Research and development expense Commitment fees and amortization of debt issuance costs Fee and commission expense Schedule of fair value assumptions Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block] Restructuring expense Expense of restructuring activities Depreciation of property, plant and equipment and amortization of intangible assets Depreciation and amortisation expense Disclosure of financial assets and liabilities Disclosure of financial assets [text block] Borrowings by name [member] Borrowings by name [member] Customer B Customer B [Member] Customer B Purchases and recharges from: Purchases of goods, related party transactions Other current and non-current liabilities Other liabilities Currency [Axis] Currency [Axis] Accretion income Accretion Income Accretion Income Entity Address, City or Town Entity Address, City or Town Receivables, prepayments and other assets Adjustments for decrease (increase) in trade and other receivables Non-adjusting events after reporting period [axis] Non-adjusting events after reporting period [axis] Right-of-use assets Beginning balance Ending balance Right-of-use assets Lease obligations Total Lease liabilities Lease liabilities Disclosure of reconciliation of changes in intangible assets and goodwill [line items] Disclosure of reconciliation of changes in intangible assets and goodwill [line items] Interest income - deposits Interest income on deposits Total financial liabilities Total Financial liabilities Minimum Lease Payments Undiscounted operating lease payments to be received Accumulated other comprehensive loss Accumulated other comprehensive income Prepayments And Other Current Assets Prepayments And Other Current Assets Prepayments And Other Current Assets Disclosure of range of exercise prices of outstanding share options [table] Disclosure of range of exercise prices of outstanding share options [table] Current Government Grants, Current Government Grants, Current Document Information [Table] Document Information [Table] Five-year Revolving and Letter of Credit Facilities Agreement Five-year Revolving and Letter of Credit Facilities Agreement [Member] Five-year Revolving and Letter of Credit Facilities Agreement Past due status [axis] Past due status [axis] Accounting Policies, Changes In Accounting Estimates And Errors [Abstract] Accounting Policies, Changes In Accounting Estimates And Errors [Abstract] Accounting Policies, Changes In Accounting Estimates And Errors [Abstract] Selling, general and administrative expenses Selling, general and administrative expense [member] Average Strike Price Financial Instruments, Foreign Currency, Strike Price Financial Instruments, Foreign Currency, Strike Price Additions Additions other than through business combinations, property, plant and equipment Total Equity attributable to owners of parent [member] Significant Other Inputs (Level 2) Level 2 of fair value hierarchy [member] Cross currency interest rate swaps (receive euros/pay US$) Cross currency swaps and cross currency interest rate swaps Currency swap contract [member] Performance Share Units (PSU) Performance Share Units (PSU) [Member] Performance Share Units (PSU) Shares available (in shares) Share-Based Payment Arrangement, Shares Available Share-Based Payment Arrangement, Shares Available Advances to suppliers Non-current prepayments Liabilities arising from financing activities [axis] Liabilities arising from financing activities [axis] Provisions Description of accounting policy for provisions [text block] Additional paid-in capital Additional paid-in capital Euro forward contracts (receive euros/pay US$) Euro Forward Contracts [Member] Euro Forward Contracts Disclosure of temporary difference, unused tax losses and unused tax credits [line items] Disclosure of temporary difference, unused tax losses and unused tax credits [line items] NEW YORK NEW YORK Share-based payments (in shares) Increase (decrease) through share-based payment transactions, shares Increase (decrease) through share-based payment transactions, shares Leases Disclosure of leases [text block] EUR Term Loan A EUR Term Loan A [Member] EUR Term Loan A Matched amount per dollar of additional employee contributions Matched Amount Per Dollar Of Additional Employee Contributions, Defined Contribution Plans Matched Amount Per Dollar Of Additional Employee Contributions, Defined Contribution Plans Disclosure of number and weighted average exercise prices of RSUs and PSUs Disclosure of number and weighted average exercise prices of other equity instruments [text block] Subclassifications of assets, liabilities and equities [abstract] Corporate information and statement of IFRS compliance [abstract] Customer concentration risk (as a percent) Risk Exposure Associated With Major Customers, Concentration Percentage Risk Exposure Associated With Major Customers, Concentration Percentage Document Information [Line Items] Document Information [Line Items] Impact of change in liability for uncertain tax positions Tax Effect Of Change In Uncertain Tax Position Liabilities Tax Effect Of Change In Uncertain Tax Position Liabilities Customer A Customer A [Member] Customer A Schedule of finance income Disclosure Of Summary Of Finance Income [Table Text Block] Disclosure Of Summary Of Finance Income Disclosure of reclassifications or changes in presentation [table] Disclosure of reclassifications or changes in presentation [table] Additions Additions to right-of-use assets Financial Risk Management Objectives and Policies Disclosure of financial risk management [text block] Purchases of property, plant and equipment and intangible assets Purchase of property, plant and equipment, classified as investing activities Tax at Enacted Statutory Rate Tax expense (income) at applicable tax rate Exercisable (in shares) Number of share options exercisable in share-based payment arrangement Entity Registrant Name Entity Registrant Name Loans and borrowings Borrowings, Net Of Cross Currency Swap Assets Borrowings, Net Of Cross Currency Swap Assets Non-current Government Grants, Noncurrent Government Grants, Noncurrent Revenue recognized during the year Current Unbilled Receivables, Revenue Recognized During The Year Current Unbilled Receivables, Revenue Recognized During The Year Disclosure of reconciliation of changes in intangible assets and goodwill [table] Disclosure of reconciliation of changes in intangible assets and goodwill [table] Schedule of other (income) expense, net Disclosure Of Other (Income) Expense [Table Text Block] Disclosure Of Other (Income) Expense Temporary difference, unused tax losses and unused tax credits [axis] Temporary difference, unused tax losses and unused tax credits [axis] Auditor Name Auditor Name Deductible expense for tax purpose Tax Effect Of Deductible Expense In Determining Taxable Profit (Tax Loss) Tax Effect Of Deductible Expense In Determining Taxable Profit (Tax Loss) Marketable securities Non-current Marketable Securities Non-current Marketable Securities Loan from Shareholder Loan From Shareholder [Member] Loan From Shareholder Trade payables and other current liabilities Total Trade and other current payables Entity Central Index Key Entity Central Index Key Certain non-current assets Certain Non-Current Assets Certain Non-Current Assets LIABILITIES AND EQUITY Equity and liabilities [abstract] Disclosure of contingent liabilities [line items] Disclosure of contingent liabilities [line items] Disclosure of classes of share capital [line items] Disclosure of classes of share capital [line items] Summary of property, plant and equipment Disclosure of detailed information about property, plant and equipment [text block] Other Miscellaneous Other Operating Income (Expense) Miscellaneous Other Operating Income (Expense) Disclosure of financial assets and liabilities [Table] Disclosure of detailed information about hedging instruments [table] Exercise price of outstanding share options (in dollars per share) Exercise price of outstanding share options Staff costs, maintenance costs, and utilities Cost Of Sales, Employee Expense Cost Of Sales, Employee Expense Tax (expense) benefit recognized to other comprehensive income (loss) Income tax relating to components of other comprehensive income PILOT Bonds, Letters Of Credit PILOT Bonds, Letters Of Credit [Member] PILOT Bonds, Letters Of Credit Additional employee contributions matched by employer (as a percent) Additional Percentage Of Employee Contributions Matched, Defined Contribution Plans Additional Percentage Of Employee Contributions Matched, Defined Contribution Plans Company's which have entered into related party transaction with Disclosure Of Related Party Which The Company Has Entered Into Related Party Transaction With [Table Text Block] Disclosure Of Related Party Which The Company Has Entered Into Related Party Transaction With Staff costs, maintenance costs, and utilities(2) Other employee expense Shares issued (in shares) Share-Based Payment Arrangement, Shares Issued Share-Based Payment Arrangement, Shares Issued Weighted average remaining lease term Lease, Weighted Average Remaining Lease Term Lease, Weighted Average Remaining Lease Term schedule of deferred tax assets and liabilities Disclosure of temporary difference, unused tax losses and unused tax credits [text block] Timing of revenue recognition: Timing of transfer of goods or services [member] Geographical areas [member] Geographical areas [member] Trade receivables, other than related parties Current trade receivables Change in assets and liabilities: Change In Assets And Liabilities [Abstract] Change In Assets And Liabilities Hedging instruments [member] Hedging instruments [member] Equity Equity [member] Number of shares issued (in shares) Number of shares issued Amendment Flag Amendment Flag Financial Instruments [Abstract] Financial Instruments [Abstract] Financial Instruments Other Financial Assets And Liabilities Disclosure of financial instruments [text block] Trade and other current receivables [abstract] Trade and other current receivables [abstract] Matching contribution (as a percent) Share-Based Payment Arrangement, Employer Matching Contribution, Percent Of Match Share-Based Payment Arrangement, Employer Matching Contribution, Percent Of Match Uncommitted Credit Facilities Other Borrowings [Member] Other Borrowings Current: Current Borrowings [Abstract] Current Borrowings Net liabilities Net Liabilities Assets (liabilities) Other Non-current Financial Assets Other Noncurrent Financial Assets [Member] Other Noncurrent Financial Assets Ordinary Shares In Private Placement Ordinary Shares In Private Placement [Member] Ordinary Shares In Private Placement Interest income on FVOCI investments Interest income on available-for-sale financial assets Share-based payment arrangement, vesting percentage Share-Based Payment Arrangement, Vesting Percentage Share-Based Payment Arrangement, Vesting Percentage Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Cost Of Property Plant And Equipment, Net Of Tax Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Cost Of Property Plant And Equipment, Net Of Tax Classes of intangible assets and goodwill [axis] Classes of intangible assets and goodwill [axis] Disclosure of maturity analysis of operating lease payments [line items] Disclosure of maturity analysis of operating lease payments [line items] Disclosure of nature and extent of risks arising from financial instruments [line items] Disclosure of nature and extent of risks arising from financial instruments [line items] 61 to 90 days Later than two months and not later than three months [member] Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Number of other equity instruments outstanding in share-based payment arrangement Wafer fabrication Water Fabrication [Member] Water Fabrication Carrying amount Carrying amount [member] Equipment Equipment [Member] Disposals Disposals, property, plant and equipment Total Loans and borrowings Opening balance Ending balance Borrowings Outstanding at beginning of period (in USD per share) Outstanding at end of period (in USD per share) Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement Cash And Cash Equivalents Disclosure of cash and cash equivalents [text block] Patents Copyrights, patents and other industrial property rights, service and operating rights [member] Disclosure of terms and conditions of share-based payment arrangement [table] Disclosure of terms and conditions of share-based payment arrangement [table] Proceeds from sales of property, plant and equipment Proceeds from sales of property, plant and equipment, classified as investing activities Forfeited (in shares) Number of other equity instruments forfeited in share-based payment arrangement Classes of assets [axis] Classes of assets [axis] Advances and proceeds from sale of property, plant and equipment and intangible assets Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets Others Other intangible assets [member] Foreign Currency Translation Description of accounting policy for foreign currency translation [text block] Gain on sale of East Fishkill (“EFK”) business Share of profit (loss) of joint ventures accounted for using equity method Scenario [Axis] Scenario [Axis] Income (loss) before income taxes Profit (loss) before tax Profit (loss) before tax Unused Tax Credits Due to Expire Unused Tax Credits Due To Expire [Member] Unused Tax Credits Due To Expire Land and Land Improvements Land [member] Government Grants Disclosure of government grants [text block] Net cash used in investing activities Cash flows from (used in) investing activities Schedule of accounts receivable Disclosure Of Detailed Information About Accounts Receivable [Table Text Block] Disclosure Of Detailed Information About Accounts Receivable Customer Risk Customer Risk [Member] Customer Risk Maximum borrowing capacity Borrowing Facilities, Maximum Borrowing capacity Borrowing Facilities, Maximum Borrowing capacity All levels of fair value hierarchy [member] All levels of fair value hierarchy [member] Statement of comprehensive income [abstract] Carrying Value Financial Liabilities, Carrying Amount [Abstract] Financial Liabilities, Carrying Amount Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Major customers [axis] Major customers [axis] Carrying Amount Financial assets Current portion of deferred income from government grants Current government grants Diluted weighted average ordinary shares outstanding (in shares) Weighted average common shares outstanding (in shares) Weighted average number of ordinary shares used in calculating diluted earnings per share Equity Compensation Plan 2021 Equity Compensation Plan 2021 [Member] Equity Compensation Plan 2021 Other Other temporary differences [member] EX-101.PRE 16 gfs-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 17 exhibit152responseletter001.jpg begin 644 exhibit152responseletter001.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBLC7KV^M?[.AL'MXYKN[$!>>)I%4>6[YVAER?D Z]Z<5=V$W8UZ*Q?LWB; M_H+:3_X+)/\ X_1]F\3?]!;2?_!9)_\ 'ZKE7=?C_D*[[&U16+]F\3?]!;2? M_!9)_P#'ZS(M:UNX2RM4FT]+N:_N;628VKLFV(.00GF @G:/XCUIJG?9@Y6W M1UM%8OV;Q-_T%M)_\%DG_P ?H^S>)O\ H+:3_P""R3_X_2Y5W7X_Y!=]C:HK M%^S>)O\ H+:3_P""R3_X_6;:ZQK=_%I\$4^GQ7,TMXDLK6KNA$,I0;4\P$9Z M\L::IWV8I_V1#;S:?!-=6D]Q-)):O( MN8WC0!5$BXSO)Y)Z4U3OLP'_ /L)#_T1-6W6 M)K__ !_>'_\ L)#_ -$35=/XOO\ R)EL;=%%%04%<1I__(6TW_L-:A_*6NWK MB-/_ .0MIO\ V&M0_E+6U+9_UT9G/=?UU1V]%%%8F@5QF@_\?VE_]?&J_P#I M2:[.N,T'_C^TO_KXU7_TI-;4_A?]=&9SW7]=4=G1116)H%<1X9_X_P#P_P#] M@R]_]'PUV]<1X9_X_P#P_P#]@R]_]'PUM3^%_P!=&9SW7]=4=O1116)H%8G@ M[_D2M$_Z\HO_ $$5MUB>#O\ D2M$_P"O*+_T$5:^!^J_4E_$C;HHHJ"@HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N$^*F MN3^'=!TW4[01-#_'76/M&N:?I"-E;6$S2 ?WW M/ /T"C_OJNK!4_:5DGL8XB?+3;.U^&?C36O%\6HW6JQV4-I:[51H49*?C9=6VLR6WAV"TFLXOE,\Z,WFMW*X887^?6N#D\6O9>!X/#.EL MT:3,TVH3#@RLQX0?[(4*#ZGCIU[_ .%WPRV>3X@UZ#YN'M+5QT]'@>"K[Q-JFDB_\10VEL9@#!;PQ,KJOJ^6/7T__ M %5X[J/Q)U6R\3S0Z7!:30VVI7,ML7C9F/-.DO;B&"WMG-PSS.%&5&5Y/^UMK/!QC M*,ZLHZ=BZ[:<8)ZG53_&#QO9J)+G1[.%,XS+:2J#^):N\^'7Q'_X3-[BRN[1 M+:_@3S?W1)21,X) /(P2.,GK67\5O&^BGPE7=V50K XD$:A@Q)(X M'3&.O-<;\)EDTBW\0^*9%Q;V5BT:$]'D)#8'_?('_ A5.E3J8=SY.5]!*
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�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�!U]( , #VK"T M7Q(=2U.ZTN[L_L=_;Q).46994>-B0&5AZ%2""!CCUJ+7_$]UHLTPBT:2Y@MX M/.EG>X2%6'/RQ[OOL ,D<#D<\T =$5# A@"#V-+6'IOB>UU75XK*VBDV3:9# MJ47\$MR86F6,0Q1OL+,Q[EB !Z M],4 ;6C:#'I,]Y=27=Q>WUXRF:YN-H8JHPJ@* H49. !U)/>M7:-V[ STS7G M/A_Q1=W"V37 OI;NXU'5%A@:94 $3.5CDZ] !@\$=ZZ?P3K5]XA\(:=JNH6 MR03W,2R81LA@0#N'I]* -_:N2<#)Z\=:6N/@\>":"UU(Z3.FAW=TMK#?F5!M0U?5-0\0W.IB95CU"2WBC,ZM'&$XVJH P1W;OGV MH [(J&Z@''/-+7">?=>)=4UZXN=>NM(T31[@VBBUD2(LR(K2222,#A1NP ,# M R:SY]=O+;PT19>*;35Q'K-G!%>6TR/+Y$DL8*3;1MW\/W6NV_BC M4+S4;&%KJ:&YV?9K@(-SH(PHV @$ @Y'')H [RN:N?!Z7EYNNM9U.>P^U+=_ M8)71H_,5@RC<5W[ P!"[L<>G%<9?^)K:\\7:@+_Q/K.DV0L;.XM(K%-P/F*[ M,6Q&_/"^G?K6OIWBV_3X4OK4EPM[?.TD%C( H:X9I3' 65> QRFY>W.0.E ' MH-%$?%6EZA?/-K6APS$79 #21M&9(9/3/5?JAKK-"N);GPQIMS, MY>:6RBD=SU9B@)/YT :6T;MV!NQC-&T;MV!GUKR'P1J]GK>G:.][XW\0'5K@ M*9+90!&7S]W/E8Q_P+\:Z;3X]1\9WVK7*=1TD402-@_BH/X4 =-2 $D G MK[UYOX#\5:H][)8:_/YL>H7-VVEW)&,^5,Z- ?\ : 4,/4$^E4=%O=8\1Q^" M;6?7M1M?MND3W5S+:NBO+(K1 $DJ1_$>U 'JP4 D@ $]3ZTM>;:GJFL^&CXC MT635[B^":#/J=A=SJ@GA9,JRL5 #\8ZQJGB)Q"Z: M:ZK*DI)7>&'EC:F"WS9&/6@#V,J"P8@9'0XZ4M>:>*O$&JV2?$ V]]+%_9]G M9R6I7'[EG#;B/K@59T"\T>YUNTCM?&GB*]G+$K;W"XCDP"2&_[/](,8BWY/"YS@#H.?SX]!4]>37VLW$5_J:Z[XIU7P_JXN95L!)$%L M/+#'RCN*%7!&-VYLY)Z8KTN66==!>:22,W M2[/"V>E %T@,,, 1 MZ&EK@="\9WO]A>&K,:==:MJ]_HZ7K,LB(#@*&+,Q '+#\ZT(O'<5Y8:8VGZ7 M=W&H:@TRI8ED1HS"VV4NQ.T!6XR,YR,4 ==15#1]2?5=/%Q+8W-C*KM');W* MX964X.".&7N&!P17.G7KSPZ=-\/R0RZOK$L$DY+7,<>Y ^,;WV[F^8# ';)Q M0!V&T;MV!G&,TO2J5MJ4* .L(!QD XY'M2URNG^,WN+S38[ M[1+S3K?5,BQGF=&#MM+A7"DE&*@D ^A'7BJNE_$(:BFDW3Z%>VVF:I,+>WNY M'C/[T@X!0'<%)4@-_0@T =F !T&*" PP0"/0URND>-#K-ZHM='NGT][B2V%X MDB/L="P)DC!W(I*D GU&0,U%%X^CDCAU Z1=IH4]P+:+4RZ;22^Q7*9W!"W M;W!P!0!UY .<@'-*0",$9%>?Z/XBE.H6R:A?79WZUJ<";641^7%YA DR,[55 M>,=P,TVZ\9ZCJ5WX7EM=,O;'3M2U)/+N9&0BXA,V]K;Z@-2T^XM;^R$1^QJZ2M.)6V1^6RG#9;Y><8/7CFHM)U[5K[XARZ??6- MQI\4>E";[-)(DBLQEQO5E)SQQ^'T) .R"@$D GK[T8 ).!D]37GGB?5=5_X M3I[+=J-OIEEI,EZS6=Q&A<@_?(.20,;0OKSTK0A\:S?NK#3M%U#5+B/3;>]= MS+&F4D!QN)(!?Y>@'//2@#LR 1@@&C:-V[ STS7,_P#"7R7MAIUUHVBWE^E] M:"[#%EACB0XX9V.-_/W1GH3TJI'\0(KNUT5].TB\NKC5UN/)@#HIC:%@KAV) MP "3R">G'44 =E2$!AA@"/0UR4?CN*:PMS%I5VVJSWDMBNG;D#K-'DOE\[=H M SNST([G%">)7N=8T:"ZL]4TVY>YN('MF"E'*0E\DC.],A7;V5RDC M6URLL;@E02%D .8BV.-W?@X-4?#/B_6;WPAI=Y<:)=7NHWKR >446/:I)WL^ M=J#^$ \DCH>M '=TA4%@Q R.AQTKSZ_\>:A7*Z9"0.QP# MB@#L" 000"#V-&!C&!TQ7&:I\05TV?5RNB7MQ9Z/*B7UU&\85%9%;/[]_# MFBO?Z*))%C;D[B<#J%"]3C/O7<:5?/J6G174MEUCM6C.-@5'=@>F02!3M.\:'5-2:*TT>ZEL5NWL MVNXY$8QNK%27C!W(F5/)]C@ T =7161KVO)HBVD:6LUY>WLWD6MK"0&D;:6) M)8@*H4$DFN0\5>,]1D\-WUM96-Y8:O!>6MK=()8]\*32*%=&R5(<$J#V.<@8 MH ]&H & ,"LE[J31/#23O;:A>S0Q(/(7$T[L<#!(X)R>6Z=3TK$E\>BQ76$ MU32)[2ZTVQ-^T*S1R^9%DCAE/#9&,''44 =C17*0>-TCO##JVE76EQ/92W\$ MT[HP>&/:7R%)*L RG!]:S1XKU6_\5>%(3I=[IEEJ#SR#S7C83QB!F4,%)*L# MM.#^?!H [VBN(\;WNK'7_#FCV/VV*VOIY//EM)TB=@L;-M!;H!@,?4#%3Q>/ MHY(X=0.D7:Z%/<"VBU,NFTDOL5RF=P0MP&]P< 4 =A2,JMC< <)O$^MVNJ>+K&")XK:Q MT#[5;SJR9CD*RG?ZG)0 #MMSWH ]#HKC]+\:MOL[?6-+NM.6XL7NX+F=T82+ M&JERP4DH<,&P>WOQ4FF^.%O;K31* .LHK,O=:BL-[ MNKBYN(;:,2(BR)"P624LQPJ;N!W)Q@4 ==17+P>,3>::);+1KZXOQ=M92V:[ M<8H [2BLJXUM--\-2ZSJ]N]BL$)FGA++(T>/XU MR MTV]L],U'5(DBO'9,7$)#\,H.Y0V 1GJ!VZ4 >A$ D$@9'0^E!56&"H(SGD5Q MX^(%N3]L_LRY_L3[5]E_M'S(\;M_E[O+SNV;^-V/?&.:R_&/C>^3P[KDNC:= M>>192&U.IQN@"3*P#80G<5!.TMCKGL": /1&4,,, 1Z$4MI]:SM&T6WT2VF@@=Y!+=3W1:3&0TKEV P.F6K"OO'L M-I+J,L6EW-QIFF2F*]O4D0!&7&_:A.YPN>2!V.,XJ6\\9LEY?1Z9HM[JEOI^ MW[7/;,GRDJ'VHI.9&"D$@>H')XH ZG:"P8@9'0TM/([:;4&M=)N[RRTP MXO;E'1/+.T,P5&(9RJD$CCTY/%,U'Q^MM<:BECHUWJ,.G6T=YUSI4]]IUS*R'S511 MR5!)1OG4X/8]CQ1X;\9SR6.@Q:SIMW:#4;5?(O9W0K-(L6]MP!RA8!F&>H'8 M\4 =J%"YP ,G)Q2UR%AX]AO)-/FDTNYM]+U*40V=Z\B'S&;.PL@.Y0V."1W& M<9J[X9\42^)6FFBT>ZMK!&D1+N:1,2NCE& 4'=C(/)&.#0!H7FC07NMZ=JDD MD@EL$F2-!C:PD"@Y_P"^16D , 8 KA?&U_?Z.+N_G\4G2H?+VZ;:V\".9Y0 MN2)-Z,6RQ 4CCOGH_Q%JGB6TT?0;];BWLO,N+&.]A6(.[O+*B.@)R%4!CR, MD^HQR =MM&[=@9Z9HP 20!D]:6L?7;35+QK9++5AIEFF][N:-%,Q 'RA2ZLJ MCJ22,\#% &OM&[=@9QC-+7FVG^(-=U*UTC2TU-U.HZC=1PZLL*"26SA4L)%4 MKLW,< -MQCD#D5IV4_B*[GUGP[#K ^TV%U!_Q,984\TVTB!SA0NPR AE!VXQ MSC- ';4@4*,* !Z"N'TBY\07_P#PD.FZ?K0NH[:>&&TU2ZA0E2?]>OR*%./S(]T"X*R+W5N1QV-=Q10!SGAK09=+N;JYFTS0[ RJ MJ)%I=OM( R26DVJ6SQQ@8QWS63K/@F\U+Q!JUV%TN>#48(X5GO(C)-9!5*D1 M*1@@YW=1@GG-=E>WD&GV-Q>W4GEV]O$TLKX)VHHR3@<] :DAFCN((YXFW1R* M'1L8R",@T D^ M"]:\/+HUSI]U8W%Y:6TO;^YF9%*^9]HW8P.V-W( MS^=;?@W2+_0?"UGI&H/;2/9H((Y("V'10 "01PW7(Y'O6]10!P5OX+U=-(L/ M#4MU9'0[*[CF69=_VB2..3S$C*XVCD*"V3D#H,UTGAW1I=&&J"65)/MFHS7B M;,_*KD8!]^*M7FM6%AJ-GI]Q.5N[PMY$2QLY8#&2=H. ,CDX'-&D:S8:[:-= MZ;.9[<.8Q)Y;*K$==I8#:<-7OK^TO"D<+1VT?D,I5 .6.0O)]^@ MKT2F/+'&\:/(JM(=J G!8X)P/4X!/X4 (=*U#2?$ITQ;.YAVH^GF3 MS$?((;Y^." 1[@53O="\8:UI;Z'JFI:6FGS+Y5U>6L;BXGBZ, A^5"PX)RV, MG KK[2\AOK?S[5=^9F,0AP,;>WS_I5.#X=2S_8X=8N;6\M'U"XU34(%C*I+.Z[455YP MBY)Y.20#7H%% '"7WP[@M[VXE\.1VFG07NF7%A>0A2%,Y S^-=510!B^$=%F\.^$M,TB>5)9; M2 1,\>=K$>F:R_["\0:)J6H3>')].DLM0G:ZDM;\.ODS-C>R,F0VLMO'*6#7$GE1[49LM@MR0.!A3R<#\Z .4C M\#,_@EM$N+I4O([N>\M;N$',$K3/+&XSW&X ^O([UG67@OQ#HL/AA],N=,DN M=(T^6RE^T^9L?>4.5VC/\'?UKT.F1RQR[O+D5]K%6VG.".H/O0!QN]7OK235M2TR338!;QLD%M&P;CDEF)8@D^P %7=:\*3:AH.F)9W,=MK6E" M-[.\P<*Z@!E;N48 @C_"NJHH X;6O!5_JT/BS%S;1R:W:VT,8.XB-HPP;/'( MR>*U;/\ X347<(O1H'V7,8K*\TB#4=*OM-N#($N-261YXD$;K1;O0YIKB&0:=HG]FR! M,_,^Z,[AGM\A_.J=IX,U;23I]]IUS9/J-I/?9CGW"*6&XF,FTL 2K+A><'H: M[NF2RQPQF2618T'5F. /QH Q],MO$-L+;[=>V=R9)99+O$;+Y:D?NTA]E. 2 MV21GI5#Q;X?+X%U*7Q)9ZCM#1;;PO)>6)T"WN$<3*K_:7A202+$5^Z#D M%L]!TS7?50U76K#1889+^40Q!8V=G<@D*%4$DX!/3M0!RT'@6<7MJ]Q< M0O FI:A=R*N>.E=K:7D-]"98"Q0.T9W(R'ZMM0CO'U1XW>[NPDP?:S$?)QZ%AP!@"M#4O %[J*:K!))ILMO)JRZM9K<1 M&13)M"M',AX*$9&1SSGM7H-% 'GT?P^GEL;_ /<:'I-U(\$MHFEV:A(I(7$B ML[[59\L ". ..>:V-)T?73XMDUW69M/ -C]D2WM-Y"_/NW%F SGZ#''7K71 M7=Y#91++.6"-(D8VHSGY'/0=ZGH YG5_#5QJ.M7]]'/$J7.C2:6\YDVVZG;;K) 8E6,D9;!.XEL9)/3I794UW2*-I)&5$4%F9C@ # MJ2: /-=*^'.H6=WH4\D.B0RZ96-Y6+Q]/GD9QC/H&%:2WMN]Z;178S"(3<(=NPD@'=C'4'C.:L M4 >?Z7X&U*#Q-8:K=?V1!-:.[3WNGQM%-J *LH$J !!DD,?OPQ[1DJ!DXQGH*BF^&DBW5]%;V/AN6WO+M[D7UY8++=0! MVW.@#*5?DD*21@$<'%>E44 <9J/@RZO-'\7V4=S C:W*'@)!Q&/)CCPW'JA/ M'K4GB;P2?$M_>O+273O#.G'[%+;J=,L0K2R.NW>SE0 MR #/RKGKR36Q%X8N8_\ A$,SQ'^PT*S=?WG^CF+Y?Q.>>U;>J:QIVB6@N]3O M(;2W+A!)*V 6/0?7BH=*\1:-KID&E:I:7C1_?6&4,R?4=10!Q\7@K6HO#EGH M\ZZ%J5K:33#[+>0DQSQL=R,6VDI(I+?=R"#72^$=!G\.^'DTZ>X$CB220",L M4A#,2(TW$G:H.!GT_"MZB@#RZT^&NIPMIAE&BFYL=0BNY=2V.]U>A)-Q#LPR MA([ L"0.@K1E\#:E=>([;4)CI*207PN?[4MXFBO)8@VX1.% 4Y&$+$G([9KT M"B@#!\1Z)>:C<:7J.F30QZCID[2PBX!,]OIO)MT959 M]I."S!1P.>I JU0!A^+M&NM?\.SZ?9W*P2N\;?.6"2*KAFC8KR%8 J<=C7'M M\-[V1=:,46B::FHZ.^GI;6$3*D;ELAV; +YR\)'7K^S M::95M(]-O+"=1G>?/6,97MQL/YBJ=GX>\2R:QX>GU2\TUK71O,'^CJ^^XW0M M&'(/"GD?*,]3ST%;DOBO0(-6&ERZO:)?%Q'Y)E&0YZ*>P8^G6KD^JZ?;:C;: M=->01WMT&,%NS@/(%!)(7J0 #0!2U31I;_Q#H.HI*BQZ=+,\BMG+AXF08_%L MUS,/@K6ET6V\+27EB?#]O<(XF57^TO"D@D6(K]T'( +9Z#IFN_JAJNM:9HD" M3ZG>PVL;ML0R-@NWH!U)^E %7PYHTNBPZBDTJ2&ZU&XNUV9X61RP!SW%8WB' MPIJ>J:IK4UI<6BVVJZ,=.D$V[?&X\W:PQP1F7GZ5O-XET1-&35SJEI_9SG:E MP)048YQ@'N<\8ZYH7Q)HC:,VKC5+3^SE.UK@R@(#G&TGL<\8ZYH RM5\)-JU MSI FF06UK8W-G<*,[G$L:IE?IM/6L;P_X N-*O\ 2S-8>&HHM/ZWEIIZBYNL M+M4L2O[L]&)4DDCC&:ZVV\3:'=Z9/J4&JVC65N2)YC( L1'9L_=/(Z^M2:3K M^DZZLK:7?P77DD"01MRF>F1U&>WK0!SGQ+D7^P+:"VG,>N-=12:2JJ69IU8# MIZ;6(/H":KZG\.X6MM ^QVVF7K:1;-:_9M4AWQ3HP7+$X)5]RYW8/4^M=Y10 M!YU-\/[XZ590K%HC".^DNKC2X[?[/9RJR;50[%RQ3 (+ Y/7MAVG?#Z^LY68 MR:;"C:S;ZF(;2$QQQI'&$,:K^ Y[\DXZ5Z'574M2M-(TV?4+^;R;6W7?+(5) MVCUP,F@"IXET.+Q)X;O]'FD,27<1C\P+G8>H..^"!QWKD[#P)=)++)+IWAG3 MB+*:W4Z98A7ED==N]G*@H ,_*N_>@#!_X1*9X/"<,LT3)HT31W &?WH-LT/R_BV>>U9MKX1\ M1Q6_A_2I;[3FTO1+J*2.15?SIXXP516'W5(4C."T6[,PU":P62\$9??Y9#*5+<[0Y/3MFK6J^#/$$FDZSH6FWNG)I>I7$ER M))U?SHC(^]X\#@@MG#9R >AKNHKR&>ZN+:,L9;<<]JR;K0/$OB)[:V\07>E1:7%/'<2P M6$X*,&569S@+N )P,G&.*[*B@#S>]^&\IU#5#:6/AR>+4;I[D7M_8K-OZ9=ZLGAZ]L(+35'65GG1O,M)/+6-F15&U^$4 M@': ?4<5V5% 'F]]\-Y_[0U.2UM/#UZ-1D\XWFJ62RW%LY4*Q4;2KC(W ': M2>HK:/A"94\31Q3P+'JNGQ6< ";1&4B>/) & /F' KKJ* .0O_"-U=_V7MN8 M5^QZ/V<_,\J1J&'L-A_.JMGX1UJ[31++7KJPDL-(C^3[*'#W+^48@7SPH M"LW SDXZ=*[FJ>J:K9:+8/?:A.(;=652VTL2S$!0 2220 * .$T+X'XM.GE221)IY M"R9QAY7<=?9@*UHI%FB25,[74,-RE3@^H/(_> %-=;P[HV@Z7]KIPM&,]X9!)(\# MJW101@[!^9KN:* ,:&?75U+38+J&T,+P3->/"'(20%=@5CC@@MP1GCVK/\8Z M'K&N_8(+)[%M/C=GO+6[9U6Y(QL5MH.5!R2O0\9XXKJ:* .3N]$UZ^BTV_9M M+@U?2[AGMTBWF!XF38R-D9&0>: M[%W6-&=V"JHR6)P /6A65T#HP96&00<@B@".U:9[2%KE561W>LWPDL=?L;C5/LUUKD=M'/=:CA)8VG\MHUMA\NW ;!.&XR:DU M674/^$<\9ZX-9U-+K2M2F%DL=TZQQJFP[2@.'!R1ALC'3%=V_@SPW(UPSZ+9 MDW+%IWFJ7L#Z:)K6V@CN62)(Q;*PW1@[7WEVY8$^F,5Z#I<0G\+V<+, MZK)9(I:-RC % ,AAR#[CD5%?>%-!U.]>\O=)M9[B1-CO)&#O &!N]<#IGIVK M5BB2&)(HU"QHH55'0 =!0!XYX9TM;FP^'$/VR^1;BTNY972Y(;JRW_;3'.\21>8D7GD[ADGKG<0N,UZ/8>& M]%TMXFL=-M[JY')'MTH X"PTVZU3 MQ=X=?6KVX-_)X?N#/+97SJKLLL*AE,; <@Y.."<>@K'\.MJ$>A^"]'LAJ$UK M>:=->2Q1:D]NTCKY:A5DSE5 8ML4CU]:]@CTRQAN()XK2&.2WA-O"R(!Y<1P M2@QT'RKQ["JL_AG1+G3;;3I=,MVM+7_CWCV8\KM\I'*\>E '#6\VN23Z)H.J MWUQ!;76I7<9DAOMTYBCCWQPM,A!#9+ X(8A.O)I][IEN?%?A2T77;Z_2#4KN M,M]L;?$5@9A&S*V6*],M\Q!P4PO@^GE[,^C 552\\17EQX?M+G^T)AJL%UJDMO#?FU?E MT,<0D!!"HCCY5(R>:](F\/Z1<:3)I4VG6\FGR.9'MV0%&8OO)(]=QS]:?J>B MZ9K$$<.H64-PD3;H]Z\QG&,J>HXXXH \^A;7GG\.Z5?ZE=0)-JUW Q@O0\K6 MZP.ZQR2+U8$;<_>& ZGJ]@]SH-I=W]Q;_\)(EDKO>$3B%K99O*$S$L M,OP&SG!P#TKTNVT+2K..SCMM/MXDLF9[8(@'E,P(8CW(8Y/?)I+C0=)NX+N& MXT^WECO)!+<*Z B1P Q]P%7![8% '"BV\3BQU:PCNS:(;FU:UM[G5_,G(.3 M+")^74L%&TG)Y...C1)J%SI]]I%A6[3:?J.IY=XV!/EPW(+-\X5C MG.1M/W17:IX5T%-,ETX:3:_9)G$DD9CSO<=&)/)88&#U&*:OA+P^FGRV TBU M-M+()9%*9+..C$GG(['.10!G^#+M7_M.P?\ M6&ZM)E\VTU*X%PT&Y 1LERQ M=2.>6)'/3I5*6*37_&?B"RO=4O[.VTVWM_LR6EV]N!O5F:5MI&[D8^;*C:>* MZK3-'T[1H'ATZSBMD=M[[!R[=,L>I. .35?5/#>BZU,DVI:;;W,JIL#R)R5Z M[2>Z^QXH \^\)-/KOBSPQK&H3W1O)O#KSR%9W1782Q*#M!QA@=Q&,$D'' KL M?%-W%8X)Y(DN-5\N948@2)]GF;:?49 ./85N)IUG'=QW26T2SQ0FWC= M5 *QY!VCT&5''M3KBRMKN6WDN($D>VD\V%F&3&^"NX>^&(_&@#R[39=0C\,> M&M??6=3EO;C6([:4/=.8FA>X:,H8\[3\O\1&[/?M5.%KW2M&:WTZ>_K#I6T=*DG\=MH3:OK TZ#1HYMBW\JN\AF MD&XR [LXXZ\X&> *Z>W\,Z):V36D.F6Z0/*L[KLSOD4@JQ)Y)!48)]!5X65L M+]KX0)]K:(0F;'S% 20N?3))_&@#S#2]4OM>TCPY8//JMY?_ &*:XG6"^^QJ MZ+)Y:O)*N')XZ+UR2>U'A;4KK5;SP-F<'],2ZFM+;4=0\BYG@D,;[1%(X0..5+,H&1@^G6L: M_#VVJZ1X_%K!KVGV\5PT[/*B3(#)$7;);&+[F'4 M-0E70K&*2QM&N79&?[,QRX)^?) ZYYR>O-%F;C2I_!=Y;:QJ%[+K#B.\2XNG ME2=6MVD,BH253:RC[@ P<5W5EI-AIQD-G:QPF1$1RHY94&U0?7 XJKI_AC0] M)O#=V&EVMO/@J'C3&T$Y(7^Z#Z#% &5\,_\ DG&B?]<#_P"A&N3GO;\^"M1\ M7?VK?KK$&I2(EN+EQ"@2Y\I8##G8H65E;:=9Q6EG D%O$,)&@ MPJCV%9[^%]"DU7^TVTJU-YY@E\TQC)<='QTW?[76@#C+W4]3ANM1\'K?7(U& M[U6,6EQYA\Q+.7,KL#U^01S(#VPM9LMUXFU0>(-0M#=I=V>I36]K.VJB&V@6 M)P%5X2=K!@ 26!)W<'I7J+Z782:K'JCVD+7\<1A2X*C>J$Y*@^E4[KPMH-[J M7]H7.E6LMT65FD:,'.O7!( MZ$UU\-E;6UQHZM?:!93ZM?I#62)E7!1I#F0CW8DYJ&[\-:+?0R17.FV\B27!NFRN#YI&"^1R&QQGTH M\VAU35VL[K3!J-W;^1XHM;)76\,\D<3JA>/S3R^"S?>SCISBK>JWU_H%YXCT MNSU2^%HLFEA9KBX:9[5;B5HY65W)(X48R>"X56.]B7VN,C!..#CO6)K^LWR0W_B#3KC5!'!JR6T=Q M/J/EQ?+,L;QK;+\KKPPRPW'DUZ+:^%="LK9[:WTJVCB>5)F 3)9T(*,2>25( M&/3%1S>#_#MQ/=33:-9O)=%C,6C!WD]3CL3W(Y- &?X4_P"1E\9_]A2/_P!) M8:H7#WLWCSQ!(M[>M#I>GVUS;V4.$S,&D*CER%"@GU^55'X4^.RMHKV:\C@1;F=5264#YG5<[03[;C^= 'F7A> M7Q'<1>&=7#W1^VE'O)KK5A)%)5US M49]2.KI;F-[MFBD1KLQ&(QYVGY"3G&[(ZXKT:S\+:#8:A]OM-*M8;H%BLB1@ M;"WWBHZ*3SG&,YK+\->!=,T6SLVNK.TN-2MY))!WY\%ZIXM_M6_36+;494CMUN7$*!+GRE@,.=ARH R1NRV@^7I@#%;OC6\,5GI]C$]^+F_O%ABCLIA"\N%9V4R M'E%PI)*_-Q@=:S?#_@6;3=;L+^Y728%L(Y%C73K8QF9W 7<^2< #.$' +'FN MLU/2-/UFV6WU&TBN8E<2*L@^ZPZ,#U!Y/(]: /-[*XUV[M/$6C6VH-#+9ZG; M)##/J;/(R,BO) MR1N#'#8/)&2,]ZZKP9= S:II\@U:"ZM7C:6TU&Y%R80Z_ M*4ERQ96P3RQ((/ K0/@_PXTM ',3Q2:]XZUC3KS4;^TM=/LK=[>*TNWM]QD\S=*2 MA!;&T Y48/'-JY[K['BK2:;91W,%Q':PI+;PF"%E0#R MXSC*CT'RKQ["@#F_'OW/#?\ V'[3^9J#Q7Y'_":^$OL03^V/M;E]GW_LGE/Y MF[_9W;,9[XQ74:IH^G:W:"UU.SBNX X<1RKD!AT/UYJ'2O#FC:$TC:7I=K:/ M+_K'AB"L_L3U- 'FWAR[\3ZGIVB:\/M2W-U>(US+/JH^SO&TA#Q" G:I R!@ M;LJ.3S6UX>+ZE90^(=0\0WEG>OJLL+0M=$086=HUM_*)V9( &<;LG.:ZN/PM MH,.J?VE'I5JMYYAE$@C'#GJX'0,?7K2CPQH8U?\ M8:5:_;]_F>?Y8SOQC=Z M;L<;NM 'G&D7?B?5-.MM=C^U)>2:B0\LVJA;;8)RC0_9R=H^4%1QNW8.:DU" M34VT;7=8CUS4XKNT\1"UMMERWEQQ-<1H5,?W6&';[P..,8KT+_A%M!_M7^T_ M[*M?MGF>=YOEC_6?W\=-W^UUJRVBZ:]M-;M90F&>?[3*A7AY=P;>??7^+Q-IUCXPTI=2O'LXH-,N8FN[AIS"[W!#$,Y)Q\BG'2K7BK4-2\'7NJQ:1 MJ-]<*^A279%W<-/Y,JRH@E4N3M^5W.!\OR=.*]%NM$TR^:X:ZL8)C6]H^E7+2B[U?[4[R*@*2QY)*D'(.W"_,.!76^"[:6+PKI]S<7MW>7-Y; MQ7$TES,7^=D4D*#]U?8?S)-6+'PIH.FB86>E6L/GQ&&3:G6,]4]E]AQ6I!!% M:V\5O!&L<,2!$11@*H& !^% 'G/C5H/^$6O+C3/[/;P['=^;JJPY6Y:59P9- MA^[OW =1D\X(XK7\165K!X\\)7<5O&EQ<7TWFRA?F?;:2@9/H!VK9F\(^'KC M5/[2FT>S>\+B4RF,&]5OGOK_1K2XNG(+2R)EC@8Z_08 MH VPZ&0H&7>!DKGD"L/Q%?6.FW-A8S,!OP3PJX +,> !] M ;MKHMI9ZO+J,*A))+6*U"@ !4C+$?\ H?Z4S5O#>C:])#)JNFV]V\(81-*N M2@.,X^N!^5 '%QZ)+HGB+PHNHR1/)=ZE?7EQL&(ENI(F*JF?0;P">3@GJ:DC MN=)LO$/BV]OX!/:6^I6CV\:)O9[WR%&(U[R'*CZ]:ZQ?"F@II+Z4NDVHL7D\ MTP;/EW\?,/0\#D4DGA+P_-I46ER:1:-8Q2^EV\ M']H:UXKCM8)-7NK;%JY#1PE"%@5FZ,^X@D],X X&3#H;WEO\1]3_ +=-I_:$ MFEQ/')9DB%;=9&X<-R'W,>22,=,8-=!;>$?#UG9W5I!H]FEM=J%N(O+!60#. M,@]<9-,3P?HEOI.HZ?9:?!:IJ$+0SNB LP*E>2>N 3@'B@#;+J$+Y&T#.?:O M)K35[];WPQK%M/JGV;5]2$8EO=1W_:87#G'V8?(@ VD%<$8&>M>KP0I;6T4$ M8.R- BY] ,"L5/!7AJ-65-$LU#.'XC^ZP.X;?[O//&* .%>74$\*W?B$ZSJ9 MO;77WAA7[4_E"'[=Y7EM'G:PVDCY@2. " !57Q/YNJ>!/&NK7FJ7J7%O?3VD M<(N6$*1HZHJ>5G82PP3W=WH]G-/.,2N\8._C&3ZG'&>N* )O$D?F^&-53?(G^B2G=&Y M1AA2>".17G>@:-'3 M>.ML'NA<2)%A2$D<=6!+#GG&,UHW'AO1;JR^QSZ;;O;^23ZD^M '":I-K-]K/B>PL=2:-HKRQ M$4#W9@\Q#$&>*-QDHS8/(&?YU7$FH76G7>DZ??>@.]D&%)]P.A[57'A+P^N MG/8#2+4VTD@E=2F2SCHQ/7<.QSD4 <7'J\UO)IMC%<:S:W$7B&""[M;^Z$S1 MH\+L$$H)+HW!^9B<^G J;5]=FCU?Q79_;K_FYT^TM8[.50ZR2KRBEN$W=V[# MGKBNP'A30!I^U76-+LO&MA'=7=JUG8VMQ KZB]W);R.[AL2-\P MR%4[23C\:T_$EWJ/A#4]3_LW4+^Y)\.W5[LNYVG GC= )%#9"\.257"\#BNS M'@_PZ%*C1[0!HC"W[O[R%MV&]?FR>>Y-:4FGVX$+0"1ER?+8@LO MT) X]J ."UYI/"?AF_U'2O$=YVD^T)?:N+MI6&TK)&"25ZD';A?F''2NET[POH6DFCK=W%K9ZA(M-CMI&NY#(HE,1="^A'J*@@\/:/;6,=E#IUNEM',MPL83CS0P8.?5L@')YXH I^+;ZZT+P-J] M[IY8W-G8R/"SDN057ACGKCKSUQ7+WHN/#^J:)'I^KZC=KJ5G=?:/M%V\X?9# MO65=Q.P[L#Y<#YNG2O1719$9'4,C##*1D$>E9>F>&=$T:=I].TRVMI63R]R) MR$SG:/1?8<4 M>R\(^']-N(Y[/2+2"6)S)&Z1X, M;8(^7T&&;@<* ..N&O9_B#K1%[>F#3M- MMKF"RBG98WE)F^\ >0=H!'0\9Z"L'PO-XCNK?PSK(>Z+7KQO>37.K!X;A'4E ME2 G",#R H!&T@YYKT]+*VCOIKU($6YF18Y)0/F95R5!/H-S?F:S[7PMH-CJ M/]H6NE6L5T&9ED6,#:6^\5'12\O;]O!NM^+/[5OX]6L]1F2&!;EQ"@CG\M(3 M#G8VY0,D@DELYZ5U?AOP+IFCVEJ]W9VEQJ,$TLPN0G\32.RGG^(!@,]>*U)/ M"^A3:I_:I7))P>* +?AR^@U/PWIM[;7,]S#-;HRS7"@2/QU< ;O7'& M:U*C@@AM;>.WMXDBAB4(D<:A551P .@J2@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "@\#-%% ' 2_$A)K.QO+>UGMX& MULZ=/Y]M)ED E&4& 2Y,8^4 D$XQFN@C\9Z*^GWMY)-/;K92K#<13V\B2H[8 MV+Y9&XEMPQ@'.>*Y:TT#6@;*TDTN5%LO%$NH-,TL>R2"0SL'7YL\;T!! .3Q MG!P>(O".K:EJ>N7<%O(5-_I]Y;K'<")KA84PZJP.4;DX)QR!]: .H_X371$L M;ZZN)I[5;$(;F.YMWBDB5SA6*L,[2>XXX/H:'\9:4D5JPCOWFNE=XK9+&4S% M%."YCV[E7I@D#.1CK7(ZAX6NM3T76WM=#U2*[N(8+>)M3U(32S*LH=EP7954 M)M!O'\9PZY':ZI=VK6'V22/3+W[/+&RR%PQRZ!E.XCKP0.* - MV3QAHJ6-C=Q7$MRM_N^RQ6T#R2R[?O80#<-O?(&#P>:C;QMH*V5K=&ZE*W4[ MVT<8MY#)YR@EHRFW<'^4\$9SCU%<[9:!?:#>Z)K%GH=PZ10W<5U8+>+/-&9I M%D\P/(P#'*_,-W\7&<4FG>&M8_MG3=4N++RO-UZYU*>$R(3;1O;-$@;!P6)" MD[V: .RT;7+'78)Y+-I0UO*89HIHFBDB< ':RL 1P0?H:=KMW>6&@:A> M6$*37=O;O+%$^<.R@G;QZXQ6)IUIJFDZUXCO%TUKA+_4X&A"S(N8O)BC>3D_ MPE6XZG''45U9&1@]* .+UCQZEC!X;N;.W2>WU7RYYF)_U-LQC4R<>C31_AFK M]SXLBL_$6JVUT8H=+TNRBFN;ELEA+(Q"H .ORJ. ,DL!7+Z'X$U$VOB#3-4A M$=HMG)I>E/YBL3 TDD@?@_*1NB'./]734\):_J?@/4)=1M_*\0WVHQ7\MN+@ M*2(60+&)%. 2D?!!X+=J .YTKQ%8:O&38V0&"N!D$@ MC([C%4/$GB5]!UK08&&;6^EF28)$TDAVQ%E"!>22V.QJIX8TG9KTVIR:1JUH MZVWV=)]4U+[1(P+;F4('";E.MO&&C M7/E*)IHI)+L6)BGMWC=)BN\(RL,KE>03P&SN_$!N MIX[&X2.>:U^S(H*,6&W]XHR,JV <55M_">KRVOBJ+^SKFVENY(+_ $N6YO1< M,LT2KL5W9V;=N09Y*@' ) H [>^\5:/ITUY#<7+"6S,2RHD3.=TN?+10 =S' M'W1D]/6IM)UZQUDW"6QF2>V8+/!<0M%)'D97*L <$=#T/X5P]WX2U>^\.0W\ M]K*NKR:T-6NK2&Z$1N<* 6./F).3P.X!IZKXETW1[^VL+IIVN[I&>"&"W>5G"E0 MV H/3<"?;)Z U6?QIHD=\ULTT^U+@6KW(MI#;I-G&PRXV@Y('7&>.O%)=Z9= MR_$'2M46'=9V^G7,+R[A\KN\148SGD*W(':N,MO!UW;PSZ+>Z/J]]%)?R2"> M/5S%9M$\QD#,@?(9<\J$.2.O.: .TO?&FBZ?>SVT\MQBVD6*XN$M9&A@=L85 MY NU3\R]^,C.*K^(_&MAH\&JPPM-)>V-JTKE+:22*%RA9!(ZC"YX/)'!R<"N M2\4^'O$NMV?B.RDL=3N;J>5S8RKJ0ALQ "B^6L@R_!'SH1DY)Q5ZZL=?AA\ M6VMOX?N+C^WT\ZWD::$"%FMUC:.7+Y!4K_#N!SUH [K1[N2_T2PO)@HEN+:. M5]HP,LH)Q^=YV,59P$P$4L"!G)XSBN MBT.WEL_#^FVTZ;)H;6*.1<@X8( 1D<=17%VVFZGH>BW'AFY\/7VK:8)W>TN= M/O$A8QM(9 LA,B,I4G&1D$#\* -RX\1ZE:+X;2\TQ+6ZU.]-K#G8,9['D U=\3:\V@Z?"\-M]JO;NX2TM+??L$DKYQEN<* "2?0&N-'A[Q M!INE>'YAIT]]-9ZU+?/:1WBR/# Z2A4\R5EW%=ZCK6SK,&L^)-/M;J#19].U M'2KZ*]MH;Z:(K>(&LQHD5II%RT&+QY$:0"-)"2PX'W\= M.U.U9=;\8P6VDRZ!=:W9-H<1^5&H&9) Z_,K'@=\T =/<^+9%\"V6O0V16]U"* M6MG*>3--@(A/7 +9)] 356?QI<1_#B?Q$+6(7]J#%<6S$[8YED$^(]3DT7PSJN MJ11K))9VDMPB/T8HA8 ^W%9NDS^++H6=S>'1!:2JLDBQ++O"D9XR<9JGK-UK M/B'PQKFECPOJ%E+GZ]XH\1V;:KH=KI4.F.S"U6]:0R7*J2-Y*\1@X MXX8XYIUAXW?4KGPY''9B$ZC<75M=Q2-E[>6!&+*".#\RXSW'-5=!/B#PAHR> M'QXE5H_"FLZ19Z)JL4,=_JEI MJ-S?WMK%($$AN X=8V; RNX8SC.T],T =)JFOS6'B>RTI(8VCN+&YNF M2UBXLXK?5K"P-X]KN)1E,1DB8'J58<>Q##M4R66K M:]XG_MFYTJ73;:TTZ>UMX;B6-I9I)2I)(1F55 0#DY)-8VK>#M:_X5WI?]F6 MRC7[?11IES:F10)XGB"/&6SMRK?,ISC((_BH VV\0^(+_P 1KI>E1:8@72X+ MYWNO,.3(SC:-IZ#;^M5]0\N: M+XAOKNR1-0U:6RCCL$F4^5;PRJV&?(!8@NQP?0 F@#GI3I?!D.B^+M)UK1=-6XB&ZVNH9)-QA5ND\9<\$=& .2K=.*RM7\* MZM<:!KMN=)^V?:?$L=^MKYD?[^V#1%OO,%Y",,,10!V&G-XF^VK_ &E)HS6N M#N%J)/,Z<8W''6L#1_%/B7Q!I2ZSI=OHT\)7*6() ' K#UK1;_6[*4-X&^Q^*&4J MFL6EQ#%%')VE$BN)2H/.TJ3V]Z /4:Y#2/'EG/X?TJ]U,-%=ZD9Q!;VT+RF0 MQN5(4*"2< '\^PKK(5=((UE??(% 9\8W'')KS[PWX9U>P_X0W[59[/[.^W_: MOWB'R_,)V=#SG/;..] '2KXST5M*74!-.5:Y-H(/LTGGF<9S'Y6-VX8)QCIS MTYK0TC6;+7+5[BR=R(Y&AE22-HWBD'565@"#R.OJ*X?_ (1W6K'5CK,>GM<,1T/M75V&HZS)%'-<:"8//O"GE>?'OA@V\2 MR8)!;(QM4G@CT- $)\1-H]L!KV_[5<74Z6D%G:R2R21*QVG8FX\+@D].1TSB MM;2]4LM9TZ*_T^836TN=K;2IR"0000"""""",@BN=\;:7-?RZ9/'I=[=K;M) MF?3;L07=L6 P4)9593C# GTX-:'@^#6+;P^D>MO(UUYLA3SBC2B(L=@D*?*7 MVXR1QF@!+OQGH=CJ,EE/<3!HI5AFF6UE:&&1L;5>4+L4GQ_8IAA1NN(G;[P (.U,G P:FU33?$UO>^*%TW3Y2M]>VMW')4B M21(PY^64;&(+#'OG% &OJGQ!TVU\/:U?VD=T]YIEMY[6=S9S0R'.=A*L@.PD M5(^A=T"%D7.>6 KB9?"FN7[^)WC MT_44CU#06L[9M3ODEE>;+G#8?7'TC72E]8P1&WT M_48X);>6+<-LF) K*0P(()QSQS0!UUWXWT"S-LIO)+A[JW%U EI;R3M+%_>4 M(IR/7TI-/\<^'M5O;2ULKUY3> _9I?L\@BE(7<560KM+ Y7.1@CJ#6-X4\+ MWVC:YIDTEBL%O#HKV[[9_-$&=6;P)K&G+9_Z9 M* -.R\?:?))[:7P_)?VUWJ4-_#(ETL1=1'$I\M@P995*$C. <=>:V?!-IK5JVI?V M@=0&GL\?V&/4Y8Y;E<*=^YD)R,XQDD\&@#0U+Q#;:3J]PE[>P16EOISWLJ>3 M(TBJKX+[AD%<<;<;LT:=XQT/5+Q[6WNI%D6$W"F>WDA62('!D1G4!U&1R"1S M7/\ C3P[JNK7VLR6-IYJ7'AR>QB/F*NZ9GR%Y(QQW/'O4WB?PO?ZU>V$5N@B MA_L:_LI)MP B>5(U3C.3]UNGI0!/>_$#2GT;4I]+F=KN'3Y[RT^TVLL<=P(T M)RC,%$BYQG:>A_&MG3-?M+Z%T:8?:[>UAN+I%1@(Q(I8$>OW6Z$]*Y6[C\2: MOX8ET8>&1:-'I,]M)+/+$V^4PE$6 JYP">I8+QQ]$33]>T;4]0:WT26^74]+ MM;='CGC58)HD=2)-S [?G!RH;H>* .BG\;:#!!8S?:9IEO;<7<*V]K+*WDG' M[QE5257GJP%9VB^.[2?PKI.IZF^;O4?,,5O8V\DS2!7()5%#-@ D].?>LCP M_I.N^%&TV[.BS:@TNA6EA-#!-$'MIH0W!+, 4.\Y*DX*]#FLNS\'ZWI]MX?O MKFPU!GM[.XM+JUTJ^6*6$O-YBLIWJKKV(R/X3VH [^7QCH<>EVNH+=O-#=R& M*!(()))9'&=RB-5+[A@Y&.,TU!K6 B-D8H(XV^<-R& M!9@1@8QC%YBA,B.?+,4:@DJ2,Y4Y'KGJ,$@&ZFIVDFK3 M:6LN;R&%)Y(]IX1RP4YQCDHW&<\5C/X\\/+#92)=SSF^@-Q:QP6DTDDL8."0 MBJ3Q]*IZA%K&E^.KG5K+1IM2M[W3HK53#-&GE2QR2-\^]A\I$G49/!XK-\%> M&=6TB]\/27UH(UL]!DLYF\Q6V3&:-@O!YX4G(XXH Z.3QIH2Z;8W\=W)<17Y M86J6]O)++*5^]B-5+?+@YR..]9NC>/;*ZT>\U._F40#4Y;*S$$$C23!3\@$8 M!8N1G( ['@8K&TG0M;\/7>FZN=)EO#"^HP36D,L?F(D]SYLAT MK^TIKUXX!02)-C/EM'MW!L#@$ZL 1^(KSJV\*ZC));WJZ7=PL^NVUU(M[?">?R8HV7S)"6(!R0 JDG %>FT M 5PB1-*%("AOF.Q:PUR[NIK>. M6/?Y4IN K E@IXD4XSG%9B>"]4AM)]"FTW5KM9+YY!<#5?+LFB:8R;V0/N# M'[H4Y89SS0!W%YX_\-V%W/;W%](AMIA!?;JKR13V\D+;&SM8!U!*G!P1QQ7)ZAX8U6?PQXPLX[(-/J.K? M:+=/,3]Y'^YYSG ^XW!P>*Z*+3;M?B)=:J8<63Z3#;K+N',BRR,1C.>C YQC MF@"?Q5JVH:+H-S?:;8)=S11O(1++L2-54L6;N>F ,DD=!DBAJOBJ6Q\.:/= MQQV_V[5#$D0GDV0QEHS([N>NU55C[X [YJUXQ:_?PW?66GZ36\L $,D M2>660@%O,=>,GMD^U3M?06MO<6DQ>WE61T3<0"2I!8Y&3T]ZW], M'B47?_$U;23;;3_QZK('W=OO'&*X?4/"FJ:S::U.NCM9PZEJ5A*M@TL:N(XG M7S96V-M#,,\!B<*.]=QI?A;1]%NS=6%M)',4*%FN)'&#CLS$=A0!9U?6K'1+ M>.:]D<>=((88XHVDDEB]ALFCGLI2 MUN[NH)>/ ;[K9 XW' !.:T?%.GWTFI:#K%C:M>-I=T\DMJCJKNCQ-&2I8A=P MW X)&1GFN>O/#VM:JVK:I_9SV\E_JFFRQVDDL?F)#;R(6=B&*Y(#' ). ._% M '5H&7!"Y+&,G(]=N<]JYZS\=V)U%+"X\UHTTJ/49=0 M%M(D)1E+%L$':N%)Y/7Y>H-=%K$$MUH>H6\*[I9;:1$7(&6*D KV- MU;+-H/VZ&;PO!ITL;3QK&)H]Y:.0Y)PVX+E0PY].: .NTKQ/IVKW7V6!;R*9 MHO.1;JTD@\R/(&Y=ZC(Y'N,BJOBO6M1TE]'M]+CM7N-1OA:AKK=L0>6[Y^7G M^#'XUE>%K#5[/78U@M=7L=#6V99;75;N.XVRY78(2'=@ -^ M(I_#T7V8SVEOJ0FNMLOEE8_)D7.00?O,O3GF@"Y'J.IZ/9W=_P")[C2XK*% MV^U63(.<<@YSG( Y)--7QKHPM[^:=[JU-C;_:IXKJUDBD$//SA64%AP1QGG MBLO7? ]M'X>N(M M2+L3V]R(I;EV6;R95DV9=B!G!&?4C-9?B/1M;\4G6;Z+ M1Y[(G09].MK>YEB\R>61E;^%V4*-@&21RQ[4 =,WC?1E^S#-ZTEV)#:QK92E M[@)MW,B[OT@'V2SL;J&5]R_(S^3M&,Y.=C=/2L.V\-:M'X8T>S:SQ<6_ MB)KV5/,3Y83=2/NSG!^5E.!SSTH [?4KBYM=-N9[*S:\NHXRT5NKA/-;'"[C MP/K7)R^+=5T'4)K?Q%#82(NESZEOL"^8Q%MW(P;KG=PW&2#Q74:S<7]KHUW/ MI5F+R_2(FWMRX0._8$D@ ?C7$V.B7VIZ)K&F:AHFJ0:CJUG)%=:M>RV[ L5( M50LYOM0BLU^T[MB[PW)V\]JQHK/7/$&HZ FI:3/ID6D M[Y;B9IXV\V8Q-$HBV,3CYV;+!>@XI?$7@R6[T[2K"*6_U*!=7AN;DW=V69(@ MXD$#D<#GF@#H]*'B(7#_VPVEF#9\GV-9 V[(Z[CC&,T_5]>L=$-LET9GF MNG*006\+2R2$#)PJ@G ')/04S2?#6E:'-)-I]O)$\B[6+3R29&<]&8UE^)+/ M4(O$^A:[9:?+J$5DEQ!/;PN@D E"8==[*#@I@C/0T 5](\=6T]CJE[?.WDQ: MLUA:)#;R&63Y$(3R\%M^2V1@8P7#'4(K"6W^S2++# M([*"&7;D$*VX#'S< =:YV/2?%,-O=2OIUY!;WFORWEU:V%W&EP]NT*A-KAP! M\X&X!@>#@XZU1X;UZW35731+QE?6;'4X$>^6>1XX_+#(7DD),@"$X)V]@Q&* M .WO?&NBV$\T4\EUBW56NI$M)72V# $>:P7"'!!(/0 M(!XU5HYU$@Q@@@LH?(QUQBK[:1J^AZAX@M[#1);VVU6UA2UD2>/9"R0>44D+ ML&Q\H.0&SD\9H ZWPUJ$VK^%M(U*Y"">[LX9Y @PNYD#' ],FL37/&*K M;3XK6.73XC"-2N2QS;F=BD..WWASGH"#6OX4LKC3?!^BV-W%Y=S;6$$4L>X' M:ZH 1D'!Y':N1MO %]K>D:M-K.JZE87>M2R2W5G"T#1QC[L:DE&)VHJ=&Z@X MQ0!U>I^*]+TK4_[,F-U+?F 7 M[:UDFWDD:10P5N N006Y!QC!ST-ZU%?#D4=W%;2Q M%]XGD&\;F"E6QGKD9''7%WPGX6U;2M6T*YO;956&QO\ S]LBL(99[A)5C'.3 M@;AD<<=>10!IV_BBXFUW1[.&Y@NK>\N[^"9U@:,KY.<* 2>01@GH<9&,UOZS M<:E;:)7T'6X[(W+VGVR":SW!60,$=2K$D$%EYSR#VQ63:Z6\GA75-,/A"^9YD\ MR7^T[R'??R$C),D;N0_ P3@# P!Q7T71KJPUR]\3RZ;J$"6FEO;PQ:E?+-< M3G<';+;V5%&Q0.>I8GW /0Z*KV%T;[3K6[,31&>%)?+;JFX X/N,U8H **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M3<-VW(SUQ1D9 R,GM7F^J^'M*FUZ*PT2!I_$*W\=[>:LQW26D?F!RK2?[2Y1 M8A_",O$MS&IUNSN[U[6\/^MMOL[$1*C=5&$' X.XYZT > ML%@" 2 3T]Z6O-O%>CZ3J*3H+$ZAXJU>V4VJR'+6(VA1(K?\L8U;YL]6;(&3 MQ5#XCZS;W6AZKX:DUF"(Z=IC2WCO.L<\5KIKWCRWERXA\PHZ/&OR G_:/! MSP:;IOB?7M7GTG1EO(+>\DFOTNKU+<'AQRQR[_+ MD1]C%6VG.T^A]#3ZXGP&EZ;'Q1')-$;W^VKE?.1,*6V( VTDX['&3Z5GV/CG M4KN\\-[A"MN\,:ZP-O*32L\2!3VQ+$PQZ&@#T:BO+HO'&L7]Q86WFSVR7=M+ MJ(FM-,>[D\EIF6! J@@#8-Q8CG( Q79>&M8OK[PP;[5X#:7,)E61IH6@5E1B M!)M?E0R@-@],F@#?HKS?1O%^JOK^A0W%X][:ZJ)0[?V9);1*5B:16A=L%U^7 M'.<@@TVU\3>)9=$\-Z^][:&VUK4+>)[3[/CR(I'X"OG).W@Y[G(QC! /2J*\ MUE\7:_:>'M8UJ6>"01ZI+I=G;):EMI^U>4LC;3N8@?PCK@=S3;CQMK6BV6L3 MR07M_;V]B)[>YN]*EM,3F0)Y; @;A\ZL,YGTB6S\B52N%RP *L"V!U!7J:PU1I=2 M%PZ>+[6&W66+Y8RLD.#P<[>1P,=#ZT >OT5R^A7^JQ^*]6T/4KR.]6WMK>ZA MG$(B8"0R*5(!P<&/(/OWK(U+Q'K-AXBNH[^^&DVJ72)9F?3VDM;B(A>7G!^1 MR2PP2N,#@T =_17"7WBO4[?PEXTU)&B^T:3=SQ6I*(M;U MC6XM'OK2S32I8[>.&>#>MQ(8UD;>V">>E '8)+'([HDB,T9PZ@Y M*G&<'TX(-/KR^:?6[*_^(6J:=?P6OV"5+DQ-!YOG.EG$Q4DD87 QQSS[5V&M M:GJP\'+J.C6OFWLD<,@C5/,*HQ7>57(W,JEB!D9(H Z"BO+-8U[4KWPI?"T\ M1EYX+^Q1M]@UM96D$>\^>X^5-W& I! .30!Z-17F=YXDU+3_$&N:X;IGL[7P[;WZ6!4;2S> M;A<]OF7)/7'':K.E>)=?_M"UCF^VWD%Q;2O<22Z-+:I:R*FY2K, "A(*X.3G M'- 'H=%>:Z;KGBN\B\)2/JEH/^$AM2T@%H,6Y$0DW)SR2 1@\9.<<8,G45YO_ ,)5XD^R6]N$ M:.:36HK&*\O-/> 3P/&6W>6V#N4@@XP#M[9JKXBU;Q!'8ZYI3:N/.L-0TT)= MQP!'>.>105(!QP>XZC@]: /4J*\]UCQ!KNDZQ/9*GR!G=E8 YS]X9SUQQ0!Z([K&C.[!44$LS' ]32JRNH96 M#*PR"#D$5YOXI?46\3>*8#J+?8(_#)F%KY8VY83KU]% M;>^O[::QU*Q?=%Y(C%N8X5<$/G)&,@Y^O'2@#T"BO-=+\7:O-K.AQO?F[MM7 MDDB+C2Y(($_=.Z-#(^"X^7OG(.1BM?P VJW7@=Y[C4C<77WAPL(4M9((AJV5YCGE\Q$ /;$L3 C_:%4X? M'&LW]Q86QEN+5;JS?4O-M-,>[?RGF98$VJ" -@!+$/>VVK++ MN8Z9);1(RQF0&%FP67@CG)((- 'HU%>70>,/$47@S2=7NKJ.2YUJZCM85@L6 MD^S+^\+.%4EI&*IP. "1U .>G\):QJE_?:E:7\=W);P"-[:]N=/>T:4-G>B;"0[9R.&(& M/KST&A=ZQK^H3^)KC3+^WLX-$:)6QGU!ZGO MP.PJ+7O$>I:9J7B3^STM$GMY]+BB=X1EO.D"-O(Y88/'IVH ]#HKE]'O]6@\ M8WVA:E>QWT:V,5[%,L B9"SNC(0"01\H([_6L'Q=XMU/3)];GT[40ZZ5$'%M M!ILDR;@F]EGEZ*3Z*1@$$T >C45S/B_7+[2_!+ZMIHB6[+VPC$HRO[R:-"#^ M#&L'6_%6N>$;K4K:[N+?4V&EF]M7,'D[)!*L6U@"#C8V['/ M(QUK);Q3?_\ "/ZZ+O44GNX-'GN7T[4=+-O(CJO4*?EDBZ@]>W/- 'I;S110 MF:25$B4;B[, H'KGTI]>3ZGJ>K6Y\:WK7D4UO9Z):RQV4MNK199)3C:>,9!S MZY&>@KH)M6U[5+[Q#_9E_;V,.C!8XXWMQ)Y\GDK*2Y)&%^8 ;<'J(M>\57KKI][!IMN=&L]07-N)76282$KR<;?E'OQQUJS?:Y?ZM\%+C78YA M:7\VC-7N;;GIG!QW&?:@#N:*X6QO=>O\ 58=!M]72 V>F0W4]VUJK MO,\K.%4*3@* AR>ISVK5\/>(IM2\#_VS?&V@GA6=9W)*PAH7=&;N0N4)[X!H M Z6BO-M,\9:I!K&GQWES+?6M[9SSNSZ8]HJM&@<&(M@LI&1SST.:EM->\3): M>$=2NKZTE@UZYB$T"V^WR%DB>0*C9Y&!@D\\?A0!Z)17F">+_$,'@^#6KBYB MDEU'4!86T45DTGD 3.AD*J=TC;4.%&.<>^7W/C;6](TO6)'M[N[2%+?[%>7> MERVV9)9?+*,F!OVY5AM R#CK0!Z917&^&=;U>Y\0R:?="^N[%K4S+>7.E269 MCE# &/Y@ P(.1CD;3G-)]:FJ M:AJMWXS@T#3KR.QC2P-]-,8!*SDR;%0 G '#$GKTZ4 =&EU;R,BI<1,SE@H# M@[BO#8]<=_2IJ\G\*ZCJ%K;:';Q6]I/=SSZT_*#F5)F("L>54L<'GIBMC0?% M-^9F76-7C@NELI)[BQU#3VM#$R@$M&_1XQSD@MQ@YH ] HKS?2O&.J1:UI<5 MY=2WUK?VL\SLVF/:HK1H'!B+8+*1DZU)M-M(8[, MOY7^D-'YA"G<[;5.%&,X'J:6Z\;ZWHVG:Q*]O>7L4,$+6EW=Z5+:_O9)1$49 M2!OQN5AMP2,CWH ],HKC/#6MZQ<>(387(O[NQ>U,HN[G29+/RI58#9\P 8," M2.XVG.:IZ[XHURR?6]*L?);5Q>0KINZ/(,4D1DY'?'E3C/L* .\DECA"F61$ M#,%!8XR3P!]31)+'%M\R1$W,%7<<9)Z >]>=:AXON=2NH)[-+:32Q5M9GL TVJ"YG'C%8(#-%\L161ES@'D=/ER.G7F@# MV"D+!1EB /(-/&JOIUZUK;64L8E$421(PV1GC3ZE<:6G@;4 MM.TJWU*S6TU:Q+VE\"#!OGB8*@).$QR!VS79?$'4+K2_ VI75E.UO/B.,3KU MB5Y%1G'H0K$Y]J .EW L5!&1U&:7(]:\_P#$_@OP_H?@[4=3TNTCL-2T^UDN M8-1C.)_,12P+/U?)&"&SG-8DEL-;\;0/A+/ +IXM3^V2Z8DRL[*6ZL68,#Y4D9WKR!]V0-^#B@#U:DR/45B^%CGP/HI_ZA ML'_HM:\V\ 6.@R^%M"DG\ W=S=-$A:_%G"RLV?O[B^<=\XS0![&6"]2!]:6O M/_#VA:7XMNM=U/Q!90ZE2%9B!GH"!0!Z]17(^+S_ ,5'X, /)U5^/;[- M-7,^";B;PXZ7,TC-I&MZC=Q.6.1;78N)%0^RR*H7V91_>H ]-^R6HOC?>3&+ MIHA"9L?,4!)"Y],DG\:GKQW0-+L-9_X5U::G:0WEN=&NW,4Z!UW PX.#WYJ] MXBM8O#MQXET72B\>F7/AB[O'M Y*02K\@9 ?NA@QX'&5S0!ZID'O1FO%I++3 M9-.T/3]'\(W&C:]>^4;34W2*!0R!6=MZ.2WRACMQEN>.N+_C$GR_BAR>-.LL M?]\/0!ZSD>HH+*"%)&3T![UPFB:#81:M:RCXZBC8DJH5\,I0<#83T&!F@#U*BJ.BW M5K>Z'87-C.]Q:2VZ-#+(26="HP6)YSCKGO5Z@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#E;/P-#I\TKVFNZW"LU MPUS)&MPFUW9LL3\F3GZ]*EO? ^F7UY1^:MQ;FWEG(7S6!7:6W8^]CO3+CQ! ;6TN=+,.IQ3W<=LS6 M\ZL$#'!;(SG;U(],GM5Q-6TZ34&T]-0M6O4&6MUF4R#ZKG- %:/29(-:L[F" MX>.R@LY+>M;M4[O5M.L)HH;S4+6VEEXC2:949_H">: ,K1?!NFZ#/92 MVLMT_P!BMY;6W65P0D3NK%> ,X*#&><>M1/X'T[; UM=7UIE7X?$FG3^)KK0%F7[;;01SN"Z\ABW &-AQ\N'RWU)J[IWBK2-0\. M6>NF]@MK*YC5PUQ,B["PSM8YP&'<9K0GU*QMK(7MQ>VT5H0")Y)56,@]/F)Q MS0!EW7A*RF:PDM+B[TZXL;?[+#/9NJMY/'R$,I5A\H/(X(XQ5Z#1K6'1&TEV MGN+9XWCD-Q*SO('SNW,>>-N" MI4X)(+' YXKF;?P=J;W^DV0TV[M++3M3%XIDU!);6*-&9@(5&');@8/ M7=G&* ,T^$]+?0[W2)$E>UN[F2Z?,F&61Y#)N5AC!#%"!0#S][&[IS6E%J^F36#7\6HVDEDGWKA)U,:_5LXIT M6IZ?/8F^AOK:2S )-PDRF, =?F!Q0!1TOP\--N_M,FJZG?2+%Y,?VN<,J+D$ MX"@ G@?,V3QUIUWXE*_@K3GN[F8W%YY=Q?Q:BT M'F#RUGC96##C/)1->H2Y4X+% /E3K MAB><4 ;,6D6T.NW.L*7^U7,$=N^3\NU"Y7 ]S6\AO[62U9@HG292A). -P.,YXJ6U MN[:^MDN;2XBN('SMEA<.K8..".* .:U+P!IFJ'5(Y;S48K35&,EU:0SA8GDV MA=_W<@_*O&<$CD5/J7@K3]2O;NX-W?VRWRJE[#;3[$N@HVC?P2/E^4E2I(XK MH)YX;6!Y[B6.*%!EY)&"JH]23TK%U#Q7IUE'I4\,T%U:ZA>?91<13J8X_P!V M[EBPR"!L(_&@"1O"^G-;ZW /-6/65*W(##@>4(OEXX^51Z\U8N]%@N]'CTWS M[F".(((Y8)2DB%,;2"/IT(P>XJ>'5-/N;%KZ"^M9;1ZA=7%[Y(DO)95$JB M)]\87:H4;6R?N\YYS23^ ]/N6O1-?:DT&H(HO;<3A4N6"!-[84'<0HS@@''( MK?M-3T_4/-^Q7UM<^2=LODRJ^P^AP>/QJ!-V",>^:GT_PI#8NI M?5-5NXXX6@ABN;@%(D(P< ;C@ 9;<:MKK^GQ:?;W.HWEG8O+#'(R2W283>. M!NS@C((!'!P<59N]4T^PACFO+ZUMXI" CS3*BL3TP2>: *%KX7T^SCT)(C-C M1(C%:Y<<@Q^7\W'/R_3FJ\O@O39(SYAGAN(_,@E25,E=R,&&0<$9'H012S316\32S2)'&O5W8 #\30!B)X4L_) MMEN+N^NI+>^6_$UQ-N=I0I49XP%P?NJ *;J7@_3=4.JM,]RCZD;=I7CD *-" MAZU6_MVVEU&"WM); M6YB8RK/*ETG[ED ."N>"K>^CGAGU?5VM;I EW;_ &A=EQ\H M4[OERNX#D(5!YXK4LM.GM=7U"Y:Y=K:=85AMRY*Q;%()4=%SD<#TSWJ:WU?3 M;NZ-K;:C:37 0.8HYE9PIY!P#G'(YI4U33Y;]["._M7O$&6MUF4R*/=(B7T<$ MX1;L*-H+\9!*\$J5R.*?=^#;.>\NI[>^U&P6\V_:H;.<1I-A0H)X)4[0!E"I M( JU=>(K:&^T2"WV746K3O#'/%("J[8GDSD9R/DQ^-;- '$GP=<7GBSQ!=R7 M=_86MW!;0Q2VDZ@S(J,'4@AB,9'. >3@]:V;?PGI]EJEA?63W%J;*S%BD,3C MRWA7E58$$G!Y!!!]W]K;-*<1B:94+GVR>: .>@\ 6$ TS_B9:K(VENK6+23J? M(4*5V ;<%2IP=P)QCFM?0M!M_#]M-;6EQ:K2ZSI=O )YM2LXX2I<2/.H4J#@G)/3) ^I MH Q)/ .BOINLV/\ I*Q:M<_:9V67#(^_>-AQ\H#98>Y-6KOPG93R64UIG M7-G;_98I[-U5O)X^0AE92. 1D<=L5)?>*M)L+_2+22ZB8ZJ[+;R+(NS 0MN) MST. !C.215MM;TE=3&F-JED+\]+4W">:>_W,Y_2@!L6BVD>A-H\AFN+62)XI M#/*SO('SNW,>>_TN/4+? M[58('N$,BC:.YZ]N_ID4 5O^$.TP>&[/0U:X6"S=9+:99,2Q.I)#AL=1D]L8 M.#5[2='&E>>[7U]>S3L"\MW*&/ P %4!5'T SWS4VGZOINK1N^FZA:7J(<.U MM,L@4^AVDXJY0!@S^$M-N-'UC2W,_P!GU:9YKG#C=N< ':<<#Y146I>#+'4; MN^G%Y?VJ:@H6^@MI@J7("[?FR"0=N%)4J2!6Y>7MKI]L]S>W,-M;I]Z6:0(J M_4G@5#%K&F3V4=Y#J-I):R,$2=)U*,Q. P."<]J *EOX:LK/7AJUI)/;O\ M9H[5[>-@(71-VS*XSE=QQ@BH;[PEINH7-]/,9]][+:RR[7 &;=@T>...1SZU M?M=;TF]M)KNTU2RN+:#/FS17".D>.3N8' _&J%AXJL=4\1?V7I\L%W#]B^UB M[MYUD0_O-FWCC/?.: +ZZ1;+K\FL@O\ :I+5;5N?EV*S,./7+&L>^\"Z9J$N MIB6ZOUM-3)>[LXY@L4CE F_IN!PJ\ X.!D5T_09-5EU&Q=+9UO;IO>VWV21[R0$K#DG8NT+CDYSUR <\5KW.LZ7902SW6I6<$,,GE M2R2SJJH^ =K$G@X(.#ZU8MKF"\MTN+6>.>"0922)PRL/4$<&@#!A\&60DDEO M+_4K^9K9[2.6YN/FAB;&X(4"X)P/FY;@P>/Q MH R;_P #:9J$E\7N+V.._L5L;F*.0!9$4,%)RI(8!CR#^%/U#P;97]W=W"7N MH6?VZ-8[R.UF"K,J5..]:?]O:.;6:Z_M:Q^SP;?-E^T)LCW $ M;CG R"",^M6;.^M-1M5N;&Z@NK=_NRP2!T;Z$<4 4;'P]I^G7\]W:HT;2VL- MIY8/R+'%NV!1V^^?TID'AK3X/"0\,@2MIWV0V9#/\YC*[3R.^#UK79E1"S,% M51DDG JC;:YI%Y>?8[75+*>ZV"3R8KA&?81D-M!SC!!S[T 9/\ PA=NOV66 M'5M5AO(+?[*;R.5/-EBW%@KY0J<$G! !'K6A%XMZ3-J3Z='JED]\F=ULMPAE7'7*YR/RJ+1/$6E>(8[B3 M2[R*X6WF:&38X;!4D9X/0X.#W% &7%X&LDN["\FU+4[JYL,K#)<3*W[LKM:, M@*%*D=3C<<#G@5S.E^$=4.IZ!#)I]Y:6FD71G!GU!)X8T".JQP 8<@EEYD * M@8%>DW4QM[2:*028ECD\PR!U8="&/'YJJRO=3_,H4Y78$"JA!YR #GDYQ6]'(DL:R1NKHX#*R MG((/0@TV>XAM8'GN)HX88QN>21@JJ/4D\"@#-TK0AIMU)79BZ$0,QSBX.9,MU^ASD>M-_X0:PGXU*^U'4T M%M+:QI>3 B..1=KXVJ"25XRQ)]ZV9];TFVU!-/GU2RBO9,;+>2X19&STPI.3 M6=>>+M,TJ0KJMU:6H:]^QPG[2K;CM5LMTV8SR#T&#W% %>#P-917>G7DNI:G MM6T=K>75_<6=I;VT[1&5KI2@ Q@L> IY^Z>E M31:QIDUG'>1:C:26LC;$G2=2C-Z!LX)H S_^$1TL^'6T0B8VIG:X5_,Q)'(T MIEW*PZ$.QK'*UW/RJJV\0N)/MUM"84PWR$' M=R1W(WN ?]HTRP\7:#J.C-JT.J6BV*2-&\TLRJJ,"1\Q)P,XR,]00:T[2\M= M0MDN;*YAN;=_NRPR!U;Z$<&@#!L_ NC6&DIIL N! E^FH#,F6\Q&4J,X^Z-B MC'H *5?!6G+=2S?:+PH^HKJ8@,@V)."22O&<$G)&?IBNDJA9:WI.I7,MO8ZI M974\7^LB@N$=D[<@'(H +;2+:UUF_P!5C+_:+U(DER?EQ'NVX';[YK/U#PE: M7NJR:I;7M_IE],BI/-8S!/."_=WJP920. <9QQFK\>NZ1-=/;1:K8O<)((GB M6X0NKGHI&<@\'BG)K.ER-*J:E9LT*&24+.I**"5+'G@ @C)[@T 8\O@729=$ MO--:6])O)H[BXNVN"T\DD;*RL7;/3:H P .!5FU\+Q1Q74%[J>HZI;7,)AD MM[^59$*GKP%'/:M&RU?3-3MGN;#4;2[@0D/+!.LBKCKD@X%)I^KZ9JRR-INH MVEZL9PYMIUD"GT.TG% &"O@'3S'%;76I:M>:=$RE+"YNM\/RG*AN-S@8'#,1 MQ5F^\(07FMW&K0ZIJECDP:DFG2ZI9 M1WSXVVSW""5L],+G)_*@#-L?!>DZ? MP)JUJWARQUB[BNK@RI-';SVNZ)MNZ.50&5N.>@(]"*N#5-/-\+$7UL;LDJ(/ M.7S,@!B-N<\ @_0BK= '.:3X171VMEAUS69;>W01I;37"M'M"[0" H/ ]^U: MFBZ1;:#HMII5F7-M:QB./S#EL#U-9OB3QAIGAZPO9#<[F5C*T MNX-YIDSNW[@#NSV]*T%UK2FTPZDNIV1L!UNA.OE#M]_./UI8M8TR?3FU&'4; M22Q4$MV!5N'7-(N(#/#JMC)" M$#F1+A"H4DJ#D'H2",^H(IDWB'1+>R6]FUC3X[1W,:SO75(6@ MN[NXF,D\B%2N-QZ G 'I6K=:MIME8K?7>H6EO9MC;<2S*D9STPQ..:GM[ MF"\MTN+::.>"0922)PRL/4$<&@#-U#PY8ZEHUMIDQE6.U:)[>6-L21/'C:RM MC@\?J1WJOJ/@_3-376Q<-3ZUMSW$-K%YMQ-'%'D M+OD8*,DX R?4D#\:;]LMOM$EO]HA\^)!))'O&Y%.<,1U X//M0!B6WA62VN8 M9O\ A)-=E$;AO+EN4*/@]&&SD&J[>!K11<16>K:O8V5P[O)9VUR%BRY);;E2 MR DDX4CK5B\\9:5IJ2W%]>64=GYT$,$R72.9?-"X)'\(&[/4_*"W2FP>--). MK:E97EW9V:VD\4,4L]TBBY+Q))E] &Y8V5MIMA;V-G$L-M;QK%% M&O1548 _*IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** /)AI#W9MX+JP>6$^.)YG22(E3'LE(8@C[N<<]*=K6D MO#JGB$1:;(VDIJ^G75U;PP$K+"(U\PA /GP0I8 '.TUZO10!S/AFYTB]U75+ MK1M,D@A<1"2\\MHH[EP&X52!G:, MCG(&3CCAK!/L/B2RM[&![O_ (G#N^G7 M^F,MS9[W8O,MPGRLH#%ANSD$#.:]?HH *\L\(M3N$9DN+BQCC-M?:6; MNVOU&_"1LGS(V201D=0<'K7J=% 'DVHN]IJ.M3S^'7DO+[PU;>79+&Y#NHE\ MV+S%&^,M,>%H;RV;2[NW=[32&M+=DM:2R3Z4\ZV]X-F_>AP5) (#^Q&>:T-,LDTS^P M-2U"&[GT"*]OI/WVGF-(7DV^5((06*QY$FTD#'F#@9KU^B@#BOAS% D'B*2S MLI;2SFUJ66WCDA,64,47S!2 0"*XWE\'ZW'&C.[V$ZJJC)),;8 %:] M% 'D^LZ'_9FF^"I[:".QTZVC+7CC3_M"QS&%0DDD8P2?OC<>A:J81K31VG2' M[18W6NB47=WI3I;6Q$6#.ENC[F4L, M@;B6]#7LE% 'BL5F)X_$LET=0^SMJ M%C"3P?>IE6YNK)IKC3H;S2+;6[>XO+JRL)(5OH MA$07,!R6V/Y9;;D';[&O9** /'M?LXM:3Q-=:-82_P!C72:="X6W:-;F9;D% MV52 3A"H+8[>U=E9Z9%8?%"5[.R6WM9-%16,,6Q&=9C@' QD _E77T4 %>1M MI0M86NKC2W;2X/%=Q/>Q);%BT.'$;E0,LBN5;@'U[5ZY10!X]K%A%K4FN7&F M:?*=#O+W2HRHMV1+B1;@>:ZJ0#C84!;&#M]J]F>UO4:* /*-;MSIEW MXI2+2(GLI=4L'_>6SO!"/+0M,8TQO"LHR!QGK6->V=Q>P>,@BRWD5W9V&R6' M3FM8YRL[!BB]3@$#.2?PQ7N%% 'E_C#P]<'6-4M]!T_RO/\ #CQ;;:/RQ(5F M3]WD8&XIN ^M5;VYT:_\7::=$TJ:V8:)?QN38O;YPL>V/#*,EW!E,<9 M()5>PR0,GJ<#)H X_P ):%#1UZ9'6LOPQ M"FE1^'KSQ#IUS-8#0Q:0;K-Y_(F$K%E*!25+)L ..=N*]@K&U;PW:ZM>Q7OV MJ^L[N.,P^=9W!C9HR<[3V(SSTR.QH Q?A6(AX!MA! UO#]KO/+A88,:_:9<* M1[#BI?B?M_X5OK6]&=/*7!71:7I=IHVF0:?8Q>5;0+A%W%CUR22>2 M2222>I--U?2K77-*GTV]#&WG #A6P>"#U^HH \SUY+35SJ<_AK3Y8K6#PS?6 MUT4LWA#LRKY,(4J,LN'. .,X[UIW>BQ6%YX5CL-.$,2:;>^:(8<#>8(P-V!] MXXQSR<5Z/10!Y=I6A)8Z1\-);73A;W2%?M$BPX==]G(7WG&>7QG/?%+X3_LJ MWT[P]I-UH=Q+XCM;DM5X<=09+9I/)?S5'S* 2I(R,D=\=ZGA6XTZVT5)[&+3[-[C4)[.ZOK M"2X^QQ/+F.(1*0%=D.1NZ 8 SD5ZL=*M3KBZP0WVM;8VH.[C86#'CUR!5V@# MR#PI9W:WNA;K:Y5(_$E_)F2U,&$:VD*MLQ\@.X<>^.M>OT44 >3^+G>?7_$E MJ;6&VDDM4BB_XE'HK4,L#S'S4E9O*.T'YPK+QW MP:C\&:,;G4?"1U+2V*P:1?,5N(G0U1UB>ZN=.O'\F2WNHM;6YFT^UTPYB M5+E?WSRD$L2@W;E/.[ &,U[510!Y7?Z6+GPC\2IUL&DGNKB9H&,)+R*+>(IM MXR?FSC'?-27MM92ZIXRLM4M[\)>VMI(K6MLSR,BH S+P0VUN2.&[MI;:XC62&5"DB-T92,$'VQ4O2@#D/'EP\":,IAB6W:^!EO9+4W M M,(Q5P@[DX4,>!NKADM9;MM3LIX+JX2X\2Z?= 369B$T)\H-)L "G:<_KWKV MBB@#RKQ?IDYUKQ*\%A+)9F'29KB.&$GSHX[B0R@ #YB$'(ZXK9T6>TU'XI7. MI:;:RBT?1DC-R;=HTE<2DX&0,D @9_#M7>44 %>//I=_%/>P+9W'E^$7>YLB M(SB4/<+.%3^\1"ACX_OXKV&B@#R!]/U"VD\-:]7,S69G^SS3LK M1[T_AQ&-F[MC'>NV\!V4=II%Y+#/J<.3DG[I;/:NL\#VL:2:S?PWL]TE[O3:* /(M.B#^%?"_A^*QG3Q%9:E!)= V[ Q%)=TTK/C&UEW!SFNM^'_EPVNLV1B>*YAU:[:1&B*?*\SLA!(P05Y&,UV%% &9XC1I/"^KH MBEG:RF"JHR2=AX%<=X4TH/XFCFN['(7PQ80AI8N A0SQO'*EJJE) 0RX[$'I3?'TTD/AV,+:Q3Q/>0+,\MN9UMTW@F4QC[V MT@'TSR>!74T4 >>>"I)%\=^(&DEN9H[RTM)+>XEL_(6?895AT44 >*Z>UG=^!8-)LK.4ZY+KIFB9;9LY6]),N_&-JHI!.>Q%7=2B5/"_ MBO0)K&X?Q#?:C<26H%NQ,Q>3,$JN!C:J[><_+L/3%>GZ1I-MHFFK86>_R5DD MD&]LG+NSMS]6-7J /*=>*Z9J.KFQW7EWW5K-]FA\9)/(_DL^(OLJKNP 25W8&?6O6** /)TMY;75X M=2OK2=M*MO$U[-./)9@NZ+;%*5 R5#'KCC.:9>6']JWU[=V]C*VCWOB33WB1 MH&590JJLLFTC[I(P21@X->MT4 "HR^H^)=0MX)(=,O;]9+17C,>_$2*\@4@$!G!Y[XSWKKJ* *.MRS0:# MJ,UM:_:YTMI&CM_^>K!3A/Q/'XUY7ITDS:[X2GMYY'BC@FMF:'3#;P6LDD.$ MBSC/WAT).,#."17L5% 'C5F]BFB_#[3O[.GAU2PU*WBNS);-&8I-CB0%B #N M89X)SC/:K,FA7/\ PK*5K>S=)CKLES>*MMYDDD"WK$G9UX%=W:>#=- MM;ZVN?.OITM9&EM;>>Z:2*!R"-RJ>X#,!DG&>,5T- 'C^K:7<:UI7B2\TO4+ MK4;B6R@AE\K3#!',BS!RH''F.$WC'HP'M71>%X8;WQ-#8- Q32S: MQ;2RE58G&6&TX7L">F:[ZB@ KR'48@OA3Q1X?ELKA_$5[J4\EL!;N3*7EW0R MJ^,;57;SGY=A'&*]>HH Y#PMIPB\6>+KV:VQ-)?Q!)FCP646T7W3Z9W=*Z^B MB@#QG7!%'X.\6Z+HT4 >2OJ5V^GH9K"Q% MJVM*7UJ/2G",!#D3^2^TBNSTCP_::-/=7,/_V5<:4?"][%?7<.E1?;F6XGTPG[.\KAD)AZHI&\*3T! XS7 M;^!+*.TT>[DAN+B>*ZO9;A6FM/LP^; .Q.RD@L.F=Q-=310!D>*=*;6_"VIZ MV3>)8+"ZBO/$9FTHQF)@T"ND<<;L.JA6 MBD;)_P">GO7L]% 'DFLZ7_9]SK>RSE^PVFKZ.ZE82P$,:Q!B !R !SBM&XTV M*\C^)5T+'S#=VZ"W=H3F1?L28"Y&?O=AW]Z]*HH H:&''A_31*&$@M8MP;KG M8,YJ_110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110!YW93-K^C7OBC6_$E_I>G_:IHK>.UN!!';QI*8E+''S,67)W M9'(&*DDUN8Z7X4^Q>(TU42ZVMK/>0*%$R>7*=K!3C/"YQC)&<"M2/PSK.D75 MY_PCVL6EO8W<[7#6M[9F<0R.3O)+ M/@\$A5; /&<5C>(+2^\&:8FO6>NZI=K;31"[MKZ82I/$[JC8X^1ANR"N!QC% M:UWX;U36])FL]598Y[.YL+1H'MI4.X/\TCAN<>G&1WXAE\,ZWK#6T'B M'6K6YT^"9)C;VED83<,A#+YC-(WRA@#M &2/3B@#E+S5]VO^*EO-6\41O9W8 M2UCTR"62-%\F-L<(R [B3AB/?BMRYU_4F^'6B WT!US65@M%N;=U*J[C,D@( MX^5 [<<9%7D\->(+'6-8N])US3X(-3N1<,EQIS2O&WEJG#"90>$!Y%06/PXT M^&338M0>/4['3[:5([:[MU=6GEDWR3'/&3T QQD\T 95[XAU&'X5:\#?/_;. MC.UI)#-6W@M!L$J/N64!2!G!*D=^.>*T+C1/$>IZ5J6 MFZIK6FR6]Y9RVP-MIKQLC.I4-DS,"!D\8&?44 8'A?4=!NY=+*^,M4NK^148 MVTEVS*[[*L^'+*_\9:%'XAO=?U2T>^+R6T%E,(H[:/<0@Q@[VP 2 M6SR>F*[:PM?L.G6MIOW^1"D6[&-VT 9Q^%%]=T2.:R\/Z[:V^F22/)%# M=V)F>UW$L1&PD4%] &+I7B35[S5/#%G=W1,\>JW^G7S1C:ER88I-K M%>V<*V/6M[6]0N[?QUHMG%<.EO-I]]))&#PS)Y6TGW&X_G3'\"Q0:/IEOINH M20:CIUR]W#?3()3),^[S#(N1N#[VR 1CC!&*L67AO4)-9;6-R2:E)H3:II]\W#3(8MS M#/\ ?CZ5I) S'@Y) 'Y5?U M'P FH> =.\.C4##=Z?;)!!J"1<@B/RV^7/W64L"N>_M4DGA36+;7(-3TC6+* M!TTN'3I$NK%I@PC9FWC;*N,[NG/2@#G/$6N:QHFB^*=(FU:>673ELI[;4,!) MA#-*%*L5 !8;6&0!D&I8]6A77])M_#'B35=5NI+I!=VEPQEC%J<[W8E!LQV. M1D\$ 8B=61%C!^50%( R3\Q))K9U703? M:SIFKVES]DOK)RK/LW">!OOQ,,C@D @]B,XZT <+K.O:C%HGB%VU*\B6'Q1# M:"2 DR1P,8-RH ">C-P 3S70>&Y--FU=?LFK^)[B549O+U&&X2$C&.2\:C// M'.:6^\#3W%AJ<-OJ<<4]WK,>K1R26Y=8V0QD(5##<,Q]-?$?B'7="\0^;\TUS&QL2V M[HN!Y10C@9(//7->L#I7%W?A3Q'?Z+-H-YXDMI],FC,$DSV!-V\1X(+^9LW8 MXW;/?&:[&&)8(8XD!"(H503G@#% 'GOA[Q;JPT#PY;K;C4=0U6:]02W$_EA/ M*D<@L0I.-HQP.PK0B\<7DL"68TN$ZV^J2:8MN+D^3O2/S&DW[,[-G/W")A/-?6FI)%J U=] M4MI'@W(F^(1-&R[@64J#R"#R/3D Z#1[O4;NVE_M33ULKF*4QXCF\R.4 AT M; .#GH0""#]3SFK:U+X*2WMFE@N)M4OIWCGU&\:"W@!RX0R$,1Q@*N/7& *V M;+3=<@A1KG6TFN'O//G(M<1^5MQY,:EB5'0[B6.<^O!XATB_U1+46 M$MO=VWGP7"D='7*G(QD$'UX- %O1;^XU/2HKJZLQ:3.6#1+,LJ\$@,KCAE., M@\<'H*YN^\\T>STZTG>S>-7AFU 0W,X=5;=#&RX< -U+#)!%;'A/PZ MOAC1C8K,DA>>2X;RHO*B0NV2L:9.U!V&36-XF\$7OB.2\MY=2LWTZ[((6YL! M+/:< 'R)-PVYQD9!P23[4 1VOB'7H?$7C 2V"WEM8/"MK!%<_-EHU('* $, M69B3MZ?,!FJ-_P"/=1ETWQ'8PPZ8NJV6E27T,UCJ/VB-0,@Y/E@AUZA2N#QR M.M:&L^ KG4Y];$>K1QVFJ"WD:*6V,A$L.P#<=X#QL$PRXR<]::G@&YFN=0GO M-1LT%[I,NF?9[&Q\F.%7.0RC>23USGKQTQ0!"WCRZLUT[3'@TL:H;".[N6O= M4\B)5;(4*Y0EG;:3C: .YZ9GM_']QJYT>+0M(2ZFU*UGG'GW8C2 PNJ.K,JM MD;B0" ?8/,-X&E2<%E/R!<%-Z,N=P/?%5E^*=LT@N_)L/[)-W]E#_ -HK M]J^_Y?F>1M^YN_VMV.<5KV_@LP:'I&G?;PW]GZH=0\SR<>9F21]F,\?ZS&>> MG2J5IX"N[!DL;74K./2$NC.H^P W04OO,7FEL;] #;KQ]J,$6J7Z MZ!&VE:7?M9W4S7F)&VN%+QILP0-P)!8=P,U?\/:GK%WXW\4V=XD/V&TEA6WV MSEBF8U8#;L'W@2Q.>#QR.:+GP6;CPUKVD?;PIU6\ENO-\G/E;V5MN,\XV]K:JMY&]GJ2QL]N83O21%5 0^[&W:.FWKWH S_$&IZQ:^.?#%C9 M)"UE=&3P<=:Y_PGXNUJU\/Z++J6G^?I]W?-9?;I+T MO.7>9U5BA7[F<+][..<8KL-:T.YU'6M%U2TO([>73I7+++"9%EC=0KKPPP<# M@\X]#6?!X+,/AC2-'^W@G3]0CO?-\G_6;9C+MQGC.<9R?7% %+6/'UUHMZQN M]-LHK);M;8++J*K=R N$\Q(=I!7G.-V<)/%-OJ"0_9;2^6*W M*SEB@\J-@NW8."&W$YZL1R!DXTWPTO)+.]L(]5L8[>XO#=FX_L_==.?-\T+) M)O\ F ( R #@ <5U.E:'2*X\G*9].U"^>TO; MG7/#B3V<*WUPX)A>5RCA7"_O%7,9/IN/-=G?Z']M\3:/K'V@(-.CN$\K9GS/ M-"#.<\8V^ASFK&NZ4FN:#?:6[F,74+1B0#)C8CA@/4'!_"@#FI_B L+>) -/ M+?V4%^R_O?\ C\8NT14_L;.QO7L;>UL)O M*YC WR.P&6)8G Z <] M7)?#6JZ?J]]?^'=6M[2/4)!-/S>$TN_&UKXA-UMCAB"R6GEY$LBK(J.3GLLT@QCG(]* (+OQB_FWPTVRANH;6 MTMI_/FNE@CS,QP&9A@*J .3R>0 #69%\21_9>NSM;V-W/I(@9GT^]\ZW=96V MAC)MRH4ABW!P!GFBW^&[VGAP:='JB2W,>H0WLH0P))ML 41HF8J%4O\ <*L003N[AATH UO#NL7F MKQS27$.GF%=IANM/O1<0RYSD9VJ01QVQR,'KB'6]?O['Q!IVBZ=I\-S<7UO/ M,LDTYC2/RS&/FPK'!W]AU ]%R5^[@;G7L3W)*,&C\Q2K>63M9>^ 1C&#UK0'@BXM9X[ZQU../48-1N[V)Y;R0&Z&JPG67U6/5)+AK4F$LB>6L8C#Y"A./O9S MSF@#JM4U-(O-2NLB"T@>>7;R=JJ6./RKD-'^(7V[5=-L[I-+']I([0+9: MB+B2)E0OLE7:,94'D$C(QZ&NOU+3H=6TB[TV[R8;N!X)=O!VLI4X].M8>C>' MM7L);9+S5+&:VMH3$H@T\123'& TC%FY _NA=LC=,8S\N=^>_2N M+CL+\C1?#=G+?/;:=K,4J6TNER1-%#',7)DGW&-T"_=VX+97W% '3:QX_ET7 M5)(KJWTM+>.[CM_);4U^V2*S*OFK" >,MG!8' )XZ4[5?&^HVEMX@U&QT6&Z MTW1&>*9WNBDLDB(&;:NPC:NX DG/!P.,&O<_#[4)M,U'2XM:MHK.YO6OT;[% MF8R&7S0LC[_F4-QP 2 .>.<+Q1::C;6OBG0[*:]+ZL#(+9-)D;SYY(U5C%.& M*+&2/F#C*_-ST- '0ZG\0_L^HWEG:1Z4'L8(Y9UO]1%NTC.F\1Q#:N#M &#D<#WJ:7POJ=MK)U+2=7A@EN+.*T MN_/M/,W^66VR*%90K?.W&"O3CB@!WPYNI[WX?:-ZWHF#"6";<9)R04! M]_2@#*A^),%O-<1ZF-,?R[":_5M+OQ=#$0!>-OE7#8(P>AYZ8J]9^*M8&LZ) MI^J:)!;C5TDDCD@NS)Y02/?M8%%^;H...O/'*R>&M1NM-U&WUF\M;FVGL9;8 MP:=8"!GW#!?+.QW8X ! YYSQCF=,@U/Q!XB\/K/=7D\-A:7"3N=+DLO(WQ", M;BY(:4D_PG VDXYH V]/\?RS>(=/TR]M]+C:_E>%8+;4UN+BW959AYJ*,#(4 MC(8X) YZTVW\>:E/H0U7^Q8%2YO!86$1NSNFF,K1DM\F$0;2<\G@\=*2R\": MK:V_A^$ZS9!-"E5K9(M/*+*H1HR9/WF2Y5NHP,Y)!SQ=_P"$(=?"%IH\6HA; MNRO3?6UT8M>)7U>V8+:Z79,+:UOI%C8 MM/(-Z. I4G@'C/RXY%;6I>-M5MD\17-IHMO-9Z!*13AM[X$U#5GUF?4=:A:YU.UM[<^3:%4A$4A<;07)(.>YZY/L-&X\(&?2 MO%EE]N"_V^\C!_*_U&Z!(NF?FQLSVZX]Z (+OQA?M>ZJNE:3%=VNDP)+=/+< MF.1R\?F;(UVD$A"#R1R<>]=!H>I'6/#^G:H8A$;RUCN/+W;MF]0V,]\9ZUY_ MK]O<:)J.M065Q?QC4K&,2)'I,EQY\BQF,>3(C81B H(<''!'&:[KPQ93Z;X3 MT>QN5VSVUC##(H.<,J $?F* //Y?$GB6[L+&XGCA\Y?%+6<4=M:F@\$W4ZM=F^ M\N:\FM+BW/DAA!+;_=)!.'![CCC(]Z )?#?B]=9UB[TF8Z>UU! EPLNG7GVB M)T8E>N 58$<@CH0:N^)=;N-$@MWACL0LLA5[B_O5MH80!G))!))Z ?7%/T7 M3=2LYYY]1O+.4R*JQQ6=GY")C.3DLS,3D=\# X[U6U_P]=ZEK.E:M8W=M#LR*EU;&:-A(%RYNKS5)-+*Q7F80Z MJ[>8L@7YD.P'.,X)X)&"ZY\>7]@MU:76C1/JMMJ%M9-!!=$QR"?[CJY4'U!! M'??\ A+5])O=&BMM2^T--XA>_%P;0DPLUO+N\P!L%"V!QMP#C.<&I?$/A M?4XH4O9+P7&K:AKEA))-;6Q$<"1L%7"%F.%Y))/.3TH ?XG\3:H-)UC2KV!- M/U.U-C<)+9W+.LD,ERJ\,54@Y5E(QW]ZOQ^*VM[F]L["P,VH7&MR6,$<]VVQ MF6%9&D)(.Q H/RJ#STZFGWG@>]U<:I<:IJL#WUZMK$KP6I2.&*"7S0H4N22Q MSDY[CTYDF\$3"::]M-26+4!J[ZI;2O!N1"T0B:-EW LI7/((/(].0"Q=^(M9 ML-&-Q>Z39VMTMUY#O<:@L=J$QGSO,(W;>VW;NSVQS6!<>/M3U#1HI=)BTXW4 M>N6^FSO'=^;!(&9#E'"'*L&VDXRO.,D5KW?A+6+QK"^N-;M[C4[.\>Z0369- ML T?E[%C#Y&T<@EB*K^ M2*7[#6X'GN-2M]5C>2S.$GCV94@.,QG8,#@ MCU- #E\6/9W.HVUMIQEU*;6ET^**2\8QO(;=)&?)!\M N>%';.,L:==^.KW3 M%OK6]TB-M3L[JSA,-O1ZG&FHMJJ MZI!+]G)2-Q"L3(R[LLK -W!^8>G*2^"+F^DN;S4-3B?4;F\L[AWAMRL:QVT@ M=8U4L3S\V6)/+=.,4 :>C:[?W6OW^BZK8V]M=6T$5RC6UP94>.0NHY95((*' MM3M;UVZLM5T[1]-LXKG4+Y991Y\QCCBCCV[F8A6/5E '.>V*L0Z*8O%MWKG MVC(N+*&T\G9]W8\C;MV><^9C&.U0:WH5S?:KIVKZ;>16NH6*R1J9H3+')')M MW*P#*>JJ00>,=\T <;XC\0ZQK=GIMC;VR6EPNO#3M0BCU"2+"71+66?41)>#6 M/[7NI1!M65]A38J[CM4+M R3]WWK=\0Z0NO^'=0TAIW@6\MWA,J#)3<,9QW^ MG>@#E],^(B2ZF;/41I?_ !Y2WI;3=0%T81'M+I( HP<-P1D'!JY:>*]573EU MC5-$CM](DLGO1-!=>9)"BIO D4JO)7^Z6P>/>H&\%:A>:A876H:G9-';VLUD M]K;6)BB:"55#;?G)5OE'/(QQCN9K/PCJATY-(U375N=(BLGLEA@MO*>9&38# M*Q9@2%Z;0O//M0 )XLU:STN35]:T2.WTP6+WHEMKKS6C"J&$JVEYI\.LZ1;6RZE#*]L;>Z,I1TC,GER HN"5!Y&1D$>])'X1U2[TQ M])UK75N=,%B]D(K:V\EI RA=\C%FRP XP ,DGVJ2W\*:C<7^G3ZYJT%Y'IL4 MB6ZV]J82[.GEEY"7;)VDC &23[4 26_B]I]*\)WOV(+_;[1J4\W_4;H'EZX M^;&W';KFLVT\=:G<66FZI+HMO%I=YJ T\M]K)F5FE,0<+LP5W ?Q9I^F^"=4 MMD\.V]WK<$UGH,H:VCCLRC2H(FC&]BY^8!AR !P>#GBW%X+,7AC3-&^W@FRU M*.^\WR?O[;@S;<;N.NW.??':@#&L_$VJW"LVL6L3(OB5=/M_LMVZ%,,5^;"+ MN48'!SNR#@8]ZF?P66\*W.B?;P#-J1O M_.\GIFZ\_;C=_P !SGWQVH H:IX\U*STW6M8M-$AN=*TNXDM69KLI-(Z$*S! M=A&P,S@$X[5W$LGEPO)C.U2V/H*\C\36%_P#8_$?AO39;[;J-Z98K0Z7( M6=Y&5F*W 8QB+=DG(!'(XXKUJY!-I, ,G8PP/I0!Q>E>.=2N[/P_J=[HL%MI MFM/'#&R79>6*1U)4LNP#:2,9!SR"1V$"^+[S5-$M-4NM(6"QEU6"T@\J^=9& M?[3Y99@JCY 1]TD[L$$8J#P=X7U:[\+>$5U2_1;'3HX;M;0VI2?S0A"J[%L8 M4L>-H/ SW)VXO!9C\+Z=HWV\$V>HI?>;Y/W]MP9MN,\==N<^^.U %&X\=:G# M::EJ:Z+;G3--U%[&X=KLB5PLHC+HNS!QD'!([CW-\^)]7N[Z_.DZ+%>6&GW8 MM)V-ULFD<;=YC0KM(7=_$PS@_BEQX+,_AG6='^WA3J5_)>>;Y/\ J]\HDVXW M5 X&2,G@UM7\3:CC7?#-]97VE&PNF::Z\3/J'FBW++ &MY!AP M#RN0 3E<[NQK2_X0BYNKB:^O]3B?4)]2M+V5H;6Z4 M9\WQ1MXVFNPNF?V9#>&U96U "[8"3RS((=OW:G9267VE9XI&T\?:[U&\LTC>XM[=Y4$C%5RJD\D ^GI7,:7XIUV\MM& MTZ*PLI]7N=-6_N))+EDB2,X"G(CR68D_*!@8/)XSU^HV:ZAIEW9,Y1;B%XBP M'(# C/ZURMGX1UC3CIEY:ZO9?VE9V(TZ1WLF,,T((*9429# C.0V#D\4 ;GA MO7!K^DFZ:W-M/%/+;7$!?=Y&KF\+V^EK;6D( MFVW6IK%/=#&6$,8!)(Q@;L9/ ]:W_#FAKH&E?9#<-9+FVBGCSLE0.N>N",BI*J:7;3V6E6MKG[-*UK3[RZECU..\U-HH-6LM2?S69W8".6$_*5&=I"D@;] 'L]%>,LNL:C'K6H&YTV MTU*#5I8HKZ[U>6)[;;+B./RA&5V%=ORY^8-D]:VU&EWM[XEO_$.JW-E>V&J" M*"2*Y9'MX@L9B")R"'R?X3NW$ZAO%_P!+%G%&MNQ>:0]- M@_B!YYZ<&M"TNQ=I(PAGB\N1H\31E"V.XSU!['O7E.H6<.JW:K?>9,$\:&!< MR,-J&($J,'@<"H[JZU&6:"P5UDLKCQ-?PRI&Y@N))XX94=X'\N55.2C;0V#Z'#*?Q%2UXY>6<%O:>+/LDTM MM=2>)[2$O%.P=8V>VSCGCEFY_"M?7K6P_MN;1[>U3[/I6G+(_P!NU26&*,2, M^&0*&9W^4Y8GC@"@#TRBO)O#._Q/=>$8]5NKBYCE\.22SIY[*)G62) M3U[U'96USJ.D:5;+?6]V;.[U&)=+O[Z2'[3$EP40AQDDQ@ #((PW;K0!Z[17 ME*:E9ZU9Z#I5O:3N1]LO2W,$$L$4LJ)).Y2)6."[!2Q M]>%)_"FVET+N#S1%-$-[)MFC*-\K$9P>QQD'N"#7FEUI^@-XF\*16E]->6<. MJ7D6Z:X9EA80,WE*W&55L8Y/<9[56TB0ZG=Z!IVK7,ITRXN]79E:9E6:9+DB M-&((R IG'M0!ZW17D5MOO-3T_2EO;I])3Q-!;5F,>_.2H?>O M7MCM77>"XA9:OXITN%I/L=GJ""WB=R_E![>)R 220-S$X]Z .OHKQ^XD4^#= M1\0-=S#Q5%JTD4>+AMZ2"ZV1P!,XVE-HVXP02?>NL\(627'B3Q/J4\D\L\&K M26\ :5BD2>5$Q 7..2?3L* .BU37M/TBRO[JZG&VPA$]PB?,Z(O'O%ME9QW/Q+F Q<_V9;E076EP)22C1@%@V&SGCD=ZU->TC3]1^*6 MGQ7FY?/T6Z0,LK(=WF1 ;<'KAC_D4 =]17EFFZAJ&M>1I=U/*)_#5G']7>YTVVU">]3[3=3:M,9ISO(E@:$Q[+MMSXH\,Z9>RNFDW3W!G02&-9950&-&((R.7.WN5'I0!T&LZU::%9)=7G MFL))4@CCAC+O)(QPJJHZDUH(V]%;!&1G!&"*\.)HTMM'TH0O(]]>"*.,W;6T3;49R)7 )VX7[ MH&6.!0!UU%>,VFI36UO?VPNXX[6R\4:>H6"Z>6*&-C%O4.V#LW%L@\9)%7_% MNL2#5O%JVFH2+!%;:7#/)#*1Y"/<.)2"#\IV'DCI^% 'HEWKMI9ZC)8,EQ+= M1V;7OE0Q%V:,-MPH'5LGI5V*[@FGD@253-&JO)'GYD#9VY';.#^5>1>)H-/T MG6?$D>BW#((O"4[[8YV<1-OX*DDE21@X'U[Y/3>%+.S3XB>))\?Z3]GLB,R$ MDAHV+'&?4"@#O:*\VU".QU+6_&;ZY>2Q/IT8@!')Y5[_ $>]-VSSN_G,D<;* MQR<;@2>1CKCI0!Z/;3BYM8IQ')&)4#A)5*NN1G# ]#ZBI:\J\.);ZW=Z?:^( M;B1K:'PU8SVLV?>H?"R3>(]1\.P:OZ;:Q3B5M1CDEMGC^9'5 I8Y_X$*P MO!"F[\"S6ES)+/&EQ>VH,DC%O+6>1%7=G/"@#.<\5Q/A?2=/O;3X<6QWF&73 MKN2=(YF&]]D.02#D#.,@8Z>F: /9JBN+F"U5&N)4B5Y%C4N<99CA0/Y ["LR,0:AI1M+V6*2VL_% M\$$217;R1Q1,L9*JYP2NXMCT[4 >W45R'CI"]KX>MHYIHHIM8MXG,,I0LA#Y M7<#G!%<;K&E0V>E_$!K>:[C&CE9M.474F+5S;I(2G/=CG_\ 6: /6H;H37-Q M (9D,!4%WC(5\C/RG^+'0^AJ'5]5M=$TN;4;TL+>'&\JN3R0HX^I%>:Z]?7! MUC78)KN:*QFUC2X+IEE*!('B7>-P/RAC@$C'WC6;XE2U@D\;:?IM[*]G#IUA MMC\\R+ YG?(7)..Q_&@#V:::*V@DGGD6.*-2[NQP%4#))/IBJNI:M::5HMSJ MUPY-G;P-.[(-QV 9R!WXKS3QAI5MIMQXBT^U-P+6X\+75U+&]P[AYHW&USDG MYN3D]^];_B*&VM_@IJD5GCR!H\A7#EAS&2>23W)H [='$D:NO1@"*=7E5X5T M;4-*F\+W4MQ=7>C7DTZB=IO/*1*T4C*21GS" #_M$>U)X3M[W[7X7OX+K3(3 M=(6N'&L33S:@IB);=&T8!<-ALY^7!'2@#U:BN*URR34_B7HUEXNO MMVG:A,UE(+AU%N4CC8;0#@V2&*T7[0R>5$;96 M3:H.#O=FSQ\W3VH ]3M;F.\LX+J$DQ31K(A(P<$9'\ZFKQ^-;W5-8-G<166"CCZD5Y-H M2ZQ?V&G:O)<:9:ZJ^IA9KN?5Y1,S><0]N8?+V\KE F<#@U'K:V5WX'\0:G?W M<@UK^V9+<@W#94+] 'M5%N.U\G3W\3:7H]W/%IT3Z4R^5.Q^SSO<@.J$D[O5D:OXFTG0YX;>]N'^TS*6CMX('GE91U(2-6;'OC%86D646C?$F\ MTZQ,R62, ^N*CLKJ#3?B=XB74)8H+F^MK9]/>=MH MDB16#JI/HY)('/S T ;D/B_0KC1KW5DOQ]DL03=%HG5X,#)#QD;P<=B*VPRL M@<'Y2,Y]J\E\0ZY=ZAX;\=6-U'H\DD&E+))=:868,S;QL=C_ !*%!QV#5V?B M&Y75/ ^K6.D7D,VH2Z;*D,<,H+EC&0 ,'K0 I^(7A@.?^)B_D!]ANQ:R_9MV M%E29[J$2=) M$^0@LO(X[]C0!ZEI.L:?KEE]KTVY6XA#F-B 058=592 5(]" :CT;7]+\06\ MUQI5XES%#,T$C*"-KC!(Y [$'/0YXKS6#6;G3/#GBG3=.G34-9NM4%K!?P$* MEU&?&-I9S:,VEZ;J=DEI$&N$E#7$"':18[B]E\N1HF:+ M3;F1=RDJPW+&0<$$<&L[X8ZC8K\/-"MS>6XG\G;Y9E7=G<>,9SFLSP0GBHZ% M<'3)]&6T_M*]V"YAE:3_ (^),Y*L!USVH [#4_%FC:1<16UU<2M=2Q^:MO;V MTL\NS^\4C4L![D"B/Q;H4NB2ZPFH(;&&012R;&W1N6"[63&Y3EAP1GFL+P_= MVVF^._%=MJ,[2=TCG:J\# MN3]*AT_7M+U6_O[&RNTENM/D$=U$ 08V/3J.>AY''%E8MO:W%A>Z[XITZ)I+O3M9N$NH4'-S:%8RZ M8[LOWU]P1_%0!VMUXRT*TM8+F6\D,<]Q):Q>5;2R,\L98.H55)X*-SC'%3Z7 MXGT?63.MC>AY;==TT,D;1RQCU*. P'OBO-=&OK62/P;?+<1_99/$.J2),6PI M5OM)!R?7(KHM7N[35OB'I)TF:*XEL;*[.H2P,&"1.@"([#C)<;@O7Y2: -2+ MXC>%Y;>.Y%_.EK( 5N);&XCBP>A,C(% ]R<5LW&NZ;:W<]K-=!9H+0WLB[6. M(02-^0,'D'@<^U>4VLGB.'X/:-'<76FQ^'[JSBMKR:*U=I[:VD7:7Y?:<9 ) MQP"3CBMW6H(K7Q-K%O #BB'.?E#R <]^* .EMO'GA^\,/V>6_<3;?+8: M7<[6ST.[R\8YZ]*L7_C#1=-O9K.::YDGMP#.MK9S7 AR,C>8T8+QSSCCFN;\ M(SZDF@Z$9/%^D?9A:V^ZV^R*'V[%^3=YO7'&!(-0-I#:F6&4>5!_J_E9 MEW)P/E;&X>Q%<3X5LH]47P+874DQLV\-2220)*R+(0T &X C(&: /6Z*\CTM M_M,^AZ)J5U,=&&I:K!MDN& D,,I$$;/G) 7>0">=H]*[[PYQ*DEHT)Y=4P0.N .IQ0!I:7J4&KZ>E[;"58W9UVRH48%6*D$' MDO=1:=.8#=N)9O,C#*"6'#\KP?XA@]Z .WHKRG5)=.T'PTU_XXTB6956Y>Y%P JEIW#;@K+DD'Y>3CGI4]TMEHVKZ3'X\!O M7G$D:PEDG.YCM;?M&X8SN(H ]/HKRK1K5M,A^'^J17U^UUJD6V^DENI)1,&M M'DY0DCAE&,#M5#0+RZTFZTR42-J-U?03BUU"RU-YDOG$3.#/;R. M!Q0![)65IWB&QU5;1K03O'=>=LD\EMH\I]C!CT4YZ9ZX.*\[TV6VMM,\&:OI MNKW-SK6I74"7@:\>0W"NI,X:,D@!.3P!MV@51L=0U*PT/1VTQY/M"V&ORQQ* M20\J3 IE>A()X^M 'K5UJEK9ZC86,S,)[YG2 !202B%SD]N :NUY/;0:)9>) M/ U[8:K/=33PW$\V^[>:YNXG5R?,A \M1TZ'Y3@ "@#V&RU"UU&.22TF$J12O [ 'AT8JP_ @ MBK->(1!M.T>*PTZ0+!=>)[RWOA+J,D(*J\QCC:0;FC#$#D#+=">I2SFSC=6,B&=E4JK,(Q@'Y=YZ9% 'JL.J6L^KW6EQN MQNK6*.652IP%D+!>>_W&K.N?%NGVVKW.FB"_GFM1']H:WM7D2(OC:I('4@@^ MPYKG_"%IIUC\1/%%MIER\T$=I9 JT[2^4V9B4#,2<=#C/&ZN?UBSCTZ^\=WM MG)<0W U#3E#K<2<"1H&;C=CDD_0' P.* /7J*\DUFS:XTCX@:R]]J"WNEWH_;8_[ M2-CLF\P0^=O\L[,9QC=TS[=<4^[N8K*SGNIB1%!&TCD#.%49/Z"O*YM=M[$7 M=Q!K>K76F1>&R8[I7Q.Q^T,@<%@!NZ .1T .3UJH'GT_Q!N6QFLWP M]X0T[0K2W#V]K=7T#RLMZULJR /(SX!Y(QOQUIMIXRL[ZX1;>PU*2UDF>"*\ M6WS"[J2" 0<@94C) &>]4](\=KJ&@#4IM(U!'DO9;2""*(.TI61U&.<#A/F) M( .>>E '0RZ-I1?ZN MX>%6D3Z,1D5S6H^/X+?2X[FUTR]EG_M.'3I[5XPLD+NRY!&<$E6!7!()(YJY M>^-]/LI;L-::A+#8@?;KB&#=':DJ&(#@'!J6T\::7=7C0.EU:H;1[V&XN8M MD0#@@XH U5T?3%TTZ:NG68L",&U$"^4>_W,8_2GV>FV.G*5 MLK*VME*A<01*@P,X' Z#)_,UCZ?XRL;^ZM8&M+^T%[&TMG)=0;%N54;CMY)! MV\X8 X[57T_Q_I>I?V;)%::BEMJ?RVES+!MCD?:6V9SD-A6ZC!P<$T ;KZ1I MDEU)=/IUHUQ+M\R4P*7?:05R<9." 1Z8%.N=*TZ\NX;NZL+6>Y@_U,TL*L\? M^ZQ&1^%JV9N$M[FW*NT;Q7,1C=&'4$=#]02#ZT .MM+T^R??:6%K _S#=%"JGYB" MW0=R 3ZXJ.YT/2+VV%M=:78SP!S((I;=&4,3DM@C&222361+XZTN*:4FWOC8 MPW/V2741#_HZ2[MA!.V]Y#&$P*4C8="JXP#SVI9]'TRZLC97&G6DUJ7+F"2!60L223M(QG M))S[UCV7C?3;Z>S"6]]':7TABL[V6';#<-@D!3G(R <%@ >V:T]9UNUT2&!I MTFEEN91#;V\";Y)G()PH^@))) ')H LQZ?90QV\<5G;HELF26=M]KECO8PK&'IO7:2",C& <@X MXY%9NJ_$&&PT/4[Q=(U*.[M+,W<=O=0[/-3H&R"0 "1D?> /2@#I[C2--N[A MKBYTZTFG:,Q-))"K,4/5H!P/R%I ![ 'N:T-4\6:7I%W=6UV\H>U MMDN92D98 .Y1%&.2[," N.: +UIHVEV%U+FV=M<2_ZR6&!49_J0,FGWNG M6UZ8YGMK5[J#+6TT\(D,+D?>'<=NA&<=:Q'\<:=;6NHRWUI?V,NGVWVN6WN( M@)&AY&]<,0PR".N0>N*EMO&6G37[VL\-Y98M7O(Y;N+8DL*8W.ISGC<"0P!P M>E #]+\-FQT_4UN+S[3J&J.TEU="+8&8H$4*N3A54 9/3KS3_#_ (7T[0-/ ML8HK6U>]MK2*U>]6W5))0B!=O3)JO8^--.O+BVCDMKZR2[B::TFNX=B7 M"JNXE>20=OS88 XR<<4:=XRL=16*466HV]I/ UQ!=SV^(I8P-VX$$E?EY&X# M- &K'HVEQ:BVHQZ;9I?-G==;3SV^V.9, Y!!.W(((#8)J?5O$-MI-W;60M[J\O MKE6>.UM$#.47&YCD@!02!DD&)8E"QL.A48P"/ M:EOM/LM3MC;7]G;W/>@ M"9M$TEED5M+LBLL0AD!MTP\8Z*>.5'8=*=!H^F6L#06^G6D,+Q^4T<<"JK)S M\I '3YFX]SZUA6_C_2KDVSI:Z@+2XNOL2W;08B6;>4"DYSRPQD C)P2#4-AX M^@FM-2N;W3KRV6VU V$">6&>XDSM"* 3ELYR.@'.>M '00:#H]K T%OI-C#" MR-&T<=NBJ4;JI '0]Q4XTZR%\M\+.W^UK'Y0G\I?,"?W=V,X]JPI?'6E6NGW M]U?0WEF^GO"MS;S1#S8Q*P5&P"0RDGJ">A[C%#^-;9;J*S&DZLU_+;?:ELQ; MCS!'O9,G+8'*YY/<=SB@#9O-&TO49XI[[3;.YFA_UZ2=)(]KAHD/RD'E2'! M!^E '22:?92@B2SMW!A,!W1*76[R;6U0-(X4 LW) &1R2.H]:HGQKISPV1M; M:^NKJ\$ACLXH,3*(SMD+AB NUL#D\DC&: -6ZT/2;Z"""[TNRN(;< 0QRVZ. ML8' V@C Z#I5H6MNLR3+!$)43RU<(-RIP=H/8<#CVKGCXZTG[-8RQQWDLE[/ M+;1VZ0'S5FC!WQLO\+#:?;OG'-4K[XA0Q6=K+::5?RS/J:Z=/;/&%DADP&(( MW8)*D$8)!SUH Z^&WAMHS'!#'$A8L5C4*,DY)P.Y))/UJM:Z1IEDRM::=:6[ M*S.#% J$,V-QX'4X&?7 K'_X3G25FU19([N.#2]XO+EH?W43* =N<\L0> 3 M^8S6O_&B?V9J4:6E]IVI1Z;/>VJ7L(7S B_>7!(."5RIP>>E '07.C:7>6[P M76FV<\+R>((P6]^M-ET+1YDF272K&19E1)0UNA#JOW0W'(';/2 MH[358X?"MOJ^I3+'&MDMS<2D8"C8&8X'XUE?\)W8(C-UMY$B5X(F6%@T89 0A'0CT(]J8]A9R+<+):0.MS M_KPT8(EXQ\W][@ <]JS[GQ/I=J=-WS$IJ$3SPR*/E$2)O:1CV4 CGU(JKI_C M*PU"ZM8#:7]J+V-I+.6Y@V+ M6_B=B22>3VQ5WPYXEM/%%@+ZPM[M+1E5HY9XM@ER.=O/.",'WZ9KE+?QAJ$^ MMZR;N6[LK*UU2WL($%I&P)8Q##,6SEBY]@I!ZT =]):6TLIEDMXGD,9B+L@) M*'JN?0^E1Q:980:=_9T5C;1V.TK]F2)1'@\D;<8P-+&PO[ZR2RU"\GL8DGN!:PAPD; D-DD#H#QU M/8'FEN?&FG1_9A9V][J+W%HM\$LH=Y6!ONNV2,9YP.IP<#B@#?-O"UPMP88S M.JE%D*C<%)!(!ZX.!Q["JK:-I;ZD-2;3;-KX=+DP*91_P+&?UK'C\6:>UW>W M*WD\MI#IL%Z(DMB<(Y?#+CYBQVXVXXP/4U4U3QIC0M>%O:WFGZM8Z9+?117L M*@E0K;7&"00&&",Y]10!U+6%F\,\+6D#17!+3(8P5E)&"6'?( Z^E0W.BZ5> M72W5UIEG/<(I19I8%9PI[ D9QR>*KW.M0Z5X5;6M0+F&"U%Q,8UR<;03@52; MQE:!+58]/U*6YN][6]HL $LD:8S+@D!4^9>6(Z@8S0!J7FB:3J"0I>Z797*0 M<1+-;HXC_P!W(X_"K2VT"SB=8(Q,$\L2!!N"9SMSZ9[5SS^.])6VL)4CO)9+ MZ>2VBMT@/FK-&#NC93]UAM(YX[YQS2KXXTLZ?)1W$=V+$V+0_P"D>>1N M"!0<'*G=G.,MT(%\WT^_C/ZTDNA:1/>27QM*0$.%)!4YZJ3 MT/<52G\IXZA!X-5H-'TRULOL5OIUG%:;@_D1P*J;@00=H&,Y .?:L(^-K* M$_98[74M0NHK.&[D%O;@DQN"0_4 ?=/&<\\ U._C73&-B+*&]U![RT%ZB6D. MXI >CL"1C/3'))!P.* -_P"SP_:3<^3'YY3RS+M&[;G.W/7&><5#?Z98:I ( M-0L;:[B!R([B)9%SZX(-0:%K=GXBT>#5=/9VM9RX0NNTG:Q4G'U4UHT 5(]+ MTZ&P:PBL+5+-@5-NL*B,@]1MQBH;/0-&T^X%Q9:186TP! DAMD1L'J,@9K1H MH SSH.CG4?[1.DV/V[.?M/V=/,SZ[L9IU]HNE:G(LFH:99W;H-JM<0+(5'H" M0:O44 58M-L(4@2*RMHUMR6A58E B)!!*\<<$CCUJ6:W@N#'YT,I:?:7B*DZ;<27%CI=E:S2??D@MT1F^I R:MQ00P> M9Y44:SCLY=)L7M8V+)"UNA16/4A<8!Y/ MYU/::?96%N;>SL[>VA/)CAB"+^0&*LT4 0K9VJ67V-;:$6NSR_("#9LQC;MZ M8QVI@T^R'2SMQ^Y\C_5+_JO[G3[OMTJS10!D+X4\.*P9= TH$'((LX^/TJ>^ MT'1M3G6>_P!)L+N91A9)[9)&'T)&:T** &B-%C$810@&T*!QCTQ4,-A9VYA, M-I!&88S%$4C \M#CY5QT' X'H*L44 4Y](TVZM'M+C3K26V=S(\,D*LC,3DL M5(P2225D8.WCY>..*LT4 4]0TG3M6B6+4M/M; MR-#N5;F%9 I]0&!JU'%'#$D42*D: *J*,!0.@ IU% %*ST?3-.EFEL=.L[62 M"!4,G^\0.?QI+/1-)T\S&RTRRMC/_KO)@5/,_P![ Y_&KU% $ LK55MU M%M"%MO\ 4 1C$7&WY?[O!(X[<5!;:+I5E>RWMIIEG!=2Y\R>*!5=\] MHH I6^C:7:WTM];Z;9PWDN?,N(X%61_JP&34L5A9PM$T5I!&T6\1E(P"FXY; M''&3R?6K%% %"VT/2+.Y:YM=+LH)VU@A(C6+,<87Y%SM7CL,G [9JO<:'I%Y9Q6=SI=E-:P_ZJ"2W1D3 M_=4C _"K]% %'/$EOI%GIS6+2V=IJE MU-/!;WWDF]BE>5T(8$$!2ZDJ2,XKTNB@#RV+PAKUI;:BL.F6XW:U9ZM!"EWD M,L?E[HMS<[AL/)X-37/@V]74-99M"745U2@RPY-,U;P?>ZL--MF9(H M4T&[TV>0-DI)*L2@@=Q\C?E7?>'_"MQ!>:CMY;*)MUV^J23@R; M"F8D). R\+:G!X5\$:>Z1BXTBZ@ENP'& JQ2*<'ORPKNJ* /.; M?PYJD7AY-)O_ Y;:C#;:C<3*1>>7(RR22.LD3#!1AOP02#R>:Z;P?8:KIVD MS0ZI+*Q:Y=[:*:X,\D,)QM1I#]X@ACGG@@9.*Z"B@#SB;POKQ\,WG@]+.$V5 MQ>2.NI&<86"2*+N[M+5)K:]T5]/+F4*8I-SL"0>H.X#BFOX8OIH/!L,B MJ%TR!XKPAQE=UJT7R^OS&NTHH \U\.>"KC3O[&L;S08W.G.A:_;4Y6C;RQ\C MQQ9X8D*<$ #GK6_XU\.3ZVVD7=O +E].N6E>U^T- 9D9&1@KKC##((Y ."#U MKJZ* //6\(W4VBW MM'BT^XGU.RG*/>M/(T4,J,2[,2-V V ">,%=&729[ MBP-M!/<:@]TY8L&P1D@)E%]SZ"M'6K7Q5XG\-ZSID^F6>GI/I[PQJUQYCR7! M[AAPJ8R.1DY'3'/;T4 <0_AF\UV_UJ75+06D&IZ/#9;/-#M'(K3$G(]-ZD'U M^E9I\%:WJO@_46U;R/\ A(+VZM[EU$Q$9$!0)'O7D!@C'(Y!D)[5Z310!YK= M^#KJ_P!$U]+;0%T^[NM->SMVN-2>XD)_"MUK^IVX5EC MM6T>^L)9,\HTPC"D#O\ =;\J["B@#SW0?"MU;W6GM<>'88)[&)LW4VJ2SH9= MA0&-,G@Y.=P& <8I-'\.ZS9ZM;26&DIHULD4HO+4WYFM+ABA"B.+G8-^#D!3 M@$8.:]#HH X+P[X?U73]?LYK;3&T73XXY!>VJZ@9K>9B/E\J/D)AN.-XQY8O#,3GUV=O6J-]X M-U>[MKZW>RC=8-?;5[?%V8Q=(^X-'E?FC8!CSTR!VKTNB@#SF?P?=7>BZF+; M1(]/N;F>SV":_:>1XXIUD;>S$J /FP 3W]:ZA=*NAX_DUC:OV1M+6U#;N=XE M9NGI@BMZB@#S*T\)Z]96>C6US9F_LK>&Y66RBOS JS/,721B,;QL)&.<9Z&I M_#'A+6=+NM!CNK>!(M,O=0D>2.7>K8P>>*]&HH YC7M.U*+Q/IG MB#3+5+UK:WFM)K4RB-BDA1@RD\9!C&0<<'VJB;'Q+%KFG^)9K"TN;O[)-9W- MC;S;/+1I%>,JS\,0%PW0'.1Z5VM% ' Z5X3U6WU;2-2N4A63^U;W4;N-)-PA M$T3(J X&XC*Y..N:9?\ AC65N+^\MK:.=_\ A(X=3BA\X*9(EA1",G@'(/!] M*]!HH X6;PAJ%]X9\6:\47#75U MIT6G_9M*O+:&(W*R&::=%7J. @V]3R<]!BN^HH YO4O#LVJ_#J7PZ\BPW$NG M"VW]0K[ /Q&15*+3M;UOQ%HM]JVFPV$&EQS%P)Q+Y\DB>7A0!P@!8\X)XXKL M:* /.=)\!:A]DUBPU*5%MUTZ72-*=6W%+9V<[F'8X,2X_P"F?O4OA[PI<6]Y MIIO/#T<$MC&=UV^J23*9-A0&)"3@')^\!@''->@T4 8?@S2[G1/!FCZ9>*JW M-K:I%*%;(# N?N_"NJ3+JP1(_P#2?$5KJ,>7',,?D;B??]VW%=Y10!P5 MYX4U2;P9XGTQ(X_M.H:E-,%&E5AD]C@&L[Q-X0U[6QXDM9+1;J2]W_8+ MR:_98H(C& (_*'1MP;G&#NR3QBO3J* .0TO1=3%_X@O+FV6 ZC8VT44?F!B' M2-U8$CW8.AS7H M=% 'GVJ>'?%-U)J]Y%+;Q:A=Z790;[65H@TD*S;GP;K M$MUJLUGHT=I!J&A7&G+$]]YLB2'E6=F)X8\<$XQD]>/4Z* .:\2:+>:G\.[_ M $6V5#>3:>;=%9L#?MQU^M9WBCPO/>^(--UF*Q:_C@M)+2:UCO&MG 9E975@ M0#@J002.H/:NVHH \ON=-NM$U3P>+32+>"[?4;RX:S6[:0-FW?.9'SE]H^F? M;FK3^%MTX(,*6_D;2X& Y!+>G09[UZ$]O#++%+)#& M\D))C=E!*$C!(/;()%24 >>7OA?6M8O;[5I[6*VFNKW32EJ9@Q2&VEWLS,.- MQW-P,\ <\U=\1:%JUWXAU:>SM8YK;4M!;3_,,P4Q2@RL,@]0?, R.E=M10!R M/A_P_?Z=JU_<7"((YM*LK5"'R?,B60./I\XYKF]'L[_P;?Z*LG]GRWC>'XK. M>VFO5A,;0L3O!((9/WA!QR, X->I55O=-L=21$OK*VNE0Y59XE<*?49'% '( M_#>34(_!6@HMM%+!.US)/.'V;%,KLC*N/F#9'?@'-=Q2*JHH50%4# & !2T M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!Y&*** //K M/Q#<^&?#'B*PNI)+K4=%F,5IYK%WN%F.;;)/))+!/^ &H6\1W7AB6R\+?VI9 M)=VFGQW%W?:H9)?.DYI^I>'9Y];_ +8TS4Y-/O7MQ;3'R5E25 Q9C*6;!SW.< MT 8.G^-=7UVYT*WTVRM(7U"SFN9VN2["(Q2K&VW&-P))QTZ@^QM6_C&]GTRQ MB^RP#6IM5.F3P<[(RC%I''.<>4N\<_Q+6Q:^'!;ZQI^I2W]SR,78@#G*=ACFL70]&-[X_U/Q.UE=6EMY2P017*[3)-@"28+U'RI&@)Y.#V M- %KQK?ZQ93^'H])N((3=:FMO+YR,VX%'8#@CCY3G\*R[KQGKD.F^)-56TL! M9:3=26D:-O,DKJZ ,>K7$MP\B@!HV<@_+]" >: ,WQSK<\4&M:*B((G\- MWMYYH)WADP@ ]OG)_"FV_C"32=+U6*_@3S-.TZ"[M N\N=3UN>ZN;K2I]+9A"D:I'(5.Y5'<;?QS[ 53U+P]_:_B_08$M+ MM+71H_\ 2KJ1=D=PHV-'&/[_ .\1'/8;".IH W=9U75-(\'/JIM89KZV@2>Y M@3.T@8,H3G.0N['7H*R=<\2VGND5<&&"+S'?/& O?K7&^&O D:?#^;1]3$\4M^WFR?O TEO MMVB%0W(S&J1CN,K0 [5?%FM^&_M\&J1:?<3KI%SJ-K);*Z(6A W1NK,3_$IW M C// K2U3Q/ZL[C4-2D:A)%"DD#J MWRCGVZ"@#,;QEK\/A?1]8N[?3[:+5"CFX\N62*RB:+>#*%.22<#J ,\GC)ZO MPYJ4^JZ0EU//I]P6=@D^GR^9#*H/##T/J,G'K58>';JUT32=/TW6)[1]-A2% M9/+5UF54"_.AZ],\$8-5K'PU>:-';I8:@[//J;7NHR&-%$JLA#*% ^49"=.< MC)/6@#J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@"O%?VT]]<64>G.#1?WUMIEC->WDHBMH M5WR.03@?0U-LB/.-5L3&LC%5+?:$P"0#@9[XJ/P6QM]9U:SUL#_A*6;S9YB5>'+#Q!XC^$5CH,6DZ?'9W=J8A?3W98HI8_. M(@GWAV&[KCFK5X/[%^)&H>(!(?*L'LK2[=CUMYD*%F/^RXB8^P- 'I:ZE9-J M;Z:MW";Y(A,UN'&\(3@,5ZXSWK-?QGX8CU$V#Z_IRW0?RS&;EM!(-1UCP[>7=J!G>J;T6 #WV*A^K&NM1K.+X9:>NCZ+I^J:,] MB#-%-@#N'=8T9W8*JC))Z 4RUNH+VUBNK69)K>9 \ M6VH6J75G/'/ ^=LD;!E.#@X(]P16/)XX\*Q7;VDOB+2X M[A)#$\;W2*5<'!4Y/!SQ5#X8?\D\TSZS?^CGKF_#O]OWGA_7M-L=%T^XMKC5 M-0B%Q=WA51NF<'=&(R2!GIGGVH ]1!! (.0>A%+6?H6FG1O#^G:6TQG-G;1P M&5NK[5"Y_'%:% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4A 8$'H>*6B@#*G\-:-<:3:Z7+I\36=H%%O' MR/*VC *D<@XXR#GFEL/#FCZ7+%+96$4,D0D".N<_/MWDD]2=BY)YX%:E% %: M]L+7484BO($FC21)55N@=&#*?J" :;<:997=[:WL]NCW-H6,$I'S1[AAL'T( MZBK=% %>PL+72[&&RLH$@MH5VQQIT4>@J&?1=-NA?B>SBD%_&([H,,^:H! ! M_ FKU% %6/3;**[CNH[:-)XH/LZ.!@K'D':/;('Y5D2^!/"TUT]Q)H=FSN_F M.NSY&;^\4^Z3[D5T-% #&BC:$PE%\LKM*XXQTQ6%8>!_#6F7,-S9:1#!+ 08 MV0M\OT&:Z"B@#G;?P'X7M;F.X@T>".6.02(REAA@ZU+2M M7U!X9+&6?PA;S^0"1Y3-,YX]* /9Z*\J\5V3>&M6OO\ A'EE@N)_#5]*YC=B MTDL;1;9#SRXW-\W7FFQR>'M*\6>&)- G\V(:?=SW$5K,9/, B!5F&2-Y^;D\ MGOTH ]7HKQ?0[JWM?$/@R^MFTZU_M*1S/Y%X\\\B/ [*+AS@,=P'7^(''0U% MI0TU?!VBZC9W(?Q+_;20HWG$S$&Z(:,C.=GE9..F.?>@#VVBO&KEK0^$M2U6 M28?\)FFK21Q-YI^T+*+G;'$HSG88]ORC@J2:NWMM/'I/Q$UJQ\YM6MKN:&VD M5V+0Q^3$7V#L<$G(YX'I0!ZQ17FWA2R2V\56$FGWFAP0264C36VG74DS7*?+ MMD8$8R#_ !'D[B.:])H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *DVE:=%68?0D9J:2UMYBYE@BSCD2W1+5( "^ [OM^\Y"@9X'7CFNIH MH III6G1H433[55:02E5A4 N.C=.OO5#P]X8LM TZVMPD5Q<6_F!;IH0),,[ M-C/4#YL=:VZ* *YL+-KT7IM(#= 8$YC&\#TW8S4J11QES'&BEVW/M&-QZ9/J M>!3Z* *UKI]E9-(UI9V]N9#ES%&$W'WP.:LT44 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+: MVNJ?\)38O$+MM*5$^U+;[LD[SMQCJ =I8#DKGMD'J:R]1\0:?I4[Q7;R*8X# M<.PB9E1.1DD#')& .I/2@#C$T;Q+_9=M-'=7<5S+.C+#Y\K89!,P:3=]U68Q MJ5'& .N>)0VN75YE0)XTL7T]+F.&:=\VJR) A8*T^S;@D MD8D4]!GZY +_AIYI-$C,T$L#"25564R;BH=@K?O/G (P0#T!Q6%8:C=Q#1_ MM$6J_N99TNLVD[9Y>% M'/S\?KTYH7QGHLDTT,4\DDT;^6(TB8L[;]A"COA@0?SZU'6X-1O=9O+>T9Q-]HM0 'D5?(V2$% MBA!"E]X)![#TK%SH5EJ;1",74L<81RPQNDV#MG//0@>^*ETC6[#6D>>R M$I/E1R?O(6C9HV!*,-P&0?FQ^- '(#6O$NG:=OD21([/3=Y-W#(S2LMN22S! M"-WFC'+C('0[@:?%J^N2VTMQ#+<2RQB16)M7WQGS(R(RJQX#E"3G81SZ5KVW MC"VN+!9M0@AA5UD\ZW5WEDBVA,HZ>6"'^?!7Z8SFK-MXDT6W%O:VT4D0>3RA M"EL5\IC(4PPQ\N6!'X9Z4 9]I/KS:G)&9K]8I+\,XFM@?+@^S[PJMC;RXVGD MX/'!.:I6>H>(KV2UEN1J,$(NRI3[*0SHT&0''EC $F5R!@9^\< UNGQEI CD M8&Y9HW='C2W=F4J@=L@#H%8'].O%/D\7Z/%O8RS&-=VV1('99"I"L$('S$%@ M,#W]#@ Y]=5\416+B&VN/M4=JVVW:S8H +7.,UU>D-?8O M(;YFD,-P4BF:,(94V*V<#C@LRY']WUJ*S\2Z9?:J=,BE87:J28W0@@@*2OU M89'U]#@N?$NF6@*-.N)&MXKVZ22ZO M[F(/N81E?.5(V&?N']TR#N< M$'M==\2IHKS1?9)I9$LI+L,%.S"$#:2.<\_YS37\9:+%)#'-/)%++(8_+DB9 M60A@GS ].6'YYZ D &)'?:C'87<TDTZ%UBC@N%RX+DK'P K$%,@8.>O0XV[O5EM;Z:V,0_ M=V;71--)C#>9]I&Q&=V2VD9 $"ESNV]%#*2??UXH Y^S M&LP76EY%[<0@(4BDBN<*SW#>8"Y*X$<90 R [@IQU-7(X+G3-0AU!4U1;-M4 M,9@!GG*P)!,@8I\QPTASTQCR_2M1O&%C!<31W221QQ+*S3JI9!LF,6W. =Q8 M=,=3P3UILOC/3WBMVL1)=[=BGG$0EHRK,P/S!3@ MK@'EEZC[W.+EYJ\6GS:C'Y"*+.Q^VLY. P)DR#@$C[A.<'KTJMJ7BRTL9)(% MCEDNHI(5:(1MEE>5(RRX&3C>/KQ]: '>&9]8E@(U?>SM;P3!FA\O:[KETQ_L MD?49YK,U36-?AUR]ALK6Y:TCB(W&V+!3F+YTPN&.UI#MW$DKC [V;OQI;1%6 MMXU>/#%S(71H]L=PS!AM.,-;%>,GKQP,VD\6Z>#=_:4GMQ;/*I9XSB3RU#-M M/1$KYDI^4?O%R^$XSM'RG-)'K6O1 M^6CVUU*LLBI!(;)@63[1M9I !A#Y1SSMZ9 [5I>(/$PT*]L[?[-',;B.20*T M^QVV-&NV-=IWN?,X7(Z=:E;Q5IB74MKFX:XCE6(Q+ Q8LP173&TD@ 1D\9&2>AX!J/B&QMSQ8\C:%0]1C//7C7A\9:<\,4DT5W 9'E4!H&.U8Y!&S,0,!=S#KZ M^QH'C/1)7EBBFDG=)!%LCA9RY+,HP .1E2/UZ$&@!/!VIW>J:=<2WT[23+*% M\MXO+:(&-&P1M7J22/8CG.:RX_[=AOI8[>.XB66Z<><8B^U&N6R0#Q]SD''H M>E73XHTG3$B%G:,MCYDZRF"W(V&,98A5'3@Y^GN*MOXLTZ&5XYV?Y78%HHW= M51652S';A1EA_G- &'Y_BFXMX8IQ.97BCD\U+?RS$[1W 8#MP4B/.>7]P D6 MJ>*5"+!%+-Y=EOC6YMI%:X?R6/S8C 5O, 7!9>!T.X&NNT[5+75+>2XM68Q) M(T99EV@E>#UK)T[QC:7MEY\EO-'(T_E101J97D4IYJ. !T,9#'T.1R1R .\* MFZ6V M^R.(\FSRQ#X^5A( H7(.21@DY$\ZZY$9FA%_ HN1(TD,3.VS[1%N !!R-F\X M )(!]ZTF\9W'EHZ:4&6=!-;MYS$&(L5+/MC)3'RG #?>Z\5O3ZQ;6NCQZG*P M>!T5]UO^\4@C.0>,CWXS^- %#0-0U&^O]2@O !'8R?9]P7'F/DN&^GEM#_P( ML.U9NI:YJ\/B"\M[-+B>.V(_T>&TW!D,+.3YG3=N"@#(SG&#GC2'BW0XFFVR M2+&JF1I1;OL8^4LN Z51LBBN+7RS(?LK.&8X!'[T*O8O6@#-M+SQ)< M!-TYCC$-S+YC64A)91%Y:N#&AY+2'"KDA0 <@FHK*?7Y-074-EV@,=G#+%-! MQ*/M,R.WW5( 1@_W5.-I('2M9?&FCR&(0M=3F7;M\JV=AN;=A<@8!^1_ICFH MX?&NF-+,TS/%9A4>*Z,;;&1H!-DG'RG;NX]O4C(!E^']7UN6^L+.99QY0@CN M86M6VQJ;178M(>C"0@8)SST/4=S6%8>*-(O[F.&S,CSW#N&"0G(*!,ER!@8$ MD?)]0*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K M(U.WT66X>+4985FO(/(V/-L+H&S\O(Y#,.1SDCVK7KG-8T.[O-;CU"TD*.L, M<61,R\"=';@<@16&.@STYK1DTK4T\.FRCEDDD6\:0+]I8,]OYY8)YG4'9@=>V, MXYH LQZ3HT%Z;17(FDD%X+8W#'!$F_<%SP-_/IU%-_L#1V>2V1Y%>1_M2QI< MN"C;]Q= #\OS$]..<=.*K>'M"O+#4Y[Z^D9WDM8X5SVH\:[C MR<'U.&6V#+$RWDAW$W"OD\\@H",'(Z^M '5QZ/8PZ=;V"QM M]GMW22-6D8D,K;@22"]2M](TO3)[A46 MWE$LUU$5:1@UL\;(=RD':2%!Q]S;W% &[_8.@ 74LLGFM%G[1--=L[)\JGYV M+< *JGGMSW.:-YX?TJ3Q1:W,6J6]O2/^^@P;/535ZQT36]/O8TB,7DO&M(N;I[[9(YF MR_$[[/F*,2JYP,E%/'I[FN=?P_XED>VC,JB!(Y0V;N1CL?SML;9.&VAXAG'. MTDG@5IZUH^K7%A8P64C Q69 C2LRQ'8R84$\#: M[#'T]!CC]=T[6;0P!7U&X,\UU+.;>6=CM\U3$J;3A&V$@ X3KFM"'0=>GU6Y M>\G:.REN(V,<-Y*,JIFW8^;(R&BR,C.#P !0!T-[I6G:M<,9R9)(XGMY%24C MY'P2K 'V4C/X4UO#^F_;UO0DD=P9&AZ$; MB."X.R6X,NR/[0RF0L_FL0 >2'.X'^$XQBGCP]I-S+%.'FE>!D4L+ISN:*0N MH?!PVURQP>F2*H:3H%[#KUOJ-T76**.Y6*%KIY3$KF':I)/S?U\F:*. MX9-\)W@;E!Y&2^#]:BD\(Z/)+-*8I@\K[R5N'7:WF++E<'@[T4\?RXKFAX8\ M0AY)O-<2,L"7#"]=FN=C2EBN<; 2Z$*"!P1P*4Z)XEGFNX;:ZNHI80(X[RXO M'PP^QJN H&T_O6#%P.JMW&" =*?"6C-$8VMG8%2K$RL2V1*"2<\D^?+D^K9[ M"H[SP[IEW=Q1>9MD%XFH-$7+$L@VY )^4'@'L>1WK)7PYK+01D7EVC1I(T:/ M>M\DA>,KG:?F7"OPV?O$=#@5IO#/B![F>=)660_+)(+URTZ^=OPH/$8V8&!@ M<;>G- ';O:0-?17K+^_BB>)6R>%8J6&.G5%_*LVR\+Z3970NK>%Q)O$BDS,P M!'F8P"<8_>R?G["L9/#.JL8_-OKEQA8V\R\<_N_(=&! ."=Y4YZ\9SD5=CT. M[DT'0M/ 64'VIT'A[3K9@8TE"K-YZ(96*HV2?E!/ RQX_P%&-8D-Q*NH7/GF*Y,;?;I%'F$H8"5 M!"X&'R,8YZ&@#:B\/:-<-V"OMBHIO"&G3:@EPQ ME$01@\"RN%D+,K'=@\CY!P>*PY/#6OJ]X+29K=9)YY&VWCD3J]TLH 7I&1&) M%.,9+]>I&YH6CWMG>FXO;FYE MHXHEEN6?:=SELC.TG!09Y/R]>Y );2RT61 M=3L;>X$LEV7%VHN2TA.T(W.\27@YR#Y08<8Y)]2:)/#&J^: MTT5[>K0\9Q@1[@1TYYS0!TL>D6L5E=VD?G)#=/([A9F!!D) M+%3G*Y))XQ@GBLBZT3PY80VMM>7!A2*%Q&DMXR[H5VEE(SS&-JY!X'XG+K2P MUBWTO68LAYIFD:T,]PY8E@>&8'@9X&W:0,=^:PV\':G>63B\D9IC;7$*9NY/ ME#S*Z G/901W[#D 4 ;EOIOAY2PM+YD:7 0Q7S JI8_(GS?*-S'@=\>@QH7. M@Z;<:=::<\)2WM=OV=(Y&4IM4J,$'/W21^-8?]@:PFH&XCG&!+\I:=L^7YY< M*3UQMP,51M/#7B F&>YEQ<1SR-%B[=A"'@5=PR3D"12=I)X/N10!T-QX;T.+ M3I4N(0EH@+NS3,H4"$0DDYXQ&H&>V,]>:LIH.GC3+O3RLLD%X6:)-+UN M\EMGTB\\@+&PF!E*Y="'BQCL67:WJK&@#0@TK2XM/DTA#NB#F22-IBS[FZX']T8]JLZ'X>OM+T"?3GE+*^GPPJKSM(%F M$95\;LX4G;P./:@"ZUOH%I-%--=PK*'CVO-=3AR<=\_2J_\ PC?A ME+>1G*FUMT$$J/=L8DVQ>5AQNP"(SC)YYSZ5E6W@N]:RM=-NYPMO'YZS7$3* M9)TE0 AMRD9'*Y'95QCH(-1\$ZE<0:I:6[0+9ZA]HDFC9S\T@+F#MW+J6/\ MTR4&".=7BA"1N^P;Y)A'DM M@X SGH>E=#3&AB=@SQHS#&"5!/!R/UYH X[_ (36\1YY)-.@\E8+;9&LS%_- MEFDB(.$Y4%."!GIQ\V!:_P"$LOBCD:.BE!;*RRW)4^9--Y0'W#\HY.3@XQQU MQT3V%G)G?:0-N0QG=&#E2-9 M#/;VR64/VB4R1.GG.?+E7S@.?+P5)A;G(..=O'++3Q=>NMHKVULUU=6\$@#7 M.R!2TK^Q6OGK/]FA\Y#D<8QU)_.@#FHO'!DC^U/8)#9%0%DEG(8.;9;C#*$.!M;;D$G(Z M&I]&\1W&KWLI*"&-+>3,/4"1)F0G)4-_#T(%=&]M!(&#P1L&)+ H#G(VG/X< M?2B&UM[=0L$$42@;0$0* /3B@#E4\57*V.C2K&EU/>V<+LGF!$\QWA3)(4D8 M,A/]*2#Q=>77DH;!()I#$R*MQO5@QE7#$IQ\T78=".G2NGATZRMEVP6=O$N= MV$B51G@YX'L/R%2"V@4@B&,$8P0HXQG'\S^9H Y"S\<7+V]HT^EB1C8Q7=RU ML[$+O1F&T%<$?+W8)TL[=7B!$;")04SUQQQG)IL>F6,,L4D-I#&T6[R]B!0N[J<#C/O M]?4T 9>G>)EO]2U*T6%-MFGF+(CL1( [H1\R+@@QGIN'OQ5'3?&-SJ4]E!'I MUOYET8WRMX61(WC,F2=GW@%(VX[CG!KIELK5#,4MXD:;/FLB!2^>Y(ZTRRTV MRTZVBM[2VBBCB'RA5&Y;3X?LR00%$69MYEDN)(#_!]S* YQD#LMZ@ M=,T>6&":UFO+QH)8X_+9PJQRM\IDPO)C!YP<'H#Q4=[XRDTZ2Z$U@K00EXTE M\_YG=/+ZJ$X!\SMD\=#D5TCZ?92VJ6LEG;O;IC;$T2E%^@Q@4R\TJROK1K6> MW7RF(/R?(000001R.5'Y4 ++R;4_,^SQ/9%+6.5!(P:"62XE@. T8+':,MG/!X-4O^$RNY#MATJ%V22.* M4F[(4.]R]N-IV'-V,\226,*)B'SR;KYD:262+Y5V_,H:,DD MD<@#)LO$)U"[U"S M2V,4UDCF8E\["6/E]N=R#?[ CKFL*V\:7T5B&:S6\D2W^T3,\PBPJPVS-M 0 MY)-QG!]#SC '9P65O;374T4>)+IQ),2<[B%"#Z#"CC_&G"TM@"!;Q8(VGY!T MP!C\E7\AZ4 M:8VG6+^=NLK=O/QYN8E/F8Z;N.?QH Y4>(]270?#MZKVLDUY(XF$LPCC<"*5 M\;PIQRH.0.<>F:TM$\4KK5\+5+-X7$/GR;WYC1E1H\C'\0<_0QL.<5M2V5I/ M ();6&2%>1&\8*C\*2.RMXKRXNT3$]PJ+(V3RJYVCV W'\S0!RMAX\^UVBWD MM@D-JY;RY#.><0M*0=R#D;<<9'7!.*5_'1^T^1#8QS,T2O'B9@-QDAC*L3'C M@SCE2W0YQ6W8>&=(TZ)HX+-64A!B9C)@)G8!NSC&3CZU>6QLUE:5;6 2-@,X MC&3C&,GVP/R% '-7'C.2#4)+$6,,LPVJI2=PN_SHHF4L8QT:81273RZ?;^5"D:;$G8OYQN9+<_P>2IP>F0174(ZR(KHP9&&593D$>HJN-.LE:%EL[<&%2L1$2_ MNP>R\<#Z581%C1410JJ,!0, #TH 6BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D! end GRAPHIC 18 gfs-20231231_g1.jpg begin 644 gfs-20231231_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X0+T17AI9@ 34T *@ @ ! $[ ( M . !2H=I 0 ! !6)R= $ < "T.H< < $, /@ M &UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YTF5L/"]R M9&8Z;&D^/"]R9&8Z4V5Q/@T*"0D)/"]D8SIC&UP;65T83X-"B @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P '!04& M!00'!@4&" <'" H1"PH)"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H M*2LL*QH@+S,O*C(G*BLJ_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@# M, .; P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ ^D:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH \N^)NA:=XE^)_@#2=;M_M-C,/^2T_#G_N)_\ I.M>@U;;25C-13;NCS[_ (47\.?^A=_\ MGKC_ ..4?\*+^'/_ $+O_D]??\*+^'/_0N_P#D]N/_ (Y7H-%'-+N')'L>??\ "B_AS_T+O_D]@T4QY]_PHOX<_\ 0N_^3UQ_\N/_CE>@T4 MQY]_PHOX<_P#0N_\ D]N/_CE>@T4QY]_PHOX<_]"[_ .3UQ_\ '*/^%%_#G_H7?_)ZX_\ CE>@T4QY] M_P *+^'/_0N_^3UQ_P#'*/\ A1?PY_Z%W_R>N/\ XY7H-%'-+N')'L>??\*+ M^'/_ $+O_D]??\*+^'/\ MT+O_ )/7'_QRC_A1?PY_Z%W_ ,GKC_XY7H-%'-+N')'L>3>+_@SX"TOP/KNH M6&@^5=6FG7$\,GVR=MCK&S*<%R#@@<'BNY\ ?\DU\,_]@BU_]$K1X_\ ^2:^ M)O\ L$77_HEJ/ '_ "37PS_V"+7_ -$K3;;CJ))*6AT%%%%06%%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 >?>,/\ DM/PY_[B?_I.M>@UY]XP M_P"2T_#G_N)_^DZUZ#5/9$QW?]= HHHJ2@HHHH **** .2?6=?UW7-4LO"TV MFV5OI$HMI[F_M9+@SSF-)-BJDD>Q55URQ+9+< ;N2KG:O M*T21SJB)N!$4H=6$:DJ5&TKD$YPN9HWP]UCPI;:)=:*^EWM_IZWLBLW.>L6N?#:]O\ Q3JUS +> MZL-9G@GG%SJMY ("BHC@V\)"3Y6-2"S*03SD 4 =+=?$+PU9R7BW%[,JV,XM MKB5;*=HXYBZH(]X0J7RZ_*#G!!Z3QI]L^P^5)8SK,+@IO$ M7DE/,W%>0-O.0!DD9QKGP-J3)XC@U8*7;=Y268@*_=QNW<@9QCOGB@#9TWX@^&M6OK: MTL;Z5YKF5X(]]G/&HF0,6A9F0*LH"L3&Q#8YQR*EM/&_A^^OI+6VOF9T$I#F MWE6*;RCB3RI"H24J<@A"V,'TK!M_ VIQ?V=NGM#]E\5W6M/AVY@E^T;5'R_? M_?+D=.#R>,Y7A_X7ZAI%Q:6\_P!FGMM,CNEM+R75;R5W,B/&F+9B(82$D(8C M?G'"KG*@'07'Q0\/'0-0U'2Y+F]:UTY]1BA-E<1?:8E ^9&:/YERR@LN0N%X=>NF^Q6CVHN9&N0T?DKMW$MN ( ]2!ZUQ8^'6IOH^CV,MS:+] MC\(SZ%.RLQS-(D*AU^7E/W;G0:AX9NM<^&3^'+^2&TNY;%;=I(6,T: M.H&#R%++D#(P,C(H SO$'Q+TZT\&ZGJNB--+=V;Q0^1(JLFP M@Y#\1>,#X2\*Z;J6HV\NH2W5S;6S_9K.:/F5PI?RL.Z8!)"-R3A< M[B*Q-4\$^(/$5OKEYJ9TVSU+4;>SM(8+:X>6%(X)C*7:0QJQ9B[#&W "KR<\ M=)XVT.\U_P /);:88/M<%[:WD2W$A2-S#.DA4L%8KD*1D*><<4 9FA_$2RN] M;U#2M7D^SW$>KR:?:%+2;RGPH9%>7!19#S\I8$\8'(SL6_C+0KK7FT>"]9KL M3/ ";>01/*@R\:S%?+9U .45BPVMD?*<<^_@?4W@F4S6@:3Q5'K0^=L"%71B MOW?O_*>.G3FJ.B_#:^TOQ%;F86]SIUIJ<^H07$NJ7C./,9W"BT!$".ID(\P$ M@@$[,L< 'I5%%% !1110 4444 <_X_\ ^2:^)O\ L$77_HEJ/ '_ "37PS_V M"+7_ -$K1X__ .2:^)O^P1=?^B6H\ ?\DU\,_P#8(M?_ $2M5]DG[1T%%%%2 M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?>,/\ DM/PY_[B M?_I.M>@UY]XP_P"2T_#G_N)_^DZUZ#5/9$QW?]= HHHJ2@HHHH *\S/C^ZE\ M0:W97/C'PCH']GZ@UI#:ZE;EII$"(P1G@XAF\;V=X+/^QKJ.)CJT5A=0ZC9W$,JETW M[!&R!EU$$NMV6HJK.VX1PV_EL"-N-Q;H,XQW'2@#8C^('AV6RE MNX;JZE@CG6W#1Z?<-YTI+#9$ F96&QMP3<5VG=C%56^(FF2ZSX>L].BN+R'6 MY)XUN%MYE\AHL@AE*9!W J0VTK@D\5E_\(7XAM/ NEZ18WD7GVNHSW-U%#J$ M]FMU"\DS!//B7S$P9$8X')4CIS4.@_#[5]&70M\EC,=/U._GF"SR &"Y+\J6 M5B77<.&/./O4 =9I7C+0M:U$V6FWC2S$2&,M;R1QW C;:YBD90LH4D E"P&1 MZT_7/%NB^')4CU>Z>)VC:8B.WDF\J)2 9)-BGRT!/WVPOOQ7'^"?AS?>&]3T ML7PMYK?1X98;>Z;5+R>24$;%*V[D10?)G<%W@G@;:UO$OAC6;G7K[4M -A(V MJ:3_ &7<+?2N@@ 9V25 J-O_ -:V4.T' ^83.;>U\ MQ(]PY&#EV?G(VPOWQ4GAOPE/H'B:YNQ/'+9MI-CI\/)\PF#S/KK1]8;RK"'2(K\2Q6LLSH3+*KLY0,%C58U)8@ 9Y;D5L77B_0K.#4I MI[]1%I<4SR)+ UNA3 M.Q48.&&WGSDT&/[2M-:;3KVZ&C76IZ?%=?\3?VG=Z MTNG65RVC76F:?:VUS)/&C3@;Y7D:-#R4C& AP 3DYP #4T3Q[HFJ:7)/->_9 MY;2QCO;L3V\L"K$P/[U#(HWQY5L.I9>.M9WB#XDV%IX2U#5=&D/G:?<6<=S% MJ-G/;F*.:=$+E) C8V,Q#=,KWP14>H>"]=E:YFTK4H+*Z;PR-*@N%=@T=P&) M#@@<+S]X?,.N.*PY/AKXBDMO$+P/I]O<:J=,>!+C4;F^\I[6Y,C;Y95WR J1 MCIC[N !N(!UT_C:SNA8_V/>0QN^J16-U#J%K<0S)O0ML$94,CD8*EP%([]*Z MJO/Y/!>N:EKBZWJ)T^VNGU:SNI+:"XDECC@MXW7 /^2:^&?^P1:_\ HE:/'_\ R37Q M-_V"+K_T2U'@#_DFOAG_ +!%K_Z)6J^R3]HZ"BBBI*"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** //O&'_ "6GX<_]Q/\ ])UKT&O/O&'_ "6G MX<_]Q/\ ])UKT&J>R)CN_P"N@4445)04444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110!S_C__ ))KXF_[!%U_Z):CP!_R M37PS_P!@BU_]$K1X_P#^2:^)O^P1=?\ HEJ/ '_)-?#/_8(M?_1*U7V2?M'0 M4445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_C7P5J/B7 M6M#U;1/$/]AWVC_:/*E^Q+<[O-55/#, .%(Y!Z]L5G?\(?\ $;_HJ7_EO6__ M ,57H-%5S,GE5[GGW_"'_$;_ **E_P"6];__ !5'_"'_ !&_Z*E_Y;UO_P#% M5Z#11S,.5?TV>??\(?\ $;_HJ7_EO6__ ,51_P (?\1O^BI?^6];_P#Q5>@T M4Y!!S,.5?TV6?^$/^(W_14O\ RWK?_P"*H_X0 M_P"(W_14O_+>M_\ XJLJ+Q=XCUK2\6VIBPN=-T>YO9Y8K>-A=SPSO"H8,#MC M/DN2%VM\XPPQS/<^-O$%IKR:C+!='2YK>-X;0VP%NR20(483[?\ 6FX;R]N_ MA,MLP-U',PY5_39>_P"$/^(W_14O_+>M_P#XJC_A#_B-_P!%2_\ +>M__BJZ M7PCK=MK>@Q/#J3:E/ %2YG>V:W+.5#;A&RJ0I# KQ@J0?? M\(?\1O\ HJ7_ );UO_\ %4?\(?\ $;_HJ7_EO6__ ,57H-%',PY5_39XSKB_ M$?1_'GA;PX/B,)AK_P!KS@T4??\(?\1O\ HJ7_ );UO_\ %4?\(?\ $;_HJ7_EO6__ M ,57H-%',PY5_39YMJ'@#Q[JFFW6GW_Q.\VUNX7@FC_L"!=Z,"K#(8$9!/(Y MKN= TK^PO#6F:3YWG_8+2*V\W;M\S8@7=C)QG&<9-:%%)ML%%+4****10444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Y=XFTV\\2_&^/0O\ MA(]78T[GX<:3-IUK9VMWJ%C'#9O8RM;RK MONH'(:1)"RG[S G%[7PQ:S16US=7;S,A>:Z92Y"1K&B_*JC"J@'3)ZDDDFMJO/O^%3? M]3_XY_\ !S_]A1_PJ;_J?_'/_@Y_^PHLNX7EV/0:*\^_X5-_U/\ XY_\'/\ M]A1_PJ;_ *G_ ,<_^#G_ .PHLNX7EV*_C;_DNWPP_P"XM_Z3+7I->:S_ 4L M;F_M;ZY\9>,9KNSW_9KB35%:2#>,-L8QY7(X..HJS_PJ;_J?_'/_ (.?_L*+ M+N%Y=CT&BO/O^%3?]3_XY_\ !S_]A1_PJ;_J?_'/_@Y_^PHLNX7EV/0:*\^_ MX5-_U/\ XY_\'/\ ]A1_PJ;_ *G_ ,<_^#G_ .PHLNX7EV/0:*\^_P"%3?\ M4_\ CG_P<_\ V%'_ J;_J?_ !S_ .#G_P"PHLNX7EV/0:*\^_X5-_U/_CG_ M ,'/_P!A1_PJ;_J?_'/_ (.?_L*++N%Y=CT&BO/O^%3?]3_XY_\ !S_]A1_P MJ;_J?_'/_@Y_^PHLNX7EV/0:*\^_X5-_U/\ XY_\'/\ ]A1_PJ;_ *G_ ,<_ M^#G_ .PHLNX7EV/0:*\6^)/@R\\'?#W4M=TSQUXRENK3RMB7&KED.Z5$.0%! MZ,>_6O::&M+@FV[,****DH**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH \^_P";E/\ N4O_ &\KT&O/O^;E/^Y2_P#;RO0:J1,>H4445)04444 M%%%>,1ZZ/!?CWQGKCH9([^]FM1'G_67,-G;RV\8'33 LS$6[2,X(/#%TSW&">.F'S:SK?B/QIH$EB^GVEY M;:GK5E'+-"\D:Q0N(PQC#J78JHZ,HR<]!@@'K-%>8W/Q&U:3P]I\MHUC;:G) M'>_:(1IUU?&1[:7R6*1Q%=D;.,^8[@+E1\W)#-0\8ZUXI\.S1:,EA9HWA>+5 MKU;N)Y#*+B-RL495UV8"/ER'Y*_+P<@'J-%>03>/]0\-^%])337M)H[#2=/D MGM?[.N9W<2 !MTZE8K?Y1E=Q8MZ= ;EKK\^A3^*OL5S;P7-YXL:!#-9SWC$? M8H'.R"#YY&PO3*@#+$\8(!ZG17.> _$5SXH\(P:E?Q)%=>?/!*L<;1J6BF>/ M(5B2N=F=I)(SC)QFN$\&Z[KL&@>%]"T&33H!WDD][;/-M,4ZJ %61.OF M'O[]L$ ]>HKS2W^)6IRZ#:WCVEFMSK&AP7NDPD, ]V[K$\3'/S*'F@(Q@X8^ MF:+KXAZXGBB^M+#3VO+?3+Z&PFM[?1[N62Y++&995N$S%"%$N0C[B0AR1N& M#TNBO/D\7>(&\3WFDZB;/2C+)=6]E'6P&1G*G M/.^'/%_BZ/P;H5O!>Z=<7)\+OK$MW?V\LKR%"H"'$H))##+D]03CG% 'L=%> M9'XDZQI6GWNH:W:V-Q$?#O\ ;MK!:(\;1\X\EW9FW_>3YPJ]#\O2HIOB%XGL MM!U6::PCN+BU2T>WO)='O-/MV>6=8GA*3G<2H.X.IP0P^48P0#U*BO)O$OB+ MQ6QFTG^U+&"^T_Q%I<'VRUM)8TFBG:,A6C\\G 8D,-^'7CYH4445)04444 %8EUX-T"],AN].67S-2 MCU5MTC_\?4:JJR=>,*BC'0X.0G4-\5S+%(E MP1@R)(K!D."1\I'!([FJC?#GPP;>UA2PFA^R333V\D%]/%)%)*]I%1AC O#<]O80MI[)%I\#6T*PW,L8:%BI>.3:P\U&*@LK[@QSG.33+GX> M^&;JQLK.73Y!!8V@L8ECNYDW6XQ^YD*N#+'P/E?<.O')K)75KV&YTKPMX(U. MUNW^PW%S_:6J[KL%(9%B$7R.A9@[[2Q.5$?(9C6)<_$W7[[2'U/1+?3;6"#P MNNORQ7<;S,S R;H59748.SA^<8^Z<_* =;>_#?PMJ"%+K3I6B:VBM7B2]G2- MXXQB/=HC$Y+$L5V\. N> MNP=*NW/C/6M'&M:;K4^E'4;$6307<-G<>5(+EVC"^0IDD>0,CX56^?*_$=#TR2S>QLO*: MQMI;6W/FNVR*1@[KRW.64')R1CBN(M/B%XAOK"V@MDL$OY/$IT5KBYT^>%#' M]E:<2_9VDWHWW?E9N<'[N>+=I\1+ZQA2Y\2"Q6R@N]2L+NY@C>,&:VW/&Z@L MVU6CBERI).[&&[$ ZN'PAH4%MHL$6GJ(]"_Y!P,CGR/DV=2@ZMI?A!?"5G96O]DA%Y&T0"H1#(Q8;L29?;C9[F@#L[7P9H5GK"ZG;VDBSI*\\<9NI6@BD M?.^1(2WEHQW-EE4$[FYY.66/@;P]IT"0VEBZQQV4FGHK7,K[;=V#-&-S' R! MCT P,#BN2\20_P!I^./$D-KJL.G?;/"MG%#?-+MC5I+FX5/F!'WB0!@YYXYQ M5>R5?"FKWD47A:'PSJ[:5=/:1Z/-')I^J>4D;AF4(CB5&<@;D'!?YF!X .]7 MPIHB[,Z?&ZKIW]E[)&9U-KQ^[*DD,..IR3ZU2@^'WAN"RGM?L4TR7 A61KF] MGGD*Q.'C02.Y8*K#(4$#KQR:Q= \,^%[7PWX>\0>?':W\HMKAM:WJMQ?R2@? M++*PS(LA?&P\$-$U/[>;RT??'3_DBVN_]N__ M *41UZ#5?9)7Q/\ KN%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 >??\W*?]RE_[>5Z#7GW_ #5Z#52)CU"BBBI*"BBB@ MHHHH *QM8\)Z1KE]'>WT5Q'=QQ&$7%G>S6LC1DYV,T3J67/(!) .<=36S10! M@WW@K0+_ $^RLI+%K>"PC,5K]BN)+5HHV #('B96VD 97.#@$@X%23>#]!GB MN(GTZ-8KC3?[)DCC=D7[(-V(@%("@;FY&#SUX%5O'M[/9>#KC[)*\,UW-;V* MS1\-%Y\Z0EP>Q D)!]0*XOQ]-#_:MMHVDVM\J^&K)+VPAT_3;B>,7H(^SQL8 M48(H1'4@X^68=LB@#J/&'@2UU[0;Z#3H($O[JUM[(R7$CE#!%-Y@0CD=WYQD MYY.*O#P)X?&E3V#6D\D=Q-'/)-)>SO<&2,@QL)RYD!7:-N&&.W4UQLNL:EK? MCN#7/!UQI\:7/A5+M6OX7E#*968)M1U*DG@MD[<$;3GB=OB?J%SX:\1:Q96= MM&EAX=LM8M(IE9COGCE_J, '66?@;P]8-&UK8LK1WXU$,]S M*Y-R(O*\UBS$LQ0D$G.XG<=:7D+P3Q[BN]'4JPR"",@GD'-2+:PK9BT\M3 (_+\MAN!7&,'/ M48]:\P\'^*M5T/0=)L-8DTMK,>$EU6VE"20B 0K$I25\ON!$BG>2VMM/NH)UTZXTX/YESM*E)RSX!CX?@$$\<4 >E6/@7 MPYI^GWEC%IWG6][$L$Z7D\ESOB4$+'F5F(1WT]V\:9R51IG8H"0,A<9VKG.!CB-:\0:D-6AT+Q);Z;J%U9:QI,T= MS;PS01[9Y64'9YC$.C1,1EBI!&5ZBNI\*DV>N>(]&C_X];.\2:V4# B2:-79 M!["3S"/0,!VH FL_ OA[3[^*[M;*13!,T\%NUW,]O!(V?>)O#/C'_A94?BGP;+H?\ R"!ITD>J MM-_SV,A($8_W><^O%'_%X_\ J1O_ "??\ %X_^I&_\G*/^ M+Q_]2-_Y.4N7S*YO(]!HKS[_ (O'_P!2-_Y.4?\ %X_^I&_\G*.7S#F\CT&B MO/O^+Q_]2-_Y.4?\7C_ZD;_R/\ ZD;_ M ,G*.7S#F\CKO$6CC7_#]WIIE,#S*#%,!DQ2*0R/COM=5./:G:/ID=A'/$ M-&TXW310W$\MW#]GFFO+V:YE,7/R"25V95Y)P"!DYZUP]]XA^)^G:]I>C7MS MX&CU#5O-^Q0^7?'S?*7?)\P&%PISR1GMFM+_ (O'_P!2-_Y.4 MZ-S>SS--&C[T5F=R3@],GIQTXK&_XO'_ -2-_P"3E'_%X_\ J1O_ "332M+%CRR9' M7[1O>ZE=FXE\MBRHH58XT4D#@(BYX&6+'O7+?\7C_P"I&_\ )RC_ (O'_P!2 M-_Y.4??\ %X_^I&_\G*/^+Q_]2-_Y.4??\7C_Z MD;_R@T5Y]_Q>/\ ZD;_ ,G*/^+Q_P#4C?\ DY1R M^8@T5Y]_Q>/_ *D;_P G*/\ B\?_ %(W_DY1R^83>+/#/Q6\8^&+O0M3E\&Q6MWLWO;M=*XVNKC!((ZJ.W2O6:'M82 MUDV%%%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 ,ED6&%Y7#%44L0B%F('H!DD^PYKC;;XBB[T#4M0CT>XBFM]532K M6TN7\M[B63RA&7X/E F49!!*@$D9^6NUKAI?!.HMINMB*>U^US^($UJQ#,VP MF/R2L7R01@ Y$ MP^'RMX1TS2KF*PN+V*20W-^\7[R!)G9[@0-@LI;<4'*X!SDE<$ Z?0]5;6M, M%^(/)MYG8VQW[C-"#A)>G <#;>-O^2[?##_N+?\ I,M>DUYM MXV_Y+M\,/^XM_P"DRUZ30 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'ETLOC3Q+\3_ M !7I.B>,O[#L='^Q^5%_9<-SN\V'<>6P1RI/)/7MBM#_ (0_XC?]%2_\MZW_ M /BJ/!__ "6GXC?]PS_TG:O0:MNQG&-]6>??\(?\1O\ HJ7_ );UO_\ %4?\ M(?\ $;_HJ7_EO6__ ,57H-%+F97*OZ;//O\ A#_B-_T5+_RWK?\ ^*H_X0_X MC?\ 14O_ "WK?_XJO0:*.9ARK^FSS[_A#_B-_P!%2_\ +>M__BJ/^$/^(W_1 M4O\ RWK?_P"*KT&BCF8M__ (JC_A#_ (C?]%2_ M\MZW_P#BJ]!HHYF'*OZ;//O^$/\ B-_T5+_RWK?_ .*H_P"$/^(W_14O_+>M M_P#XJO0:*.9ARK^FSS[_ (0_XC?]%2_\MZW_ /BJ/^$/^(W_ $5+_P MZW_^ M*KT&BCF8&+_P#X3+[?]B^U_P#$T_LNWB_LW?$!_JMW M[WS/N_[.,UTG_"'_ !&_Z*E_Y;UO_P#%5Z#11S,.5?TV>??\(?\ $;_HJ7_E MO6__ ,51_P (?\1O^BI?^6];_P#Q5>@T4@T4@T4^#M2\-S7_ (\_M:UU'7+73YK;^QX(,I(2 M6.X9/12.,'GKQ7K->??%G_F2?^QML/\ V>O0:'LA1T;04445)84444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110!Y]X/\ ^2T_$;_N&?\ I.U>@UY] MX/\ ^2T_$;_N&?\ I.U>@U4MR8[??^84445)04444 %>??%J[U:UM_#QT&[N M8+D:D\OEV\K)]I\JUGF$+ 'YE9HU!!X.:]!K.U/1+;5=0TJ[N'E632[HW4(0 M@!F,3Q8;(.1MD;ICD#Z4 <$OB2XU_P"+VA7&DZE/_8:Q-;^1%*1'/*]J;@LZ M]&*H\&.N"6J[:?%))_$4VEO::>Y%M=SQBRU9;F6,P$?).J)MB9@20 [XVD5K M:!\.M%\-Q:7'IC72IIEQ<7$"NZG)F4J5;Y>0JD!<8P%&Q#,2W R2.* ,N+XF:[/;J\/A6UWS:,NMPA]6 M('V?'S*Y$)VR9*X4!E.3EEQ@W;_XE/';W%[I.C&]L-.TZ#4M2EDN?*DAAE4O MB--K"1UC5F(+(.@!.>-6#P)ID$<*)/=D0Z+_ &(N77F#CYC\OW^.O3VJK=?# M72[F!+=+[4;>V>RAL+Z"&2,+J$$0PJ2Y0D<%@3&4)#$9Z8 &:A\0ELK?Q#-' MIWG)HMY9VRGS]OGBX6%MWW?EV^=TYSM[9X0^.KW[+X@O?[)LHK'1[IK(3W6J M+!YLH9!N8L@6./#Y+;BWRD!&XS-JWPYT[5M0O9SJ.I6D&H26\MU9VSQK%+)! MM\MSE"P("(,!@"%&15BZ\":==:5J%C]IO(OMVIC5#,CIOAG5T=2F5*X!C7A@ MW?.: %\$^,$\86-_*L5JDEA>&UD:SN_M,$OR(X>.3:NY2''\(Y![8)XZQL+B M\\*>*]?76M8AU6PU35&M93JEP88O)GD\M3 7\HH H4J5QCTZUWGAWPQ!XSC#E V6Y!SQMP9]6^*,.F>0KV]A;F\U"ZM;.?4M2%I;O';_+)*\A0[ MPT>&QO;W3KC14,=G>VS1F55*;'#;T9'W G!-?N6@2T^RV2S M[-+UI1>6Y+[3%,IC#V\HQ_==?O#=P,]M8^$+.RU*ROVO=0NKJTT^73_-N;C> MTJR.DCNS8SOW1C&T@ $@ #&5=?#*PU&WN8M7UG5]1,MBVGQ2W,D1DMX&969 M581@L28TRTF]N.O)R )'%XEM-.MDL]9E6)8VMU?:T)38R MG[S?Q$L5SAU/<);F+45FND\H,Q::W"YB5E1R#N8_ M=! )XZ*7P-ILNJ37[3W8EFU6'56 ==HECB$2J/E^[M4$CKGOVI-*\$6ND7B& MVU35&TZ(RM#I+S)]EB,F=PP$#NOS-A79E7/ &%P $+F>Q.F: M7J=A=W4$4=\9#/&5B9#,FU0K@,#C+@;C\U>D5R>C?#ZQT75-.NXM4U2Y32H9 M+?3[6XE1HK:%P!Y:X0,P 50"S,V !DUUE !1110 4444 >??%G_F2?\ L;;# M_P!GKT&O/OBS_P R3_V-MA_[/7H-4]D2OB84445)04444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110!Y]X/_Y+3\1O^X9_Z3M7H->?>#_^2T_$;_N& M?^D[5Z#52W)CM]_YA1114E!1110 5Q^O23ZQX]LO#;WEU::&6 MX82(B)YB$.JC)8[2"3M!.,@]A6/K?ARWUJXM;M;JZT_4+/<+>^LV421JV-ZX M=61E; R&4C(!&" 0 >?7&MQVUDMCH>OZU*L7B/2P;?48+J"XMH9KA08FDG > M5&VO][/!*DD8KIK#Q]+>ZI8LVDB/1-2OY].LK\7.Z1YHO,Y>'8-B,89 K!V/ M"Y"[N)T^'>FG?->7^I7M]-?6M]/>W$RF29[:3?$I4*(U0'C"*N0?7FI;/P'I MUEK,-XEW>R6MM=2WMKICLGV:VN)=V^1 $#Y/F2$!F*@N< <8 .:^'/C#5_\ MA'O"]IXAL7D75X)5M+YK[SIYY(U9R)$91MW*K%2';A1NVDX&9K?Q1DUKPCXG MM+(V=K=PZ#-J%O=:1K NS#CY2CO&H$GR7(N!?Z>,6TFR20-< MQ!D!) ^8$KR0#GGBLR]\77L/Q$T^75=-U;1-.MM%U"ZGANIH&6;RV@.X+#*X M)4;OO8/S<=379:WX?M=>TB+3KR29(8YX)PT3 -NAD611R#P2@S[9Z4S4O#-A MJNMV^IWWF2/!9W%EY.1Y.]5E\!ZW%<6#Z)?3 MZ ^JZ=/:WID81@J&#,%4QRJ9(\A2P^;ACBK/CKQAJT^DZS%H-H8K+3-2M+*X MU)+TQ3"4RPLX2,+RF)%0G>"26&"!SL/\,-+N-)O+"^U+5+Q+C3O[+BEFDCWV MEKD'RXR(QG.UR'4M2M+;4)XKJ[LK:2-89IX]NV0Y M0L#B- 0&"G:"1GF@#$TKQGJ$5\FDZ1ILFI75_JVK(KZGJA5(1;SX(W")B$(; M"J%.W"C)&6&A8_$*[UFTT;^P]#%Q>:A8/?W%O-=^6MNB,$95?8=[ER0HPH(! M)*UJ:?X&TW3=8M]2@GNVFM[F^N55W4J6NW#R X7. 1\O/ ZYKF]:\'7&A6FE MP^&+#6;LV=E<6RW6GWUK'.RR.K^5()E"F-CSO0[U*C Y)H O:UXGN-9^ NH> M)K(2:;<76A27D0BF.^!C$6&' !R#W %4?#3E_%>BMXURA(/O@D?A70 MRZ?;W&E/IUPGFVTD)@D1CC>A7:02/4>E '"Z]-X@N_&/BO3?#U[*ETOA^U>S MB,VU$E:6X#%AMOASIB:;?VNI7^HZH]]#! ]U=2HDT:0$M"$, M2H%*,2P;&[=R2<#%ZQ\)10ZI_:.KZG?:[=) ]M"^H+"!#&Y!D55BC13NV+DL M"<+@$ D$ SM!\-7*V>CZNOB349M0E"37LD]T\L%XKKN=%@+>7&.@U3V1*^) MA1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GW@__ )+3 M\1O^X9_Z3M7H->?>#_\ DM/Q&_[AG_I.U>@U4MR8[??^84445)04444 %%%% M !1110!D>*]8?P_X1U358462:UM7DB1C@-)CY ?8M@5POCO5VT&ST;PZOBR/ M3;^&UDU"2]OK\0FZ>(8CC9F89625LE1QMC88 P*[_P 1:0GB#PUJ.DR2&(7M ML\(E7K&64@,/<'!_"JOA[2Y8IKC6M2CEBU;4H8$NXGD1TA\I2 D97^#+?"-]X1C%];:IHUW=?99[UK>$_-;D,Y"M\R[BH^4D%L M<#)K2T_XD1:E&TEOIKJJZ(^JD23#<&1V1H3@$<,A^8$_2I#\-;&*\MKK3-9U M?39K1[MK=K:2$B(7,BR2(%>-@5W+P"#C)[@$+-=;N;GX)WVMV,DUA<7&F1W*-!,5>$ MN%. XP,/#J:5>ZE-;:O36_C37=#GGDFC2.#4;8RN6*),9%:,$\X#PL0.P< < 5)/ASI]S;W,>HZ MIJE_+.;91<7$D?F11V\PFCC7:@&W<.206;/+="-'1]-N1XGUK6K^+R7NO*M+ M:,L&/V>'>58X) W/+(V.NW;G!R ;M%%% !1110 4444 %%%% 'GWQ9_YDG_ M +&VP_\ 9Z]!KS[XL_\ ,D_]C;8?^SUZ#5/9$KXF%%%%24%%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 >72Q>-/#7Q/\5ZMHG@W^W+'6/L?E2_ MVI#;;?*AVGALD\L1R!T[YK0_X3#XC?\ 1+?_ "X;?_XFO0:*KF\B.7LSS[_A M,/B-_P!$M_\ +AM__B:/^$P^(W_1+?\ RX;?_P")KT&BBZ[#Y7W_ "//O^$P M^(W_ $2W_P N&W_^)H_X3#XC?]$M_P#+AM__ (FO0:*+KL'*^_Y'GW_"8?$; M_HEO_EPV_P#\31_PF'Q&_P"B6_\ EPV__P 37>W%Q#:6TMQ=2I#!"A>261@J MHH&2Q)X YS56]US2=-6V;4=4L[1;MPEN9[A$$S'HJ9/S$^@HNNP??\)A\1O^B6_^7#;_ /Q-'_"8?$;_ *);_P"7#;__ !->@T4778.5]_R/ M/O\ A,/B-_T2W_RX;?\ ^)H_X3#XC?\ 1+?_ "X;?_XFO0:*+KL'*^_Y'GW_ M F'Q&_Z);_Y<-O_ /$T?\)A\1O^B6_^7#;_ /Q->@T4778.5]_R//O^$P^( MW_1+?_+AM_\ XFC_ (3#XC?]$M_\N&W_ /B:]!HHNNP??\)A\1O^B6 M_P#EPV__ ,31_P )A\1O^B6_^7#;_P#Q->@T4778.5]_R//O^$P^(W_1+?\ MRX;?_P")H_X3#XC?]$M_\N&W_P#B:]!HHNNPA?V'KFKWSV@ MO-FE6@GVQERF2-P(Y7TQR.>:SO\ A;/_ %('CG_P3?\ V=5RLGF1Z#17GW_" MV?\ J0/'/_@F_P#LZ/\ A;/_ %('CG_P3?\ V='*PYXGH-%>??\ "V?^I \< M_P#@F_\ LZ/^%L_]2!XY_P#!-_\ 9T(_MJ-(+;3+FXC M42,J[UAZ=RJ-'<%B. -Q/7F;Q%HMQX>U"_ M^Q7L-Y!;Q27MS');E4MH'NGG"SD-\X,KE^ @\JWE4_>W5T/_ MG_J0/'/\ MX)O_ +.C_A;/_4@>.?\ P3?_ &='*PYXG2^#]:N/$'AB#4+L0F1Y9HQ+;@B* MX5)719D!)(1U4..3PPY(Y.Y7GW_"V?\ J0/'/_@F_P#LZ/\ A;/_ %('CG_P M3?\ V='*PYXGH-%>??\ "V?^I \<_P#@F_\ LZ/^%L_]2!XY_P#!-_\ 9T+K[5_B5X.\0VW@7QBMIH7V[[2DFD,) M'\Z$(NP!B#@CG)''K76_\+9_ZD#QS_X)O_LZ.5ASQ/0:*\^_X6S_ -2!XY_\ M$W_V='_"V?\ J0/'/_@F_P#LZ.5ASQ/0:*\^_P"%L_\ 4@>.?_!-_P#9T?\ M"V?^I \<_P#@F_\ LZ.5ASQ/0:*\^_X6S_U('CG_ ,$W_P!G1_PMG_J0/'/_ M ()O_LZ.5ASQ/0:*\^_X6S_U('CG_P $W_V='_"V?^I \<_^";_[.CE8<\3T M&BO/O^%L_P#4@>.?_!-_]G1_PMG_ *D#QS_X)O\ [.CE8<\3T&BO/O\ A;/_ M %('CG_P3?\ V='_ MG_J0/'/\ X)O_ +.CE8<\3T&BO-K_ .--GI=E)>:G MX+\96=K'C?/<:4(T3) &6+@#)('U->DTFFMQJ2>P4444AA1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% 'GW_-RG_@UY]_P W*?\ @U4B8]0HHHJ2@HHHH **HZWJL&@Z!J&KWB2/;Z?:R74JQ %V5%+$*"0,X M'&2*Y_4OB3HVE^ +;Q=/#>O97.P);Q1J9PQ)!4KNP"N&W?-QM;KB@#KJ**S= M(UVVUFXU2&U25&TN]-E,9 &<1I)E<$Y&)%ZX.0>* -*BBLS4]=MM*U+2;&X M29I=6N6MH#& 55EB>0ELD8&$/3/.* -.BJ.MZK!H.@:AJ]XDCV^GVLEU*L0! M=E12Q"@D#.!QDBK-M.MU:0W$8(25%=0W4 C/- $M%9NN:M-HUC]JATB]U15R M9$LVA#1J!DL?-D0$<=B3[56\+>)&\4Z5%J4>C:AIUI<0Q3VTEZT'^D)(NX%1 M'(Y'&,A@I^8>^ #;HHK-;7+9?%4>@%)?M4ED]Z'P-FQ75",YSG+CMC&>: -* MBBB@ HK-TC7+;6I=2CM4E0Z;>M93>8 -SJJL2N"*TJ "BBB@ HHH MH **** //OCI_P D6UW_ +=__2B.O0:\^^.G_)%M=_[=_P#THCKT&J^R2OB? M]=PHHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S[_ )N4 M_P"Y2_\ ;RO0:\^_YN4_[E+_ -O*]!JI$QZA1114E!1110!S_CZVGO/AMXEM M;.&2>XFTFZCBBB0L\C&%@%4#DDDX %>7^(/#6O3V^OZ2NEW4NFV-G/J.GE8& M8RW%TBAD3 ^\K&Z) YQ,/Q]PHH \B\;VU_'=^-[&+2-3NIM9CL9+%K6RDECD M" +(#(H*H5V$[6()&, D@&M=:(9/$VO&W\/Z@GB&?Q+!/INJ_89/+C@"V_F, M)\;438LH89^?.T;CP/5+[7+;3] MK/1M8DL=4EM_#T]F^H>$=1@N8;71;BW+796-EBD>5F>YER6 E/#Y.TD[JU/& M&F:I=ZINAT"3[99+IKVETFCSW%PR1M&\ACN=VR *=X,:KN;!Z[N/99]6LK;6 M+/2YIMM[>QRRP1;&.]8]N\YQ@8WKU(SGCO5R@"IJJ-)HUZD:EW:WD"JHR2=I MX%>;ZIH^L2? OPG8P6DH>V@T[^TK.2T>9C"D:B1'@5E>0!L%HP02%(P>A]3H MH \;M-#N8_#=I]NL;N]\-+X@:>ZTN/0Y+9/LWDE5$=D6DD,(N-K[" JXP/3['5K M+4KF^M[*;S9=/G^SW*[&'ER;%?;R.?E=3D9'-0Z-KEMKBWQM$E3[#>RV4GF@ M#+QG!(P3QSQT/M0!X]-X3O=9\/:E=:WH5U>:E'X"LUMGN;5GD6^6.V@LGG\^,VB+%)Y(4F6,2#L&P0#_ DB*WT2 M:'3O#?\ PE6B7M_X;A?4/(TUK*2[>U#R9LO,A568;8-Z#(_=E@#M-=Q:_$"Q MNFMK@:;J,>D7DZV]MK$B1BVF=FVI@;_,"LW"L4"G(P<$$ZFM^&=+\0M;MJ<4 M_FVV\136UU+;2(' #+OB96VG RN<' R.!0!XYIUC=Q^"?#,5A;S;/%EHVA7A M:3YT'G/('8YY*PF[YYY*]J]X1%CC5(U"(H 55& !Z"LRU\-:397%A+:VOE?V M=!]GM(EE?RH$QCY8\[ V.-V-V"1G!(K4H **** "BBB@#S[XZ?\ )%M=_P"W M?_THCKT&O/OCI_R1;7?^W?\ ]*(Z]!JOLDKXG_7<****DH**** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH \^_P";E/\ N4O_ &\KT&O/O^;E/^Y2 M_P#;RO0:J1,>H4445)04444 %%%% '(^*;*ZN/&_A6>WMII88/MOFR)&66/= M 0NXC@9/ SU-<)X7\ QC3O"%E-H4EFNI>&;NTUN3[*49G*V^Q9CC.X'?M#0*@7PZS^&+U'M[P::=7@GAMH?"LB62;8L/G3VE,SPL3R %Q)AP, M7KF MLZO!HFF/>W*22X9(XX8@"\TCL%2-#DH1QQD \SM= EDO/"U]=>&/(^S66JV<3PV$QV M@LIMFV.&>!2OF%4<_)O*C&<57TGX?6S66DQWOADE9?!8:\26T.'OE$87S 1S M,NZ0+N^9><8Q7KECKEMJ&N:II4*2K/I9B$S. %;S$WKM.*T9]#GU&>VO I\[9LD3[-.28B)'P"5'S#8:T->\(W=R M/%VHW&D7%]K$*::VG7CVFZ82HB;WA(SM;(^8H3T )( KTSQ+XEC\-Q:>6T^\ MU";4;P6=O;V?E[VD*._)D=% Q&W.?2LZ?X@6-CI6K76JZ;J.GW&D0I/*>ZUZYDA9=(NGB='<;6\U8R@4^ MI; ZFN^K-UC7+;1&T\722O\ VA>I91>6 =KN"06R1Q\IZ9/M0!S'BN^V^)_" M&L)9:G-96=Y=BX:#3;B5X_W$D8)C5"^"W .,$$$$@@UT/]I6VOZ6UM:K?P_; MH)D1KC3YX"F %);S$78?F& V-W)&<'%J^U,V5Y9VRV%Y=&Z,@#V\89(MJ%OG M8D!=V-H)ZD@<4[2=4M]9TJWU"R+>3.N0'&&0YP58=F!!!'8@T 87.TQE-JEE )8Y5< YQV\%RESYGEK*/ M*D,;>9$R9(]-P&X?[0R#V-2T4 %%%% !1110 4444 >??'3_ )(MKO\ V[_^ ME$=>@UY]\=/^2+:[_P!N_P#Z41UZ#5?9)7Q/^NX4445)04444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110!Y]_S5Z#7F6IZQINB_M%K< M:SJ-II\#>%!&LMW.L2EC=D[06(&< G'L:ZW_ (3_ ,'?]#9H?_@RA_\ BJMI MZ$1:U.@HKG_^$_\ !W_0V:'_ .#*'_XJC_A/_!W_ $-FA_\ @RA_^*J;,KF1 MT%%<_P#\)_X._P"ALT/_ ,&4/_Q5'_"?^#O^ALT/_P &4/\ \519AS(Z"BN? M_P"$_P#!W_0V:'_X,H?_ (JC_A/_ =_T-FA_P#@RA_^*HLPYD=!17/_ /"? M^#O^ALT/_P &4/\ \51_PG_@[_H;-#_\&4/_ ,519AS(K>,]RZAX4E<@6T>N M)Y^>GS03)'G_ +:M&/J17*ZIX=\5^(;?Q%K>FW%K8S3W*O86M[IDAN,6;DP8 M?S5V*[JSC*'B4YR#BNIU'Q=X$U;3YK&_\4:');S##*-4C0C!R"&5P5((!!!! M! (((JU_PG_@[_H;-#_\&4/_ ,519AS(\PURQ;7-4\27_P#PBVK)K>J6]B^@ MW@?\)_X._P"ALT/_ ,&4/_Q5'_"?^#O^ALT/ M_P &4/\ \519AS(S?B&989O"EZMI>7,-EKJ3W'V.TDN'CC^S3KN*1JS8RRC. M.XKE_&=I?>++#Q5JNF:5J M_[%33K59;.6&>ZD,OF/MB91)M4;0"0,DMCIFN MZ_X3_P '?]#9H?\ X,H?_BJ/^$_\'?\ 0V:'_P"#*'_XJBS#F1PVKZ%-H<_C M2TT+PX6TJZ@TPI:Q6LI@D9I)%N'$<14RD($+HIRX !SGG BT*Y31[FWO?#UY M/I"^*;:[^QV>C2VT;6IM1YC);?,1'G=NCY)R01N;;7K'_"?^#O\ H;-#_P#! ME#_\51_PG_@[_H;-#_\ !E#_ /%4680^*M#N+'2[NTT-=U>$6ENUGLYC8 PJTWF%5(7[XX&<5V/@/YM-U66/_CWEUJ^># P"OGL&(]07 M#G/?.:FD\>>#)8FC;Q;HH#*5)75(E//H0V0?<5%9>,O NG6$%E9>)]!AM[=! M'%&NI1850, ?>HLPYD=/17/_ /"?^#O^ALT/_P &4/\ \51_PG_@[_H;-#_\ M&4/_ ,519AS(Z"BN?_X3_P '?]#9H?\ X,H?_BJ/^$_\'?\ 0V:'_P"#*'_X MJBS#F1T%%<__ ,)_X._Z&S0__!E#_P#%4?\ "?\ @[_H;-#_ /!E#_\ %468 M3?&;Q?X:U3X1ZU9Z9XATJ\NI/(V06]['([XGC)PH8 MDX )^@KUFF_A1*=Y/^NX4445)84444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110!EZGX8T#6KE;C6=#TW4)U01K+=VDA_ M^"V'_P")KH**+L.5'/\ _" >#O\ H4]#_P#!;#_\31_P@'@[_H4]#_\ !;#_ M /$UT%%%V'*CG_\ A /!W_0IZ'_X+8?_ (FC_A /!W_0IZ'_ ."V'_XFN@HH MNPY4<_\ \(!X._Z%/0__ 6P_P#Q-'_" >#O^A3T/_P6P_\ Q-=!11=ARHY_ M_A /!W_0IZ'_ ."V'_XFC_A /!W_ $*>A_\ @MA_^)KH**+L.5'/_P#" >#O M^A3T/_P6P_\ Q-'_ @'@[_H4]#_ /!;#_\ $UT%%%V'*CQ_Q?X2\.6WQG^' M5C;>']+AM+S^T_M-O'91K'/LMU*[U PV#R,]#7H'_" >#O\ H4]#_P#!;#_\ M37+>-O\ DNWPP_[BW_I,M>DT78#O\ H4]# M_P#!;#_\3704478?^/O!/A6S^&WB6ZL_#.CP7$.DW4D4L5A$KQL(6(92%R"",@B MCP#X)\*WGPV\-75YX9T>>XFTFUDEEEL(F>1C"I+,2N223DDUN?$?_DEGBO\ M[ MY_P"B'H^''_)+/"G_ &!;/_T0E%V'*B3_ (0#P=_T*>A_^"V'_P")H_X0 M#P=_T*>A_P#@MA_^)KH**+L.5'/_ /" >#O^A3T/_P %L/\ \31_P@'@[_H4 M]#_\%L/_ ,3704478A_P#@MA_^)KH***5PLD%%%% PHHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH \V\;?\ )=OAA_W%O_29:])KS;QM_P EV^&'_<6_])EK MTF@ HHHH **** "BBB@#F_B/_P DL\5_]@6\_P#1#T?#C_DEGA3_ + MG_Z( M2CXC_P#)+/%?_8%O/_1#T?#C_DEGA3_L"V?_ *(2@#I**** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@#S;QM_R7;X8?]Q;_P!)EKTFO-O&W_)=OAA_ MW%O_ $F6O2: "BBB@ HHHH **** .;^(_P#R2SQ7_P!@6\_]$/1\./\ DEGA M3_L"V?\ Z(2CXC_\DL\5_P#8%O/_ $0]'PX_Y)9X4_[ MG_Z(2@#I**** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@#S;QM_P EV^&'_<6_])EKTFO- MO&W_ "7;X8?]Q;_TF6O2: "BBB@ HHHH **** .;^(__ "2SQ7_V!;S_ -$/ M1\./^26>%/\ L"V?_HA*V-8TN#7-"O\ 2;TN+:_MI+:4QG#!'4J<'L<$UY]; M?!*"SM8K6S^('CR"WA01Q11:T%2-0,!5 CP , "@#TVBO-O^%-_]5'^('_@ M\_\ L*/^%-_]5'^('_@\_P#L* /2:*\V_P"%-_\ 51_B!_X//_L*/^%-_P#5 M1_B!_P"#S_["@#TFBO-O^%-_]5'^('_@\_\ L*/^%-_]5'^('_@\_P#L* /2 M:*\V_P"%-_\ 51_B!_X//_L*/^%-_P#51_B!_P"#S_["@#TFBO-O^%-_]5'^ M('_@\_\ L*/^%-_]5'^('_@\_P#L* /2:*\V_P"%-_\ 51_B!_X//_L*/^%- M_P#51_B!_P"#S_["@#TFBO-O^%-_]5'^('_@\_\ L*/^%-_]5'^('_@\_P#L M* /2:*\V_P"%-_\ 51_B!_X//_L*/^%-_P#51_B!_P"#S_["@#TFBO-O^%-_ M]5'^('_@\_\ L*/^%-_]5'^('_@\_P#L* /2:*\V_P"%-_\ 51_B!_X//_L* M/^%-_P#51_B!_P"#S_["@#TFBO-O^%-_]5'^('_@\_\ L*/^%-_]5'^('_@\ M_P#L* /2:*\V_P"%-_\ 51_B!_X//_L*/^%-_P#51_B!_P"#S_["@#TFBO-O M^%-_]5'^('_@\_\ L*/^%-_]5'^('_@\_P#L* /2:*\V_P"%-_\ 51_B!_X/ M/_L*/^%-_P#51_B!_P"#S_["@#TFBO-O^%-_]5'^('_@\_\ L*/^%-_]5'^( M'_@\_P#L* /2:*\V_P"%-_\ 51_B!_X//_L*/^%-_P#51_B!_P"#S_["@#TF MBO-O^%-_]5'^('_@\_\ L*/^%-_]5'^('_@\_P#L* /2:*\V_P"%-_\ 51_B M!_X//_L*R_$_PUN?#?A'6-)68X &23P!BMN@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@"O?1WL5B-X0T1M!71Q:/'9I<-=1B*XECDBE:1I&=)58.I+.W(8<,1T.* / M/--O]1\0BST>_P!6U"&"SLM6D2YMKMX99WMKL6\+NZD%]J')!)#,-S($.V-6^;"E:[^\\$>'[[2K+3 MIK%EMK%&C@$-S+$P1AAU+HP9E;^(,2&/+9-:E>&[>2#1K8P1R,"P:5Y" %"JH+DE550 JC"J.@%:E M!1110!YMXV_Y+M\,/^XM_P"DRUZ37FWC;_DNWPP_[BW_ *3+7I- !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %5[^:XM]/FELK7[9<*N8X/,";SZ;CP![_ ,^E M6*#R* .%TWQ7K.M:;X9@A-G::CK%O-4TD<2QX!"KN!.6=1DGIFL^V\?: MUJVE:A>V"V4#:)8&YO8Y(V<7$BM(&13N&P8A;!.3\P].>@A\%O8Z9HT>F:EY M-[HZ21PW,D&]71_O*R;AZ*>",%1[BJG_ KE(+%[/3M5EMX;RS%GJ!:$.URF MYF+*<@(Y\QQG!&&Z<4 48OB)=?VI=B06I@*R>3 1M>WP(_*>1L_=DWLW08"D MC.#7::+JMKK&EQ75G=QW:XV/+&I4%P.?E/*^N#V(JIJ_ABTUFV:UNG9;7[') M:I$@ V;UV%P?4*2!Z9/K4GA[1'T6UN!<77VNZNIS//,(_+#-M51A?^B'KI*YSXBJ6^%WBI5!+'1KL =?W+T ) M\./^26>%/^P+9_\ HA*Z2N<^'2E?A=X55@0PT:T!!'3]RE='0 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110!X]!X%\.>-?C3X\_P"$FT[[;]C_ +.\C]_)'LWV_P WW&&< M[5Z^E=!_PHOX<_\ 0N_^3UQ_\@T4QY]_PHOX M<_\ 0N_^3UQ_\N/_CE=[/<(L+!L!2')VD'(QSSD4QQG_"B_AS_P!"[_Y/7'_QRC_A1?PY_P"A=_\ )ZX_^.5Z#4-O>6UV\Z6M MQ%,UO)Y4PC<,8GP&VMCH<,IP><$>M'-+N')'L<)_PHOX<_\ 0N_^3UQ_\N/_CE>@U#->6UM-!#<7$,4MRYC@21PK2L%+%5!ZG )P.P M)HYI=PY(]CA/^%%_#G_H7?\ R>N/_CE'_"B_AS_T+O\ Y/7'_P %#)++*X5(U R68G@ 9)-/1UDC5XV#HP!5E.01ZBCFEW#DCV//_ M /A17PY_Z%W_ ,GKC_XY1_PHOX<_]"[_ .3UQ_\ '*[+5M>TC08$FUW5;+38 MI&V))>7"0JS8S@%B,G%,TCQ'H?B#SO[!UG3]3\C;YOV*Z2;R]V<;MI.,X.,^ MAHYI=PY(]CD/^%%_#G_H7?\ R>N/_CE'_"B_AS_T+O\ Y/7'_P 6P MOA9&XB%TT9E$&\;R@(!;;UQD@9Z9(HYI=PY(]CA/^%%_#G_H7?\ R>N/_CE' M_"B_AS_T+O\ Y/7'_P \MKMIEM;B*>14U'-+N' M)'L>??\ "B_AS_T+O_D]$_! MVI>#=0\.:5]CNI/%%C \GVF63*$LQ&'8CJHYZ\5[37GWQ9_YDG_L;;#_ -GK MT&AMM*XHI)NP4445)84444 %%%% !1110 4444 %%%% !1110 5YM\:;"VU3 M3?">GW\?FVMWXHLX)H]Q7>C"16&1@C()Y'->DUY]\6?^9)_[&VP_]GJH[D3^ M$/\ A1?PY_Z%W_R>N/\ XY1_PHOX<_\ 0N_^3UQ_\@T4QY]_PHOX<_\ 0N_^3UQ_ M\N/_CE=Q:ZE8WTUS#97MON/_CE'_"B_AS_ -"[_P"3UQ_\7:6V#!.6V@G'7 S5^6\MH+B"WGN(HYKDE8(WN/\ XY1_PHOX<_\ 0N_^3UQ_\N/_CE'_"B_AS_T M+O\ Y/7'_P X@"M-"K@O&&SM++U&<'&>N#4U'-+N')'L>??\ M"B_AS_T+O_D]?>#_\ DM/Q&_[AG_I.U>@U4MR8[??^84445)04444 9#'+%*@9)%(P58'@@@X(-4!8Z#J4U\BVNG7,M7/Q!T];6^OY=,N]=GTMXIH+6.VQ''(&$8 M!-P65X^78A22< @5G6^K7VK:QX"UW5]9:0WFK7KMIIBB"VGEP7"[4VJ')08 M5MQ;+=-O0^HCPUH2ZE)J*Z+IPOI)%E>Y%HGF,Z_=8MC)(R<'J*5/#>AQ:JVJ M1Z-IZ:@\GFM=K:H)6?:5W%\9SAF&<]"1WH \;O?&&LZIH&MVM[>WUU8:KX,U M#48_MT%K%T10CQ)"6=(RLC "5F;CKP,G@FO1X/"'AJUCD2V\/:5"DJR+(L=E&H<2 "0'"\A M@JAO4 9Z4^Y\+>'[R[^U7FA:;<7'E"'SI;.-G\L=$W$9V^W2@"SK'_("O_\ MKVD_]!->=+KNHZ%\#?!#:.)1/>VVF69DA6(R1J\2@E/-(CW' 4;SMRPSGH?4 M'19(V210Z,"&5AD$>AJJ^DZ=+I TJ6PM7TX1"$6;0J8?+ P$V8QM &,8XH M\YM?$WB:>WL]'O+N:PEN=??33J4C6DMW%$+7@K]T@[02#5>^ MCU*X\>HEEXM:2\LO#]\'U&TMX"[-'6MN3]HTBV$$B1X?)W0KD##\\C[WO6O;:'I-FL:VFEV<"Q0&VC$5N MBA(BVA99+AXYG8 M,9$8[#L P"#P,$2!-*LEADM5LWC%L@5K=00L)&.4 9@%Z#)XYI)] T>ZO M[6^N=)L9KNR %K<26R-) !T",1E?PH \VT_4=0B\2:AH^GWSZ8NK>+;J*6^B M1&>,)9QR!$\Q636P 7:A6/@UY]\6?^9)_[&VP_]GKT M&J>R)7Q,****DH**** "BBB@ HHHH **** "BBB@ HHHH *\^^+/_,D_]C;8 M?^SUZ#7GWQ9_YDG_ +&VP_\ 9ZJ.Y,_A/0:***DH**** "BH5O+9[Z2S2XA: MZCC61X X+JC$A6*]0"58 ]\'TJ:@ HHHH \.EU*X\,ZYXDN; ;9_$>H76DP, M,G%X'06YQTZ32DGT0>E:5O86^E?L\^-=/LDV6UH^M01+_=19IE _("O4SI&F ML5+:?:DKUC<636%L;2Z,AG@,*^7*9"2Y9<8 M;<22<])_^0E\//^PL/_2*>K7BG_DHG@;_ *^KS_TDDKJ9;&TG:W:: MUAD:U??;EXP3"VTKN7^Z=I(R.Q(I9;.VGN(+B>WBDFMB6@D= 6B)&TE2>1D$ M@X[&@#Q[2M=\2ZCX8T%]3\0W5V?$GAZ]GG3[-;H()(TC*M'MCSDAF!#%@D7.I%(O"D6I>?:K8AV/4]>N+Q!X>@U*.:2RA9[>=Y)$*QH M@C#*3LP'8X(Y;&:]&ETK3YVNS/86TAOHA!=%X5/VB,!@$?(^9<,PP2ABX;#KCG[NXD96MZQUG5)==?1+6^&F+?^)+V"2_ MMK6 2@10*ZJ,H4+L'=$N[":QNM'T^>TGE\Z6WDM4:.1^/G92,%N!R>>!0!Y MYI'B'Q)XDU+P[IO]NRV N+;4Q<7=I;0EKHVUQ'%'*HD1E7<"6( Q\QQC@C-O MO'VO7W@#2KZTU&^M]3/AQM4N6L;>T$:OC:LLSW!.(]P.4B0MU]@?78M+L()+ M9X;&VC>TA,%NR0J##&<91#CY5^5>!Q\H]*IR>%?#TR6:S:#IDBV"[+0-9QD6 MR^D?'R#@=,4 *:)PZ2*1D,&'!!'<56U;7-)T&V2XUS4[/38'?8DMY<)"K-@G M:"Q )P"<>U %ZBH[>XAN[:*XM94F@F0/'+&P974C(8$<$$??";_F=O^QMO_P#V2O0:J6Y,/A"BBBI*"BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@#S[P?\ \EI^(W_<,_\ 2=J]!KS[ MP?\ \EI^(W_<,_\ 2=J]!JI;DQV^_P#,****DH**** "O(Y-0U.RUW7H-'OV MT^2_\9V]G+.D22,(GLHMVT." W P2#@@9!&0?7*IG1]-,K2G3K0R-<"Z9S N M3,%VB0G'WPH W=<#% 'G<'C'5-#@-_KFK27.E:5KMUI=_/+#$K/$4!AE;8J@ M,LA1/E"@A\D$@54U+Q'XT@NK#29);^.]&AOJMP]DEB"LK2GY)#<%%\J(84[! MO.5)8=3Z>^D:;);7%N^GVK0W,OG3Q&!2LLF0=[#&&;*@Y// ]*CU;P_HVOQQ MQZ[I-CJ:1$M&MY;),$)ZD!@<4 >=W?BWQ$MQ::M=WC6^G):Z?+=1Z0UI>0VS MRE3*MPK-YQ!##8\+$;<-AL?-1L)=9TJ:]M].URZA;4_&[VHWGA[1=0U2WU*_TBPNK^UQY%U/;(\L6#D;7(RN"21@]: M9-I>@VU\MU<6.G17=U-O%>HMI^HW?VA M+;5$O?,CN7L4@@,:R,@MU5_/=D*!'#@]6)"XQ7H*7GA'^W%T6.XT3^U8KEKM M;!7B\])V4LTHC^\'*NQ+8R0Q.>:N0^'-$MM3N=1M]&T^*^NU9+BZCM466920 M2'<#+ D#()["@#R6ZUCQ%?>"E@U+7KF]&O>"+G5)%^SP)Y,JQQ';'MC'RL)6 M4AMQ[@K7::Q%J$/P)NX]/GN;B]70CLE4 3-^YYV[ !NQG&!G..]=6FC:7&L* MQZ;:*+>W-K"%@4>7"< Q+QPAVK\HXX'I4UG96NG6<5II]M#:VT*[8X8(PB(/ M0*. * .>1_"2P>%3:B (S8T,6F[@&%L[=G5/+SG/R_=)Y -^>73V@C"Z>T2,R^654-\A41OO+99A]WH?0=/\-:%I.H37^E:+IU ME>7 (FN+:T2.20$Y.YE )R1GGO3X- T>UO[J^MM)L8;N]!%U<1VR+).#U#L! MEOQH \NTW6O%M_9Z;YGBRZ1M0\*#7'=+*UW13 )\B9C(V'S,G<&/R\%%;/6EMEMX6629UE9PQ=2WEG:H(!!Y7#+SGTVSL-$EC4V M%KI[I;Q-IZF&-"(HU.UH..B@J 4Z KTXK(3P!HQ\63:S=65CSM)+) M"MF8#(5>,G.W_6 # &-O7T .-\4^.M;MKMKO3KC4(/L4FG) M.1I"9W(HM6O+_^VYC;6WBRWT=-/^SP^4T$C0J2S;-^ MX>:2"&'09!KO[SPUH6HW[7VH:+IUU=M'Y37$]HCR%/[NXC./:ISH^FL'#:=: M$/(]6U'QZ.JOY2*94 M++]DR,?+OCD#_+CF,CD9%=[6-HV@G3M6U75+N:&XOM3D3?)%!Y06*,%8TP68 MD@%B3GDL< # &S0 4444 %%%% 'GWQ9_YDG_ +&VP_\ 9Z]!KS[XL_\ ,D_] MC;8?^SUZ#5/9$KXF%%%%24%%%% !1110 4444 %%%% !1110 4444 %>??%G M_F2?^QML/_9Z]!KS[XL_\R3_ -C;8?\ L]5'POI M9;BW@$DEK)N^T(?+C485$9P0 V1C)%>@W.CZ;>23O=Z=:3O<1K%,TL"L944E ME5LCD DD ]"33SIUDTMS(UG;F2[01W#F)(-1NFMCIZ6OG);1)^Z6,SXC/F!?-);Z72)=/GN28I2B321NYC9,*=ZQ."')4$=!Z;>:'I.HZ6FF:AI=E= M6"!0EI/;H\2A?NX0C QVXXJO>^%/#NI6-K9:CH.F7=K9KMMH)[.-XX!@#"*1 MA1@ <>E 'EU]K&HV6I^-?$FA:Q-OFT_1Y;8RVR>7B5R VPJ&P!N !;/SMDY M*W=2UKQ1HUQXC8>)[JZAT#4=/CA2:TM@;E)S!YB3%8QD .VTH$(REW6 MA:1>WZ597%Q)$(7FEMT=VC#;PA)&2H8!L=,C-/ETC3;C[1Y^G6LOVIT> MXWP*?.9,;"V1\Q7:N">F!CI0!YJ?&'BB;Q?=O MPMG:Z^FEFWD>QBLS$2JG< MSN+@S$/O4*,'Y0%;.2:1XA\23W&BW=UK]Q)%JNO7^E/;"V@5(HH_M/ENI$>[ M>ODKR201U4]3WD]EX7.J7&OW-MI!O],!6XU&2.+S;0"/<0TIY3"/GDCY6ST- M2^1X?MX+"01:;%$]SYMDVV-5:>0,=T9_OL&8I*4,RH-A\Q@%^51QD=\GD\U0\*/X<3X/:"VM@<26_V@?-YW]I^:N[[GSF M7S\Y ^8\YXS7?66G66F1/%IMG;VDJJ^&M"77/[ M:71=.&JY)^WBT3S\E=I_>8W?=XZ].* .'D\4:Y_:TFHKJ16*+Q1'HG]C^3&4 M:%BJERVWS/,P_G9W;=H V]36?INN>*=3OM$#>)KB%-8UC4M/=$M+H:Z8RLAR2#^S[;3W?3[F0CR(T)MIW!,G3[CD2'=T)WG/6@#S?2/$OB+7;WPQ MILOB233OMD.K+A56V@EL+C&[@<%:NJ>/=>N_!EG=6>H M7MOJ*:)/J$SZ?;VBPG:Q2.>5[ACB)BN[9$K-@]>@/=:E\/\ 1=4U[3KNZL;" M33[*WN8CILEDCQ2--)'(9,'@$-&3T.2Q.?71FTWPSK=M:ZG<6>DZA!:HQMKM MXHI5A4?>V.00H^7G![>U 'G>M^+?$LUIXCU2QUF2P31] LM4AM(;>%XY)94E M9E&K^VG@L+;2KF">UABFCACC=9+?:?*5@.#'M8[0>,$XZTD&@8\ M72Z[=RPRNEK]DLXXX-A@B)#.&8L=Y+*O("@ 8P>20#'\6_\ (_\ @/\ ["-U M_P"D,]=3J/\ R"[K_KB__H)J#5M!TC7H$AUW2K+4HHVWI'>6Z3*K8QD!@<'% M,LO#FB:;%%'IVCZ?:1PAQ$L%JB",/C> .-V!G'7 S0!D?##_DD_A;_L$VW_ M *+6JT1B_P"%TW?]H@>;_8L/]EE\=/-E^T;,_P 7^HW8[;<]JU;/P/X3TZ9I M=/\ #&C6LCQM$SP:?$A9&&&4D+T(X([U??";_F=O^QMO_\ V2O0:J6Y,/A"BBBI*"BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@#S[P?_ ,EI^(W_ '#/_2=J]!KS[P?_ ,EI M^(W_ '#/_2=J]!JI;DQV^_\ ,****DH**** "BBB@ HHHH *Y6],MS\3((1G M_0M'EGME)^4RR2!"WU"ICV#GUKJJS+[1Q1=_:?FKN^Y\YE\_.0/F/.>,U3 MU3QEJ\/CJV%C>WSZ>?$$>DR1R0VL=HP,8WHN2;AY 3NW?*G!XP/F] 7PUH2Z MY_;2Z+IPU7)/V\6B>?DKM/[S&[[O'7IQ2/X9T&35)-3DT33FOY&1GNVM(S*S M(5*$OC)*E5(YX*C'04 <+;>+=4<@D,&?Y1AQSGT?2 MO#B6EYK%[J+V][=:O(OV@K;>6AB1-B1E2S9 7.23R6;@# %_^Q],VX_LZTP; M;[)CR%_U'_/+I]S_ &>GM0!Y7XP^(&M6NGRZEI5W>Q-8:;8WEQ%!!:K:1O.Q M.R9YB97W ;5$2C&1EB3\MS6?$?B*UU+Q+J$&MRI;:-KEA9PV MX3')%-]F$@ M=BA?_ELQ!# @^HP!WUUX4\/7UQ'/?:#IES-%;FVCDFLXW9(<$>6"1PF&8;>F M&/K5E]&TN1)TDTVT9;F5)IU:!2)73;L=N.678F">1M&.@H Q-)C_ -3OYY_M%UJ$X=G";0D:C;'&! MD\*,DGNS,<#.!IT %%%% !1110 4444 %%%% 'GWQ9_YDG_L;;#_ -GKT&O/ MOBS_ ,R3_P!C;8?^SUZ#5/9$KXF%%%%24%%%% !1110 4444 %%%% !1110 M4444 %>??%G_ )DG_L;;#_V>O0:\^^+/_,D_]C;8?^SU4=R9_">@T445)044 M44 %%%% !1110 4$X4D#/L.]%% 'DT-]-=?#3PEI\%C&[;0S+Y8AEVR2BTD,($EO!(PD,._))4/DCH -HQ M\N38OO#^C:H\KZGI%A>-,JK(UQ;)(7"A@H.0<@!WQZ;F]30!PFF^*=;C\5:9 MH]UJ1NK:/Q#=Z;+=R0QJUY$MDTR!MJA0RR':2@7)CQCJ*Z7X?:U=Z_X6>^O[ MD7,G]H7L22*J@&-+F1$ V@ X55&>_6M.3PQH$VBQZ/+H>FOI<1W1V+6D9@0Y M)R(\;1R2>G0/G%QYR;=GOC=G_9W9XS3K6]U71M:UC4K#5)$MY?&T-C-8&& M,Q2I,((V8L5WAAO!&U@/EY!R:]$TWP9X7T:^6\TCPWI%A=("%GM;&*)U!&#A ME4'D5>.CZ:P<-IUH0]RMVP,"_-.I!64\I/J$>B:HKY:QVMF+*QMHH@B6L9(+XP@ HHHH **** "BBB M@ HHHH \^^$W_,[?]C;?_P#LE>@UY]\)O^9V_P"QMO\ _P!DKT&JEN3#X0HH MHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \^U'X?>(_\ A--9 M\0>&?&O]B_VOY'GP?V5' .O?%'_ A_Q&_Z*E_Y;UO_ /%5 MZ#15??\(?\1O\ HJ7_ );UO_\ %4?\(?\ $;_HJ7_EO6__ ,57H-%' M,PY5_39Y]_PA_P 1O^BI?^6];_\ Q5'_ A_Q&_Z*E_Y;UO_ /%5Z#11S,.5 M?TV>??\ "'_$;_HJ7_EO6_\ \51_PA_Q&_Z*E_Y;UO\ _%5H>-_&$^@ZCI^F M6$T-M<74,UR\\VGSWVV.+8"HAA(=B3(#NSA51B>U5?$/C^YTO3/#W]G16=[> MZG)9/M__BJ/^$/^(W_14O\ RWK?_P"*KK?$FIWND:!;^XB0E8C*L:K@$[ MG).=HQSM!;T!KE]2\2>(_P#A7FE>)--NM,AGN[&W?[%+ITDYGN9@H2-")TV@ MNX'(;'4GBCF8M__ (JC_A#_ (C?]%2_\MZW_P#B MJ34O'VH^'_%5KINM-IYCCMXVO(X(9/-?]Q+))<1 L?W0>(1[=K'+@;LX4]7X M8U@:WHJW$EW87%TCM'=)8RB1+>3.?)8AC\Z@J#TR>< $"CF8_E>7L_7=GVQWKI/^$/^(W_14O\ RWK?_P"* MJO\ \W3?]R9_[>UZ31S,.5?TV>??\(?\1O\ HJ7_ );UO_\ %4?\(?\ $;_H MJ7_EO6__ ,57H-%',PY5_39Y]_PA_P 1O^BI?^6];_\ Q5'_ A_Q&_Z*E_Y M;UO_ /%5Z#11S,.5?TV>??\ "'_$;_HJ7_EO6_\ \51_PA_Q&_Z*E_Y;UO\ M_%5Z#11S,.5?TV>??\(?\1O^BI?^6];_ /Q5'_"'_$;_ **E_P"6];__ !5> M@U'-M_\ XJNX_M*Q_P"?RW_[^K_C3?[6T[_H(6O_ '^7_&CF8+-4U+2)O$?C_^T[72]1AU!+;^ MQHH=[QG(&Y&!&02.XYZ5Z35(ZUI8.#J5F#[SK_C2?VWI7_03L_\ P(7_ !I- MMC44MB]15'^V]*_Z"=G_ .!"_P"-(==TA?O:I9#ZW"?XTAE^BL_^W]'_ .@M M8_\ @2G^-']OZ/\ ]!:Q_P# E/\ &@#0HK//B#1@,G5[$#WN4_QIO_"2:'_T M&=/_ / I/\: -*BLW_A)-#_Z#.G_ /@4G^-(?$NA 9.M:>![W2?XT :=%9?_ M E&@?\ 0'0<'7]+_ / R/_&@#6HK(_X2SPY_T']+_P# V/\ QH_X2SPY_P!! M_2__ -C_P : ->N7\>>$+GQCING0V&K?V3=:=J,6H0W/V83X>,,%&TL!U8' MG(XZ)-('UOXO_BJ?,QM_P#XJC_A#_B-_P!%2_\ +>M__BJZ M4^-_"BC+>)]&'UU"+_XJD_X3GPE_T-&B_P#@PB_^*HYF'*OZ;.;_ .$/^(W_ M $5+_P MZW_^*H_X0_XC?]%2_P#+>M__ (JND_X3GPE_T-&B_P#@PB_^*I#X M[\(@9/BG10/?48O_ (JCF8M__ (JNA_X3[P?_ M -#9H?\ X,H?_BJ;_P +"\%_]#?H/_@SA_\ BJ.9ARK^FS _X0_XC?\ 14O_ M "WK?_XJLWQ'HWQ&\/\ A75=9_X67]H_LZRFN_)_L&W3S/+0OMW9.,XQG!KL M?^%A>"_^AOT'_P &,"CF8M__BJW/ANP;X5^%"I!']C6@X/_ $Q2NEHY MF'*OZ;//O^$/^(W_ $5+_P MZW_^*H_X0_XC?]%2_P#+>M__ (JO0:*.9ARK M^FSS[_A#_B-_T5+_ ,MZW_\ BJ/^$/\ B-_T5+_RWK?_ .*KT&BCF8M_\ XJC_ (0_XC?]%2_\MZW_ /BJ]!HHYF'*OZ;//O\ MA#_B-_T5+_RWK?\ ^*H_X0_XC?\ 14O_ "WK?_XJO0:*.9ARK^FSS[_A#_B- M_P!%2_\ +>M__BJ/^$/^(W_14O\ RWK?_P"*KT&BCF8M__ (JC_A#_ (C?]%2_\MZW_P#BJ]!HHYF'*OZ;.7\!^$+GP=INHPW^ MK?VM=:CJ,NH37/V809>0*&&T,1U4GC YZ<5U%%%)NXTK*R"BBBD,**** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BO'O"_A>\\:ZEXKO+_ ,9>*[+[ M'XBO+.&"PU0QQ)&A4J I!QC<1QQ@#BN@_P"%3?\ 4_\ CG_P<_\ V%59+J0I M-[(]!HKS[_A4W_4_^.?_ <__84?\*F_ZG_QS_X.?_L*++N.\NQZ#17GW_"I MO^I_\<_^#G_["C_A4W_4_P#CG_P<_P#V%%EW"\NQT/B#P[>:AJ=IJVAZE%IF MJ6L$MLLT]J;B-HI=I8% Z_!_0Y]$LK&RN=0M)+4649G2^ MN!YL=LZLH9$D5-Q"D!@,J6W#D4W_ (5-_P!3_P".?_!S_P#84?\ "IO^I_\ M'/\ X.?_ +"BR[A>78[.YL9[S3;^SGN(]MPCQPLD1!C1DV_-ECO.@T5Y]_P MJ;_J?_'/_@Y_^PH_X5-_U/\ XY_\'/\ ]A19=PO+L5_^;IO^Y,_]O:])KS7_ M (4I9?VM_:?_ F?C#[=Y'V?[5_:B^=Y6[=LW[,[<\[>F>:L_P#"IO\ J?\ MQS_X.?\ ["BR[A>78]!HKS[_ (5-_P!3_P".?_!S_P#84?\ "IO^I_\ '/\ MX.?_ +"BR[A>78]!HKS[_A4W_4_^.?\ P<__ &%'_"IO^I_\<_\ @Y_^PHLN MX7EV/0:*\^_X5-_U/_CG_P '/_V%'_"IO^I_\<_^#G_["BR[A>78]!KR;XIZ M%IOB7XN?#?2=,O%= M[]L\16=G-!?ZH9(GC_QH_X4O\ #O\ MZ%2Q_P#'O\:[FB@#AQ\&/AV#D>%+'\0W^-+_ ,*:^'G_ $*>G_\ ?)_QKMZ* M .(_X4U\//\ H4]/_P"^3_C2CX-_#P'(\)Z?^*'_ !KMJ* .+_X4]\/?^A2T MW_OU_P#7H_X4]\/?^A2TW_OU_P#7KM** .+_ .%/?#W_ *%+3?\ OU_]>G#X M0_#\#_D4M+_[\UV5% '&_P#"HOA__P!"EI?_ 'X%'_"HOA__ -"EI?\ WX%= ME10!QX^$G@ # \(Z5^-N*/\ A4O@#_H4=)_\!EKL** ./_X5+X _Z%'2?_ 9 M:$-(_&U4UUU% ')?\*I\!?]"AH__@(G^%'_ JGP%_T*&C_ /@( MG^%=;10!R0^%?@)3QX0T;\;-#_2G?\*M\!_]"?HO_@%'_A75USOC,:;'I4=W MK5_J=O;0/\EMIMU)!+=RL,)&OE%9'8\A45L$GD' ( *W_"K? ?\ T)^B_P#@ M%'_A0/A=X$!R/!^B_C8Q_P"%X@- M(R$"78$ *G*,68D'BN@\5ZSJ5)H9E9R9Y)(4U2WFL9S>M?Q+]JEEN<%)UDDD7?#AB1& M'C=55MK!5&5Y!/74 !O^A.T'_P6P_\ MQ-=/10!#9V=MI]G%:6%O';6T*A(H8D"HBCH !P![5-110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110!Y]\)O^9V_[&V__ /9*]!KS[X3?\SM_V-M__P"R5Z#52W)A\(44 M45)045GZQKNG:#:I/J<[1B601Q111/++,Y_A2- 7G- &]15>^O[32[":]U&YB MM;6!"\LTSA511W)/2LW1_%VC:Y>M9V4UQ'=B(3"WO+.:UD>/.-Z+*BEU!X)4 M$#(SU% &U17,Z5\0_#FM/9"QN;L)J!VVD]SIMS;PW#;2P5))(U1B0I( .3@X MK6;7M,3Q(F@-=*-4>V^UK;[3DQ;MN[.,=0>,Y."<8!H T**IV.K66I7-];V4 MWFRZ?/\ 9[E=C#RY-BOMY'/RNIR,CFLB/QWHDU_-:6PU2XD@N6M97M]&NY8E ME5MK+YBQ%.#U.<4 ='16!JGC;0=&OI[2]NY3+:H)+K[/:33K:(1D-,\:,L0P M"G-7UUW39-3M-/BNTDN;VV:[MQ&"RRPJ5!<,!MQ^\3OSGB@#0HK"O/ M&WA[3_/-[J2P"VOX]-F9XW"I<2*K*A.,8(=3N^Z,\D8-6=3\2:5H\ERFHW7D MM:V,FH3#RW;;;Q_??@'./0<^@H U**PM+\9Z+J]]#9VTEY#<7"&2!+W3[BT\ M]0 3Y9E10^ 02%R<<]*II\1_#3_,+B^6W^T&V-V^EW2VPD$GED&] '4T5BZCXOT325U)KZ\9/[+\G[6$@D@- &S16'I'C+1=X2>6 M(S0I=V4]L9XQC+1^:B^8!D9*YQD>HK0DU:RBUN#2))L7UQ!)<11;&^:-&56; M.,#!=>"<\_6@"Y1110 4444 %%%% 'GWQ9_YDG_L;;#_ -GKT&O-?C7/=6VE M>%)]/M/MUW%XGLW@M?-$?GN%D*IO/"Y.!D\#.:7_ (3;XG?]$C_\N6V_^)JG MLB5\3/2:*\V_X3;XG?\ 1(__ "Y;;_XFC_A-OB=_T2/_ ,N6V_\ B:DH])HK MS;_A-OB=_P!$C_\ +EMO_B:/^$V^)W_1(_\ RY;;_P")H ])HKS;_A-OB=_T M2/\ \N6V_P#B:/\ A-OB=_T2/_RY;;_XF@#TFBO-O^$V^)W_ $2/_P N6V_^ M)K?^'GC*;QQX;FU*ZTK^RIX+R6TDMOM GVM&0#\P4 \^W;K0!U5%%% !1110 M 4444 %%%% !1110 4444 %9&N>%]+\0W%G/J0NQ-8ES;R6M_/:LA< -S$ZD MY QSV)]36O10!@7W@G0M3M;6#4+>XN5MHVA5I+Z??";_F=O\ L;;_ /\ 9*]!KS[X3?\ ,[?]C;?_ /LE>@U4MR8?"%%%%24< M5XFGBT3XB:)X@UF18=&BL+JT>ZE.(K2>1X2C.W1 P1DW' R0,_,,\3X@\13: MMX9\8R2W&D:AI\":>RZWIMB]O%,RM(ZR>6H7E6P-Q!Q7M=% '!>+=< MT?Q+X<2;P]J-IKT6E:E97M];Z9.MR_DI.K'Y4))QM+8[["!GI3;K6]+\7^// M"K>%;VWU0:9-/=7MW9R"6.WA>WDC$;L. SNRD(3GY"<<5W]% '@7@K4+)_"/ M@"*S\4+KE]#=6I;0&DMW%HNUEDDVQ(LB^4C,V9&9>.1DJ1LW5SKLMI<_$"TT MVQFL8M2&IPW7VZ3[0;")3"46$0[2&B,D@_>=9-W8"O9** /-O"GBWP[IOBSQ MC!J.O:99S76LI)!%<7D<;2JUI;A64,02"> 14O@#2KR:ZUR]CU_4;>W3Q'?% MK"..W,+XF.02T1DY[X<>V*[R_O[;3-/GO;Z3RK>!"\C;2Q 'H!DD]@ "2>!S M65JGC/1-'N_LM[/<-.L0GECMK*>X,$9Z/+Y:-Y8.#R^.A]#0!S6C>(]&\'W7 MB6P\47D6GWDFJ7%ZB7'#7T4F&C,(ZS$*!'M3+!DQCD9Q/#\7_"'W'@G4?$NW M1[%=(O;1VNV")9O)+%+%%(YX0[%91DCE,=<"O6H9HKFWCGMY$EAE4/')&P97 M4C(((Z@CO3Z /&[BSM->@O+F>);O2-;\9P^467,=U +=(693_$C,C@$<$#(. M#5#6'U"T?Q7H6L^;-69\*2ZM>+J<<-D_P!KM[;[=+YCK(92K#(^;Y 50L1DKS[E58:C:G5CIOF$ M78@%QY90C>&2+X@7"7:QP,VB.+I&4JJ^:IW M@G*XQSDY%=1#JN@7^BZU:#QG-XX22PE\_2[6>REG:+;A_+2W2-B2&QU[@#DB MN_HH \P\,ZK$_BO1;'1O$UKXSTWRW_>2Q0R7>DA83AVEB"X#G";70.2W4X(J MWXUED@^($$T$C1RQ^%M49'1L,I#P$$$=#7HE% 'C$=YKVD:<3H.H:I?7]]X+ M?4MMS??%G_F2?\ L;;#_P!G MKT&O/OBS_P R3_V-MA_[/7H-4]D2OB845S?Q!LGO? &LJE[=6@CLYI6-LX0R M!8V.PM@D*3C.T@\8S@D'BM0 M/O* >T45XK'I-VWA7PQXCLYX[]-,A@MX9+IBER)HKG&R ?.#YYQ"3O'R;3EQ MQ78?#O6VN&N=+N+-(Y\RW;W:3;S=/]HDBE=EP/+_ 'D;;5RP";1D;< [JO- MO@?_ ,BEK/\ V'[[_P!&5Z37FWP/_P"12UG_ +#]]_Z,H ])HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@#S[X3?\SM_P!C;?\ _LE>@UY]\)O^9V_[&V__ /9*]!JI M;DP^$****DH**** "BBB@ HHHH Y?QO\ZZ!#( ;:76[83ANA"[G3/_;58_QQ M6/8>(=(\'>*O%<7BN_MM+EO;Y;ZVFNY GVN#[/$@$9/WRAC9=@R1QQ\PSV>L M:5;ZWI,UA=EUCDVLKQD!HW5@R.N01N5E5AD'D#BKB@JH!8L0,%CU/Y4 >-^/ MM=6'2[&QTVWN_#Q;0I;BRM'U233#"_ 18X;=2T\RX!\DL% (! ))&A+K.K3Z MMHVF+?7;?\)=!8WD-Q%(P6'RE#W80@X0-&J8 P-TC'DGGU6LXZ+$_B1-9GN) MYI88&@MX7V^7 '*EV4!02S;%Y8G &!C)R >63"^N]4CN'US68WN/&<^ENL6H MRH@M-DA,(0-M'(X<#>O\++A<-N/$$ECH,.G7^H7)MU\1ZA9QW%[KTM@@CB,A M2.6[57E)[* 06VC)(&#[-10!XMX8NM0\2CPI::KK&J[&T346G\B^GMWEDAN8 MXT+E6#[E&01(B?? M%>F51;2()/$":O*\DD\5L;>%&(V1!FW.R\9W-M0$DGA!@#G(!>HHHH **** M"BBB@ HHHH **** //OBS_S)/_8VV'_L]>@UY]\6?^9)_P"QML/_ &>O0:I[ M(E?$QDT,5S;R07$:2PRJ4DCD4,KJ1@@@]01VJA?>'=$U.*UCU+1]/O([/_CV M6XM4D$'3[@(^7H.GH*TJ*DHB2V@BN)9XX(TFFVB614 9\<#)ZG&>,U2N/#NB M7FDII=WH^GSZ;? _P#Y%+6?^P_??^C*])KS;X'_ /(I:S_V'[[_ -&4 >DT444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110!Y]\)O^9V_[&V__P#9*]!KR[3?#/Q*\-:EKW_".2^%9+'5 M-7N-13[>UR95\PC .P #A1QSSGFM#_B\?_4C?^3E6U=F<796L>@T5Y]_Q>/_ M *D;_P G*/\ B\?_ %(W_DY2Y?,KF\CT&BO/O^+Q_P#4C?\ DY1_Q>/_ *D; M_P G*.7S#F\CT&BO/O\ B\?_ %(W_DY1_P 7C_ZD;_R/_J1O_)RCE\PYO(]!HKS[_B\?_4C?^3E'_%X_P#J1O\ R;Y6,YSNW/_J1O_)RCE\PYO(]!HKS[_B\?_4C?^3E'_%X M_P#J1O\ R/_J1O_)RCE\PYO(]!HKS[_B\?_4C?^3E'_%X_ M^I&_\G*.7S#F\CT&BO/O^+Q_]2-_Y.4?\7C_ .I&_P#)RCE\PYO(/BS_ ,R3 M_P!C;8?^SUZ#7EVI>&?B5XEU+0?^$CE\*QV.EZO;ZB_V!KD2MY9.0-X(/#'C MCG'->HT/9(4=VPHHHJ2PHHHH **** "O-O@?_P BEK/_ &'[[_T97I->;? _ M_D4M9_[#]]_Z,H ])HHHH **** "BBB@ HHKAO'?B;Q+I?B?PUH7A&+2FNM: M^U9?5%D*)Y**_6,@C(+=CSCI32N)NRN=S17GW_%X_P#J1O\ R@T5Y]_Q>/\ ZD;_ ,G*/^+Q_P#4C?\ DY1R^8@T5Y]_ MQ>/_ *D;_P G*/\ B\?_ %(W_DY1R^8@T5Y]_P 7C_ZD;_R@T5Y]_Q>/_J1O_)RC_B\?_4C?^3E'+YAS>1Z#17GW_%X_P#J M1O\ R1Z#17GW_%X_\ J1O_ "1Z#17GW_ !>/_J1O_)RC_B\?_4C?^3E'+YAS>1Z#17GW_%X_^I&_ M\G*/^+Q_]2-_Y.4??\7C_ .I&_P#)RC_B\?\ U(W_ ).4??\7C_P"I&_\ )RC_ (O'_P!2-_Y.4??\ %X_^I&_\ MG*/^+Q_]2-_Y.4??\7C_ZD;_R@T5 MY]_Q>/\ ZD;_ ,G*/^+Q_P#4C?\ DY1R^8@T5R_PV\37GC'X>Z;KNIQ0 M175WYN]+=2J#;*Z# ))Z*._6NHI-6=AIW5PHHHI#"BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \ MV_YNF_[DS_V]KTFO-O\ FZ;_ +DS_P!O:])H **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "O-O@?_P BEK/_ &'[[_T97I->;? _ M_D4M9_[#]]_Z,H ])HHHH **** "BBB@ KS[QA_R6GX<_P#<3_\ 2=:]!KS[ MQA_R6GX<_P#<3_\ 2=:J.Y,MON_,]!HHHJ2@HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \^^!?\ R1;0O^WC M_P!*)*]!KS[X%_\ )%M"_P"WC_THDKT&JE\3)A\*"BBBI*"BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@#S[4?B#XC_P"$TUGP_P"&?!7]M?V1Y'GS M_P!JQV_^MC#K\KK_ +PX)Z=LT?\ "8?$;_HEO_EPV_\ \31X/_Y+3\1O^X9_ MZ3M7H-6[+H9I-ZW//O\ A,/B-_T2W_RX;?\ ^)H_X3#XC?\ 1+?_ "X;?_XF MO0:*5UV*Y7W_ "//O^$P^(W_ $2W_P N&W_^)H_X3#XC?]$M_P#+AM__ (FO M0:*+KL'*^_Y'GW_"8?$;_HEO_EPV_P#\31_PF'Q&_P"B6_\ EPV__P 37H-% M%UV#E??\CS[_ (3#XC?]$M_\N&W_ /B:/^$P^(W_ $2W_P N&W_^)KT&BBZ[ M!ROO^1Y]_P )A\1O^B6_^7#;_P#Q-'_"8?$;_HEO_EPV_P#\37H-%%UV#E?? M\CS[_A,/B-_T2W_RX;?_ .)H_P"$P^(W_1+?_+AM_P#XFO0:*+KL'*^_Y'C6 M[XC?\+3_ .$R_P"%=?\ ,%_LK['_ &Y;_P#/?S?,W_IMQ[Y[5TG_ F'Q&_Z M);_Y<-O_ /$UZ#11==@Y7W_(\^_X3#XC?]$M_P#+AM__ (FC_A,/B-_T2W_R MX;?_ .)KT&BBZ[!ROO\ D>??\)A\1O\ HEO_ )<-O_\ $T?\)A\1O^B6_P#E MPV__ ,37H-%%UV#E??\ (\^_X3#XC?\ 1+?_ "X;?_XFC_A,/B-_T2W_ ,N& MW_\ B:]!HHNNP??\)A\1O^B6_^7#;_ /Q-'_"8?$;_ *);_P"7#;__ M !->@T4778.5]_R//O\ A,/B-_T2W_RX;?\ ^)H_X3#XC?\ 1+?_ "X;?_XF MO0:*+KL'*^_Y'GW_ F'Q&_Z);_Y<-O_ /$T?\)A\1O^B6_^7#;_ /Q->@T4 M778.5]_R/-I_B/XLTO4M(A\1^ /[,M=4U&'3TN?[9BFV/(< [44DX )[#CK7 MI->??%G_ )DG_L;;#_V>O0:':UQ1O=H****DL**** "BBB@ KS;X'_\ (I:S M_P!A^^_]&5Z37C7A6V^)O@JVU'3]/\&6.H6]QJ5Q>1S2:JD;$2/D#;SVH ]E MHKS;_A)_BQ_T3W3?_!VG^%'_ D_Q8_Z)[IO_@[3_"@#TFBO-O\ A)_BQ_T3 MW3?_ =I_A1_PD_Q8_Z)[IO_ (.T_P * /2:*\V_X2?XL?\ 1/=-_P#!VG^% M'_"3_%C_ *)[IO\ X.T_PH ])KS[QA_R6GX<_P#<3_\ 2=:K_P#"3_%C_HGN MF_\ @[3_ K#;4_%FI?&GP)_PF'AZVT7R_[0^S^1>BX\W-O\V<#Y<87ZY]JJ M.Y,MON_,]EHHHJ2@HHHH **** *&L:WI^@V:7.JW'DI)((8E5&>2:0]$1%!9 MV.#\J@G@\<50B\;:#)IFI7[7L6NK65 MYJ%U8VTV^YM$C>9-C#8) 2AR1@Y /3\:N5XCJ^B^';_3/'FHV-I8SQ:?X<@F MTN6!5,=LRV\S+)"5X4Y5?F7G@55U*-=3UC6&\2:_H^D:Q(\!TR2\TJ2XOUB: M)/*>Q99U)_>;_EC0G?NW YQ0![Q6%JOC/1-&O)K6\FNI)K=!)<"TL)[H6ZD9 M!D,2,(\@$_-CCGI6%X$TBQ;Q-XLU::VAEU)=8>!;MXAYBQ_9X"44GE5))) [ MFLS7K[2].\5:Q-:^-'\$ZK)+ \\6J+;M::@$50)D23#,"@\HF.1"#'R,@$@' M>V>NZ9J%_P#8[&\CN)OLD5Z/*RR-!(6$;JX^5@2C8P>V>A%:%>*6NB:?XCN[ MR3Q%X=LK>2'P7;,E@;;9#;N9;OYDB8?NSQE<_,H8C/6L;Q/J%EKOA9EU6WT5 M=6_X1FWF2ZU<27=Y=N]N6'V.'(*?,6S*C'#+\RG&0 ?0E5-3U.ST?3WO=2F\ MFWC959]I;!9@J\ $]6 KQX:?)?Z9XTUO38#=:XEO8BWO%0RSQHUE#YK1$$,& M9&;[A#-@#/ JA=6&D/X=U9O#WB#1+FREM+5)K3PUIDEI"K&[BV2R.)I%68#< M /E<@YZ+P >]U4O]3M-,^S?;IO*^U7"VT/RD[I&SM7@<9P>3Q7DFNZ=9Z%K_ M (CTG3+..P\.B/2+C4[6RC\N-;=IIEN'*IT4HBB0CJBG/&:11IH\5+_PB(MQ MX8.M:68/L6W[(;K$WG>3M^7&WR=VWC=G^+=0!ZW?ZM9:9-917TWE/?W(M;8; M&;S)2C/MX''RHQR<#CZ5G3Q>(-)37%LYSJEE9Z1*FHS-Y+"5+Z3SG(Q(02\B@ M%PNTC< 0#W:BO#)O#_ARP\$>#YY9_#ME+-I"S26WB*U_T/4)7CA+2/-P%G ! M 8[VPS87&:]9\'78OO!>D7*V4U@LEI&5MIY7E>(8X!=\,W'=N3WH VJ*** " MBBB@ HHHH \^^!?_ "1;0O\ MX_]*)*]!KS[X%_\D6T+_MX_]*)*]!JI?$R8 M?"@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \^\'_\EI^( MW_<,_P#2=J]!KS[P?_R6GXC?]PS_ -)VKT&JEN3';[_S"BBBI*"BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //OBS_ M ,R3_P!C;8?^SUZ#7GWQ9_YDG_L;;#_V>O0:I[(E?$PHHHJ2@HHHH **** " MBBB@ HHHH **** "BBB@ KS[QA_R6GX<_P#<3_\ 2=:]!KS[QA_R6GX<_P#< M3_\ 2=:J.Y,MON_,]!HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH \^^!?\ R1;0O^WC_P!*)*]!KS[X M%_\ )%M"_P"WC_THDKT&JE\3)A\*"BBBI*"BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@#S[P?_P EI^(W_<,_])VKT&O/O!__ "6GXC?]PS_TG:O0 M:J6Y,=OO_,****DH**** "BBB@ KE_'NFR:QH]G803V'FR7\3BQU"4I#J*H2 M[V[$ D@JK-C:WW.5(S7451U?1;#7K$6FJ6_G1K(LJ%79'B=3E71U(9&'9E(( M]: /-;;7$\'6.MKIV@C0-3BGT[SM',B2V*I-=>1Y]OY>W&]5PWRGD8-5V^'7AB2TFMY;&:59[B.ZEDD MOIWE>:,820R%]^X#H<]AZ"@# F\9^)XX;JS%K;R7>FZJ;&^U"TTR>ZC6,PK- M'(MJDGF<^8B$!VVD$\@\9ESXZ-O>-X@@M-.O;YO#43K/ \P1I7NO*V$-@J@D M.2"@=<$$\8KN/^$$\/\ ]GPV:VUQ&(9WN$N([Z=+GS'R'8W ?S22#@Y8Y Z M /3P1XZ2.SAX"Q8JV2=Q+$DL9ZL^H6?Q(OA MX@73M2G-UX>19(898(P&O)0KA/,)#*2< LRG )&"5KI;;X@ZA+X^L=-5[2ZT MR^U&YL08-/N5\DQ)(P/VIR(Y6)B(947Y22-QVY;?M_AYX:MIVG6RFEG>6WF> M:XOIYI'>W0DW)/$-MIT[7,%[=1):Q2QO;*ENQ8 F4 MJY;;W7@''7YJMZ'\0?%6J64LT.B-J$EQI+WUHL>E75G'#,,%8&EF^6;<'X=- MH.QN,,".VM/"6B6,.EQ6UB%CTE9$LE,KL(E==K#D_-D''S9JG;?#SPO:13Q) MIGF13VYM3'<7$LR10DY,<2NQ$2Y ^5-H^5?08 ,*REO/B%H.HZ/?ZNEO@UY]\6?^9)_[&VP M_P#9Z]!JGLB5\3"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "O/O&'_) M:?AS_P!Q/_TG6O0:\V^(\]YI?Q"\$Z[;Z)JNK6NG?;_M":7:&=T\R)$7@8 R M3W(X!]*J.Y$]CTFBO/O^%L_]2!XY_P#!-_\ 9T?\+9_ZD#QS_P"";_[.CE8^ M>)Z#17GW_"V?^I \<_\ @F_^SH_X6S_U('CG_P $W_V='*PYXGH-%>??\+9_ MZD#QS_X)O_LZ/^%L_P#4@>.?_!-_]G1RL.>)Z#17GW_"V?\ J0/'/_@F_P#L MZ/\ A;/_ %('CG_P3?\ V='*PYXGH-%>??\ "V?^I \<_P#@F_\ LZ/^%L_] M2!XY_P#!-_\ 9T@T5Y]_PMG_J0/'/_ ()O_LZ/^%L_]2!XY_\ !-_] MG1RL.>)Z#17GW_"V?^I \<_^";_[.C_A;/\ U('CG_P3?_9T@T5Y]_ MPMG_ *D#QS_X)O\ [.C_ (6S_P!2!XY_\$W_ -G1RL.>)Z#17GW_ MG_J0/ M'/\ X)O_ +.C_A;/_4@>.?\ P3?_ &='*PYXGH-%>??\+9_ZD#QS_P"";_[. MC_A;/_4@>.?_ 3?_9T@T5Y]_PMG_J0/'/_@F_^SH_X6S_ -2!XY_\ M$W_V='*PYXGH-%>??\+9_P"I \<_^";_ .SH_P"%L_\ 4@>.?_!-_P#9T@T5Y]_P +9_ZD#QS_ .";_P"SH_X6S_U('CG_ ,$W_P!G1RL.>)Z#17GW M_"V?^I \<_\ @F_^SH_X6S_U('CG_P $W_V='*PYXA\"_P#DBVA?]O'_ *42 M5Z#7#?!G3[S2_A'HMGJ=I/9W4?G[X+B(QNF9Y",J0",@@_0UW-$OB80^%!11 M14E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y]X/_Y+3\1O^X9_ MZ3M7H->?>#_^2T_$;_N&?^D[5Z#52W)CM]_YA1114E!1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GWQ9_YDG_ +&V MP_\ 9Z]!KS[XL_\ ,D_]C;8?^SUZ#5/9$KXF%%%%24%%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 >/0>.O#G@KXT^//^$FU'[%]L_L[R/W$DF_ M9;_-]Q3C&Y>OK70?\+T^'/\ T,7_ )(W'_QNO0:*JZ9"4ELSS[_A>GPY_P"A MB_\ )&X_^-T?\+T^'/\ T,7_ )(W'_QNO0:*/=':7?\ K[SS[_A>GPY_Z&+_ M ,D;C_XW1_PO3X<_]#%_Y(W'_P ;KT&BCW0M+O\ U]YY]_PO3X<_]#%_Y(W' M_P ;H_X7I\.?^AB_\D;C_P"-UZ#11[H6EW_K[SS[_A>GPY_Z&+_R1N/_ (W1 M_P +T^'/_0Q?^2-Q_P#&Z]!HH]T+2[_U]YY]_P +T^'/_0Q?^2-Q_P#&Z/\ MA>GPY_Z&+_R1N/\ XW7H-%'NA:7?^OO//O\ A>GPY_Z&+_R1N/\ XW1_PO3X M<_\ 0Q?^2-Q_\;KT&BCW0M+O_7WGGW_"]/AS_P!#%_Y(W'_QNC_A>GPY_P"A MB_\ )&X_^-UZ#11[H6EW_K[SS[_A>GPY_P"AB_\ )&X_^-T?\+T^'/\ T,7_ M )(W'_QNO0:*/="TN_\ 7WGGW_"]/AS_ -#%_P"2-Q_\;H_X7I\.?^AB_P#) M&X_^-UZ#11[H6EW_ *^\\^_X7I\.?^AB_P#)&X_^-T?\+T^'/_0Q?^2-Q_\ M&Z]!HH]T+2[_ -?>>??\+T^'/_0Q?^2-Q_\ &Z/^%Z?#G_H8O_)&X_\ C=>@ MT4>Z%I=_Z^\\^_X7I\.?^AB_\D;C_P"-T?\ "]/AS_T,7_DC>??\ "]/AS_T,7_DC/[-+'A 64G+J!U8<=>:]IHHH; M70$FM6%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[ M0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ M .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y M^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H M_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/ M^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +% M%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_ MM"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X M/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ MY^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\ M: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ M !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L4 M57_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ M )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T M+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ MOZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_ M[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_Q MH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^ MT+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5 M_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^ MX/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ MG[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^ M_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C M_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: M+%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M" MS_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0 ML_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y M^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ M +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ M/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_Q MH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : +%% M5_[0L_\ G[@_[^C_ !H_M"S_ .?N#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M M"S_Y^X/^_H_QH L457_M"S_Y^X/^_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^ M?N#_ +^C_&C^T+/_ )^X/^_H_P : +%%5_[0L_\ G[@_[^C_ !H_M"S_ .?N M#_OZ/\: +%%5_P"T+/\ Y^X/^_H_QH_M"S_Y^X/^_H_QH L457_M"S_Y^X/^ M_H_QH_M"S_Y^X/\ OZ/\: +%%5_[0L_^?N#_ +^C_&C^T+/_ )^X/^_H_P : # /_9 end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
12 Months Ended
Dec. 31, 2023
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2023
Current Fiscal Year End Date --12-31
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-40974
Entity Registrant Name GLOBALFOUNDRIES Inc.
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One 400 Stonebreak Road Extension
Entity Address, City or Town Malta
Entity Address, State or Province NY
Entity Address, Postal Zip Code 12020
Title of 12(b) Security Ordinary shares, par value US$0.02 per share
Trading Symbol GFS
Security Exchange Name NASDAQ
Entity Common Stock, Shares Outstanding 553,548,190
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag true
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Central Index Key 0001709048
Document Fiscal Year Focus 2023
Document Fiscal Period Focus FY
Amendment Flag false
Document Financial Statement Error Correction [Flag] false
Business Contact  
Document Information [Line Items]  
Entity Address, Address Line One 400 Stonebreak Road Extension
Entity Address, City or Town Malta
Entity Address, State or Province NY
Entity Address, Postal Zip Code 12020
City Area Code (518)
Local Phone Number 305-9013
Contact Personnel Name John Hollister
Contact Personnel Email Address ir@gf.com

XML 21 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Audit Information
12 Months Ended
Dec. 31, 2023
Auditor Information [Abstract]  
Auditor Firm ID 1051
Auditor Name KPMG LLP
Auditor Location Singapore
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 2,387 $ 2,352
Marketable securities 1,033 622
Receivables, prepayments and other assets 1,420 1,487
Inventories 1,487 1,339
Total current assets 6,327 5,800
Non-current assets:    
Property, plant and equipment, net 10,164 10,596
Goodwill and intangible assets, net 391 363
Marketable securities 468 372
Deferred tax assets 241 292
Receivables, prepayments and other assets 343 281
Other non-current financial assets 110 137
Total non-current assets 11,717 12,041
Total Assets 18,044 17,841
Current liabilities:    
Trade payables and other current liabilities 2,349 2,849
Current portion of long-term debt 571 223
Current portion of lease obligations 32 75
Provisions 54 102
Current portion of deferred income from government grants 93 110
Total current liabilities 3,099 3,359
Non-current liabilities:    
Non-current portion of long-term debt 1,801 2,288
Other non-current liabilities 1,190 1,474
Non-current portion of lease obligations 350 270
Provisions 186 196
Non-current portion of deferred income from government grants 267 294
Total non-current liabilities 3,794 4,522
Total liabilities 6,893 7,881
Equity:    
Ordinary shares, $0.02 par value, 553,548 thousand and 547,755 thousand shares issued and outstanding as of December 31, 2023 and 2022, respectively 11 11
Additional paid-in capital 24,027 23,831
Accumulated deficit (13,001) (14,021)
Accumulated other comprehensive loss 67 92
Equity attributable to the shareholders of GLOBALFOUNDRIES INC. 11,104 9,913
Non-controlling interests 47 47
Total equity 11,151 9,960
Total liabilities and equity $ 18,044 $ 17,841
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - $ / shares
shares in Thousands
Dec. 31, 2023
Dec. 31, 2022
Statement of financial position [abstract]    
Par value per share (in dollars per share) $ 0.02 $ 0.02
Number of shares issued (in shares) 553,548 547,755
Number of shares outstanding (in shares) 553,548 547,755
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Net revenue $ 7,392 $ 8,108 $ 6,585
Cost of revenue 5,291 5,869 5,572
Gross profit 2,101 2,239 1,013
Research and development expense 428 482 478
Selling, general and administrative expense 473 496 595
Restructuring expense 71 94 0
Operating expenses 972 1,072 1,073
Income (loss) from operations 1,129 1,167 (60)
Finance income 149 51 6
Finance expense (137) (111) (114)
Gain on sale of East Fishkill (“EFK”) business 0 403 0
Other income (expense), net (57) 22 (8)
Income (loss) before income taxes 1,084 1,532 (176)
Income tax expense (66) (86) (78)
Net income (loss) for the year 1,018 1,446 (254)
Attributable to:      
Shareholder of GLOBALFOUNDRIES INC. 1,020 1,448 (250)
Non-controlling interest (2) (2) (4)
Net income (loss) for the year $ 1,018 $ 1,446 $ (254)
Net income (loss) per share attributable to the equity holders of the Company:      
Basic weighted average ordinary shares outstanding (in shares) 552 539 506
Diluted weighted average ordinary shares outstanding (in shares) 556 552 506
Basic loss per share (in USD per share) $ 1.85 $ 2.69 $ (0.49)
Diluted loss per share (in USD per share) $ 1.83 $ 2.62 $ (0.49)
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of comprehensive income [abstract]      
Net income (loss) for the year $ 1,018 $ 1,446 $ (254)
Attributable to:      
Shareholder of GLOBALFOUNDRIES INC. 1,020 1,448 (250)
Non-controlling interest (2) (2) (4)
Net income (loss) for the year 1,018 1,446 (254)
Items that may be reclassified subsequently to profit or loss:      
Share of foreign exchange fluctuation reserve of joint ventures 14 (23) (12)
Effective portion of changes in the fair value of cash flow hedges (27) 187 (45)
Fair value gain (loss) on investments measured at fair value through other comprehensive income 9 (9) 0
Income tax effect (19) (18) 3
Total other comprehensive income that will be reclassified to profit or loss, net of tax (23) 137 (54)
Attributable to:      
Shareholders of GLOBALFOUNDRIES INC. (25) 146 (50)
Non-controlling interests 2 (9) (4)
Total other comprehensive income (loss) for the year (23) 137 (54)
Total comprehensive income (loss)      
Shareholders of GLOBALFOUNDRIES INC. 995 1,594 (300)
Non-controlling interests 0 (11) (8)
Total comprehensive income (loss) for the year $ 995 $ 1,583 $ (308)
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income (loss) $ 1,018 $ 1,446 $ (254)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 1,451 1,623 1,618
Share-based payments 150 181 223
Interest and income taxes paid, net [1] (9) (68) (107)
Finance income (149) (51) (6)
Finance expense 137 111 114
Amortization of deferred income from government grants (29) (28) (33)
Deferred income taxes 50 82 93
(Gain) Loss on disposal of property, plant and equipment and other 13 (103) (39)
Gain on the sale of a business 0 (403) 0
Change in assets and liabilities:      
Receivables, prepayments and other assets (169) 35 (387)
Inventories (148) (261) (202)
Trade and other payables (190) 60 1,819
Net cash provided by operating activities 2,125 2,624 2,839
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of property, plant and equipment and intangible assets (1,804) (3,059) (1,767)
Proceeds from government grants 138 0 0
Advances and proceeds from sale of property, plant and equipment and intangible assets 24 41 324
Purchase of marketable securities (1,419) (1,302) 0
Proceeds from sale of marketable securities 945 306 0
Proceeds from sale of a business 236 0 0
Other investing activities (2) (44) (7)
Net cash used in investing activities (1,882) (4,058) (1,450)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from issuance of equity instruments 42 168 1,444
Repayments of shareholder loan 0 0 (568)
Net proceeds from borrowings 46 971 617
Repayments of debt and finance lease obligations (305) (390) (960)
Proceeds from government grants 5 93 83
Increase in restricted cash 0 0 34
Net cash provided by (used in) financing activities (212) 842 650
Effect of exchange rate changes on cash and cash equivalents 4 5 (8)
Net increase (decrease) in cash and cash equivalents 35 (587) 2,031
Cash and cash equivalents at the beginning of the year 2,352 2,939 908
Cash and cash equivalents at the end of the year $ 2,387 $ 2,352 $ 2,939
[1] Includes interest paid of $121 million, $96 million and $101 million for years ended December 31, 2023, 2022 and 2021, respectively, and interest received of $123 million, $32 million and $1 million for the years ended December 31, 2023, 2022 and 2021, respectively, and taxes paid of $11 million, $4 million and $7 million for the years ended December 31, 2023, 2022 and 2021, respectively.
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of cash flows [abstract]      
Interest paid $ 121 $ 96 $ 101
Interest received 123 32 1
Income taxes paid, classified as operating activities $ 11 $ 4 $ 7
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Total
Ordinary Share
Additional Paid-In Capital
Loan from Shareholder
Accumulated Deficit
Hedging Reserve
Foreign Currency Translation Reserve and Investments Reserves
Non- controlling Interest
Beginning balance $ 7,241 $ 7,175 $ 10 $ 11,707 $ 10,681 $ (15,219) $ (15) $ 11 $ 66
Beginning balance (in shares) at Dec. 31, 2020     500,000            
Proceeds from issuance of equity instruments (in shares)     32,000            
Proceeds from issuance of equity instruments 1,445 1,445 $ 1 1,444          
Share-based payments 223 223   223          
Repayment of loan from shareholder (568) (568)     (568)        
Conversion of loan from shareholder       10,113 (10,113)        
Net income (loss) for the year (254) (250)       (250)     (4)
Other comprehensive income (54) (50)         (42) (8) (4)
Ending balance (in shares) at Dec. 31, 2021     532,000            
Ending balance at Dec. 31, 2021 8,033 7,975 $ 11 23,487 0 (15,469) (57) 3 58
Beginning balance 8,033 7,975 $ 11 23,487 0 (15,469) (57) 3 58
Proceeds from issuance of equity instruments (in shares)     6,000            
Proceeds from issuance of equity instruments 163 163   163          
Share-based payments (in shares)     10,000            
Share-based payments 181 181   181          
Net income (loss) for the year 1,446 1,448       1,448     (2)
Other comprehensive income $ 137 146         160 (14) (9)
Ending balance (in shares) at Dec. 31, 2022 547,755   548,000            
Ending balance at Dec. 31, 2022 $ 9,960 9,913 $ 11 23,831 0 (14,021) 103 (11) 47
Beginning balance 9,960 9,913 $ 11 23,831 0 (14,021) 103 (11) 47
Proceeds from issuance of equity instruments (in shares)     6,000            
Proceeds from issuance of equity instruments 46 46   46          
Share-based payments 150 150   150          
Net income (loss) for the year 1,018 1,020       1,020     (2)
Other comprehensive income $ (23) (25)         (37) 12 2
Ending balance (in shares) at Dec. 31, 2023 553,548   554,000            
Ending balance at Dec. 31, 2023 $ 11,151 11,104 $ 11 24,027 0 (13,001) 66 1 47
Beginning balance $ 11,151 $ 11,104 $ 11 $ 24,027 $ 0 $ (13,001) $ 66 $ 1 $ 47
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization
12 Months Ended
Dec. 31, 2023
Corporate information and statement of IFRS compliance [abstract]  
Organization Organization
GLOBALFOUNDRIES Inc. (“GLOBALFOUNDRIES”) is an exempted company with limited liability incorporated under the laws of the Cayman Islands. The address of GLOBALFOUNDRIES’ registered office is P.O. Box 309, Ugland House, Grand Cayman, KY1-1104 Cayman Islands.
GLOBALFOUNDRIES and its subsidiaries (together referred to as the “Company”) is one of the world’s largest pure-play semiconductor foundries and offers a full range of mainstream wafer fabrication services and technologies. The Company manufactures a broad range of semiconductor devices, including microprocessors, mobile application processors, baseband processors, network processors, radio frequency modems, microcontrollers, and power management units.
GLOBALFOUNDRIES is a majority owned subsidiary of Mubadala Technology Investments LLC (“Shareholder”) through its subsidiaries, Mubadala Technology Investment Company and MTI International Investment Company LLC. Mubadala Technology Investments LLC is a subsidiary of Mamoura Diversified Global Holding PJSC (“MDGH”). Mubadala Investment Company PJSC (“MIC”) is the ultimate parent company. See Note 29 for further discussion of the Company’s related party disclosures.
The Company previously entered into an agreement with Semiconductor Components Industries, LLC (“ON Semiconductor”) to sell the Company’s business in East Fishkill, New York, including buildings, facilities, certain equipment, inventories, and certain contracts. Under the agreement the Company will manufacture 300mm wafers for ON Semiconductor until the end of 2025 for additional fees, allowing ON Semiconductor to increase its 300mm production at the East Fishkill fab over several years. Under the agreement, ON Semiconductor committed to minimum fixed cost payments in each year through 2023. On December 31, 2022, the Company completed the sale of the EFK business for a total purchase price of $406 million, and recognized a gain amounting to $403 million.
The consolidated financial statements were authorized by the GLOBALFOUNDRIES’ Board of Directors on April 29, 2024 to be issued and subsequent events have been evaluated for their potential effect on the consolidated financial statements through April 29, 2024.
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation
12 Months Ended
Dec. 31, 2023
Corporate information and statement of IFRS compliance [abstract]  
Basis of Presentation Basis of Presentation
The consolidated financial statements of the Company have been presented in United States (“U.S.”) dollars, and prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). These financial statements have been prepared on the historical cost basis except as otherwise described in the notes below.
Basis of Consolidation—The consolidated financial statements comprise the financial statements of GLOBALFOUNDRIES and its subsidiaries. Subsidiaries are fully consolidated from the date of acquisition, being the date on which GLOBALFOUNDRIES obtains control, and continue to be consolidated until the date when such control ceases. All intercompany transactions, balances, income and expenses are eliminated in full on consolidation. Wholly-owned subsidiaries and controlled entities included in these consolidated financial statements are disclosed in Note 29.
Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the subsidiary and has the ability to affect those returns through its power over the subsidiary. Specifically, the Company controls a subsidiary if the Company (a) has power over the subsidiary, (b) is exposed, or has rights, to variable returns from its involvement with subsidiary, and (c) has the ability to use the power to affect its returns.
Profit or loss and each component of other comprehensive income (loss) (“OCI”) are attributed to the Shareholder of the Company and to the non-controlling interests.
A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.
If the Company loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized in the consolidated statements of operations. Any investment retained is recognized at fair value.

Foreign Currency Translation—Assets and liabilities of foreign operations having a functional currency other than the U.S. dollar are translated at the rate of exchange prevailing at the reporting date and revenue and expenses at the rate of exchange prevailing at the dates of the transactions during the period. Gains or losses on translation of foreign operations are included in OCI.
In preparing the consolidated financial statements of the Company, foreign currency-denominated monetary assets and liabilities are translated into the functional currency using the closing rate at the applicable consolidated statement of financial position dates. Non-monetary assets and liabilities, denominated in a foreign currency and measured at fair value, are translated at the rate of exchange prevailing at the date when the fair value was determined and non-monetary assets measured at historical cost are translated at the historical rate. Revenue and expenses are measured in the functional currency at the rates of exchange prevailing at the dates of the transactions with gains or losses included in the statements of operations.
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Material Accounting Policies
12 Months Ended
Dec. 31, 2023
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Summary of Material Accounting Policies Summary of Material Accounting Policies
The Company has consistently applied the following accounting policies to all periods presented in these consolidated financial statements, except if mentioned otherwise. In addition, the Company adopted Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) from 1 January 2023. The amendments require the disclosure of ‘material’, rather than ‘significant’, accounting policies. The amendments also provide guidance on the application of materiality to disclosure of accounting policies, assisting entities to provide useful, entity-specific accounting policy information that users need to understand other information in the financial statements. Management reviewed the accounting policies and made updates to the information disclosed in Note 3 Material accounting policies (2022: Significant accounting policies) in certain instances in line with the amendments.
Investments in Joint Operations—A joint operation is an arrangement in which the Company has joint control whereby the Company has rights to assets, and obligations for the liabilities, relating to an arrangement. The Company accounts for each of its assets, liabilities and transactions, including its share of those held or incurred jointly, in relation to the joint operation.
Cash and Cash Equivalents—Cash and cash equivalents consist of highly liquid time deposits and investments that are readily convertible into cash, which are not subjected to significant risk of changes in value, and have original maturities of three months or less at the time of purchase.
Trade Accounts Receivable—Trade accounts receivable are recognized initially at fair value. A provision for impairment of trade accounts receivable is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivable.
Inventories—Inventories are stated at standard cost adjusted to the lower of cost or net realizable value. The Company measures the cost of its inventory based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Financial Instruments:
Category of financial instruments and measurement
Recognition and Initial Measurement—Trade receivables are initially recognized when they are originated. All other financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.
A financial asset (unless it is a trade receivable without a significant financing component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value in the profit and loss (“FVPL”), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant financing component is initially measured at the transaction price.
Classification and Measurement—All recognized financial assets are measured based on amortized cost or fair value. The classification is based on two criteria, the Company’s business model for managing the assets and whether the instrument’s contractual cash flows represent solely payments of principal and interest (“SPPI”).
The assessment of whether contractual cash flows on debt instruments are solely comprised of principal and interest is made based on the facts and circumstances at the initial recognition of assets.
Financial assets include trade and other receivables. These are recorded at amortized cost when such financial assets are held with the objective to collect contract cash flows that meet the SPPI criterion.
Financial assets recorded at FVPL comprise unquoted equity instruments which the Company had not irrevocably elected, at initial recognition, to classify at fair value through other comprehensive income (“FVOCI”).
Financial assets recorded at FVOCI comprise marketable securities that are quoted debt instruments when such financial assets are held with the objectives of both collecting contractual cash flows and selling these financial assets, and meet the SPPI criterion. Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or
losses and interest income which are recognized in the consolidated statements of operations. Interest income from these financial assets is included in finance income using the effective interest rate method.
Derecognition of financial assets
The Company derecognizes a financial asset only when the contractual rights to the cash flows from the financial asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the financial asset to another entity. On derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in the consolidated statements of operations.
On derecognition of an investment in a debt instrument at FVOCI, the difference between the asset’s carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss that had been recognized in OCI is recognized in the consolidated statements of operations.
Impairment of financial assets
The Company will record an allowance for expected credit losses (“ECL”) for all loans to related parties, marketable securities (that are quoted debt instruments), contract assets, and trade receivables and other receivables not recorded at FVPL. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive. The shortfall is then discounted using the asset’s effective interest rate.
The Company estimated its ECL for its contract assets and trade receivables at an amount equal to lifetime credit losses, while marketable securities and other receivables are measured at 12-months ECL if they are determined to have low credit risk at the reporting date.
Offsetting of Financial Instruments—Financial assets and financial liabilities are offset and the net amount reported in the consolidated statements of financial position when there is an enforceable legal right to offset the recognized amounts, and there is an intention to settle on a net basis, or to realize the assets and settle the liabilities simultaneously.
Derivative Financial Instruments and Hedge Accounting—Through its operating, investing and financing activities in the normal course of business, the Company is exposed to various types of market risk including foreign exchange risk, interest rate risk and risks associated with changes in the market price of certain commodities. The Company uses derivative financial instruments, such as foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps to mitigate a portion of the risks associated with changes in foreign currency exchange rates, interest rates and commodity prices. The Company’s objective for holding derivatives include reducing, eliminating and efficiently managing the economic impact of these exposures as effectively as possible. The Company’s derivative programs include strategies that both qualify and do not qualify for hedge accounting treatment. However, the Company does not use derivative financial instruments for trading or speculative purposes.
Derivative financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently remeasured at fair value at each reporting date. Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Foreign currency forward contracts are used to hedge a portion of certain foreign currency-denominated forecasted operating expenditures, primarily in Euro (“EUR”), Japanese Yen (“JPY”) and Singapore Dollar (“SGD”). The Company also hedges future cash flows for certain foreign currency-denominated forecasted capital expenditures, primarily in EUR and JPY. Certain foreign currency forward contracts not designated as hedging instruments are also used to manage the variability in foreign exchange rates on certain balance sheet amounts and to manage other foreign currency exposures.
The Company uses interest rate swaps, cross-currency interest rate swaps and cross-currency swaps to protect itself against adverse fluctuations in interest rates and foreign currency exchange rates and to reduce its exposure to variability in forecasted cash flows associated with the Company’s floating-rate and foreign currency-denominated debt.
The Company also uses commodity swaps to hedge forecasted electricity and natural gas purchases to minimize the impact of commodity price movements on the reported earnings of the Company and on future cash flows related to fluctuations of the contractually specified, separately identifiable and reliably measurable commodity risk component.
At the inception of the hedge relationship, the Company documents the relationship between the hedging instrument and the hedged item along with its risk management objectives and its strategy for undertaking various hedge transactions. Furthermore, at the inception of the hedge, and on an ongoing basis, the Company documents whether there continues to be an economic relationship between the hedged item and the hedging instruments. The Company designates these derivative instruments in cash flow hedges of forecasted operating and capital expenditures or floating-rate and foreign currency-denominated debt, as applicable, and evaluates hedge effectiveness prospectively.
The effective portion of the gain or loss on these contracts is reported as a component of OCI and reclassified to the consolidated statements of operations in the same line item and in the same period during which the associated hedged forecasted transaction affects earnings. For hedges of capital expenditures, the amount in OCI is incorporated into the initial carrying amounts of the non-financial assets and depreciated over the average useful life of the associated assets. Any
ineffective portion of hedges or changes in fair value from excluded components of the hedge are immediately recorded in the consolidated statements of operations.
Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated, or exercised, or when it no longer meets the criteria for hedge accounting. When a forecasted transaction is no longer expected to occur, the gain or loss accumulated in OCI is recognized immediately in the consolidated statements of operations.
Property, Plant and Equipment —Construction in progress and property, plant and equipment are stated at historical cost, net of accumulated depreciation. The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Major additions and improvements are capitalized as appropriate, only when it is probable that future economic benefits associated with the item and the cost of the item can be measured reliably; minor replacements and repairs are charged to the consolidated statements of operations. The Company also capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company also records capital-related government grants as a reduction to property, plant and equipment.
Commencement of depreciation related to construction in progress and property, plant and equipment involves determining when the assets are available for their intended use. The Company considers various factors which include functionality, engineering specifications, nature and usage of assets among others, in assessing the conditions necessary for the assets to be capable of operating in the manner intended by the management. The Company also factors in the length of time it takes for the assets to reach the tooling qualification criteria from the initial point of when the assets are received. Depreciation is calculated on a straight-line basis over the estimated useful life of the assets as follows:
Building and leasehold/land improvements
Up to 50 years (or the remaining lease term of related land on which the buildings are erected, if shorter)
Equipment
2 to 10 years
Computers
5 years
The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023. The impact of the change in estimated useful lives of certain buildings resulted in an increase to income before income taxes of $76 million for the year ended December 31, 2023.
Leases—The Company determines if an arrangement is a lease or contains a lease at inception. That is, if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
Right-of-use assets—Right-of-use (“ROU”) assets are reported within property, plant and equipment, and are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. ROU assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets.
Lease liabilities—At the commencement date of the lease, the Company recognizes lease liabilities at the present value of the lease payments to be made over the lease term.
In calculating the present value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. The carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments or a change in the assessment of an option to purchase the underlying assets. The Company’s lease liabilities are separately reported in the consolidated statements of financial position under non-current portion of lease obligations and current portion of lease obligations.
Short-term leases and leases of low-value assets—The Company applies the short-term lease recognition exemption to leases that have a lease term not exceeding 12 months, or for leases of low-value assets. The payment for such leases is recognized in the Company’s consolidated statements of operations on a straight-line basis over the lease term.
Intangible Assets—Technology, patent, software licenses and similar rights acquired separately are stated at cost less accumulated amortization or are adjusted to fair value when impaired. Intangible assets acquired through business combinations which include customer relationships and manufacturing and process technology, are recorded at estimated fair values at the date of acquisition. Intangible assets are amortized based on the pattern in which the economic benefits of the respective intangible asset are consumed, which is, in general, on a straight-line basis over their estimated useful lives of between 3 and 10 years. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.
Impairment of Non-Financial Assets—The Company reviews, at each reporting date, the carrying amount of the Company’s property, plant and equipment and finite lived intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.
If any indication exists, the recoverable amount of the asset is estimated in order to determine the extent, if any, of the impairment loss. Where it is not possible to estimate the recoverable amount of an individual assets, the Company estimates the recoverable amount of the cash generating unit (“CGU”) to which the asset belongs. The recoverable amount of an asset or CGU is estimated to be the higher of an asset’s or CGU’s fair value less costs to dispose and its value in use. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset or CGU is considered impaired and is written down to its recoverable amount. The Company also evaluates, and adjusts, if appropriate, the asset’s useful lives, at each reporting date or when impairment indicators exist.
In assessing value in use, the estimated future post-tax cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
Impairment losses are recognized in the consolidated statements of operations to the extent the recoverable amount, measured at the present value of discounted cash flows attributable to the assets, is less than their carrying value.
If the recoverable amount subsequently increases, the impairment loss previously recognized will be reversed to the extent of the increase in the recoverable amount, provided that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset in prior years. The impairment loss reversal is recognized immediately in the consolidated statements of operations.
Revenue Recognition—The Company generates revenue primarily from fabricating semiconductor wafers for its customers using the manufacturing processes based on their own or third parties’ proprietary integrated circuit designs and, to a lesser extent, the Company also generates revenue from engineering and other pre-fabrication services such as non-recurring engineering (“NRE”) services, which include design services and mask production.
The Company recognizes revenue when performance obligations are satisfied. The performance obligations are satisfied at the point at which control of the wafers is transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location. NRE services are recognized over time as the Company performs the services based on a percentage of costs incurred over total expected costs.
The Company generally requires a purchase order from all of its customers, to which the Company responds with an order acknowledgement and a copy of the Company’s standard terms and conditions. The Company also enters into master supply agreements (“MSA”) with certain of its customers that may specify additional terms and conditions, such as pricing formulas based on volume, volume discounts, calculation of yield adjustments, indemnifications, transfer of title and risk of loss, and payment terms. The Company also requires a purchase order from its customers with which it has MSAs for specific products and quantities. As a result, the Company has concluded that the combination of a purchase order and order acknowledgement, including the Company’s standard terms and conditions, and the MSA, if applicable, create enforceable rights and obligations between the Company and its customers. For certain customers under long-term supply agreements (“LTAs”) with minimum volume requirements that are subject to a certain breakage fee if such commitment is not met, the Company has concluded that LTAs’ terms and conditions generally constitute enforceable rights and obligations for revenue recognition purposes, unless the underlying facts and circumstances vary and indicate otherwise.
Typically, goods and services provided under the Company’s contracts are accounted for as a single performance obligation. However, in some contracts, the Company provides multiple distinct goods or services to a customer. In those cases, the Company accounts for the distinct contract deliverables as separate performance obligations at the stated contract value, which appropriately represents the individual performance obligation’s estimated standalone selling price.
The Company estimates for the breakage fee arising from not meeting the minimum purchase requirements under certain LTAs with customers as variable consideration and includes such fee in the contract transaction price if not constrained, and accordingly, recognizes as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreement. Given the volumes under these arrangements are usually not guaranteed and subject to subsequent negotiations or changes, breakage fees that are constrained are not included in the contract transaction price for revenue recognition purposes.
The Company estimates the variable consideration related to volume rebates and yield adjustments for certain contracts that may be refundable to customers through the issuance of a credit note, and accordingly, recognizes revenue in accordance with the pattern applicable to the performance obligation, subject to a constraint. The Company determines the amounts to be recognized based on the amount of potential refund required by the contract, historical experience and other surrounding facts and circumstances. These potential revenue adjustments are accrued and netted against accounts receivable on the consolidated statements of financial position.
Our contracts may be subsequently modified to reflect changes in scope or customer requirements. Generally, our contract modifications are for goods or services that are distinct from the existing contract and are accounted for as a new contract and performance obligation, which are recognized prospectively. If contract modifications are for goods or services that are
not distinct from the existing contract, they are accounted for as if they are part of the original contract with the effect of the contract modification recognized as an adjustment to revenue on a cumulative catch-up basis.
A contract asset (“unbilled accounts receivables”) is recognized when the Company has recognized revenue, but not issued an invoice for payment. The Company has determined that unbilled accounts receivables are not considered a significant financing component of the Company’s contracts. Contract assets are included in receivables, prepayments and other assets on the consolidated statements of financial position and are transferred to trade receivables when invoiced (see Note 6).
A contract liability is recognized when the Company receives payments in advance of the satisfaction of performance obligations and are included as deferred revenue on the consolidated statements of financial position (see Note 11). This includes upfront non-refundable capacity access fees under certain LTAs with customers which are accounted for as additional wafer price considerations and recognized as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreements.
Provisions—Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Provisions are mainly made up of site restoration obligations, as well as restructuring charges. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived assets.
A provision for restructuring is recognized when the Company has approved a detailed and formal restructuring plan, and the restructuring either has commenced or has been announced publicly. Future operating losses are not provided for.
The Company records site restoration obligations in the period in which they are incurred at their estimated fair value. Site restoration obligations consist of the present value of the estimated costs of dismantlement, removal, site reclamation and similar activities associated with facilities built on land held under long-term operating leases. The site restoration obligations are recorded as a liability at the estimated present value as of the related long-lived asset’s inception discounted using a pre-tax rate that reflects the current market assessment of the time value of money and risks specific to the site restoration obligations. After initial recognition, the liability is increased for the passage of time, with the increase being reflected as accretion expense in the line item “finance expenses” in the consolidated statements of operations. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived asset. Subsequent adjustments in the discount rates, estimated amounts, timing and probability of the estimated future costs and changes resulting from the passage of time are recognized as an increase or decrease in the carrying amount of the liability and the related site restoration cost capitalized as part of the carrying amount of the related long-lived asset on a prospective basis. If the decrease in the liability exceeds the remaining carrying amount of the related long-lived assets, the excess is recognized in the consolidated statements of operations.
Deferred Tax Assets—Deferred tax assets are recognized for all deductible temporary differences, carryforward of unused tax credits and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized except in respect of deductible temporary differences associated with investments in subsidiaries, associates and interests in joint ventures, deferred tax assets are recognized only to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized.
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each balance sheet date and are recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance sheet date.
Earnings Per Share—Basic earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding during the year.
Diluted earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding, adjusted for the effects of all potentially dilutive ordinary shares. The weighted average number of ordinary shares outstanding is increased by the number of additional ordinary shares that would have been issued by the Company assuming exercise of all options with exercise prices below the average market price for the year.
Share-based compensation—Share-based compensation expense related to share awards is recognized based on the fair value of the awards granted.
The grant date fair value of equity-settled share-based payment awards granted to employee is recognized as an employee benefit expense, with a corresponding increase in equity, over the vesting period of the awards, The amount recognized as an expense is adjusted to reflected the number of awards for which the service and non-market performance conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that meet the service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual performance.
Government Grants—Government grants are recognized when there is reasonable assurance that the grant will be received and the Company will be in compliance with all attached conditions. When the grant relates to an expense item it is recognized as deferred income and released to the consolidated statements of operations over the period necessary to match the grant on a systematic basis to the costs that it is intended to compensate and is presented as a reduction of those costs. Where the grant relates to acquisition of assets, it is recognized as a reduction in the basis of the asset and released as a reduction to depreciation expense in equal amounts over the expected useful life of the related asset. Grants the Company received are primarily provided in connection with construction and operation of the Company’s manufacturing facilities, employment and research and development.
Research and Development Costs—Research costs are expensed as incurred. Development costs are recognized as intangible assets if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the assets.
Borrowing Costs—Borrowing costs directly attributable to the construction phase of property, plant and equipment are capitalized as part of the cost of assets which are constructed by the Company and for which a considerable period of time (at least six months) is planned for construction. Borrowing costs are capitalized from the start of construction until the date the asset is ready for its intended use. All other borrowing costs are recognized as an expense in the period in which they are incurred.
Current Income Tax—Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted by the balance sheet date.
Recent Accounting Pronouncements and Developments
Recent Accounting Pronouncement, Adopted:
Amendments to IFRS 7, IFRS 9 and IAS 39 Interest Rate Benchmark Reform
Phase 1 Amendments - On 1 January 2020, the Company adopted the Phase 1 amendments arising from the Interbank Offered Rate (“IBOR”) reform amendments issued in September 2019, which provides temporary relief from applying specific hedge accounting requirements to hedge relationships directly affected by IBOR reform, such that the effect is that IBOR reform should not generally cause hedge accounting to terminate.
Phase 2 Amendments - On 1 January 2021, the Company adopted the Phase 2 amendments arising from the IBOR reform issued in August 2020. The Phase 2 amendments address issues that arise from the implementation of the IBOR reform, including the replacement of an interest rate benchmark with an alternative benchmark rate. The key reliefs provided to the Company are as follows:
financial instruments measured at amortized cost are allowed to account for changes in the basis for determining contractual cash flows as a direct consequence of the IBOR reform by updating the effective interest rate, provided that the new basis is economically equivalent to the previous basis, such that there is no immediate gain or loss recognized; and
most IFRS 9 hedge relationships that are directly affected by the IBOR reform are allowed to continue.
As of June 30, 2023, the Company had completed the transition of the affected rates on borrowings from USD London Interbank Offered Rate to Term Secured Overnight Financing Rate (“SOFR”) and assessed the changes to be economically equivalent in accordance with IFRS 9. Any future impact has been deemed to be immaterial to the Company.

Recent Accounting Pronouncements, Not Adopted:
The Company has not adopted the following new, revised or amended IFRS standards that have been issued by the IASB but are not yet effective:
Non-current Liabilities with Covenants - Amendments to IAS 1 - Effective for annual periods beginning on or after January 01, 2024;
Lease Liability in a Sale and Leaseback - Amendments to IFRS 16 - Effective for annual periods beginning on or after January 01, 2024;
Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7-Effective for annual periods beginning on or after January 01, 2024
General Requirement for Disclosure of Sustainability-related Financial Information - IFRS S1 -Effective for annual reporting periods beginning on or after January 1, 2024; and
Climate Related Disclosures - IFRS S2 - Effective for annual reporting periods beginning on or after January 1, 2024
As of the date the accompanying financial statements were authorized for issue, the Company continues to evaluate the impact on its financial position and performance as a result of the initial adoption of the aforementioned standards or interpretations and related applicable period. The Company does not anticipate the impacts of the standards effective for annual periods beginning on or after January 01, 2024 will have a material impact on the financial statements.
New Legislation:
In August 2022, the CHIPS and Science Act was signed into U.S. law. Designed to boost investment in domestic high tech-research and development and catalyze investment in domestic semiconductor manufacturing capacity the CHIPS and Science Act provides a 25% refundable advanced manufacturing investment tax credit (“AMITC”) on certain investment and other financial incentives to promote investments in domestic semiconductor manufacturing beginning in 2023. The Company has analyzed the provisions of the new law and determined that certain capital expenditures will qualify under the law and provide a refundable tax credit to the Company on its 2023 tax return.
In August 2022, the U.S. Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new corporate alternative minimum tax ("CAMT") of 15% for corporations with an average global adjusted financial statement income in excess of $1 billion over a consecutive three year period, as well as a 1% excise tax on qualifying stock repurchases. The CAMT is effective for tax years beginning after December 31, 2022. The Company has estimated no tax liability relating to CAMT for the current fiscal year. It is possible that the CAMT could result in an additional tax liability in a particular year due to offsetting the U.S. tax liability with prior year losses. The Company continues to evaluate the impact the IRA may have on its operations and consolidated financial statements in future periods.
Legislation and administrative guidance continue to evolve under the Organization for Economic Co-operation and Development's ("OECD") international tax reform centering on a global minimum tax regime ("Pillar 2") effective beginning in fiscal year 2024. The Pillar 2 regime seeks to collect additional top-up taxes from multinational groups whose effective tax rates are lower than 15% at a jurisdictional level. The initiative will also trigger additional compliance obligations, such as the requirement to file an annual GloBE Information Return within 15 months of the end of the fiscal year. Pillar 2 is being accounted for under the scope of IAS 12 Income Taxes, which includes an amendment in May 2023 granting temporary relief from accounting for deferred taxes arising from jurisdictions implementing Pillar 2 minimum taxes. Under the amendment, the Company is applying the exception of neither recognizing nor disclosing deferred tax adjustments related to Pillar 2 income taxes.
The effective tax rate is computed at a jurisdictional level with reference to GloBE income for all constituent entities of the multinational group in that jurisdiction. Singapore announced in its 2024 budget that it will enact a domestic top-up tax and income inclusion rule (“IIR”) effective in 2025. The Company and its subsidiaries are considered constituent entities forming part of the multinational group led by Mubadala Diversified Global Holding, PJSC. Eligibility to safe harbor and Pillar 2 top-up taxes payable as well as Pillar 2 filing and reporting requirements by the Company are partially dependent upon and influenced by GloBE income calculations of Mubadala subsidiaries having operations in the jurisdictions in which it operates.
The Company and its subsidiaries operate in Germany, the Netherlands, France, Bulgaria, the United Kingdom, Japan, Korea and Malaysia which have enacted Pillar 2 rules in 2023, Singapore announced in its 2024 budget that it will enact domestic top-up tax and income inclusion rule effective in 2025. The Dutch IIR regime may apply to GloBE income from the United States and Germany entities in the Company’s structure but the Company continues to analyze whether a Pillar 2 income tax expense and cash tax detriment are expected to arise from the Netherlands or any other material jurisdictions in 2024. Similarly, the recently announced Singapore rules may cause an additional liability beginning in 2025. Several jurisdictions are yet to finalize their Pillar 2 implementation timeline, including the United States, India, Cayman Islands and the United Arab Emirates. The Cayman Islands and Bulgaria are jurisdictions in which the Company operates with statutory tax rates below 15% and the Company’s Singapore operations include incentive tax rates below 15% which may be more likely to result in a tax liability under Pillar 2 if transitional safe harbor rules do not apply. The Company is tracking legislative updates from these and other jurisdictions to determine if any Pillar 2 taxes may be payable in fiscal 2024.
XML 32 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Critical Accounting Judgements, Estimates, and Assumptions
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Changes in estimates Critical Accounting Judgements, Estimates and Assumptions
The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities,
income and expenses as well as the disclosure of commitments and contingencies. Actual results may differ from these estimates and such differences may be material to the consolidated financial statements.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised if the revision affects only that year, or in the year of the revision and future years if the revision affects both current and future years.
Determination of useful lives of property, plant and equipment—The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023. The impact of the change in estimated useful lives of certain buildings resulted in an increase to income before income taxes of $76 million for the year ended December 31, 2023.
Inventory Valuation—Inventory is based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost. The cost of raw materials is determined using applicable raw material purchase prices. The cost of supplies is determined based on a weighted-average cost formula. Work in process and finished goods are valued at the cost of direct materials and a proportion of manufacturing labor and overhead costs based on normal operating capacity.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Impairment Assessment of Non-Financial Assets—Impairment exists when the carrying value of an asset or CGU exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The fair value less costs to sell calculation is based on a discounted cash flow analysis that a potential buyer would perform in determining a transaction value of the CGU less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. When preparing the discounted cash flow analysis, the Company makes judgments in determining the independent cash flows that can be related to a specific CGU based on its asset usage model and manufacturing capabilities in addition to the discount rate used in the analysis. In addition, because judgments are made regarding the remaining useful lives of assets and expected future revenue and expenses associated with the assets, changes in these estimates based on changes in economic conditions or business strategies could result in material impairment charges in future periods.
Income Taxes and Realization of Deferred Tax Assets—In determining taxable income for financial statement reporting purposes, management makes certain estimates and judgments specific to taxation issues. These estimates and judgments are applied in the calculation of certain tax liabilities and in the determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for income tax and financial statement reporting purposes.
Deferred taxes are recognized for unused losses, among other factors, to the extent that it is probable that taxable profit will be available against which the losses can be utilized.
This evaluation requires the exercise of judgment with respect to, among other things, benefits that could be realized from available tax strategies and future taxable income, as well as other positive and negative factors. The ultimate realization of deferred tax assets is dependent upon, among other things, the Company’s ability to generate future taxable income that is sufficient to utilize loss carry-forwards or tax credits before their expiration or the Company’s ability to implement prudent and feasible tax planning strategies.
If estimates of projected future taxable income and benefits from available tax strategies are reduced as a result of a change in the assessment or due to other factors, or if changes in current tax regulations are enacted that impose restrictions on the timing or extent of the Company’s ability to utilize net operating losses and tax credit carry-forwards in the future, the Company may be required to reduce the amount of total deferred tax assets resulting in a decrease of total assets. Likewise, a change in the tax rates applicable in the various jurisdictions or unfavorable outcomes of any ongoing tax audits could have a material impact on the future tax provisions in the periods in which these changes could occur.
In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax rules and the potential for future adjustment of uncertain tax positions by the tax authorities in the countries in which the Company operates. If estimates of these taxes are greater or less than actual results, an additional tax benefit or charge may result.
Share-based compensationShare-based compensation expense is recognized based on the grant date fair value of the awards. The fair value of Restricted Share Units (“RSUs”) is determined based on the closing price of the ordinary stock on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model for options. The fair value of Performance Share Units (“PSUs”) is estimated using a Monte Carlo simulation. Both models require management to make certain assumptions of future expectations based on historical and current data. The assumptions
include the estimated fair value of the Company’s stock, expected term of the awards, expected volatility, dividend yield, and risk-free interest rate. These estimates involve inherent uncertainties and the application of management’s judgment.
The principles of modification accounting are applied when a new share-based payment is granted as a replacement for another share-based payment that is cancelled. When modification accounting is applied, the entity accounts for any incremental fair value in addition to the grant-date fair value of the original award. In the case of a replacement, the incremental fair value is the difference between the fair value of the replacement award and the net fair value of the cancelled award, both measured at the date on which the replacement award is issued. The net fair value is the fair value of the cancelled award measured immediately before the cancellation, less any payment made to the employees on cancellation.
A package of modifications might include several changes to the terms of a grant, some of which are favorable to the employee and some not. In the event the net effect is not beneficial to the employee, cancellation accounting will be applied. Cancellations or settlements of equity-settled share-based payments during the vesting period by the Company are accounted for as accelerated vesting; therefore, the amount that would otherwise have been recognized for services received is recognized immediately.
In September 2023, the people and compensation committee of GlobalFoundries approved a modification to the 2023 PSUs, to adjust the return on invested capital (“ROIC”) performance threshold. The modification did not increase the fair value of the 2023 PSUs as the non-market performance condition was not considered when determining the fair value on the modification date. The Company will cumulatively adjust the expense based on the number of shares probable of vesting based on ROIC metrics and the grant date fair value.
XML 33 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash And Cash Equivalents
12 Months Ended
Dec. 31, 2023
Statement of cash flows [abstract]  
Cash And Cash Equivalents Cash And Cash Equivalents
(in millions)December 31,
2023
December 31,
2022
Cash balances on hand and at banks$490 $990 
Other cash and cash equivalents1,897 1,362 
Total$2,387 $2,352 
Movements in cash and cash equivalents are presented in the Company’s consolidated statements of cash flows.
The following presents the reconciliation of assets, liabilities and equity arising from financing activities:
Non-cash changes
(in millions)
As of December 31, 2021
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2022
Assets
(Liabilities and Equity)
Restricted cash$$— $— $— $— $
Government grants receivable(1)
47 (93)18 (1)81 $52 
Other receivables(1)— — — — $(1)
Debt(2,013)(670)(6)10 168 $(2,511)
Lease obligations(426)89 (18)$(345)
Share capital(11)— — — — $(11)
Additional Paid-In Capital(23,487)(168)— — (176)$(23,831)
Total$(25,890)$(842)$(6)$18 $74 $(26,646)
Non-cash changes
(in millions)
As of
December 31, 2022
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2023
Assets
(Liabilities and Equity)
Restricted cash$$— $— $— $— $
Government grants receivable(1)
52 (5)23 101 $172 
Other receivables(1)— — — $— 
Debt(2,511)182 (17)(30)$(2,372)
Lease obligations(345)77 (117)(5)$(382)
Share capital(11)— — — — $(11)
Additional Paid-In Capital
(23,831)(42)— (154)$(24,027)
Total$(26,646)$212 $(111)$(33)$(41)$(26,619)
(1)Government grants receivable of $172 million and $52 million are included in receivables, prepayments and other assets in the consolidated statements of financial position as of December 31, 2023 and 2022, respectively.

Geographical concentration of cash and cash equivalents is as follows:
(in millions)December 31,
2023
December 31,
2022
United States of America$481 $484 
Republic of Singapore1,666 1,775 
Other240 93 
Total$2,387 $2,352 
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Receivables, Prepayments and Other Assets
12 Months Ended
Dec. 31, 2023
Trade and other current receivables [abstract]  
Receivables, Prepayments and Other Assets Receivables, Prepayments and Other Assets
(in millions)December 31, 2023December 31, 2022
Current:
Trade receivables, other than related parties(1)
$1,002 $824 
Other receivables255 497 
Unbilled accounts receivable(2)
33 24 
Receivables from government grant66 52 
Receivables from related parties (Note 29)
12 11 
  Other current financial assets52 79 
Total$1,420 $1,487 
Non-current:
Advances to suppliers(3)
213 235 
Non-trade receivables
— 10 
Receivables from government grant
106 — 
Payment in Lieu of Tax (“PILOT”) Bonds
— 11 
Other24 25 
Total$343 $281 
(1)The Company’s trade receivables, other than related parties, are all classified as current and are expected to be collected within one year. The Company’s provision for sales returns was not material for either of the years ended December 31, 2023 and 2022. See the table below for the aging of the Company’s trade receivables, other than related parties.
(2)Unbilled accounts receivable represents amounts recognized on revenue contracts less associated advances and progress billings. These amounts will be billed in accordance with the agreed-upon contractual terms or upon shipment of products or rendering services.
(3)Primarily represents advances to supplier to offset against future purchases.
The following table presents the activities in unbilled accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$24 $43 
Revenue recognized during the year101 87 
Amounts invoiced(92)(106)
Ending balance$33 $24 
The following table presents the aging of accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Receivables neither past due nor impaired$880 $708 

Less than 30 days114 83 
31 to 60 days22 
61 to 90 days11 
Total$1,002 $824 
XML 35 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories
12 Months Ended
Dec. 31, 2023
Inventories [Abstract]  
Inventories Inventories
Inventories consist of the following:
(in millions)December 31,
2023
December 31,
2022
Work in progress$928 $1,024 
Raw materials and supplies559 315 
Total$1,487 $1,339 
XML 36 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment
12 Months Ended
Dec. 31, 2023
Disclosure of detailed information about property, plant and equipment [abstract]  
Property, Plant and Equipment Property, Plant and Equipment
(in millions)
Land and
Land
Improvements
Building and
Leasehold
Improvements
EquipmentComputer
Construction
in Progress
Total
Cost
As of December 31, 2021
$130 $7,576 $22,350 $435 $1,423 $31,914 
Additions(1)
— 67 27 — 3,564 3,658 
Transfers from construction in progress409 935 21 (1,366)— 
Disposals(8)(182)(725)(17)(237)(1,169)
Effects of exchange rate changes(1)(3)(18)— — (22)
As of December 31, 2022
122 7,867 22,569 439 3,384 34,381 
Additions(1)
16 121 19 745 905 
Transfers from construction in progress— 616 1,979 (2,602)— 
Disposals— (25)(297)(2)(15)(339)
Effect of exchange rate changes— 11 — — 13 
As of December 31, 2023
$138 $8,581 $24,281 $448 $1,512 $34,960 
Accumulated Depreciation
As of December 31, 2021
$37 $4,266 $18,507 $384 $7 $23,201 
Additions(1)
443 975 23 — 1,447 
Disposals(4)(164)(674)(16)— (858)
Effects of exchange rate changes— (1)(4)— — (5)
As of December 31, 2022
$39 $4,544 $18,804 $391 $7 $23,785 
Additions(1)
322 976 19 — 1,322 
Disposals— (18)(296)(2)— (316)
Effect of exchange rate changes— — — 
As of December 31, 2023
$44 $4,849 $19,488 $408 $7 $24,796 
Net book value as of December 31, 2022
$83 $3,323 $3,765 $48 $3,377 $10,596 
Net book value as of December 31, 2023
$94 $3,732 $4,793 $40 $1,505 $10,164 
(1)     The Company earned investment tax credits related to the Company’s construction of a wafer fabrication facility in Saratoga County, New York (which were netted against additions relating to Building and Leasehold Improvements and Equipment). These credits were generally earned based on when the related assets were placed in service. The Company recorded the investment tax credits as a reduction of property, plant and equipment costs. As of December 31, 2023, and 2022, the investment tax credits included in property, plant and equipment amounted to $226 million and $179 million, respectively.
Construction in progress includes property, plant and equipment that are still in progress of construction and qualification process for equipment, necessary for these assets to be operating in the manner for their intended use. When these assets are completed and placed in service, they are transferred to property, plant and equipment and depreciation commences. The Company transferred $2.6 billion and $1.4 billion in 2023 and 2022, respectively, from construction in progress to the respective property, plant and equipment category.
The gross amount of ROU assets recorded under leases, which are included in property, plant and equipment amounted to $996 million and $888 million as of December 31, 2023 and 2022, respectively. The net carrying value of ROU assets amounted to $335 million and $282 million as of December 31, 2023 and 2022, respectively. Amortization of ROU assets is included in depreciation expense. Depreciation expense for the years ended December 31, 2023, 2022 and 2021 for all ROU assets was $57 million, $82 million and $81 million, respectively.
Depreciation expense on property, plant and equipment is as follows:
(in millions)202320222021
Cost of revenue$1,259 $1,377 $1,309 
Research and development expenses38 40 73 
Selling, general and administrative expenses25 30 29 
Total$1,322 $1,447 $1,411 
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2023
Intangible Assets [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Cost (in millions)
Technology,
Licenses and
Similar Rights
SoftwarePatentsGoodwillOthersTotal
As of December 31, 2021
$1,202 $284 $229 $18 $132 $1,865 
Additions62 96 — — 163 
Disposals(47)(12)(3)— — (62)
As of December 31, 2022
1,217 368 226 18 137 1,966 
Additions61 96 — — — 157 
Disposals(40)— — — — (40)
As of December 31, 2023
$1,238 $464 $226 $18 $137 $2,083 
Accumulated Amortization
As of December 31, 2021
$867 $278 $212 $— $131 $1,488 
Additions150 10 16 — — 176 
Disposals(46)(12)(3)— — (61)
As of December 31, 2022
971 276 225  131 1,603 
Additions121 — — 129 
Disposals(40)— — — — (40)
As of December 31, 2023
$1,052 $283 $225 $ $132 $1,692 
Net book value as of December 31, 2022
$246 $92 $1 $18 $6 $363 
Net book value as of December 31, 2023
$186 $181 $1 $18 $5 $391 

Amortization expense on intangible assets is as follows:
(in millions)202320222021
Cost of revenue$61 $91 $113 
Research and development expenses63 70 74 
Selling, general and administrative expenses15 20 
Total$129 $176 $207 
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Other Financial Assets And Liabilities Other Financial Assets And Liabilities
The following foreign currency forward contracts are outstanding at December 31, 2023 and 2022 (in millions, except average foreign currency/US$):
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Notional
Amount
Average
Foreign
Currency/
US$
Average
Strike
Price
Maturity
Outstanding as of December 31, 2022:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$46 $$(32)$— $1,203 0.94 — 2023 - 2024
Singapore dollar forward contracts (receive Singapore$/pay US$)15 — (1)— 496 1.37 — 2023
Japanese yen forward contracts (receive Japanese yen/pay US$)18 — (20)— 236 127.22 — 2023 - 2024
79 (53)— 1,935 
Interest rate swaps— 42 — — 795 — 
0.382% - 1.731%
2023 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
— — (3)535 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 51 — — 796 1.37 
1.830% - 1.941%
2028
Commodity swaps
— — (8)(2)47 — 512.562023
Total$79 $98 $(61)$(5)$4,108 
Outstanding as of December 31, 2023:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$14 $— $(4)$— $845 0.91 — 2024 - 2025
Singapore dollar forward contracts (receive Singapore$/pay US$)— (1)— 483 1.33 — 2024 - 2025
Japanese yen forward contracts (receive Japanese yen/pay US$)
(7)— 116 140.20 — 2024 - 2025
28 (12)— 1,444 
Interest rate swaps17 — — 653 — 
0.442% - 1.761%
2024 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
(3)— 519 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 73 — — 1,127 1.37 
1.83% - 1.941%
2028
Commodity swaps
— (27)(14)237 0.91 73.592024 - 2025
Total$52 $80 $(42)$(14)$3,980 
The following table presents the fair values and locations of these derivative instruments recorded in the consolidated statements of financial position:
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Outstanding as of December 31, 2022:
Derivatives designated as hedging instruments
Foreign currency forwards$69 $$(52)$— 
Interest rate swaps— 42 — — 
Cross currency swaps and cross currency interest rate swaps — 53 — (3)
Commodity swaps— — (8)(2)
Derivatives not designated as hedging instruments
Foreign currency forwards10 — (1)— 
Total$79 $98 $(61)$(5)
Outstanding as of December 31, 2023:
Derivatives designated as hedging instruments
Foreign currency forwards$24 $— $(9)$— 
Interest rate swaps17 — — 
Cross currency swaps and cross currency interest rate swaps74 (3)— 
Commodity swaps— (22)(11)
Derivatives not designated as hedging instruments
Foreign currency forwards(3)— 
Commodity swaps— — (5)(3)
Total$52 $80 $(42)$(14)
The following table presents the effect of derivatives designated as hedging instruments on the consolidated statements of operations and comprehensive income (loss) (net of tax):
As of December 31, 2023 and 2022, the estimated amount of loss from cash flow hedges currently retained in consolidated statements of comprehensive income (loss) expected to be reclassified into the consolidated statements of operations within the next 12 months is approximately $15 million and $17 million, respectively.
(in millions)
Amount of
Gains
(Losses)
Recognized in
Accumulated
OCI
on Derivatives
(effective
Portion)
Amount of
Gains (Losses)
Reclassified
from
Accumulated
OCI to cost of
Property,
Plant and
Equipment
Location of
Gains (Losses)
Reclassified from
Accumulated
OCI into Income
Amounts of
Gains
(Losses)
Reclassified
from
Accumulated
OCI into
Income
(Effective
Portion)
Amount of
Gain
(Losses)
Reclassified
into
Income
(Missed Forecast)
Location of Gains
(Losses)
 Recognized into
Income (Ineffective
Portion)
Amount of
Gain
(Losses)
Recognized
into
Income
(Ineffective
Portion)
Year ended December 31, 2022
Derivatives designated as hedging instruments— Forward currency forward contracts$(105)$(93)Cost of revenue and operating expenses$(76)— Other income (expense)$(5)
Derivatives designated as hedging instruments— Interest rate swaps55 — Finance expense— Other income (expense)— 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
72 — Cost of revenue and operating expenses— — Other income (expense)
Derivatives designated as hedging instruments – Commodity swaps
(5)— Cost of revenue and operating expenses26 — Other income (expense)(8)
Year ended December 31, 2023
Derivatives designated as hedging instruments— Forward currency forward contracts$17 $(17)Cost of revenue and operating expenses$34 — Other income (expense)— 
Derivatives designated as hedging instruments— Interest rate swaps— Finance expense28 — Other income (expense)— 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
31 — Finance expense— Other income (expense)(4)
Other income (expense)31 — 
Derivatives designated as hedging instruments – Commodity swaps
(32)— Cost of revenue and operating expenses(4)Other income (expense)— 
Other income (expense)— (13)
The following table presents the effect of derivatives not designated as hedging instruments on the consolidated statements of operations:
(in millions)
Location of Gains (Losses) Recognized in Income on Derivative
Amount of Gains (Losses) Recognized in Income on Derivative
Year ended December 31, 2021
Derivatives not designed as hedging instruments—foreign currency forwards contractsSelling, general and administrative expenses$(17)
Year ended December 31, 2022
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(22)
Total gain/(loss)
$(22)
Year ended December 31, 2023
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(16)
Derivatives not designed as hedging instruments—commodity swaps
Other income (expense)(8)
Total gain/(loss)
$(24)
XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trade Payables and Other Liabilities
12 Months Ended
Dec. 31, 2023
Subclassifications of assets, liabilities and equities [abstract]  
Trade Payables and Other Liabilities Trade Payables and Other Liabilities
(in millions)December 31,
2023
December 31,
2022
Current:
Trade payables$511 $532 
Accrued expenses496 573 
Contract liabilities(1)
895 592 
Advances and deposits(2)
68 93 
Payable for property, plant and equipment and Intangible Assets
282 961 
Other(3)
97 98 
Total$2,349 $2,849 
Non-current:
Payable for Intangible Assets76 92 
Contract liabilities(1)
1,088 1,326 
Other(3)
26 56 
Total$1,190 $1,474 
(1)Contract liabilities comprises contract liabilities for payments received in advance of the satisfaction of performance obligations for wafers, as well as NRE services.
(2)Advances and deposits include advances from customers of $22 million (2022: $73 million) collected for purchase orders.
(3)Other includes other financial liabilities, due from related parties, deferred tax liabilities and non-current advances and deposits. See Note 10 for further details on other financial liabilities.
The following table presents the activities in contract liabilities for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning contract liabilities balance$1,918 $1,901 
Cash receipts in advance of satisfaction of performance obligations805 1,189 
Released to the consolidated statements of operations (1)
(759)(951)
Amounts credited to customers— (221)
Other(2)
19 — 
Ending contract liabilities balance$1,983 $1,918 
Current$895 $592 
Non-current1,088 1,326 
Total$1,983 $1,918 
(1)Of revenue released to the consolidated statements of operations for the years ended December 31, 2023 and 2022, $476 million and $522 million, respectively were included in the beginning balance of the contract liabilities.
(2)Includes $19 million reclassification from accrued liabilities to contract liabilities.
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt
12 Months Ended
Dec. 31, 2023
Borrowing costs Abstract [Abstract]  
Long-Term Debt Long-Term Debt
(in millions)December 31,
2023
December 31,
2022
Current:
Term loans$571 $223 
Non-current:
Term loans1,801 2,288 
Total$2,372 $2,511 
The above balances are net of $7 million and $12 million of unamortized debt issuance costs for the years ended December 31, 2023 and 2022, respectively.
Movements in interest bearing borrowings for the year ended December 31, 2023 and 2022 were as follows:
(in millions)December 31, 2023December 31, 2022
Opening balance$2,511 $2,013 
New loans and borrowings46 971 
Repayments(228)(301)
Other43 (172)
Ending balance$2,372 $2,511 
Terms and Debt Repayment Schedule
The following table summarizes term loan facilities. The below arrangements are all considered to be secured.
DescriptionCurrencyNominal Interest
Rate
Interest
Payment
Terms
Principal
Payment
Terms
Year
of
Maturity
2023
Carrying
Amount
2022
Carrying
Amount
2018 Tool Equipment Purchase and Lease Financing(1)
USD
SOFR + 1.60%
QuarterlyQuarterly2023— 19 
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly202421 85 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual202564 — 
EUR Term Loan A
EUR
EURIBOR + 2.60%
QuarterlySemi-Annual2025— 
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 1.75%
Semi- AnnualSemi-Annual202636 36 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202560 59 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 1.75%
Semi- AnnualSemi-Annual2024368 13 
Various
EUR, USDVarious2024-202613 11 
Current total571 223 
Non-current:
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly2024— 21 
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 2.25%
Semi-AnnualSemi-Annual202672 108 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202534 93 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual2025586 649 
EUR Term Loan AEUR
EURIBOR + 2.60%
QuarterlySemi-Annual202582 89 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 2.25%
Semi-AnnualSemi-Annual202630 387 
2021 SGD EDB LoanSGD1.40%Semi-AnnualSemi-Annual2041987 923 
Various
EUR, USDVarious2024-202710 18 
Non-current total1,801 2,288 
Total$2,372 $2,511 
(1)On March 2, 2018, GLOBALFOUNDRIES SINGAPORE PTE, LTD. (“GFS”) entered into several Equipment Purchase and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $375 million. The total minimum lease payments amount to $375 million, to be paid in equal quarterly installments through March 1, 2023.
(2)On January 21, 2019, GFS entered into several Equipment Purchase Agreements and Lease Agreements with five banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ Fabs in Singapore for a total of $425 million.
(3)On October 31, 2019, the Company, GLOBALFOUNDRIES Dresden Module One Limited Liability Company & Co., KG. and GLOBALFOUNDRIES Dresden Module Two Limited Liability Company & Co. KG. entered into a term facilities agreement with Bank of America Merrill Lynch International Designated Activity Company and ING Bank, a branch of ING-DIBA AG, as coordinating mandated lead arrangers, and Bank of America Merrill Lynch International Designated Activity Company as facility and security agent, which provides a maximum incremental facility commitment totaling $750 million secured by certain qualifying equipment assets.
(4)On April 23, 2020, GFS entered into several Equipment Purchase Agreements and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $300 million.
2021 SGD EDB Loan—On September 3, 2021, the Company entered into a loan agreement with Singapore Economic Development Board (“EDB”), which provided loan facilities with maximum drawdown of $1,149 million (SGD 1,541 million) at a fixed nominal interest rate of 1.4%. The difference between the nominal interest rate of the loan and the market interest rate for an equivalent loan is recognized as a government grant. The loan matures on June 1, 2041, with interest-only payments for the first 5 years and principal repayments commence thereafter, payable on a semi-annual basis.
As of December 31, 2023, the Company’s total drawdown was $1.1 billion, of which $971 million was drawn down in 2022.
As of December 31, 2023 and 2022, $987 million and $923 million respectively, were recorded in long-term debt based on an effective interest rate of 3.20% and $179 million and $184 million respectively, were recorded in deferred income from government grants.
5-year Revolving and Letter of Credit Facilities Agreement—On October 13, 2021, the Company entered into an amendment to the 5-year Revolving and Letter of Credit Facilities Agreement to increase the commitment to $1.0 billion.
The following table summarizes unutilized credit facilities available to the Company to maintain liquidity to fund operations:
(in millions)December 31, 2023December 31, 2022
SGD EDB Loan$— $42 
Revolving Credit Facility1,012 1,012 
Uncommitted Credit Facilities(1)
46 64 
Total$1,058 $1,118 
(1) Credit facility made available to the Company, but the lender is not obligated to loan funds.
Assets pledged as security Various assets have been pledged to secure borrowings under pledged agreements for the Company. Cash and cash equivalents, trade accounts receivables, property, plant and equipment, inventories, and financial assets have been pledged to secure borrowings under pledged agreements for the Company. The Company is not allowed to pledge these assets as security for other borrowings or to sell them outside normal course of business.
XML 41 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases
12 Months Ended
Dec. 31, 2023
Disclosure of Leases [Abstract]  
Leases Leases
The Company has various lease agreements for certain of its offices, facilities, and equipment. Leases may include one or more options to renew. Renewals are not in the determination of the lease term unless the renewals are deemed to be reasonably certain at lease commencement. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. All leases were measured under a single criterion with the exception of those with terms not exceeding 12 months and low-value leases.
(in millions)December 31,
2023
December 31,
2022
Amortization of right-of-use assets$57 $82 
Interest expense on lease liabilities21 23 
Short-term and low-value leases expense— 
Total net lease cost$78 $106 
Weighted average remaining lease term12.4 years7.18 years
Weighted average discount rate5.16 %4.75 %
The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2023 and 2022:
December 31, 2023December 31, 2022
(in millions)
Minimum
Lease
Payments
Present
Value of
Payments
Minimum
Lease
Payments
Present
Value of
Payments
Within 1 year$44 $32 $92 $75 
2-5 years194 128 184 146 
After 5 years283 222 151 124 
$521 $382 $427 $345 
Less: amounts representing
finance charges(139)— (82)— 
Present value of minimum
lease payments
$382 $382 $345 $345 
Current32 75 
Non-current350 270 
Total$382 $345 
Supplemental cash flow information related to leases is as follows:
(in millions)December 31,
2023
December 31,
2022
Cash flows used in operating activities:
Payments of short-term and low-value leases$— $(1)
Interest paid(21)(23)
Cash flows used in financing activities:
Payment of lease obligations(77)(89)
The following table summarizes the movement of ROU assets which primarily relates to building and leasehold improvements during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$282 $305 
Additions 117 59 
Disposals
(7)— 
Amortization(57)(82)
Ending balance$335 $282 
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions
12 Months Ended
Dec. 31, 2023
Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]  
Provisions Provisions
The movement in provision for asset retirement obligations and restructuring expenses during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$298 $349 
Arising during the period
Accretion cost(4)
Restructuring expenses
71 91 
Utilized(1)
(136)(52)
Released to the consolidated statements of operations(2)
$— (88)
Ending balance$240 $298 
(1) Includes $10 million and $40 million related to asset retirement obligations, $126 million and $5 million related to restructuring expense and $0 and $7 million related to sale of EFK business for the years ended December 31, 2023 and 2022, respectively.
(2) Relates to the derecognition of asset retirement obligation related to the sale of the EFK business.
The Company records a provision for site restoration costs as required by legal and contractual obligations if assessed to be probable that it will incur such costs. Because of the long-term nature of the liability, the greatest uncertainty in estimating the provision is the costs that will be incurred. The Company has estimated costs based on currently available information provided by experts about the extent of restoration work required.
The provision has been calculated using a discount rate of 1.72% to 3.35% (2022: 1.58% to 4.04%), which is the risk-free rate in the jurisdiction of the liability. The site restoration costs are expected to be incurred on site abandonment for owned property and on lease expiration for leasehold land. The expected timing of incurring site restoration costs is consistent with the remaining useful lives of the underlying property, plant and equipment.
See Note 21 for information regarding the Company’s restructuring initiative.
XML 43 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Government Grants
12 Months Ended
Dec. 31, 2023
Government grants [Abstract]  
Government Grants Government Grants
The following table presents the movement in deferred income from government grants for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$404 $176 
Received/receivable during the period81 270 
Fair value of EDB loan
— 
Capitalized to fixed assets
(74)— 
Released to the consolidated statements of operations(58)(42)
Ending balance$360 $404 
Current93 110 
Non-current267 294 
Total$360 $404 
Government grants were recognized in the consolidated statements of operations as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Cost of revenue$29 $30 $33 
Research and development expenses29 11 — 
Selling, general and administrative— — 
Total balance$58 $42 $33 
The Company has received government support in the form of investment grants, research and development subsidies, refundable credits, subsidized loans and miscellaneous receipts for employee support. Amounts receivable from the government but not yet received have been included in receivables, prepayments and other assets. Certain investment grants are subject to forfeiture in declining amounts over the life of the agreement if the Company does not maintain agreed upon conditions specified in the relevant grant agreements. The Company continues to comply with the government grant conditions mainly relating to qualifying property, plant and equipment and employment levels.
XML 44 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Issued Capital and Reserves
12 Months Ended
Dec. 31, 2023
Share Capital, Reserves, and Other Equity Interest [Abstract]  
Issued Capital and Reserves Issued Capital and Reserves
Share Capital—On September 12, 2021, the Company effected a 1-for-2 reverse share split, which was approved by our board of directors on September 9, 2021.
On October 27, 2021, the Company completed an initial public offering, issuing 30,250,000 ordinary shares, as well as 1,595,744 ordinary shares in a concurrent private placement agreement.
As of December 31, 2023, there were 1,300 million ordinary shares and 200 million preferred shares with a par value of $0.02 authorized, and 554 million ordinary shares issued and outstanding.
Additional Paid-In Capital—Additional paid-in capital represents the excess of assets less liabilities contributed to GLOBALFOUNDRIES by shareholders over the share capital issued in exchange for those contributions and share-based compensation charges for share-based payments.
Reserves
All other reserves as stated in the consolidated statements of changes in equity:
Hedging Reserve—The cash flow hedge reserve contains the effective portion of the cash flow hedge relationships incurred as at the reporting date.
Foreign Currency Translation Reserve—The foreign currency translation reserve is used to record exchange differences arising from the translation of Advanced Mask Technology Centre GmbH & Co. KG (“AMTC”) and Maskhouse Building Administration GmbH & Co. KH (“BAC”)’s financial statements for consolidation purpose.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Revenue
12 Months Ended
Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Net Revenue Net Revenue
The following table presents the Company’s revenue disaggregated based on revenue source and timing of revenue recognition. The Company believes these categories best depict the nature and timing of revenue.
(in millions)202320222021
Type of goods and services:
Wafer fabrication$6,820 $7,627 $6,204 
Engineering and other services
572 481 381 
Total$7,392 $8,108 $6,585 
Timing of revenue recognition:
Revenue recognized over time$471 $445 $357 
Revenue recognized at a point in time6,9217,6636,228
Total
$7,392 $8,108 $6,585 
The Company recognizes revenue when wafers are transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location, as determined by the agreed shipping terms.
The Company’s remaining performance obligations that are completely or partially unsatisfied as of December 31, 2023, was approximately $20 billion pertaining to wafer products under certain long-term supply arrangements with customers. The Company recognizes revenue as the wafer products are shipped based on the agreed shipping terms. Generally, the amount and timing of recognition of the remaining performance obligations are subject to change and are affected by several factors, including terminations, subsequent modifications in the scope of contracts, and uncertainty in meeting volume commitments. Based on the current terms of the contracts, these performance obligations are expected to be substantially satisfied within the next five years.
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cost of Revenue
12 Months Ended
Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Cost of Revenue Cost of Revenue
(in millions)202320222021
Depreciation of property, plant and equipment and amortization of intangible assets (1)
$1,321 $1,468 $1,422 
Inventory changes materials costs and other
1,742 1,834 1,726 
Staff costs, maintenance costs, and utilities(2)
2,228 2,567 2,424 
Total$5,291 $5,869 $5,572 
(1)Amounts are net of amortization of government grants relating to assets. See Note 8 for the detailed movements of property, plant and equipment.
(2)Staff costs, maintenance costs, and utilities costs include share-based compensation of $48 million, $64 million and $55 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Research and Development Expenses
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Research and Development Expenses Research and Development Expenses
(in millions)202320222021
Staff costs, maintenance costs, and utilities(1)
$230 $247 $257 
Depreciation of property, plant and equipment and amortization of intangible assets
119 110 147 
Other (2)
79 125 74 
Total$428 $482 $478 
(1)Staff costs, maintenance costs, and utilities costs include share-based compensation of $25 million, $27 million and $22 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
(2)Other primarily includes material costs and net (income) expenses related to research funding agreements and wafer, labor, software license costs allocated (to) and from cost of revenue.
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Selling, General and Administrative Expenses
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Selling, General and Administrative Expenses Selling, General and Administrative Expenses
(in millions)202320222021
Staff costs, maintenance costs, and utilities (1)
$342 $417 $537 
Depreciation of property, plant and equipment and amortization of intangible assets25 45 49 
Other (2)
106 34 
Total$473 $496 $595 
(1)Staff costs, maintenance costs, and utilities costs include share-based payments of $96 million, $92 million and $152 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively. See Note 3 for further discussion on the timing of expense recognition.
(2)Other primarily includes net professional charges, marketing expenses and facility costs, (gain) loss on tool sales and certain contract cancellation fees. Real estate transfer taxes are also included in Other.
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring
12 Months Ended
Dec. 31, 2023
Restructuring [Abstract]  
Restructuring Restructuring
In December 2022, the Company’s management approved and commenced a restructuring plan aimed to realign the Company’s business and strategic priorities. This worldwide restructuring plan included a reduction in the number of full-time employees, as well as a reduction in leased workspaces and engagement of consultants for strategic support. The Company met the recognition criteria for the provisioning of phase one restructuring costs in the fourth quarter of 2022.
In February 2023, the Company announced phase two to the restructuring plan. Costs arising from this restructuring program comprised of termination benefits and costs associated with direct transition works.
The Company incurred $71 million and $94 million of restructuring charges for the years ended December 31, 2023, and 2022, respectively, which included $3 million of accelerated share-based compensation expense in 2022. These expenses are included in restructuring expense in the Company’s consolidated statements of operations, and unpaid amounts are included in provisions within current liabilities on the consolidated statements of financial position.
The changes to the restructuring provisions recorded on the consolidated statements of financial position as of December 31, 2023 and 2022 are summarized as follows:
(in millions)20232022
Beginning balance
$86 $— 
Provision7191 
Amounts paid(126)(5)
Ending balance
$31 $86 
The actual costs that the Company will incur may differ from these estimates based on the timing required to complete the restructuring plan, the number of people invoiced and the final termination benefits.
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation
12 Months Ended
Dec. 31, 2023
Share-based payment arrangements [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company incurred share-based compensation expense of $148 million, $173 million, and $223 million during the years ended December 31, 2023, 2022 and 2021, respectively. As of December 31, 2023 and 2022, the additional paid-in capital related to the share proceeds amounted to $46 million and $163 million, respectively. The Company incurred $21 million, $10 million and $5 million of payroll taxes associated with the share-based compensation expense for the years ended December 31, 2023 ,2022, and 2021 respectively.
As of December 31, 2023 and 2022, the Company has 3,485,505 shares and 2,826,758 shares respectively, available for future grant under the 2018 Share Incentive Plan (as described below).
As of December 31, 2023 and 2022, the Company has 17,011,837 shares and 13,648,116 shares respectively, available for future grant under the 2021 Equity Compensation Plan.
RSUs
In 2023 and 2022, the Company granted RSUs under the 2021 Equity Compensation Plan. The RSUs have a time-based vesting requirement, which provides that the RSUs will generally vest in three annual installments, with 33.33% vesting on each one-year anniversary of the vesting commencement date subject to the employee’s continued employment with the Company.
Number of
RSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
847,430 $39.59 
Granted3,416,545 $57.09 
Forfeited(314,158)$55.36 
Exercised
(738,387)$49.51 
Outstanding as of December 31, 2022
3,211,430 $54.39 
Granted2,426,183 $62.94 
Forfeited(390,769)$55.35 
Exercised(1,093,061)$55.28 
Outstanding as of December 31, 2023
4,153,783 $58.87 
Prior to the IPO, the value of the RSUs was determined by the Company’s Board of Directors. Because there had been no public market for the ordinary shares, the Board of Directors determined the fair value at the time of grant of the RSU by contemporaneous valuations performed by unrelated third-party valuation firms as well as a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors.
As of December 31, 2023, 2022 and 2021, there was $107 million, $88 million, and $26 million, respectively, of total unrecognized compensation cost related to outstanding RSUs.
PSUs
In 2023 and 2022, the Company granted performance stock units (“PSUs”) under the 2021 Equity Compensation Plan to certain senior level employees. Each PSU represents a contingent right to receive shares of the Company’s stock if the Company meets certain performance measures over the requisite performance period. The PSU awards entitle recipients to receive, upon vesting, a number of shares that ranges from 0% to 200% of the number of PSUs awarded, depending on the level of achievement of the specified performance conditions.
The PSUs vest subject to achievement of a performance target based on an absolute ROIC and relative total shareholder return (“TSR”) versus the SOX Index over a 3 year performance period subject to the grantee remaining employed by the Company through the end of the applicable performance period.
Number of
PSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
  
Granted
571,277 70.85 
Forfeited
(34,082)70.91 
Outstanding as of December 31, 2022
537,195 $70.91 
Granted875,646 $69.73 
Forfeited(220,422)$69.90 
Outstanding as of December 31, 2023
1,192,419 $69.96 
The Company uses the Monte Carlo simulation model to estimate the fair value of the PSUs at the date of grant. The equity volatility was determined based on the historical volatilities of comparable publicly traded companies over a look back period of 2.84 years and 2.74 years in 2023 and 2022, respectively, commensurate with the remaining term of the PSUs. The risk-free interest rate is based on the United States Treasury with a remaining term equivalent to the remaining performance measurement period. Dividends are not paid on the Company’s stock.
The assumptions used to value the Company’s PSUs granted during the period presented and their expected lives were as follows:
December 31, 2023
December 31, 2022
Expected dividend yield
Expected volatility50.93%45.50%
Risk-free interest rate4.60%2.55%
Compensation expense is recognized for the PSU awards based on a graded attribution basis over the vesting period. As of December 31, 2023, and 2022 there was $22 million and $24 million, respectively, of total unrecognized compensation expense related to the PSUs.

Share Options
In 2017, the Company approved the Share Incentive Plan, which was intended to attract and retain talented employees and align shareholder and employee interests. Share options under the Share Incentive Plan vested over a five-year period.
In 2019, the Company offered to exchange the share options under the Share Incentive Plan with new share options under the “2018 Share Incentive Plan,” under which the Company may grant up to 25 million options to purchase shares in the Company with an exercise price of $10.00 per share. The options vest based on service over four or five years, depending on the timing of the grant, and contingent upon a liquidity event (change in control or IPO) with the earliest vesting date on the one-year anniversary of a liquidity event. On April 19, 2019, the Company issued the share options subject to the tender offer. The exchange of 2017 plan options into 2018 plan options resulted in a total incremental fair value of $64 million, of which $39 million was recognized in the second quarter of 2021 when an IPO became probable. The remainder was attributed prospectively. In the fourth quarter of 2021, the Company modified the earliest vesting date from one year post-anniversary of a liquidity event to six-months post-anniversary of a liquidity event, and shortened the contractual term for options held by US taxpayers to be the calendar year end after or within the year of vest. The options that remain outstanding at expiration will be auto-exercised through the broker.
The share options are effective for a term of 10 years from the grant date. Because the vesting and exercisability of these share options were dependent on a qualified liquidity event, the Company had to assess the probability of such an event in order to determine the expenses related to the share-based payments for the period. On June 30, 2021, the Company deemed an IPO to be probable under IFRS.
Upon the tender offer, the Company measured the pre-modification value of the old share options and compared that to the fair value of the new share options using the Black-Scholes option pricing model. The equity volatility was determined based on the historical volatilities of comparable publicly traded companies over a period equal to the expected average share-based payments life. The risk-free rate of interest was interpolated from the U.S. Constant Maturity Treasury rate curve to reflect the remaining expected life of share options. The fair value of the ordinary shares underlying the stock options has historically been determined by the Company’s Board of Directors. Because there had been no public market for the ordinary shares, the Board of Directors determined the fair value of the ordinary shares at the time of grant of the option by contemporaneous valuations performed by unrelated third-party valuation firms as well as a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors.
The Company did not grant any stock options in 2023 and 2022.
The following table shows a summary of the share option’s activity for the year ended December 31, 2023 and 2022.
Number of
Share options
Weighted
average
exercise price
per Share
Outstanding as of December 31, 2021
21,749,558 $10.03 
Exercised
(14,956,321)$10.00 
Forfeited(532,634)$10.00 
Outstanding as of December 31, 2022
6,260,603 $10.02 
Exercised(4,468,985)$10.02 
Forfeited(151,579)$10.00 
Outstanding as of December 31, 2023
1,640,039 $10.02 
Exercisable balance as of December 31, 2023
1,485,670 $10.03 
The following table summarizes information about employees’ share options outstanding as of December 31, 2023:
Outstanding
Range of exercise prices
Number
Outstanding
Weighted
average
remaining
 contractual life
(in years)
$10.02 1,640,039 2.67
The weighted average remaining contractual life is calculated based on the 10-year contract terms of the options and the weighted average exercise price is calculated using the exercise price of the outstanding options, which pertain to the 2018 Share Incentive Plan.
As of December 31, 2023, 2022 and 2021, there was $1 million, $7 million and $63 million, respectively, of total unrecognized compensation cost related to outstanding stock options.
ESPP
In connection with, and prior to the consummation of the Company's initial public offering in 2021, the Company's board of directors adopted the GLOBALFOUNDRIES Inc. 2021 Employee Stock Purchase Plan (the “ESPP”). The ESPP is administered by the Company's board of directors or, as applicable, its delegate (the “ESPP Administrator”).
The ESPP provides eligible employees with an opportunity to purchase ordinary shares through payroll deduction of up to 10% of their eligible compensation. A participant may purchase a maximum of 2,500 ordinary shares during a purchase period. Amounts deducted and accumulated by the participant are used to purchase ordinary shares at the end of each six-month purchase period. Participants in the ESPP receive a one-time grant of 50 RSUs upon enrollment in the ESPP. The Company matches 20% of each employee’s contributions on an after-tax basis.
Subject to certain equitable adjustments in connection with certain events affecting the outstanding ordinary shares reserved for issuance as awards, the maximum aggregate number of ordinary shares that may be issued or transferred under the ESPP with respect to awards is 7,500,000 ordinary shares; provided that the share reserve under the ESPP will, unless otherwise determined by the board of directors, automatically increase on January 1 of each year for 8 years commencing on January 1, 2023 and ending on (and including) January 1, 2031 in an amount equal to 0.25% of the total number of ordinary shares outstanding on December 31 of the preceding year. In no event will the number of ordinary shares that may be issued or transferred pursuant to rights granted under the ESPP exceed 18,750,000, in the aggregate, subject to the adjustments described above.
As of December 31, 2023, of the Company has issued 620,481 shares under this plan reflecting employees’ contribution and the 20% Company match.
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance Income and Expenses
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Finance Income and Expenses Finance Income and Expenses
Finance Income
(in millions)202320222021
Interest income - deposits
$92 $31 $
Interest income on FVOCI investments
30 — 
Accretion income
27 12 
Total finance income
$149 $51 $6 
Finance Expenses
(in millions)202320222021
Interest on long-term debt$80 $69 $72 
Interest on lease obligations21 23 27 
Commitment fees and amortization of debt issuance costs13 13 12 
Accretion costs and other23 
Total finance expenses$137 $111 $114 
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gain on Sale of a Business
12 Months Ended
Dec. 31, 2023
Non-Current Asset Held For Sale And Discontinued Operations [Abstract]  
Gain on Sale of a Business Gain on Sale of a Business
In April 2019, the Company entered into an Asset Purchase Agreement with ON Semiconductor pursuant to which the Company agreed to transfer substantially all the assets and employees related to the EFK business. On December 31, 2022, the Company completed the sale of the EFK business for a total purchase price of $406 million, of which $170 million was received in prior years, and the remaining $236 million was received in January 2023. The Company recognized a gain upon the completion of the sale of $403 million after derecognition of net liabilities of $9 million.
The following is the breakdown of the net liabilities that were derecognized:
(in millions)December 31,
2022
Property, plant and equipment$83 
Inventories43 
Total Assets126 
Lease liabilities(47)
Other current and non-current liabilities(88)
Total Liabilities(135)
Net Liabilities$(9)
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Income (Expense), Net
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Other Income (Expense), Net Other Income (Expense), Net
(in millions)202320222021
Loss on hedging activities
$(78)$— $— 
Other(1)
21 $22 $(8)
Total other income (expense), net$(57)$22 $(8)
(1) Relates primarily to share of profits of joint ventures, and gains on the sales of property, plant and equipment and intangible assets.
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income taxes [Abstract]  
Income Taxes Income Taxes
For tax reporting purposes, the Company consolidates its entities under GLOBALFOUNDRIES Inc., a Cayman Islands entity as described in Note 1. Accordingly, the Company has presented the domestic portion of the disclosures below based on its country of domicile in the Cayman Islands.
As a Cayman Islands corporation, the Company’s domestic statutory income tax rate is 0.00%. The difference between the Company’s domestic statutory income tax rate and its (expense) benefit for income taxes is due to the effect of the tax rates in the other jurisdictions in which the Company operates. Principally, for the years ended December 31, 2023 and 2022, the Company is subject to United States’ federal and state taxes with a combined statutory tax rate of 21.6% and 22.1%, respectively; German corporation and trade taxes with a combined statutory tax rate of 31.6%; and Singapore’s statutory tax rate of 17.0%.
Income tax expense consisted of the following:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Current income tax expense:
       Current income tax benefit (expense)$(13)$(14)$
       Adjustments in respect of current income tax of previous year(3)(5)(1)
Deferred tax
     Net operating and investment allowance carryforwards(74)(44)(78)
     Currency effect on non-monetary assets of subsidiary23 (12)(37)
     Other change in temporary differences(11)36 
Income tax expense reported in the consolidated statements of operations
$(66)$(86)$(78)
A reconciliation between tax expense and accounting profit multiplied by the Company’s statutory rate of 0.0% is as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Income (Loss) before income taxes$1,084 $1,532 $(176)
Tax at Enacted Statutory Rate$— $— $— 
Foreign tax rate differential(65)(98)(75)
Adjustments in respect to current income tax of previous years(1)(5)(1)
Government grants exempt from tax
Deductible expense for tax purpose(2)— (1)
Impact of unrecognized deferred tax assets(20)57 
Non-deductible expenses for tax purposes— (21)(4)
Effects of foreign exchange gains (loss)10 (14)(22)
Impact of change in liability for uncertain tax positions
Withholding Tax— (11)— 
Other effects(2)
Income tax (expense) benefit
$(66)$(86)$(78)
Effective income tax rate(6.1)%(5.6)%44.3 %
The Company has determined that it is probable that 100% of deferred tax assets can be realized in Singapore. The Company has determined that realization of deferred taxes associated with loss carryforwards is limited to reserves for uncertain tax positions in the United States and Germany that would generate future taxable income, and deferred tax assets resulting from consolidation of AMTC and BAC.

Components of the Company’s deferred tax assets and liabilities are attributable as follows:
(in millions)December 31,
2023
December 31,
2022
Accelerated depreciation on property, plant and equipment$(12)$(18)
Losses, credits and investment allowances available for offsetting against future taxable income231 277 
Accrued expenses11 16 
Inventory
Other comprehensive income (loss)
(8)
Currency effect(1)— 
Other(2)
Net deferred tax assets$235 $266 
The classification of the net deferred tax assets in the statements of financial position is as follows:
(in millions)December 31,
2023
December 31,
2022
Deferred tax assets$241 $292 
Deferred tax liabilities(1)
(6)(26)
Net deferred tax assets$235 $266 
(1) Included in Other non-current liabilities in the statements of financial position.
Total unrecognized deferred tax assets as of December 31, 2023 and 2022 was $3,665 million and $3,708 million, respectively. The Company does not anticipate any significant changes to the total amounts of unrecognized deferred tax assets within the next 12 months of the reporting date. Deferred tax assets have not been recognized in respect to these items because it is not probable that future taxable profit will be available against which the Company can utilize the benefits.
As of December 31, 2023 and 2022, the Company has accumulated corporate losses in Germany of $1,119 million and $1,132 million, respectively, and trade tax losses in Germany of $830 million and $851 million, respectively. Except for a fully deductible base amount, utilization of German net operating loss carryforwards is limited to 60.0% of taxable income in any one year. German net operating losses do not expire with the passage of time, but may forfeit partially or completely as a result of legal entity restructurings.
As of December 31, 2023 and 2022, the Company has unutilized capital allowances on the property, plant and equipment held in Singapore of $440 million and $713 million, respectively, and unutilized tax losses available for carryforward of $58 million and $58 million, respectively. Under Singapore tax law, unutilized capital allowances and unutilized tax losses are deductible to the extent of income available. Unutilized capital allowances and unutilized tax losses can be carried forward indefinitely subject to compliance with the conditions that there is no substantial change in shareholders and no change in the Company’s principal activities, where applicable. As of December 31, 2023 and 2022, the Company has investment allowances of $843 million and $843 million, respectively in Singapore which can be carried forward indefinitely. These carryforward tax attributes have been fully recognized as deferred tax assets.
As of December 31, 2023 and 2022, the Company has gross operating loss carryforwards in the United States of $5,984 million and $7,307 million, respectively; $4,434 million will expire in years 2029 through 2037. As of December 31, 2023 and 2022, the Company has $821 million and $822 million, respectively of California gross operating loss carryforwards and, in the other states in which it operates, it has gross operating loss carryforwards of $868 million and $885 million, respectively. The state carryforwards expire beginning in 2026. In addition, the Company has U.S. research and development tax credit carryforwards of $186 million and $157 million for the years December 31, 2023 and 2022, respectively, that will expire in years 2030 through 2043. The Company has California research and development tax credits of $22 million and $17 million as of December 31, 2023 and 2022, respectively, that do not expire. In addition, the Company has nonrefundable New York Empire Zone credit carryforwards of $947 million and $1,115 million as of December 31, 2023 and 2022, respectively, that do not expire. Five other states have research and development tax credits, Texas, Minnesota, Vermont, North Carolina, and New Jersey for which the Company has calculated a total credit carryforward of $10 million and $8 million for the years December 31, 2023 and 2022, respectively. These credits have a carryforward that expire between 2030 through 2043. These carryforward attributes have not been recognized as deferred tax assets.
At December 31, 2023 and 2022, no deferred tax liabilities were recorded for taxes that would be payable on the undistributed earnings of the Company’s subsidiaries. It is the Company’s intention to indefinitely reinvest the undistributed earnings of its foreign subsidiaries except in certain limited cases, which are not expected to have a material tax effect. The cash that is permanently reinvested is typically used to expand operations.
A reconciliation of deferred taxes, net is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$266 $351 
Tax (expense) benefit recognized to consolidated statements of operations
(50)(67)
Tax (expense) benefit recognized to other comprehensive income (loss)
19 (18)
Ending balance$235 $266 
As of December 31, 2023 and 2022, the Company’s current tax receivables were $0 and $1 million, respectively, related to its subsidiaries in Europe.
As of December 31, 2023 and 2022, the Company’s current income tax payable of $19 million and $14 million is composed of $10 million, $4 million, $5 million and $2 million, $3 million, $9 million, respectively, for entities incorporated in Europe, the United States/Cayman Islands and Singapore, respectively. The current income tax payable amounts include the following uncertain tax provisions: $2 million in the United States for December 31, 2023 and $0 for December 31, 2022; $5 million and $8 million in Singapore for December 31, 2023 and 2022, respectively; $2 million and $3 million in Europe for December 31, 2023 and 2022, respectively, for exposure arising from unutilized capital allowances and domestic related party transactions. Europe had no current income taxable amounts included in uncertain tax provisions for either December 31, 2023 and 2022.
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share
12 Months Ended
Dec. 31, 2023
Earnings per share [abstract]  
Earnings Per Share Earnings Per Share
Basic and diluted earnings (loss) per share has been calculated for the years ended December 31, 2023, 2022, and 2021 as follows:
(in millions except per share amounts)
202320222021
Net income (loss) attributable to equity shareholders of the Company
$1,020 $1,448 $(250)
Weighted average ordinary shares outstanding
Basic552 539 506 
Diluted556 552 506 
Total basic and diluted earnings per share attributable to equity shareholders
Basic$1.85 $2.69 $(0.49)
Diluted$1.83 $2.62 $(0.49)
For the years ended December 31, 2023, 2022 and 2021, there were 1 million, 6 million and 22 million share options outstanding, respectively. Share options for the years ended December 31, 2023, 2022 and 2021 were not included in the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee Benefits Plans
12 Months Ended
Dec. 31, 2023
Employee Benefits [Abstract]  
Employee Benefits Plans Employee Benefits Plans
Retirement Savings Plans—The Company has a retirement savings plan, commonly known as a 401(k) plan, which allows participating employees in the United States to contribute a portion of their pre-tax salary up to Internal Revenue Service limits. The Company matches employee contributions dollar for dollar for the first 3% of participants’ contributions and 50 cents on each dollar of additional 3% of participants’ contributions, to a maximum of 4.5% of eligible compensation. The Company’s contributions to the 401(k) plan were $25 million, $32 million and $31 million for the years ended December 31, 2023, 2022 and 2021, respectively.
The Company also has an employee benefits plan that requires the Company to make monthly contributions based on the statutory funding requirement into a Central Provident Fund for substantially all Singapore citizens and permanent residents. The Company’s contributions under this plan were $29 million, $31 million and $29 million for the years ended December 31, 2023, 2022 and 2021, respectively.
See Note 22 for our Employee Stock Purchase Plan.
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures
12 Months Ended
Dec. 31, 2023
Related party [Abstract]  
Related Party Disclosures Related Party Disclosures
The consolidated financial statements include the following subsidiaries which are all wholly owned, except for Advanced Mask Technology Centre GmbH & Co. KG, Maskhouse Building Administration GmbH & Co. KG, Advanced Mask Technology Center Verwaltungs GmbH, and Maskhouse Building Administration Verwaltungs GmbH:
Subsidiary
Jurisdiction of
Incorporation or
Organization
December 31, 2023December 31, 2022December 31, 2021
GLOBALFOUNDRIES Dresden Module One LLCUnited StatesXXX
GLOBALFOUNDRIES Dresden Module Two LLCUnited StatesXXX
GLOBALFOUNDRIES Innovation LLC (formerly GLOBALFOUNDRIES Innovation Investments LLC)United StatesXXX
GLOBALFOUNDRIES Investments LLCUnited StatesXXX
GLOBALFOUNDRIES U.S. Inc.United StatesXXX
GLOBALFOUNDRIES U.S. 2 LLCUnited StatesXXX
GLOBALFOUNDRIES Borrower LLCUnited StatesXXX
Hudson Valley Research Park Sewage Works CorporationUnited StatesN/AXX
Hudson Valley Research Park Water-Works CorporationUnited StatesN/AXN/A
GF Power LLCUnited StatesXXN/A
GLOBALFOUNDRIES Finance Inc.Cayman IslandsXXN/A
GLOBALFOUNDRIES France SASFranceXXN/A
GLOBALFOUNDRIES Dresden Module One Holding GmbHGermanyXXX
GLOBALFOUNDRIES Dresden Module One LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two Holding GmbHGermanyXXX
GLOBALFOUNDRIES Management Services LLC & Co. KGGermanyXXX
Advanced Mask Technology Center GmbH & Co. KG (50%)GermanyXXX
Maskhouse Building Administration GmbH & Co. KG (50%)GermanyXXX
Advanced Mask Technology Center Verwaltungs GmbH (50%)GermanyXXX
Maskhouse Building Administration Verwaltungs GmbH (50%)GermanyXXX
GLOBALFOUNDRIES Europe Sales & Support GmbHGermanyXXX
GLOBALFOUNDRIES Engineering Private LimitedIndiaXXX
GLOBALFOUNDRIES Japan Ltd.JapanXXX
GLOBALFOUNDRIES Malaysia Sdn. Bhd.MalaysiaXXN/A
GLOBALFOUNDRIES Netherlands Cooperatief U.A.The NetherlandsXXX
GLOBALFOUNDRIES Netherlands Holding B.V.The NetherlandsXXX
GLOBALFOUNDRIES Bulgaria EADBulgariaXXX
GF Asia Investments Pte. Ltd.SingaporeXXX
GF Asia Sales Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Singapore Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Taiwan Ltd.TaiwanXXX
GLOBALFOUNDRIES Europe Ltd.United KingdomXXX
GA (Chengdu) Technology Co., Limited ChinaXXX
GLOBALFOUNDRIES China (Beijing) Co., LimitedChinaXXX
GLOBALFOUNDRIES China (Shanghai) Co., LimitedChinaXXX
Nanjing APD Technologies Co. Ltd.ChinaN/AN/AX
Related parties represent associated companies, the shareholder, directors and key management personnel of the Company and entities controlled, or significantly influenced by such parties. Pricing policies and terms of these transactions are approved by the Audit Committee or the Company’s management, as applicable.
Below are the related parties which the Company has entered into transactions with:
December 31,
2023
December 31,
2022
Related Party Name
SMPJoint ventureJoint venture
Mubadala Investment Company PJSC
Shareholder entityShareholder entity
Mubadala Technology Investment Company
Shareholder entityShareholder entity
MDC General Services Holding Company L.L.C
Shareholder entityShareholder entity
Balances with related parties included in the consolidated statements of financial positions are as follows:
December 31, 2023December 31, 2022
(in millions)Due from
Related
Parties
Due to
Related
Parties
Due from
Related
Parties
Due to
Related
Parties
SMP$12 $10 $11 $10 
Total(1)
$12 $10 $11 $10 
(1)The total amounts of $12 million and $11 million due from related parties as of the years ended December 31, 2023 and 2022, respectively, have been included in receivables, prepayments and other assets (see Note 6). The total amounts of $10 million and $10 million due to related parties’ balance for the years ended December 31, 2023 and 2022, respectively, have been included in trade and other payables (see Note 11).
The following table presents the related party transactions included in the consolidated statements of operations:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Purchases and recharges from:
SMP(1)
$61 $60 $60 
Total
$61 $60 $60 
Other transactions with:
SMP (reimbursement of expenses and contribution of tools)$61 $52 $45 
MDC General Services Holding Company L.L.C (recharge of expenses)
— 
Total$66 $52 $48 
(1)Purchases from SMP were primarily comprised of wafers.
Terms and Conditions of Transactions with Related Parties
Outstanding balances at the year-end are unsecured, interest free, repayable on demand and settlement occurs in cash. The Company has not recorded any allowance relating to amounts owed by related parties for the years ended December 31, 2023 and 2022. This assessment is undertaken each financial year through examining the financial position of the related party and the market in which the related party operates.
Transactions with Shareholder:
Shareholder Loan Agreement—The Company, as a borrower, entered into loan facilities with its shareholder in 2012 to 2016 (collectively the “Shareholder Loans”). The Shareholder Loans were non-interest bearing and principal repayment, in whole or in part, was entirely at the Company’s discretion as explicitly stated in the loan agreement. The Shareholder Loans were subordinated to any claims of other unsubordinated and subordinated creditors, including beneficiaries under guarantees issued, of the Company. The loans had no maturity date and remained outstanding until the loans were paid in full. Further, there were no contingent settlements in the agreements. Since the Shareholder Loans did not contain any contractual obligations to deliver cash, but rather allowed the Company to make repayment at its absolute discretion and further prohibited the shareholder from demanding repayment, the Company treated the Shareholder Loans as equity.
The Company repaid $568 million during the year ended December 31, 2021.
On October 1, 2021, the Company’s board approved the conversion of the Shareholder Loans to additional paid-in-capital, and on October 3, 2021, the Company executed an agreement with Mubadala Investment Company PJSC (“Mubadala”) to convert the remaining $10.1 billion of the Shareholder Loan balance into additional paid-in-capital (the ”Conversion”). The Conversion did not have an impact on shares outstanding or have any dilutive effects, as no additional shares were issued.
Compensation of Key Management Personnel
The compensation of key management personnel during the following years were as follows:
(in millions)202320222021
Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer
     Short-term benefits(1)
$$$
     Share-based payments(1)
21 19 42 
Board of Directors
Total
$33 $29 $53 
(1) For the year ended December 31, 2023, the amounts include short-term benefits and share-based payments for the Chief Business Officer and Chief Operating Officer.
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Financial Risk Management Objectives and Policies Financial Risk Management Objectives and Policies
GLOBALFOUNDRIES has implemented a cash investment policy which determines the overall objectives of the Company’s investment strategy. This policy is aimed to ensure the preservation of capital and the maintenance of sufficient liquidity necessary to fund operations while balancing the needs for appropriate returns. The cash investment policy limits permissible investments and credit quality.
The primary objective of the Company’s capital management is to ensure that it maintains a healthy capital ratio in order to support its business and maximize shareholder value.
The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions. There are no regulatorily-imposed requirements on the level of share capital which the Company is required to maintain.
The Company monitors capital using a gearing ratio, which is net debt divided by total capital plus net debt. The Company’s policy is to keep the gearing ratio within a range to meet the business needs of the Company.
The Company includes within net debt, interest bearing loans and borrowings and obligations under lease less bank balances, cash and marketable securities. Capital includes total equity including non-controlling interests less cumulative changes in fair value.
The Company’s interest-bearing loans and borrowings have certain financial covenants. Restrictive covenants in the Company’s credit facilities may prevent the Company from pursuing certain transactions or business strategies, including by limiting the Company’s ability to, in certain circumstances:
incur additional indebtedness;
pay dividends or make distributions;
acquire assets or make investments outside of the ordinary course of business;
sell, lease, license, transfer or otherwise dispose of assets;
enter into transactions with the affiliates;
create or permit liens;
guarantee indebtedness; and
engage in certain extraordinary transactions.
As of December 31, 2023, the Company is in compliance with the financial covenants.
Risks Arising from Financial Instruments—The main risks arising from the Company’s financial instruments are market risk (including foreign currency risk, interest rate risk and commodity price risk), credit risk and liquidity risk. The Board of Directors reviews and approves policies for managing each of these risks which are summarized below.
Market Risk—Market price risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market prices comprise the following types of risk: interest rate risk, foreign currency risk and commodity price risk.
Commodity Risk— Although the Company operates facilities that consume commodities, the Company’s exposure to commodity price risk is not material. The Company has established forecasted transaction risk management programs to protect against fluctuations in commodity prices and may use commodity derivatives contracts, such as commodity swaps, in these hedging programs. In addition, the Company has sourcing plans in place that are designed to mitigate the risk of a potential supplier concentration for its key commodities.
Interest Rate Risk—The Company’s exposure to market risk for changes in interest rates relates primarily to interest-earning financial assets and interest-bearing financial liabilities. The Company’s interest-earning financial assets are mostly
highly liquid investments and include money market funds, marketable securities and time deposits. As these financial assets have weighted-average maturity of less than one year, the Company’s exposure to interest risk is not material. The Company’s interest-bearing financial liabilities include fixed and floating rate loans and lease obligations. Floating rate loans bear interest at Base Rate or SOFR or EURIBOR plus a fixed premium. The Company uses pay-fixed / receive-float interest rate swaps to protect itself against adverse fluctuations in interest rates and to reduce its exposure to variability in cash flows from forecasted interest payments on its floating-rate debt facility to the extent that it is practicable and cost effective to do so.
Cash Flow Sensitivity Analysis for Variable Rate InstrumentsThe sensitivity of net income in the consolidated statements of operations is the effect of the assumed changes in interest rates on the Company’s net income for one year, based on the floating rate financial liabilities held on December 31, 2023, after taking into account interest rate hedges.
A hypothetical change in benchmark interest rates of 10% from current rates would not have a material impact on the consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021, after taking into account interest rate hedges.
Foreign Currency RiskAs a result of foreign operations, the Company has non-US-dollar denominated costs, assets and liabilities, primarily denominated in the EUR, JPY and SGD. Movements in foreign exchange rates could cause foreign currency denominated expenses to increase as a percentage of net revenue, affecting the Company’s profitability and cash flows. The Company uses foreign currency forward contracts to reduce exposure to foreign currency fluctuations from its foreign currency denominated expenditures. The Company may also economically hedge foreign currency risk related to its non-US-dollar denominated assets and liabilities with currency forward contracts.
The Company also incurs a certain portion of its interest expense in EUR and SGD, exposing the Company to exchange rate fluctuations between US dollar and the EUR or SGD. The Company uses cross-currency swaps and cross-currency interest rate swaps to reduce its exposure to variability from foreign exchange rates impacting cash flows arising from Company’s foreign currency denominated debt to the extent that it is practicable and cost effective to do so.
Exposure to Currency RiskThe Company’s exposure to foreign currency risk against financial assets and financial liabilities was as follows, based on notional amounts:
(in millions)
EUR
JPY
SGD
December 31, 2022
Receivables and prepayments
$120 $— $16 
Cash and cash equivalents
48 420 
Loans and borrowings
45 — — 
Trade and other payables
(388)(73)(149)
$(175)$(69)$287 
December 31, 2023
Receivables and prepayments
$86 $— $28 
Cash and cash equivalents
$104 $$19 
Loans and borrowings
$11 $— $— 
Trade and other payables
$(253)$(97)$(121)
$(52)$(92)$(74)
A hypothetical 10% change in the relative value of the U.S. dollar to other currencies would not have a material impact on the consolidated statements of operations for the years ended December 31, 2023, 2022 and 2021, after taking into account foreign currency hedges
Credit Risk—Credit risk can be defined as the risk of suffering financial loss from financial instruments due to the failure by a counterparty to fulfill an obligation. Financial instruments that subject the Company to concentrations of credit risk include investments and cash equivalents, accounts receivable and derivatives. The Company generally places investments with high-credit-quality counterparties and, by policy, limits the amount of credit exposure to any one counterparty based on an analysis of that counterparty's relative credit standing. As required per the investment policy, substantially all of the Company’s investments in debt instruments are in investment-grade instruments. Counterparty credit-rating criteria for derivatives are similar to those for other investments.
The Company generally does not require collateral to secure accounts receivable. Credit risk with respect to trade receivables is mitigated by credit evaluations the Company performs on its customers, the short duration of payment terms for the significant majority of its customer contracts and by the diverse nature of the Company’s customer base. The expected credit losses of trade and other receivables are not significant.
The Company’s ten largest customers account for approximately 79% and 74% of the outstanding trade receivables balance as of December 31, 2023 and 2022, respectively. The Company considers the concentration of credit risk for the remaining accounts receivable not material.
Exposure to Credit Risk—The carrying amount of financial assets represents the assets’ maximum credit exposure.
The aging of financial assets including trade receivables is as follows:
Past Due but Not Impaired
(in millions)TotalNeither past
Due Nor
Impaired
< 30 Days31-90 Days91-120 DaysGreat
than
120 days
December 31, 2022$2,254 $2,137 $84 $33 $— $— 
December 31, 2023$2,785 $2,651 $127 $$— $— 
Liquidity RiskThe Company monitors its risk of a shortage of funds by monitoring its cash flow situation. Ongoing cash forecasting and review processes have been set up to determine the amount of internal and external funding needed in order to meet the Company’s financial obligations as they become due. The Company has set up a process of mid- and long-term financial planning. The Company’s financing structure, including maturities of debt, is determined in response to the financing requirements identified with the long-term business planning process.
The table below summarizes the maturity profile of the Company’s financial liabilities:
(in millions)Carrying
Value
Contractual
Cash Flows
1 Year or
Less
1 to 5 Years
Greater
than
5 Years
December 31, 2022
Loans and borrowings$2,511 $2,706 $229 $1,443 $1,034 
Lease obligations345 427 92 184 151 
Derivative liabilities
66 66 61 — 
Trade payables and other liabilities2,265 2,265 2,171 63 31 
Total$5,187 $5,464 $2,553 $1,695 $1,216 
December 31, 2023
Loans and borrowings$2,372 $2,558 $575 $971 $1,012 
Lease obligations382 521 44 194 283 
Derivative liabilities
56 56 42 14 — 
Trade payables and other liabilities1,438 1,438 1,354 55 29 
Total$4,248 $4,573 $2,015 $1,234 $1,324 
In preparing the maturity profile, undiscounted interest payments are calculated based on contractual interest rates where these are fixed, or, in the case of discounted liabilities for leases, based on the interest rate implicit in the financing arrangement. For variable interest arrangements undiscounted payments are determined based on the interest rate prevailing at the reporting date.
Assets and Liabilities Measured at Fair Value—The Company uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:
Level 1—observable inputs such as quoted prices in active markets for identical assets or liabilities
Level 2—inputs other than quoted prices in active markets in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for similar assets or liabilities that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability; and
Level 3—unobservable inputs for which little or no market data exists, therefore requiring management judgment to develop the Company’s own models with estimates and assumptions.
Cash Equivalents - Cash equivalents include investments in government obligation-based money market funds, other money market instruments and interest-bearing deposits with initial or remaining terms of three months or less. The fair value of cash equivalents approximates its carrying value due to the short-term nature of these instruments.
Marketable Securities - Marketable securities utilizing Level 1 and Level 2 inputs include U.S. Treasury Securities, U.S. Government Sponsored Enterprises, floating rate securities, money market mutual funds, corporate debt instruments and other Notes, bonds or debt securities issued by non-U.S. sovereign or multilateral entities, as these securities all have quoted prices in active markets.
For assets and liabilities that are recognized at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period. Foreign currency forward contracts are classified within Level 2. The fair values of foreign currency forward contracts are determined using quantitative models that require the use of multiple market inputs, including interest rates, prices and maturity dates to generate pricing curves,
which are used to value the positions. The market inputs are generally actively quoted and can be validated through external sources. For foreign currency forward contract asset and liability positions with maturity dates which fall between the dates of quoted prices, interpolation of rate or maturity scenarios are used in determining fair values. During the years ended December 31, 2023 and 2022, there were no transfers between Level 1, 2 and Level 3 fair value measurements.
Financial Instruments Measured at Fair Value on a Recurring Basis
The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis:
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2022
Assets:
Cash equivalents(1)
$961 $961 $— $— 
Investments in equity instruments(2)
$15 $— $— $15 
Investment in marketable securities(3)
$994 $994 $— $— 
Derivatives(3)
$177 $— $177 $— 
Liabilities:
Derivatives(3)
$66 $— $66 $— 
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2023
Assets:
Cash equivalents (1)
$1,897 $1,626 $271 $— 
Investments in equity instruments (2)
$19 $— $— $19 
Investments in marketable securities(3)
$1,501 $1,189 $312 $— 
Derivatives(4)
$132 $— $132 $— 
Liabilities:
Derivatives(4)
$56 $— $56 $— 
(1)Included in cash and cash equivalents on the Company’s consolidated statements of financial position.
(2)Included in current and non-current receivables, prepayments and other assets on the Company’s consolidated statements of financial position.
(3)Included in current and non-current marketable securities on the Company’s consolidated statements of financial position.
(4)Consists of foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps. Included in other current and non-current financial assets and liabilities, as applicable, on the Company’s consolidated statements of financial position.
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
Certain assets such as equity method investments, intangible assets and property, plant and equipment, and other non-financial assets, are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities (that have not been re-measured or impaired in the current period), grants receivable, loans receivable, lease obligations and the current and non-current portions of the Company’s long-term debt.
The following table shows the carrying and fair values of the Company’s financial liabilities at amortized cost (“FLAC”) not recorded at fair value on a recurring basis. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.
(in millions)December 31, 2023December 31, 2022
Financial Liability
Category
Carrying
Amount
Fair ValueCarrying
Amount
Fair Value
Other long-term debtFLAC$2,372 $2,319 $2,511 $2,414 
Total$2,372 $2,319 $2,511 $2,414 
Estimated fair values of loans and borrowings is based on quoted prices for similar liabilities for which significant inputs are observable and represents a Level 2 valuation. The fair values are estimated based on the type of loan and maturity. The Company estimates the fair value using market interest rates for the Company’s debts with similar maturities.
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2023
Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Commitments—The Company’s unconditional purchase commitments are as follows:
(in millions)December 31,
2023
December 31,
2022
Contracts for capital expenditures$1,136 $2,774 
Contracts for operating expenditures2,786 3,587 
Total
$3,922 $6,361 
Due within the next 12 months
$970 $2,732 
In addition to the above, the Company obtained letters of credit to primarily guarantee payments for utility supplies and foreign statutory payroll related charges. The Company has obtained letters of credit of $23 million and $20 million at December 31, 2023 and 2022, respectively, and bank guarantees of $54 million and $4 million at December 31, 2023 and 2022, respectively.
The Company has a patent license agreement with LSI Technology Corporation (“LSI”) under which the parties grant to one another a license to use certain of each other’s patents. Under the terms of the patent license agreement, the Company may provide wafer capacity in lieu of payment for royalties. Such royalties under the patent license agreement are waived until such time the interest of LSI in SMP falls below 49%. In exchange, the Company has waived capacity shortfall obligations from LSI. Should the interest of LSI in SMP fall below 49%, the Company may be required to make royalty payments to LSI under this patent license agreement. The Company has not made any royalty payments to LSI. The patent license agreement continues for as long as the joint venture agreement between the parties remains.
On April 28, 2021, IBM sent the Company a letter alleging for the first time that it did not fulfill its obligations under the contracts entered into with IBM in 2014 and 2015 associated with the acquisition of IBM’s Microelectronics division. IBM asserted that the Company engaged in fraudulent misrepresentations during the underlying negotiations, and claimed the Company owed them $2.5 billion in damages and restitution. On June 7, 2021, the Company filed a complaint with the New York State Supreme Court (the “Court”) seeking a declaratory judgment that the Company did not breach the relevant contracts. IBM subsequently filed its complaint with the Court on June 8, 2021. On September 14, 2021, the Court granted the Company’s motion to dismiss IBM’s claims of fraud, unjust enrichment and breach of the implied covenant of good faith and fair dealing. IBM appealed the dismissal of its fraud claim, and on April 7, 2022, the New York Appellate Division reversed the Court’s decision. Discovery and dispositive motion practice have been completed and the parties are awaiting a trial date. The Company believes, based on discussions with legal counsel, that it has meritorious defenses against IBM’s claims and intends to vigorously defend against them.
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Operating Segments Information
12 Months Ended
Dec. 31, 2023
Operating Segments [Abstract]  
Operating Segments Information Operating Segments Information
(a)Operating segments, segment revenue, operating results
The Company’s chief operating decision-maker is the Company’s Chief Executive Officer who makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis. There are no segment managers who are held accountable by the chief operating decision-maker, or anyone else, for operations, operating results, and planning for levels or components below the consolidated unit level. Accordingly, the Company has determined that the Company has a single reportable segment and operating segment structure.
(b)Revenue based on customers’ headquarters and non-current assets by geography were as follows:
For the year ended December 31,
Revenue by Geography202320222021
(in millions)
United States$4,262 $4,898 $3,975 
Europe, the Middle East, and Africa1,533 1,182 805 
Other1,597 2,028 1,805 
Total
$7,392 $8,108 $6,585 
Non-current Assets by Geography20232022
(in millions)
United States$4,738 $5,149 
Germany2,400 2,462 
Singapore3,801 3,508 
Other457 532 
Total$11,396 $11,651 
Non-current assets include property, plant, equipment, right-of-use assets, intangible assets, investments in joint venture and associates, restricted cash (non-current) and receivables, prepayments and other assets (non-current).
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Customer And Supplier Concentration
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Customer And Supplier Concentration Customer And Supplier Concentration
Significant customers and suppliers are those that account for greater than 10% of the Company’s revenue and purchases in any of the years presented.
The Company earned a substantial portion of revenue from two customers in 2023 , 2022 and 2021: Customer A amounted to 8%, 9% and 12% of total revenue, respectively, and Customer B amounted to 17%, 16%, and 15% of total revenue, respectively. As of December 31, 2023 and 2022, the amounts due from Customer A included in accounts receivable were $122 million and $71 million, respectively, and the amounts due from Customer B included in accounts receivable were $237 million and $163 million, respectively. The loss of the significant customers or the failure to attract new customers could have a material adverse effect on the Company’s business, results of operations and financial condition.
For the year ended December 31,
Revenue by major customer
202320222021
(in millions)Amount%Amount%Amount%
Customer A$620 8$746 9$811 12
Customer B$1,279 17$1,329 16$995 15
The Company purchased 63%, 54% and 46%, of its SOI wafers, a key input into its products, from a single supplier in 2023, 2022 and 2021, respectively. As of December 31, 2023 and 2022, the net amount due to the supplier was $61 million and $56 million, respectively. Any failure in the supplier’s ability to provide SOI wafers could materially and adversely affect the Company’s results of operations, financial condition, business and prospects.
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Material Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Basis of Measurement These financial statements have been prepared on the historical cost basis except as otherwise described in the notes below.
Basis of Consolidation
Basis of Consolidation—The consolidated financial statements comprise the financial statements of GLOBALFOUNDRIES and its subsidiaries. Subsidiaries are fully consolidated from the date of acquisition, being the date on which GLOBALFOUNDRIES obtains control, and continue to be consolidated until the date when such control ceases. All intercompany transactions, balances, income and expenses are eliminated in full on consolidation. Wholly-owned subsidiaries and controlled entities included in these consolidated financial statements are disclosed in Note 29.
Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the subsidiary and has the ability to affect those returns through its power over the subsidiary. Specifically, the Company controls a subsidiary if the Company (a) has power over the subsidiary, (b) is exposed, or has rights, to variable returns from its involvement with subsidiary, and (c) has the ability to use the power to affect its returns.
Profit or loss and each component of other comprehensive income (loss) (“OCI”) are attributed to the Shareholder of the Company and to the non-controlling interests.
A change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction.
If the Company loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other components of equity, while any resulting gain or loss is recognized in the consolidated statements of operations. Any investment retained is recognized at fair value.
Foreign Currency Translation
Foreign Currency Translation—Assets and liabilities of foreign operations having a functional currency other than the U.S. dollar are translated at the rate of exchange prevailing at the reporting date and revenue and expenses at the rate of exchange prevailing at the dates of the transactions during the period. Gains or losses on translation of foreign operations are included in OCI.
In preparing the consolidated financial statements of the Company, foreign currency-denominated monetary assets and liabilities are translated into the functional currency using the closing rate at the applicable consolidated statement of financial position dates. Non-monetary assets and liabilities, denominated in a foreign currency and measured at fair value, are translated at the rate of exchange prevailing at the date when the fair value was determined and non-monetary assets measured at historical cost are translated at the historical rate. Revenue and expenses are measured in the functional currency at the rates of exchange prevailing at the dates of the transactions with gains or losses included in the statements of operations.
Investments in Joint Operations Investments in Joint Operations—A joint operation is an arrangement in which the Company has joint control whereby the Company has rights to assets, and obligations for the liabilities, relating to an arrangement. The Company accounts for each of its assets, liabilities and transactions, including its share of those held or incurred jointly, in relation to the joint operation
Cash and Cash Equivalents
Cash and Cash Equivalents—Cash and cash equivalents consist of highly liquid time deposits and investments that are readily convertible into cash, which are not subjected to significant risk of changes in value, and have original maturities of three months or less at the time of purchase.
Trade Accounts Receivable
Trade Accounts Receivable—Trade accounts receivable are recognized initially at fair value. A provision for impairment of trade accounts receivable is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivable.
Inventories
Inventories—Inventories are stated at standard cost adjusted to the lower of cost or net realizable value. The Company measures the cost of its inventory based on a standard cost process with appropriate adjustments for purchasing and manufacturing variances, which approximates weighted average cost.
Inventory allowances are made on an item-by-item basis, except where it may be appropriate to group similar or related items. An allowance is made for the estimated losses due to obsolescence based on expected future demand and market conditions. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.
Financial Instruments
Financial Instruments:
Category of financial instruments and measurement
Recognition and Initial Measurement—Trade receivables are initially recognized when they are originated. All other financial assets and financial liabilities are initially recognized when the Company becomes a party to the contractual provisions of the instrument.
A financial asset (unless it is a trade receivable without a significant financing component) or financial liability is initially measured at fair value plus or minus, for an item not at fair value in the profit and loss (“FVPL”), transaction costs that are directly attributable to its acquisition or issue. A trade receivable without a significant financing component is initially measured at the transaction price.
Classification and Measurement—All recognized financial assets are measured based on amortized cost or fair value. The classification is based on two criteria, the Company’s business model for managing the assets and whether the instrument’s contractual cash flows represent solely payments of principal and interest (“SPPI”).
The assessment of whether contractual cash flows on debt instruments are solely comprised of principal and interest is made based on the facts and circumstances at the initial recognition of assets.
Financial assets include trade and other receivables. These are recorded at amortized cost when such financial assets are held with the objective to collect contract cash flows that meet the SPPI criterion.
Financial assets recorded at FVPL comprise unquoted equity instruments which the Company had not irrevocably elected, at initial recognition, to classify at fair value through other comprehensive income (“FVOCI”).
Financial assets recorded at FVOCI comprise marketable securities that are quoted debt instruments when such financial assets are held with the objectives of both collecting contractual cash flows and selling these financial assets, and meet the SPPI criterion. Movements in the carrying amount are taken through OCI, except for the recognition of impairment gains or
losses and interest income which are recognized in the consolidated statements of operations. Interest income from these financial assets is included in finance income using the effective interest rate method.
Derecognition of financial assets
The Company derecognizes a financial asset only when the contractual rights to the cash flows from the financial asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the financial asset to another entity. On derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in the consolidated statements of operations.
On derecognition of an investment in a debt instrument at FVOCI, the difference between the asset’s carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss that had been recognized in OCI is recognized in the consolidated statements of operations.
Impairment of financial assets
The Company will record an allowance for expected credit losses (“ECL”) for all loans to related parties, marketable securities (that are quoted debt instruments), contract assets, and trade receivables and other receivables not recorded at FVPL. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive. The shortfall is then discounted using the asset’s effective interest rate.
The Company estimated its ECL for its contract assets and trade receivables at an amount equal to lifetime credit losses, while marketable securities and other receivables are measured at 12-months ECL if they are determined to have low credit risk at the reporting date.
Offsetting of Financial Instruments—Financial assets and financial liabilities are offset and the net amount reported in the consolidated statements of financial position when there is an enforceable legal right to offset the recognized amounts, and there is an intention to settle on a net basis, or to realize the assets and settle the liabilities simultaneously.
Derivative Financial Instruments and Hedge Accounting—Through its operating, investing and financing activities in the normal course of business, the Company is exposed to various types of market risk including foreign exchange risk, interest rate risk and risks associated with changes in the market price of certain commodities. The Company uses derivative financial instruments, such as foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps to mitigate a portion of the risks associated with changes in foreign currency exchange rates, interest rates and commodity prices. The Company’s objective for holding derivatives include reducing, eliminating and efficiently managing the economic impact of these exposures as effectively as possible. The Company’s derivative programs include strategies that both qualify and do not qualify for hedge accounting treatment. However, the Company does not use derivative financial instruments for trading or speculative purposes.
Derivative financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently remeasured at fair value at each reporting date. Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative.
Foreign currency forward contracts are used to hedge a portion of certain foreign currency-denominated forecasted operating expenditures, primarily in Euro (“EUR”), Japanese Yen (“JPY”) and Singapore Dollar (“SGD”). The Company also hedges future cash flows for certain foreign currency-denominated forecasted capital expenditures, primarily in EUR and JPY. Certain foreign currency forward contracts not designated as hedging instruments are also used to manage the variability in foreign exchange rates on certain balance sheet amounts and to manage other foreign currency exposures.
The Company uses interest rate swaps, cross-currency interest rate swaps and cross-currency swaps to protect itself against adverse fluctuations in interest rates and foreign currency exchange rates and to reduce its exposure to variability in forecasted cash flows associated with the Company’s floating-rate and foreign currency-denominated debt.
The Company also uses commodity swaps to hedge forecasted electricity and natural gas purchases to minimize the impact of commodity price movements on the reported earnings of the Company and on future cash flows related to fluctuations of the contractually specified, separately identifiable and reliably measurable commodity risk component.
At the inception of the hedge relationship, the Company documents the relationship between the hedging instrument and the hedged item along with its risk management objectives and its strategy for undertaking various hedge transactions. Furthermore, at the inception of the hedge, and on an ongoing basis, the Company documents whether there continues to be an economic relationship between the hedged item and the hedging instruments. The Company designates these derivative instruments in cash flow hedges of forecasted operating and capital expenditures or floating-rate and foreign currency-denominated debt, as applicable, and evaluates hedge effectiveness prospectively.
The effective portion of the gain or loss on these contracts is reported as a component of OCI and reclassified to the consolidated statements of operations in the same line item and in the same period during which the associated hedged forecasted transaction affects earnings. For hedges of capital expenditures, the amount in OCI is incorporated into the initial carrying amounts of the non-financial assets and depreciated over the average useful life of the associated assets. Any
ineffective portion of hedges or changes in fair value from excluded components of the hedge are immediately recorded in the consolidated statements of operations.
Hedge accounting is discontinued when the hedging instrument expires or is sold, terminated, or exercised, or when it no longer meets the criteria for hedge accounting. When a forecasted transaction is no longer expected to occur, the gain or loss accumulated in OCI is recognized immediately in the consolidated statements of operations.
Property, Plant, and Equipment
Property, Plant and Equipment —Construction in progress and property, plant and equipment are stated at historical cost, net of accumulated depreciation. The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at each balance sheet date. Major additions and improvements are capitalized as appropriate, only when it is probable that future economic benefits associated with the item and the cost of the item can be measured reliably; minor replacements and repairs are charged to the consolidated statements of operations. The Company also capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company also records capital-related government grants as a reduction to property, plant and equipment.
Commencement of depreciation related to construction in progress and property, plant and equipment involves determining when the assets are available for their intended use. The Company considers various factors which include functionality, engineering specifications, nature and usage of assets among others, in assessing the conditions necessary for the assets to be capable of operating in the manner intended by the management. The Company also factors in the length of time it takes for the assets to reach the tooling qualification criteria from the initial point of when the assets are received. Depreciation is calculated on a straight-line basis over the estimated useful life of the assets as follows:
Building and leasehold/land improvements
Up to 50 years (or the remaining lease term of related land on which the buildings are erected, if shorter)
Equipment
2 to 10 years
Computers
5 years
The Company periodically assesses the estimated useful lives of property, plant and equipment. As a result of a review completed in April 2023, the Company concluded the estimated maximum useful life of certain buildings should be increased from 26 years to 50 years. This change in estimate was applied prospectively, effective beginning in the first quarter of 2023.
Leases
Leases—The Company determines if an arrangement is a lease or contains a lease at inception. That is, if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
Right-of-use assets—Right-of-use (“ROU”) assets are reported within property, plant and equipment, and are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. ROU assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets.
Lease liabilities—At the commencement date of the lease, the Company recognizes lease liabilities at the present value of the lease payments to be made over the lease term.
In calculating the present value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. The carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments or a change in the assessment of an option to purchase the underlying assets. The Company’s lease liabilities are separately reported in the consolidated statements of financial position under non-current portion of lease obligations and current portion of lease obligations.
Short-term leases and leases of low-value assets—The Company applies the short-term lease recognition exemption to leases that have a lease term not exceeding 12 months, or for leases of low-value assets. The payment for such leases is recognized in the Company’s consolidated statements of operations on a straight-line basis over the lease term.
Intangible Assets
Intangible Assets—Technology, patent, software licenses and similar rights acquired separately are stated at cost less accumulated amortization or are adjusted to fair value when impaired. Intangible assets acquired through business combinations which include customer relationships and manufacturing and process technology, are recorded at estimated fair values at the date of acquisition. Intangible assets are amortized based on the pattern in which the economic benefits of the respective intangible asset are consumed, which is, in general, on a straight-line basis over their estimated useful lives of between 3 and 10 years. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.
Impairment of Non-Financial Assets—The Company reviews, at each reporting date, the carrying amount of the Company’s property, plant and equipment and finite lived intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.
If any indication exists, the recoverable amount of the asset is estimated in order to determine the extent, if any, of the impairment loss. Where it is not possible to estimate the recoverable amount of an individual assets, the Company estimates the recoverable amount of the cash generating unit (“CGU”) to which the asset belongs. The recoverable amount of an asset or CGU is estimated to be the higher of an asset’s or CGU’s fair value less costs to dispose and its value in use. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset or CGU is considered impaired and is written down to its recoverable amount. The Company also evaluates, and adjusts, if appropriate, the asset’s useful lives, at each reporting date or when impairment indicators exist.
In assessing value in use, the estimated future post-tax cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
Impairment losses are recognized in the consolidated statements of operations to the extent the recoverable amount, measured at the present value of discounted cash flows attributable to the assets, is less than their carrying value.
If the recoverable amount subsequently increases, the impairment loss previously recognized will be reversed to the extent of the increase in the recoverable amount, provided that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset in prior years. The impairment loss reversal is recognized immediately in the consolidated statements of operations.
Revenue Recognition
Revenue Recognition—The Company generates revenue primarily from fabricating semiconductor wafers for its customers using the manufacturing processes based on their own or third parties’ proprietary integrated circuit designs and, to a lesser extent, the Company also generates revenue from engineering and other pre-fabrication services such as non-recurring engineering (“NRE”) services, which include design services and mask production.
The Company recognizes revenue when performance obligations are satisfied. The performance obligations are satisfied at the point at which control of the wafers is transferred to the customer, which is determined to be at the point of wafer shipment from the Company’s facilities or delivery to the customer location. NRE services are recognized over time as the Company performs the services based on a percentage of costs incurred over total expected costs.
The Company generally requires a purchase order from all of its customers, to which the Company responds with an order acknowledgement and a copy of the Company’s standard terms and conditions. The Company also enters into master supply agreements (“MSA”) with certain of its customers that may specify additional terms and conditions, such as pricing formulas based on volume, volume discounts, calculation of yield adjustments, indemnifications, transfer of title and risk of loss, and payment terms. The Company also requires a purchase order from its customers with which it has MSAs for specific products and quantities. As a result, the Company has concluded that the combination of a purchase order and order acknowledgement, including the Company’s standard terms and conditions, and the MSA, if applicable, create enforceable rights and obligations between the Company and its customers. For certain customers under long-term supply agreements (“LTAs”) with minimum volume requirements that are subject to a certain breakage fee if such commitment is not met, the Company has concluded that LTAs’ terms and conditions generally constitute enforceable rights and obligations for revenue recognition purposes, unless the underlying facts and circumstances vary and indicate otherwise.
Typically, goods and services provided under the Company’s contracts are accounted for as a single performance obligation. However, in some contracts, the Company provides multiple distinct goods or services to a customer. In those cases, the Company accounts for the distinct contract deliverables as separate performance obligations at the stated contract value, which appropriately represents the individual performance obligation’s estimated standalone selling price.
The Company estimates for the breakage fee arising from not meeting the minimum purchase requirements under certain LTAs with customers as variable consideration and includes such fee in the contract transaction price if not constrained, and accordingly, recognizes as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreement. Given the volumes under these arrangements are usually not guaranteed and subject to subsequent negotiations or changes, breakage fees that are constrained are not included in the contract transaction price for revenue recognition purposes.
The Company estimates the variable consideration related to volume rebates and yield adjustments for certain contracts that may be refundable to customers through the issuance of a credit note, and accordingly, recognizes revenue in accordance with the pattern applicable to the performance obligation, subject to a constraint. The Company determines the amounts to be recognized based on the amount of potential refund required by the contract, historical experience and other surrounding facts and circumstances. These potential revenue adjustments are accrued and netted against accounts receivable on the consolidated statements of financial position.
Our contracts may be subsequently modified to reflect changes in scope or customer requirements. Generally, our contract modifications are for goods or services that are distinct from the existing contract and are accounted for as a new contract and performance obligation, which are recognized prospectively. If contract modifications are for goods or services that are
not distinct from the existing contract, they are accounted for as if they are part of the original contract with the effect of the contract modification recognized as an adjustment to revenue on a cumulative catch-up basis.
A contract asset (“unbilled accounts receivables”) is recognized when the Company has recognized revenue, but not issued an invoice for payment. The Company has determined that unbilled accounts receivables are not considered a significant financing component of the Company’s contracts. Contract assets are included in receivables, prepayments and other assets on the consolidated statements of financial position and are transferred to trade receivables when invoiced (see Note 6).
A contract liability is recognized when the Company receives payments in advance of the satisfaction of performance obligations and are included as deferred revenue on the consolidated statements of financial position (see Note 11). This includes upfront non-refundable capacity access fees under certain LTAs with customers which are accounted for as additional wafer price considerations and recognized as revenue upon satisfaction of performance obligations for wafers over the expected term of the agreements.
Provisions
Provisions—Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Provisions are mainly made up of site restoration obligations, as well as restructuring charges. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived assets.
A provision for restructuring is recognized when the Company has approved a detailed and formal restructuring plan, and the restructuring either has commenced or has been announced publicly. Future operating losses are not provided for.
The Company records site restoration obligations in the period in which they are incurred at their estimated fair value. Site restoration obligations consist of the present value of the estimated costs of dismantlement, removal, site reclamation and similar activities associated with facilities built on land held under long-term operating leases. The site restoration obligations are recorded as a liability at the estimated present value as of the related long-lived asset’s inception discounted using a pre-tax rate that reflects the current market assessment of the time value of money and risks specific to the site restoration obligations. After initial recognition, the liability is increased for the passage of time, with the increase being reflected as accretion expense in the line item “finance expenses” in the consolidated statements of operations. The associated site restoration costs are capitalized as part of the carrying amount of the underlying asset and depreciated over the estimated useful life of the related long-lived asset. Subsequent adjustments in the discount rates, estimated amounts, timing and probability of the estimated future costs and changes resulting from the passage of time are recognized as an increase or decrease in the carrying amount of the liability and the related site restoration cost capitalized as part of the carrying amount of the related long-lived asset on a prospective basis. If the decrease in the liability exceeds the remaining carrying amount of the related long-lived assets, the excess is recognized in the consolidated statements of operations.
Deferred Tax Assets
Deferred Tax Assets—Deferred tax assets are recognized for all deductible temporary differences, carryforward of unused tax credits and unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carryforward of unused tax credits and unused tax losses can be utilized except in respect of deductible temporary differences associated with investments in subsidiaries, associates and interests in joint ventures, deferred tax assets are recognized only to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized.
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each balance sheet date and are recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance sheet date.
Earnings Per Share
Earnings Per Share—Basic earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding during the year.
Diluted earnings per share is calculated by dividing the net income (loss) attributable to equity holders of the Company by the weighted average number of ordinary shares outstanding, adjusted for the effects of all potentially dilutive ordinary shares. The weighted average number of ordinary shares outstanding is increased by the number of additional ordinary shares that would have been issued by the Company assuming exercise of all options with exercise prices below the average market price for the year.
Share-based compensation
Share-based compensation—Share-based compensation expense related to share awards is recognized based on the fair value of the awards granted.
The grant date fair value of equity-settled share-based payment awards granted to employee is recognized as an employee benefit expense, with a corresponding increase in equity, over the vesting period of the awards, The amount recognized as an expense is adjusted to reflected the number of awards for which the service and non-market performance conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that meet the service and non-market performance conditions at the vesting date. For share-based payment awards with non-vesting conditions, the grant date fair value of the share-based payment is measured to reflect such conditions and there is no true-up for differences between expected and actual performance.
Share-based compensationShare-based compensation expense is recognized based on the grant date fair value of the awards. The fair value of Restricted Share Units (“RSUs”) is determined based on the closing price of the ordinary stock on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model for options. The fair value of Performance Share Units (“PSUs”) is estimated using a Monte Carlo simulation. Both models require management to make certain assumptions of future expectations based on historical and current data. The assumptions
include the estimated fair value of the Company’s stock, expected term of the awards, expected volatility, dividend yield, and risk-free interest rate. These estimates involve inherent uncertainties and the application of management’s judgment.
The principles of modification accounting are applied when a new share-based payment is granted as a replacement for another share-based payment that is cancelled. When modification accounting is applied, the entity accounts for any incremental fair value in addition to the grant-date fair value of the original award. In the case of a replacement, the incremental fair value is the difference between the fair value of the replacement award and the net fair value of the cancelled award, both measured at the date on which the replacement award is issued. The net fair value is the fair value of the cancelled award measured immediately before the cancellation, less any payment made to the employees on cancellation.
A package of modifications might include several changes to the terms of a grant, some of which are favorable to the employee and some not. In the event the net effect is not beneficial to the employee, cancellation accounting will be applied. Cancellations or settlements of equity-settled share-based payments during the vesting period by the Company are accounted for as accelerated vesting; therefore, the amount that would otherwise have been recognized for services received is recognized immediately.
In September 2023, the people and compensation committee of GlobalFoundries approved a modification to the 2023 PSUs, to adjust the return on invested capital (“ROIC”) performance threshold. The modification did not increase the fair value of the 2023 PSUs as the non-market performance condition was not considered when determining the fair value on the modification date. The Company will cumulatively adjust the expense based on the number of shares probable of vesting based on ROIC metrics and the grant date fair value.
Government Grants
Government Grants—Government grants are recognized when there is reasonable assurance that the grant will be received and the Company will be in compliance with all attached conditions. When the grant relates to an expense item it is recognized as deferred income and released to the consolidated statements of operations over the period necessary to match the grant on a systematic basis to the costs that it is intended to compensate and is presented as a reduction of those costs. Where the grant relates to acquisition of assets, it is recognized as a reduction in the basis of the asset and released as a reduction to depreciation expense in equal amounts over the expected useful life of the related asset. Grants the Company received are primarily provided in connection with construction and operation of the Company’s manufacturing facilities, employment and research and development.
Research and Development Costs
Research and Development Costs—Research costs are expensed as incurred. Development costs are recognized as intangible assets if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the assets.
Borrowing Costs
Borrowing Costs—Borrowing costs directly attributable to the construction phase of property, plant and equipment are capitalized as part of the cost of assets which are constructed by the Company and for which a considerable period of time (at least six months) is planned for construction. Borrowing costs are capitalized from the start of construction until the date the asset is ready for its intended use. All other borrowing costs are recognized as an expense in the period in which they are incurred.
Current Income Tax
Current Income Tax—Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted by the balance sheet date.
Income Taxes and Realization of Deferred Tax Assets—In determining taxable income for financial statement reporting purposes, management makes certain estimates and judgments specific to taxation issues. These estimates and judgments are applied in the calculation of certain tax liabilities and in the determination of the recoverability of deferred tax assets, which arise from temporary differences between the recognition of assets and liabilities for income tax and financial statement reporting purposes.
Deferred taxes are recognized for unused losses, among other factors, to the extent that it is probable that taxable profit will be available against which the losses can be utilized.
This evaluation requires the exercise of judgment with respect to, among other things, benefits that could be realized from available tax strategies and future taxable income, as well as other positive and negative factors. The ultimate realization of deferred tax assets is dependent upon, among other things, the Company’s ability to generate future taxable income that is sufficient to utilize loss carry-forwards or tax credits before their expiration or the Company’s ability to implement prudent and feasible tax planning strategies.
If estimates of projected future taxable income and benefits from available tax strategies are reduced as a result of a change in the assessment or due to other factors, or if changes in current tax regulations are enacted that impose restrictions on the timing or extent of the Company’s ability to utilize net operating losses and tax credit carry-forwards in the future, the Company may be required to reduce the amount of total deferred tax assets resulting in a decrease of total assets. Likewise, a change in the tax rates applicable in the various jurisdictions or unfavorable outcomes of any ongoing tax audits could have a material impact on the future tax provisions in the periods in which these changes could occur.
In addition, the calculation of tax liabilities involves dealing with uncertainties in the application of complex tax rules and the potential for future adjustment of uncertain tax positions by the tax authorities in the countries in which the Company operates. If estimates of these taxes are greater or less than actual results, an additional tax benefit or charge may result.
Recent Accounting Pronouncements and Developments
Recent Accounting Pronouncements and Developments
Recent Accounting Pronouncement, Adopted:
Amendments to IFRS 7, IFRS 9 and IAS 39 Interest Rate Benchmark Reform
Phase 1 Amendments - On 1 January 2020, the Company adopted the Phase 1 amendments arising from the Interbank Offered Rate (“IBOR”) reform amendments issued in September 2019, which provides temporary relief from applying specific hedge accounting requirements to hedge relationships directly affected by IBOR reform, such that the effect is that IBOR reform should not generally cause hedge accounting to terminate.
Phase 2 Amendments - On 1 January 2021, the Company adopted the Phase 2 amendments arising from the IBOR reform issued in August 2020. The Phase 2 amendments address issues that arise from the implementation of the IBOR reform, including the replacement of an interest rate benchmark with an alternative benchmark rate. The key reliefs provided to the Company are as follows:
financial instruments measured at amortized cost are allowed to account for changes in the basis for determining contractual cash flows as a direct consequence of the IBOR reform by updating the effective interest rate, provided that the new basis is economically equivalent to the previous basis, such that there is no immediate gain or loss recognized; and
most IFRS 9 hedge relationships that are directly affected by the IBOR reform are allowed to continue.
As of June 30, 2023, the Company had completed the transition of the affected rates on borrowings from USD London Interbank Offered Rate to Term Secured Overnight Financing Rate (“SOFR”) and assessed the changes to be economically equivalent in accordance with IFRS 9. Any future impact has been deemed to be immaterial to the Company.

Recent Accounting Pronouncements, Not Adopted:
The Company has not adopted the following new, revised or amended IFRS standards that have been issued by the IASB but are not yet effective:
Non-current Liabilities with Covenants - Amendments to IAS 1 - Effective for annual periods beginning on or after January 01, 2024;
Lease Liability in a Sale and Leaseback - Amendments to IFRS 16 - Effective for annual periods beginning on or after January 01, 2024;
Supplier Finance Arrangements - Amendments to IAS 7 and IFRS 7-Effective for annual periods beginning on or after January 01, 2024
General Requirement for Disclosure of Sustainability-related Financial Information - IFRS S1 -Effective for annual reporting periods beginning on or after January 1, 2024; and
Climate Related Disclosures - IFRS S2 - Effective for annual reporting periods beginning on or after January 1, 2024
As of the date the accompanying financial statements were authorized for issue, the Company continues to evaluate the impact on its financial position and performance as a result of the initial adoption of the aforementioned standards or interpretations and related applicable period. The Company does not anticipate the impacts of the standards effective for annual periods beginning on or after January 01, 2024 will have a material impact on the financial statements.
New Legislation:
In August 2022, the CHIPS and Science Act was signed into U.S. law. Designed to boost investment in domestic high tech-research and development and catalyze investment in domestic semiconductor manufacturing capacity the CHIPS and Science Act provides a 25% refundable advanced manufacturing investment tax credit (“AMITC”) on certain investment and other financial incentives to promote investments in domestic semiconductor manufacturing beginning in 2023. The Company has analyzed the provisions of the new law and determined that certain capital expenditures will qualify under the law and provide a refundable tax credit to the Company on its 2023 tax return.
In August 2022, the U.S. Inflation Reduction Act (the "IRA") was signed into law. The IRA establishes a new corporate alternative minimum tax ("CAMT") of 15% for corporations with an average global adjusted financial statement income in excess of $1 billion over a consecutive three year period, as well as a 1% excise tax on qualifying stock repurchases. The CAMT is effective for tax years beginning after December 31, 2022. The Company has estimated no tax liability relating to CAMT for the current fiscal year. It is possible that the CAMT could result in an additional tax liability in a particular year due to offsetting the U.S. tax liability with prior year losses. The Company continues to evaluate the impact the IRA may have on its operations and consolidated financial statements in future periods.
Legislation and administrative guidance continue to evolve under the Organization for Economic Co-operation and Development's ("OECD") international tax reform centering on a global minimum tax regime ("Pillar 2") effective beginning in fiscal year 2024. The Pillar 2 regime seeks to collect additional top-up taxes from multinational groups whose effective tax rates are lower than 15% at a jurisdictional level. The initiative will also trigger additional compliance obligations, such as the requirement to file an annual GloBE Information Return within 15 months of the end of the fiscal year. Pillar 2 is being accounted for under the scope of IAS 12 Income Taxes, which includes an amendment in May 2023 granting temporary relief from accounting for deferred taxes arising from jurisdictions implementing Pillar 2 minimum taxes. Under the amendment, the Company is applying the exception of neither recognizing nor disclosing deferred tax adjustments related to Pillar 2 income taxes.
The effective tax rate is computed at a jurisdictional level with reference to GloBE income for all constituent entities of the multinational group in that jurisdiction. Singapore announced in its 2024 budget that it will enact a domestic top-up tax and income inclusion rule (“IIR”) effective in 2025. The Company and its subsidiaries are considered constituent entities forming part of the multinational group led by Mubadala Diversified Global Holding, PJSC. Eligibility to safe harbor and Pillar 2 top-up taxes payable as well as Pillar 2 filing and reporting requirements by the Company are partially dependent upon and influenced by GloBE income calculations of Mubadala subsidiaries having operations in the jurisdictions in which it operates.
The Company and its subsidiaries operate in Germany, the Netherlands, France, Bulgaria, the United Kingdom, Japan, Korea and Malaysia which have enacted Pillar 2 rules in 2023, Singapore announced in its 2024 budget that it will enact domestic top-up tax and income inclusion rule effective in 2025. The Dutch IIR regime may apply to GloBE income from the United States and Germany entities in the Company’s structure but the Company continues to analyze whether a Pillar 2 income tax expense and cash tax detriment are expected to arise from the Netherlands or any other material jurisdictions in 2024. Similarly, the recently announced Singapore rules may cause an additional liability beginning in 2025. Several jurisdictions are yet to finalize their Pillar 2 implementation timeline, including the United States, India, Cayman Islands and the United Arab Emirates. The Cayman Islands and Bulgaria are jurisdictions in which the Company operates with statutory tax rates below 15% and the Company’s Singapore operations include incentive tax rates below 15% which may be more likely to result in a tax liability under Pillar 2 if transitional safe harbor rules do not apply. The Company is tracking legislative updates from these and other jurisdictions to determine if any Pillar 2 taxes may be payable in fiscal 2024.
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Material Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]  
Summary of property, plant and equipment Depreciation is calculated on a straight-line basis over the estimated useful life of the assets as follows:
Building and leasehold/land improvements
Up to 50 years (or the remaining lease term of related land on which the buildings are erected, if shorter)
Equipment
2 to 10 years
Computers
5 years
Property, Plant and Equipment
(in millions)
Land and
Land
Improvements
Building and
Leasehold
Improvements
EquipmentComputer
Construction
in Progress
Total
Cost
As of December 31, 2021
$130 $7,576 $22,350 $435 $1,423 $31,914 
Additions(1)
— 67 27 — 3,564 3,658 
Transfers from construction in progress409 935 21 (1,366)— 
Disposals(8)(182)(725)(17)(237)(1,169)
Effects of exchange rate changes(1)(3)(18)— — (22)
As of December 31, 2022
122 7,867 22,569 439 3,384 34,381 
Additions(1)
16 121 19 745 905 
Transfers from construction in progress— 616 1,979 (2,602)— 
Disposals— (25)(297)(2)(15)(339)
Effect of exchange rate changes— 11 — — 13 
As of December 31, 2023
$138 $8,581 $24,281 $448 $1,512 $34,960 
Accumulated Depreciation
As of December 31, 2021
$37 $4,266 $18,507 $384 $7 $23,201 
Additions(1)
443 975 23 — 1,447 
Disposals(4)(164)(674)(16)— (858)
Effects of exchange rate changes— (1)(4)— — (5)
As of December 31, 2022
$39 $4,544 $18,804 $391 $7 $23,785 
Additions(1)
322 976 19 — 1,322 
Disposals— (18)(296)(2)— (316)
Effect of exchange rate changes— — — 
As of December 31, 2023
$44 $4,849 $19,488 $408 $7 $24,796 
Net book value as of December 31, 2022
$83 $3,323 $3,765 $48 $3,377 $10,596 
Net book value as of December 31, 2023
$94 $3,732 $4,793 $40 $1,505 $10,164 
(1)     The Company earned investment tax credits related to the Company’s construction of a wafer fabrication facility in Saratoga County, New York (which were netted against additions relating to Building and Leasehold Improvements and Equipment). These credits were generally earned based on when the related assets were placed in service. The Company recorded the investment tax credits as a reduction of property, plant and equipment costs. As of December 31, 2023, and 2022, the investment tax credits included in property, plant and equipment amounted to $226 million and $179 million, respectively.
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash And Cash Equivalents (Tables)
12 Months Ended
Dec. 31, 2023
Statement of cash flows [abstract]  
Disclosure of cash and cash equivalents
(in millions)December 31,
2023
December 31,
2022
Cash balances on hand and at banks$490 $990 
Other cash and cash equivalents1,897 1,362 
Total$2,387 $2,352 
Disclosure of reconciliation of assets and liabilities arising from financing activities
The following presents the reconciliation of assets, liabilities and equity arising from financing activities:
Non-cash changes
(in millions)
As of December 31, 2021
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2022
Assets
(Liabilities and Equity)
Restricted cash$$— $— $— $— $
Government grants receivable(1)
47 (93)18 (1)81 $52 
Other receivables(1)— — — — $(1)
Debt(2,013)(670)(6)10 168 $(2,511)
Lease obligations(426)89 (18)$(345)
Share capital(11)— — — — $(11)
Additional Paid-In Capital(23,487)(168)— — (176)$(23,831)
Total$(25,890)$(842)$(6)$18 $74 $(26,646)
Non-cash changes
(in millions)
As of
December 31, 2022
Assets
(Liabilities and Equity)
Cash
Flows
(Inflows)/
Outflows
Addition
Foreign
exchange
movement
Others
As of
December 31, 2023
Assets
(Liabilities and Equity)
Restricted cash$$— $— $— $— $
Government grants receivable(1)
52 (5)23 101 $172 
Other receivables(1)— — — $— 
Debt(2,511)182 (17)(30)$(2,372)
Lease obligations(345)77 (117)(5)$(382)
Share capital(11)— — — — $(11)
Additional Paid-In Capital
(23,831)(42)— (154)$(24,027)
Total$(26,646)$212 $(111)$(33)$(41)$(26,619)
(1)Government grants receivable of $172 million and $52 million are included in receivables, prepayments and other assets in the consolidated statements of financial position as of December 31, 2023 and 2022, respectively.
Disclosure of geographical concentration of cash and cash equivalents
Geographical concentration of cash and cash equivalents is as follows:
(in millions)December 31,
2023
December 31,
2022
United States of America$481 $484 
Republic of Singapore1,666 1,775 
Other240 93 
Total$2,387 $2,352 
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Receivables, Prepayments and Other Assets (Tables)
12 Months Ended
Dec. 31, 2023
Trade and other current receivables [abstract]  
Schedule of accounts receivable
(in millions)December 31, 2023December 31, 2022
Current:
Trade receivables, other than related parties(1)
$1,002 $824 
Other receivables255 497 
Unbilled accounts receivable(2)
33 24 
Receivables from government grant66 52 
Receivables from related parties (Note 29)
12 11 
  Other current financial assets52 79 
Total$1,420 $1,487 
Non-current:
Advances to suppliers(3)
213 235 
Non-trade receivables
— 10 
Receivables from government grant
106 — 
Payment in Lieu of Tax (“PILOT”) Bonds
— 11 
Other24 25 
Total$343 $281 
(1)The Company’s trade receivables, other than related parties, are all classified as current and are expected to be collected within one year. The Company’s provision for sales returns was not material for either of the years ended December 31, 2023 and 2022. See the table below for the aging of the Company’s trade receivables, other than related parties.
(2)Unbilled accounts receivable represents amounts recognized on revenue contracts less associated advances and progress billings. These amounts will be billed in accordance with the agreed-upon contractual terms or upon shipment of products or rendering services.
(3)Primarily represents advances to supplier to offset against future purchases.
Schedule of unbilled accounts receivables
The following table presents the activities in unbilled accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$24 $43 
Revenue recognized during the year101 87 
Amounts invoiced(92)(106)
Ending balance$33 $24 
The following table presents the aging of accounts receivable as of December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Receivables neither past due nor impaired$880 $708 

Less than 30 days114 83 
31 to 60 days22 
61 to 90 days11 
Total$1,002 $824 
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories (Tables)
12 Months Ended
Dec. 31, 2023
Inventories [Abstract]  
Schedule of inventories
Inventories consist of the following:
(in millions)December 31,
2023
December 31,
2022
Work in progress$928 $1,024 
Raw materials and supplies559 315 
Total$1,487 $1,339 
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure of detailed information about property, plant and equipment [abstract]  
Summary of property, plant and equipment Depreciation is calculated on a straight-line basis over the estimated useful life of the assets as follows:
Building and leasehold/land improvements
Up to 50 years (or the remaining lease term of related land on which the buildings are erected, if shorter)
Equipment
2 to 10 years
Computers
5 years
Property, Plant and Equipment
(in millions)
Land and
Land
Improvements
Building and
Leasehold
Improvements
EquipmentComputer
Construction
in Progress
Total
Cost
As of December 31, 2021
$130 $7,576 $22,350 $435 $1,423 $31,914 
Additions(1)
— 67 27 — 3,564 3,658 
Transfers from construction in progress409 935 21 (1,366)— 
Disposals(8)(182)(725)(17)(237)(1,169)
Effects of exchange rate changes(1)(3)(18)— — (22)
As of December 31, 2022
122 7,867 22,569 439 3,384 34,381 
Additions(1)
16 121 19 745 905 
Transfers from construction in progress— 616 1,979 (2,602)— 
Disposals— (25)(297)(2)(15)(339)
Effect of exchange rate changes— 11 — — 13 
As of December 31, 2023
$138 $8,581 $24,281 $448 $1,512 $34,960 
Accumulated Depreciation
As of December 31, 2021
$37 $4,266 $18,507 $384 $7 $23,201 
Additions(1)
443 975 23 — 1,447 
Disposals(4)(164)(674)(16)— (858)
Effects of exchange rate changes— (1)(4)— — (5)
As of December 31, 2022
$39 $4,544 $18,804 $391 $7 $23,785 
Additions(1)
322 976 19 — 1,322 
Disposals— (18)(296)(2)— (316)
Effect of exchange rate changes— — — 
As of December 31, 2023
$44 $4,849 $19,488 $408 $7 $24,796 
Net book value as of December 31, 2022
$83 $3,323 $3,765 $48 $3,377 $10,596 
Net book value as of December 31, 2023
$94 $3,732 $4,793 $40 $1,505 $10,164 
(1)     The Company earned investment tax credits related to the Company’s construction of a wafer fabrication facility in Saratoga County, New York (which were netted against additions relating to Building and Leasehold Improvements and Equipment). These credits were generally earned based on when the related assets were placed in service. The Company recorded the investment tax credits as a reduction of property, plant and equipment costs. As of December 31, 2023, and 2022, the investment tax credits included in property, plant and equipment amounted to $226 million and $179 million, respectively.
Schedule of depreciation expense
Depreciation expense on property, plant and equipment is as follows:
(in millions)202320222021
Cost of revenue$1,259 $1,377 $1,309 
Research and development expenses38 40 73 
Selling, general and administrative expenses25 30 29 
Total$1,322 $1,447 $1,411 
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2023
Intangible Assets [Abstract]  
Schedule of goodwill and intangible assets rollforward
Cost (in millions)
Technology,
Licenses and
Similar Rights
SoftwarePatentsGoodwillOthersTotal
As of December 31, 2021
$1,202 $284 $229 $18 $132 $1,865 
Additions62 96 — — 163 
Disposals(47)(12)(3)— — (62)
As of December 31, 2022
1,217 368 226 18 137 1,966 
Additions61 96 — — — 157 
Disposals(40)— — — — (40)
As of December 31, 2023
$1,238 $464 $226 $18 $137 $2,083 
Accumulated Amortization
As of December 31, 2021
$867 $278 $212 $— $131 $1,488 
Additions150 10 16 — — 176 
Disposals(46)(12)(3)— — (61)
As of December 31, 2022
971 276 225  131 1,603 
Additions121 — — 129 
Disposals(40)— — — — (40)
As of December 31, 2023
$1,052 $283 $225 $ $132 $1,692 
Net book value as of December 31, 2022
$246 $92 $1 $18 $6 $363 
Net book value as of December 31, 2023
$186 $181 $1 $18 $5 $391 
Schedule of amortization expense
Amortization expense on intangible assets is as follows:
(in millions)202320222021
Cost of revenue$61 $91 $113 
Research and development expenses63 70 74 
Selling, general and administrative expenses15 20 
Total$129 $176 $207 
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Disclosure of financial assets and liabilities
The following foreign currency forward contracts are outstanding at December 31, 2023 and 2022 (in millions, except average foreign currency/US$):
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Notional
Amount
Average
Foreign
Currency/
US$
Average
Strike
Price
Maturity
Outstanding as of December 31, 2022:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$46 $$(32)$— $1,203 0.94 — 2023 - 2024
Singapore dollar forward contracts (receive Singapore$/pay US$)15 — (1)— 496 1.37 — 2023
Japanese yen forward contracts (receive Japanese yen/pay US$)18 — (20)— 236 127.22 — 2023 - 2024
79 (53)— 1,935 
Interest rate swaps— 42 — — 795 — 
0.382% - 1.731%
2023 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
— — (3)535 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 51 — — 796 1.37 
1.830% - 1.941%
2028
Commodity swaps
— — (8)(2)47 — 512.562023
Total$79 $98 $(61)$(5)$4,108 
Outstanding as of December 31, 2023:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$14 $— $(4)$— $845 0.91 — 2024 - 2025
Singapore dollar forward contracts (receive Singapore$/pay US$)— (1)— 483 1.33 — 2024 - 2025
Japanese yen forward contracts (receive Japanese yen/pay US$)
(7)— 116 140.20 — 2024 - 2025
28 (12)— 1,444 
Interest rate swaps17 — — 653 — 
0.442% - 1.761%
2024 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
(3)— 519 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 73 — — 1,127 1.37 
1.83% - 1.941%
2028
Commodity swaps
— (27)(14)237 0.91 73.592024 - 2025
Total$52 $80 $(42)$(14)$3,980 
Disclosure of financial assets and liabilities
The following foreign currency forward contracts are outstanding at December 31, 2023 and 2022 (in millions, except average foreign currency/US$):
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Notional
Amount
Average
Foreign
Currency/
US$
Average
Strike
Price
Maturity
Outstanding as of December 31, 2022:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$46 $$(32)$— $1,203 0.94 — 2023 - 2024
Singapore dollar forward contracts (receive Singapore$/pay US$)15 — (1)— 496 1.37 — 2023
Japanese yen forward contracts (receive Japanese yen/pay US$)18 — (20)— 236 127.22 — 2023 - 2024
79 (53)— 1,935 
Interest rate swaps— 42 — — 795 — 
0.382% - 1.731%
2023 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
— — (3)535 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 51 — — 796 1.37 
1.830% - 1.941%
2028
Commodity swaps
— — (8)(2)47 — 512.562023
Total$79 $98 $(61)$(5)$4,108 
Outstanding as of December 31, 2023:
Forward contracts:
Euro forward contracts (receive euros/pay US$)
$14 $— $(4)$— $845 0.91 — 2024 - 2025
Singapore dollar forward contracts (receive Singapore$/pay US$)— (1)— 483 1.33 — 2024 - 2025
Japanese yen forward contracts (receive Japanese yen/pay US$)
(7)— 116 140.20 — 2024 - 2025
28 (12)— 1,444 
Interest rate swaps17 — — 653 — 
0.442% - 1.761%
2024 - 2026
Cross currency interest rate swaps (receive euros/pay US$)
(3)— 519 0.89 
3.834% - 4.182%
2024 - 2026
Cross currency swaps (receive Singapore $/pay US$)— 73 — — 1,127 1.37 
1.83% - 1.941%
2028
Commodity swaps
— (27)(14)237 0.91 73.592024 - 2025
Total$52 $80 $(42)$(14)$3,980 
Disclosure of fair value of financial instruments
The following table presents the fair values and locations of these derivative instruments recorded in the consolidated statements of financial position:
Fair Value of Derivative Instruments
Derivative Instruments
Other
Current
Financial
Assets
Other
Non-current
Financial
Assets
Other
Current
Financial
Liabilities
Other
Non-current
Financial
Liabilities
Outstanding as of December 31, 2022:
Derivatives designated as hedging instruments
Foreign currency forwards$69 $$(52)$— 
Interest rate swaps— 42 — — 
Cross currency swaps and cross currency interest rate swaps — 53 — (3)
Commodity swaps— — (8)(2)
Derivatives not designated as hedging instruments
Foreign currency forwards10 — (1)— 
Total$79 $98 $(61)$(5)
Outstanding as of December 31, 2023:
Derivatives designated as hedging instruments
Foreign currency forwards$24 $— $(9)$— 
Interest rate swaps17 — — 
Cross currency swaps and cross currency interest rate swaps74 (3)— 
Commodity swaps— (22)(11)
Derivatives not designated as hedging instruments
Foreign currency forwards(3)— 
Commodity swaps— — (5)(3)
Total$52 $80 $(42)$(14)
Sensitivity analysis for types of market risk
(in millions)
Amount of
Gains
(Losses)
Recognized in
Accumulated
OCI
on Derivatives
(effective
Portion)
Amount of
Gains (Losses)
Reclassified
from
Accumulated
OCI to cost of
Property,
Plant and
Equipment
Location of
Gains (Losses)
Reclassified from
Accumulated
OCI into Income
Amounts of
Gains
(Losses)
Reclassified
from
Accumulated
OCI into
Income
(Effective
Portion)
Amount of
Gain
(Losses)
Reclassified
into
Income
(Missed Forecast)
Location of Gains
(Losses)
 Recognized into
Income (Ineffective
Portion)
Amount of
Gain
(Losses)
Recognized
into
Income
(Ineffective
Portion)
Year ended December 31, 2022
Derivatives designated as hedging instruments— Forward currency forward contracts$(105)$(93)Cost of revenue and operating expenses$(76)— Other income (expense)$(5)
Derivatives designated as hedging instruments— Interest rate swaps55 — Finance expense— Other income (expense)— 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
72 — Cost of revenue and operating expenses— — Other income (expense)
Derivatives designated as hedging instruments – Commodity swaps
(5)— Cost of revenue and operating expenses26 — Other income (expense)(8)
Year ended December 31, 2023
Derivatives designated as hedging instruments— Forward currency forward contracts$17 $(17)Cost of revenue and operating expenses$34 — Other income (expense)— 
Derivatives designated as hedging instruments— Interest rate swaps— Finance expense28 — Other income (expense)— 
Derivatives designated as hedging instruments— Cross currency swaps and cross currency interest rate swaps
31 — Finance expense— Other income (expense)(4)
Other income (expense)31 — 
Derivatives designated as hedging instruments – Commodity swaps
(32)— Cost of revenue and operating expenses(4)Other income (expense)— 
Other income (expense)— (13)
The following table presents the effect of derivatives not designated as hedging instruments on the consolidated statements of operations:
(in millions)
Location of Gains (Losses) Recognized in Income on Derivative
Amount of Gains (Losses) Recognized in Income on Derivative
Year ended December 31, 2021
Derivatives not designed as hedging instruments—foreign currency forwards contractsSelling, general and administrative expenses$(17)
Year ended December 31, 2022
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(22)
Total gain/(loss)
$(22)
Year ended December 31, 2023
Derivatives not designed as hedging instruments—foreign currency forwards contractsOther income (expense)$(16)
Derivatives not designed as hedging instruments—commodity swaps
Other income (expense)(8)
Total gain/(loss)
$(24)
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trade Payables and Other Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Subclassifications of assets, liabilities and equities [abstract]  
Schedule of current and noncurrent trade and other payables
(in millions)December 31,
2023
December 31,
2022
Current:
Trade payables$511 $532 
Accrued expenses496 573 
Contract liabilities(1)
895 592 
Advances and deposits(2)
68 93 
Payable for property, plant and equipment and Intangible Assets
282 961 
Other(3)
97 98 
Total$2,349 $2,849 
Non-current:
Payable for Intangible Assets76 92 
Contract liabilities(1)
1,088 1,326 
Other(3)
26 56 
Total$1,190 $1,474 
(1)Contract liabilities comprises contract liabilities for payments received in advance of the satisfaction of performance obligations for wafers, as well as NRE services.
(2)Advances and deposits include advances from customers of $22 million (2022: $73 million) collected for purchase orders.
(3)Other includes other financial liabilities, due from related parties, deferred tax liabilities and non-current advances and deposits. See Note 10 for further details on other financial liabilities.
The following table presents the activities in contract liabilities for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning contract liabilities balance$1,918 $1,901 
Cash receipts in advance of satisfaction of performance obligations805 1,189 
Released to the consolidated statements of operations (1)
(759)(951)
Amounts credited to customers— (221)
Other(2)
19 — 
Ending contract liabilities balance$1,983 $1,918 
Current$895 $592 
Non-current1,088 1,326 
Total$1,983 $1,918 
(1)Of revenue released to the consolidated statements of operations for the years ended December 31, 2023 and 2022, $476 million and $522 million, respectively were included in the beginning balance of the contract liabilities.
(2)Includes $19 million reclassification from accrued liabilities to contract liabilities.
Explanation of significant changes in contract assets and contract liabilities
The following table presents the activities in contract liabilities for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning contract liabilities balance$1,918 $1,901 
Cash receipts in advance of satisfaction of performance obligations805 1,189 
Released to the consolidated statements of operations (1)
(759)(951)
Amounts credited to customers— (221)
Other(2)
19 — 
Ending contract liabilities balance$1,983 $1,918 
Current$895 $592 
Non-current1,088 1,326 
Total$1,983 $1,918 
(1)Of revenue released to the consolidated statements of operations for the years ended December 31, 2023 and 2022, $476 million and $522 million, respectively were included in the beginning balance of the contract liabilities.
(2)Includes $19 million reclassification from accrued liabilities to contract liabilities.
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt (Tables)
12 Months Ended
Dec. 31, 2023
Borrowing costs Abstract [Abstract]  
Disclosure of detailed information about borrowings
(in millions)December 31,
2023
December 31,
2022
Current:
Term loans$571 $223 
Non-current:
Term loans1,801 2,288 
Total$2,372 $2,511 
Movements in interest bearing borrowings for the year ended December 31, 2023 and 2022 were as follows:
(in millions)December 31, 2023December 31, 2022
Opening balance$2,511 $2,013 
New loans and borrowings46 971 
Repayments(228)(301)
Other43 (172)
Ending balance$2,372 $2,511 
The following table summarizes term loan facilities. The below arrangements are all considered to be secured.
DescriptionCurrencyNominal Interest
Rate
Interest
Payment
Terms
Principal
Payment
Terms
Year
of
Maturity
2023
Carrying
Amount
2022
Carrying
Amount
2018 Tool Equipment Purchase and Lease Financing(1)
USD
SOFR + 1.60%
QuarterlyQuarterly2023— 19 
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly202421 85 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual202564 — 
EUR Term Loan A
EUR
EURIBOR + 2.60%
QuarterlySemi-Annual2025— 
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 1.75%
Semi- AnnualSemi-Annual202636 36 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202560 59 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 1.75%
Semi- AnnualSemi-Annual2024368 13 
Various
EUR, USDVarious2024-202613 11 
Current total571 223 
Non-current:
2019 Tool Equipment Purchase and Lease Financing(2)
USD
SOFR + 1.75%
QuarterlyQuarterly2024— 21 
2019 USD Dresden Equipment Financing(3)
USD
SOFR + 2.25%
Semi-AnnualSemi-Annual202672 108 
2020 USD Equipment Financing(4)
USD
SOFR + 1.90%
QuarterlyQuarterly202534 93 
USD Term Loan AUSD
SOFR + 2.90%
QuarterlySemi-Annual2025586 649 
EUR Term Loan AEUR
EURIBOR + 2.60%
QuarterlySemi-Annual202582 89 
2019 EUR Dresden Equipment Financing(3)
EUR
EURIBOR + 2.25%
Semi-AnnualSemi-Annual202630 387 
2021 SGD EDB LoanSGD1.40%Semi-AnnualSemi-Annual2041987 923 
Various
EUR, USDVarious2024-202710 18 
Non-current total1,801 2,288 
Total$2,372 $2,511 
(1)On March 2, 2018, GLOBALFOUNDRIES SINGAPORE PTE, LTD. (“GFS”) entered into several Equipment Purchase and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $375 million. The total minimum lease payments amount to $375 million, to be paid in equal quarterly installments through March 1, 2023.
(2)On January 21, 2019, GFS entered into several Equipment Purchase Agreements and Lease Agreements with five banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ Fabs in Singapore for a total of $425 million.
(3)On October 31, 2019, the Company, GLOBALFOUNDRIES Dresden Module One Limited Liability Company & Co., KG. and GLOBALFOUNDRIES Dresden Module Two Limited Liability Company & Co. KG. entered into a term facilities agreement with Bank of America Merrill Lynch International Designated Activity Company and ING Bank, a branch of ING-DIBA AG, as coordinating mandated lead arrangers, and Bank of America Merrill Lynch International Designated Activity Company as facility and security agent, which provides a maximum incremental facility commitment totaling $750 million secured by certain qualifying equipment assets.
(4)On April 23, 2020, GFS entered into several Equipment Purchase Agreements and Lease Agreements with four banks to sell and leaseback certain semiconductor manufacturing equipment located in GFS’ fabrication facilities in Singapore for a total of $300 million.
The following table summarizes unutilized credit facilities available to the Company to maintain liquidity to fund operations:
(in millions)December 31, 2023December 31, 2022
SGD EDB Loan$— $42 
Revolving Credit Facility1,012 1,012 
Uncommitted Credit Facilities(1)
46 64 
Total$1,058 $1,118 
(1) Credit facility made available to the Company, but the lender is not obligated to loan funds.
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Disclosure of Leases [Abstract]  
Schedule of leases
(in millions)December 31,
2023
December 31,
2022
Amortization of right-of-use assets$57 $82 
Interest expense on lease liabilities21 23 
Short-term and low-value leases expense— 
Total net lease cost$78 $106 
Weighted average remaining lease term12.4 years7.18 years
Weighted average discount rate5.16 %4.75 %
Schedule of lease liabilities
The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2023 and 2022:
December 31, 2023December 31, 2022
(in millions)
Minimum
Lease
Payments
Present
Value of
Payments
Minimum
Lease
Payments
Present
Value of
Payments
Within 1 year$44 $32 $92 $75 
2-5 years194 128 184 146 
After 5 years283 222 151 124 
$521 $382 $427 $345 
Less: amounts representing
finance charges(139)— (82)— 
Present value of minimum
lease payments
$382 $382 $345 $345 
Current32 75 
Non-current350 270 
Total$382 $345 
Supplemental cash flow information related to leases is as follows:
(in millions)December 31,
2023
December 31,
2022
Cash flows used in operating activities:
Payments of short-term and low-value leases$— $(1)
Interest paid(21)(23)
Cash flows used in financing activities:
Payment of lease obligations(77)(89)
Disclosure of lease liabilities
The following table summarizes the movement of ROU assets which primarily relates to building and leasehold improvements during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$282 $305 
Additions 117 59 
Disposals
(7)— 
Amortization(57)(82)
Ending balance$335 $282 
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions (Tables)
12 Months Ended
Dec. 31, 2023
Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]  
Schedule of movement in provision for asset retirement obligation
The movement in provision for asset retirement obligations and restructuring expenses during the years ended December 31, 2023 and 2022 is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$298 $349 
Arising during the period
Accretion cost(4)
Restructuring expenses
71 91 
Utilized(1)
(136)(52)
Released to the consolidated statements of operations(2)
$— (88)
Ending balance$240 $298 
(1) Includes $10 million and $40 million related to asset retirement obligations, $126 million and $5 million related to restructuring expense and $0 and $7 million related to sale of EFK business for the years ended December 31, 2023 and 2022, respectively.
(2) Relates to the derecognition of asset retirement obligation related to the sale of the EFK business.
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Government Grants (Tables)
12 Months Ended
Dec. 31, 2023
Government grants [Abstract]  
Disclosure of movement in deferred income from government grants
The following table presents the movement in deferred income from government grants for the years ended December 31, 2023 and 2022:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$404 $176 
Received/receivable during the period81 270 
Fair value of EDB loan
— 
Capitalized to fixed assets
(74)— 
Released to the consolidated statements of operations(58)(42)
Ending balance$360 $404 
Current93 110 
Non-current267 294 
Total$360 $404 
Disclosure of government grants recognized in consolidated statement of operations
Government grants were recognized in the consolidated statements of operations as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Cost of revenue$29 $30 $33 
Research and development expenses29 11 — 
Selling, general and administrative— — 
Total balance$58 $42 $33 
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Revenue (Tables)
12 Months Ended
Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Schedule of disaggregation of revenue
The following table presents the Company’s revenue disaggregated based on revenue source and timing of revenue recognition. The Company believes these categories best depict the nature and timing of revenue.
(in millions)202320222021
Type of goods and services:
Wafer fabrication$6,820 $7,627 $6,204 
Engineering and other services
572 481 381 
Total$7,392 $8,108 $6,585 
Timing of revenue recognition:
Revenue recognized over time$471 $445 $357 
Revenue recognized at a point in time6,9217,6636,228
Total
$7,392 $8,108 $6,585 
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cost of Revenue (Tables)
12 Months Ended
Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Schedule of cost of revenues
(in millions)202320222021
Depreciation of property, plant and equipment and amortization of intangible assets (1)
$1,321 $1,468 $1,422 
Inventory changes materials costs and other
1,742 1,834 1,726 
Staff costs, maintenance costs, and utilities(2)
2,228 2,567 2,424 
Total$5,291 $5,869 $5,572 
(1)Amounts are net of amortization of government grants relating to assets. See Note 8 for the detailed movements of property, plant and equipment.
(2)Staff costs, maintenance costs, and utilities costs include share-based compensation of $48 million, $64 million and $55 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Research and Development Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Schedule of research and development expenses
(in millions)202320222021
Staff costs, maintenance costs, and utilities(1)
$230 $247 $257 
Depreciation of property, plant and equipment and amortization of intangible assets
119 110 147 
Other (2)
79 125 74 
Total$428 $482 $478 
(1)Staff costs, maintenance costs, and utilities costs include share-based compensation of $25 million, $27 million and $22 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively.
(2)Other primarily includes material costs and net (income) expenses related to research funding agreements and wafer, labor, software license costs allocated (to) and from cost of revenue.
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Selling, General and Administrative Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Schedule of selling, general and administrative expenses
(in millions)202320222021
Staff costs, maintenance costs, and utilities (1)
$342 $417 $537 
Depreciation of property, plant and equipment and amortization of intangible assets25 45 49 
Other (2)
106 34 
Total$473 $496 $595 
(1)Staff costs, maintenance costs, and utilities costs include share-based payments of $96 million, $92 million and $152 million for share options for the years ended December 31, 2023, 2022 and 2021, respectively. See Note 3 for further discussion on the timing of expense recognition.
(2)Other primarily includes net professional charges, marketing expenses and facility costs, (gain) loss on tool sales and certain contract cancellation fees. Real estate transfer taxes are also included in Other.
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring (Tables)
12 Months Ended
Dec. 31, 2023
Restructuring [Abstract]  
Disclosure of summary of restructuring
The changes to the restructuring provisions recorded on the consolidated statements of financial position as of December 31, 2023 and 2022 are summarized as follows:
(in millions)20232022
Beginning balance
$86 $— 
Provision7191 
Amounts paid(126)(5)
Ending balance
$31 $86 
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-based payment arrangements [Abstract]  
Disclosure of number and weighted average exercise prices of RSUs and PSUs
Number of
RSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
847,430 $39.59 
Granted3,416,545 $57.09 
Forfeited(314,158)$55.36 
Exercised
(738,387)$49.51 
Outstanding as of December 31, 2022
3,211,430 $54.39 
Granted2,426,183 $62.94 
Forfeited(390,769)$55.35 
Exercised(1,093,061)$55.28 
Outstanding as of December 31, 2023
4,153,783 $58.87 
Number of
PSUs
Weighted
average
grant date fair value
Outstanding as of December 31, 2021
  
Granted
571,277 70.85 
Forfeited
(34,082)70.91 
Outstanding as of December 31, 2022
537,195 $70.91 
Granted875,646 $69.73 
Forfeited(220,422)$69.90 
Outstanding as of December 31, 2023
1,192,419 $69.96 
Schedule of fair value assumptions
The assumptions used to value the Company’s PSUs granted during the period presented and their expected lives were as follows:
December 31, 2023
December 31, 2022
Expected dividend yield
Expected volatility50.93%45.50%
Risk-free interest rate4.60%2.55%
Disclosure of number and weighted average exercise prices of share options
The following table shows a summary of the share option’s activity for the year ended December 31, 2023 and 2022.
Number of
Share options
Weighted
average
exercise price
per Share
Outstanding as of December 31, 2021
21,749,558 $10.03 
Exercised
(14,956,321)$10.00 
Forfeited(532,634)$10.00 
Outstanding as of December 31, 2022
6,260,603 $10.02 
Exercised(4,468,985)$10.02 
Forfeited(151,579)$10.00 
Outstanding as of December 31, 2023
1,640,039 $10.02 
Exercisable balance as of December 31, 2023
1,485,670 $10.03 
Disclosure of number and weighted average remaining contractual life of outstanding share options
The following table summarizes information about employees’ share options outstanding as of December 31, 2023:
Outstanding
Range of exercise prices
Number
Outstanding
Weighted
average
remaining
 contractual life
(in years)
$10.02 1,640,039 2.67
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance Income and Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Schedule of finance income
Finance Income
(in millions)202320222021
Interest income - deposits
$92 $31 $
Interest income on FVOCI investments
30 — 
Accretion income
27 12 
Total finance income
$149 $51 $6 
Schedule of finance expenses
Finance Expenses
(in millions)202320222021
Interest on long-term debt$80 $69 $72 
Interest on lease obligations21 23 27 
Commitment fees and amortization of debt issuance costs13 13 12 
Accretion costs and other23 
Total finance expenses$137 $111 $114 
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gain on Sale of a Business (Tables)
12 Months Ended
Dec. 31, 2023
Non-Current Asset Held For Sale And Discontinued Operations [Abstract]  
Schedule of sale of facility and business
The following is the breakdown of the net liabilities that were derecognized:
(in millions)December 31,
2022
Property, plant and equipment$83 
Inventories43 
Total Assets126 
Lease liabilities(47)
Other current and non-current liabilities(88)
Total Liabilities(135)
Net Liabilities$(9)
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Income (Expense), Net (Tables)
12 Months Ended
Dec. 31, 2023
Analysis of income and expense [abstract]  
Schedule of other (income) expense, net
(in millions)202320222021
Loss on hedging activities
$(78)$— $— 
Other(1)
21 $22 $(8)
Total other income (expense), net$(57)$22 $(8)
(1) Relates primarily to share of profits of joint ventures, and gains on the sales of property, plant and equipment and intangible assets.
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income taxes [Abstract]  
Schedule of components of income tax benefit (expense)
Income tax expense consisted of the following:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Current income tax expense:
       Current income tax benefit (expense)$(13)$(14)$
       Adjustments in respect of current income tax of previous year(3)(5)(1)
Deferred tax
     Net operating and investment allowance carryforwards(74)(44)(78)
     Currency effect on non-monetary assets of subsidiary23 (12)(37)
     Other change in temporary differences(11)36 
Income tax expense reported in the consolidated statements of operations
$(66)$(86)$(78)
Reconciliation between tax benefit and accounting profit multiplied by the Company's tax rate
A reconciliation between tax expense and accounting profit multiplied by the Company’s statutory rate of 0.0% is as follows:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Income (Loss) before income taxes$1,084 $1,532 $(176)
Tax at Enacted Statutory Rate$— $— $— 
Foreign tax rate differential(65)(98)(75)
Adjustments in respect to current income tax of previous years(1)(5)(1)
Government grants exempt from tax
Deductible expense for tax purpose(2)— (1)
Impact of unrecognized deferred tax assets(20)57 
Non-deductible expenses for tax purposes— (21)(4)
Effects of foreign exchange gains (loss)10 (14)(22)
Impact of change in liability for uncertain tax positions
Withholding Tax— (11)— 
Other effects(2)
Income tax (expense) benefit
$(66)$(86)$(78)
Effective income tax rate(6.1)%(5.6)%44.3 %
schedule of deferred tax assets and liabilities
Components of the Company’s deferred tax assets and liabilities are attributable as follows:
(in millions)December 31,
2023
December 31,
2022
Accelerated depreciation on property, plant and equipment$(12)$(18)
Losses, credits and investment allowances available for offsetting against future taxable income231 277 
Accrued expenses11 16 
Inventory
Other comprehensive income (loss)
(8)
Currency effect(1)— 
Other(2)
Net deferred tax assets$235 $266 
The classification of the net deferred tax assets in the statements of financial position is as follows:
(in millions)December 31,
2023
December 31,
2022
Deferred tax assets$241 $292 
Deferred tax liabilities(1)
(6)(26)
Net deferred tax assets$235 $266 
(1) Included in Other non-current liabilities in the statements of financial position.
Schedule of deferred tax assets, net
A reconciliation of deferred taxes, net is as follows:
(in millions)December 31,
2023
December 31,
2022
Beginning balance$266 $351 
Tax (expense) benefit recognized to consolidated statements of operations
(50)(67)
Tax (expense) benefit recognized to other comprehensive income (loss)
19 (18)
Ending balance$235 $266 
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings per share [abstract]  
Schedule of basic and diluted earnings per share
Basic and diluted earnings (loss) per share has been calculated for the years ended December 31, 2023, 2022, and 2021 as follows:
(in millions except per share amounts)
202320222021
Net income (loss) attributable to equity shareholders of the Company
$1,020 $1,448 $(250)
Weighted average ordinary shares outstanding
Basic552 539 506 
Diluted556 552 506 
Total basic and diluted earnings per share attributable to equity shareholders
Basic$1.85 $2.69 $(0.49)
Diluted$1.83 $2.62 $(0.49)
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures (Tables)
12 Months Ended
Dec. 31, 2023
Related party [Abstract]  
Company's which have entered into related party transaction with
The consolidated financial statements include the following subsidiaries which are all wholly owned, except for Advanced Mask Technology Centre GmbH & Co. KG, Maskhouse Building Administration GmbH & Co. KG, Advanced Mask Technology Center Verwaltungs GmbH, and Maskhouse Building Administration Verwaltungs GmbH:
Subsidiary
Jurisdiction of
Incorporation or
Organization
December 31, 2023December 31, 2022December 31, 2021
GLOBALFOUNDRIES Dresden Module One LLCUnited StatesXXX
GLOBALFOUNDRIES Dresden Module Two LLCUnited StatesXXX
GLOBALFOUNDRIES Innovation LLC (formerly GLOBALFOUNDRIES Innovation Investments LLC)United StatesXXX
GLOBALFOUNDRIES Investments LLCUnited StatesXXX
GLOBALFOUNDRIES U.S. Inc.United StatesXXX
GLOBALFOUNDRIES U.S. 2 LLCUnited StatesXXX
GLOBALFOUNDRIES Borrower LLCUnited StatesXXX
Hudson Valley Research Park Sewage Works CorporationUnited StatesN/AXX
Hudson Valley Research Park Water-Works CorporationUnited StatesN/AXN/A
GF Power LLCUnited StatesXXN/A
GLOBALFOUNDRIES Finance Inc.Cayman IslandsXXN/A
GLOBALFOUNDRIES France SASFranceXXN/A
GLOBALFOUNDRIES Dresden Module One Holding GmbHGermanyXXX
GLOBALFOUNDRIES Dresden Module One LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two LLC & Co. KGGermanyXXX
GLOBALFOUNDRIES Dresden Module Two Holding GmbHGermanyXXX
GLOBALFOUNDRIES Management Services LLC & Co. KGGermanyXXX
Advanced Mask Technology Center GmbH & Co. KG (50%)GermanyXXX
Maskhouse Building Administration GmbH & Co. KG (50%)GermanyXXX
Advanced Mask Technology Center Verwaltungs GmbH (50%)GermanyXXX
Maskhouse Building Administration Verwaltungs GmbH (50%)GermanyXXX
GLOBALFOUNDRIES Europe Sales & Support GmbHGermanyXXX
GLOBALFOUNDRIES Engineering Private LimitedIndiaXXX
GLOBALFOUNDRIES Japan Ltd.JapanXXX
GLOBALFOUNDRIES Malaysia Sdn. Bhd.MalaysiaXXN/A
GLOBALFOUNDRIES Netherlands Cooperatief U.A.The NetherlandsXXX
GLOBALFOUNDRIES Netherlands Holding B.V.The NetherlandsXXX
GLOBALFOUNDRIES Bulgaria EADBulgariaXXX
GF Asia Investments Pte. Ltd.SingaporeXXX
GF Asia Sales Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Singapore Pte. Ltd.SingaporeXXX
GLOBALFOUNDRIES Taiwan Ltd.TaiwanXXX
GLOBALFOUNDRIES Europe Ltd.United KingdomXXX
GA (Chengdu) Technology Co., Limited ChinaXXX
GLOBALFOUNDRIES China (Beijing) Co., LimitedChinaXXX
GLOBALFOUNDRIES China (Shanghai) Co., LimitedChinaXXX
Nanjing APD Technologies Co. Ltd.ChinaN/AN/AX
Below are the related parties which the Company has entered into transactions with:
December 31,
2023
December 31,
2022
Related Party Name
SMPJoint ventureJoint venture
Mubadala Investment Company PJSC
Shareholder entityShareholder entity
Mubadala Technology Investment Company
Shareholder entityShareholder entity
MDC General Services Holding Company L.L.C
Shareholder entityShareholder entity
Schedule of balances with related parties included in the consolidated statements of financial position
Balances with related parties included in the consolidated statements of financial positions are as follows:
December 31, 2023December 31, 2022
(in millions)Due from
Related
Parties
Due to
Related
Parties
Due from
Related
Parties
Due to
Related
Parties
SMP$12 $10 $11 $10 
Total(1)
$12 $10 $11 $10 
(1)The total amounts of $12 million and $11 million due from related parties as of the years ended December 31, 2023 and 2022, respectively, have been included in receivables, prepayments and other assets (see Note 6). The total amounts of $10 million and $10 million due to related parties’ balance for the years ended December 31, 2023 and 2022, respectively, have been included in trade and other payables (see Note 11).
Schedule of related party transactions
The following table presents the related party transactions included in the consolidated statements of operations:
(in millions)December 31,
2023
December 31,
2022
December 31,
2021
Purchases and recharges from:
SMP(1)
$61 $60 $60 
Total
$61 $60 $60 
Other transactions with:
SMP (reimbursement of expenses and contribution of tools)$61 $52 $45 
MDC General Services Holding Company L.L.C (recharge of expenses)
— 
Total$66 $52 $48 
(1)Purchases from SMP were primarily comprised of wafers.
Schedule of compensation to key management personnel
The compensation of key management personnel during the following years were as follows:
(in millions)202320222021
Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer
     Short-term benefits(1)
$$$
     Share-based payments(1)
21 19 42 
Board of Directors
Total
$33 $29 $53 
(1) For the year ended December 31, 2023, the amounts include short-term benefits and share-based payments for the Chief Business Officer and Chief Operating Officer.
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies (Tables)
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Disclosure of derivative financial liabilities The Company’s exposure to foreign currency risk against financial assets and financial liabilities was as follows, based on notional amounts:
(in millions)
EUR
JPY
SGD
December 31, 2022
Receivables and prepayments
$120 $— $16 
Cash and cash equivalents
48 420 
Loans and borrowings
45 — — 
Trade and other payables
(388)(73)(149)
$(175)$(69)$287 
December 31, 2023
Receivables and prepayments
$86 $— $28 
Cash and cash equivalents
$104 $$19 
Loans and borrowings
$11 $— $— 
Trade and other payables
$(253)$(97)$(121)
$(52)$(92)$(74)
Disclosure of maturity analysis for derivative financial liabilities
The aging of financial assets including trade receivables is as follows:
Past Due but Not Impaired
(in millions)TotalNeither past
Due Nor
Impaired
< 30 Days31-90 Days91-120 DaysGreat
than
120 days
December 31, 2022$2,254 $2,137 $84 $33 $— $— 
December 31, 2023$2,785 $2,651 $127 $$— $— 
The table below summarizes the maturity profile of the Company’s financial liabilities:
(in millions)Carrying
Value
Contractual
Cash Flows
1 Year or
Less
1 to 5 Years
Greater
than
5 Years
December 31, 2022
Loans and borrowings$2,511 $2,706 $229 $1,443 $1,034 
Lease obligations345 427 92 184 151 
Derivative liabilities
66 66 61 — 
Trade payables and other liabilities2,265 2,265 2,171 63 31 
Total$5,187 $5,464 $2,553 $1,695 $1,216 
December 31, 2023
Loans and borrowings$2,372 $2,558 $575 $971 $1,012 
Lease obligations382 521 44 194 283 
Derivative liabilities
56 56 42 14 — 
Trade payables and other liabilities1,438 1,438 1,354 55 29 
Total$4,248 $4,573 $2,015 $1,234 $1,324 
Disclosure of fair value measurement of assets
The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis:
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2022
Assets:
Cash equivalents(1)
$961 $961 $— $— 
Investments in equity instruments(2)
$15 $— $— $15 
Investment in marketable securities(3)
$994 $994 $— $— 
Derivatives(3)
$177 $— $177 $— 
Liabilities:
Derivatives(3)
$66 $— $66 $— 
Fair Value Measurement at Reporting Date Using
(in millions)TotalQuoted
Prices
Identical
Assets/
Liabilities
(Level 1)
Significant
Other Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
December 31, 2023
Assets:
Cash equivalents (1)
$1,897 $1,626 $271 $— 
Investments in equity instruments (2)
$19 $— $— $19 
Investments in marketable securities(3)
$1,501 $1,189 $312 $— 
Derivatives(4)
$132 $— $132 $— 
Liabilities:
Derivatives(4)
$56 $— $56 $— 
(1)Included in cash and cash equivalents on the Company’s consolidated statements of financial position.
(2)Included in current and non-current receivables, prepayments and other assets on the Company’s consolidated statements of financial position.
(3)Included in current and non-current marketable securities on the Company’s consolidated statements of financial position.
(4)Consists of foreign currency forward contracts, interest rate swaps, cross currency swaps and commodity swaps. Included in other current and non-current financial assets and liabilities, as applicable, on the Company’s consolidated statements of financial position.
Disclosure of financial assets
The following table shows the carrying and fair values of the Company’s financial liabilities at amortized cost (“FLAC”) not recorded at fair value on a recurring basis. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.
(in millions)December 31, 2023December 31, 2022
Financial Liability
Category
Carrying
Amount
Fair ValueCarrying
Amount
Fair Value
Other long-term debtFLAC$2,372 $2,319 $2,511 $2,414 
Total$2,372 $2,319 $2,511 $2,414 
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2023
Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]  
Summary of commitments The Company’s unconditional purchase commitments are as follows:
(in millions)December 31,
2023
December 31,
2022
Contracts for capital expenditures$1,136 $2,774 
Contracts for operating expenditures2,786 3,587 
Total
$3,922 $6,361 
Due within the next 12 months
$970 $2,732 
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Operating Segments Information (Tables)
12 Months Ended
Dec. 31, 2023
Operating Segments [Abstract]  
Disclosure of geographical areas Revenue based on customers’ headquarters and non-current assets by geography were as follows:
For the year ended December 31,
Revenue by Geography202320222021
(in millions)
United States$4,262 $4,898 $3,975 
Europe, the Middle East, and Africa1,533 1,182 805 
Other1,597 2,028 1,805 
Total
$7,392 $8,108 $6,585 
Non-current Assets by Geography20232022
(in millions)
United States$4,738 $5,149 
Germany2,400 2,462 
Singapore3,801 3,508 
Other457 532 
Total$11,396 $11,651 
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Customer And Supplier Concentration (Tables)
12 Months Ended
Dec. 31, 2023
Financial Instruments [Abstract]  
Disclosure of major customers
For the year ended December 31,
Revenue by major customer
202320222021
(in millions)Amount%Amount%Amount%
Customer A$620 8$746 9$811 12
Customer B$1,279 17$1,329 16$995 15
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of reclassifications or changes in presentation [line items]      
Gain on sale of East Fishkill (“EFK”) business $ 0 $ 403 $ 0
Discontinued Operations - Tampines, Singapore Facility      
Disclosure of reclassifications or changes in presentation [line items]      
Consideration received   406 $ 170
Gain on sale of East Fishkill (“EFK”) business   $ 403  
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [line items]      
Profit (loss) before tax $ 1,084 $ 1,532 $ (176)
Building and leasehold/land improvements | Change In Accounting Estimate      
Disclosure of detailed information about property, plant and equipment [line items]      
Profit (loss) before tax $ 76    
Computer      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 5 years    
Maximum | Building and leasehold/land improvements      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 50 years    
Maximum | Equipment      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 10 years    
Minimum | Building and leasehold/land improvements      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 26 years    
Minimum | Equipment      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 2 years    
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Material Accounting Policies - Intangible Assets (Details)
12 Months Ended
Dec. 31, 2023
Minimum  
Disclosure of changes in accounting estimates [line items]  
Useful life (in years) 3 years
Maximum  
Disclosure of changes in accounting estimates [line items]  
Useful life (in years) 10 years
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Critical Accounting Judgements, Estimates, and Assumptions (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [line items]      
Profit (loss) before tax $ 1,084 $ 1,532 $ (176)
Building and leasehold/land improvements | Change In Accounting Estimate      
Disclosure of detailed information about property, plant and equipment [line items]      
Profit (loss) before tax $ 76    
Minimum | Building and leasehold/land improvements      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 26 years    
Maximum | Building and leasehold/land improvements      
Disclosure of detailed information about property, plant and equipment [line items]      
Useful life (in years) 50 years    
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of cash flows [abstract]        
Cash balances on hand and at banks $ 490 $ 990    
Other cash and cash equivalents 1,897 1,362    
Total $ 2,387 $ 2,352 $ 2,939 $ 908
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Changes in liabilities arising from financing activities [abstract]        
Liabilities arising from financing activities at beginning of period $ (26,646) $ (25,890)    
Cash Flows (Inflows)/ Outflows 212 (842)    
Addition (111) (6)    
Foreign exchange movement (33) 18    
Others (41) 74    
Liabilities arising from financing activities at end of period (26,619) (26,646)    
Cash and cash equivalents 2,387 2,352 $ 2,939 $ 908
Debt        
Changes in liabilities arising from financing activities [abstract]        
Liabilities arising from financing activities at beginning of period (2,511) (2,013)    
Cash Flows (Inflows)/ Outflows 182 (670)    
Addition (17) (6)    
Foreign exchange movement (30) 10    
Others 4 168    
Liabilities arising from financing activities at end of period (2,372) (2,511)    
Lease obligations        
Changes in liabilities arising from financing activities [abstract]        
Liabilities arising from financing activities at beginning of period (345) (426)    
Cash Flows (Inflows)/ Outflows 77 89    
Addition (117) (18)    
Foreign exchange movement (5) 9    
Others 8 1    
Liabilities arising from financing activities at end of period (382) (345)    
Share capital        
Changes in liabilities arising from financing activities [abstract]        
Liabilities arising from financing activities at beginning of period (11) (11)    
Liabilities arising from financing activities at end of period (11) (11)    
Additional Paid-In Capital        
Changes in liabilities arising from financing activities [abstract]        
Liabilities arising from financing activities at beginning of period (23,831) (23,487)    
Cash Flows (Inflows)/ Outflows (42) (168)    
Others (154) (176)    
Liabilities arising from financing activities at end of period (24,027) (23,831)    
Restricted cash        
Changes in liabilities arising from financing activities [abstract]        
Assets arising from financing activities at beginning of period 1 1    
Assets arising from financing activities at end of period 1 1    
Government grants receivable        
Changes in liabilities arising from financing activities [abstract]        
Assets arising from financing activities at beginning of period 52 47    
Cash Flows (Inflows)/ Outflows (5) (93)    
Addition 23 18    
Foreign exchange movement 1 (1)    
Others 101 81    
Assets arising from financing activities at end of period 172 52    
Cash and cash equivalents 172 52    
Other receivables        
Changes in liabilities arising from financing activities [abstract]        
Assets arising from financing activities at beginning of period (1)      
Liabilities arising from financing activities at beginning of period   (1)    
Foreign exchange movement $ 1      
Assets arising from financing activities at end of period   $ (1)    
XML 97 R78.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of geographical areas [line items]        
Cash and cash equivalents $ 2,387 $ 2,352 $ 2,939 $ 908
United States of America        
Disclosure of geographical areas [line items]        
Cash and cash equivalents 481 484    
Republic of Singapore        
Disclosure of geographical areas [line items]        
Cash and cash equivalents 1,666 1,775    
Other        
Disclosure of geographical areas [line items]        
Cash and cash equivalents $ 240 $ 93    
XML 98 R79.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current:      
Trade receivables, other than related parties $ 1,002 $ 824  
Other receivables 255 497  
Unbilled accounts receivable 33 24 $ 43
Receivables from government grant 66 52  
Receivables from related parties (Note 29) 12 11  
Other current financial assets 52 79  
Total 1,420 1,487  
Non-current:      
Advances to suppliers 213 235  
Non-trade receivables 0 10  
Receivables from government grant 106 0  
Payment in Lieu of Tax (“PILOT”) Bonds 0 11  
Other 24 25  
Total $ 343 $ 281  
XML 99 R80.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Trade and other current receivables [abstract]    
Beginning balance $ 24 $ 43
Revenue recognized during the year 101 87
Amounts invoiced (92) (106)
Ending balance $ 33 $ 24
XML 100 R81.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Receivables, Prepayments and Other Assets - Maturity Schedule (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of provision matrix [line items]    
Trade receivables, other than related parties $ 1,002 $ 824
Receivables neither past due nor impaired    
Disclosure of provision matrix [line items]    
Trade receivables, other than related parties 880 708
Less than 30 days    
Disclosure of provision matrix [line items]    
Trade receivables, other than related parties 114 83
31 to 60 days    
Disclosure of provision matrix [line items]    
Trade receivables, other than related parties 4 22
61 to 90 days    
Disclosure of provision matrix [line items]    
Trade receivables, other than related parties $ 4 $ 11
XML 101 R82.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Inventories - Summary of Inventories (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Inventories [Abstract]    
Work in progress $ 928 $ 1,024
Raw materials and supplies 559 315
Total $ 1,487 $ 1,339
XML 102 R83.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period $ 10,596  
End of period 10,164 $ 10,596
Investment tax credits, property plant and equipment 226 179
Land and Land Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 83  
End of period 94 83
Building and Leasehold Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 3,323  
End of period 3,732 3,323
Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 3,765  
End of period 4,793 3,765
Computer    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 48  
End of period 40 48
Construction in Progress    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 3,377  
End of period 1,505 3,377
Cost    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 34,381 31,914
Additions 905 3,658
Transfers from construction in progress 0 0
Disposals (339) (1,169)
Effects of exchange rate changes 13 (22)
End of period 34,960 34,381
Cost | Land and Land Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 122 130
Additions 16 0
Transfers from construction in progress 0 1
Disposals 0 (8)
Effects of exchange rate changes 0 (1)
End of period 138 122
Cost | Building and Leasehold Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 7,867 7,576
Additions 121 67
Transfers from construction in progress 616 409
Disposals (25) (182)
Effects of exchange rate changes 2 (3)
End of period 8,581 7,867
Cost | Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 22,569 22,350
Additions 19 27
Transfers from construction in progress 1,979 935
Disposals (297) (725)
Effects of exchange rate changes 11 (18)
End of period 24,281 22,569
Cost | Computer    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 439 435
Additions 4 0
Transfers from construction in progress 7 21
Disposals (2) (17)
Effects of exchange rate changes 0 0
End of period 448 439
Cost | Construction in Progress    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period 3,384 1,423
Additions 745 3,564
Transfers from construction in progress (2,602) (1,366)
Disposals (15) (237)
Effects of exchange rate changes 0 0
End of period 1,512 3,384
Accumulated Amortization    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (23,785) (23,201)
Additions (1,322) (1,447)
Disposals 316 858
Effects of exchange rate changes (5) 5
End of period (24,796) (23,785)
Accumulated Amortization | Land and Land Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (39) (37)
Additions (5) (6)
Disposals 0 4
Effects of exchange rate changes 0 0
End of period (44) (39)
Accumulated Amortization | Building and Leasehold Improvements    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (4,544) (4,266)
Additions (322) (443)
Disposals 18 164
Effects of exchange rate changes (1) 1
End of period (4,849) (4,544)
Accumulated Amortization | Equipment    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (18,804) (18,507)
Additions (976) (975)
Disposals 296 674
Effects of exchange rate changes (4) 4
End of period (19,488) (18,804)
Accumulated Amortization | Computer    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (391) (384)
Additions (19) (23)
Disposals 2 16
Effects of exchange rate changes 0 0
End of period (408) (391)
Accumulated Amortization | Construction in Progress    
Reconciliation of changes in property, plant and equipment [abstract]    
Beginning of period (7) (7)
Additions 0 0
Disposals 0 0
Effects of exchange rate changes 0 0
End of period $ (7) $ (7)
XML 103 R84.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [line items]      
Right-of-use assets $ 335 $ 282 $ 305
Cost      
Disclosure of detailed information about property, plant and equipment [line items]      
Transfers from construction in progress 0 0  
Right-of-use assets 996 888  
Cost | Construction in Progress      
Disclosure of detailed information about property, plant and equipment [line items]      
Transfers from construction in progress (2,602) (1,366)  
Accumulated Amortization      
Disclosure of detailed information about property, plant and equipment [line items]      
Right-of-use assets $ (57) $ (82) $ (81)
XML 104 R85.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, Plant and Equipment - Schedule of Depreciation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense $ 1,322 $ 1,447 $ 1,411
Cost of revenue      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense 1,259 1,377 1,309
Research and development expenses      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense 38 40 73
Selling, general and administrative expenses      
Disclosure of detailed information about property, plant and equipment [line items]      
Depreciation expense $ 25 $ 30 $ 29
XML 105 R86.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period $ 363  
Intangible assets and goodwill at end of period 391 $ 363
Technology, Licenses and Similar Rights    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 246  
Intangible assets and goodwill at end of period 186 246
Software    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 92  
Intangible assets and goodwill at end of period 181 92
Patents    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 1  
Intangible assets and goodwill at end of period 1 1
Goodwill    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 18  
Intangible assets and goodwill at end of period 18 18
Others    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 6  
Intangible assets and goodwill at end of period 5 6
Cost    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 1,966 1,865
Additions 157 163
Disposals (40) (62)
Intangible assets and goodwill at end of period 2,083 1,966
Cost | Technology, Licenses and Similar Rights    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 1,217 1,202
Additions 61 62
Disposals (40) (47)
Intangible assets and goodwill at end of period 1,238 1,217
Cost | Software    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 368 284
Additions 96 96
Disposals 0 (12)
Intangible assets and goodwill at end of period 464 368
Cost | Patents    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 226 229
Additions 0 0
Disposals 0 (3)
Intangible assets and goodwill at end of period 226 226
Cost | Goodwill    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 18 18
Additions 0 0
Disposals 0 0
Intangible assets and goodwill at end of period 18 18
Cost | Others    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 137 132
Additions 0 5
Disposals 0 0
Intangible assets and goodwill at end of period 137 137
Accumulated Amortization    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period (1,603) (1,488)
Additions (129) (176)
Disposals 40 61
Intangible assets and goodwill at end of period (1,692) (1,603)
Accumulated Amortization | Technology, Licenses and Similar Rights    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period (971) (867)
Additions (121) (150)
Disposals 40 46
Intangible assets and goodwill at end of period (1,052) (971)
Accumulated Amortization | Software    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period (276) (278)
Additions (7) (10)
Disposals 0 12
Intangible assets and goodwill at end of period (283) (276)
Accumulated Amortization | Patents    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period (225) (212)
Additions 0 (16)
Disposals 0 3
Intangible assets and goodwill at end of period (225) (225)
Accumulated Amortization | Goodwill    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period 0 0
Additions 0 0
Disposals 0 0
Intangible assets and goodwill at end of period 0 0
Accumulated Amortization | Others    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Intangible assets and goodwill at beginning of period (131) (131)
Additions (1) 0
Disposals 0 0
Intangible assets and goodwill at end of period $ (132) $ (131)
XML 106 R87.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about intangible assets [line items]      
Amortization expenses $ 129 $ 176 $ 207
Cost of revenue      
Disclosure of detailed information about intangible assets [line items]      
Amortization expenses 61 91 113
Research and development expenses      
Disclosure of detailed information about intangible assets [line items]      
Amortization expenses 63 70 74
Selling, general and administrative expenses      
Disclosure of detailed information about intangible assets [line items]      
Amortization expenses $ 5 $ 15 $ 20
XML 107 R88.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details)
$ in Millions
12 Months Ended
Dec. 31, 2023
USD ($)
$ / uSD
€ / $
¥ / $
Dec. 31, 2022
USD ($)
$ / uSD
€ / $
¥ / $
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value $ 2,319 $ 2,414
Currency risk    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount 3,980 4,108
Currency risk | Total Forward Contracts    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount 1,444 1,935
Currency risk | Euro forward contracts (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 845 $ 1,203
Average Foreign Currency/ US$ | € / $ 0.91 0.94
Average Strike Price 0 0
Currency risk | Singapore dollar forward contracts (receive Singapore$/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 483 $ 496
Average Foreign Currency/ US$ | $ / uSD 1.33 1.37
Average Strike Price 0 0
Currency risk | Japanese yen forward contracts (receive Japanese yen/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 116 $ 236
Average Foreign Currency/ US$ | ¥ / $ 140.20 127.22
Average Strike Price 0 0
Currency risk | Interest rate swaps    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 653 $ 795
Currency risk | Interest rate swaps | Minimum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.00442 0.00382
Currency risk | Interest rate swaps | Maximum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.01761 0.01731
Currency risk | Cross currency interest rate swaps (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 519 $ 535
Average Foreign Currency/ US$ | € / $ 0.89 0.89
Currency risk | Cross currency interest rate swaps (receive euros/pay US$) | Minimum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.03834 0.03834
Currency risk | Cross currency interest rate swaps (receive euros/pay US$) | Maximum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.04182 0.04182
Currency risk | Cross currency swaps (receive Singapore $/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 1,127 $ 796
Average Foreign Currency/ US$ | $ / uSD 1.37 1.37
Currency risk | Cross currency swaps (receive Singapore $/pay US$) | Minimum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.0183 0.01830
Currency risk | Cross currency swaps (receive Singapore $/pay US$) | Maximum    
Disclosure of financial assets and liabilities [Line Items]    
Average Strike Price 0.01941 0.01941
Currency risk | Commodity swaps    
Disclosure of financial assets and liabilities [Line Items]    
Notional Amount $ 237 $ 47
Average Foreign Currency/ US$ | € / $ 0.91  
Average Strike Price 73.59 512.56
Currency risk | Other Current Financial Liabilities    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value $ (42) $ (61)
Currency risk | Other Current Financial Liabilities | Total Forward Contracts    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (12) (53)
Currency risk | Other Current Financial Liabilities | Euro forward contracts (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (4) (32)
Currency risk | Other Current Financial Liabilities | Singapore dollar forward contracts (receive Singapore$/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (1) (1)
Currency risk | Other Current Financial Liabilities | Japanese yen forward contracts (receive Japanese yen/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (7) (20)
Currency risk | Other Current Financial Liabilities | Interest rate swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Current Financial Liabilities | Cross currency interest rate swaps (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (3) 0
Currency risk | Other Current Financial Liabilities | Cross currency swaps (receive Singapore $/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Current Financial Liabilities | Commodity swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (27) (8)
Currency risk | Other Non-current Financial Liabilities    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (14) (5)
Currency risk | Other Non-current Financial Liabilities | Total Forward Contracts    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Euro forward contracts (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Singapore dollar forward contracts (receive Singapore$/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Japanese yen forward contracts (receive Japanese yen/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Interest rate swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Cross currency interest rate swaps (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 (3)
Currency risk | Other Non-current Financial Liabilities | Cross currency swaps (receive Singapore $/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value 0 0
Currency risk | Other Non-current Financial Liabilities | Commodity swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial liabilities, at fair value (14) (2)
Currency risk | Other Current Financial Assets    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 52 79
Currency risk | Other Current Financial Assets | Total Forward Contracts    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 28 79
Currency risk | Other Current Financial Assets | Euro forward contracts (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 14 46
Currency risk | Other Current Financial Assets | Singapore dollar forward contracts (receive Singapore$/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 8 15
Currency risk | Other Current Financial Assets | Japanese yen forward contracts (receive Japanese yen/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 6 18
Currency risk | Other Current Financial Assets | Interest rate swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 17 0
Currency risk | Other Current Financial Assets | Cross currency interest rate swaps (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 5 0
Currency risk | Other Current Financial Assets | Cross currency swaps (receive Singapore $/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 0 0
Currency risk | Other Current Financial Assets | Commodity swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 2 0
Currency risk | Other Non-current Financial Assets    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 80 98
Currency risk | Other Non-current Financial Assets | Total Forward Contracts    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 1 3
Currency risk | Other Non-current Financial Assets | Euro forward contracts (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 0 3
Currency risk | Other Non-current Financial Assets | Singapore dollar forward contracts (receive Singapore$/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 0 0
Currency risk | Other Non-current Financial Assets | Japanese yen forward contracts (receive Japanese yen/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 1 0
Currency risk | Other Non-current Financial Assets | Interest rate swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 5 42
Currency risk | Other Non-current Financial Assets | Cross currency interest rate swaps (receive euros/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 1 2
Currency risk | Other Non-current Financial Assets | Cross currency swaps (receive Singapore $/pay US$)    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value 73 51
Currency risk | Other Non-current Financial Assets | Commodity swaps    
Disclosure of financial assets and liabilities [Line Items]    
Financial assets, at fair value $ 0 $ 0
XML 108 R89.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Other Current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities $ (42) $ (61)
Other Non-current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities (14) (5)
Other Current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 52 79
Other Non-current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 80 98
Foreign currency forwards | Other Current Financial Liabilities    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial liabilities held for trading (3) (1)
Foreign currency forwards | Other Non-current Financial Liabilities    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial liabilities held for trading 0 0
Foreign currency forwards | Other Current Financial Assets    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial assets held for trading 4 10
Foreign currency forwards | Other Non-current Financial Assets    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial assets held for trading 1 0
Commodity swaps | Other Current Financial Liabilities    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial liabilities held for trading (5)  
Commodity swaps | Other Non-current Financial Liabilities    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial liabilities held for trading (3)  
Commodity swaps | Other Current Financial Assets    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial assets held for trading 0  
Commodity swaps | Other Non-current Financial Assets    
Derivatives Not Designated As Hedging Instruments [Abstract]    
Derivative financial assets held for trading 0  
Foreign currency forwards | Other Current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities (9) (52)
Foreign currency forwards | Other Non-current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities 0 0
Foreign currency forwards | Other Current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 24 69
Foreign currency forwards | Other Non-current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 0 3
Interest rate swaps | Other Current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities 0 0
Interest rate swaps | Other Non-current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities 0 0
Interest rate swaps | Other Current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 17 0
Interest rate swaps | Other Non-current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 5 42
Cross currency swaps and cross currency interest rate swaps | Other Current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities (3) 0
Cross currency swaps and cross currency interest rate swaps | Other Non-current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities 0 (3)
Cross currency swaps and cross currency interest rate swaps | Other Current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 5 0
Cross currency swaps and cross currency interest rate swaps | Other Non-current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 74 53
Commodity swaps | Other Current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities (22) (8)
Commodity swaps | Other Non-current Financial Liabilities    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative liabilities (11) (2)
Commodity swaps | Other Current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets 2 0
Commodity swaps | Other Non-current Financial Assets    
Derivatives Designated As Hedging Instruments [Abstract]    
Derivative financial assets $ 0 $ 0
XML 109 R90.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of financial assets and liabilities [Line Items]      
Other comprehensive income that will be reclassified to profit or loss, net of tax $ (23) $ 137 $ (54)
Cash flow hedges      
Disclosure of financial assets and liabilities [Line Items]      
Other comprehensive income that will be reclassified to profit or loss, net of tax $ 15 $ 17  
XML 110 R91.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities - Effect on Financial Statements (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Foreign currency forwards    
Disclosure of detailed information about hedging instruments [line items]    
Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion) $ 17 $ (105)
Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment (17) (93)
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) 34 (76)
Amount of Gain (Losses) Reclassified into Income (Missed Forecast) 0 0
Amount of Gain (Losses) Recognized into Income (Ineffective Portion) 0 (5)
Interest rate swaps    
Disclosure of detailed information about hedging instruments [line items]    
Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion) 8 55
Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment 0 0
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) 28 6
Amount of Gain (Losses) Reclassified into Income (Missed Forecast) 0 0
Amount of Gain (Losses) Recognized into Income (Ineffective Portion) 0 0
Cross currency swaps and cross currency interest rate swaps    
Disclosure of detailed information about hedging instruments [line items]    
Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion) 31 72
Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment 0 0
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion)   0
Amount of Gain (Losses) Reclassified into Income (Missed Forecast)   0
Amount of Gain (Losses) Recognized into Income (Ineffective Portion) (4) 4
Cross currency swaps and cross currency interest rate swaps | Finance expense    
Disclosure of detailed information about hedging instruments [line items]    
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) 6  
Amount of Gain (Losses) Reclassified into Income (Missed Forecast) 0  
Cross currency swaps and cross currency interest rate swaps | Other income (expense)    
Disclosure of detailed information about hedging instruments [line items]    
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) 31  
Amount of Gain (Losses) Reclassified into Income (Missed Forecast) 0  
Commodity swaps    
Disclosure of detailed information about hedging instruments [line items]    
Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion) (32) (5)
Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment 0 0
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion)   26
Amount of Gain (Losses) Reclassified into Income (Missed Forecast)   0
Amount of Gain (Losses) Recognized into Income (Ineffective Portion) 0 $ (8)
Commodity swaps | Other income (expense)    
Disclosure of detailed information about hedging instruments [line items]    
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) 0  
Amount of Gain (Losses) Reclassified into Income (Missed Forecast) (13)  
Commodity swaps | Cost of revenue and operating expenses    
Disclosure of detailed information about hedging instruments [line items]    
Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion) (4)  
Amount of Gain (Losses) Reclassified into Income (Missed Forecast)  
XML 111 R92.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of detailed information about hedging instruments [line items]      
Amount of Gains (Losses) Recognized in Income on Derivative $ (24) $ (22)  
Foreign currency forwards      
Disclosure of detailed information about hedging instruments [line items]      
Amount of Gains (Losses) Recognized in Income on Derivative (16) $ (22) $ (17)
Commodity swaps      
Disclosure of detailed information about hedging instruments [line items]      
Amount of Gains (Losses) Recognized in Income on Derivative $ (8)    
XML 112 R93.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current:    
Trade payables $ 511 $ 532
Accrued expenses 496 573
Contract liabilities 895 592
Advances and deposits 68 93
Payable for property, plant and equipment and Intangible Assets 282 961
Other 97 98
Total 2,349 2,849
Non-current:    
Payable for Intangible Assets 76 92
Contract liabilities 1,088 1,326
Other 26 56
Total 1,190 1,474
Deposits from customers $ 22 $ 73
XML 113 R94.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Subclassifications of assets, liabilities and equities [abstract]    
Beginning contract liabilities balance $ 1,918 $ 1,901
Cash receipts in advance of satisfaction of performance obligations 805 1,189
Released to the consolidated statements of operations (759) (951)
Amounts credited to customers 0 (221)
Other 19 0
Ending contract liabilities balance 1,983 1,918
Current 895 592
Non-current 1,088 1,326
Deferred revenue $ 476 $ 522
XML 114 R95.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current:      
Current portion of long-term debt $ 571 $ 223  
Non-current:      
Non-current portion of long-term debt 1,801 2,288  
Total $ 2,372 $ 2,511 $ 2,013
XML 115 R96.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt - Narrative (Details)
$ in Millions, $ in Millions
12 Months Ended
Oct. 13, 2021
USD ($)
Sep. 03, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 03, 2021
SGD ($)
Disclosure of detailed information about borrowings [line items]            
Loans and borrowings     $ 2,372 $ 2,511 $ 2,013  
Non-current portion of long-term debt     $ 1,801 2,288    
2021 SGD EDB Loan            
Disclosure of detailed information about borrowings [line items]            
Maximum borrowing capacity   $ 1,149       $ 1,541
Nominal Interest Rate   1.40% 1.40%     1.40%
Borrowing term (in years)   5 years        
New loans and borrowings     $ 1,100 971    
Non-current portion of long-term debt     987 923    
Five-year Revolving and Letter of Credit Facilities Agreement            
Disclosure of detailed information about borrowings [line items]            
Maximum borrowing capacity $ 1,000          
Borrowing term (in years) 5 years          
Deferred Financing costs Netting            
Disclosure of detailed information about borrowings [line items]            
Loans and borrowings     7 12    
Deferred Income From Government Grants | 2021 SGD EDB Loan            
Disclosure of detailed information about borrowings [line items]            
Loans and borrowings     $ 179 $ 184    
Nominal Interest Rate     3.20%      
XML 116 R97.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt - Movements in Interest bearing Borrowings (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Borrowing costs Abstract [Abstract]    
Opening balance $ 2,511 $ 2,013
New loans and borrowings 46 971
Repayments (228) (301)
Other 43 (172)
Ending balance $ 2,372 $ 2,511
XML 117 R98.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt - Summary of Term Loan Facilities (Details)
$ in Millions, $ in Millions
Apr. 23, 2020
USD ($)
Jan. 21, 2019
USD ($)
bank
Mar. 02, 2018
USD ($)
bank
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 03, 2021
USD ($)
Sep. 03, 2021
SGD ($)
Oct. 31, 2019
USD ($)
Disclosure of detailed information about borrowings [line items]                  
Current portion of non-current borrowings       $ 571 $ 223        
Non-current portion of non-current borrowings       1,801 2,288        
Total       2,372 2,511 $ 2,013      
Number of banks | bank   5 4            
Proceeds from sales of property, plant and equipment $ 300 $ 425 $ 375            
Lease obligations       $ 382 345        
Equipment                  
Disclosure of detailed information about borrowings [line items]                  
Lease obligations     $ 375            
2018 Tool Equipment Purchase and Lease Financing                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.60%          
Current portion of non-current borrowings       $ 0 19        
2019 Tool Equipment Purchase and Lease Financing                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.75%          
Current portion of non-current borrowings       $ 21 85        
Non-current portion of non-current borrowings       $ 0 21        
USD Term Loan A                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       2.90%          
Current portion of non-current borrowings       $ 64 0        
Non-current portion of non-current borrowings       $ 586 649        
EUR Term Loan A                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       2.60%          
Current portion of non-current borrowings       $ 9 0        
Non-current portion of non-current borrowings       $ 82 89        
2019 USD Dresden Equipment Financing                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.75%          
Current portion of non-current borrowings       $ 36 36        
Non-current portion of non-current borrowings       $ 72 108        
2019 USD Dresden Equipment Financing Non-Current                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       2.25%          
2020 USD Equipment Financing                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.90%          
Current portion of non-current borrowings       $ 60 59        
Non-current portion of non-current borrowings       $ 34 93        
2019 EUR Dresden Equipment Financing                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.75%          
Current portion of non-current borrowings       $ 368 13        
Non-current portion of non-current borrowings       $ 30 387        
Maximum borrowing capacity                 $ 750
2019 EUR Dresden Equipment Financing Noncurrent                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       2.25%          
2021 SGD EDB Loan                  
Disclosure of detailed information about borrowings [line items]                  
Nominal Interest Rate       1.40%     1.40% 1.40%  
Non-current portion of non-current borrowings       $ 987 923        
Maximum borrowing capacity             $ 1,149 $ 1,541  
Various                  
Disclosure of detailed information about borrowings [line items]                  
Current portion of non-current borrowings       13 11        
Non-current portion of non-current borrowings       $ 10 $ 18        
XML 118 R99.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Long-Term Debt - Summary of Unutilized Credit Facilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of detailed information about borrowings [line items]    
Unutilized borrowing facilities $ 1,058 $ 1,118
2021 SGD EDB Loan    
Disclosure of detailed information about borrowings [line items]    
Unutilized borrowing facilities 0 42
Revolving Credit Facility    
Disclosure of detailed information about borrowings [line items]    
Unutilized borrowing facilities 1,012 1,012
Uncommitted Credit Facilities    
Disclosure of detailed information about borrowings [line items]    
Unutilized borrowing facilities $ 46 $ 64
XML 119 R100.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Additional Information about Leases (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of Leases [Abstract]      
Amortization of right-of-use assets $ 57 $ 82  
Interest expense on lease liabilities 21 23 $ 27
Short-term and low-value leases expense 0 1  
Total net lease cost $ 78 $ 106  
Weighted average remaining lease term 12 years 4 months 24 days 7 years 2 months 4 days  
Weighted average discount rate 5.16% 4.75%  
XML 120 R101.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Maturity of Lease Payments (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of maturity analysis of operating lease payments [line items]    
Minimum Lease Payments $ 521 $ 427
Present Value of Payments 382 345
Less: amounts representing finance charges (139) (82)
Minimum Undiscounted Operating Lease Payments due 382 345
Minimum present value of operating lease payments due 382 345
Current 32 75
Non-current 350 270
Total 382 345
Within 1 year    
Disclosure of maturity analysis of operating lease payments [line items]    
Minimum Lease Payments 44 92
Present Value of Payments 32 75
2-5 years    
Disclosure of maturity analysis of operating lease payments [line items]    
Minimum Lease Payments 194 184
Present Value of Payments 128 146
After 5 years    
Disclosure of maturity analysis of operating lease payments [line items]    
Minimum Lease Payments 283 151
Present Value of Payments $ 222 $ 124
XML 121 R102.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Cash Flow Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows used in operating activities:      
Payments of short-term and low-value leases $ 0 $ (1)  
Interest paid (21) (23) $ (27)
Cash flows used in financing activities:      
Payment of lease obligations $ (77) $ (89)  
XML 122 R103.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Schedule of Lease Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disclosure of Leases [Abstract]    
Beginning balance $ 282 $ 305
Additions 117 59
Disposals (7) 0
Amortization (57) (82)
Ending balance $ 335 $ 282
XML 123 R104.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions - Movement in Provision for Asset Retirement Obligations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of changes in other provisions [abstract]    
Provisions at beginning of period $ 298 $ 349
Arising during the period 2 2
Accretion cost 5 (4)
Restructuring expenses 71 91
Utilized (136) (52)
Released to the consolidated statement of operations 0 (88)
Provisions at end of period 240 298
Provisions related to asset retirement obligations (10) 40
Amounts paid 126 5
Provisions related to the sale of a business $ 0 $ (7)
XML 124 R105.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions - Narrative (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Minimum    
Disclosure of other provisions [line items]    
Discount rate (as a percent) 1.72% 1.58%
Maximum    
Disclosure of other provisions [line items]    
Discount rate (as a percent) 3.35% 4.04%
XML 125 R106.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Government Grants - Roll forward of Government Grants (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Government grants [Abstract]    
Beginning balance $ 404 $ 176
Received/receivable during the period 81 270
Fair value of EDB loan 7 0
Capitalized to fixed assets (74) 0
Released to the consolidated statements of operations (58) (42)
Ending balance 360 404
Current 93 110
Non-current 267 294
Total $ 360 $ 404
XML 126 R107.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Government Grants - Located in Consolidated Statements of Operations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Government Grants [Line Items]      
Income from government grants $ 58 $ 42 $ 33
Cost of revenue      
Government Grants [Line Items]      
Income from government grants 29 30 33
Research and development expenses      
Government Grants [Line Items]      
Income from government grants 29 11 0
Selling, general and administrative expenses      
Government Grants [Line Items]      
Income from government grants $ 0 $ 1 $ 0
XML 127 R108.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Issued Capital and Reserves (Details) - $ / shares
Sep. 12, 2021
Dec. 31, 2023
Dec. 31, 2022
Oct. 27, 2021
Disclosure of classes of share capital [line items]        
Stock split (in shares) 0.5      
Number of shares issued (in shares)   553,548,000 547,755,000  
Par value per share (in dollars per share)   $ 0.02 $ 0.02  
Number of shares outstanding (in shares)   553,548,000 547,755,000  
Ordinary shares        
Disclosure of classes of share capital [line items]        
Number of shares issued (in shares)   554,000,000   30,250,000
Number of shares authorised (in shares)   1,300,000,000    
Par value per share (in dollars per share)   $ 0.02    
Number of shares outstanding (in shares)   554,000,000    
Ordinary Shares In Private Placement        
Disclosure of classes of share capital [line items]        
Number of shares issued (in shares)       1,595,744
Preference shares        
Disclosure of classes of share capital [line items]        
Number of shares authorised (in shares)   200,000,000    
Par value per share (in dollars per share)   $ 0.02    
XML 128 R109.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Revenue - Disaggregated Revenues (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenue $ 7,392 $ 8,108 $ 6,585
Revenue recognized over time      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenue 471 445 357
Revenue recognized at a point in time      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenue 6,921 7,663 6,228
Wafer fabrication      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenue 6,820 7,627 6,204
Engineering and other services      
Disclosure of disaggregation of revenue from contracts with customers [line items]      
Revenue $ 572 $ 481 $ 381
XML 129 R110.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Revenue - Narrative (Details)
$ in Billions
12 Months Ended
Dec. 31, 2023
USD ($)
Revenue from Contracts with Customers [Abstract]  
Cash receipts from futures contracts, forward contracts, option contracts and swap contracts $ 20
XML 130 R111.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cost of Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue from Contracts with Customers [Abstract]      
Depreciation of property, plant and equipment and amortization of intangible assets $ 1,321 $ 1,468 $ 1,422
Inventory changes materials costs and other 1,742 1,834 1,726
Staff costs, maintenance costs, and utilities(2) 2,228 2,567 2,424
Total cost of revenues 5,291 5,869 5,572
Staff, maintenance, and utility costs $ 48 $ 64 $ 55
XML 131 R112.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Research and Development Expenses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Analysis of income and expense [abstract]      
Staff costs, maintenance costs, and utilities $ 230 $ 247 $ 257
Depreciation of property, plant and equipment and amortization of intangible assets 119 110 147
Other 79 125 74
Research and development expense 428 482 478
Staff, maintenance, and utility costs $ 25 $ 27 $ 22
XML 132 R113.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Selling, General and Administrative Expenses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Analysis of income and expense [abstract]      
Staff costs, maintenance costs, and utilities $ 342 $ 417 $ 537
Depreciation of property, plant and equipment and amortization of intangible assets 25 45 49
Other 106 34 9
Total 473 496 595
Expense from share-based payment transactions with employees $ 96 $ 92 $ 152
XML 133 R114.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring [Abstract]      
Restructuring expense $ 71 $ 94 $ 0
Accelerated share-based compensation expense   3  
Restructuring [Roll Forward]      
Beginning balance 86 0  
Provision 71 91  
Amounts paid (126) (5)  
Ending balance $ 31 $ 86 $ 0
XML 134 R115.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Narrative (Details)
$ / shares in Units, yr in Millions, $ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2019
USD ($)
yr
$ / shares
Dec. 31, 2017
Dec. 31, 2020
USD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based payment expenses   $ 1 $ 7 $ 63      
Additional-paid in capital   11,151 9,960 8,033     $ 7,241
Expense from share-based payment transactions with employees   $ 96 92 152      
Share-based payment arrangement, performance period (in years)   3 years          
Term (in years)   10 years          
Additional Paid-In Capital              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Additional-paid in capital   $ 24,027 23,831 23,487     $ 11,707
Minimum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based payment arrangement, vesting percentage   0.00%          
Maximum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based payment arrangement, vesting percentage   200.00%          
Share Options              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based payment expenses   $ 148 173 223      
Expense from share-based payment transactions with employees   $ 21 $ 10 5      
Lookback period (in years)   2 years 10 months 2 days 2 years 8 months 26 days        
Exercise price of outstanding share options (in dollars per share) | $ / shares         $ 10.00    
Fair value of options $ 39       $ 64    
Weighted average remaining contractual life (in years) 10 years            
Share Options | Additional Paid-In Capital              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Additional-paid in capital   $ 46 $ 163        
Share Options | Minimum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Vesting period (in years)         4 years    
Share Options | Maximum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Vesting period (in years)         5 years 5 years  
Granted (in shares) | yr         25    
Share Incentive Plan 2018              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share options available for future grant (in shares) | shares   3,485,505 2,826,758        
Equity Compensation Plan 2021              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share options available for future grant (in shares) | shares   17,011,837 13,648,116        
RSUs              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Vesting percentage   33.33%          
Vesting period (in years)   1 year          
Unrecognized compensation costs   $ 107 $ 88 $ 26      
Performance Share Units (PSU)              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Unrecognized compensation costs   $ 22 $ 24        
Employee Stock Purchase Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Matching contribution (as a percent)   20.00%          
Shares available (in shares) | shares   7,500,000          
Commencement period (in years)   8 years          
Annual increase percentage   0.25%          
Maximum grant limit (in shares) | shares   18,750,000          
Shares issued (in shares) | shares   620,481          
Employee Share Purchase Plan              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Granted (in shares) | shares   50          
Employee subscription rate (as a percent)   10.00%          
Maximum employee subscription (in shares) | shares   2,500          
Matching contribution (as a percent)   20.00%          
XML 135 R116.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - RSU and PSU Activity (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Restricted Share Units (RSU)    
Number of RSUs    
Outstanding at beginning of period (in shares) | shares 3,211,430 847,430
Granted (in shares) | shares 2,426,183 3,416,545
Forfeited (in shares) | shares (390,769) (314,158)
Exercised (in shares) | shares (1,093,061) (738,387)
Outstanding at end of period (in shares) | shares 4,153,783 3,211,430
Weighted average grant date fair value    
Outstanding at beginning of period (in USD per share) | $ / shares $ 54.39 $ 39.59
Granted (in USD per share) | $ / shares 62.94 57.09
Forfeited (in USD per share) | $ / shares 55.28 55.36
Exercised (in USD per share) | $ / shares 55.35 49.51
Outstanding at end of period (in USD per share) | $ / shares $ 58.87 $ 54.39
Performance Share Units (PSU)    
Number of RSUs    
Outstanding at beginning of period (in shares) | shares 537,195 0
Granted (in shares) | shares 875,646 571,277
Forfeited (in shares) | shares (220,422) (34,082)
Outstanding at end of period (in shares) | shares 1,192,419 537,195
Weighted average grant date fair value    
Outstanding at beginning of period (in USD per share) | $ / shares $ 70.91 $ 0
Granted (in USD per share) | $ / shares 69.73 70.85
Forfeited (in USD per share) | $ / shares 69.90 70.91
Outstanding at end of period (in USD per share) | $ / shares $ 69.96 $ 70.91
XML 136 R117.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Fair Value Assumptions (Details) - Performance Share Units (PSU)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Expected dividend yield 0.00%  
Expected volatility, share options granted 50.93% 45.50%
Risk free interest rate, share options granted 4.60% 2.55%
XML 137 R118.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Stock Option Activity (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Number of Share options    
Beginning balance (in shares) | shares 6,260,603 21,749,558
Exercised (in shares) | shares (4,468,985) (14,956,321)
Forfeited (in shares) | shares (151,579) (532,634)
Ending balance (in shares) | shares 1,640,039 6,260,603
Exercisable (in shares) | shares 1,485,670  
Weighted average exercise price per Share    
Beginning balance (in dollars per share) | $ / shares $ 10.02 $ 10.03
Exercised (in dollars per share) | $ / shares 10.02 10.00
Forfeited (in dollars per share) | $ / shares 10.00 10.00
Ending balance (in dollars per share) | $ / shares 10.02 $ 10.02
Exercisable (in dollars per share) | $ / shares $ 10.03  
XML 138 R119.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
Disclosure of range of exercise prices of outstanding share options [line items]      
Number Outstanding 1,640,039 6,260,603 21,749,558
$10.02      
Disclosure of range of exercise prices of outstanding share options [line items]      
Exercise price of outstanding share options (in dollars per share) | $ / shares $ 10.02    
Number Outstanding 1,640,039    
Weighted average remaining contractual life (in years) 2 years 8 months 1 day    
XML 139 R120.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance Income and Expenses- Finance Income (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Analysis of income and expense [abstract]      
Interest income - deposits $ 92 $ 31 $ 1
Interest income on FVOCI investments 30 8 0
Accretion income 27 12 5
Total finance income $ 149 $ 51 $ 6
XML 140 R121.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance Income and Expenses- Finance Expenses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Analysis of income and expense [abstract]      
Interest on long-term debt $ 80 $ 69 $ 72
Interest on lease obligations 21 23 27
Commitment fees and amortization of debt issuance costs 13 13 12
Accretion costs and other 23 6 3
Total finance expenses $ 137 $ 111 $ 114
XML 141 R122.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gain on Sale of a Business - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Jan. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of analysis of single amount of discontinued operations [line items]        
Gain on sale of East Fishkill (“EFK”) business   $ 0 $ 403 $ 0
Discontinued Operations - Tampines, Singapore Facility        
Disclosure of analysis of single amount of discontinued operations [line items]        
Consideration received     406 $ 170
Gain on sale of East Fishkill (“EFK”) business     403  
Net liabilities     $ (9)  
Discontinued Operations - Tampines, Singapore Facility | Other disposals of assets        
Disclosure of analysis of single amount of discontinued operations [line items]        
Consideration received $ 236      
XML 142 R123.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of analysis of single amount of discontinued operations [line items]    
Total Assets $ 18,044 $ 17,841
Lease liabilities (382) (345)
Total Liabilities $ (6,893) (7,881)
Discontinued Operations - Tampines, Singapore Facility    
Disclosure of analysis of single amount of discontinued operations [line items]    
Property, plant and equipment   83
Inventories   43
Total Assets   126
Lease liabilities   (47)
Other current and non-current liabilities   (88)
Total Liabilities   (135)
Net Liabilities   $ (9)
XML 143 R124.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Income (Expense), Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Analysis of income and expense [abstract]      
Loss on hedging activities $ (78) $ 0 $ 0
Other 21 22 (8)
Total other income (expense), net $ (57) $ 22 $ (8)
XML 144 R125.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Income tax benefit (expense) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Current income tax expense:      
Current income tax benefit (expense) $ (13) $ (14) $ 2
Adjustments in respect of current income tax of previous year (3) (5) (1)
Deferred tax      
Net operating and investment allowance carryforwards (74) (44) (78)
Currency effect on non-monetary assets of subsidiary 23 (12) (37)
Other change in temporary differences 1 (11) 36
Income tax expense $ (66) $ (86) $ (78)
XML 145 R126.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income taxes [Abstract]      
Income (Loss) before income taxes $ 1,084 $ 1,532 $ (176)
Tax at Enacted Statutory Rate 0 0 0
Foreign tax rate differential (65) (98) (75)
Adjustments in respect to current income tax of previous years (1) (5) (1)
Government grants exempt from tax 7 7 5
Deductible expense for tax purpose (2) 0 (1)
Impact of unrecognized deferred tax assets (20) 57 9
Non-deductible expenses for tax purposes 0 (21) (4)
Effects of foreign exchange gains (loss) 10 (14) (22)
Impact of change in liability for uncertain tax positions 3 1 7
Withholding Tax 0 (11) 0
Other effects 2 (2) 4
Income tax (expense) benefit $ (66) $ (86) $ (78)
Effective income tax rate (6.10%) (5.60%) 44.30%
XML 146 R127.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unrecognized deferred tax asset $ 3,665 $ 3,708  
Profit (loss), attributable to owners of parent (1,020) (1,448) $ 250
Deferred tax assets 241 292  
Current income tax receivable 0 1  
Current income tax payable 19 14  
Unused Capital Allowances      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax assets 440 713  
Unused tax losses      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax assets 58 58  
Unused Investment Allowances      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax assets $ 843 843  
Republic of Singapore      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Deferred tax assets realized (as a percent) 100.00%    
Current income tax payable $ 5 9  
Uncertain tax provisions 5 8  
Germany      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Profit (loss), attributable to owners of parent 1,119 1,132  
Trade tax losses $ 830 851  
Maximum operating loss carryforwards (as a percent) 60.00%    
United States of America      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Current income tax payable $ 4 3  
Uncertain tax provisions 2 0  
United States of America | Operating Loss Carryforward      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Operating loss carryforward 5,984 7,307  
United States of America | Unused Tax Credits Due to Expire      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Operating loss carryforward 4,434    
United States of America | Unused Research and Development Tax Credits      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unrecognized deferred tax asset 186 157  
CALIFORNIA | Operating Loss Carryforward      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Operating loss carryforward 821 822  
CALIFORNIA | Unused Research and Development Tax Credits      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unrecognized deferred tax asset 22 17  
Other states | Operating Loss Carryforward      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Operating loss carryforward 868 885  
NEW YORK | Nonrefundable New York Empire Zone      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unrecognized deferred tax asset 947 1,115  
Texas, Minnesota, Vermont, North Carolina, and New Jersey | Operating Loss Carryforward      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Unrecognized deferred tax asset 10 8  
Europe      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Current income tax payable 10 2  
Uncertain tax provisions $ 2 $ 3  
XML 147 R128.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets $ 235 $ 266 $ 351
Accelerated depreciation on property, plant and equipment      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets (12) (18)  
Losses, credits and investment allowances available for offsetting against future taxable income      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets 231 277  
Accrued expenses      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets 11 16  
Inventory      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets 3 1  
Other comprehensive income (loss)      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets 2 (8)  
Currency effect      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets (1) 0  
Other      
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]      
Net deferred tax assets $ 1 $ (2)  
XML 148 R129.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Classification of deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income taxes [Abstract]      
Deferred tax assets $ 241 $ 292  
Deferred tax liabilities (6) (26)  
Net deferred tax assets $ 235 $ 266 $ 351
XML 149 R130.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes - Reconciliation of Deferred Tax assets, Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of changes in deferred tax liability (asset) [abstract]    
Beginning balance $ (266) $ (351)
Tax (expense) benefit recognized to consolidated statements of operations (50) (67)
Tax (expense) benefit recognized to other comprehensive income (loss) 19 (18)
Ending balance $ (235) $ (266)
XML 150 R131.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings per share [abstract]      
Net income (loss) attributable to equity shareholders of the Company $ (1,020) $ (1,448) $ 250
Basic weighted average ordinary shares outstanding (in shares) 552 539 506
Weighted average common shares outstanding (in shares) 556 552 506
Total basic and diluted earnings per share attributable to equity shareholders (in USD per share) $ 1.85 $ 2.69 $ (0.49)
Total basic and diluted earnings per share attributable to equity shareholders (in USD per share) $ 1.83 $ 2.62 $ (0.49)
Number of instruments that are antidilutive in period presented (in shares) 1 6 22
XML 151 R132.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee Benefits Plans (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Employee Benefits [Abstract]      
Employee contributions matched by employer (as a percent) 3.00%    
Matched amount per dollar of additional employee contributions $ 0.50    
Additional employee contributions matched by employer (as a percent) 3.00%    
Maximum employee contributions matched by employer (as a percent) 4.50%    
Contribution 401(K) expense $ 25,000,000 $ 32,000,000 $ 31,000,000
Contribution expense $ 29,000,000 $ 31,000,000 $ 29,000,000
XML 152 R133.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of transactions between related parties [line items]    
Due from Related Parties $ 12 $ 11
Due to Related Parties 10 10
SMP    
Disclosure of transactions between related parties [line items]    
Due from Related Parties 12 11
Due to Related Parties $ 10 $ 10
XML 153 R134.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures - Transactions with Related Parties (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of transactions between related parties [line items]      
Purchases and recharges from: $ 61 $ 60 $ 60
Other transactions with: 66 52 48
SMP      
Disclosure of transactions between related parties [line items]      
Purchases and recharges from: 61 60 60
Other transactions with: 61 52 45
MDC General Services Holding Company L.L.C (recharge of expenses)      
Disclosure of transactions between related parties [line items]      
Other transactions with: $ 5 $ 0 $ 3
XML 154 R135.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures - Narrative (Details) - Loan from Shareholder - USD ($)
$ in Millions
12 Months Ended
Oct. 03, 2021
Dec. 31, 2021
Disclosure of transactions between related parties [line items]    
Payments to related parties   $ (568)
Conversion of loan from shareholder $ (10,100) $ 10,113
XML 155 R136.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Disclosures - Compensation to Key Management Personnel (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of transactions between related parties [line items]      
Amount incurred by entity for provision of key management personnel services provided by separate management entity $ 33 $ 29 $ 53
Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Short-term benefits      
Disclosure of transactions between related parties [line items]      
Amount incurred by entity for provision of key management personnel services provided by separate management entity 9 5 8
Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-based payments      
Disclosure of transactions between related parties [line items]      
Amount incurred by entity for provision of key management personnel services provided by separate management entity 21 19 42
Board of Directors      
Disclosure of transactions between related parties [line items]      
Amount incurred by entity for provision of key management personnel services provided by separate management entity $ 3 $ 5 $ 3
XML 156 R137.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of nature and extent of risks arising from financial instruments [line items]        
Cash and cash equivalents $ 2,387 $ 2,352 $ 2,939 $ 908
Currency risk | Eurodollar [Member]        
Disclosure of nature and extent of risks arising from financial instruments [line items]        
Prepayments And Other Current Assets 86 120    
Cash and cash equivalents 104 48    
Loans and borrowings 11 45    
Trade and other payables (253) (388)    
Total financial liabilities (52) (175)    
Currency risk | Japan, Yen        
Disclosure of nature and extent of risks arising from financial instruments [line items]        
Prepayments And Other Current Assets 0 0    
Cash and cash equivalents 5 4    
Loans and borrowings 0 0    
Trade and other payables (97) (73)    
Total financial liabilities (92) (69)    
Currency risk | Singapore, Dollars        
Disclosure of nature and extent of risks arising from financial instruments [line items]        
Prepayments And Other Current Assets 28 16    
Cash and cash equivalents 19 420    
Loans and borrowings 0 0    
Trade and other payables (121) (149)    
Total financial liabilities $ (74) $ 287    
XML 157 R138.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Narrative (Details)
Dec. 31, 2023
Dec. 31, 2022
Customer Risk | Ten Largest Customers    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Customer concentration risk (as a percent) 79.00% 74.00%
XML 158 R139.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Aging of Financial assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount $ 2,372 $ 2,511
Credit risk    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount 2,785 2,254
Credit risk | Receivables neither past due nor impaired    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount 2,651 2,137
Credit risk | Less than 30 days    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount 127 84
Credit risk | 31-90 Days    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount 7 33
Credit risk | 91-120 Days    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount 0 0
Credit risk | Great than 120 days    
Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]    
Carrying Amount $ 0 $ 0
XML 159 R140.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Carrying Value      
Loans and borrowings $ 2,372 $ 2,511 $ 2,013
Lease obligations 382 345  
Liquidity risk      
Carrying Value      
Loans and borrowings 2,372 2,511  
Lease obligations 382 345  
Derivative liabilities 56 66  
Trade payables and other liabilities 1,438 2,265  
Total 4,248 5,187  
Contractual Cash Flows      
Loans and borrowings 2,558 2,706  
Lease obligations 521 427  
Derivative liabilities 56 66  
Trade payables and other liabilities 1,438 2,265  
Total 4,573 5,464  
Liquidity risk | Within 1 year      
Contractual Cash Flows      
Loans and borrowings 575 229  
Lease obligations 44 92  
Derivative liabilities 42 61  
Trade payables and other liabilities 1,354 2,171  
Total 2,015 2,553  
Liquidity risk | 2-5 years      
Contractual Cash Flows      
Loans and borrowings 971 1,443  
Lease obligations 194 184  
Derivative liabilities 14 5  
Trade payables and other liabilities 55 63  
Total 1,234 1,695  
Liquidity risk | After 5 years      
Contractual Cash Flows      
Loans and borrowings 1,012 1,034  
Lease obligations 283 151  
Derivative liabilities 0 0  
Trade payables and other liabilities 29 31  
Total $ 1,324 $ 1,216  
XML 160 R141.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of fair value measurement of assets [line items]    
Assets $ 18,044 $ 17,841
Liabilities 6,893 7,881
Cash equivalents | Recurring fair value measurement    
Disclosure of fair value measurement of assets [line items]    
Assets 1,897 961
Cash equivalents | Recurring fair value measurement | Quoted Prices Identical Assets/ Liabilities (Level 1)    
Disclosure of fair value measurement of assets [line items]    
Assets 1,626 961
Cash equivalents | Recurring fair value measurement | Significant Other Inputs (Level 2)    
Disclosure of fair value measurement of assets [line items]    
Assets 271 0
Cash equivalents | Recurring fair value measurement | Significant Unobservable Inputs (Level 3)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Investments in equity instruments | Recurring fair value measurement    
Disclosure of fair value measurement of assets [line items]    
Assets 19 15
Investments in equity instruments | Recurring fair value measurement | Quoted Prices Identical Assets/ Liabilities (Level 1)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Investments in equity instruments | Recurring fair value measurement | Significant Other Inputs (Level 2)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Investments in equity instruments | Recurring fair value measurement | Significant Unobservable Inputs (Level 3)    
Disclosure of fair value measurement of assets [line items]    
Assets 19 15
Investments in marketable securities | Recurring fair value measurement    
Disclosure of fair value measurement of assets [line items]    
Assets 1,501  
Investments in marketable securities | Recurring fair value measurement | Quoted Prices Identical Assets/ Liabilities (Level 1)    
Disclosure of fair value measurement of assets [line items]    
Assets 1,189 994
Investments in marketable securities | Recurring fair value measurement | Significant Other Inputs (Level 2)    
Disclosure of fair value measurement of assets [line items]    
Assets 312 0
Investments in marketable securities | Recurring fair value measurement | Significant Unobservable Inputs (Level 3)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Derivatives | Recurring fair value measurement    
Disclosure of fair value measurement of assets [line items]    
Assets 132 177
Liabilities 56 66
Derivatives | Recurring fair value measurement | Quoted Prices Identical Assets/ Liabilities (Level 1)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Liabilities 0 0
Derivatives | Recurring fair value measurement | Significant Other Inputs (Level 2)    
Disclosure of fair value measurement of assets [line items]    
Assets 132 177
Liabilities 56 66
Derivatives | Recurring fair value measurement | Significant Unobservable Inputs (Level 3)    
Disclosure of fair value measurement of assets [line items]    
Assets 0 0
Liabilities $ 0 $ 0
XML 161 R142.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of financial assets and liabilities [Line Items]    
Carrying Amount $ 2,372 $ 2,511
Fair Value 2,319 2,414
Other long-term debt    
Disclosure of financial assets and liabilities [Line Items]    
Carrying Amount 2,372 2,511
Fair Value $ 2,319 $ 2,414
XML 162 R143.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Unconditional Purchase Commitments (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]    
Contracts for capital expenditures $ 1,136 $ 2,774
Contracts for operating expenditures 2,786 3,587
Total 3,922 6,361
Due within the next 12 months $ 970 $ 2,732
XML 163 R144.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Apr. 28, 2021
Disclosure of contingent liabilities [line items]        
Loans and borrowings $ 2,372 $ 2,511 $ 2,013  
Bank guarantees $ 54 4    
Minimum interest on license agreement 49.00%      
Provisions $ 240 298 $ 349 $ 2,500
PILOT Bonds, Letters Of Credit        
Disclosure of contingent liabilities [line items]        
Loans and borrowings $ 23 $ 20    
XML 164 R145.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Operating Segments Information - Revenue by Geography (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of geographical areas [line items]      
Revenue $ 7,392 $ 8,108 $ 6,585
United States of America      
Disclosure of geographical areas [line items]      
Revenue 4,262 4,898 3,975
Europe, the Middle East, and Africa      
Disclosure of geographical areas [line items]      
Revenue 1,533 1,182 805
Other      
Disclosure of geographical areas [line items]      
Revenue $ 1,597 $ 2,028 $ 1,805
XML 165 R146.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Operating Segments Information - Noncurrent Assets by Geography (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Disclosure of geographical areas [line items]    
Certain non-current assets $ 11,396 $ 11,651
United States of America    
Disclosure of geographical areas [line items]    
Certain non-current assets 4,738 5,149
Germany    
Disclosure of geographical areas [line items]    
Certain non-current assets 2,400 2,462
Republic of Singapore    
Disclosure of geographical areas [line items]    
Certain non-current assets 3,801 3,508
Other    
Disclosure of geographical areas [line items]    
Certain non-current assets $ 457 $ 532
XML 166 R147.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Customer And Supplier Concentration - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
SOI Wafers      
Disclosure of major customers [line items]      
Amount due to supplier $ 61 $ 56  
SOI Wafers | Supplier Risk      
Disclosure of major customers [line items]      
Supplier concentration risk (as a percent) 63.00% 54.00% 46.00%
Customer A      
Disclosure of major customers [line items]      
Percentage of entity's revenue 8.00% 9.00% 12.00%
Trade receivables $ 122 $ 71  
Customer B      
Disclosure of major customers [line items]      
Percentage of entity's revenue 17.00% 16.00% 15.00%
Trade receivables $ 237 $ 163  
XML 167 R148.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Customer And Supplier Concentration - Revenue by Major Customers (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of major customers [line items]      
Revenue from contracts with customers $ 7,392 $ 8,108 $ 6,585
Customer A      
Disclosure of major customers [line items]      
Revenue from contracts with customers $ 620 $ 746 $ 811
Percentage of entity's revenue 8.00% 9.00% 12.00%
Customer B      
Disclosure of major customers [line items]      
Revenue from contracts with customers $ 1,279 $ 1,329 $ 995
Percentage of entity's revenue 17.00% 16.00% 15.00%
EXCEL 168 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 169 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 170 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 172 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 692 505 1 true 159 0 false 10 false false R1.htm 0000001 - Document - Cover Sheet http://gf.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://gf.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS) Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS) Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 8 false false R9.htm 0000009 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 9 false false R10.htm 0000010 - Disclosure - Organization Sheet http://gf.com/role/Organization Organization Notes 10 false false R11.htm 0000011 - Disclosure - Basis of Presentation Sheet http://gf.com/role/BasisofPresentation Basis of Presentation Notes 11 false false R12.htm 0000012 - Disclosure - Summary of Material Accounting Policies Sheet http://gf.com/role/SummaryofMaterialAccountingPolicies Summary of Material Accounting Policies Notes 12 false false R13.htm 0000013 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions Sheet http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptions Critical Accounting Judgements, Estimates, and Assumptions Notes 13 false false R14.htm 0000014 - Disclosure - Cash And Cash Equivalents Sheet http://gf.com/role/CashAndCashEquivalents Cash And Cash Equivalents Notes 14 false false R15.htm 0000015 - Disclosure - Receivables, Prepayments and Other Assets Sheet http://gf.com/role/ReceivablesPrepaymentsandOtherAssets Receivables, Prepayments and Other Assets Notes 15 false false R16.htm 0000016 - Disclosure - Inventories Sheet http://gf.com/role/Inventories Inventories Notes 16 false false R17.htm 0000017 - Disclosure - Property, Plant and Equipment Sheet http://gf.com/role/PropertyPlantandEquipment Property, Plant and Equipment Notes 17 false false R18.htm 0000018 - Disclosure - Goodwill and Intangible Assets Sheet http://gf.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 18 false false R19.htm 0000019 - Disclosure - Other Financial Assets And Liabilities Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilities Other Financial Assets And Liabilities Notes 19 false false R20.htm 0000020 - Disclosure - Trade Payables and Other Liabilities Sheet http://gf.com/role/TradePayablesandOtherLiabilities Trade Payables and Other Liabilities Notes 20 false false R21.htm 0000021 - Disclosure - Long-Term Debt Sheet http://gf.com/role/LongTermDebt Long-Term Debt Notes 21 false false R22.htm 0000022 - Disclosure - Leases Sheet http://gf.com/role/Leases Leases Notes 22 false false R23.htm 0000023 - Disclosure - Provisions Sheet http://gf.com/role/Provisions Provisions Notes 23 false false R24.htm 0000024 - Disclosure - Government Grants Sheet http://gf.com/role/GovernmentGrants Government Grants Notes 24 false false R25.htm 0000025 - Disclosure - Issued Capital and Reserves Sheet http://gf.com/role/IssuedCapitalandReserves Issued Capital and Reserves Notes 25 false false R26.htm 0000026 - Disclosure - Net Revenue Sheet http://gf.com/role/NetRevenue Net Revenue Notes 26 false false R27.htm 0000027 - Disclosure - Cost of Revenue Sheet http://gf.com/role/CostofRevenue Cost of Revenue Notes 27 false false R28.htm 0000028 - Disclosure - Research and Development Expenses Sheet http://gf.com/role/ResearchandDevelopmentExpenses Research and Development Expenses Notes 28 false false R29.htm 0000029 - Disclosure - Selling, General and Administrative Expenses Sheet http://gf.com/role/SellingGeneralandAdministrativeExpenses Selling, General and Administrative Expenses Notes 29 false false R30.htm 0000030 - Disclosure - Restructuring Sheet http://gf.com/role/Restructuring Restructuring Notes 30 false false R31.htm 0000031 - Disclosure - Share-Based Compensation Sheet http://gf.com/role/ShareBasedCompensation Share-Based Compensation Notes 31 false false R32.htm 0000032 - Disclosure - Finance Income and Expenses Sheet http://gf.com/role/FinanceIncomeandExpenses Finance Income and Expenses Notes 32 false false R33.htm 0000033 - Disclosure - Gain on Sale of a Business Sheet http://gf.com/role/GainonSaleofaBusiness Gain on Sale of a Business Notes 33 false false R34.htm 0000034 - Disclosure - Other Income (Expense), Net Sheet http://gf.com/role/OtherIncomeExpenseNet Other Income (Expense), Net Notes 34 false false R35.htm 0000035 - Disclosure - Income Taxes Sheet http://gf.com/role/IncomeTaxes Income Taxes Notes 35 false false R36.htm 0000036 - Disclosure - Earnings Per Share Sheet http://gf.com/role/EarningsPerShare Earnings Per Share Notes 36 false false R37.htm 0000037 - Disclosure - Employee Benefits Plans Sheet http://gf.com/role/EmployeeBenefitsPlans Employee Benefits Plans Notes 37 false false R38.htm 0000038 - Disclosure - Related Party Disclosures Sheet http://gf.com/role/RelatedPartyDisclosures Related Party Disclosures Notes 38 false false R39.htm 0000039 - Disclosure - Financial Risk Management Objectives and Policies Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPolicies Financial Risk Management Objectives and Policies Notes 39 false false R40.htm 0000040 - Disclosure - Commitments and Contingencies Sheet http://gf.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 40 false false R41.htm 0000041 - Disclosure - Operating Segments Information Sheet http://gf.com/role/OperatingSegmentsInformation Operating Segments Information Notes 41 false false R42.htm 0000042 - Disclosure - Customer And Supplier Concentration Sheet http://gf.com/role/CustomerAndSupplierConcentration Customer And Supplier Concentration Notes 42 false false R43.htm 9954471 - Disclosure - Summary of Material Accounting Policies (Policies) Sheet http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies Summary of Material Accounting Policies (Policies) Policies http://gf.com/role/SummaryofMaterialAccountingPolicies 43 false false R44.htm 9954472 - Disclosure - Summary of Material Accounting Policies (Tables) Sheet http://gf.com/role/SummaryofMaterialAccountingPoliciesTables Summary of Material Accounting Policies (Tables) Tables http://gf.com/role/SummaryofMaterialAccountingPolicies 44 false false R45.htm 9954473 - Disclosure - Cash And Cash Equivalents (Tables) Sheet http://gf.com/role/CashAndCashEquivalentsTables Cash And Cash Equivalents (Tables) Tables http://gf.com/role/CashAndCashEquivalents 45 false false R46.htm 9954474 - Disclosure - Receivables, Prepayments and Other Assets (Tables) Sheet http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsTables Receivables, Prepayments and Other Assets (Tables) Tables http://gf.com/role/ReceivablesPrepaymentsandOtherAssets 46 false false R47.htm 9954475 - Disclosure - Inventories (Tables) Sheet http://gf.com/role/InventoriesTables Inventories (Tables) Tables http://gf.com/role/Inventories 47 false false R48.htm 9954476 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://gf.com/role/PropertyPlantandEquipmentTables Property, Plant and Equipment (Tables) Tables http://gf.com/role/PropertyPlantandEquipment 48 false false R49.htm 9954477 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://gf.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://gf.com/role/GoodwillandIntangibleAssets 49 false false R50.htm 9954478 - Disclosure - Other Financial Assets And Liabilities (Tables) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables Other Financial Assets And Liabilities (Tables) Tables http://gf.com/role/OtherFinancialAssetsAndLiabilities 50 false false R51.htm 9954479 - Disclosure - Trade Payables and Other Liabilities (Tables) Sheet http://gf.com/role/TradePayablesandOtherLiabilitiesTables Trade Payables and Other Liabilities (Tables) Tables http://gf.com/role/TradePayablesandOtherLiabilities 51 false false R52.htm 9954480 - Disclosure - Long-Term Debt (Tables) Sheet http://gf.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://gf.com/role/LongTermDebt 52 false false R53.htm 9954481 - Disclosure - Leases (Tables) Sheet http://gf.com/role/LeasesTables Leases (Tables) Tables http://gf.com/role/Leases 53 false false R54.htm 9954482 - Disclosure - Provisions (Tables) Sheet http://gf.com/role/ProvisionsTables Provisions (Tables) Tables http://gf.com/role/Provisions 54 false false R55.htm 9954483 - Disclosure - Government Grants (Tables) Sheet http://gf.com/role/GovernmentGrantsTables Government Grants (Tables) Tables http://gf.com/role/GovernmentGrants 55 false false R56.htm 9954484 - Disclosure - Net Revenue (Tables) Sheet http://gf.com/role/NetRevenueTables Net Revenue (Tables) Tables http://gf.com/role/NetRevenue 56 false false R57.htm 9954485 - Disclosure - Cost of Revenue (Tables) Sheet http://gf.com/role/CostofRevenueTables Cost of Revenue (Tables) Tables http://gf.com/role/CostofRevenue 57 false false R58.htm 9954486 - Disclosure - Research and Development Expenses (Tables) Sheet http://gf.com/role/ResearchandDevelopmentExpensesTables Research and Development Expenses (Tables) Tables http://gf.com/role/ResearchandDevelopmentExpenses 58 false false R59.htm 9954487 - Disclosure - Selling, General and Administrative Expenses (Tables) Sheet http://gf.com/role/SellingGeneralandAdministrativeExpensesTables Selling, General and Administrative Expenses (Tables) Tables http://gf.com/role/SellingGeneralandAdministrativeExpenses 59 false false R60.htm 9954488 - Disclosure - Restructuring (Tables) Sheet http://gf.com/role/RestructuringTables Restructuring (Tables) Tables http://gf.com/role/Restructuring 60 false false R61.htm 9954489 - Disclosure - Share-Based Compensation (Tables) Sheet http://gf.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://gf.com/role/ShareBasedCompensation 61 false false R62.htm 9954490 - Disclosure - Finance Income and Expenses (Tables) Sheet http://gf.com/role/FinanceIncomeandExpensesTables Finance Income and Expenses (Tables) Tables http://gf.com/role/FinanceIncomeandExpenses 62 false false R63.htm 9954491 - Disclosure - Gain on Sale of a Business (Tables) Sheet http://gf.com/role/GainonSaleofaBusinessTables Gain on Sale of a Business (Tables) Tables http://gf.com/role/GainonSaleofaBusiness 63 false false R64.htm 9954492 - Disclosure - Other Income (Expense), Net (Tables) Sheet http://gf.com/role/OtherIncomeExpenseNetTables Other Income (Expense), Net (Tables) Tables http://gf.com/role/OtherIncomeExpenseNet 64 false false R65.htm 9954493 - Disclosure - Income Taxes (Tables) Sheet http://gf.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://gf.com/role/IncomeTaxes 65 false false R66.htm 9954494 - Disclosure - Earnings Per Share (Tables) Sheet http://gf.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://gf.com/role/EarningsPerShare 66 false false R67.htm 9954495 - Disclosure - Related Party Disclosures (Tables) Sheet http://gf.com/role/RelatedPartyDisclosuresTables Related Party Disclosures (Tables) Tables http://gf.com/role/RelatedPartyDisclosures 67 false false R68.htm 9954496 - Disclosure - Financial Risk Management Objectives and Policies (Tables) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables Financial Risk Management Objectives and Policies (Tables) Tables http://gf.com/role/FinancialRiskManagementObjectivesandPolicies 68 false false R69.htm 9954497 - Disclosure - Commitments and Contingencies (Tables) Sheet http://gf.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://gf.com/role/CommitmentsandContingencies 69 false false R70.htm 9954498 - Disclosure - Operating Segments Information (Tables) Sheet http://gf.com/role/OperatingSegmentsInformationTables Operating Segments Information (Tables) Tables http://gf.com/role/OperatingSegmentsInformation 70 false false R71.htm 9954499 - Disclosure - Customer And Supplier Concentration (Tables) Sheet http://gf.com/role/CustomerAndSupplierConcentrationTables Customer And Supplier Concentration (Tables) Tables http://gf.com/role/CustomerAndSupplierConcentration 71 false false R72.htm 9954500 - Disclosure - Organization (Details) Sheet http://gf.com/role/OrganizationDetails Organization (Details) Details http://gf.com/role/Organization 72 false false R73.htm 9954501 - Disclosure - Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details) Sheet http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details) Details 73 false false R74.htm 9954502 - Disclosure - Summary of Material Accounting Policies - Intangible Assets (Details) Sheet http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails Summary of Material Accounting Policies - Intangible Assets (Details) Details 74 false false R75.htm 9954503 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions (Details) Sheet http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails Critical Accounting Judgements, Estimates, and Assumptions (Details) Details http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptions 75 false false R76.htm 9954504 - Disclosure - Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details) Sheet http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details) Details 76 false false R77.htm 9954505 - Disclosure - Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details) Sheet http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details) Details 77 false false R78.htm 9954506 - Disclosure - Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details) Sheet http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details) Details 78 false false R79.htm 9954507 - Disclosure - Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details) Sheet http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details) Details 79 false false R80.htm 9954508 - Disclosure - Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details) Sheet http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsScheduleofUnbilledAccountsReceivableDetails Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details) Details 80 false false R81.htm 9954509 - Disclosure - Receivables, Prepayments and Other Assets - Maturity Schedule (Details) Sheet http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails Receivables, Prepayments and Other Assets - Maturity Schedule (Details) Details 81 false false R82.htm 9954510 - Disclosure - Inventories - Summary of Inventories (Details) Sheet http://gf.com/role/InventoriesSummaryofInventoriesDetails Inventories - Summary of Inventories (Details) Details 82 false false R83.htm 9954511 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details) Sheet http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details) Details 83 false false R84.htm 9954512 - Disclosure - Property, Plant and Equipment - Narrative (Details) Sheet http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails Property, Plant and Equipment - Narrative (Details) Details 84 false false R85.htm 9954513 - Disclosure - Property, Plant and Equipment - Schedule of Depreciation Expense (Details) Sheet http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails Property, Plant and Equipment - Schedule of Depreciation Expense (Details) Details 85 false false R86.htm 9954514 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details) Sheet http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details) Details 86 false false R87.htm 9954515 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) Sheet http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails Goodwill and Intangible Assets - Schedule of Amortization Expense (Details) Details 87 false false R88.htm 9954516 - Disclosure - Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details) Details 88 false false R89.htm 9954517 - Disclosure - Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details) Details 89 false false R90.htm 9954518 - Disclosure - Other Financial Assets And Liabilities - Narrative (Details) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails Other Financial Assets And Liabilities - Narrative (Details) Details 90 false false R91.htm 9954519 - Disclosure - Other Financial Assets And Liabilities - Effect on Financial Statements (Details) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails Other Financial Assets And Liabilities - Effect on Financial Statements (Details) Details 91 false false R92.htm 9954520 - Disclosure - Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details) Sheet http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details) Details 92 false false R93.htm 9954521 - Disclosure - Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details) Sheet http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details) Details 93 false false R94.htm 9954522 - Disclosure - Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details) Sheet http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details) Details 94 false false R95.htm 9954523 - Disclosure - Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details) Sheet http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details) Details 95 false false R96.htm 9954524 - Disclosure - Long-Term Debt - Narrative (Details) Sheet http://gf.com/role/LongTermDebtNarrativeDetails Long-Term Debt - Narrative (Details) Details 96 false false R97.htm 9954525 - Disclosure - Long-Term Debt - Movements in Interest bearing Borrowings (Details) Sheet http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails Long-Term Debt - Movements in Interest bearing Borrowings (Details) Details 97 false false R98.htm 9954526 - Disclosure - Long-Term Debt - Summary of Term Loan Facilities (Details) Sheet http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails Long-Term Debt - Summary of Term Loan Facilities (Details) Details 98 false false R99.htm 9954527 - Disclosure - Long-Term Debt - Summary of Unutilized Credit Facilities (Details) Sheet http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails Long-Term Debt - Summary of Unutilized Credit Facilities (Details) Details 99 false false R100.htm 9954528 - Disclosure - Leases - Additional Information about Leases (Details) Sheet http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails Leases - Additional Information about Leases (Details) Details 100 false false R101.htm 9954529 - Disclosure - Leases - Maturity of Lease Payments (Details) Sheet http://gf.com/role/LeasesMaturityofLeasePaymentsDetails Leases - Maturity of Lease Payments (Details) Details 101 false false R102.htm 9954530 - Disclosure - Leases - Cash Flow Information (Details) Sheet http://gf.com/role/LeasesCashFlowInformationDetails Leases - Cash Flow Information (Details) Details 102 false false R103.htm 9954531 - Disclosure - Leases - Schedule of Lease Liabilities (Details) Sheet http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails Leases - Schedule of Lease Liabilities (Details) Details 103 false false R104.htm 9954532 - Disclosure - Provisions - Movement in Provision for Asset Retirement Obligations (Details) Sheet http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails Provisions - Movement in Provision for Asset Retirement Obligations (Details) Details 104 false false R105.htm 9954533 - Disclosure - Provisions - Narrative (Details) Sheet http://gf.com/role/ProvisionsNarrativeDetails Provisions - Narrative (Details) Details 105 false false R106.htm 9954534 - Disclosure - Government Grants - Roll forward of Government Grants (Details) Sheet http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails Government Grants - Roll forward of Government Grants (Details) Details 106 false false R107.htm 9954535 - Disclosure - Government Grants - Located in Consolidated Statements of Operations (Details) Sheet http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails Government Grants - Located in Consolidated Statements of Operations (Details) Details 107 false false R108.htm 9954536 - Disclosure - Issued Capital and Reserves (Details) Sheet http://gf.com/role/IssuedCapitalandReservesDetails Issued Capital and Reserves (Details) Details http://gf.com/role/IssuedCapitalandReserves 108 false false R109.htm 9954537 - Disclosure - Net Revenue - Disaggregated Revenues (Details) Sheet http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails Net Revenue - Disaggregated Revenues (Details) Details 109 false false R110.htm 9954538 - Disclosure - Net Revenue - Narrative (Details) Sheet http://gf.com/role/NetRevenueNarrativeDetails Net Revenue - Narrative (Details) Details 110 false false R111.htm 9954539 - Disclosure - Cost of Revenue (Details) Sheet http://gf.com/role/CostofRevenueDetails Cost of Revenue (Details) Details http://gf.com/role/CostofRevenueTables 111 false false R112.htm 9954540 - Disclosure - Research and Development Expenses (Details) Sheet http://gf.com/role/ResearchandDevelopmentExpensesDetails Research and Development Expenses (Details) Details http://gf.com/role/ResearchandDevelopmentExpensesTables 112 false false R113.htm 9954541 - Disclosure - Selling, General and Administrative Expenses (Details) Sheet http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails Selling, General and Administrative Expenses (Details) Details http://gf.com/role/SellingGeneralandAdministrativeExpensesTables 113 false false R114.htm 9954542 - Disclosure - Restructuring (Details) Sheet http://gf.com/role/RestructuringDetails Restructuring (Details) Details http://gf.com/role/RestructuringTables 114 false false R115.htm 9954543 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://gf.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 115 false false R116.htm 9954544 - Disclosure - Share-Based Compensation - RSU and PSU Activity (Details) Sheet http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails Share-Based Compensation - RSU and PSU Activity (Details) Details 116 false false R117.htm 9954545 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details) Sheet http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails Share-Based Compensation - Fair Value Assumptions (Details) Details 117 false false R118.htm 9954546 - Disclosure - Share-Based Compensation - Stock Option Activity (Details) Sheet http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails Share-Based Compensation - Stock Option Activity (Details) Details 118 false false R119.htm 9954547 - Disclosure - Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details) Sheet http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details) Details 119 false false R120.htm 9954548 - Disclosure - Finance Income and Expenses- Finance Income (Details) Sheet http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails Finance Income and Expenses- Finance Income (Details) Details 120 false false R121.htm 9954549 - Disclosure - Finance Income and Expenses- Finance Expenses (Details) Sheet http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails Finance Income and Expenses- Finance Expenses (Details) Details 121 false false R122.htm 9954550 - Disclosure - Gain on Sale of a Business - Narrative (Details) Sheet http://gf.com/role/GainonSaleofaBusinessNarrativeDetails Gain on Sale of a Business - Narrative (Details) Details 122 false false R123.htm 9954551 - Disclosure - Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details) Sheet http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details) Details 123 false false R124.htm 9954552 - Disclosure - Other Income (Expense), Net (Details) Sheet http://gf.com/role/OtherIncomeExpenseNetDetails Other Income (Expense), Net (Details) Details http://gf.com/role/OtherIncomeExpenseNetTables 124 false false R125.htm 9954553 - Disclosure - Income Taxes - Income tax benefit (expense) (Details) Sheet http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails Income Taxes - Income tax benefit (expense) (Details) Details 125 false false R126.htm 9954554 - Disclosure - Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details) Sheet http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details) Details 126 false false R127.htm 9954555 - Disclosure - Income Taxes - Narrative (Details) Sheet http://gf.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 127 false false R128.htm 9954556 - Disclosure - Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details) Details 128 false false R129.htm 9954557 - Disclosure - Income Taxes - Classification of deferred Tax Assets and Liabilities (Details) Sheet http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails Income Taxes - Classification of deferred Tax Assets and Liabilities (Details) Details 129 false false R130.htm 9954558 - Disclosure - Income Taxes - Reconciliation of Deferred Tax assets, Net (Details) Sheet http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails Income Taxes - Reconciliation of Deferred Tax assets, Net (Details) Details 130 false false R131.htm 9954559 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details) Sheet http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details) Details 131 false false R132.htm 9954560 - Disclosure - Employee Benefits Plans (Details) Sheet http://gf.com/role/EmployeeBenefitsPlansDetails Employee Benefits Plans (Details) Details http://gf.com/role/EmployeeBenefitsPlans 132 false false R133.htm 9954561 - Disclosure - Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details) Sheet http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details) Details 133 false false R134.htm 9954562 - Disclosure - Related Party Disclosures - Transactions with Related Parties (Details) Sheet http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails Related Party Disclosures - Transactions with Related Parties (Details) Details 134 false false R135.htm 9954563 - Disclosure - Related Party Disclosures - Narrative (Details) Sheet http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails Related Party Disclosures - Narrative (Details) Details 135 false false R136.htm 9954564 - Disclosure - Related Party Disclosures - Compensation to Key Management Personnel (Details) Sheet http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails Related Party Disclosures - Compensation to Key Management Personnel (Details) Details 136 false false R137.htm 9954565 - Disclosure - Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details) Details 137 false false R138.htm 9954566 - Disclosure - Financial Risk Management Objectives and Policies - Narrative (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails Financial Risk Management Objectives and Policies - Narrative (Details) Details http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables 138 false false R139.htm 9954567 - Disclosure - Financial Risk Management Objectives and Policies - Aging of Financial assets (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails Financial Risk Management Objectives and Policies - Aging of Financial assets (Details) Details 139 false false R140.htm 9954568 - Disclosure - Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details) Details 140 false false R141.htm 9954569 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 141 false false R142.htm 9954570 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details) Sheet http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details) Details 142 false false R143.htm 9954571 - Disclosure - Commitments and Contingencies - Unconditional Purchase Commitments (Details) Sheet http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails Commitments and Contingencies - Unconditional Purchase Commitments (Details) Details 143 false false R144.htm 9954572 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://gf.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 144 false false R145.htm 9954573 - Disclosure - Operating Segments Information - Revenue by Geography (Details) Sheet http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails Operating Segments Information - Revenue by Geography (Details) Details 145 false false R146.htm 9954574 - Disclosure - Operating Segments Information - Noncurrent Assets by Geography (Details) Sheet http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails Operating Segments Information - Noncurrent Assets by Geography (Details) Details 146 false false R147.htm 9954575 - Disclosure - Customer And Supplier Concentration - Narrative (Details) Sheet http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails Customer And Supplier Concentration - Narrative (Details) Details 147 false false R148.htm 9954576 - Disclosure - Customer And Supplier Concentration - Revenue by Major Customers (Details) Sheet http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails Customer And Supplier Concentration - Revenue by Major Customers (Details) Details 148 false false All Reports Book All Reports [dq-60547-EntityAddressCountry-Missing] Submission type 20-F should have a non-empty value for EntityAddressCountry in the Required Context. gfs-20231231.htm [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: gfs:NumberOfOrdinarySharesIssuedStockSplitConversionRatio, gfs:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod - gfs-20231231.htm 4 gfs-20231231.htm gfs-20231231.xsd gfs-20231231_cal.xml gfs-20231231_def.xml gfs-20231231_lab.xml gfs-20231231_pre.xml gfs-20231231_g1.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 175 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "gfs-20231231.htm": { "nsprefix": "gfs", "nsuri": "http://gf.com/20231231", "dts": { "inline": { "local": [ "gfs-20231231.htm" ] }, "schema": { "local": [ "gfs-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "gfs-20231231_cal.xml" ] }, "definitionLink": { "local": [ "gfs-20231231_def.xml" ] }, "labelLink": { "local": [ "gfs-20231231_lab.xml" ] }, "presentationLink": { "local": [ "gfs-20231231_pre.xml" ] } }, "keyStandard": 362, "keyCustom": 143, "axisStandard": 35, "axisCustom": 3, "memberStandard": 72, "memberCustom": 75, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2023": 4, "http://gf.com/20231231": 2 }, "contextCount": 692, "entityCount": 1, "segmentCount": 159, "elementCount": 858, "unitCount": 10, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1657, "http://xbrl.sec.gov/dei/2023": 43 }, "report": { "R1": { "role": "http://gf.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://gf.com/role/AuditInformation", "longName": "0000002 - Document - Audit Information", "shortName": "Audit Information", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:CurrentFinancialAssetsAvailableforsale", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R4": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical", "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:ParValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R5": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:Revenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:Revenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R6": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS)", "shortName": "CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R7": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R8": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestPaidClassifiedAsOperatingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestPaidClassifiedAsOperatingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R9": { "role": "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-8", "name": "ifrs-full:Equity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-15", "name": "ifrs-full:Equity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R10": { "role": "http://gf.com/role/Organization", "longName": "0000010 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://gf.com/role/BasisofPresentation", "longName": "0000011 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://gf.com/role/SummaryofMaterialAccountingPolicies", "longName": "0000012 - Disclosure - Summary of Material Accounting Policies", "shortName": "Summary of Material Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptions", "longName": "0000013 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions", "shortName": "Critical Accounting Judgements, Estimates, and Assumptions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://gf.com/role/CashAndCashEquivalents", "longName": "0000014 - Disclosure - Cash And Cash Equivalents", "shortName": "Cash And Cash Equivalents", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://gf.com/role/ReceivablesPrepaymentsandOtherAssets", "longName": "0000015 - Disclosure - Receivables, Prepayments and Other Assets", "shortName": "Receivables, Prepayments and Other Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://gf.com/role/Inventories", "longName": "0000016 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://gf.com/role/PropertyPlantandEquipment", "longName": "0000017 - Disclosure - Property, Plant and Equipment", "shortName": "Property, Plant and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://gf.com/role/GoodwillandIntangibleAssets", "longName": "0000018 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilities", "longName": "0000019 - Disclosure - Other Financial Assets And Liabilities", "shortName": "Other Financial Assets And Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://gf.com/role/TradePayablesandOtherLiabilities", "longName": "0000020 - Disclosure - Trade Payables and Other Liabilities", "shortName": "Trade Payables and Other Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://gf.com/role/LongTermDebt", "longName": "0000021 - Disclosure - Long-Term Debt", "shortName": "Long-Term Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://gf.com/role/Leases", "longName": "0000022 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://gf.com/role/Provisions", "longName": "0000023 - Disclosure - Provisions", "shortName": "Provisions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://gf.com/role/GovernmentGrants", "longName": "0000024 - Disclosure - Government Grants", "shortName": "Government Grants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://gf.com/role/IssuedCapitalandReserves", "longName": "0000025 - Disclosure - Issued Capital and Reserves", "shortName": "Issued Capital and Reserves", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://gf.com/role/NetRevenue", "longName": "0000026 - Disclosure - Net Revenue", "shortName": "Net Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://gf.com/role/CostofRevenue", "longName": "0000027 - Disclosure - Cost of Revenue", "shortName": "Cost of Revenue", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://gf.com/role/ResearchandDevelopmentExpenses", "longName": "0000028 - Disclosure - Research and Development Expenses", "shortName": "Research and Development Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://gf.com/role/SellingGeneralandAdministrativeExpenses", "longName": "0000029 - Disclosure - Selling, General and Administrative Expenses", "shortName": "Selling, General and Administrative Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://gf.com/role/Restructuring", "longName": "0000030 - Disclosure - Restructuring", "shortName": "Restructuring", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfRestructuringTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfRestructuringTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R31": { "role": "http://gf.com/role/ShareBasedCompensation", "longName": "0000031 - Disclosure - Share-Based Compensation", "shortName": "Share-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://gf.com/role/FinanceIncomeandExpenses", "longName": "0000032 - Disclosure - Finance Income and Expenses", "shortName": "Finance Income and Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinanceCostExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinanceCostExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://gf.com/role/GainonSaleofaBusiness", "longName": "0000033 - Disclosure - Gain on Sale of a Business", "shortName": "Gain on Sale of a Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://gf.com/role/OtherIncomeExpenseNet", "longName": "0000034 - Disclosure - Other Income (Expense), Net", "shortName": "Other Income (Expense), Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfOtherIncomeExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfOtherIncomeExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://gf.com/role/IncomeTaxes", "longName": "0000035 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://gf.com/role/EarningsPerShare", "longName": "0000036 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R37": { "role": "http://gf.com/role/EmployeeBenefitsPlans", "longName": "0000037 - Disclosure - Employee Benefits Plans", "shortName": "Employee Benefits Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://gf.com/role/RelatedPartyDisclosures", "longName": "0000038 - Disclosure - Related Party Disclosures", "shortName": "Related Party Disclosures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPolicies", "longName": "0000039 - Disclosure - Financial Risk Management Objectives and Policies", "shortName": "Financial Risk Management Objectives and Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://gf.com/role/CommitmentsandContingencies", "longName": "0000040 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://gf.com/role/OperatingSegmentsInformation", "longName": "0000041 - Disclosure - Operating Segments Information", "shortName": "Operating Segments Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://gf.com/role/CustomerAndSupplierConcentration", "longName": "0000042 - Disclosure - Customer And Supplier Concentration", "shortName": "Customer And Supplier Concentration", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfConcentrationRiskTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfConcentrationRiskTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R43": { "role": "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Summary of Material Accounting Policies (Policies)", "shortName": "Summary of Material Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://gf.com/role/SummaryofMaterialAccountingPoliciesTables", "longName": "9954472 - Disclosure - Summary of Material Accounting Policies (Tables)", "shortName": "Summary of Material Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://gf.com/role/CashAndCashEquivalentsTables", "longName": "9954473 - Disclosure - Cash And Cash Equivalents (Tables)", "shortName": "Cash And Cash Equivalents (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsTables", "longName": "9954474 - Disclosure - Receivables, Prepayments and Other Assets (Tables)", "shortName": "Receivables, Prepayments and Other Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://gf.com/role/InventoriesTables", "longName": "9954475 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureCurrentInventoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureCurrentInventoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R48": { "role": "http://gf.com/role/PropertyPlantandEquipmentTables", "longName": "9954476 - Disclosure - Property, Plant and Equipment (Tables)", "shortName": "Property, Plant and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R49": { "role": "http://gf.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954477 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R50": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables", "longName": "9954478 - Disclosure - Other Financial Assets And Liabilities (Tables)", "shortName": "Other Financial Assets And Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R51": { "role": "http://gf.com/role/TradePayablesandOtherLiabilitiesTables", "longName": "9954479 - Disclosure - Trade Payables and Other Liabilities (Tables)", "shortName": "Trade Payables and Other Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R52": { "role": "http://gf.com/role/LongTermDebtTables", "longName": "9954480 - Disclosure - Long-Term Debt (Tables)", "shortName": "Long-Term Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R53": { "role": "http://gf.com/role/LeasesTables", "longName": "9954481 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R54": { "role": "http://gf.com/role/ProvisionsTables", "longName": "9954482 - Disclosure - Provisions (Tables)", "shortName": "Provisions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R55": { "role": "http://gf.com/role/GovernmentGrantsTables", "longName": "9954483 - Disclosure - Government Grants (Tables)", "shortName": "Government Grants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://gf.com/role/NetRevenueTables", "longName": "9954484 - Disclosure - Net Revenue (Tables)", "shortName": "Net Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "56", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R57": { "role": "http://gf.com/role/CostofRevenueTables", "longName": "9954485 - Disclosure - Cost of Revenue (Tables)", "shortName": "Cost of Revenue (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R58": { "role": "http://gf.com/role/ResearchandDevelopmentExpensesTables", "longName": "9954486 - Disclosure - Research and Development Expenses (Tables)", "shortName": "Research and Development Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "58", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://gf.com/role/SellingGeneralandAdministrativeExpensesTables", "longName": "9954487 - Disclosure - Selling, General and Administrative Expenses (Tables)", "shortName": "Selling, General and Administrative Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R60": { "role": "http://gf.com/role/RestructuringTables", "longName": "9954488 - Disclosure - Restructuring (Tables)", "shortName": "Restructuring (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfRestructuringTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfRestructuringTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R61": { "role": "http://gf.com/role/ShareBasedCompensationTables", "longName": "9954489 - Disclosure - Share-Based Compensation (Tables)", "shortName": "Share-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R62": { "role": "http://gf.com/role/FinanceIncomeandExpensesTables", "longName": "9954490 - Disclosure - Finance Income and Expenses (Tables)", "shortName": "Finance Income and Expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "62", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfFinanceIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfSummaryOfFinanceIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R63": { "role": "http://gf.com/role/GainonSaleofaBusinessTables", "longName": "9954491 - Disclosure - Gain on Sale of a Business (Tables)", "shortName": "Gain on Sale of a Business (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "63", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R64": { "role": "http://gf.com/role/OtherIncomeExpenseNetTables", "longName": "9954492 - Disclosure - Other Income (Expense), Net (Tables)", "shortName": "Other Income (Expense), Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "64", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfOtherIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfOtherIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R65": { "role": "http://gf.com/role/IncomeTaxesTables", "longName": "9954493 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "65", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R66": { "role": "http://gf.com/role/EarningsPerShareTables", "longName": "9954494 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "66", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R67": { "role": "http://gf.com/role/RelatedPartyDisclosuresTables", "longName": "9954495 - Disclosure - Related Party Disclosures (Tables)", "shortName": "Related Party Disclosures (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "67", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfRelatedPartyWhichTheCompanyHasEnteredIntoRelatedPartyTransactionWithTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfRelatedPartyWhichTheCompanyHasEnteredIntoRelatedPartyTransactionWithTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R68": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables", "longName": "9954496 - Disclosure - Financial Risk Management Objectives and Policies (Tables)", "shortName": "Financial Risk Management Objectives and Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "68", "firstAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfDerivativeFinancialLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:DisclosureOfDerivativeFinancialLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R69": { "role": "http://gf.com/role/CommitmentsandContingenciesTables", "longName": "9954497 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R70": { "role": "http://gf.com/role/OperatingSegmentsInformationTables", "longName": "9954498 - Disclosure - Operating Segments Information (Tables)", "shortName": "Operating Segments Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "70", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R71": { "role": "http://gf.com/role/CustomerAndSupplierConcentrationTables", "longName": "9954499 - Disclosure - Customer And Supplier Concentration (Tables)", "shortName": "Customer And Supplier Concentration (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "71", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R72": { "role": "http://gf.com/role/OrganizationDetails", "longName": "9954500 - Disclosure - Organization (Details)", "shortName": "Organization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R73": { "role": "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails", "longName": "9954501 - Disclosure - Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details)", "shortName": "Summary of Material Accounting Policies - Schedule of Property, Plant, and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-67", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R74": { "role": "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails", "longName": "9954502 - Disclosure - Summary of Material Accounting Policies - Intangible Assets (Details)", "shortName": "Summary of Material Accounting Policies - Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-70", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-70", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R75": { "role": "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "longName": "9954503 - Disclosure - Critical Accounting Judgements, Estimates, and Assumptions (Details)", "shortName": "Critical Accounting Judgements, Estimates, and Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R76": { "role": "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails", "longName": "9954504 - Disclosure - Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details)", "shortName": "Cash And Cash Equivalents - Schedule of Cash and Cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:BalancesWithBanks", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:BalancesWithBanks", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R77": { "role": "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails", "longName": "9954505 - Disclosure - Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details)", "shortName": "Cash And Cash Equivalents - Reconciliation of Assets and Liabilities Arising from Financing Activities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R78": { "role": "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "longName": "9954506 - Disclosure - Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details)", "shortName": "Cash And Cash Equivalents - Concentration of Cash and Cash Equivalents by Geography (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-101", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfGeographicalConcentrationOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R79": { "role": "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails", "longName": "9954507 - Disclosure - Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details)", "shortName": "Receivables, Prepayments and Other Assets - Summary of Receivables, Prepayments and Other Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R80": { "role": "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsScheduleofUnbilledAccountsReceivableDetails", "longName": "9954508 - Disclosure - Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details)", "shortName": "Receivables, Prepayments and Other Assets - Schedule of Unbilled Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-4", "name": "gfs:CurrentUnbilledReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:CurrentUnbilledReceivablesRevenueRecognizedDuringTheYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R81": { "role": "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails", "longName": "9954509 - Disclosure - Receivables, Prepayments and Other Assets - Maturity Schedule (Details)", "shortName": "Receivables, Prepayments and Other Assets - Maturity Schedule (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-107", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R82": { "role": "http://gf.com/role/InventoriesSummaryofInventoriesDetails", "longName": "9954510 - Disclosure - Inventories - Summary of Inventories (Details)", "shortName": "Inventories - Summary of Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:WorkInProgress", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureCurrentInventoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:WorkInProgress", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureCurrentInventoryTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R83": { "role": "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "longName": "9954511 - Disclosure - Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details)", "shortName": "Property, Plant and Equipment - Summary of Property, Plant And Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:PropertyPlantAndEquipmentIncludingRightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "gfs:InvestmentTaxCreditsPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R84": { "role": "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "longName": "9954512 - Disclosure - Property, Plant and Equipment - Narrative (Details)", "shortName": "Property, Plant and Equipment - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:RightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-144", "name": "ifrs-full:RightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R85": { "role": "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails", "longName": "9954513 - Disclosure - Property, Plant and Equipment - Schedule of Depreciation Expense (Details)", "shortName": "Property, Plant and Equipment - Schedule of Depreciation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails", "longName": "9954514 - Disclosure - Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Goodwill and Intangible Assets Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:IntangibleAssetsAndGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-249", "name": "ifrs-full:IntangibleAssetsAndGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R87": { "role": "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "longName": "9954515 - Disclosure - Goodwill and Intangible Assets - Schedule of Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R88": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "longName": "9954516 - Disclosure - Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details)", "shortName": "Other Financial Assets And Liabilities - Financial Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:FinancialAssetsAtFairValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfFinancialAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-366", "name": "ifrs-full:NotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R89": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "longName": "9954517 - Disclosure - Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details)", "shortName": "Other Financial Assets And Liabilities - Fair Value and Location of Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-417", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-417", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R90": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails", "longName": "9954518 - Disclosure - Other Financial Assets And Liabilities - Narrative (Details)", "shortName": "Other Financial Assets And Liabilities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-419", "name": "ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R91": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "longName": "9954519 - Disclosure - Other Financial Assets And Liabilities - Effect on Financial Statements (Details)", "shortName": "Other Financial Assets And Liabilities - Effect on Financial Statements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c-425", "name": "ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-425", "name": "ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R92": { "role": "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "longName": "9954520 - Disclosure - Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details)", "shortName": "Other Financial Assets And Liabilities - Effect of Derivatives on Statements of Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R93": { "role": "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails", "longName": "9954521 - Disclosure - Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details)", "shortName": "Trade Payables and Other Liabilities - Schedule of Noncurrent and Current Trade and Other Payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R94": { "role": "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails", "longName": "9954522 - Disclosure - Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details)", "shortName": "Trade Payables and Other Liabilities - Reconciliation of Contract Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:ContractLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ifrs-full:ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "ifrs-full:ContractLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ifrs-full:ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R95": { "role": "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails", "longName": "9954523 - Disclosure - Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details)", "shortName": "Long-Term Debt - Schedule of Noncurrent and Current Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CurrentPortionOfLongtermBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": null }, "R96": { "role": "http://gf.com/role/LongTermDebtNarrativeDetails", "longName": "9954524 - Disclosure - Long-Term Debt - Narrative (Details)", "shortName": "Long-Term Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:Borrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-464", "name": "gfs:BorrowingMaturityTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R97": { "role": "http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails", "longName": "9954525 - Disclosure - Long-Term Debt - Movements in Interest bearing Borrowings (Details)", "shortName": "Long-Term Debt - Movements in Interest bearing Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:Borrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:ProceedsFromLoansAndOtherBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R98": { "role": "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "longName": "9954526 - Disclosure - Long-Term Debt - Summary of Term Loan Facilities (Details)", "shortName": "Long-Term Debt - Summary of Term Loan Facilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CurrentPortionOfLongtermBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-459", "name": "gfs:BorrowingsNumberOfBanks", "unitRef": "bank", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R99": { "role": "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails", "longName": "9954527 - Disclosure - Long-Term Debt - Summary of Unutilized Credit Facilities (Details)", "shortName": "Long-Term Debt - Summary of Unutilized Credit Facilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:UndrawnBorrowingFacilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:UndrawnBorrowingFacilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R100": { "role": "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails", "longName": "9954528 - Disclosure - Leases - Additional Information about Leases (Details)", "shortName": "Leases - Additional Information about Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:CashOutflowForLeases", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R101": { "role": "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails", "longName": "9954529 - Disclosure - Leases - Maturity of Lease Payments (Details)", "shortName": "Leases - Maturity of Lease Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R102": { "role": "http://gf.com/role/LeasesCashFlowInformationDetails", "longName": "9954530 - Disclosure - Leases - Cash Flow Information (Details)", "shortName": "Leases - Cash Flow Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c-1", "name": "gfs:ExpenseRelatingToShortTermAndLowValueLeasesForWhichRecognitionExemptionHasBeenUsed", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R103": { "role": "http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails", "longName": "9954531 - Disclosure - Leases - Schedule of Lease Liabilities (Details)", "shortName": "Leases - Schedule of Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:RightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfLeaseLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfLeaseLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R104": { "role": "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails", "longName": "9954532 - Disclosure - Provisions - Movement in Provision for Asset Retirement Obligations (Details)", "shortName": "Provisions - Movement in Provision for Asset Retirement Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:OtherProvisions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R105": { "role": "http://gf.com/role/ProvisionsNarrativeDetails", "longName": "9954533 - Disclosure - Provisions - Narrative (Details)", "shortName": "Provisions - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "c-70", "name": "gfs:DiscountRatesUsedInProvisionEstimates", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-70", "name": "gfs:DiscountRatesUsedInProvisionEstimates", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R106": { "role": "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails", "longName": "9954534 - Disclosure - Government Grants - Roll forward of Government Grants (Details)", "shortName": "Government Grants - Roll forward of Government Grants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:GovernmentGrants", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "ifrs-full:GovernmentGrants", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R107": { "role": "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "longName": "9954535 - Disclosure - Government Grants - Located in Consolidated Statements of Operations (Details)", "shortName": "Government Grants - Located in Consolidated Statements of Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromGovernmentGrants", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfGovernmentGrantsRecognizedInConsolidatedStatementOfOperationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromGovernmentGrants", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfGovernmentGrantsRecognizedInConsolidatedStatementOfOperationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R108": { "role": "http://gf.com/role/IssuedCapitalandReservesDetails", "longName": "9954536 - Disclosure - Issued Capital and Reserves (Details)", "shortName": "Issued Capital and Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "ifrs-full:NumberOfSharesOutstanding", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-485", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R109": { "role": "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails", "longName": "9954537 - Disclosure - Net Revenue - Disaggregated Revenues (Details)", "shortName": "Net Revenue - Disaggregated Revenues (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-494", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R110": { "role": "http://gf.com/role/NetRevenueNarrativeDetails", "longName": "9954538 - Disclosure - Net Revenue - Narrative (Details)", "shortName": "Net Revenue - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-9", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-9", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R111": { "role": "http://gf.com/role/CostofRevenueDetails", "longName": "9954539 - Disclosure - Cost of Revenue (Details)", "shortName": "Cost of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationAndAmortisationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationAndAmortisationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R112": { "role": "http://gf.com/role/ResearchandDevelopmentExpensesDetails", "longName": "9954540 - Disclosure - Research and Development Expenses (Details)", "shortName": "Research and Development Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "c-1", "name": "gfs:ResearchAndDevelopmentExpensesStaffCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:ResearchAndDevelopmentExpensesStaffCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R113": { "role": "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails", "longName": "9954541 - Disclosure - Selling, General and Administrative Expenses (Details)", "shortName": "Selling, General and Administrative Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "c-1", "name": "gfs:CostOfSalesEmployeeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:CostOfSalesEmployeeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R114": { "role": "http://gf.com/role/RestructuringDetails", "longName": "9954542 - Disclosure - Restructuring (Details)", "shortName": "Restructuring (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ExpenseOfRestructuringActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "gfs:ExpenseOfRestructuringActivitiesAcceleratedShareBasdCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R115": { "role": "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "longName": "9954543 - Disclosure - Share-Based Compensation - Narrative (Details)", "shortName": "Share-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R116": { "role": "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails", "longName": "9954544 - Disclosure - Share-Based Compensation - RSU and PSU Activity (Details)", "shortName": "Share-Based Compensation - RSU and PSU Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "c-513", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-511", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R117": { "role": "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "longName": "9954545 - Disclosure - Share-Based Compensation - Fair Value Assumptions (Details)", "shortName": "Share-Based Compensation - Fair Value Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "c-523", "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-523", "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R118": { "role": "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails", "longName": "9954546 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)", "shortName": "Share-Based Compensation - Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R119": { "role": "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails", "longName": "9954547 - Disclosure - Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details)", "shortName": "Share-Based Compensation - Range of Exercise Prices, Options Outstanding, and Contractual Life (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-531", "name": "ifrs-full:ExercisePriceOfOutstandingShareOptions2019", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R120": { "role": "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails", "longName": "9954548 - Disclosure - Finance Income and Expenses- Finance Income (Details)", "shortName": "Finance Income and Expenses- Finance Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestIncomeOnDeposits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfSummaryOfFinanceIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestIncomeOnDeposits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfSummaryOfFinanceIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R121": { "role": "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails", "longName": "9954549 - Disclosure - Finance Income and Expenses- Finance Expenses (Details)", "shortName": "Finance Income and Expenses- Finance Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestExpenseOnDebtInstrumentsIssued", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfSummaryOfFinanceCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:InterestExpenseOnDebtInstrumentsIssued", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfSummaryOfFinanceCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R122": { "role": "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "longName": "9954550 - Disclosure - Gain on Sale of a Business - Narrative (Details)", "shortName": "Gain on Sale of a Business - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-538", "name": "ifrs-full:ConsiderationPaidReceived", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R123": { "role": "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails", "longName": "9954551 - Disclosure - Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details)", "shortName": "Gain on Sale of a Business - Schedule of Net Assets Derecognized (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-539", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R124": { "role": "http://gf.com/role/OtherIncomeExpenseNetDetails", "longName": "9954552 - Disclosure - Other Income (Expense), Net (Details)", "shortName": "Other Income (Expense), Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "c-1", "name": "gfs:GainLossOnHedgingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfOtherIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "gfs:GainLossOnHedgingActivities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "gfs:DisclosureOfOtherIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R125": { "role": "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails", "longName": "9954553 - Disclosure - Income Taxes - Income tax benefit (expense) (Details)", "shortName": "Income Taxes - Income tax benefit (expense) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R126": { "role": "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails", "longName": "9954554 - Disclosure - Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details)", "shortName": "Income Taxes - Reconciliation of income tax expense applying statutory tax and effective tax rates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:AccountingProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AccountingProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R127": { "role": "http://gf.com/role/IncomeTaxesNarrativeDetails", "longName": "9954555 - Disclosure - Income Taxes - Narrative (Details)", "shortName": "Income Taxes - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R128": { "role": "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails", "longName": "9954556 - Disclosure - Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "Income Taxes - schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfDeferredTaxAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-540", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R129": { "role": "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails", "longName": "9954557 - Disclosure - Income Taxes - Classification of deferred Tax Assets and Liabilities (Details)", "shortName": "Income Taxes - Classification of deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:DeferredTaxAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:DeferredTaxLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R130": { "role": "http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails", "longName": "9954558 - Disclosure - Income Taxes - Reconciliation of Deferred Tax assets, Net (Details)", "shortName": "Income Taxes - Reconciliation of Deferred Tax assets, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "130", "firstAnchor": { "contextRef": "c-4", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfDeferredTaxAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R131": { "role": "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails", "longName": "9954559 - Disclosure - Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details)", "shortName": "Earnings Per Share - Computation of Basic and Diluted Earnings per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "131", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R132": { "role": "http://gf.com/role/EmployeeBenefitsPlansDetails", "longName": "9954560 - Disclosure - Employee Benefits Plans (Details)", "shortName": "Employee Benefits Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "132", "firstAnchor": { "contextRef": "c-3", "name": "gfs:PercentOfMatchDefinedContributionPlans", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "gfs:PercentOfMatchDefinedContributionPlans", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R133": { "role": "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "longName": "9954561 - Disclosure - Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details)", "shortName": "Related Party Disclosures - Balances in the Consolidated Statement of Financial Position (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "133", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfBalancesWithRelatedPartiesInTheConsolidatedStatementsOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfBalancesWithRelatedPartiesInTheConsolidatedStatementsOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R134": { "role": "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails", "longName": "9954562 - Disclosure - Related Party Disclosures - Transactions with Related Parties (Details)", "shortName": "Related Party Disclosures - Transactions with Related Parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "134", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:PurchasesOfGoodsRelatedPartyTransactions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:PurchasesOfGoodsRelatedPartyTransactions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R135": { "role": "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails", "longName": "9954563 - Disclosure - Related Party Disclosures - Narrative (Details)", "shortName": "Related Party Disclosures - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "135", "firstAnchor": { "contextRef": "c-20", "name": "ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "ifrs-full:ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R136": { "role": "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails", "longName": "9954564 - Disclosure - Related Party Disclosures - Compensation to Key Management Personnel (Details)", "shortName": "Related Party Disclosures - Compensation to Key Management Personnel (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "136", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R137": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "longName": "9954565 - Disclosure - Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details)", "shortName": "Financial Risk Management Objectives and Policies - Foreign Currency Risk Exposure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "137", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-600", "name": "gfs:PrepaymentsAndOtherCurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R138": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails", "longName": "9954566 - Disclosure - Financial Risk Management Objectives and Policies - Narrative (Details)", "shortName": "Financial Risk Management Objectives and Policies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "138", "firstAnchor": { "contextRef": "c-603", "name": "gfs:RiskExposureAssociatedWithMajorCustomersConcentrationPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-603", "name": "gfs:RiskExposureAssociatedWithMajorCustomersConcentrationPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R139": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "longName": "9954567 - Disclosure - Financial Risk Management Objectives and Policies - Aging of Financial assets (Details)", "shortName": "Financial Risk Management Objectives and Policies - Aging of Financial assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "139", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:FinancialAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfFinancialAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-611", "name": "ifrs-full:FinancialAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R140": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "longName": "9954568 - Disclosure - Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details)", "shortName": "Financial Risk Management Objectives and Policies - Maturity of Financial Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "140", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:Borrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-621", "name": "ifrs-full:Borrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R141": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954569 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Financial Risk Management Objectives and Policies - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "141", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-640", "name": "ifrs-full:Assets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R142": { "role": "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails", "longName": "9954570 - Disclosure - Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details)", "shortName": "Financial Risk Management Objectives and Policies - Assets and Liabilities not Measured at a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "142", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:FinancialAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfFinancialAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-656", "name": "ifrs-full:FinancialAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "gfs:DisclosureOfFinancialAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R143": { "role": "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails", "longName": "9954571 - Disclosure - Commitments and Contingencies - Unconditional Purchase Commitments (Details)", "shortName": "Commitments and Contingencies - Unconditional Purchase Commitments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "143", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:ContractualCapitalCommitments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:ContractualCapitalCommitments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R144": { "role": "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails", "longName": "9954572 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "144", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:Borrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "gfs:BankGuarantees", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R145": { "role": "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails", "longName": "9954573 - Disclosure - Operating Segments Information - Revenue by Geography (Details)", "shortName": "Operating Segments Information - Revenue by Geography (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "145", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-661", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } }, "R146": { "role": "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "longName": "9954574 - Disclosure - Operating Segments Information - Noncurrent Assets by Geography (Details)", "shortName": "Operating Segments Information - Noncurrent Assets by Geography (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "146", "firstAnchor": { "contextRef": "c-3", "name": "gfs:CertainNonCurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "gfs:CertainNonCurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R147": { "role": "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "longName": "9954575 - Disclosure - Customer And Supplier Concentration - Narrative (Details)", "shortName": "Customer And Supplier Concentration - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "147", "firstAnchor": { "contextRef": "c-691", "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-691", "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true, "unique": true } }, "R148": { "role": "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails", "longName": "9954576 - Disclosure - Customer And Supplier Concentration - Revenue by Major Customers (Details)", "shortName": "Customer And Supplier Concentration - Revenue by Major Customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "148", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-678", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "gfs-20231231.htm", "unique": true } } }, "tag": { "gfs_A2018ToolEquipmentPurchaseAndLeaseFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2018ToolEquipmentPurchaseAndLeaseFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Tool Equipment Purchase and Lease Financing", "label": "2018 Tool Equipment Purchase and Lease Financing [Member]", "documentation": "2018 Tool Equipment Purchase and Lease Financing" } } }, "auth_ref": [] }, "gfs_A2019EURDresdenEquipmentFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2019EURDresdenEquipmentFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 EUR Dresden Equipment Financing", "label": "2019 EUR Dresden Equipment Financing [Member]", "documentation": "2019 EUR Dresden Equipment Financing" } } }, "auth_ref": [] }, "gfs_A2019EURDresdenEquipmentFinancingNoncurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2019EURDresdenEquipmentFinancingNoncurrentMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 EUR Dresden Equipment Financing Noncurrent", "label": "2019 EUR Dresden Equipment Financing Noncurrent [Member]", "documentation": "2019 EUR Dresden Equipment Financing Noncurrent" } } }, "auth_ref": [] }, "gfs_A2019ToolEquipmentPurchaseAndLeaseFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2019ToolEquipmentPurchaseAndLeaseFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 Tool Equipment Purchase and Lease Financing", "label": "2019 Tool Equipment Purchase and Lease Financing [Member]", "documentation": "2019 Tool Equipment Purchase and Lease Financing" } } }, "auth_ref": [] }, "gfs_A2019USDDresdenEquipmentFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2019USDDresdenEquipmentFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 USD Dresden Equipment Financing", "label": "2019 USD Dresden Equipment Financing [Member]", "documentation": "2019 USD Dresden Equipment Financing" } } }, "auth_ref": [] }, "gfs_A2019USDDresdenEquipmentFinancingNonCurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2019USDDresdenEquipmentFinancingNonCurrentMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 USD Dresden Equipment Financing Non-Current", "label": "2019 USD Dresden Equipment Financing Non-Current [Member]", "documentation": "2019 USD Dresden Equipment Financing Non-Current" } } }, "auth_ref": [] }, "gfs_A2020USDEquipmentFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2020USDEquipmentFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2020 USD Equipment Financing", "label": "2020 USD Equipment Financing [Member]", "documentation": "2020 USD Equipment Financing" } } }, "auth_ref": [] }, "gfs_A2021SGDEDBLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "A2021SGDEDBLoanMember", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 SGD EDB Loan", "label": "2021 SGD EDB Loan [Member]", "documentation": "2021 SGD EDB Loan" } } }, "auth_ref": [] }, "gfs_AcceleratedDepreciationOnPropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "AcceleratedDepreciationOnPropertyPlantAndEquipmentMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated depreciation on property, plant and equipment", "label": "Accelerated Depreciation On Property, Plant, And Equipment [Member]", "documentation": "Accelerated Depreciation On Property, Plant, And Equipment" } } }, "auth_ref": [] }, "ifrs-full_AccountingEstimatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingEstimatesAxis", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting estimates [axis]", "label": "Accounting estimates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r128" ] }, "ifrs-full_AccountingEstimatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingEstimatesMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting estimates [member]", "label": "Accounting estimates [member]" } }, "en": { "role": { "documentation": "This member stands for monetary amounts in financial statements that are subject to measurement uncertainty. It also represents the standard value for the 'Accounting estimates' axis if no other member is used." } } }, "auth_ref": [ "r128" ] }, "gfs_AccountingPoliciesChangesInAccountingEstimatesAndErrorsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "AccountingPoliciesChangesInAccountingEstimatesAndErrorsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]", "label": "Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]", "documentation": "Accounting Policies, Changes In Accounting Estimates And Errors [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income (Loss) before income taxes", "label": "Accounting profit" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r54", "r55" ] }, "gfs_AccretionIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "AccretionIncome", "crdr": "credit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion income", "label": "Accretion Income", "documentation": "Accretion Income" } } }, "auth_ref": [] }, "ifrs-full_AccrualsAndDeferredIncomeIncludingContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccrualsAndDeferredIncomeIncludingContractLiabilities", "crdr": "credit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Accruals and deferred income including contract liabilities" } }, "en": { "role": { "documentation": "The amount of accruals and deferred income, including contract liabilities. [Refer: Accruals; Deferred income including contract liabilities]" } } }, "auth_ref": [ "r329", "r330" ] }, "ifrs-full_AccrualsClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccrualsClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accruals classified as current" } }, "en": { "role": { "documentation": "The amount of accruals classified as current. [Refer: Accruals]" } } }, "auth_ref": [ "r330" ] }, "gfs_AccruedExpensesTaxDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "AccruedExpensesTaxDifferenceMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accrued Expenses Tax Difference [Member]", "documentation": "Accrued Expenses Tax Difference" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAndAmortisationMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Amortization", "label": "Accumulated depreciation and amortisation [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r68", "r337", "r347", "r351", "r352" ] }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedOtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated other comprehensive income" } }, "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_AdditionalPaidinCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionalPaidinCapital", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional paid-in capital" } }, "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_AdditionalPaidinCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionalPaidinCapitalMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional paid-in capital [member]" } }, "en": { "role": { "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r325" ] }, "gfs_AdditionalPercentageOfEmployeeContributionsMatchedDefinedContributionPlans": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "AdditionalPercentageOfEmployeeContributionsMatchedDefinedContributionPlans", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional employee contributions matched by employer (as a percent)", "label": "Additional Percentage Of Employee Contributions Matched, Defined Contribution Plans", "documentation": "Additional Percentage Of Employee Contributions Matched, Defined Contribution Plans" } } }, "auth_ref": [] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Additions other than through business combinations, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Additions other than through business combinations, property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r63" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Additions to right-of-use assets" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r166" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Address Type [Domain]", "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted weighted average ordinary shares outstanding (in shares)", "terseLabel": "Weighted average common shares outstanding (in shares)", "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r91" ] }, "gfs_AdjustmentsForAmortizationOfDeferredIncomeFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "AdjustmentsForAmortizationOfDeferredIncomeFromGovernmentGrants", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of deferred income from government grants", "label": "Adjustments For Amortization Of Deferred Income From Government Grants", "documentation": "Adjustments For Amortization Of Deferred Income From Government Grants" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForCurrentTaxOfPriorPeriod", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Adjustments in respect of current income tax of previous year", "label": "Adjustments for current tax of prior periods" } }, "en": { "role": { "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods." } } }, "auth_ref": [ "r258" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Adjustments for decrease (increase) in inventories" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r355" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables, prepayments and other assets", "label": "Adjustments for decrease (increase) in trade and other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_AdjustmentsForDeferredTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDeferredTaxExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Adjustments for deferred tax expense" } }, "en": { "role": { "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_AdjustmentsForDeferredTaxOfPriorPeriods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDeferredTaxOfPriorPeriods", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net operating and investment allowance carryforwards", "label": "Adjustments for deferred tax of prior periods" } }, "en": { "role": { "documentation": "Adjustments of tax expense (income) recognised in the period for the deferred tax of prior periods." } } }, "auth_ref": [ "r333" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Adjustments for depreciation and amortisation expense" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_AdjustmentsForFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceCosts", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Finance expense", "label": "Adjustments for finance costs" } }, "en": { "role": { "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_AdjustmentsForFinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceIncome", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Finance income", "label": "Adjustments for finance income" } }, "en": { "role": { "documentation": "Adjustments for finance income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income; Profit (loss)]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Gain) Loss on disposal of property, plant and equipment and other", "label": "Adjustments for gain (loss) on disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } } }, "auth_ref": [ "r358" ] }, "gfs_AdjustmentsForGainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "AdjustmentsForGainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on the sale of a business", "label": "Adjustments For Gain (Loss) Recognised On Measurement To Fair Value Less Costs To Sell Or On Disposal Of Assets Or Disposal Groups Constituting Discontinued Operation", "documentation": "Adjustments For Gain (Loss) Recognised On Measurement To Fair Value Less Costs To Sell Or On Disposal Of Assets Or Disposal Groups Constituting Discontinued Operation" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Trade and other payables", "label": "Adjustments for increase (decrease) in trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:", "label": "Adjustments to reconcile profit (loss) [abstract]" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payments", "label": "Adjustments for share-based payments" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregated measurement [member]", "label": "Aggregated measurement [member]" } }, "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r109", "r113", "r147" ] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregated time bands [member]", "label": "Aggregated time bands [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r23", "r158", "r170", "r171", "r174", "r175", "r176", "r182", "r206", "r262", "r298", "r305" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Currencies [Domain]", "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All levels of fair value hierarchy [member]", "label": "All levels of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r70", "r148" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expenses", "label": "Amortisation, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r104" ] }, "ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity", "crdr": "debit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount incurred by entity for provision of key management personnel services provided by separate management entity", "label": "Amount incurred by entity for provision of key management personnel services provided by separate management entity" } }, "en": { "role": { "documentation": "The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]" } } }, "auth_ref": [ "r82" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due to Related Parties", "label": "Amounts payable, related party transactions" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r79", "r86" ] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due from Related Parties", "label": "Amounts receivable, related party transactions" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r79", "r86" ] }, "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AnalysisOfIncomeAndExpenseAbstract", "lang": { "en-us": { "role": { "label": "Analysis of income and expense [abstract]" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "terseLabel": "Assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r20", "r147", "r148", "r149", "r233", "r236" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [abstract]" } } }, "auth_ref": [] }, "gfs_AssetsArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "AssetsArisingFromFinancingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Assets arising from financing activities at beginning of period", "periodEndLabel": "Assets arising from financing activities at end of period", "label": "Assets Arising From Financing Activities", "documentation": "Assets Arising From Financing Activities" } } }, "auth_ref": [] }, "gfs_AssetsArisingFromFinancingActivitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "AssetsArisingFromFinancingActivitiesAxis", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Arising From Financing Activities [Axis]", "label": "Assets Arising From Financing Activities [Axis]", "documentation": "Assets Arising From Financing Activities" } } }, "auth_ref": [] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Attribution of expenses by nature to their function [axis]", "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r323", "r326" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://gf.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "gfs_AuditorInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "AuditorInformationAbstract", "lang": { "en-us": { "role": { "label": "Auditor Information [Abstract]", "documentation": "Auditor Information" } } }, "auth_ref": [] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://gf.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://gf.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "ifrs-full_AverageForeignExchangeRate": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AverageForeignExchangeRate", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average Foreign Currency/ US$", "label": "Average foreign exchange rate" } }, "en": { "role": { "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies." } } }, "auth_ref": [ "r326" ] }, "ifrs-full_BalancesWithBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BalancesWithBanks", "crdr": "debit", "calculation": { "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash balances on hand and at banks", "label": "Balances with banks" } }, "en": { "role": { "documentation": "The amount of cash balances held at banks." } } }, "auth_ref": [ "r360" ] }, "ifrs-full_BankBorrowingsUndiscountedCashFlows": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BankBorrowingsUndiscountedCashFlows", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans and borrowings", "label": "Bank borrowings, undiscounted cash flows" } }, "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r301", "r307" ] }, "gfs_BankGuarantees": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "BankGuarantees", "crdr": "credit", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank guarantees", "label": "Bank Guarantees", "documentation": "Bank Guarantees" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic loss per share (in USD per share)", "terseLabel": "Total basic and diluted earnings per share attributable to equity shareholders (in USD per share)", "label": "Basic earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r89", "r90" ] }, "gfs_BoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "BoardOfDirectorsMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Board of Directors", "label": "Board Of Directors [Member]", "documentation": "Board Of Directors" } } }, "auth_ref": [] }, "gfs_BorrowingCostsAbstractAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingCostsAbstractAbstract", "lang": { "en-us": { "role": { "terseLabel": "Borrowing costs [Abstract]", "label": "Borrowing costs Abstract [Abstract]", "documentation": "Borrowing costs [Abstract]" } } }, "auth_ref": [] }, "gfs_BorrowingFacilitiesMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingFacilitiesMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Borrowing Facilities, Maximum Borrowing capacity", "documentation": "Borrowing Facilities, Maximum Borrowing capacity" } } }, "auth_ref": [] }, "gfs_BorrowingMaturityTerm": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingMaturityTerm", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowing term (in years)", "label": "Borrowing Maturity, Term", "documentation": "Borrowing Maturity, Term" } } }, "auth_ref": [] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Borrowings", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 4.0 }, "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Loans and borrowings", "periodStartLabel": "Opening balance", "periodEndLabel": "Ending balance", "label": "Borrowings" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings by name [axis]", "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r362" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings by name [member]", "label": "Borrowings by name [member]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Nominal Interest Rate", "terseLabel": "Nominal Interest Rate", "label": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "gfs_BorrowingsNetOfCrossCurrencySwapAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingsNetOfCrossCurrencySwapAssets", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loans and borrowings", "label": "Borrowings, Net Of Cross Currency Swap Assets", "documentation": "Borrowings, Net Of Cross Currency Swap Assets" } } }, "auth_ref": [] }, "gfs_BorrowingsNumberOfBanks": { "xbrltype": "integerItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingsNumberOfBanks", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of banks", "label": "Borrowings, Number Of Banks", "documentation": "Borrowings, Number Of Banks" } } }, "auth_ref": [] }, "gfs_BorrowingsOtherIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "BorrowingsOtherIncreaseDecrease", "crdr": "debit", "presentation": [ "http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Borrowings, Other Increase (Decrease)", "documentation": "Borrowings, Other Increase (Decrease)" } } }, "auth_ref": [] }, "gfs_BuildingAndLeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "BuildingAndLeaseholdImprovementsMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building and leasehold/land improvements", "label": "Building And Leasehold Improvements [Member]", "documentation": "Building And Leasehold Improvements" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Business Contact", "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r316", "r317" ] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CALIFORNIA", "label": "CALIFORNIA" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]", "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r62", "r66", "r102", "r105", "r110", "r111", "r112", "r113", "r114", "r198", "r218", "r219" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount", "label": "Carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r66", "r105", "r110", "r112", "r113", "r198", "r218", "r219" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": -1.0, "order": 1.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails", "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at the beginning of the year", "periodEndLabel": "Cash and cash equivalents at the end of the year", "totalLabel": "Total", "label": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r13", "r125", "r144" ] }, "gfs_CashEquivalentMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CashEquivalentMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalent [Member]", "documentation": "Cash Equivalent" } } }, "auth_ref": [] }, "ifrs-full_CashFlowHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowHedgesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Cash flow hedges [member]" } }, "en": { "role": { "documentation": "This member stands for hedges of the exposure to variability in cash flows that (a) are attributable to a particular risk associated with a recognised asset or liability (such as all or some future interest payments on variable rate debt) or a highly probable forecast transaction; and (b) could affect profit or loss. [Refer: Hedges [member]]" } } }, "auth_ref": [ "r108", "r207", "r208", "r213" ] }, "gfs_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalentsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalentsInvestingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in restricted cash", "label": "Cash flows From (Used In) Decrease (Increase) In Restricted Cash And Cash Equivalents, Investing Activities", "documentation": "Cash flows From (Used In) Decrease (Increase) In Restricted Cash And Cash Equivalents, Investing Activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r115", "r127" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://gf.com/role/LeasesCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES", "terseLabel": "Cash flows used in financing activities:", "label": "Cash flows from (used in) financing activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r115", "r127" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES", "label": "Cash flows from (used in) investing activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r115", "r127" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://gf.com/role/LeasesCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES", "terseLabel": "Cash flows used in operating activities:", "label": "Cash flows from (used in) operating activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashOutflowForLeases": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashOutflowForLeases", "crdr": "credit", "presentation": [ "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total net lease cost", "label": "Cash outflow for leases" } }, "en": { "role": { "documentation": "The cash outflow for leases." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/NetRevenueNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash receipts from futures contracts, forward contracts, option contracts and swap contracts", "label": "Cash receipts from futures contracts, forward contracts, option contracts and swap contracts, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from futures contracts, forward contracts, option contracts and swap contracts except when the contracts are held for dealing or trading purposes or the receipts are classified as financing activities." } } }, "auth_ref": [ "r271" ] }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfFinancialAssetsAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Categories of financial assets [axis]", "label": "Categories of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r227" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails", "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Categories of related parties [axis]", "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85" ] }, "gfs_CertainNonCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CertainNonCurrentAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Certain non-current assets", "label": "Certain Non-Current Assets", "documentation": "Certain Non-Current Assets" } } }, "auth_ref": [] }, "gfs_ChangeInAccountingEstimateMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ChangeInAccountingEstimateMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change In Accounting Estimate", "label": "Change In Accounting Estimate [Member]", "documentation": "Change In Accounting Estimate" } } }, "auth_ref": [] }, "gfs_ChangeInAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "ChangeInAssetsAndLiabilitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in assets and liabilities:", "label": "Change In Assets And Liabilities [Abstract]", "documentation": "Change In Assets And Liabilities" } } }, "auth_ref": [] }, "ifrs-full_ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ChangesInLiabilitiesArisingFromFinancingActivitiesAbstract", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in liabilities arising from financing activities [abstract]", "label": "Changes in liabilities arising from financing activities [abstract]" } } }, "auth_ref": [] }, "gfs_ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShareBasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShareBasedPaymentsMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-based payments", "label": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-Based Payments [Member]", "documentation": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Share-Based Payments" } } }, "auth_ref": [] }, "gfs_ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShortTermBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ChiefExecutiveOfficerChiefFinancialOfficerChiefBusinessOfficerChiefOperatingOfficerShortTermBenefitsMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Short-term benefits", "label": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer Short-Term Benefits [Member]", "documentation": "Chief Executive Officer, Chief Financial Officer, Chief Business Officer, Chief Operating Officer, Short-Term Benefits" } } }, "auth_ref": [] }, "gfs_CitibankRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CitibankRevolvingCreditFacilityMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Citibank Revolving Credit Facility [Member]", "documentation": "Citibank Revolving Credit Facility" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of assets [axis]", "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r94", "r95", "r150", "r168" ] }, "ifrs-full_ClassesOfAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets [member]", "label": "Assets [member]" } }, "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r94", "r150", "r168" ] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of financial instruments [axis]", "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r218", "r220", "r221", "r222" ] }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments, class [member]", "label": "Financial instruments, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r218", "r220", "r221", "r222" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of intangible assets and goodwill [axis]", "label": "Classes of intangible assets and goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r349" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of liabilities [axis]", "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r150" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of property, plant and equipment [axis]", "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of share capital [axis]", "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails", "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital", "label": "Share capital [member]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r32" ] }, "gfs_CommoditySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CommoditySwapMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity swaps", "label": "Commodity Swap [Member]", "documentation": "Commodity Swap" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Components of equity [axis]", "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Items that may be reclassified subsequently to profit or loss:", "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income (loss) for the year", "label": "Comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r2", "r36", "r131", "r133", "r141", "r282" ] }, "ifrs-full_ComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Total comprehensive income (loss)", "label": "Comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Attributable to:", "label": "Comprehensive income attributable to [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Comprehensive income, attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r2", "r39" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders of GLOBALFOUNDRIES INC.", "label": "Comprehensive income, attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r2", "r40" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer", "label": "Computer equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r335" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Computer software [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r267" ] }, "ifrs-full_ConsiderationPaidReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConsiderationPaidReceived", "crdr": "credit", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Consideration received", "label": "Consideration paid (received)" } }, "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r121" ] }, "ifrs-full_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConstructionInProgressMember", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in Progress", "label": "Construction in progress [member]" } }, "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r335" ] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Contact Personnel Email Address", "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Contact Personnel Name", "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContinuingAndDiscontinuedOperationsAxis", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails", "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing and discontinued operations [axis]", "label": "Continuing and discontinued operations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r201" ] }, "ifrs-full_ContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContinuingOperationsMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails", "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations [member]", "label": "Continuing operations [member]" } }, "en": { "role": { "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]" } } }, "auth_ref": [ "r201" ] }, "ifrs-full_ContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContractLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning contract liabilities balance", "periodEndLabel": "Ending contract liabilities balance", "label": "Contract liabilities" } }, "en": { "role": { "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer." } } }, "auth_ref": [ "r152", "r155" ] }, "gfs_ContractLiabilitiesAmountsCreditedToCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractLiabilitiesAmountsCreditedToCustomers", "crdr": "debit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts credited to customers", "label": "Contract Liabilities, Amounts Credited To Customers", "documentation": "Contract Liabilities, Amounts Credited To Customers" } } }, "auth_ref": [] }, "gfs_ContractLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractLiabilitiesOther", "crdr": "debit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Contract Liabilities, Other", "documentation": "Contract Liabilities, Other" } } }, "auth_ref": [] }, "gfs_ContractLiabilitiesReleased": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractLiabilitiesReleased", "crdr": "debit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Released to the consolidated statements of operations", "label": "Contract Liabilities, Released", "documentation": "Contract Liabilities, Released" } } }, "auth_ref": [] }, "ifrs-full_ContractualAmountsToBeExchangedInDerivativeFinancialInstrumentForWhichGrossCashFlowsAreExchanged": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContractualAmountsToBeExchangedInDerivativeFinancialInstrumentForWhichGrossCashFlowsAreExchanged", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Contractual amounts to be exchanged in derivative financial instrument for which gross cash flows are exchanged" } }, "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to contractual amounts to be exchanged in a derivative financial instrument for which gross cash flows are exchanged. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r300" ] }, "gfs_ContractualCapitalAndOperatingCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractualCapitalAndOperatingCommitments", "crdr": "credit", "calculation": { "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Contractual Capital And Operating Commitments", "documentation": "Contractual Capital And Operating Commitments" } } }, "auth_ref": [] }, "gfs_ContractualCapitalAndOperatingCommitmentsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractualCapitalAndOperatingCommitmentsCurrent", "crdr": "credit", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due within the next 12 months", "label": "Contractual Capital And Operating Commitments, Current", "documentation": "Contractual Capital And Operating Commitments, Current" } } }, "auth_ref": [] }, "ifrs-full_ContractualCapitalCommitments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContractualCapitalCommitments", "crdr": "credit", "calculation": { "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails": { "parentTag": "gfs_ContractualCapitalAndOperatingCommitments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contracts for capital expenditures", "label": "Contractual capital commitments" } }, "en": { "role": { "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]" } } }, "auth_ref": [ "r326" ] }, "gfs_ContractualOperatingCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ContractualOperatingCommitments", "crdr": "credit", "calculation": { "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails": { "parentTag": "gfs_ContractualCapitalAndOperatingCommitments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CommitmentsandContingenciesUnconditionalPurchaseCommitmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contracts for operating expenditures", "label": "Contractual Operating Commitments", "documentation": "Contractual Operating Commitments" } } }, "auth_ref": [] }, "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents", "label": "Copyrights, patents and other industrial property rights, service and operating rights [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r268" ] }, "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract", "lang": { "en-us": { "role": { "label": "Corporate information and statement of IFRS compliance [abstract]" } } }, "auth_ref": [] }, "gfs_CostOfResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CostOfResearchAndDevelopmentMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Cost of research and development [Member]", "documentation": "Cost of research and development" } } }, "auth_ref": [] }, "gfs_CostOfRevenueAndOperatingExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CostOfRevenueAndOperatingExpensesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue and operating expenses", "label": "Cost Of Revenue And Operating Expenses [Member]", "documentation": "Cost Of Revenue And Operating Expenses" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://gf.com/role/CostofRevenueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/CostofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "totalLabel": "Total cost of revenues", "label": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r50" ] }, "gfs_CostOfSalesEmployeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CostOfSalesEmployeeExpense", "crdr": "debit", "calculation": { "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails": { "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Staff costs, maintenance costs, and utilities", "label": "Cost Of Sales, Employee Expense", "documentation": "Cost Of Sales, Employee Expense" } } }, "auth_ref": [] }, "ifrs-full_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSalesMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of sales [member]" } }, "en": { "role": { "documentation": "This member stands for the amount of all expenses directly or indirectly attributed to goods or services sold. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r323", "r326" ] }, "gfs_CostOfSalesStaffMaintenanceAndUtilityCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CostOfSalesStaffMaintenanceAndUtilityCosts", "crdr": "debit", "presentation": [ "http://gf.com/role/CostofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Staff, maintenance, and utility costs", "label": "Cost Of Sales, Staff, Maintenance, And Utility Costs", "documentation": "Cost Of Sales, Staff, Maintenance, And Utility Costs" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CreditRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CreditRiskMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit risk", "label": "Credit risk [member]" } }, "en": { "role": { "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r177", "r178", "r179", "r292" ] }, "gfs_CrossCurrencySwapsSingaporeMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CrossCurrencySwapsSingaporeMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cross currency swaps (receive Singapore $/pay US$)", "label": "Cross Currency Swaps, Singapore [Member]", "documentation": "Cross Currency Swaps, Singapore" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency [Axis]", "label": "Currency [Axis]" } } }, "auth_ref": [] }, "gfs_CurrencyEffectTaxDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrencyEffectTaxDifferenceMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency effect", "label": "Currency Effect Tax Difference [Member]", "documentation": "Currency Effect Tax Difference" } } }, "auth_ref": [] }, "ifrs-full_CurrencyRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrencyRiskMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency risk", "label": "Currency risk [member]" } }, "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r177", "r178", "r179", "r180", "r228" ] }, "ifrs-full_CurrencySwapContractMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrencySwapContractMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cross currency interest rate swaps (receive euros/pay US$)", "verboseLabel": "Cross currency swaps and cross currency interest rate swaps", "label": "Currency swap contract [member]" } }, "en": { "role": { "documentation": "This member stands for a currency swap contract. [Refer: Swap contract [member]]" } } }, "auth_ref": [ "r326" ] }, "gfs_CurrentAdvancesAndDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentAdvancesAndDeposits", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advances and deposits", "label": "Current Advances And Deposits", "documentation": "Current Advances And Deposits" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r24", "r137", "r282" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current assets:", "terseLabel": "Current:", "label": "Current assets [abstract]" } } }, "auth_ref": [] }, "gfs_CurrentBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentBorrowingsAbstract", "presentation": [ "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current:", "label": "Current Borrowings [Abstract]", "documentation": "Current Borrowings" } } }, "auth_ref": [] }, "ifrs-full_CurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentContractLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails": { "parentTag": "ifrs-full_ContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails", "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "verboseLabel": "Current", "label": "Current contract liabilities" } }, "en": { "role": { "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r152" ] }, "ifrs-full_CurrentFinancialAssetsAvailableforsale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentFinancialAssetsAvailableforsale", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Current financial assets available-for-sale" } }, "en": { "role": { "documentation": "The amount of current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Current financial assets]" } } }, "auth_ref": [ "r245" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of deferred income from government grants", "label": "Current government grants" } }, "en": { "role": { "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of lease obligations", "verboseLabel": "Current", "label": "Current lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r162" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r25", "r139", "r282" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Current liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CurrentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables neither past due nor impaired", "label": "Current [member]" } }, "en": { "role": { "documentation": "This member stands for a current time band." } } }, "auth_ref": [ "r293", "r306" ] }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPortionOfLongtermBorrowings", "crdr": "credit", "calculation": { "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails": { "parentTag": "ifrs-full_Borrowings", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "verboseLabel": "Current portion of non-current borrowings", "label": "Current portion of non-current borrowings" } }, "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 }, "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Receivables, prepayments and other assets", "totalLabel": "Total", "label": "Current prepayments and other current assets" } }, "en": { "role": { "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_CurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentProvisions", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "label": "Current provisions" } }, "en": { "role": { "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r15" ] }, "gfs_CurrentReceivablesFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentReceivablesFromGovernmentGrants", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables from government grant", "label": "Current Receivables From Government Grants", "documentation": "Current Receivables From Government Grants" } } }, "auth_ref": [] }, "ifrs-full_CurrentTaxAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssetsCurrent", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax receivable", "label": "Current tax assets, current" } }, "en": { "role": { "documentation": "The current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current income tax benefit (expense)", "label": "Current tax expense (income)" } }, "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax expense:", "label": "Current tax expense (income) and adjustments for current tax of prior periods [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax payable", "label": "Current tax liabilities" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r16" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade receivables, other than related parties", "label": "Current trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r249", "r251" ] }, "gfs_CurrentUnbilledReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentUnbilledReceivables", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsScheduleofUnbilledAccountsReceivableDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled accounts receivable", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Current Unbilled Receivables", "documentation": "Current Unbilled Receivables" } } }, "auth_ref": [] }, "gfs_CurrentUnbilledReceivablesAmountsInvoiced": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentUnbilledReceivablesAmountsInvoiced", "crdr": "credit", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsScheduleofUnbilledAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts invoiced", "label": "Current Unbilled Receivables, Amounts Invoiced", "documentation": "Current Unbilled Receivables, Amounts Invoiced" } } }, "auth_ref": [] }, "gfs_CurrentUnbilledReceivablesRevenueRecognizedDuringTheYear": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "CurrentUnbilledReceivablesRevenueRecognizedDuringTheYear", "crdr": "debit", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsScheduleofUnbilledAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized during the year", "label": "Current Unbilled Receivables, Revenue Recognized During The Year", "documentation": "Current Unbilled Receivables, Revenue Recognized During The Year" } } }, "auth_ref": [] }, "gfs_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CustomerAMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer A", "label": "Customer A [Member]", "documentation": "Customer A" } } }, "auth_ref": [] }, "gfs_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CustomerBMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer B", "label": "Customer B [Member]", "documentation": "Customer B" } } }, "auth_ref": [] }, "gfs_CustomerRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "CustomerRiskMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Risk", "label": "Customer Risk [Member]", "documentation": "Customer Risk" } } }, "auth_ref": [] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "DE", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Germany", "label": "GERMANY" } } }, "auth_ref": [] }, "ifrs-full_DebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtSecuritiesMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in marketable securities", "label": "Debt securities [member]" } }, "en": { "role": { "documentation": "This member stands for instruments held by the entity that represent indebtedness." } } }, "auth_ref": [ "r283", "r285" ] }, "gfs_DeferredFinancingCostsNettingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "DeferredFinancingCostsNettingMember", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Financing costs Netting", "label": "Deferred Financing costs Netting [Member]", "documentation": "Deferred Financing costs Netting" } } }, "auth_ref": [] }, "gfs_DeferredIncomeFromGovernmentGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "DeferredIncomeFromGovernmentGrantsMember", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Income From Government Grants", "label": "Deferred Income From Government Grants [Member]", "documentation": "Deferred Income From Government Grants" } } }, "auth_ref": [] }, "gfs_DeferredIncomeTaxDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "DeferredIncomeTaxDifferenceMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income", "label": "Deferred Income Tax Difference [Member]", "documentation": "Deferred Income Tax Difference" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "ifrs-full_DeferredTaxLiabilityAsset", "weight": -1.0, "order": 2.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r17", "r21", "r57" ] }, "gfs_DeferredTaxCurrencyEffectOnNonMonetaryAssetsOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "DeferredTaxCurrencyEffectOnNonMonetaryAssetsOfSubsidiary", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Currency effect on non-monetary assets of subsidiary", "label": "Deferred Tax, Currency Effect On Non-Monetary Assets Of subsidiary", "documentation": "Deferred Tax, Currency Effect On Non-Monetary Assets Of subsidiary" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncomeAbstract", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax", "label": "Deferred tax expense (income) [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax (expense) benefit recognized to consolidated statements of operations", "label": "Deferred tax expense (income) recognised in profit or loss" } }, "en": { "role": { "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]" } } }, "auth_ref": [ "r58" ] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "ifrs-full_DeferredTaxLiabilityAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred tax liabilities", "label": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r17", "r21", "r57" ] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "calculation": { "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/IncomeTaxesClassificationofdeferredTaxAssetsandLiabilitiesDetails", "http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails", "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net deferred tax assets", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Deferred tax liability (asset)" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r57" ] }, "ifrs-full_DepositsFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepositsFromCustomers", "crdr": "credit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deposits from customers", "label": "Deposits from customers" } }, "en": { "role": { "documentation": "The amount of deposit liabilities from customers held by the entity." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CostofRevenueDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CostofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation of property, plant and equipment and amortization of intangible assets", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r1", "r50", "r145", "r231", "r238", "r246" ] }, "ifrs-full_DepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationExpense", "crdr": "debit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation expense" } }, "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } } }, "auth_ref": [ "r326" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "presentation": [ "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails", "http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of right-of-use assets", "negatedLabel": "Amortization", "label": "Depreciation, right-of-use assets" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r163" ] }, "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Derivative And Non-Derivative Financial Liabilities, Undiscounted Cash Flows", "documentation": "Derivative And Non-Derivative Financial Liabilities, Undiscounted Cash Flows" } } }, "auth_ref": [] }, "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedContractualCashFlows": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedContractualCashFlows", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "auth_ref": [] }, "ifrs-full_DerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial assets", "label": "Derivative financial assets" } }, "en": { "role": { "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_DerivativeFinancialAssetsHeldForTrading": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialAssetsHeldForTrading", "crdr": "debit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial assets held for trading", "label": "Derivative financial assets held for trading" } }, "en": { "role": { "documentation": "The amount of derivative financial assets held for trading. [Refer: Derivative financial assets; Financial assets at fair value through profit or loss, classified as held for trading]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_DerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liabilities", "label": "Derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_DerivativeFinancialLiabilitiesHeldForTrading": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialLiabilitiesHeldForTrading", "crdr": "credit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial liabilities held for trading", "label": "Derivative financial liabilities held for trading" } }, "en": { "role": { "documentation": "The amount of derivative financial liabilities held for trading. [Refer: Derivative financial liabilities; Financial liabilities at fair value through profit or loss that meet definition of held for trading]" } } }, "auth_ref": [ "r329" ] }, "gfs_DerivativesDesignatedAsHedgingInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DerivativesDesignatedAsHedgingInstrumentsAbstract", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives Designated As Hedging Instruments [Abstract]", "label": "Derivatives Designated As Hedging Instruments [Abstract]", "documentation": "Derivatives Designated As Hedging Instruments" } } }, "auth_ref": [] }, "ifrs-full_DerivativesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativesMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivatives [member]" } }, "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r283", "r285", "r294", "r308" ] }, "gfs_DerivativesNotDesignatedAsHedgingInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DerivativesNotDesignatedAsHedgingInstrumentsAbstract", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives Not Designated As Hedging Instruments [Abstract]", "label": "Derivatives Not Designated As Hedging Instruments [Abstract]", "documentation": "Derivatives Not Designated As Hedging Instruments" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForBorrowingCostsExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowing Costs", "label": "Description of accounting policy for borrowing costs [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for interest and other costs that the entity incurs in connection with the borrowing of funds." } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Tax Assets", "label": "Description of accounting policy for deferred income tax [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for deferred income tax. [Refer: Deferred tax expense (income)]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Description of accounting policy for earnings per share [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Measurement", "label": "Description of accounting policy for fair value measurement [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments", "label": "Description of accounting policy for financial instruments [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Description of accounting policy for foreign currency translation [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Government Grants", "label": "Description of accounting policy for government grants [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Current Income Tax", "label": "Description of accounting policy for income tax [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Description of accounting policy for intangible assets other than goodwill [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForInvestmentsInJointVentures", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in Joint Operations", "label": "Description of accounting policy for investments in joint ventures [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for investments in joint ventures. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Description of accounting policy for leases [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForMeasuringInventories", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Description of accounting policy for measuring inventories [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant, and Equipment", "label": "Description of accounting policy for property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "label": "Description of accounting policy for provisions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]" } } }, "auth_ref": [ "r327" ] }, "gfs_DescriptionOfAccountingPolicyForRecentAccountingPronouncementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DescriptionOfAccountingPolicyForRecentAccountingPronouncementsPolicyTextBlock", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements and Developments", "label": "Description Of Accounting Policy For Recent Accounting Pronouncements [Policy Text Block]", "documentation": "Description Of Accounting Policy For Recent Accounting Pronouncements" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Description of accounting policy for recognition of revenue [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Costs", "label": "Description of accounting policy for research and development expense [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSubsidiariesExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Consolidation", "label": "Description of accounting policy for subsidiaries [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Accounts Receivable", "label": "Description of accounting policy for trade and other receivables [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r126" ] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility, share options granted", "label": "Expected volatility, share options granted" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r193" ] }, "ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities", "presentation": [ "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of nature of entity's operations and principal activities", "label": "Description of nature of entity's operations and principal activities" } }, "en": { "role": { "documentation": "The description of the nature of the entity's operations and principal activities." } } }, "auth_ref": [ "r8" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk free interest rate, share options granted", "label": "Risk free interest rate, share options granted" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r193" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted loss per share (in USD per share)", "terseLabel": "Total basic and diluted earnings per share attributable to equity shareholders (in USD per share)", "label": "Diluted earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r89", "r90" ] }, "gfs_DisclosureCurrentInventoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureCurrentInventoryTextBlock", "presentation": [ "http://gf.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of inventories", "label": "Disclosure Current Inventory [Text Block]", "documentation": "Disclosure Current Inventory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of compensation to key management personnel", "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]" } }, "en": { "role": { "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]" } } }, "auth_ref": [ "r82" ] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsExplanatory", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of sale of facility and business", "label": "Disclosure of analysis of single amount of discontinued operations [text block]" } }, "en": { "role": { "documentation": "The disclosure of the analysis of the single amount of discontinued operations. [Refer: Discontinued operations [member]]" } } }, "auth_ref": [ "r200" ] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of analysis of single amount of discontinued operations [line items]", "label": "Disclosure of analysis of single amount of discontinued operations [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of analysis of single amount of discontinued operations [table]", "label": "Disclosure of analysis of single amount of discontinued operations [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations." } } }, "auth_ref": [ "r200" ] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionExplanatory", "presentation": [ "http://gf.com/role/CostofRevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of cost of revenues", "label": "Disclosure of attribution of expenses by nature to their function [text block]" } }, "en": { "role": { "documentation": "The disclosure of attribution of expenses by nature to line items by function in the statement of profit or loss." } } }, "auth_ref": [ "r323", "r326" ] }, "gfs_DisclosureOfBalancesWithRelatedPartiesInTheConsolidatedStatementsOfFinancialPositionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfBalancesWithRelatedPartiesInTheConsolidatedStatementsOfFinancialPositionTableTextBlock", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of balances with related parties included in the consolidated statements of financial position", "label": "Disclosure Of Balances With Related Parties In The Consolidated Statements Of Financial Position [Table Text Block]", "documentation": "Disclosure Of Balances With Related Parties In The Consolidated Statements Of Financial Position" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfConsolidationExplanatory", "presentation": [ "http://gf.com/role/Organization" ], "lang": { "en-us": { "role": { "terseLabel": "Organization", "label": "Disclosure of basis of consolidation [text block]" } }, "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://gf.com/role/BasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Disclosure of basis of preparation of financial statements [text block]" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://gf.com/role/LongTermDebt" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt", "label": "Disclosure of borrowings [text block]" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://gf.com/role/CashAndCashEquivalents" ], "lang": { "en-us": { "role": { "terseLabel": "Cash And Cash Equivalents", "label": "Disclosure of cash and cash equivalents [text block]" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of cash and cash equivalents", "label": "Disclosure Of Cash And Cash Equivalents [Table Text Block]", "documentation": "Disclosure Of Cash And Cash Equivalents" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfChangesInAccountingEstimatesLineItems", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of changes in accounting estimates [line items]", "label": "Disclosure of changes in accounting estimates [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfChangesInAccountingEstimatesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfChangesInAccountingEstimatesTable", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of changes in accounting estimates [table]", "label": "Disclosure of changes in accounting estimates [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the changes in accounting estimates." } } }, "auth_ref": [ "r128" ] }, "ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptions" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in estimates", "label": "Disclosure of changes in accounting policies, accounting estimates and errors [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for changes in accounting policies, accounting estimates and errors." } } }, "auth_ref": [ "r129" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of classes of share capital [line items]", "label": "Disclosure of classes of share capital [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of classes of share capital [table]", "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://gf.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Disclosure of commitments and contingent liabilities [text block]" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsExplanatory", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of commitments", "label": "Disclosure of commitments [text block]" } }, "en": { "role": { "documentation": "The disclosure of commitments." } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfConcentrationRiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfConcentrationRiskTextBlock", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentration" ], "lang": { "en-us": { "role": { "terseLabel": "Customer And Supplier Concentration", "label": "Disclosure Of Concentration Risk [Text Block]", "documentation": "Disclosure Of Concentration Risk" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfContingentLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfContingentLiabilitiesLineItems", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of contingent liabilities [line items]", "label": "Disclosure of contingent liabilities [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfContingentLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfContingentLiabilitiesTable", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of contingent liabilities [table]", "label": "Disclosure of contingent liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to contingent liabilities." } } }, "auth_ref": [ "r100" ] }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCostOfSalesExplanatory", "presentation": [ "http://gf.com/role/CostofRevenue" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Revenue", "label": "Disclosure of cost of sales [text block]" } }, "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfCurrentAndNoncurrentTradeAndOtherPayablesTableTextBlock", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of current and noncurrent trade and other payables", "label": "Disclosure Of Current And Noncurrent Trade And Other Payables [Table Text Block]", "documentation": "Disclosure Of Current And Noncurrent Trade And Other Payables" } } }, "auth_ref": [] }, "gfs_DisclosureOfDeferredTaxAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfDeferredTaxAssetsTableTextBlock", "presentation": [ "http://gf.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of deferred tax assets, net", "label": "Disclosure Of Deferred Tax Assets [Table Text Block]", "documentation": "Disclosure Of Deferred Tax Assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDepreciationAndAmortisationExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of depreciation expense", "label": "Disclosure of depreciation and amortisation expense [text block]" } }, "en": { "role": { "documentation": "The disclosure of depreciation and amortisation expense. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfDerivativeFinancialLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfDerivativeFinancialLiabilitiesTableTextBlock", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of derivative financial liabilities", "label": "Disclosure of Derivative Financial Liabilities [Table Text Block]", "documentation": "Disclosure of Derivative Financial Liabilities" } } }, "auth_ref": [] }, "gfs_DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfDetailedInformationAboutAccountsReceivableTableTextBlock", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accounts receivable", "label": "Disclosure Of Detailed Information About Accounts Receivable [Table Text Block]", "documentation": "Disclosure Of Detailed Information About Accounts Receivable" } } }, "auth_ref": [] }, "gfs_DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfDetailedInformationAboutActivityInUnbilledAccountsReceivablesTableTextBlock", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of unbilled accounts receivables", "label": "Disclosure Of Detailed Information About Activity In Unbilled Accounts Receivables [Table Text Block]", "documentation": "Disclosure Of Detailed Information About Activity In Unbilled Accounts Receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://gf.com/role/LongTermDebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about borrowings", "label": "Disclosure of detailed information about borrowings [text block]" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about borrowings [line items]", "label": "Disclosure of detailed information about borrowings [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails", "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about borrowings [table]", "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r362" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutHedgingInstrumentsLineItems", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about hedging instruments [line items]", "label": "Disclosure of detailed information about hedging instruments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutHedgingInstrumentsTable", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of financial assets and liabilities [Table]", "label": "Disclosure of detailed information about hedging instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of hedging instruments." } } }, "auth_ref": [ "r207" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of amortization expense", "label": "Disclosure of detailed information about intangible assets [text block]" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r106" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentTables", "http://gf.com/role/SummaryofMaterialAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of property, plant and equipment", "label": "Disclosure of detailed information about property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r67" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://gf.com/role/NetRevenueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of disaggregation of revenue", "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]" } }, "en": { "role": { "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]" } } }, "auth_ref": [ "r154" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of disaggregation of revenue from contracts with customers [line items]", "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of disaggregation of revenue from contracts with customers [table]", "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r154" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://gf.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Disclosure of earnings per share [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r93" ] }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEmployeeBenefitsExplanatory", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Benefits Plans", "label": "Disclosure of employee benefits [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for employee benefits." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://gf.com/role/OperatingSegmentsInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments Information", "label": "Disclosure of entity's operating segments [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of fair value measurement of assets", "label": "Disclosure of fair value measurement of assets [text block]" } }, "en": { "role": { "documentation": "The disclosure of the fair value measurement of assets." } } }, "auth_ref": [ "r150" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of fair value measurement of assets [line items]", "label": "Disclosure of fair value measurement of assets [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of fair value measurement of assets [table]", "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r150" ] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of fair value of financial instruments", "label": "Disclosure of fair value of financial instruments [text block]" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfFinanceCostExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceCostExplanatory", "presentation": [ "http://gf.com/role/FinanceIncomeandExpenses" ], "lang": { "en-us": { "role": { "terseLabel": "Finance Income and Expenses", "label": "Disclosure of finance cost [text block]" } }, "en": { "role": { "documentation": "The disclosure of finance cost. [Refer: Finance costs]" } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfFinancialAssetsAndLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfFinancialAssetsAndLiabilitiesLineItems", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of financial assets and liabilities [Line Items]", "label": "Disclosure of financial assets and liabilities [Line Items]", "documentation": "Disclosure of financial assets and liabilities [Line Items]" } } }, "auth_ref": [] }, "gfs_DisclosureOfFinancialAssetsAndLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfFinancialAssetsAndLiabilitiesTable", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of financial assets and liabilities [Table]", "label": "Disclosure of financial assets and liabilities [Table]", "documentation": "Disclosure of financial assets and liabilities [Table]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Disclosure of financial assets and liabilities", "label": "Disclosure of financial assets [text block]" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r226" ] }, "gfs_DisclosureOfFinancialAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfFinancialAssetsTableTextBlock", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of financial assets", "label": "Disclosure Of Financial Assets [Table Text Block]", "documentation": "Disclosure Of Financial Assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Other Financial Assets And Liabilities", "label": "Disclosure of financial instruments [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of financial assets and liabilities", "label": "Disclosure of financial liabilities [text block]" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r226" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Risk Management Objectives and Policies", "label": "Disclosure of financial risk management [text block]" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpenses" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, General and Administrative Expenses", "label": "Disclosure of general and administrative expense [text block]" } }, "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasExplanatory", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical areas", "label": "Disclosure of geographical areas [text block]" } }, "en": { "role": { "documentation": "The disclosure of geographical information." } } }, "auth_ref": [ "r241" ] }, "ifrs-full_DisclosureOfGeographicalAreasLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasLineItems", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical areas [line items]", "label": "Disclosure of geographical areas [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGeographicalAreasTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasTable", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical areas [table]", "label": "Disclosure of geographical areas [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to geographical areas." } } }, "auth_ref": [ "r241" ] }, "gfs_DisclosureOfGeographicalConcentrationOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfGeographicalConcentrationOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical concentration of cash and cash equivalents", "label": "Disclosure Of Geographical Concentration Of Cash And Cash Equivalents [Table Text Block]", "documentation": "Disclosure Of Geographical Concentration Of Cash And Cash Equivalents" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGovernmentGrantsExplanatory", "presentation": [ "http://gf.com/role/GovernmentGrants" ], "lang": { "en-us": { "role": { "terseLabel": "Government Grants", "label": "Disclosure of government grants [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for government grants." } } }, "auth_ref": [ "r77" ] }, "gfs_DisclosureOfGovernmentGrantsRecognizedInConsolidatedStatementOfOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfGovernmentGrantsRecognizedInConsolidatedStatementOfOperationsTableTextBlock", "presentation": [ "http://gf.com/role/GovernmentGrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of government grants recognized in consolidated statement of operations", "label": "Disclosure Of Government Grants Recognized In Consolidated Statement Of Operations [Table Text Block]", "documentation": "Disclosure Of Government Grants Recognized In Consolidated Statement Of Operations" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://gf.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Disclosure of income tax [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r60" ] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "presentation": [ "http://gf.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of fair value assumptions", "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options." } } }, "auth_ref": [ "r194" ] }, "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Disclosure of intangible assets and goodwill [text block]" } }, "en": { "role": { "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsLineItems", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about intangible assets [line items]", "label": "Disclosure of detailed information about intangible assets [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about intangible assets [table]", "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r106" ] }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInventoriesExplanatory", "presentation": [ "http://gf.com/role/Inventories" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Disclosure of inventories [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for inventories." } } }, "auth_ref": [ "r75" ] }, "gfs_DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfLeaseLiabilitiesExplanatoryTableTextBlock", "presentation": [ "http://gf.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of lease liabilities", "label": "Disclosure Of Lease Liabilities Explanatory [Table Text Block]", "documentation": "Disclosure Of Lease Liabilities Explanatory" } } }, "auth_ref": [] }, "gfs_DisclosureOfLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfLeaseLiabilitiesTableTextBlock", "presentation": [ "http://gf.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of lease liabilities", "label": "Disclosure Of Lease Liabilities [Table Text Block]", "documentation": "Disclosure Of Lease Liabilities" } } }, "auth_ref": [] }, "gfs_DisclosureOfLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfLeasesAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of Leases [Abstract]", "documentation": "Disclosure of Leases" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://gf.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Disclosure of leases [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r172", "r173" ] }, "gfs_DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfMajorComponentsOfTaxExpenseIncomeTableTextBlock", "presentation": [ "http://gf.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of components of income tax benefit (expense)", "label": "Disclosure Of Major Components Of Tax Expense (Income) [Table Text Block]", "documentation": "Disclosure Of Major Components Of Tax Expense (Income)" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMajorCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMajorCustomersLineItems", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of major customers [line items]", "label": "Disclosure of major customers [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMajorCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMajorCustomersTable", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of major customers [table]", "label": "Disclosure of major customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the entity's major customers." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Material Accounting Policies", "label": "Disclosure of material accounting policy information [text block]" } }, "en": { "role": { "documentation": "The entire disclosure of material accounting policy information applied by the entity." } } }, "auth_ref": [ "r7" ] }, "gfs_DisclosureOfMaturityAnalysisForDerivativeAndNonDerivativeFinancialLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfMaturityAnalysisForDerivativeAndNonDerivativeFinancialLiabilitiesLineItems", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]", "label": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Line Items]", "documentation": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities" } } }, "auth_ref": [] }, "gfs_DisclosureOfMaturityAnalysisForDerivativeAndNonDerivativeFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfMaturityAnalysisForDerivativeAndNonDerivativeFinancialLiabilitiesTable", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Table]", "label": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities [Table]", "documentation": "Disclosure Of Maturity Analysis For Derivative And Non-Derivative Financial Liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems", "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of maturity analysis of operating lease payments [line items]", "label": "Disclosure of maturity analysis of operating lease payments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable", "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of maturity analysis of operating lease payments [table]", "label": "Disclosure of maturity analysis of operating lease payments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments." } } }, "auth_ref": [ "r171" ] }, "gfs_DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfMovementInDeferredIncomeFromGovernmentGrantsTableTextBlock", "presentation": [ "http://gf.com/role/GovernmentGrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of movement in deferred income from government grants", "label": "Disclosure Of Movement In Deferred Income From government Grants [Table Text Block]", "documentation": "Disclosure Of Movement In Deferred Income From government Grants" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of nature and extent of risks arising from financial instruments [line items]", "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of nature and extent of risks arising from financial instruments [table]", "label": "Disclosure of nature and extent of risks arising from financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments." } } }, "auth_ref": [ "r216", "r217" ] }, "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory", "presentation": [ "http://gf.com/role/GainonSaleofaBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on Sale of a Business", "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations." } } }, "auth_ref": [ "r201" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://gf.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of number and weighted average exercise prices of RSUs and PSUs", "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r361" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://gf.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of number and weighted average exercise prices of share options", "label": "Disclosure of number and weighted average exercise prices of share options [text block]" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r190" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://gf.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of number and weighted average remaining contractual life of outstanding share options", "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r191" ] }, "gfs_DisclosureOfOtherIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfOtherIncomeExpenseTableTextBlock", "presentation": [ "http://gf.com/role/OtherIncomeExpenseNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of other (income) expense, net", "label": "Disclosure Of Other (Income) Expense [Table Text Block]", "documentation": "Disclosure Of Other (Income) Expense" } } }, "auth_ref": [] }, "gfs_DisclosureOfOtherIncomeExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfOtherIncomeExpenseTextBlock", "presentation": [ "http://gf.com/role/OtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "terseLabel": "Other Income (Expense), Net", "label": "Disclosure Of Other (Income) Expense [Text Block]", "documentation": "Disclosure Of Other (Income) Expense" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsExplanatory", "presentation": [ "http://gf.com/role/ProvisionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of movement in provision for asset retirement obligation", "label": "Disclosure of other provisions [text block]" } }, "en": { "role": { "documentation": "The disclosure of other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DisclosureOfOtherProvisionsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsLineItems", "presentation": [ "http://gf.com/role/ProvisionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of other provisions [line items]", "label": "Disclosure of other provisions [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsTable", "presentation": [ "http://gf.com/role/ProvisionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of other provisions [table]", "label": "Disclosure of other provisions [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about property, plant and equipment [abstract]", "label": "Disclosure of detailed information about property, plant and equipment [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://gf.com/role/PropertyPlantandEquipment" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment", "label": "Disclosure of property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r69" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about property, plant and equipment [line items]", "label": "Disclosure of detailed information about property, plant and equipment [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about property, plant and equipment [table]", "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_DisclosureOfProvisionMatrixLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionMatrixLineItems", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of provision matrix [line items]", "label": "Disclosure of provision matrix [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfProvisionMatrixTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionMatrixTable", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of provision matrix [table]", "label": "Disclosure of provision matrix [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the provision matrix." } } }, "auth_ref": [ "r293" ] }, "ifrs-full_DisclosureOfProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionsExplanatory", "presentation": [ "http://gf.com/role/Provisions" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "label": "Disclosure of provisions [text block]" } }, "en": { "role": { "documentation": "The disclosure of provisions. [Refer: Provisions]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "presentation": [ "http://gf.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of leases", "label": "Disclosure of quantitative information about right-of-use assets [text block]" } }, "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r168" ] }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of range of exercise prices of outstanding share options [line items]", "label": "Disclosure of range of exercise prices of outstanding share options [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of range of exercise prices of outstanding share options [table]", "label": "Disclosure of range of exercise prices of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the range of exercise prices of outstanding share options." } } }, "auth_ref": [ "r191" ] }, "ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReclassificationsOrChangesInPresentationLineItems", "presentation": [ "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reclassifications or changes in presentation [line items]", "label": "Disclosure of reclassifications or changes in presentation [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReclassificationsOrChangesInPresentationTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReclassificationsOrChangesInPresentationTable", "presentation": [ "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reclassifications or changes in presentation [table]", "label": "Disclosure of reclassifications or changes in presentation [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to reclassifications or changes in presentation." } } }, "auth_ref": [ "r9" ] }, "gfs_DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAndAverageEffectiveTaxRateTableTextBlock", "presentation": [ "http://gf.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation between tax benefit and accounting profit multiplied by the Company's tax rate", "label": "Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate [Table Text Block]", "documentation": "Disclosure Of Reconciliation Of Accounting Profit Multiplied By Applicable Tax Rates And Average Effective Tax Rate" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of goodwill and intangible assets rollforward", "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [text block]" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reconciliation of changes in intangible assets and goodwill [line items]", "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]", "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill." } } }, "auth_ref": [ "r349" ] }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reconciliation of assets and liabilities arising from financing activities", "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesLineItems", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities [line items]", "label": "Disclosure of reconciliation of liabilities arising from financing activities [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of reconciliation of liabilities arising from financing activities [table]", "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities." } } }, "auth_ref": [ "r277" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://gf.com/role/RelatedPartyDisclosures" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Disclosures", "label": "Disclosure of related party [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r87" ] }, "gfs_DisclosureOfRelatedPartyWhichTheCompanyHasEnteredIntoRelatedPartyTransactionWithTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfRelatedPartyWhichTheCompanyHasEnteredIntoRelatedPartyTransactionWithTableTextBlock", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Company's which have entered into related party transaction with", "label": "Disclosure Of Related Party Which The Company Has Entered Into Related Party Transaction With [Table Text Block]", "documentation": "Disclosure Of Related Party Which The Company Has Entered Into Related Party Transaction With" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpenses" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Expenses", "label": "Disclosure of research and development expense [text block]" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r322" ] }, "gfs_DisclosureOfRestructuringTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfRestructuringTextBlock", "presentation": [ "http://gf.com/role/Restructuring" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring", "label": "Disclosure of restructuring [Text Block]", "documentation": "Disclosure of restructuring" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://gf.com/role/NetRevenue" ], "lang": { "en-us": { "role": { "terseLabel": "Net Revenue", "label": "Disclosure of revenue from contracts with customers [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for revenue from contracts with customers." } } }, "auth_ref": [ "r159", "r160" ] }, "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSegmentsMajorCustomersExplanatory", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of major customers", "label": "Disclosure of major customers [text block]" } }, "en": { "role": { "documentation": "The disclosure of major customers." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://gf.com/role/IssuedCapitalandReserves" ], "lang": { "en-us": { "role": { "terseLabel": "Issued Capital and Reserves", "label": "Disclosure of share capital, reserves and other equity interest [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://gf.com/role/ShareBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Disclosure of share-based payment arrangements [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r183" ] }, "gfs_DisclosureOfSummaryOfFinanceCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfSummaryOfFinanceCostsTableTextBlock", "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of finance expenses", "label": "Disclosure Of Summary Of Finance Costs [Table Text Block]", "documentation": "Disclosure Of Summary Of Finance Costs" } } }, "auth_ref": [] }, "gfs_DisclosureOfSummaryOfFinanceIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfSummaryOfFinanceIncomeTableTextBlock", "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of finance income", "label": "Disclosure Of Summary Of Finance Income [Table Text Block]", "documentation": "Disclosure Of Summary Of Finance Income" } } }, "auth_ref": [] }, "gfs_DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfSummaryOfResearchAndDevelopmentExpensesTableTextBlock", "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpensesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of research and development expenses", "label": "Disclosure Of Summary Of Research And Development Expenses [Table Text Block]", "documentation": "Disclosure Of Summary Of Research And Development Expenses" } } }, "auth_ref": [] }, "gfs_DisclosureOfSummaryOfRestructuringTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfSummaryOfRestructuringTableTextBlock", "presentation": [ "http://gf.com/role/RestructuringTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of summary of restructuring", "label": "Disclosure of summary of restructuring [Table Text Block]", "documentation": "Disclosure of summary of restructuring" } } }, "auth_ref": [] }, "gfs_DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gf.com/20231231", "localname": "DisclosureOfSummaryOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpensesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of selling, general and administrative expenses", "label": "Disclosure Of Summary Of Selling, General And Administrative Expenses [Table Text Block]", "documentation": "Disclosure Of Summary Of Selling, General And Administrative Expenses" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "presentation": [ "http://gf.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "schedule of deferred tax assets and liabilities", "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]" } }, "en": { "role": { "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]" } } }, "auth_ref": [ "r59" ] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]", "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]", "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]", "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]", "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r192" ] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Payables and Other Liabilities", "label": "Disclosure of trade and other payables [text block]" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables, Prepayments and Other Assets", "label": "Disclosure of trade and other receivables [text block]" } }, "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r322" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of related party transactions", "label": "Disclosure of transactions between related parties [text block]" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r81" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails", "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of transactions between related parties [line items]", "label": "Disclosure of transactions between related parties [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails", "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of transactions between related parties [table]", "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_DiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DiscontinuedOperationsMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations [member]", "label": "Discontinued operations [member]" } }, "en": { "role": { "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r201" ] }, "gfs_DiscontinuedOperationsTampinesSingaporeFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "DiscontinuedOperationsTampinesSingaporeFacilityMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails", "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations - Tampines, Singapore Facility", "label": "Discontinued Operations - Tampines, Singapore Facility [Member]", "documentation": "Discontinued Operations - Tampines, Singapore Facility" } } }, "auth_ref": [] }, "gfs_DiscountRatesUsedInProvisionEstimates": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "DiscountRatesUsedInProvisionEstimates", "presentation": [ "http://gf.com/role/ProvisionsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate (as a percent)", "label": "Discount Rates Used In Provision Estimates", "documentation": "Discount Rates Used In Provision Estimates" } } }, "auth_ref": [] }, "ifrs-full_DisposalsIntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsIntangibleAssetsAndGoodwill", "crdr": "credit", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Disposals", "label": "Disposals, intangible assets and goodwill" } }, "en": { "role": { "documentation": "The decrease in intangible assets and goodwill resulting from disposals. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r348" ] }, "gfs_DisposalsOfRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "DisposalsOfRightOfUseAssets", "crdr": "credit", "presentation": [ "http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Disposals", "label": "Disposals Of Right-Of-Use Assets", "documentation": "Disposals Of Right-Of-Use Assets" } } }, "auth_ref": [] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Disposals", "label": "Disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r64" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Accounting Standard", "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r316" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction [Flag]", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r315", "r316", "r317", "r319" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Registration Statement", "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r311" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Shell Company Report", "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r316" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r318" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "gfs_EURTermLoanAMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EURTermLoanAMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EUR Term Loan A", "label": "EUR Term Loan A [Member]", "documentation": "EUR Term Loan A" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net income (loss) per share attributable to the equity holders of the Company:", "label": "Earnings per share [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://gf.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of basic and diluted earnings per share", "label": "Earnings per share [text block]" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r89" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of exchange rate changes on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r118", "r119" ] }, "gfs_EmployeeBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "EmployeeBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Employee Benefits [Abstract]", "documentation": "Employee Benefits [Abstract]" } } }, "auth_ref": [] }, "gfs_EmployeeSharePurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EmployeeSharePurchasePlanMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Share Purchase Plan", "label": "Employee Share Purchase Plan [Member]", "documentation": "Employee Share Purchase Plan" } } }, "auth_ref": [] }, "gfs_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]", "documentation": "Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "gfs_EngineeringAndOtherPreFabricationServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EngineeringAndOtherPreFabricationServicesMember", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Engineering and other services", "label": "Engineering And Other Pre-Fabrication Services [Member]", "documentation": "Engineering And Other Pre-Fabrication Services" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Addresses, Address Type [Axis]", "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r313" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r313" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r313" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r320" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r313" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r313" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r321" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "http://gf.com/role/RelatedPartyDisclosuresCompensationtoKeyManagementPersonnelDetails", "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity's total for related parties [member]", "label": "Entity's total for related parties [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r85" ] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment", "label": "Equipment [Member]" } } }, "auth_ref": [] }, "gfs_EquipmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EquipmentsMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment", "label": "Equipments [Member]", "documentation": "Equipments" } } }, "auth_ref": [] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "terseLabel": "Beginning balance", "periodEndLabel": "Ending balance", "verboseLabel": "Additional-paid in capital", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r20", "r28", "r130", "r132", "r147", "r148", "r149" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Equity:", "label": "Equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r20" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Equity and liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Equity attributable to the shareholders of GLOBALFOUNDRIES INC.", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r19" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r6" ] }, "gfs_EquityCompensationPlan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EquityCompensationPlan2021Member", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Compensation Plan 2021", "label": "Equity Compensation Plan 2021 [Member]", "documentation": "Equity Compensation Plan 2021" } } }, "auth_ref": [] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity [member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r6" ] }, "gfs_EuroForwardContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EuroForwardContractsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro forward contracts (receive euros/pay US$)", "label": "Euro Forward Contracts [Member]", "documentation": "Euro Forward Contracts" } } }, "auth_ref": [] }, "us-gaap_EurodollarMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EurodollarMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eurodollar [Member]", "label": "Eurodollar [Member]" } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]" } } }, "auth_ref": [] }, "gfs_EuropeTheMiddleEastAndAfricaMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "EuropeTheMiddleEastAndAfricaMember", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe, the Middle East, and Africa", "label": "Europe, The Middle East, And Africa [Member]", "documentation": "Europe, The Middle East, And Africa" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price of outstanding share options (in dollars per share)", "label": "Exercise price of outstanding share options" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r191" ] }, "gfs_ExercisePriceRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ExercisePriceRangeOneMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "$10.02", "label": "Exercise Price Range One [Member]", "documentation": "Exercise Price Range One" } } }, "auth_ref": [] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Expected dividend as percentage, share options granted" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r193" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment expenses", "label": "Expense from share-based payment transactions" } }, "en": { "role": { "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets." } } }, "auth_ref": [ "r197" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense from share-based payment transactions with employees", "label": "Expense from share-based payment transactions with employees" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r326" ] }, "ifrs-full_ExpenseOfRestructuringActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseOfRestructuringActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring expense", "label": "Expense of restructuring activities" } }, "en": { "role": { "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations." } } }, "auth_ref": [ "r49" ] }, "gfs_ExpenseOfRestructuringActivitiesAcceleratedShareBasdCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ExpenseOfRestructuringActivitiesAcceleratedShareBasdCompensationExpense", "crdr": "debit", "presentation": [ "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated share-based compensation expense", "label": "Expense of restructuring activities, accelerated share-basd compensation expense", "documentation": "Expense of restructuring activities, accelerated share-basd compensation expense" } } }, "auth_ref": [] }, "gfs_ExpenseOfRestructuringActivitiesAfterAcceleratedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ExpenseOfRestructuringActivitiesAfterAcceleratedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision", "label": "Expense of restructuring activities, after accelerated share-based compensation expense", "documentation": "Expense of restructuring activities, after accelerated share-based compensation expense" } } }, "auth_ref": [] }, "ifrs-full_ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction", "crdr": "debit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments to related parties", "label": "Expense recognised during period for bad and doubtful debts for related party transaction" } }, "en": { "role": { "documentation": "The amount of expense recognised during the period in respect of bad or doubtful debts due from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r80" ] }, "gfs_ExpenseRelatingToShortTermAndLowValueLeasesForWhichRecognitionExemptionHasBeenUsed": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ExpenseRelatingToShortTermAndLowValueLeasesForWhichRecognitionExemptionHasBeenUsed", "crdr": "debit", "presentation": [ "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails", "http://gf.com/role/LeasesCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term and low-value leases expense", "negatedLabel": "Payments of short-term and low-value leases", "label": "Expense Relating To Short-Term And Low-Value Leases For Which Recognition Exemption Has Been Used", "documentation": "Expense Relating To Short-Term And Low-Value Leases For Which Recognition Exemption Has Been Used" } } }, "auth_ref": [] }, "ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Explanation of significant changes in contract assets and contract liabilities", "label": "Explanation of significant changes in contract assets and contract liabilities [text block]" } }, "en": { "role": { "documentation": "The explanation of the significant changes in the contract assets and the contract liabilities. [Refer: Contract assets; Contract liabilities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_FeeAndCommissionExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FeeAndCommissionExpense", "crdr": "debit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment fees and amortization of debt issuance costs", "label": "Fee and commission expense" } }, "en": { "role": { "documentation": "The amount of expense relating to fees and commissions." } } }, "auth_ref": [ "r332" ] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 4.0 }, "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Finance expense", "totalLabel": "Total finance expenses", "label": "Finance costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r42" ] }, "gfs_FinanceExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "FinanceExpenseMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance expense", "label": "Finance Expense [Member]", "documentation": "Finance Expense" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance income", "totalLabel": "Total finance income", "label": "Finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r332" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Amount", "label": "Financial assets" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r215", "r218", "r219", "r221", "r293" ] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets, at fair value", "verboseLabel": "Fair Value", "label": "Financial assets, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r215" ] }, "ifrs-full_FinancialAssetsCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsCategoryMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets, category [member]", "label": "Financial assets, category [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r227" ] }, "gfs_FinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "FinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Abstract]", "label": "Financial Instruments [Abstract]", "documentation": "Financial Instruments" } } }, "auth_ref": [] }, "gfs_FinancialInstrumentsForeignCurrencyStrikePrice": { "xbrltype": "pureItemType", "nsuri": "http://gf.com/20231231", "localname": "FinancialInstrumentsForeignCurrencyStrikePrice", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average Strike Price", "label": "Financial Instruments, Foreign Currency, Strike Price", "documentation": "Financial Instruments, Foreign Currency, Strike Price" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total financial liabilities", "totalLabel": "Total", "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r215" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financial liabilities, at fair value", "label": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r215" ] }, "gfs_FinancialLiabilitiesCarryingAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "FinancialLiabilitiesCarryingAmountAbstract", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Value", "label": "Financial Liabilities, Carrying Amount [Abstract]", "documentation": "Financial Liabilities, Carrying Amount" } } }, "auth_ref": [] }, "gfs_FinancialLiabilitiesUndiscountedCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "FinancialLiabilitiesUndiscountedCashFlowsAbstract", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contractual Cash Flows", "label": "Financial Liabilities, Undiscounted Cash Flows [Abstract]", "documentation": "Financial Liabilities, Undiscounted Cash Flows" } } }, "auth_ref": [] }, "gfs_FiveYearRevolvingAndLetterOfCreditFacilitiesAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "FiveYearRevolvingAndLetterOfCreditFacilitiesAgreementMember", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Five-year Revolving and Letter of Credit Facilities Agreement", "label": "Five-year Revolving and Letter of Credit Facilities Agreement [Member]", "documentation": "Five-year Revolving and Letter of Credit Facilities Agreement" } } }, "auth_ref": [] }, "ifrs-full_ForwardContractMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ForwardContractMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total Forward Contracts", "label": "Forward contract [member]" } }, "en": { "role": { "documentation": "This member stands for a contract between two parties for the purchase or sale of an underlying asset at a specified future date for a settlement price determined in advance." } } }, "auth_ref": [ "r326" ] }, "gfs_ForwardContractsCurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ForwardContractsCurrencySwapMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forwards", "label": "Forward Contracts, Currency Swap [Member]", "documentation": "Forward Contracts, Currency Swap" } } }, "auth_ref": [] }, "ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss", "crdr": "credit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain (Losses) Recognized into Income (Ineffective Portion)", "label": "Gain (loss) on hedge ineffectiveness recognised in profit or loss" } }, "en": { "role": { "documentation": "The gain (loss) recognised in profit or loss on hedge ineffectiveness. [Refer: Gain (loss) on hedge ineffectiveness]" } } }, "auth_ref": [ "r209", "r211" ] }, "gfs_GainLossOnHedgingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GainLossOnHedgingActivities", "crdr": "credit", "calculation": { "http://gf.com/role/OtherIncomeExpenseNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on hedging activities", "label": "Gain (Loss) On Hedging Activities", "documentation": "Gain (Loss) On Hedging Activities" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnCashFlowHedgesNetOfTax", "crdr": "credit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gains (Losses) Recognized in Accumulated OCI on Derivatives (effective Portion)", "label": "Gains (losses) on cash flow hedges, net of tax" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, net of tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]" } } }, "auth_ref": [ "r46", "r210", "r214" ] }, "ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss", "crdr": "credit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gains (Losses) Recognized in Income on Derivative", "label": "Gains (losses) on financial assets at fair value through profit or loss" } }, "en": { "role": { "documentation": "The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]" } } }, "auth_ref": [ "r202" ] }, "ifrs-full_GainsLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeBeforeTax", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value gain (loss) on investments measured at fair value through other comprehensive income", "label": "Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on financial assets measured at fair value through other comprehensive income applying paragraph 4.1.2A of IFRS 9, before tax, before reclassification adjustments. [Refer: Financial assets measured at fair value through other comprehensive income; Other comprehensive income]" } } }, "auth_ref": [ "r47", "r203" ] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical areas [axis]", "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r241", "r261", "r287", "r291" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical areas [member]", "label": "Geographical areas [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r241", "r261", "r287", "r291" ] }, "ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GoodsOrServicesTransferredAtPointInTimeMember", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized at a point in time", "label": "Goods or services transferred at point in time [member]" } }, "en": { "role": { "documentation": "This member stands for goods or services transferred to customers at a point in time. [Refer: Performance obligations satisfied at point in time [member]]" } } }, "auth_ref": [ "r288" ] }, "ifrs-full_GoodsOrServicesTransferredOverTimeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GoodsOrServicesTransferredOverTimeMember", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized over time", "label": "Goods or services transferred over time [member]" } }, "en": { "role": { "documentation": "This member stands for goods or services transferred to customers over time. [Refer: Performance obligations satisfied over time [member]]" } } }, "auth_ref": [ "r288" ] }, "ifrs-full_GoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GoodwillMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill [member]" } }, "en": { "role": { "documentation": "This member stands for goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r265" ] }, "ifrs-full_GovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GovernmentGrants", "crdr": "credit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "totalLabel": "Total", "label": "Government grants" } }, "en": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]" } } }, "auth_ref": [ "r329" ] }, "gfs_GovernmentGrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsAbstract", "lang": { "en-us": { "role": { "label": "Government grants [Abstract]", "documentation": "Government grants [Abstract]" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsAdjustmentForFairValueOfEDBLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsAdjustmentForFairValueOfEDBLoan", "crdr": "credit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of EDB loan", "label": "Government Grants, Adjustment For Fair Value Of EDB Loan", "documentation": "Government Grants, Adjustment For Fair Value Of EDB Loan" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsCapitalizedToFixedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsCapitalizedToFixedAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Capitalized to fixed assets", "label": "Government Grants Capitalized To Fixed Assets", "documentation": "Government Grants Capitalized To Fixed Assets" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsCurrent", "crdr": "debit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current", "label": "Government Grants, Current", "documentation": "Government Grants, Current" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsLineItems", "presentation": [ "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Government Grants [Line Items]", "label": "Government Grants [Line Items]", "documentation": "Government Grants [Line Items]" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsNoncurrent", "crdr": "debit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current", "label": "Government Grants, Noncurrent", "documentation": "Government Grants, Noncurrent" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsReceivableMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Government grants receivable", "label": "Government Grants Receivable [Member]", "documentation": "Government Grants Receivable" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsReceivedDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsReceivedDuringPeriod", "crdr": "debit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received/receivable during the period", "label": "Government Grants Received During Period", "documentation": "Government Grants Received During Period" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsReleasedToFinancialStatements": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsReleasedToFinancialStatements", "crdr": "credit", "presentation": [ "http://gf.com/role/GovernmentGrantsRollforwardofGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Released to the consolidated statements of operations", "label": "Government Grants Released To Financial Statements", "documentation": "Government Grants Released To Financial Statements" } } }, "auth_ref": [] }, "gfs_GovernmentGrantsTable": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "GovernmentGrantsTable", "presentation": [ "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Government Grants [Table]", "label": "Government Grants [Table]", "documentation": "Government Grants [Table]" } } }, "auth_ref": [] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost", "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r62", "r102", "r111", "r114", "r198", "r219", "r221", "r293" ] }, "ifrs-full_GrossLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossLeaseLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease obligations", "label": "Gross lease liabilities" } }, "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r169", "r299" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r247" ] }, "ifrs-full_HedgingInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HedgingInstrumentsAxis", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging instruments [axis]", "label": "Hedging instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r205", "r207" ] }, "ifrs-full_HedgingInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HedgingInstrumentsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectofDerivativesonStatementsofOperationsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging instruments [member]", "label": "Hedging instruments [member]" } }, "en": { "role": { "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used." } } }, "auth_ref": [ "r205", "r207" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails", "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax expense", "negatedTotalLabel": "Income tax (expense) benefit", "label": "Tax expense (income)" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r43", "r52", "r54", "r55", "r88", "r146", "r232" ] }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome", "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax (expense) benefit recognized to other comprehensive income (loss)", "label": "Income tax relating to components of other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r45", "r53" ] }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax effect", "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]" } } }, "auth_ref": [ "r48" ] }, "gfs_IncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "IncomeTaxesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income taxes [Abstract]", "label": "Income taxes [Abstract]", "documentation": "Income taxes [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxesPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxesPaidClassifiedAsOperatingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes paid, classified as operating activities", "label": "Income taxes paid, classified as operating activities" } }, "en": { "role": { "documentation": "The cash outflow for income taxes paid, classified as operating activities." } } }, "auth_ref": [ "r359" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r125" ] }, "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of equity instruments (in shares)", "label": "Increase (decrease) in number of ordinary shares issued" } }, "en": { "role": { "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r326" ] }, "gfs_IncreaseDecreaseThroughAdditionalChangesAssetsArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughAdditionalChangesAssetsArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Addition", "label": "Increase (Decrease) Through Additional Changes, Assets Arising From Financing Activities", "documentation": "Increase (Decrease) Through Additional Changes, Assets Arising From Financing Activities" } } }, "auth_ref": [] }, "gfs_IncreaseDecreaseThroughChangeInAccretionCostOtherProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughChangeInAccretionCostOtherProvision", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion cost", "label": "Increase (Decrease) Through Change In Accretion Cost, Other Provision", "documentation": "Increase (Decrease) Through Change In Accretion Cost, Other Provision" } } }, "auth_ref": [] }, "gfs_IncreaseDecreaseThroughChangesInFairValuesAssetsArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughChangesInFairValuesAssetsArisingFromFinancingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows (Inflows)/ Outflows", "label": "Increase (Decrease) Through Changes In Fair Values, Assets Arising From Financing Activities", "documentation": "Increase (Decrease) Through Changes In Fair Values, Assets Arising From Financing Activities" } } }, "auth_ref": [] }, "gfs_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesAssetsArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesAssetsArisingFromFinancingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange movement", "label": "Increase (Decrease) Through Effect Of Changes In Foreign Exchange Rates, Assets Arising From Financing Activities", "documentation": "Increase (Decrease) Through Effect Of Changes In Foreign Exchange Rates, Assets Arising From Financing Activities" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange movement", "label": "Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r123" ] }, "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows (Inflows)/ Outflows", "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]" } } }, "auth_ref": [ "r122" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effects of exchange rate changes", "label": "Increase (decrease) through net exchange differences, property, plant and equipment" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r65" ] }, "gfs_IncreaseDecreaseThroughOtherChangesAssetsArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughOtherChangesAssetsArisingFromFinancingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Others", "label": "Increase (Decrease) Through Other Changes, Assets Arising From Financing activities", "documentation": "Increase (Decrease) Through Other Changes, Assets Arising From Financing activities" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Others", "label": "Increase (decrease) through other changes, liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r124" ] }, "gfs_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughShareBasedPaymentTransactionsShares", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payments (in shares)", "label": "Increase (decrease) through share-based payment transactions, shares", "documentation": "Increase (decrease) through share-based payment transactions, shares" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payments", "label": "Increase (decrease) through share-based payment transactions, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r5" ] }, "ifrs-full_IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTimeValueOfMoneyAdjustmentOtherProvisions", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Arising during the period", "label": "Increase through adjustments arising from passage of time, other provisions" } }, "en": { "role": { "documentation": "The increase in other provisions through adjustments arising from the passage of time. [Refer: Other provisions]" } } }, "auth_ref": [ "r98" ] }, "gfs_IncreaseDecreaseThroughTransactionsWithOwnersConversionOfLoanToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughTransactionsWithOwnersConversionOfLoanToEquity", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of loan from shareholder", "negatedTerseLabel": "Conversion of loan from shareholder", "label": "Increase (Decrease) Through Transactions With Owners, Conversion Of Loan To Equity", "documentation": "Increase (Decrease) Through Transactions With Owners, Conversion Of Loan To Equity" } } }, "auth_ref": [] }, "gfs_IncreaseDecreaseThroughTransactionsWithOwnersRepaymentOfLoanToShareholder": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IncreaseDecreaseThroughTransactionsWithOwnersRepaymentOfLoanToShareholder", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment of loan from shareholder", "label": "Increase (Decrease) Through Transactions With Owners, Repayment Of Loan To Shareholder", "documentation": "Increase (Decrease) Through Transactions With Owners, Repayment Of Loan To Shareholder" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring expenses", "label": "Increase (decrease) through transfers and other changes, other provisions" } }, "en": { "role": { "documentation": "The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]" } } }, "auth_ref": [ "r346" ] }, "ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers from construction in progress", "label": "Increase (decrease) through transfers from construction in progress, property, plant and equipment" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]" } } }, "auth_ref": [ "r338" ] }, "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Addition", "label": "Increase through new leases, liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r275", "r279" ] }, "ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of options", "label": "Incremental fair value granted, modified share-based payment arrangements" } }, "en": { "role": { "documentation": "The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r196" ] }, "gfs_IntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "IntangibleAssetsAbstract", "lang": { "en-us": { "role": { "label": "Intangible Assets [Abstract]", "documentation": "Intangible Assets [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsAndGoodwill", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and intangible assets, net", "periodStartLabel": "Intangible assets and goodwill at beginning of period", "periodEndLabel": "Intangible assets and goodwill at end of period", "label": "Intangible assets and goodwill" } }, "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsAndGoodwillMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets and goodwill", "label": "Intangible assets and goodwill [member]" } }, "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r349" ] }, "gfs_IntangibleAssetsPayableNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "IntangibleAssetsPayableNoncurrent", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_NoncurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payable for Intangible Assets", "label": "Intangible Assets Payable, Noncurrent", "documentation": "Intangible Assets Payable, Noncurrent" } } }, "auth_ref": [] }, "gfs_InterestAndIncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "InterestAndIncomeTaxesPaid", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest and income taxes paid, net", "label": "Interest And Income Taxes Paid", "documentation": "Interest And Income Taxes Paid" } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnDebtInstrumentsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnDebtInstrumentsIssued", "crdr": "debit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest on long-term debt", "label": "Interest expense on debt instruments issued" } }, "en": { "role": { "documentation": "The amount of interest expense on debt instruments issued. [Refer: Interest expense; Debt instruments issued]" } } }, "auth_ref": [ "r326" ] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails", "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails", "http://gf.com/role/LeasesCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense on lease liabilities", "negatedLabel": "Interest paid", "verboseLabel": "Interest on lease obligations", "label": "Interest expense on lease liabilities" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r164" ] }, "ifrs-full_InterestIncomeOnAvailableforsaleFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestIncomeOnAvailableforsaleFinancialAssets", "crdr": "credit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income on FVOCI investments", "label": "Interest income on available-for-sale financial assets" } }, "en": { "role": { "documentation": "The amount of interest income on available-for-sale financial assets. [Refer: Interest income; Financial assets available-for-sale]" } } }, "auth_ref": [ "r364" ] }, "ifrs-full_InterestIncomeOnDeposits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestIncomeOnDeposits", "crdr": "credit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income - deposits", "label": "Interest income on deposits" } }, "en": { "role": { "documentation": "The amount of interest income on deposits. [Refer: Interest income]" } } }, "auth_ref": [ "r326" ] }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestPaidClassifiedAsOperatingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Interest paid", "label": "Interest paid, classified as operating activities" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } } }, "auth_ref": [ "r120" ] }, "ifrs-full_InterestRateSwapContractMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestRateSwapContractMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate swaps", "label": "Interest rate swap contract [member]" } }, "en": { "role": { "documentation": "This member stands for an interest rate swap contract. [Refer: Swap contract [member]]" } } }, "auth_ref": [ "r326" ] }, "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestReceivedClassifiedAsOperatingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Interest received", "label": "Interest received, classified as operating activities" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as operating activities." } } }, "auth_ref": [ "r120" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/InventoriesSummaryofInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/InventoriesSummaryofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "totalLabel": "Total", "label": "Current inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r12", "r74", "r249" ] }, "gfs_InventoriesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "InventoriesAbstract", "lang": { "en-us": { "role": { "label": "Inventories [Abstract]", "documentation": "Inventories [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_InventoriesTotal": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InventoriesTotal", "crdr": "debit", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventories" } }, "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } } }, "auth_ref": [ "r12" ] }, "gfs_InventoryTaxDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "InventoryTaxDifferenceMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "label": "Inventory Tax Difference [Member]", "documentation": "Inventory Tax Difference" } } }, "auth_ref": [] }, "gfs_InvestmentTaxCreditsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "InvestmentTaxCreditsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Investment tax credits, property plant and equipment", "label": "Investment Tax Credits, Property Plant And Equipment", "documentation": "Investment Tax Credits, Property Plant And Equipment" } } }, "auth_ref": [] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of equity instruments", "label": "Issue of equity" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r5" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, $0.02 par value, 553,548 thousand and 547,755 thousand shares issued and outstanding as of December\u00a031, 2023 and 2022, respectively", "label": "Issued capital" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r253" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Share", "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r6" ] }, "currency_JPY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "JPY", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan, Yen", "label": "Japan, Yen" } } }, "auth_ref": [] }, "gfs_JapaneseYenForwardContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "JapaneseYenForwardContractsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japanese yen forward contracts (receive Japanese yen/pay US$)", "label": "Japanese Yen Forward Contracts [Member]", "documentation": "Japanese Yen Forward Contracts" } } }, "auth_ref": [] }, "ifrs-full_JointControlOrSignificantInfluenceMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointControlOrSignificantInfluenceMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MDC General Services Holding Company L.L.C (recharge of expenses)", "label": "Entities with joint control or significant influence over entity [member]" } }, "en": { "role": { "documentation": "This member stands for entities that have joint control or significant influence over the entity. Joint control is a contractually agreed sharing of control of an arrangement, which exists only when decisions about the relevant activities require the unanimous consent of the parties sharing control. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but not control or joint control of those policies." } } }, "auth_ref": [ "r83" ] }, "ifrs-full_JointVenturesWhereEntityIsVenturerMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesWhereEntityIsVenturerMember", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresBalancesintheConsolidatedStatementofFinancialPositionDetails", "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SMP", "label": "Joint ventures where entity is venturer [member]" } }, "en": { "role": { "documentation": "This member stands for joint ventures in which the entity is a joint venturer. A venturer is a party to a joint venture and has joint control over that joint venture. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r84" ] }, "ifrs-full_LandMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LandMember", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land and Land Improvements", "label": "Land [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "After 5 years", "label": "Later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r170", "r171", "r182", "r298", "r304", "r307" ] }, "ifrs-full_LaterThanFourMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFourMonthsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Great than 120 days", "label": "Later than four months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than four months." } } }, "auth_ref": [ "r326" ] }, "ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneMonthAndNotLaterThanThreeMonthsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "31-90 Days", "label": "Later than one month and not later than three months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than three months." } } }, "auth_ref": [ "r296", "r303", "r307" ] }, "ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneMonthAndNotLaterThanTwoMonthsMember", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "31 to 60 days", "label": "Later than one month and not later than two months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than two months." } } }, "auth_ref": [ "r293", "r306", "r326" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2-5 years", "label": "Later than one year and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than five years." } } }, "auth_ref": [ "r297", "r307" ] }, "ifrs-full_LaterThanThreeMonthsAndNotLaterThanFourMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanThreeMonthsAndNotLaterThanFourMonthsMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "91-120 Days", "label": "Later than three months and not later than four months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three months and not later than four months." } } }, "auth_ref": [ "r326" ] }, "ifrs-full_LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember", "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "61 to 90 days", "label": "Later than two months and not later than three months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two months and not later than three months." } } }, "auth_ref": [ "r293", "r306", "r326" ] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease obligations", "totalLabel": "Total", "negatedTerseLabel": "Lease liabilities", "label": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease obligations", "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r276", "r280" ] }, "gfs_LeasePaymentsFinanceCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "LeasePaymentsFinanceCharges", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": "gfs_MinimumUndiscountedOperatingLeasePaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: amounts representing finance charges", "label": "Lease Payments, Finance Charges", "documentation": "Lease Payments, Finance Charges" } } }, "auth_ref": [] }, "gfs_LeaseWeightedAverageRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "LeaseWeightedAverageRemainingLeaseTerm", "presentation": [ "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term", "label": "Lease, Weighted Average Remaining Lease Term", "documentation": "Lease, Weighted Average Remaining Lease Term" } } }, "auth_ref": [] }, "ifrs-full_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building and Leasehold Improvements", "label": "Leasehold improvements [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } } }, "auth_ref": [ "r335" ] }, "gfs_LeasesWeightedAverageDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "LeasesWeightedAverageDiscountRate", "presentation": [ "http://gf.com/role/LeasesAdditionalInformationaboutLeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Leases, Weighted Average Discount Rate", "documentation": "Leases, Weighted Average Discount Rate" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quoted Prices Identical Assets/ Liabilities (Level 1)", "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r70", "r148" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Other Inputs (Level 2)", "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r148" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Unobservable Inputs (Level 3)", "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r148" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Levels of fair value hierarchy [axis]", "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r70", "r148" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "negatedTotalLabel": "Total Liabilities", "terseLabel": "Liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r20", "r147", "r148", "r149", "r233", "r237" ] }, "ifrs-full_LiabilitiesArisingFromFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Liabilities arising from financing activities at beginning of period", "periodEndLabel": "Liabilities arising from financing activities at end of period", "label": "Liabilities arising from financing activities" } }, "en": { "role": { "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivitiesAxis", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities arising from financing activities [axis]", "label": "Liabilities arising from financing activities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r277" ] }, "gfs_LiabilitiesArisingFromFinancingActivitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "LiabilitiesArisingFromFinancingActivitiesDomain", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Arising From Financing Activities [Domain]", "label": "Liabilities Arising From Financing Activities [Domain]", "documentation": "Liabilities Arising From Financing Activities [Domain]" } } }, "auth_ref": [] }, "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesArisingFromFinancingActivitiesMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities arising from financing activities [member]", "label": "Liabilities arising from financing activities [member]" } }, "en": { "role": { "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_LiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities [member]", "label": "Liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r150" ] }, "gfs_LicenseAgreementMinimumInterestPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "LicenseAgreementMinimumInterestPercentage", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum interest on license agreement", "label": "License Agreement, Minimum Interest Percentage", "documentation": "License Agreement, Minimum Interest Percentage" } } }, "auth_ref": [] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line items by function", "label": "Line items by function [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r323", "r326" ] }, "ifrs-full_LiquidityRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiquidityRiskMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liquidity risk", "label": "Liquidity risk [member]" } }, "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r177", "r178", "r179", "r292" ] }, "gfs_LoanFromShareholderMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "LoanFromShareholderMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/RelatedPartyDisclosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan from Shareholder", "label": "Loan From Shareholder [Member]", "documentation": "Loan From Shareholder" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "gfs_LocationIncomeStatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "LocationIncomeStatementAxis", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Location, Income Statement [Axis]", "label": "Location, Income Statement [Axis]", "documentation": "Location, Income Statement" } } }, "auth_ref": [] }, "gfs_LocationIncomeStatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "LocationIncomeStatementDomain", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Location, Income Statement [Domain]", "label": "Location, Income Statement [Domain]", "documentation": "Location, Income Statement [Domain]" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails": { "parentTag": "ifrs-full_Borrowings", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/LongTermDebtNarrativeDetails", "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails", "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current portion of long-term debt", "verboseLabel": "Non-current portion of non-current borrowings", "label": "Non-current portion of non-current borrowings" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_LongtermBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowingsMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesnotMeasuredataRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "verboseLabel": "Other long-term debt", "label": "Long-term borrowings [member]" } }, "en": { "role": { "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r276", "r280" ] }, "gfs_LossesCreditsAndInvestmentAllowancesAvailableForOffsettingAgainstFutureTaxableIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "LossesCreditsAndInvestmentAllowancesAvailableForOffsettingAgainstFutureTaxableIncomeMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Losses, credits and investment allowances available for offsetting against future taxable income", "label": "Losses, Credits And Investment Allowances Available For Offsetting Against Future Taxable Income [Member]", "documentation": "Losses, Credits And Investment Allowances Available For Offsetting Against Future Taxable Income" } } }, "auth_ref": [] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment", "label": "Machinery [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r260" ] }, "ifrs-full_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorCustomersAxis", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Major customers [axis]", "label": "Major customers [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_MajorCustomersMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorCustomersMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customers [member]", "label": "Customers [member]" } }, "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } } }, "auth_ref": [ "r242" ] }, "gfs_MatchedAmountPerDollarOfAdditionalEmployeeContributionsDefinedContributionPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "MatchedAmountPerDollarOfAdditionalEmployeeContributionsDefinedContributionPlans", "crdr": "debit", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Matched amount per dollar of additional employee contributions", "label": "Matched Amount Per Dollar Of Additional Employee Contributions, Defined Contribution Plans", "documentation": "Matched Amount Per Dollar Of Additional Employee Contributions, Defined Contribution Plans" } } }, "auth_ref": [] }, "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAnalysisForDerivativeFinancialLiabilities", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of maturity analysis for derivative financial liabilities", "label": "Disclosure of maturity analysis for derivative financial liabilities [text block]" } }, "en": { "role": { "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r223" ] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity [axis]", "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r23", "r158", "r170", "r171", "r174", "r175", "r176", "r182", "r206", "r225", "r262", "r298" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/ProvisionsNarrativeDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [] }, "gfs_MaximumOperatingLossCarryforwardsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "MaximumOperatingLossCarryforwardsPercentage", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum operating loss carryforwards (as a percent)", "label": "Maximum Operating Loss Carryforwards, Percentage", "documentation": "Maximum Operating Loss Carryforwards, Percentage" } } }, "auth_ref": [] }, "gfs_MaximumPercentageOfEmployeeContributionsMatchedDefinedContributionPlans": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "MaximumPercentageOfEmployeeContributionsMatchedDefinedContributionPlans", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum employee contributions matched by employer (as a percent)", "label": "Maximum Percentage Of Employee Contributions Matched, Defined Contribution Plans", "documentation": "Maximum Percentage Of Employee Contributions Matched, Defined Contribution Plans" } } }, "auth_ref": [] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement [axis]", "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r109", "r113", "r147" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/ProvisionsNarrativeDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [] }, "gfs_MinimumPresentValueOfOperatingLeasePaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "MinimumPresentValueOfOperatingLeasePaymentsDue", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Minimum present value of operating lease payments due", "label": "Minimum Present Value Of Operating Lease Payments due", "documentation": "Minimum Present Value Of Operating Lease Payments due" } } }, "auth_ref": [] }, "gfs_MinimumUndiscountedOperatingLeasePaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "MinimumUndiscountedOperatingLeasePaymentsDue", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Minimum Undiscounted Operating Lease Payments due", "label": "Minimum Undiscounted Operating Lease Payments due", "documentation": "Minimum Undiscounted Operating Lease Payments due" } } }, "auth_ref": [] }, "gfs_MiscellaneousOtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "MiscellaneousOtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://gf.com/role/OtherIncomeExpenseNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Miscellaneous Other Operating Income (Expense)", "documentation": "Miscellaneous Other Operating Income (Expense)" } } }, "auth_ref": [] }, "stpr_NY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "NY", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NEW YORK", "label": "NEW YORK" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "calculation": { "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net liabilities", "totalLabel": "Net Liabilities", "label": "Assets (liabilities)" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r281", "r326" ] }, "ifrs-full_NewProvisionsOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NewProvisionsOtherProvisions", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Released to the consolidated statement of operations", "label": "New provisions, other provisions" } }, "en": { "role": { "documentation": "The amount recognised for new other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r345" ] }, "gfs_NewProvisionsOtherProvisionsAssetRetirementObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NewProvisionsOtherProvisionsAssetRetirementObligations", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provisions related to asset retirement obligations", "label": "New Provisions, Other Provisions, Asset Retirement Obligations", "documentation": "New Provisions, Other Provisions, Asset Retirement Obligations" } } }, "auth_ref": [] }, "gfs_NewProvisionsOtherProvisionsSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NewProvisionsOtherProvisionsSaleOfBusiness", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provisions related to the sale of a business", "label": "New Provisions, Other Provisions, Sale Of Business", "documentation": "New Provisions, Other Provisions, Sale Of Business" } } }, "auth_ref": [] }, "gfs_NonCurrentAssetHeldForSaleAndDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentAssetHeldForSaleAndDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Non-Current Asset Held For Sale And Discontinued Operations [Abstract]", "label": "Non-Current Asset Held For Sale And Discontinued Operations [Abstract]", "documentation": "Non-Current Asset Held For Sale And Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "gfs_NonCurrentBondsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentBondsReceivable", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment in Lieu of Tax (\u201cPILOT\u201d) Bonds", "label": "Non-Current Bonds Receivable", "documentation": "Non-Current Bonds Receivable" } } }, "auth_ref": [] }, "gfs_NonCurrentMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentMarketableSecurities", "crdr": "debit", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Non-current Marketable Securities", "documentation": "Non-current Marketable Securities" } } }, "auth_ref": [] }, "gfs_NonCurrentNontradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentNontradeReceivables", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-trade receivables", "label": "Non-Current Nontrade Receivables", "documentation": "Non-Current Nontrade Receivables" } } }, "auth_ref": [] }, "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 }, "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables, prepayments and other assets", "totalLabel": "Total", "label": "Non-Current Prepayments And Other Current Assets", "documentation": "Non-Current Prepayments And Other Current Assets" } } }, "auth_ref": [] }, "gfs_NonCurrentReceivablesFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "NonCurrentReceivablesFromGovernmentGrants", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables from government grant", "label": "Non-current Receivables From Government Grants", "documentation": "Non-current Receivables From Government Grants" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-adjusting events after reporting period [axis]", "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r51" ] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-adjusting events after reporting period [member]", "label": "Non-adjusting events after reporting period [member]" } }, "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r51" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r18", "r134", "r136" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Non- controlling Interest", "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r24", "r138", "r282" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets:", "verboseLabel": "Non-current:", "label": "Non-current assets [abstract]" } } }, "auth_ref": [] }, "gfs_NoncurrentBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "NoncurrentBorrowingsAbstract", "presentation": [ "http://gf.com/role/LongTermDebtScheduleofNoncurrentandCurrentBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current:", "label": "Noncurrent Borrowings [Abstract]", "documentation": "Noncurrent Borrowings" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentContractLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_NoncurrentPayables", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails": { "parentTag": "ifrs-full_ContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails", "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "verboseLabel": "Non-current", "label": "Non-current contract liabilities" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r152" ] }, "ifrs-full_NoncurrentFinancialAssetsAvailableforsale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentFinancialAssetsAvailableforsale", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Marketable securities", "label": "Non-current financial assets available-for-sale" } }, "en": { "role": { "documentation": "The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_NoncurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current portion of deferred income from government grants", "label": "Non-current government grants" } }, "en": { "role": { "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current portion of lease obligations", "verboseLabel": "Non-current", "label": "Non-current lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r162" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r25", "r140", "r282" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities:", "label": "Non-current liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayables", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Trade and other non-current payables" } }, "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_NoncurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayablesAbstract", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current:", "label": "Trade and other non-current payables [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPrepayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPrepayments", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Advances to suppliers", "label": "Non-current prepayments" } }, "en": { "role": { "documentation": "The amount of non-current prepayments. [Refer: Prepayments]" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_NoncurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentProvisions", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "label": "Non-current provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r15" ] }, "gfs_NonrefundableNewYorkEmpireZoneMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "NonrefundableNewYorkEmpireZoneMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonrefundable New York Empire Zone", "label": "Nonrefundable New York Empire Zone [Member]", "documentation": "Nonrefundable New York Empire Zone" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneMonthMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneMonthMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less than 30 days", "label": "Not later than one month [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one month." } } }, "auth_ref": [ "r295", "r302", "r307" ] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Within 1 year", "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r22", "r170", "r171", "r182", "r298", "r307" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "label": "Notional amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r326" ] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Number of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r195", "r361" ] }, "ifrs-full_NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented", "presentation": [ "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of instruments that are antidilutive in period presented (in shares)", "label": "Number of instruments that are antidilutive in period presented" } }, "en": { "role": { "documentation": "Number of (units of) instruments that are antidilutive in the period presented." } } }, "auth_ref": [ "r92" ] }, "gfs_NumberOfOrdinarySharesIssuedStockSplitConversionRatio": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "NumberOfOrdinarySharesIssuedStockSplitConversionRatio", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock split (in shares)", "label": "Number Of Ordinary Shares Issued, Stock Split Conversion Ratio", "documentation": "Number Of Ordinary Shares Issued, Stock Split Conversion Ratio" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Number of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r361" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Number of other equity instruments forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r361" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in shares)", "periodEndLabel": "Outstanding at end of period (in shares)", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r361" ] }, "gfs_NumberOfOtherEquityInstrumentsOutstandingSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "NumberOfOtherEquityInstrumentsOutstandingSharesAbstract", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of RSUs", "label": "Number Of Other Equity Instruments Outstanding, Shares [Abstract]", "documentation": "Number Of Other Equity Instruments Outstanding, Shares" } } }, "auth_ref": [] }, "gfs_NumberOfOtherEquityInstrumentsWeightedAverageExercisePriceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "NumberOfOtherEquityInstrumentsWeightedAverageExercisePriceAbstract", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value", "label": "Number Of Other Equity Instruments, Weighted Average Exercise Price [Abstract]", "documentation": "Number Of Other Equity Instruments, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails", "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "terseLabel": "Number Outstanding", "label": "Number of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r184", "r188", "r191" ] }, "gfs_NumberOfShareOptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "NumberOfShareOptionsAbstract", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Share options", "label": "Number Of Share Options [Abstract]", "documentation": "Number Of Share Options" } } }, "auth_ref": [] }, "gfs_NumberOfShareOptionsAvailableForFutureGrant": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "NumberOfShareOptionsAvailableForFutureGrant", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share options available for future grant (in shares)", "label": "Number of Share Options Available For Future Grant", "documentation": "Number of Share Options Available For Future Grant" } } }, "auth_ref": [] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in shares)", "label": "Number of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Number of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r187" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Number of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Number of share options granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares authorised (in shares)", "label": "Number of shares authorised" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r29" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical", "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued (in shares)", "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r324" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical", "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r31" ] }, "ifrs-full_OperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OperatingExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Operating expenses", "label": "Operating expense" } }, "en": { "role": { "documentation": "The amount of all operating expenses." } } }, "auth_ref": [ "r332" ] }, "gfs_OperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "OperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "Operating Segments [Abstract]", "documentation": "Operating Segments [Abstract]" } } }, "auth_ref": [] }, "gfs_OrdinarySharesInPrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OrdinarySharesInPrivatePlacementMember", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares In Private Placement", "label": "Ordinary Shares In Private Placement [Member]", "documentation": "Ordinary Shares In Private Placement" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r89", "r331" ] }, "gfs_OtherBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherBorrowingsMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncommitted Credit Facilities", "label": "Other Borrowings [Member]", "documentation": "Other Borrowings" } } }, "auth_ref": [] }, "ifrs-full_OtherCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CashAndCashEquivalentsScheduleofCashandCashequivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other cash and cash equivalents", "label": "Other cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r360" ] }, "ifrs-full_OtherComponentsOfDeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComponentsOfDeferredTaxExpenseIncome", "crdr": "debit", "presentation": [ "http://gf.com/role/IncomeTaxesIncometaxbenefitexpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other change in temporary differences", "label": "Other components of deferred tax expense (income)" } }, "en": { "role": { "documentation": "The amount of components of deferred tax expense or income that the entity does not separately disclose in the same statement or note. [Refer: Deferred tax expense (income)]" } } }, "auth_ref": [ "r333" ] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss) for the year", "terseLabel": "Other comprehensive income", "label": "Other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r4", "r35", "r46", "r143" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Attributable to:", "label": "Other comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Other comprehensive income, attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The amount of other comprehensive income attributable to non-controlling interests. [Refer: Non-controlling interests; Other comprehensive income]" } } }, "auth_ref": [ "r332" ] }, "ifrs-full_OtherComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders of GLOBALFOUNDRIES INC.", "label": "Other comprehensive income, attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of other comprehensive income attributable to owners of the parent." } } }, "auth_ref": [ "r332" ] }, "ifrs-full_OtherComprehensiveIncomeBeforeTaxCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeBeforeTaxCashFlowHedges", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Effective portion of changes in the fair value of cash flow hedges", "label": "Other comprehensive income, before tax, cash flow hedges" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income, before tax]" } } }, "auth_ref": [ "r26", "r47" ] }, "gfs_OtherComprehensiveIncomeEffectTaxDifferenceMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherComprehensiveIncomeEffectTaxDifferenceMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income Effect Tax Difference [Member]", "documentation": "Other Comprehensive Income Effect Tax Difference" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income that will be reclassified to profit or loss, net of tax", "terseLabel": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r254", "r255" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other current financial assets", "label": "Other current financial assets" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r11" ] }, "gfs_OtherCurrentFinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherCurrentFinancialAssetsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Financial Assets", "label": "Other Current Financial Assets [Member]", "documentation": "Other Current Financial Assets" } } }, "auth_ref": [] }, "gfs_OtherCurrentFinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherCurrentFinancialLiabilitiesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Financial Liabilities", "label": "Other Current Financial Liabilities [Member]", "documentation": "Other Current Financial Liabilities" } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other current payables" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other current receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_OtherDisposalsOfAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherDisposalsOfAssetsMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other disposals of assets", "label": "Other disposals of assets [member]" } }, "en": { "role": { "documentation": "This member stands for disposals of assets that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r256" ] }, "ifrs-full_OtherEmployeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherEmployeeExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CostofRevenueDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CostofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Staff costs, maintenance costs, and utilities(2)", "label": "Other employee expense" } }, "en": { "role": { "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r340" ] }, "ifrs-full_OtherFinanceCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinanceCost", "crdr": "debit", "calculation": { "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/FinanceIncomeandExpensesFinanceExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion costs and other", "label": "Other finance cost" } }, "en": { "role": { "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]" } } }, "auth_ref": [ "r326" ] }, "gfs_OtherGeographicalAreaMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherGeographicalAreaMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Geographical Area [Member]", "documentation": "Other Geographical Area" } } }, "auth_ref": [] }, "gfs_OtherIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherIncomeExpenseMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense)", "label": "Other Income (Expense) [Member]", "documentation": "Other Income (Expense)" } } }, "auth_ref": [] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other investing activities", "label": "Other inflows (outflows) of cash, classified as investing activities" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as investing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r117" ] }, "ifrs-full_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Others", "label": "Other intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r350" ] }, "ifrs-full_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other current and non-current liabilities", "label": "Other liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_OtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "gfs_NonCurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other non-current assets" } }, "en": { "role": { "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_OtherNoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentFinancialAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current financial assets", "label": "Other non-current financial assets" } }, "en": { "role": { "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]" } } }, "auth_ref": [ "r11" ] }, "gfs_OtherNoncurrentFinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherNoncurrentFinancialAssetsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-current Financial Assets", "label": "Other Noncurrent Financial Assets [Member]", "documentation": "Other Noncurrent Financial Assets" } } }, "auth_ref": [] }, "gfs_OtherNoncurrentFinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherNoncurrentFinancialLiabilitiesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFairValueandLocationofDerivativeInstrumentsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-current Financial Liabilities", "label": "Other Noncurrent Financial Liabilities [Member]", "documentation": "Other Noncurrent Financial Liabilities" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other non-current liabilities" } }, "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } } }, "auth_ref": [ "r329" ] }, "ifrs-full_OtherNoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentPayables", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_NoncurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other non-current payables" } }, "en": { "role": { "documentation": "The amount of non-current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r329" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 5.0 }, "http://gf.com/role/OtherIncomeExpenseNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "totalLabel": "Total other income (expense), net", "label": "Other operating income (expense)" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r332" ] }, "ifrs-full_OtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherProvisions", "crdr": "credit", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails", "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Provisions at beginning of period", "periodEndLabel": "Provisions at end of period", "terseLabel": "Provisions", "label": "Other provisions" } }, "en": { "role": { "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r27", "r96" ] }, "gfs_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]", "label": "Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]", "documentation": "Other Provisions, Contingent Liabilities, and Contingent Assets [Abstract]" } } }, "auth_ref": [] }, "gfs_OtherPurchasesOfGoodsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherPurchasesOfGoodsRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other transactions with:", "label": "Other Purchases Of Goods, Related Party Transactions", "documentation": "Other Purchases Of Goods, Related Party Transactions" } } }, "auth_ref": [] }, "gfs_OtherReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherReceivablesMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables [Member]", "documentation": "Other Receivables" } } }, "auth_ref": [] }, "gfs_OtherResearchAndDevelopmentExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherResearchAndDevelopmentExpenses", "crdr": "debit", "calculation": { "http://gf.com/role/ResearchandDevelopmentExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Research And development Expenses", "documentation": "Other Research And development Expenses" } } }, "auth_ref": [] }, "gfs_OtherSellingGeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherSellingGeneralAndAdministrativeExpenses", "crdr": "debit", "calculation": { "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails": { "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Selling, General And Administrative Expenses", "documentation": "Other Selling, General And Administrative Expenses" } } }, "auth_ref": [] }, "gfs_OtherStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "OtherStatesMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other states", "label": "Other states [Member]", "documentation": "Other states" } } }, "auth_ref": [] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other effects", "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r54" ] }, "ifrs-full_OtherTemporaryDifferencesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTemporaryDifferencesMember", "presentation": [ "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other temporary differences [member]" } }, "en": { "role": { "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r334" ] }, "gfs_PILOTBondsLettersOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "PILOTBondsLettersOfCreditMember", "presentation": [ "http://gf.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "PILOT Bonds, Letters Of Credit", "label": "PILOT Bonds, Letters Of Credit [Member]", "documentation": "PILOT Bonds, Letters Of Credit" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITIONParenthetical", "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Par value per share (in dollars per share)", "label": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_PastDueStatusAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusAxis", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Past due status [axis]", "label": "Past due status [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r293" ] }, "ifrs-full_PastDueStatusMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsMaturityScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Past due status", "label": "Past due status [member]" } }, "en": { "role": { "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used." } } }, "auth_ref": [ "r293" ] }, "gfs_PaymentsOfDebtAndFinanceLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PaymentsOfDebtAndFinanceLeaseObligations", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of debt and finance lease obligations", "label": "Payments Of Debt And Finance Lease Obligations", "documentation": "Payments Of Debt And Finance Lease Obligations" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://gf.com/role/LeasesCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of lease obligations", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r274" ] }, "gfs_PercentOfMatchDefinedContributionPlans": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "PercentOfMatchDefinedContributionPlans", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee contributions matched by employer (as a percent)", "label": "Percent Of Match, Defined Contribution Plans", "documentation": "Defined Benefit Liability, Percentage Of Employee Contributions Matched By Company" } } }, "auth_ref": [] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of entity's revenue", "label": "Percentage of entity's revenue" } }, "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r363" ] }, "gfs_PerformanceShareUnitsPSUMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "PerformanceShareUnitsPSUMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Share Units (PSU)", "label": "Performance Share Units (PSU) [Member]", "documentation": "Performance Share Units (PSU)" } } }, "auth_ref": [] }, "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans", "crdr": "debit", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contribution expense", "label": "Post-employment benefit expense in profit or loss, defined benefit plans" } }, "en": { "role": { "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]" } } }, "auth_ref": [ "r339", "r340" ] }, "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PostemploymentBenefitExpenseDefinedContributionPlans", "crdr": "debit", "presentation": [ "http://gf.com/role/EmployeeBenefitsPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contribution 401(K) expense", "label": "Post-employment benefit expense, defined contribution plans" } }, "en": { "role": { "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods." } } }, "auth_ref": [ "r71" ] }, "gfs_PotentialIncomeTaxConsequences": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PotentialIncomeTaxConsequences", "crdr": "credit", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax provisions", "label": "Potential Income Tax Consequences", "documentation": "Potential Income Tax Consequences" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://gf.com/role/IssuedCapitalandReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preference shares", "label": "Preference shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r331" ] }, "gfs_PrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayments And Other Current Assets", "label": "Prepayments And Other Current Assets", "documentation": "Prepayments And Other Current Assets" } } }, "auth_ref": [] }, "gfs_PresentValueOfOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PresentValueOfOperatingLeasePaymentsToBeReceived", "crdr": "credit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": "gfs_MinimumPresentValueOfOperatingLeasePaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Present Value of Payments", "label": "Present Value Of Operating Lease Payments To Be Received", "documentation": "Present Value Of Operating Lease Payments To Be Received" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds from borrowings", "label": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r273" ] }, "ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Advances and proceeds from sale of property, plant and equipment and intangible assets", "label": "Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets" } }, "en": { "role": { "documentation": "The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]" } } }, "auth_ref": [ "r353" ] }, "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from government grants", "label": "Proceeds from government grants, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r342" ] }, "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from government grants", "label": "Proceeds from government grants, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from government grants, classified as investing activities. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r342" ] }, "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingOtherEquityInstruments", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of equity instruments", "label": "Proceeds from issuing other equity instruments" } }, "en": { "role": { "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r272" ] }, "gfs_ProceedsFromLoansAndOtherBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ProceedsFromLoansAndOtherBorrowings", "crdr": "debit", "presentation": [ "http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New loans and borrowings", "label": "Proceeds From Loans And Other Borrowings", "documentation": "Proceeds From Loans And Other Borrowings" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromNoncurrentBorrowings", "crdr": "debit", "presentation": [ "http://gf.com/role/LongTermDebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New loans and borrowings", "label": "Proceeds from non-current borrowings" } }, "en": { "role": { "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r354" ] }, "gfs_ProceedsFromSaleOfMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ProceedsFromSaleOfMarketableSecurities", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of marketable securities", "label": "Proceeds From Sale Of Marketable Securities", "documentation": "Proceeds From Sale Of Marketable Securities" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sales of property, plant and equipment", "label": "Proceeds from sales of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r270" ] }, "gfs_ProceedsFromSettlementOfLoansIssuedToJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ProceedsFromSettlementOfLoansIssuedToJointVentures", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of a business", "label": "Proceeds From Settlement Of loans Issued To Joint Ventures", "documentation": "Proceeds From Settlement Of loans Issued To Joint Ventures" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of goods and services:", "label": "Product and Service [Domain]" } } }, "auth_ref": [] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 10.0 }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss) for the year", "terseLabel": "Net income (loss) for the year", "verboseLabel": "Net income (loss)", "label": "Profit (loss)" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r3", "r34", "r116", "r131", "r133", "r233", "r235", "r282", "r290" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Attributable to:", "label": "Profit (loss), attributable to [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interest", "label": "Profit (loss), attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r37", "r135" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS", "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shareholder of GLOBALFOUNDRIES INC.", "negatedTerseLabel": "Profit (loss), attributable to owners of parent", "negatedLabel": "Net income (loss) attributable to equity shareholders of the Company", "label": "Profit (loss), attributable to owners of parent" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) before income taxes", "terseLabel": "Profit (loss) before tax", "label": "Profit (loss) before tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r199", "r246", "r247", "r309", "r310" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) from operations", "label": "Profit (loss) from operating activities" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r264", "r332" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessScheduleofNetAssetsDerecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r10", "r66" ] }, "gfs_PropertyPlantAndEquipmentAndIntangibleAssetsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PropertyPlantAndEquipmentAndIntangibleAssetsPayableCurrent", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payable for property, plant and equipment and Intangible Assets", "label": "Property, Plant, And Equipment And Intangible Assets Payable, Current", "documentation": "Property, Plant, And Equipment And Intangible Assets Payable, Current" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentIncludingRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentIncludingRightofuseAssets", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "periodStartLabel": "Beginning of period", "periodEndLabel": "End of period", "label": "Property, plant and equipment including right-of-use assets" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment including right-of-use assets whose underlying assets would be presented as property, plant and equipment if they were owned. [Refer: Property, plant and equipment; Right-of-use assets]" } } }, "auth_ref": [ "r328", "r336" ] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails", "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Property, plant and equipment [member]" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r67", "r265", "r289" ] }, "ifrs-full_ProvisionUsedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProvisionUsedOtherProvisions", "crdr": "debit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Utilized", "label": "Provision used, other provisions" } }, "en": { "role": { "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r97" ] }, "gfs_PurchaseOfInvestmentInMarketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "PurchaseOfInvestmentInMarketableSecurities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of marketable securities", "label": "Purchase Of Investment In Marketable Securities", "documentation": "Purchase Of Investment In Marketable Securities" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of property, plant and equipment and intangible assets", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r269" ] }, "ifrs-full_PurchasesOfGoodsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchasesOfGoodsRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://gf.com/role/RelatedPartyDisclosuresTransactionswithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases and recharges from:", "label": "Purchases of goods, related party transactions" } }, "en": { "role": { "documentation": "The amount of goods purchased by the entity in related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r263" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Range [axis]", "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r151", "r176", "r191", "r284", "r286", "r362" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/ProvisionsNarrativeDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails", "http://gf.com/role/ProvisionsNarrativeDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ranges [member]", "label": "Ranges [member]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r151", "r176", "r191", "r284", "r286", "r362" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ranges of exercise prices for outstanding share options [axis]", "label": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r191" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ranges of exercise prices for outstanding share options [member]", "label": "Ranges of exercise prices for outstanding share options [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "auth_ref": [ "r191" ] }, "ifrs-full_RawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RawMaterials", "crdr": "debit", "calculation": { "http://gf.com/role/InventoriesSummaryofInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/InventoriesSummaryofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and supplies", "label": "Current raw materials" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]" } } }, "auth_ref": [ "r252", "r341" ] }, "ifrs-full_RawMaterialsAndConsumablesUsed": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RawMaterialsAndConsumablesUsed", "crdr": "debit", "calculation": { "http://gf.com/role/CostofRevenueDetails": { "parentTag": "ifrs-full_CostOfSales", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/CostofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory changes materials costs and other", "label": "Raw materials and consumables used" } }, "en": { "role": { "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]" } } }, "auth_ref": [ "r50", "r246" ] }, "gfs_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedCostOfPropertyPlantAndEquipmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedCostOfPropertyPlantAndEquipmentNetOfTax", "crdr": "debit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gains (Losses) Reclassified from Accumulated OCI to cost of Property, Plant and Equipment", "label": "Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Cost Of Property Plant And Equipment, Net Of Tax", "documentation": "Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Cost Of Property Plant And Equipment, Net Of Tax" } } }, "auth_ref": [] }, "gfs_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossDueToMissedForecastNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossDueToMissedForecastNetOfTax", "crdr": "debit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain (Losses) Reclassified into Income (Missed Forecast)", "label": "Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Profit Or Loss Due To Missed Forecast, Net Of Tax", "documentation": "Reclassification Adjustments On Cash Flow Hedges For Which Hedged Item Affected Profit Or Loss Due To Missed Forecast, Net Of Tax" } } }, "auth_ref": [] }, "ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReclassificationAdjustmentsOnCashFlowHedgesForWhichHedgedItemAffectedProfitOrLossNetOfTax", "crdr": "debit", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesEffectonFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts of Gains (Losses) Reclassified from Accumulated OCI into Income (Effective Portion)", "label": "Reclassification adjustments on cash flow hedges for which hedged item affected profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of reclassification adjustments on cash flow hedges for which the hedged item affected profit or loss, net of tax. [Refer: Reclassification adjustments on cash flow hedges, net of tax]" } } }, "auth_ref": [ "r212", "r214" ] }, "gfs_RecognizableDeferredTaxAssetsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "RecognizableDeferredTaxAssetsPercentage", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets realized (as a percent)", "label": "Recognizable Deferred Tax Assets, Percentage", "documentation": "Recognizable Deferred Tax Assets, Percentage" } } }, "auth_ref": [] }, "ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract", "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofDeferredTaxassetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of changes in deferred tax liability (asset) [abstract]", "label": "Reconciliation of changes in deferred tax liability (asset) [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReconciliationOfChangesInOtherProvisionsAbstract", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of changes in other provisions [abstract]", "label": "Reconciliation of changes in other provisions [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract", "presentation": [ "http://gf.com/role/PropertyPlantandEquipmentSummaryofPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of changes in property, plant and equipment [abstract]", "label": "Reconciliation of changes in property, plant and equipment [abstract]" } } }, "auth_ref": [] }, "ifrs-full_RecurringFairValueMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RecurringFairValueMeasurementMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recurring fair value measurement", "label": "Recurring fair value measurement [member]" } }, "en": { "role": { "documentation": "This member stands for fair value measurements which other IFRSs require or permit in the statement of financial position at the end of each reporting period. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r147" ] }, "gfs_RelatedPartyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "RelatedPartyAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related party [Abstract]", "label": "Related party [Abstract]", "documentation": "Related party [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfNoncurrentBorrowings", "crdr": "credit", "presentation": [ "http://gf.com/role/LongTermDebtMovementsinInterestbearingBorrowingsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments", "label": "Repayments of non-current borrowings" } }, "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r354" ] }, "gfs_RepaymentsOfShareholderLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "RepaymentsOfShareholderLoans", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of shareholder loan", "label": "Repayments Of Shareholder Loans", "documentation": "Repayments Of Shareholder Loans" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/ResearchandDevelopmentExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/ResearchandDevelopmentExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expense", "totalLabel": "Research and development expense", "label": "Research and development expense" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r107" ] }, "gfs_ResearchAndDevelopmentExpenseStaffMaintenanceAndUtilityCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ResearchAndDevelopmentExpenseStaffMaintenanceAndUtilityCosts", "crdr": "debit", "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Staff, maintenance, and utility costs", "label": "Research And Development Expense, Staff, Maintenance, And Utility Costs", "documentation": "Research And Development Expense, Staff, Maintenance, And Utility Costs" } } }, "auth_ref": [] }, "gfs_ResearchAndDevelopmentExpensesDepreciationAndAmortisation": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ResearchAndDevelopmentExpensesDepreciationAndAmortisation", "crdr": "debit", "calculation": { "http://gf.com/role/ResearchandDevelopmentExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation of property, plant and equipment and amortization of intangible assets", "label": "Research And development Expenses, Depreciation And Amortisation", "documentation": "Research And development Expenses, Depreciation And Amortisation" } } }, "auth_ref": [] }, "gfs_ResearchAndDevelopmentExpensesStaffCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "ResearchAndDevelopmentExpensesStaffCosts", "crdr": "debit", "calculation": { "http://gf.com/role/ResearchandDevelopmentExpensesDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/ResearchandDevelopmentExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Staff costs, maintenance costs, and utilities", "label": "Research And Development Expenses, Staff Costs", "documentation": "Research And Development Expenses, Staff Costs" } } }, "auth_ref": [] }, "ifrs-full_ReserveOfCashFlowHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfCashFlowHedgesMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Reserve", "label": "Reserve of cash flow hedges [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]" } } }, "auth_ref": [ "r244", "r248" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Reserve and Investments Reserves", "label": "Reserve of exchange differences on translation [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r78", "r248" ] }, "gfs_RestrictedCashMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "RestrictedCashMember", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsReconciliationofAssetsandLiabilitiesArisingfromFinancingActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash [Member]", "documentation": "Restricted Cash" } } }, "auth_ref": [] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs", "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing restricted share units." } } }, "auth_ref": [ "r344" ] }, "gfs_RestrictedShareUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "RestrictedShareUnitsRSUMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Share Units (RSU)", "label": "Restricted Share Units (RSU) [Member]", "documentation": "Restricted Share Units (RSU)" } } }, "auth_ref": [] }, "gfs_RestructuringAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "RestructuringAbstract", "lang": { "en-us": { "role": { "label": "Restructuring [Abstract]", "documentation": "Restructuring [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_RestructuringProvision": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestructuringProvision", "crdr": "credit", "presentation": [ "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Restructuring provision" } }, "en": { "role": { "documentation": "The amount of provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions]" } } }, "auth_ref": [ "r266" ] }, "gfs_RestructuringRollForward": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "RestructuringRollForward", "presentation": [ "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring [Roll Forward]", "label": "Restructuring [Roll Forward]", "documentation": "Restructuring" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained earnings" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r253", "r255" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r6", "r248" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenue", "label": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r41", "r142", "r199", "r230", "r234", "r239", "r240", "r242", "r246", "r247", "r282" ] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationRevenuebyMajorCustomersDetails", "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "verboseLabel": "Revenue from contracts with customers", "label": "Revenue from contracts with customers" } }, "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } } }, "auth_ref": [ "r153", "r154" ] }, "gfs_RevenueFromContractsWithCustomersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "RevenueFromContractsWithCustomersAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contracts with Customers [Abstract]", "label": "Revenue from Contracts with Customers [Abstract]", "documentation": "Revenue from Contracts with Customers [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_RevenueFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromGovernmentGrants", "crdr": "credit", "presentation": [ "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from government grants", "label": "Income from government grants" } }, "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } } }, "auth_ref": [ "r343" ] }, "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod", "crdr": "credit", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesReconciliationofContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash receipts in advance of satisfaction of performance obligations", "label": "Revenue that was included in contract liability balance at beginning of period" } }, "en": { "role": { "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]" } } }, "auth_ref": [ "r156" ] }, "ifrs-full_ReversalOfProvisionsForCostOfRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReversalOfProvisionsForCostOfRestructuring", "crdr": "credit", "presentation": [ "http://gf.com/role/ProvisionsMovementinProvisionforAssetRetirementObligationsDetails", "http://gf.com/role/RestructuringDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts paid", "negatedLabel": "Amounts paid", "label": "Reversal of provisions for cost of restructuring" } }, "en": { "role": { "documentation": "The amount of reversals of provisions for the cost of restructuring. [Refer: Restructuring provision]" } } }, "auth_ref": [ "r49" ] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "presentation": [ "http://gf.com/role/LeasesScheduleofLeaseLiabilitiesDetails", "http://gf.com/role/PropertyPlantandEquipmentNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Right-of-use assets" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r161", "r167" ] }, "gfs_RiskExposureAssociatedWithMajorCustomersConcentrationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "RiskExposureAssociatedWithMajorCustomersConcentrationPercentage", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer concentration risk (as a percent)", "label": "Risk Exposure Associated With Major Customers, Concentration Percentage", "documentation": "Risk Exposure Associated With Major Customers, Concentration Percentage" } } }, "auth_ref": [] }, "gfs_RiskExposureAssociatedWithMajorSuppliersConcentrationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "RiskExposureAssociatedWithMajorSuppliersConcentrationPercentage", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier concentration risk (as a percent)", "label": "Risk Exposure Associated With Major Suppliers, Concentration Percentage", "documentation": "Risk Exposure Associated With Major Suppliers, Concentration Percentage" } } }, "auth_ref": [] }, "country_SG": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "SG", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Republic of Singapore", "label": "SINGAPORE" } } }, "auth_ref": [] }, "currency_SGD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "SGD", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Singapore, Dollars", "label": "Singapore, Dollars" } } }, "auth_ref": [] }, "gfs_SOIWafersMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "SOIWafersMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOI Wafers", "label": "SOI Wafers [Member]", "documentation": "SOI Wafers" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast", "label": "Forecast [Member]" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r312" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r314" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expense", "totalLabel": "Total", "label": "Selling, general and administrative expense" } }, "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } } }, "auth_ref": [ "r332" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofAmortizationExpenseDetails", "http://gf.com/role/GovernmentGrantsLocatedinConsolidatedStatementsofOperationsDetails", "http://gf.com/role/PropertyPlantandEquipmentScheduleofDepreciationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, general and administrative expense [member]" } }, "en": { "role": { "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r323", "r326" ] }, "gfs_SellingGeneralAndAdministrativeExpensesDepreciationAndAmortisation": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "SellingGeneralAndAdministrativeExpensesDepreciationAndAmortisation", "crdr": "debit", "calculation": { "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails": { "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/SellingGeneralandAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation of property, plant and equipment and amortization of intangible assets", "label": "Selling, General And Administrative Expenses, Depreciation And Amortisation", "documentation": "Selling, General And Administrative Expenses, Depreciation And Amortisation" } } }, "auth_ref": [] }, "ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SensitivityAnalysisForEachTypeOfMarketRisk", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Sensitivity analysis for types of market risk", "label": "Sensitivity analysis for types of market risk [text block]" } }, "en": { "role": { "documentation": "The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]" } } }, "auth_ref": [ "r224" ] }, "gfs_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTerm": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardTerm", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term (in years)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Term", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Term" } } }, "auth_ref": [] }, "gfs_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentage", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting percentage", "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Percentage", "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Award Vesting Percentage" } } }, "auth_ref": [] }, "gfs_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period (in years)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementAnnualIncreasePercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementAnnualIncreasePercentage", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual increase percentage", "label": "Share-Based Payment Arrangement, Annual Increase Percentage", "documentation": "Share-Based Payment Arrangement, Annual Increase Percentage" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementCommencementPeriod": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementCommencementPeriod", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commencement period (in years)", "label": "Share-Based Payment Arrangement, Commencement Period", "documentation": "Share-Based Payment Arrangement, Commencement Period" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementEmployeeSubscriptionRate": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementEmployeeSubscriptionRate", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee subscription rate (as a percent)", "label": "Share-Based Payment Arrangement, Employee Subscription Rate", "documentation": "Share-Based Payment Arrangement, Employee Subscription Rate" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementEmployerMatchingContributionPercentOfMatch": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementEmployerMatchingContributionPercentOfMatch", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Matching contribution (as a percent)", "label": "Share-Based Payment Arrangement, Employer Matching Contribution, Percent Of Match", "documentation": "Share-Based Payment Arrangement, Employer Matching Contribution, Percent Of Match" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementLookbackPeriod": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementLookbackPeriod", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lookback period (in years)", "label": "Share-Based Payment Arrangement, Lookback Period", "documentation": "Share-Based Payment Arrangement, Lookback Period" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementMaximumEmployeeSubscriptionShares": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementMaximumEmployeeSubscriptionShares", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum employee subscription (in shares)", "label": "Share-Based Payment Arrangement, Maximum Employee Subscription, Shares", "documentation": "Share-Based Payment Arrangement, Maximum Employee Subscription, Shares" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementMaximumGrantLimit": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementMaximumGrantLimit", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum grant limit (in shares)", "label": "Share-Based Payment Arrangement, Maximum Grant Limit", "documentation": "Share-Based Payment Arrangement, Maximum Grant Limit" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementPerformancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementPerformancePeriod", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, performance period (in years)", "label": "Share-Based Payment Arrangement, Performance Period", "documentation": "Share-Based Payment Arrangement, Performance Period" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementSharesAvailable": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementSharesAvailable", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares available (in shares)", "label": "Share-Based Payment Arrangement, Shares Available", "documentation": "Share-Based Payment Arrangement, Shares Available" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementSharesIssued", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued (in shares)", "label": "Share-Based Payment Arrangement, Shares Issued", "documentation": "Share-Based Payment Arrangement, Shares Issued" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementVestingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementVestingPercentage", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, vesting percentage", "label": "Share-Based Payment Arrangement, Vesting Percentage", "documentation": "Share-Based Payment Arrangement, Vesting Percentage" } } }, "auth_ref": [] }, "gfs_ShareBasedPaymentArrangementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareBasedPaymentArrangementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangements [Abstract]", "label": "Share-based payment arrangements [Abstract]", "documentation": "Share-based payment arrangements [Abstract]" } } }, "auth_ref": [] }, "gfs_ShareCapitalReservesAndOtherEquityInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareCapitalReservesAndOtherEquityInterestAbstract", "lang": { "en-us": { "role": { "label": "Share Capital, Reserves, and Other Equity Interest [Abstract]", "documentation": "Share Capital, Reserves, and Other Equity Interest [Abstract]" } } }, "auth_ref": [] }, "gfs_ShareIncentivePlan2018Member": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "ShareIncentivePlan2018Member", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Incentive Plan 2018", "label": "Share Incentive Plan 2018 [Member]", "documentation": "Share Incentive Plan 2018" } } }, "auth_ref": [] }, "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossBeforeTax", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOTHERCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Share of foreign exchange fluctuation reserve of joint ventures", "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, before tax" } }, "en": { "role": { "documentation": "Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, before tax." } } }, "auth_ref": [ "r44" ] }, "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails", "http://gf.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on sale of East Fishkill (\u201cEFK\u201d) business", "label": "Share of profit (loss) of joint ventures accounted for using equity method" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r332" ] }, "ifrs-full_ShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOptionsMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Options", "label": "Share options [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing share options." } } }, "auth_ref": [ "r344" ] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangements [member]", "label": "Share-based payment arrangements [member]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r192" ] }, "gfs_SingaporeDollarForwardContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "SingaporeDollarForwardContractsMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Singapore dollar forward contracts (receive Singapore$/pay US$)", "label": "Singapore Dollar Forward Contracts [Member]", "documentation": "Singapore Dollar Forward Contracts" } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of changes in equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of changes in equity [line items]", "label": "Statement of changes in equity [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of changes in equity [table]", "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://gf.com/role/GainonSaleofaBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract", "lang": { "en-us": { "role": { "label": "Subclassifications of assets, liabilities and equities [abstract]" } } }, "auth_ref": [] }, "gfs_SupplierNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "SupplierNameAxis", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Name [Axis]", "label": "Supplier Name [Axis]", "documentation": "Supplier Name" } } }, "auth_ref": [] }, "gfs_SupplierNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "SupplierNameDomain", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Name [Domain]", "label": "Supplier Name [Domain]", "documentation": "Supplier Name [Domain]" } } }, "auth_ref": [] }, "gfs_SupplierRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "SupplierRiskMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Risk", "label": "Supplier Risk [Member]", "documentation": "Supplier Risk" } } }, "auth_ref": [] }, "gfs_TaxEffectOfChangeInUncertainTaxPositionLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfChangeInUncertainTaxPositionLiabilities", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impact of change in liability for uncertain tax positions", "label": "Tax Effect Of Change In Uncertain Tax Position Liabilities", "documentation": "Tax Effect Of Change In Uncertain Tax Position Liabilities" } } }, "auth_ref": [] }, "gfs_TaxEffectOfDeductibleExpenseInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfDeductibleExpenseInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deductible expense for tax purpose", "label": "Tax Effect Of Deductible Expense In Determining Taxable Profit (Tax Loss)", "documentation": "Tax Effect Of Deductible Expense In Determining Taxable Profit (Tax Loss)" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Non-deductible expenses for tax purposes", "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } } }, "auth_ref": [ "r54" ] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign tax rate differential", "label": "Tax effect of foreign tax rates" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r54" ] }, "gfs_TaxEffectOfGovernmentGrantsExemptFromTax": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfGovernmentGrantsExemptFromTax", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Government grants exempt from tax", "label": "Tax Effect Of Government Grants Exempt From Tax", "documentation": "Tax Effect Of Government Grants Exempt From Tax" } } }, "auth_ref": [] }, "gfs_TaxEffectOfPriorYearIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfPriorYearIncome", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Adjustments in respect to current income tax of previous years", "label": "Tax Effect Of Prior Year Income", "documentation": "Tax Effect Of Prior Year Income" } } }, "auth_ref": [] }, "gfs_TaxEffectOfUnrecognizedDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfUnrecognizedDeferredTaxAssets", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Impact of unrecognized deferred tax assets", "label": "Tax Effect Of Unrecognized Deferred Tax assets", "documentation": "Tax Effect Of Unrecognized Deferred Tax assets" } } }, "auth_ref": [] }, "gfs_TaxEffectOfWithholdingTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOfWithholdingTaxes", "crdr": "credit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Withholding Tax", "label": "Tax Effect Of Withholding Taxes", "documentation": "Tax Effect Of Withholding Taxes" } } }, "auth_ref": [] }, "gfs_TaxEffectOnForeignExchangeRates": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TaxEffectOnForeignExchangeRates", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Effects of foreign exchange gains (loss)", "label": "Tax Effect On Foreign Exchange Rates", "documentation": "Tax Effect On Foreign Exchange Rates" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax at Enacted Statutory Rate", "label": "Tax expense (income) at applicable tax rate" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r54" ] }, "ifrs-full_TaxRateEffectFromChangeInTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxRateEffectFromChangeInTaxRate", "presentation": [ "http://gf.com/role/IncomeTaxesReconciliationofincometaxexpenseapplyingstatutorytaxandeffectivetaxratesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate", "label": "Tax rate effect from change in tax rate" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r55" ] }, "gfs_TechnologyLicensesAndSimilarRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "TechnologyLicensesAndSimilarRightsMember", "presentation": [ "http://gf.com/role/GoodwillandIntangibleAssetsScheduleofGoodwillandIntangibleAssetsRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Technology, Licenses and Similar Rights", "label": "Technology, Licenses And Similar Rights [Member]", "documentation": "Technology, Licenses And Similar Rights" } } }, "auth_ref": [] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]", "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/IncomeTaxesscheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Temporary difference, unused tax losses and unused tax credits [member]", "label": "Temporary difference, unused tax losses and unused tax credits [member]" } }, "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r59" ] }, "gfs_TenLargestCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "TenLargestCustomersMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ten Largest Customers", "label": "Ten Largest Customers [Member]", "documentation": "Ten Largest Customers" } } }, "auth_ref": [] }, "gfs_TexasMinnesotaVermontNorthCarolinaAndNewJerseyMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "TexasMinnesotaVermontNorthCarolinaAndNewJerseyMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Texas, Minnesota, Vermont, North Carolina, and New Jersey", "label": "Texas, Minnesota, Vermont, North Carolina, And New Jersey [Member]", "documentation": "Texas, Minnesota, Vermont, North Carolina, And New Jersey" } } }, "auth_ref": [] }, "ifrs-full_TimingOfTransferOfGoodsOrServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TimingOfTransferOfGoodsOrServicesAxis", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of transfer of goods or services [axis]", "label": "Timing of transfer of goods or services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_TimingOfTransferOfGoodsOrServicesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TimingOfTransferOfGoodsOrServicesMember", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of revenue recognition:", "label": "Timing of transfer of goods or services [member]" } }, "en": { "role": { "documentation": "This member stands for all timings of the transfer of goods or services in contracts with customers. It also represents the standard value for the 'Timing of transfer of goods or services' axis if no other member is used." } } }, "auth_ref": [ "r288" ] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION", "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables and other current liabilities", "totalLabel": "Total", "label": "Trade and other current payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesAbstract", "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current:", "label": "Trade and other current payables [abstract]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gf.com/role/TradePayablesandOtherLiabilitiesScheduleofNoncurrentandCurrentTradeandOtherPayablesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables", "label": "Current trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r250", "r330" ] }, "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivablesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Trade and other current receivables [abstract]", "label": "Trade and other current receivables [abstract]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedParties", "crdr": "debit", "calculation": { "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails": { "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/ReceivablesPrepaymentsandOtherAssetsSummaryofReceivablesPrepaymentsandOtherAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables from related parties (Note 29)", "label": "Current receivables due from related parties" } }, "en": { "role": { "documentation": "The amount of current receivables due from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 2.0 }, "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Trade and other payables", "terseLabel": "Trade payables and other liabilities", "label": "Trade and other payables" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayablesToTradeSuppliers", "crdr": "credit", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due to supplier", "label": "Trade payables" } }, "en": { "role": { "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business." } } }, "auth_ref": [ "r330" ] }, "ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayablesUndiscountedCashFlows", "crdr": "credit", "calculation": { "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails": { "parentTag": "gfs_DerivativeAndNonDerivativeFinancialLiabilitiesUndiscountedCashFlows", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables and other liabilities", "label": "Trade and other payables, undiscounted cash flows" } }, "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows in relation to trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r301", "r307" ] }, "ifrs-full_TradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivables", "crdr": "debit", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade receivables", "label": "Trade receivables" } }, "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } } }, "auth_ref": [ "r251" ] }, "gfs_TradeTaxGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "TradeTaxGainsLosses", "crdr": "credit", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade tax losses", "label": "Trade Tax Gains (Losses)", "documentation": "Trade Tax Gains (Losses)" } } }, "auth_ref": [] }, "ifrs-full_TradingEquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradingEquitySecuritiesMember", "presentation": [ "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in equity instruments", "label": "Trading equity securities [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that (a) are acquired or incurred principally for the purpose of selling or repurchasing it in the near term; or (b) on initial recognition are part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking." } } }, "auth_ref": [ "r283", "r285" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://gf.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ifrs-full_TypesOfHedgesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesAxis", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Types of hedges [axis]", "label": "Types of hedges [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r207", "r208", "r213" ] }, "ifrs-full_TypesOfHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesMember", "presentation": [ "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedges [member]", "label": "Hedges [member]" } }, "en": { "role": { "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used." } } }, "auth_ref": [ "r207", "r208", "r213" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Types of risks [axis]", "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r177", "r178", "r179", "r181", "r204", "r216", "r217" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://gf.com/role/CustomerAndSupplierConcentrationNarrativeDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesAgingofFinancialassetsDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesForeignCurrencyRiskExposureDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesMaturityofFinancialLiabilitiesDetails", "http://gf.com/role/FinancialRiskManagementObjectivesandPoliciesNarrativeDetails", "http://gf.com/role/OtherFinancialAssetsAndLiabilitiesFinancialAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risks [member]", "label": "Risks [member]" } }, "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r177", "r178", "r179", "r181", "r204", "r216", "r217" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://gf.com/role/ShareBasedCompensationFairValueAssumptionsDetails", "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Types of share-based payment arrangements [axis]", "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r192" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://gf.com/role/CashAndCashEquivalentsConcentrationofCashandCashEquivalentsbyGeographyDetails", "http://gf.com/role/IncomeTaxesNarrativeDetails", "http://gf.com/role/OperatingSegmentsInformationNoncurrentAssetsbyGeographyDetails", "http://gf.com/role/OperatingSegmentsInformationRevenuebyGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States of America", "label": "UNITED STATES" } } }, "auth_ref": [] }, "gfs_USDTermLoanAMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "USDTermLoanAMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "USD Term Loan A", "label": "USD Term Loan A [Member]", "documentation": "USD Term Loan A" } } }, "auth_ref": [] }, "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UndiscountedOperatingLeasePaymentsToBeReceived", "crdr": "debit", "calculation": { "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails": { "parentTag": "gfs_MinimumUndiscountedOperatingLeasePaymentsDue", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/LeasesMaturityofLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum Lease Payments", "label": "Undiscounted operating lease payments to be received" } }, "en": { "role": { "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r171" ] }, "ifrs-full_UndrawnBorrowingFacilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UndrawnBorrowingFacilities", "crdr": "credit", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofUnutilizedCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unutilized borrowing facilities", "label": "Undrawn borrowing facilities" } }, "en": { "role": { "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]" } } }, "auth_ref": [ "r278" ] }, "gfs_UnrecognizedExpenseFromShareBasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "http://gf.com/20231231", "localname": "UnrecognizedExpenseFromShareBasedPaymentTransactionsWithEmployees", "crdr": "debit", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation costs", "label": "Unrecognized Expense From Share-Based Payment Transactions With Employees", "documentation": "Unrecognized Expense From Share-Based Payment Transactions With Employees" } } }, "auth_ref": [] }, "gfs_UnusedCapitalAllowancesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "UnusedCapitalAllowancesMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused Capital Allowances", "label": "Unused Capital Allowances [Member]", "documentation": "Unused Capital Allowances" } } }, "auth_ref": [] }, "gfs_UnusedInvestmentAllowancesMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "UnusedInvestmentAllowancesMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused Investment Allowances", "label": "Unused Investment Allowances [Member]", "documentation": "Unused Investment Allowances" } } }, "auth_ref": [] }, "gfs_UnusedResearchAndDevelopmentTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "UnusedResearchAndDevelopmentTaxCreditsMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused Research and Development Tax Credits", "label": "Unused Research and Development Tax Credits [Member]", "documentation": "Unused Research and Development Tax Credits" } } }, "auth_ref": [] }, "gfs_UnusedTaxCreditsDueToExpireMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "UnusedTaxCreditsDueToExpireMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused Tax Credits Due to Expire", "label": "Unused Tax Credits Due To Expire [Member]", "documentation": "Unused Tax Credits Due To Expire" } } }, "auth_ref": [] }, "ifrs-full_UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized deferred tax asset", "label": "Unused tax credits for which no deferred tax asset recognised" } }, "en": { "role": { "documentation": "The amount of unused tax credits for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax credits [member]]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_UnusedTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxCreditsMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforward", "label": "Unused tax credits [member]" } }, "en": { "role": { "documentation": "This member stands for tax credits that have been received and are carried forward for use against future taxable profit." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforward", "label": "Unused tax losses for which no deferred tax asset recognised" } }, "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_UnusedTaxLossesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxLossesMember", "presentation": [ "http://gf.com/role/IncomeTaxesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused tax losses", "label": "Unused tax losses [member]" } }, "en": { "role": { "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit." } } }, "auth_ref": [ "r59" ] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://gf.com/role/SummaryofMaterialAccountingPoliciesIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Useful life (in years)", "label": "Useful life measured as period of time, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r101" ] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "presentation": [ "http://gf.com/role/CriticalAccountingJudgementsEstimatesandAssumptionsDetails", "http://gf.com/role/SummaryofMaterialAccountingPoliciesScheduleofPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Useful life (in years)", "label": "Useful life measured as period of time, property, plant and equipment" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r61" ] }, "gfs_VariousFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "VariousFinancingMember", "presentation": [ "http://gf.com/role/LongTermDebtSummaryofTermLoanFacilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Various", "label": "Various Financing [Member]", "documentation": "Various Financing" } } }, "auth_ref": [] }, "gfs_WaterFabricationMember": { "xbrltype": "domainItemType", "nsuri": "http://gf.com/20231231", "localname": "WaterFabricationMember", "presentation": [ "http://gf.com/role/NetRevenueDisaggregatedRevenuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Wafer fabrication", "label": "Water Fabrication [Member]", "documentation": "Water Fabrication" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in USD per share)", "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r361" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in USD per share)", "label": "Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r361" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in USD per share)", "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r361" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationRSUandPSUActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in USD per share)", "periodEndLabel": "Outstanding at end of period (in USD per share)", "label": "Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r361" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in dollars per share)", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r189" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollars per share)", "label": "Weighted average exercise price of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r187" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r186" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in dollars per share)", "periodEndLabel": "Ending balance (in dollars per share)", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r184", "r188" ] }, "gfs_WeightedAverageExercisePricePerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gf.com/20231231", "localname": "WeightedAverageExercisePricePerShareAbstract", "presentation": [ "http://gf.com/role/ShareBasedCompensationStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price per Share", "label": "Weighted Average Exercise Price Per Share [Abstract]", "documentation": "Weighted Average Exercise Price Per Share" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://gf.com/role/ShareBasedCompensationNarrativeDetails", "http://gf.com/role/ShareBasedCompensationRangeofExercisePricesOptionsOutstandingandContractualLifeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining contractual life (in years)", "label": "Weighted average remaining contractual life of outstanding share options" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r191" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://gf.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://gf.com/role/EarningsPerShareComputationofBasicandDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average ordinary shares outstanding (in shares)", "label": "Weighted average number of ordinary shares used in calculating basic earnings per share" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r91" ] }, "ifrs-full_WorkInProgress": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WorkInProgress", "crdr": "debit", "calculation": { "http://gf.com/role/InventoriesSummaryofInventoriesDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gf.com/role/InventoriesSummaryofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work in progress", "label": "Current work in progress" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]" } } }, "auth_ref": [ "r252", "r341" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "41", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_41&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_l&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "90", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_90&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_b&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "98", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_b&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "ab", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_ab&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_a&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_d&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18A&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_b&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_e&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_a&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_c&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_e&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "86", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_86&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "39", "IssueDate": "2023-01-01", "Paragraph": "86", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2023-en-r&anchor=para_86_b&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44B", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B_e&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Accounting policies", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS08_g7-31_TI", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "116", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_a&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "116", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_b&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "58", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_58&doctype=Standard", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "51", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Section": "Presentation and disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23A&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24A&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24B&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24E", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24E_a&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.11&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22_c&doctype=Standard", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_b&doctype=Standard", "URIDate": "2023-03-23" }, "r259": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_a&doctype=Standard", "URIDate": "2023-03-23" }, "r260": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2023-03-23" }, "r261": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r262": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r263": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "21", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_a&doctype=Standard", "URIDate": "2023-03-23" }, "r264": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r265": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r266": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r267": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r268": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_e&doctype=Standard", "URIDate": "2023-03-23" }, "r269": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r270": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r271": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_h&doctype=Standard", "URIDate": "2023-03-23" }, "r272": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r273": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r274": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r275": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44B&doctype=Standard", "URIDate": "2023-03-23" }, "r276": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r277": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44D&doctype=Standard", "URIDate": "2023-03-23" }, "r278": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard", "URIDate": "2023-03-23" }, "r279": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2023-03-23" }, "r280": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r281": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r282": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r283": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r284": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r285": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r286": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r287": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r288": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r289": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r290": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r291": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r292": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r293": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r294": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r295": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r296": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r297": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r298": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r299": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11D", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r300": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11D", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11D_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r301": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11D&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r302": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r303": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r304": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r305": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r306": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG20D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r307": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r308": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG40B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r309": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r310": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r316": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r317": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r318": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r320": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r321": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80&doctype=Standard", "URIDate": "2023-03-23" }, "r334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_a&doctype=Standard", "URIDate": "2023-03-23" }, "r337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2023-03-23" }, "r340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "5", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_5&doctype=Standard", "URIDate": "2023-03-23" }, "r341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2023-03-23" }, "r344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2023-03-23" }, "r346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard", "URIDate": "2023-03-23" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expired 2023-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_112_c&doctype=Standard&forcepdf=true", "URIDate": "2023-03-23" } } } ZIP 176 0001709048-24-000013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001709048-24-000013-xbrl.zip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�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�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�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